1 00:00:05,000 --> 00:00:09,240 >>GOOD MORNING, EVERYONE. 2 00:00:09,240 --> 00:00:15,280 THIS IS SAMIA NOURSI AND THE 3 00:00:15,280 --> 00:00:19,360 EXECUTIVE SECRETARY OF THIS 4 00:00:19,360 --> 00:00:21,640 COMMITTEE. 5 00:00:21,640 --> 00:00:23,960 WE ARE WAITING FOR A FEW MORE 6 00:00:23,960 --> 00:00:25,880 MEMBERS SO WE CAN HAVE A FORUM 7 00:00:25,880 --> 00:00:28,360 TO START THIS MEETING. 8 00:00:28,360 --> 00:00:29,840 WE WILL START SHORTLY. 9 00:00:29,840 --> 00:00:33,600 >>GOOD MORNING, SARAH AND 10 00:00:33,600 --> 00:00:34,760 SAMIA. 11 00:00:34,760 --> 00:00:35,880 IT'S JUDY. 12 00:00:35,880 --> 00:00:37,200 >>Samia Noursi: GOOD MORNING, 13 00:00:37,200 --> 00:00:47,320 JUDY. 14 00:01:05,840 --> 00:01:06,400 >>Samia Noursi: WE'RE STARTING 15 00:01:06,400 --> 00:01:07,520 THE MEETING. 16 00:01:07,520 --> 00:01:10,000 AS I MENTIONED, I WOULD LIKE TO 17 00:01:10,000 --> 00:01:12,840 CALL TO ORDER THE 58th MEETING 18 00:01:12,840 --> 00:01:14,880 OF THE NIH ADVISORY COMMITTEE ON 19 00:01:14,880 --> 00:01:18,160 RESEARCH AND WOMAN'S HEALTH. 20 00:01:18,160 --> 00:01:21,120 I'M SAMIA NOURSI FOR SCIENCE 21 00:01:21,120 --> 00:01:23,240 POLICY AND PLANNING AND ANNAL IS 22 00:01:23,240 --> 00:01:24,880 SIS AND THE EXECUTIVE SECRETARY 23 00:01:24,880 --> 00:01:26,640 OF THIS COMMITTEE. 24 00:01:26,640 --> 00:01:28,720 THIS MEETING IS OPEN TO THE 25 00:01:28,720 --> 00:01:31,640 PUBLIC VIA LIVE BROADCAST ON THE 26 00:01:31,640 --> 00:01:37,640 NIH VIDEO CAST NETWORK AND IT'S 27 00:01:37,640 --> 00:01:40,120 BEING RECORD FORWARD OUR OR 28 00:01:40,120 --> 00:01:41,840 KIVES AND FUTURE DEMAND BY THE 29 00:01:41,840 --> 00:01:42,400 PUBLIC. 30 00:01:42,400 --> 00:01:45,160 IF YOU WILL REMEMBER OF THE 31 00:01:45,160 --> 00:01:47,960 PUBLIC, FOR THE FEDERAL REGISTER 32 00:01:47,960 --> 00:01:49,360 NOTICE, YOU MAY SUBMIT YOUR 33 00:01:49,360 --> 00:01:57,200 QUESTIONS IN WRITING TO ME YOU 34 00:01:57,200 --> 00:02:01,440 WILL RECEIVE A RESPONSE FROM ME 35 00:02:01,440 --> 00:02:04,680 CORRECTLY. 36 00:02:04,680 --> 00:02:06,680 WE ARE PARTICIPATING REMOTELY. 37 00:02:06,680 --> 00:02:09,560 THEY ARE PARTICIPATING THROUGH 38 00:02:09,560 --> 00:02:09,760 ZOOM. 39 00:02:09,760 --> 00:02:12,720 NOW I'M TURNING TO OUR MEMBERS. 40 00:02:12,720 --> 00:02:14,600 AS MEMBERS OF THIS FEDERAL 41 00:02:14,600 --> 00:02:16,400 ADVISORY COMMITTEE, YOU ARE 42 00:02:16,400 --> 00:02:20,960 SPECIAL GOVERNMENT EMPLOYEES. 43 00:02:20,960 --> 00:02:22,200 SEGs WHICH MEANS YOU ARE 44 00:02:22,200 --> 00:02:23,960 SUBJECT TO THE SAME ETHIC RULES 45 00:02:23,960 --> 00:02:25,520 THAT APPLY TO GOVERNMENT 46 00:02:25,520 --> 00:02:26,360 EMPLOYEES. 47 00:02:26,360 --> 00:02:28,800 THESE RULES ARE DESCRIBED IN THE 48 00:02:28,800 --> 00:02:31,360 PAMPHLET EP TITLED "STANDARDS OF 49 00:02:31,360 --> 00:02:33,040 ETHICAL CONDUCT FOR EMPLOYEES OF 50 00:02:33,040 --> 00:02:34,800 THE EXECUTIVE BRANCH." 51 00:02:34,800 --> 00:02:37,080 YOU RECEIVE THE COPY OF THIS 52 00:02:37,080 --> 00:02:41,080 DOCUMENT WHEN YOU WERE APPOIN 53 00:02:41,080 --> 00:02:51,280 APPOINTED. 54 00:02:51,560 --> 00:02:53,040 YOU RECEIVED A COPY OF THIS 55 00:02:53,040 --> 00:02:54,920 DOCUMENT WHEN YOU WERE 56 00:02:54,920 --> 00:02:55,160 APPOINTED. 57 00:02:55,160 --> 00:02:57,000 AT EVERY MEETING, WE LIKE TO 58 00:02:57,000 --> 00:02:59,360 REVIEW THE STEPS WE TAKE AND THE 59 00:02:59,360 --> 00:03:01,840 PROCESS WE FOLLOW TO IDENTIFY 60 00:03:01,840 --> 00:03:04,600 AND ADDRESS ANY CONFLICTS 61 00:03:04,600 --> 00:03:06,400 BETWEEN THE PUBLIC 62 00:03:06,400 --> 00:03:08,280 RESPONSIBILITIES AND YOUR 63 00:03:08,280 --> 00:03:09,480 PRIVATE INTERESTS. 64 00:03:09,480 --> 00:03:11,480 AS YOU KNOW, BEFORE EVERY 65 00:03:11,480 --> 00:03:13,800 MEETING, YOU PROVIDE US WITH A 66 00:03:13,800 --> 00:03:16,120 GREAT DEAL OF INFORMATION ABOUT 67 00:03:16,120 --> 00:03:18,480 YOUR PROFESSIONAL, PERSONAL AND 68 00:03:18,480 --> 00:03:20,280 FINANCIAL INTERESTS. 69 00:03:20,280 --> 00:03:22,440 WE USE THIS INFORMATION AS THE 70 00:03:22,440 --> 00:03:23,760 FOUNDATION FOR ASSESSING WHETHER 71 00:03:23,760 --> 00:03:26,760 YOU HAVE ANY REAL, POTENTIAL, OR 72 00:03:26,760 --> 00:03:28,360 APPARENT CONFLICTS OF INTEREST 73 00:03:28,360 --> 00:03:29,840 THAT COULD COMPROMISE YOUR 74 00:03:29,840 --> 00:03:31,840 ABILITY TO BE OBJECTIVE IN 75 00:03:31,840 --> 00:03:36,080 GIVING AT VICE DURING EXIT' 76 00:03:36,080 --> 00:03:42,720 MEETINGS. 77 00:03:42,720 --> 00:03:44,720 WE HAVE IDENTIFIED WE WOULD 78 00:03:44,720 --> 00:03:46,320 ISSUE YOU A WAIVER OR RECUSE YOU 79 00:03:46,320 --> 00:03:48,760 FROM A PARTICULAR PORTION OF THE 80 00:03:48,760 --> 00:03:49,600 MEETING. 81 00:03:49,600 --> 00:03:51,520 WE USUALLY WAVE CONFLICTS OF 82 00:03:51,520 --> 00:03:53,320 INTEREST FOR GENERAL MATTERS 83 00:03:53,320 --> 00:03:54,640 BECAUSE WE BELIEVE YOUR ABILITY 84 00:03:54,640 --> 00:03:56,920 TO BE OBJECTIVE WILL NOT BE 85 00:03:56,920 --> 00:03:58,800 EFFECTED BY YOUR FINANCIAL 86 00:03:58,800 --> 00:03:59,560 INTERESTS. 87 00:03:59,560 --> 00:04:01,680 WE ALSO RELY A GREAT DEAL ON 88 00:04:01,680 --> 00:04:02,200 YOU. 89 00:04:02,200 --> 00:04:04,040 YOU NEED TO BE ATTENTIVE DURING 90 00:04:04,040 --> 00:04:06,000 MEETINGS TO THE POSSIBILITY THAT 91 00:04:06,000 --> 00:04:07,800 AN ISSUE COULD ARISE THAT COULD 92 00:04:07,800 --> 00:04:12,680 EFFECT OUR APPEAR TO EFFECT YOUR 93 00:04:12,680 --> 00:04:15,240 FINANCIAL INTERESTS WITH RESPECT 94 00:04:15,240 --> 00:04:16,960 TO A SPECIFIC PARTY OR MATTER. 95 00:04:16,960 --> 00:04:18,880 YOU WILL BE ASKED TO RECUSE 96 00:04:18,880 --> 00:04:19,680 YOURSELF FROM THAT PORTION OF 97 00:04:19,680 --> 00:04:22,400 THE MEETING. 98 00:04:22,400 --> 00:04:26,000 BEFORE INTRODUCTION, I WILL 99 00:04:26,000 --> 00:04:26,920 BRIEFLY REVIEW BEST PRACTICES 100 00:04:26,920 --> 00:04:29,400 FOR OUR ZOOM PARTICIPANTS. 101 00:04:29,400 --> 00:04:31,080 PLEASE MUTE YOUR MIC IF YOU ARE 102 00:04:31,080 --> 00:04:32,280 NOT SPEAKING. 103 00:04:32,280 --> 00:04:36,120 YOU CAN LEAVE YOUR CAMERA ON, WE 104 00:04:36,120 --> 00:04:36,480 HAVE BANDWIDTH. 105 00:04:36,480 --> 00:04:38,520 STATE YOUR NAME BEFORE MAKING 106 00:04:38,520 --> 00:04:42,200 COMMENTS AND MOTIONS OR 107 00:04:42,200 --> 00:04:43,880 RECOMMENDATIONS INTRODUCE TO USE 108 00:04:43,880 --> 00:04:45,600 A HEAD SEAT AND IT WILL RESULT 109 00:04:45,600 --> 00:04:47,760 IN THE CLEARER SOUND AND PROVIDE 110 00:04:47,760 --> 00:04:50,080 THE LEAST AMOUNT OF AUDIO 111 00:04:50,080 --> 00:04:50,680 FEEDBACK. 112 00:04:50,680 --> 00:04:52,080 IF APPROXIMATE YOU HAVE A 113 00:04:52,080 --> 00:04:53,360 QUESTION, OR WOULD LIKE TO MAKE 114 00:04:53,360 --> 00:04:55,400 A COMMENT, PLEASE UTILIZE THE 115 00:04:55,400 --> 00:04:57,520 CHAT FEATURE. 116 00:04:57,520 --> 00:04:58,840 THE ZOOM CHAT WILL BE KEPT AS 117 00:04:58,840 --> 00:05:00,840 PART OF THE OFFICIAL MEETING 118 00:05:00,840 --> 00:05:01,800 RECORD. 119 00:05:01,800 --> 00:05:04,520 REMINDER THAT YOU WILL BE 120 00:05:04,520 --> 00:05:06,520 PRESENTING TWO CONCEPT 121 00:05:06,520 --> 00:05:08,320 CLEARANCES IN THE AFTER SO YOU 122 00:05:08,320 --> 00:05:11,000 HOPE THAT YOU WILL BE IN 123 00:05:11,000 --> 00:05:12,280 ATTENDANCE FOR THE VOTES. 124 00:05:12,280 --> 00:05:15,080 WE'LL UTILIZE THE SAMPLE 125 00:05:15,080 --> 00:05:16,040 FUNCTION FOR THAT PURPOSE AND 126 00:05:16,040 --> 00:05:17,800 DURING THE VOTE, MULTIPLE CHOICE 127 00:05:17,800 --> 00:05:19,840 PORTION WILL DISPLAY ON YOUR 128 00:05:19,840 --> 00:05:20,320 SCREEN. 129 00:05:20,320 --> 00:05:21,800 AND WE WOULD LIKE YOU TO SELECT 130 00:05:21,800 --> 00:05:23,920 THE NEW RESPONSE AND CLICK 131 00:05:23,920 --> 00:05:26,800 SUBMIT BUT WE'LL GET TO THAT 132 00:05:26,800 --> 00:05:27,000 LATER. 133 00:05:27,000 --> 00:05:28,800 AS I GO THROUGH THE ROSTER, WHEN 134 00:05:28,800 --> 00:05:30,760 YOU HEAR YOUR NAME, UNMUTE YOUR 135 00:05:30,760 --> 00:05:32,600 MIC AND INTRODUCE YOURSELVES. 136 00:05:32,600 --> 00:05:36,920 BY NAME AND WHAT INSTITUTION YOU 137 00:05:36,920 --> 00:05:37,320 PRESENT. 138 00:05:37,320 --> 00:05:42,720 Dr. ANDERSON. 139 00:05:42,720 --> 00:05:46,000 GOOD MORNING, EVERYONE, GARNET 140 00:05:46,000 --> 00:05:49,400 ANDERSON FROM HUTCHINSON CANCER 141 00:05:49,400 --> 00:05:50,240 CENTER. 142 00:05:50,240 --> 00:05:57,280 >>Samia Noursi: Dr. ANINA. 143 00:05:57,280 --> 00:05:58,960 >>GOOD MORNING. 144 00:05:58,960 --> 00:06:00,680 IRENE FROM SOCIETY FOR WOMEN'S 145 00:06:00,680 --> 00:06:01,480 HEALTH RESEARCH. 146 00:06:01,480 --> 00:06:03,320 >>Samia Noursi: THANK YOU, VERY 147 00:06:03,320 --> 00:06:06,280 MUCH. 148 00:06:06,280 --> 00:06:10,200 Dr. BRIEGAL. 149 00:06:10,200 --> 00:06:11,320 >>Dr. HIGGINS. 150 00:06:11,320 --> 00:06:13,880 >>STEVE HIGGINS FROM THE 151 00:06:13,880 --> 00:06:14,720 UNIVERSITY OF VERMONT. 152 00:06:14,720 --> 00:06:17,640 >>Samia Noursi: THANK YOU. 153 00:06:17,640 --> 00:06:18,200 Dr. JAGSI. 154 00:06:18,200 --> 00:06:22,160 >>HELLO, RASH MA JAGSI FROM 155 00:06:22,160 --> 00:06:23,840 EMERY UNIVERSITY IN ATLANTA. 156 00:06:23,840 --> 00:06:25,240 >>Samia Noursi: Dr. 157 00:06:25,240 --> 00:06:25,480 McGREGOR. 158 00:06:25,480 --> 00:06:27,520 >>HI, ALISON McGREGOR FROM 159 00:06:27,520 --> 00:06:30,080 UNIVERSITY OF SOUTH CAROLINA 160 00:06:30,080 --> 00:06:30,400 GREENVILLE. 161 00:06:30,400 --> 00:06:32,280 >>Samia Noursi: THANK YOU. 162 00:06:32,280 --> 00:06:32,760 Dr. MILLANCE. 163 00:06:32,760 --> 00:06:35,680 >>GOOD MORNING, THELMA MILLANCE 164 00:06:35,680 --> 00:06:36,600 FROM COLOMBIA UNIVERSITY. 165 00:06:36,600 --> 00:06:40,040 >>Samia Noursi: THANK YOU. 166 00:06:40,040 --> 00:06:40,680 Dr. NOEL. 167 00:06:40,680 --> 00:06:50,880 >>GOOD MORNING, EVERYONE. 168 00:06:50,880 --> 00:06:52,520 Dr. NOEL LOUISIANA STATE 169 00:06:52,520 --> 00:06:53,000 UNIVERSITY. 170 00:06:53,000 --> 00:06:53,720 >>Samia Noursi: Dr. JONES. 171 00:06:53,720 --> 00:06:55,480 >>GOOD MORNING, EVERYONE. 172 00:06:55,480 --> 00:06:57,840 ANDRE JONES FROM UNIVERSITY OF 173 00:06:57,840 --> 00:06:59,440 NORTH CAROLINE CHAPEL HILL. 174 00:06:59,440 --> 00:07:00,040 >>Samia Noursi: THANK YOU. 175 00:07:00,040 --> 00:07:03,600 Dr. ROBINSON. 176 00:07:03,600 --> 00:07:07,040 >>GOOD MORNING, EVERYBODY, 177 00:07:07,040 --> 00:07:08,120 MICHELLE ROB I AM SON UNIVERSITY 178 00:07:08,120 --> 00:07:10,560 OF ALABAMA AT BIRMINGHAM. 179 00:07:10,560 --> 00:07:12,280 >>Samia Noursi: THANK YOU. 180 00:07:12,280 --> 00:07:17,760 Dr>>JUDY FROM THE UNIVERSITY OF 181 00:07:17,760 --> 00:07:19,000 COLORADO MEDICAL CAMPUS. 182 00:07:19,000 --> 00:07:20,440 >>Samia Noursi: THANK YOU. 183 00:07:20,440 --> 00:07:22,240 Dr. SADOFSKY. 184 00:07:22,240 --> 00:07:26,080 >>FROM WOMEN'S RESEARCH 185 00:07:26,080 --> 00:07:29,120 INSTITUTE AT UNIVERSITY EVER 186 00:07:29,120 --> 00:07:30,440 PITTSBURGH. 187 00:07:30,440 --> 00:07:31,040 >>Samia Noursi: Dr. SHARP. 188 00:07:31,040 --> 00:07:32,280 >>WILL NOT BE JOINING TODAY. 189 00:07:32,280 --> 00:07:34,640 >>Dr. SIMON. 190 00:07:34,640 --> 00:07:36,800 >>Dr. SIMON HAS NOT JOINED US 191 00:07:36,800 --> 00:07:36,960 YET. 192 00:07:36,960 --> 00:07:37,560 >>Samia Noursi: THANK YOU. 193 00:07:37,560 --> 00:07:39,600 AND Dr. TEMPLETON. 194 00:07:39,600 --> 00:07:41,920 >>GOOD MORNING, KIM TEMPLETON 195 00:07:41,920 --> 00:07:43,280 AMERICAN MEDICAL WOMEN'S 196 00:07:43,280 --> 00:07:44,120 ASSOCIATION AND THE UNIVERSITY 197 00:07:44,120 --> 00:07:45,960 OF KANSAS AND KANSAS CITY. 198 00:07:45,960 --> 00:07:46,800 >>Samia Noursi: THANK YOU, 199 00:07:46,800 --> 00:07:47,080 EVERYONE. 200 00:07:47,080 --> 00:07:48,720 WE WERE ONE MORE HOUSEKEEPING 201 00:07:48,720 --> 00:07:55,600 ITEM TO TAKE CARE OF YOU HAVE 202 00:07:55,600 --> 00:07:57,640 THE MINUTES FROM OCTOBER 18th, 203 00:07:57,640 --> 00:08:00,120 2022 FOR YOUR REVIEW. 204 00:08:00,120 --> 00:08:01,400 IS THERE A MOTION ON THE TABLE 205 00:08:01,400 --> 00:08:03,880 TO ACCEPT THE OCTOBER 18th, 206 00:08:03,880 --> 00:08:04,520 2022 MINUTES AS WRITTEN. 207 00:08:04,520 --> 00:08:06,040 >>I MOVE TO ACCEPT THOSE 208 00:08:06,040 --> 00:08:07,560 MINUTES AS WRITTEN. 209 00:08:07,560 --> 00:08:09,560 >>Samia Noursi: THANK YOU. 210 00:08:09,560 --> 00:08:12,000 Dr. RAGGENSTEINER HAS THE 211 00:08:12,000 --> 00:08:13,320 MOTION DO I HEAR A SECOND. 212 00:08:13,320 --> 00:08:14,640 >>SECOND. 213 00:08:14,640 --> 00:08:15,720 >>Samia Noursi: WHO IS THAT? 214 00:08:15,720 --> 00:08:17,920 >>Dr. JAGSI. 215 00:08:17,920 --> 00:08:18,720 >>Samia Noursi: THANK YOU, 216 00:08:18,720 --> 00:08:20,520 Dr. JAGSI. 217 00:08:20,520 --> 00:08:22,400 Dr. JAGSI HAS SECONDED THE 218 00:08:22,400 --> 00:08:24,040 MOTION. 219 00:08:24,040 --> 00:08:25,480 THE POLL HAS BEEN OPEN TO 220 00:08:25,480 --> 00:08:27,360 RESPOND IF YOU ARE IN FAVOR, 221 00:08:27,360 --> 00:08:30,520 OPPOSED OR ABSTAIN. 222 00:08:30,520 --> 00:08:40,840 YOU HAVE 30 SECONDS. 223 00:09:00,760 --> 00:09:01,400 >>Samia Noursi: HAVE THE VOTES 224 00:09:01,400 --> 00:09:02,040 BEEN RECORDED. 225 00:09:02,040 --> 00:09:04,760 >>YES WITH 12 IN FAVOR. 226 00:09:04,760 --> 00:09:05,280 >>Samia Noursi: GREAT. 227 00:09:05,280 --> 00:09:05,640 THANK YOU. 228 00:09:05,640 --> 00:09:08,560 THE OCTOBER 18th, 2022 MEETING 229 00:09:08,560 --> 00:09:10,440 MINUTES HAVE BEEN ACCEPTED WITH 230 00:09:10,440 --> 00:09:16,400 12 IN FAVOR. 231 00:09:16,400 --> 00:09:17,720 NOW I WOULD LIKE TO INTRODUCE 232 00:09:17,720 --> 00:09:19,920 THE CHAIR Dr. JANINE CLAYTON. 233 00:09:19,920 --> 00:09:24,120 Dr. CLAYTON -- 234 00:09:24,120 --> 00:09:27,080 >>Janine A. Clayton: THANK YOU, 235 00:09:27,080 --> 00:09:28,680 Dr. NOURSI AND I'M EXCITED TO 236 00:09:28,680 --> 00:09:32,520 BE HERE WITH YOU ALL TODAY. 237 00:09:32,520 --> 00:09:42,960 I WILL BE RIGHT WITH YOU. 238 00:09:51,360 --> 00:09:52,680 GOOD MORNING, EVERYONE. 239 00:09:52,680 --> 00:09:55,400 IT'S MY PLEASURE TO BRING THE 240 00:09:55,400 --> 00:09:56,960 ORWH DIRECTOR'S REPORT TO YOU 241 00:09:56,960 --> 00:09:59,920 AND I'M GOING TO COVER THE SIX 242 00:09:59,920 --> 00:10:02,800 YEARS JUST BRIEFLY OPENING 243 00:10:02,800 --> 00:10:04,720 UPDATES ON NIH, FUNDING BUDGET 244 00:10:04,720 --> 00:10:06,840 AND LEGISLATIVE INFORMATION, 245 00:10:06,840 --> 00:10:08,960 POLICY AND SCIENTIFIC 246 00:10:08,960 --> 00:10:09,600 INFORMATION. 247 00:10:09,600 --> 00:10:11,200 I'LL DESCRIBE SOME OF OUR 248 00:10:11,200 --> 00:10:12,320 COLLABORATIONS WITH THE NIH 249 00:10:12,320 --> 00:10:14,320 INSTITUTE CENTERS AND OFFICES OR 250 00:10:14,320 --> 00:10:16,000 ICOs AND GIVE YOU A BRIEF 251 00:10:16,000 --> 00:10:19,280 UPDATE ON CAREERS AND THEN I 252 00:10:19,280 --> 00:10:20,040 WILL CLOSE. 253 00:10:20,040 --> 00:10:23,600 BEFORE WE BEGIN, OUR FORMAL 254 00:10:23,600 --> 00:10:25,760 REMARKS, I DID WANT TO PROVIDE 255 00:10:25,760 --> 00:10:28,000 REMARKS REGARDING THE RECENT 256 00:10:28,000 --> 00:10:30,960 PASSING OF CONGRESSWOMAN 257 00:10:30,960 --> 00:10:33,480 PATRICIA SCHROEDER. 258 00:10:33,480 --> 00:10:36,360 PAT SCHROEDER WAS A LONG-TIME 259 00:10:36,360 --> 00:10:38,240 CONGRESSWOMAN OVER TWO DECADES 260 00:10:38,240 --> 00:10:40,720 AND A PIONEER FOR WOMEN AND 261 00:10:40,720 --> 00:10:42,480 POLITICS. 262 00:10:42,480 --> 00:10:45,480 CONGRESSWOMAN SCHROEDER WAS A CO 263 00:10:45,480 --> 00:10:46,800 RESPONSE OVERTIME WOMEN'S HEALTH 264 00:10:46,800 --> 00:10:49,080 EQUITY ACT OF 1990 THAT CREATED 265 00:10:49,080 --> 00:10:51,360 THE NIH WOMEN OF RESEARCH. 266 00:10:51,360 --> 00:10:53,040 SHE'S NEAR AND DEAR TO OUR 267 00:10:53,040 --> 00:10:54,320 HEARTS. 268 00:10:54,320 --> 00:10:55,880 ORWH WAS ESTABLISHED TO EXPAND 269 00:10:55,880 --> 00:10:57,400 WOMEN'S HEALTH RESEARCH AT NIH 270 00:10:57,400 --> 00:11:00,080 AND INCORPORATE IT IN OUR 271 00:11:00,080 --> 00:11:01,400 MISSION FROM THE OUTSET WAS 272 00:11:01,400 --> 00:11:03,800 EFFORTS RELATED TO RECRUITMENT, 273 00:11:03,800 --> 00:11:05,320 RETENTION AND ADVANCEMENT OF 274 00:11:05,320 --> 00:11:06,640 WOMEN AND SCIENCE CAREERS. 275 00:11:06,640 --> 00:11:08,320 SHE WAS THE FIRST WOMAN ELECTED 276 00:11:08,320 --> 00:11:12,160 IN THE COLORADO STATE 277 00:11:12,160 --> 00:11:13,960 LEGISLATURE TO SERVE ON THE 278 00:11:13,960 --> 00:11:15,520 HOUSE ARMED SERVICES COMMITTEE 279 00:11:15,520 --> 00:11:17,160 AND THE FIRST WOMAN TO BE 280 00:11:17,160 --> 00:11:20,640 INDUCTED INTO THE NATIONAL 281 00:11:20,640 --> 00:11:24,160 WOMEN'S HEALTH. 282 00:11:24,160 --> 00:11:26,040 I'M GOING TO PULL ONE OF HER 283 00:11:26,040 --> 00:11:27,800 QUOTES HERE BECAUSE I THINK IT 284 00:11:27,800 --> 00:11:32,120 IS CERTAI APP RA PO. 285 00:11:32,120 --> 00:11:33,680 WE NEED TO MAKE SURE THAT WOMEN 286 00:11:33,680 --> 00:11:35,960 HAVE ACCESS TO QUALITY 287 00:11:35,960 --> 00:11:36,680 HEALTHCARE. 288 00:11:36,680 --> 00:11:38,320 WOMEN'S HEALTH IS IMPORTANT AND 289 00:11:38,320 --> 00:11:40,000 WE NEED TO MAKE SURE THAT WOMEN 290 00:11:40,000 --> 00:11:44,680 HAVE THE CARE THAT THEY NEED. 291 00:11:44,680 --> 00:11:48,760 IMPACT IS OFTEN SOMETHING THAT 292 00:11:48,760 --> 00:11:51,600 WE THINK ABOUT MAYBE NOT A DAILY 293 00:11:51,600 --> 00:11:56,640 BASIS BUT SHE HAD AN IMPACT. 294 00:11:56,640 --> 00:11:57,720 RIPPLE IN THE POND. 295 00:11:57,720 --> 00:12:01,320 THE STONE THAT'S THROWN INTO THE 296 00:12:01,320 --> 00:12:01,960 LAKE. 297 00:12:01,960 --> 00:12:02,880 AND THE WAVE THAT CRASHES 298 00:12:02,880 --> 00:12:03,480 THROUGH THE SHORE. 299 00:12:03,480 --> 00:12:06,880 I AM THE CHANGE THAT YOU CAN'T 300 00:12:06,880 --> 00:12:07,480 SEE. 301 00:12:07,480 --> 00:12:08,600 THE FORCE THAT PICKS THINGS 302 00:12:08,600 --> 00:12:15,680 MAKES THINGS HAPPEN.KONG RUSS WA 303 00:12:15,680 --> 00:12:17,120 SCHROEDER HAD A PRO FOUND IMPACT 304 00:12:17,120 --> 00:12:20,520 ON WOMEN'S HEALTH. 305 00:12:20,520 --> 00:12:24,280 AND AS I MOVE ON, I LIKE TO 306 00:12:24,280 --> 00:12:25,600 INCLUDE DATA IN ALL OF MY 307 00:12:25,600 --> 00:12:26,920 PRESENTATIONS AND I PROMISED 308 00:12:26,920 --> 00:12:28,400 THERE WON'T BE TOO MUCH DATA BUT 309 00:12:28,400 --> 00:12:30,480 I WANT TO HAVE THIS RIGHT UP 310 00:12:30,480 --> 00:12:31,920 FRONT AND THIS INFORMATION IS 311 00:12:31,920 --> 00:12:36,720 FROM THE WOMEN'S W.H.O. 2023 312 00:12:36,720 --> 00:12:38,520 REPORT AND THIS LOOKED AT 313 00:12:38,520 --> 00:12:40,320 COUNTRIES AND TERRITORIES AROUND 314 00:12:40,320 --> 00:12:45,360 THE WORLD FROM 2000 TO 2020. 315 00:12:45,360 --> 00:12:48,800 THIS DATA IS ON MATERNAL 316 00:12:48,800 --> 00:12:49,960 MORTALITY. 317 00:12:49,960 --> 00:12:52,960 2000 IS THE DARK BLUE AND 2020 318 00:12:52,960 --> 00:12:55,040 IS THE KEEL COLOR AND YOU CAN 319 00:12:55,040 --> 00:12:57,000 SEE IN THESE REGIONS WITH A 320 00:12:57,000 --> 00:12:59,880 REDUCTION OF MATERNAL MORTALITY 321 00:12:59,880 --> 00:13:01,200 NORTHERN, SOUTHERN AND WESTERN 322 00:13:01,200 --> 00:13:03,560 EUROPE WITH MORE MODEST 323 00:13:03,560 --> 00:13:13,760 REDUCTIONS AND NORTH AMERICA AND 324 00:13:13,760 --> 00:13:15,320 THIS IN CONTRAST TO OUR 325 00:13:15,320 --> 00:13:17,080 COMPARABLE REGIONS. 326 00:13:17,080 --> 00:13:19,200 HERE IS ANOTHER SET OF DATA THAT 327 00:13:19,200 --> 00:13:22,800 I DO WANT TO SHARE WITH YOU AND 328 00:13:22,800 --> 00:13:23,560 THIS IS THE COMMODITIES FUNDS 329 00:13:23,560 --> 00:13:27,280 AND IT LOOKS AT HIGH INCOME 330 00:13:27,280 --> 00:13:28,440 COUNTRIES AND DESCRIBES A 331 00:13:28,440 --> 00:13:34,040 VARIETY OF IMPORTANT PARAMETERS. 332 00:13:34,040 --> 00:13:38,240 THE U.S. HAS THE LOWEST LIFE 333 00:13:38,240 --> 00:13:40,760 EXPECTANT' AND THE HIGHEST 334 00:13:40,760 --> 00:13:42,400 MATERNAL INFANT MORTALITY RATES 335 00:13:42,400 --> 00:13:43,760 AMONG HIGH INCOME COUNTRIES IN 336 00:13:43,760 --> 00:13:44,440 THE WORLD. 337 00:13:44,440 --> 00:13:46,280 ALSO THE HIGHEST RATE OF 338 00:13:46,280 --> 00:13:50,320 INDIVIDUALS WITH MULTIPLE 339 00:13:50,320 --> 00:14:00,840 CHRONIC CONDITIONS AND IS ONE OF 340 00:14:05,440 --> 00:14:06,680 THE GOOD POINTS IS THE U.S. HAD 341 00:14:06,680 --> 00:14:10,640 HIGH SCREENING RATES FOR BREAST 342 00:14:10,640 --> 00:14:12,280 AND COLORECTAL CANCER AND HIGH 343 00:14:12,280 --> 00:14:21,880 VACCINATION RATES FOR THE FLU. 344 00:14:21,880 --> 00:14:25,080 THE RATES ARE VERY, VERY 345 00:14:25,080 --> 00:14:25,880 DISTURBING. 346 00:14:25,880 --> 00:14:27,320 THE ADVISORY COMMITTEE FOR 347 00:14:27,320 --> 00:14:28,560 RESEARCH ON WOMEN'S HEALTH 348 00:14:28,560 --> 00:14:30,520 PLAYED A CRITICAL ROLE IN 349 00:14:30,520 --> 00:14:32,400 ORGANIZING, CONDUCTING, AND 350 00:14:32,400 --> 00:14:34,080 SUMMARIZING THE WOMEN'S HEALTH 351 00:14:34,080 --> 00:14:37,000 CONFERENCE OF 2021, ADVANCING 352 00:14:37,000 --> 00:14:40,880 NIH RESEARCH ON WOMEN'S HEALTH 353 00:14:40,880 --> 00:14:41,720 CONGRESSIONAL REQUEST. 354 00:14:41,720 --> 00:14:43,840 AND BUILDING UPON THE 355 00:14:43,840 --> 00:14:44,440 OPPORTUNITIES THAT WERE 356 00:14:44,440 --> 00:14:47,200 IDENTIFIED IN THE REPORT, FROM 357 00:14:47,200 --> 00:14:50,200 THAT CONFERENCE, WE WANT TO 358 00:14:50,200 --> 00:14:53,400 THANK A CHWH MEMBERS FOR 359 00:14:53,400 --> 00:14:54,480 ORGANIZING THE CONFERENCE AND 360 00:14:54,480 --> 00:14:56,360 YOU RECALL PULLING FORWARD ALONG 361 00:14:56,360 --> 00:14:57,920 WITH THE LEAD FOR THIS ACTIVITY, 362 00:14:57,920 --> 00:15:04,600 Dr. SARAH TEMKIN AND ALONG 363 00:15:04,600 --> 00:15:06,760 WITH Dr. SAMIA NOURSI A 364 00:15:06,760 --> 00:15:08,560 FRAMEWORK FOR CHRONIC DISEASE. 365 00:15:08,560 --> 00:15:10,480 MULTI MORBIDITY WAS HIGHLIGHTED 366 00:15:10,480 --> 00:15:12,120 IN THAT WOMEN'S HEALTH 367 00:15:12,120 --> 00:15:13,160 CONFERENCE REPORT AND ALIGNED 368 00:15:13,160 --> 00:15:15,160 WITH GOAL ONE OF THE NIH WIDE 369 00:15:15,160 --> 00:15:16,360 STRATEGIC PLAN FOR WOMEN'S 370 00:15:16,360 --> 00:15:18,360 HEALTH RESEARCH, IS ADVANCING 371 00:15:18,360 --> 00:15:19,680 RIGOROUS RESEARCH RELEVANT TO 372 00:15:19,680 --> 00:15:27,280 THE HEALTH OF WOMEN AND ARE NEW 373 00:15:27,280 --> 00:15:29,400 FUNDING HIGHLIGHTS. 374 00:15:29,400 --> 00:15:32,520 UNDERSTANDING CHRONIC 375 00:15:32,520 --> 00:15:33,920 CONDITIONS, UNDER STUDIED AMONG 376 00:15:33,920 --> 00:15:34,520 WOMEN. 377 00:15:34,520 --> 00:15:37,920 THE FRAMEWORK USED FOR THAT, 378 00:15:37,920 --> 00:15:41,480 THESE TWO ARE NOTICES OF FUNDING 379 00:15:41,480 --> 00:15:42,280 OPPORTUNITIES INCLUDE THE 380 00:15:42,280 --> 00:15:43,960 FRAMEWORK THAT WAS PRESENTED AT 381 00:15:43,960 --> 00:15:45,640 WOMEN'S HEALTH CONFERENCE 382 00:15:45,640 --> 00:15:47,600 LOOKING AT FEMALE-SPECIFIC 383 00:15:47,600 --> 00:15:50,240 CONDITIONS LIKE MENOPAUSE OR 384 00:15:50,240 --> 00:15:50,840 CANCER. 385 00:15:50,840 --> 00:15:51,960 CONDITIONS THAT ARE MORE COMMON 386 00:15:51,960 --> 00:15:54,000 IN WOMEN OR MORBIDITY IS GREATER 387 00:15:54,000 --> 00:15:56,080 FOR WOMEN LIKE IN MENTAL HEALTH 388 00:15:56,080 --> 00:15:57,480 CONDITIONS. 389 00:15:57,480 --> 00:15:58,680 POTENTIALLY UNDER STUDIED IN 390 00:15:58,680 --> 00:16:00,920 WOMEN SUCH AS INTIMATE PARTNER 391 00:16:00,920 --> 00:16:02,960 VIOLENCE AND THOSE CONDITIONS 392 00:16:02,960 --> 00:16:03,800 THAT ARE CRON PICK AND HAVE HIGH 393 00:16:03,800 --> 00:16:05,920 MORBIDITY FOR WOMEN LIKE CHRONIC 394 00:16:05,920 --> 00:16:07,840 OBSTRUCTIVE PULMONARY DISEASE 395 00:16:07,840 --> 00:16:08,440 HAS. 396 00:16:08,440 --> 00:16:10,120 THE FIRST RECEIPT DATE FOR THESE 397 00:16:10,120 --> 00:16:12,520 TWO NEW FUNDING OPPORTUNITIES IS 398 00:16:12,520 --> 00:16:14,640 MAY 19th AND WE ARE PARTNERING 399 00:16:14,640 --> 00:16:16,920 WITH A VARIETY OF ICOs 400 00:16:16,920 --> 00:16:18,360 DEPICTED HERE ON THE BOTTOM OF 401 00:16:18,360 --> 00:16:20,280 THE SLIDE SO VERY EXCITED TO BE 402 00:16:20,280 --> 00:16:23,600 HAVING THIS NEW FUNDING 403 00:16:23,600 --> 00:16:24,920 OPPORTUNITIES AVAILABLE TO 404 00:16:24,920 --> 00:16:26,880 RESEARCHERS TO ADDRESS CHRONIC 405 00:16:26,880 --> 00:16:28,800 DISEASES IN FEDERAL UNDER 406 00:16:28,800 --> 00:16:32,000 STUDIED AND EFFECT WOMEN. 407 00:16:32,000 --> 00:16:34,160 AS I MOVE ONTO THE NEXT SECTION 408 00:16:34,160 --> 00:16:37,280 OVER NIH UPDATES, I WANT TO 409 00:16:37,280 --> 00:16:41,840 HIGHLIGHT Dr. JOANN JONI RUTTERS 410 00:16:41,840 --> 00:16:45,440 THE DIRECTOR OF NCATS FOR 411 00:16:45,440 --> 00:16:46,840 ADVANCING TRANSLATIONAL SCIENCES 412 00:16:46,840 --> 00:16:49,200 AND YOU WILL HEAR FROM HER 413 00:16:49,200 --> 00:16:50,040 TODAY. 414 00:16:50,040 --> 00:16:52,200 Dr. RUTTER WILL OVERSEE THE 415 00:16:52,200 --> 00:16:53,600 DIVERSE -- SHE'S OVERSEEING THE 416 00:16:53,600 --> 00:16:55,040 DIVERSE PORTFOLIO RESEARCH 417 00:16:55,040 --> 00:16:57,640 ACTIVITIES IN NCATS AND PROVING 418 00:16:57,640 --> 00:17:00,120 THE TRANSLATIONAL PROCESSES OF 419 00:17:00,120 --> 00:17:01,400 TURNING SCIENTIFIC DISCOVERIES 420 00:17:01,400 --> 00:17:03,200 INTO HEALTH INTERVENTIONS AND 421 00:17:03,200 --> 00:17:06,440 THE PORTFOLIO FOR NCATS IS THE 422 00:17:06,440 --> 00:17:08,440 TRANSLATIONAL SCIENCE AWARDS OR 423 00:17:08,440 --> 00:17:09,600 CTSA PROGRAM THAT PLAYED A ROLE 424 00:17:09,600 --> 00:17:12,560 IN THE AGENCY'S COVID-19 425 00:17:12,560 --> 00:17:13,640 RESPONSE. 426 00:17:13,640 --> 00:17:16,880 Dr. RUTTER JOINED NCATS IN 427 00:17:16,880 --> 00:17:18,720 2019 AND SERVED AS ACTING 428 00:17:18,720 --> 00:17:21,720 DIRECTOR IN APRIL OF 2021 AND 429 00:17:21,720 --> 00:17:24,120 HER EARLIER WORK AT NIH INVOLVED 430 00:17:24,120 --> 00:17:25,640 THE ALL OF US PROGRAM AND THE 431 00:17:25,640 --> 00:17:29,320 NATIONAL INSTITUTE ON DRUG 432 00:17:29,320 --> 00:17:29,800 ABUSE. 433 00:17:29,800 --> 00:17:31,520 SHE BRINGS TO 11 THE NUMBER OF 434 00:17:31,520 --> 00:17:32,960 IC DIRECTORS INSTITUTE AND 435 00:17:32,960 --> 00:17:34,600 CENTER DIRECTORS THAT ARE WOMEN 436 00:17:34,600 --> 00:17:36,280 CURRENTLY AND I WANT TO 437 00:17:36,280 --> 00:17:38,560 HIGHLIGHT CHANGES IN IC 438 00:17:38,560 --> 00:17:42,360 LEADERSHIP, Dr. PETER 439 00:17:42,360 --> 00:17:44,320 KILLMARKS ARE ACTING DIRECTORS 440 00:17:44,320 --> 00:17:49,320 OF NIAID. 441 00:17:49,320 --> 00:17:51,440 ON THE RIGHT, I ALSO WANT TO 442 00:17:51,440 --> 00:17:53,120 HIGHLIGHT ON BEHALF OF NIH 443 00:17:53,120 --> 00:17:54,400 LEADERSHIP THE VERY FIRST NIH 444 00:17:54,400 --> 00:17:56,640 WIDE STRATEGIC PLAN FOR 445 00:17:56,640 --> 00:17:58,320 DIVERSITY, EQUITY, INCLUSION AND 446 00:17:58,320 --> 00:17:58,800 ACCESSIBILITY. 447 00:17:58,800 --> 00:18:01,560 AND I REFER YOU TO THE NIH 448 00:18:01,560 --> 00:18:03,920 LEADERSHIP WEBSITE FOR MORE 449 00:18:03,920 --> 00:18:05,800 INFORMATION ABOUT THAT IMPORTANT 450 00:18:05,800 --> 00:18:10,000 NEW STRATEGIC PLAN. 451 00:18:10,000 --> 00:18:11,920 WE ALSO WANT TO ACKNOWLEDGE 452 00:18:11,920 --> 00:18:15,480 Dr. RENEE WAGERSAN AND ARPA-H 453 00:18:15,480 --> 00:18:17,360 WHO CELEBRATED THEIR FIRST 454 00:18:17,360 --> 00:18:18,720 BIRTHDAY ON MARCH 15th. 455 00:18:18,720 --> 00:18:23,920 AS YOU KNOW, ARPA-H STANDS FOR 456 00:18:23,920 --> 00:18:25,160 ADVANCED RESEARCH AGENCY FOR 457 00:18:25,160 --> 00:18:26,800 HEALTH AND IT SUPPORTS 458 00:18:26,800 --> 00:18:29,320 TRANSFORMATIVE RESEARCH TO DRIVE 459 00:18:29,320 --> 00:18:31,360 BIOMEDICAL AND HEALTH 460 00:18:31,360 --> 00:18:32,000 BREAKTHROUGHS TO TRANSFORM 461 00:18:32,000 --> 00:18:33,960 HEALTH SOLUTIONS FOR ALL SO 462 00:18:33,960 --> 00:18:35,480 HAPPY BIRTHDAY ARPA-H. 463 00:18:35,480 --> 00:18:38,840 WE CONTINUE TO LOOK FORWARD TO 464 00:18:38,840 --> 00:18:40,840 ADVANCES THROUGH ARPA-H AND THAT 465 00:18:40,840 --> 00:18:42,720 INCLUDING WOMEN'S HEALTH, 466 00:18:42,720 --> 00:18:45,160 HOPEFULLY IN THE FUTURE. 467 00:18:45,160 --> 00:18:47,160 AND IMPORTANT PART OF THIS 468 00:18:47,160 --> 00:18:48,680 MEETING IS TO PROVIDE YOU WITH 469 00:18:48,680 --> 00:18:52,520 AN UPDATE ON ORWH RESEARCH 470 00:18:52,520 --> 00:18:53,480 PROGRAMS AND FUNDING. 471 00:18:53,480 --> 00:18:55,600 EACH YEAR I HIGHLIGHT THE BUDGET 472 00:18:55,600 --> 00:18:58,080 HISTORY FOR YOU AND YOU CAN SEE 473 00:18:58,080 --> 00:19:00,640 IN THE SLIDE ON THE LEFT THE 474 00:19:00,640 --> 00:19:03,360 BUDGET HISTORY FOR ORWH. 475 00:19:03,360 --> 00:19:06,280 FOR THE FIRST 10 YEARS OF THE 476 00:19:06,280 --> 00:19:07,560 OFFICE'S EXISTENCE, YOU CAN SEE 477 00:19:07,560 --> 00:19:10,120 A STEADY INCREASE IN OUR BUDGET 478 00:19:10,120 --> 00:19:13,040 AND THEN IN 2002, A SIGNIFICANT 479 00:19:13,040 --> 00:19:15,040 INCREASE OF OVER 10 MILLION TO 480 00:19:15,040 --> 00:19:21,480 CREATE THE BIRCH PROGRAM. 481 00:19:21,480 --> 00:19:23,960 SUBSEQUENTLY A FLAT BUDGET AND 482 00:19:23,960 --> 00:19:28,120 RECENTLY IN 2021 A BUDGET OF 483 00:19:28,120 --> 00:19:29,800 $51.5 MILLION, 2022, 484 00:19:29,800 --> 00:19:30,600 60.6 MILLION AND ON THE RIGHT 485 00:19:30,600 --> 00:19:32,320 YOU CAN SEE THE BREAKDOWN IF 486 00:19:32,320 --> 00:19:34,080 TERMS OF OUR EXTRAMURAL GRANT 487 00:19:34,080 --> 00:19:38,880 AWARDS AND THE PROFILE HERE. 488 00:19:38,880 --> 00:19:41,280 LET ME HIGHLIGHT FOR YOU. 489 00:19:41,280 --> 00:19:42,920 OUR BIRCH PROGRAM AT ABOUT A 490 00:19:42,920 --> 00:19:44,200 QUARTER OF OUR FUNDING AND THE 491 00:19:44,200 --> 00:19:45,640 SCORE PROGRAM AND A LITTLE MORE 492 00:19:45,640 --> 00:19:49,520 THAN A QUARTER OF VARIETY OF 493 00:19:49,520 --> 00:19:51,600 OTHER ORWH SIGNATURE PROGRAMS 494 00:19:51,600 --> 00:19:54,800 AND OUR SIX AND GENDER RO1 495 00:19:54,800 --> 00:19:56,320 APPROXIMATE U3 PROGRAM AND 496 00:19:56,320 --> 00:19:59,720 ADMINISTRATIVE SUPPLEMENTS. 497 00:19:59,720 --> 00:20:02,440 THIS 20.4% REPRESENTS OTHER IC 498 00:20:02,440 --> 00:20:05,040 CO FUNDING AND HERE IS ANOTHER 499 00:20:05,040 --> 00:20:09,000 NEW SECTION ON OTHER CAREER 500 00:20:09,000 --> 00:20:14,240 PROGRAMS. 501 00:20:14,240 --> 00:20:15,880 THE BIRCH PROGRAM REPRESENTING 502 00:20:15,880 --> 00:20:17,640 THREE QUARTERS OF THAT FUNDING 503 00:20:17,640 --> 00:20:20,720 BUT ALSO OUR CAREER CONTINUITY 504 00:20:20,720 --> 00:20:22,840 SUPPLEMENTS FOR WHICH ORWH TOOK 505 00:20:22,840 --> 00:20:24,040 A LEADERSHIP ROLE IN DEVELOPING 506 00:20:24,040 --> 00:20:26,120 THROUGH THE WORKING GROUP AND 507 00:20:26,120 --> 00:20:28,520 BIOMEDICAL CAREERS, DIVERSITY 508 00:20:28,520 --> 00:20:29,960 SUPPLEMENT OF KINDS, EFFORTS 509 00:20:29,960 --> 00:20:33,080 FOCUSED ON ADDRESSING SEXUAL 510 00:20:33,080 --> 00:20:35,200 HARASSMENT, LOAN REPAYMENT AND 511 00:20:35,200 --> 00:20:37,360 RECRUITMENT AND REENTRY AND 512 00:20:37,360 --> 00:20:38,160 REINTEGRATION SUPPLEMENTS AND 513 00:20:38,160 --> 00:20:41,360 YOU WILL HEAR A LITTLE BIT MORE 514 00:20:41,360 --> 00:20:42,960 FROM OUR ASSOCIATE DIRECTOR OF 515 00:20:42,960 --> 00:20:44,880 CAREERS ABOUT PROPOSED CONCEPTS 516 00:20:44,880 --> 00:20:46,520 FOR EXPANDING THE REENTRY 517 00:20:46,520 --> 00:20:49,200 PROGRAM LATER TODAY. 518 00:20:49,200 --> 00:20:51,680 UNTIL TERMS OF THE IPSOS-REID TO 519 00:20:51,680 --> 00:20:54,160 USE THE AND CENTERS TO WHOM THE 520 00:20:54,160 --> 00:20:57,400 ORWT FUNDS FLOW, YOU CAN SEE 521 00:20:57,400 --> 00:21:01,640 HERE NICHD, IN THE LEAD WITH 522 00:21:01,640 --> 00:21:02,960 SUBSTANTIAL PREPORTION RELATED 523 00:21:02,960 --> 00:21:09,160 TO THE BIRCH PROGRAM AND NIA AND 524 00:21:09,160 --> 00:21:11,360 NHLBA IN THE TOP FIVE HERE AND 525 00:21:11,360 --> 00:21:13,520 IF WE REMOVE THE BIRCH YOU CAN 526 00:21:13,520 --> 00:21:16,960 SEE A LITTLE BIT MORE EASILY 527 00:21:16,960 --> 00:21:18,240 THESE INSTITUTES WITH WHOM WE 528 00:21:18,240 --> 00:21:21,280 HAVE PROVIDED THE MAJORITY OF 529 00:21:21,280 --> 00:21:22,800 FUNDING AS WELL AS OTHER 530 00:21:22,800 --> 00:21:24,360 INSTITUTES AND CENTERS THAT HAVE 531 00:21:24,360 --> 00:21:26,120 RECEIVED WOMEN'S HEALTH SUPPORT 532 00:21:26,120 --> 00:21:32,480 FROM ORWH OVER FOR FY22. 533 00:21:32,480 --> 00:21:33,800 HERE IS A LITTLE BIT MORE DETAIL 534 00:21:33,800 --> 00:21:39,000 FOR YOU WITH THE ORWH SIGNATURE 535 00:21:39,000 --> 00:21:39,960 PROGRAMS DELINEATED. 536 00:21:39,960 --> 00:21:41,920 YOU CAN SEE THE BIRCH PROGRAM 537 00:21:41,920 --> 00:21:43,680 OUR ORWH INVESTMENTS AS WELL AS 538 00:21:43,680 --> 00:21:46,560 THE CO-FUNDING ICs FOR BIRCH. 539 00:21:46,560 --> 00:21:47,960 WE SEE DID RECEIVE ADDITIONAL 540 00:21:47,960 --> 00:21:53,080 FUNDING FROM NCI AND NIAAA AND 541 00:21:53,080 --> 00:21:56,160 NNIAD IN 2022 IN TERMS IT OF THE 542 00:21:56,160 --> 00:21:57,720 CAREER PROGRAMS AND HERE ARE THE 543 00:21:57,720 --> 00:21:59,480 INSTITUTES AND CENTERS WITH WHOM 544 00:21:59,480 --> 00:22:01,040 WE COLLABORATE FORWARD OUR SCORE 545 00:22:01,040 --> 00:22:04,680 PROGRAM, THERE ARE FIVE 546 00:22:04,680 --> 00:22:05,880 INSTITUTES THAT ARE 547 00:22:05,880 --> 00:22:10,160 ADMINISTERING AND SUPPORTING THE 548 00:22:10,160 --> 00:22:10,680 SCORE PROGRAM. 549 00:22:10,680 --> 00:22:12,440 SEX AND GENDER RO1. 550 00:22:12,440 --> 00:22:13,400 EIGHT INSTITUTES THAT ARE 551 00:22:13,400 --> 00:22:15,080 WORKING WITH US ON THE SEX AND 552 00:22:15,080 --> 00:22:17,920 GENDER RO1 AND SUPPORTING THOSE 553 00:22:17,920 --> 00:22:18,360 EFFORTS. 554 00:22:18,360 --> 00:22:21,360 IN TERMS OF THE SEX AND GENDER 555 00:22:21,360 --> 00:22:22,200 ADMINISTRATIVE SUPPLEMENTS EIGHT 556 00:22:22,200 --> 00:22:25,520 INSTITUTES ARE RECEIVING 557 00:22:25,520 --> 00:22:27,160 GRANTEES FROM THOSE -- THEY ARE 558 00:22:27,160 --> 00:22:28,440 RECEIVING FUNDING AND OUR U3 559 00:22:28,440 --> 00:22:30,560 UNDER STUDIED, UNDER REPORTED 560 00:22:30,560 --> 00:22:33,560 AND UNDER STUDIED POPULATIONS OF 561 00:22:33,560 --> 00:22:35,800 WOMEN AND PROGRAM AT $3 MILLION 562 00:22:35,800 --> 00:22:38,600 WITH 11 INSTITUTES AND FOR OTHER 563 00:22:38,600 --> 00:22:41,120 INSTITUTES, CO FUNDING A WIDER 564 00:22:41,120 --> 00:22:42,800 VARIETY OF INSTITUTES AND 565 00:22:42,800 --> 00:22:46,560 CENTERS AT ALMOST $9 MILLION FOR 566 00:22:46,560 --> 00:22:50,360 ORWH CO FUNDING AND SUPPORT FOR 567 00:22:50,360 --> 00:22:51,080 FY22. 568 00:22:51,080 --> 00:22:52,360 AND WE DECIDE TODAY SHARE WITH 569 00:22:52,360 --> 00:22:56,680 YOU AN FY23 ORWH RECEIVED A 570 00:22:56,680 --> 00:23:01,200 BUDGET OF $76.48 MILLION WITH AN 571 00:23:01,200 --> 00:23:01,760 ADDITIONAL $17 MILLION WITH 572 00:23:01,760 --> 00:23:03,840 THESE REQUIREMENTS FROM THE U.S. 573 00:23:03,840 --> 00:23:04,440 CONGRESS AND FIVE MILLION 574 00:23:04,440 --> 00:23:05,840 DOLLARS TO SUPPORT THE BIRCH 575 00:23:05,840 --> 00:23:09,040 PROGRAM AND IN ADDITION AND 576 00:23:09,040 --> 00:23:10,120 $10 MILLION ESTABLISH AN OFFICE 577 00:23:10,120 --> 00:23:12,440 OF AUTOIMMUNE DISEASE RESEARCH 578 00:23:12,440 --> 00:23:13,480 AND TWO MILLION DOLLARS TO 579 00:23:13,480 --> 00:23:14,920 CONTRACT WITH THE NATIONAL A CAT 580 00:23:14,920 --> 00:23:16,680 PIECE OF SCIENCE AND ENGINEERING 581 00:23:16,680 --> 00:23:18,480 AND MEDICINE TO CONDUCT A STUDY 582 00:23:18,480 --> 00:23:20,720 ON GAPS IN NIH WOMEN'S HEALTH 583 00:23:20,720 --> 00:23:21,400 RESEARCH. 584 00:23:21,400 --> 00:23:27,880 THE CONGRESSIONAL LANGUAGE 585 00:23:27,880 --> 00:23:35,560 REQUIRED EVALUATE SEX 586 00:23:35,560 --> 00:23:37,400 DIFFERENCES AND RACIAL AND 587 00:23:37,400 --> 00:23:39,880 HEALTH DISPARITIES AND DETERMINE 588 00:23:39,880 --> 00:23:41,680 THE LEVEL IN WOMEN'S HEALTH 589 00:23:41,680 --> 00:23:43,320 RESEARCH AT NIH AND ALONG WITH 590 00:23:43,320 --> 00:23:46,800 THE REQUIREMENT FOR THE NATIONAL 591 00:23:46,800 --> 00:23:48,240 ACADEMIES TO REPORT TO CONGRESS 592 00:23:48,240 --> 00:23:49,440 IN 18 MONTHS ON RECOMMENDATIONS 593 00:23:49,440 --> 00:23:53,600 TO ADDRESS RESEARCH GAPS AND 594 00:23:53,600 --> 00:23:57,760 WOMEN'S HEALTH RESEARCH. 595 00:23:57,760 --> 00:23:59,560 HERE IS A LITTLE BIT MORE DETAIL 596 00:23:59,560 --> 00:24:01,560 ON THE OMNIBUS LANGUAGE RELATED 597 00:24:01,560 --> 00:24:03,680 TO THE NEW OFFICE AUTOIMMUNE 598 00:24:03,680 --> 00:24:04,800 DISEASE RESEARCH. 599 00:24:04,800 --> 00:24:07,480 AS MANY AUTOIMMUNE DISS EFFECT 600 00:24:07,480 --> 00:24:10,680 WOMEN AS STATED IN HAD 601 00:24:10,680 --> 00:24:11,400 CONGRESSIONAL LANGUAGE. 602 00:24:11,400 --> 00:24:13,400 AND NATIONAL ACADEMY OF SCIENCE 603 00:24:13,400 --> 00:24:15,120 ENGINEERING AND MEDICINE 2022 604 00:24:15,120 --> 00:24:17,400 REPORT RECOMMENDED THE 605 00:24:17,400 --> 00:24:18,840 ESTABLISHMENT OF AN NIH OFFICE 606 00:24:18,840 --> 00:24:22,040 OF AUTOIMMUNE DISEASE RESEARCH 607 00:24:22,040 --> 00:24:32,480 AND THE APPROPRIATIONS AND 608 00:24:35,200 --> 00:24:36,760 DISTRICTS THE OADR FOR THE 609 00:24:36,760 --> 00:24:38,400 DEVELOPMENT OF A MULTI INSTITUTE 610 00:24:38,400 --> 00:24:40,520 AND CENTER STRATEGIC RESEARCH 611 00:24:40,520 --> 00:24:43,120 PLAN TO IDENTIFY OF AREAS OF 612 00:24:43,120 --> 00:24:44,920 INNOVATION EMERGING AREAS OF 613 00:24:44,920 --> 00:24:46,240 INNOVATION AND RESEARCH 614 00:24:46,240 --> 00:24:47,880 OPPORTUNITIES TO COORDINATE AND 615 00:24:47,880 --> 00:24:49,640 FOSTER COLLABORATIVE RESEARCH 616 00:24:49,640 --> 00:24:50,680 ACROSS THE INSTITUTES AND 617 00:24:50,680 --> 00:24:54,600 CENTERS AND ANNUALLY EVALUATE 618 00:24:54,600 --> 00:24:56,480 THE PORTFOLIO AND TO PROVIDE 619 00:24:56,480 --> 00:24:59,280 RESOURCES TO SUPPORT PLANNING, 620 00:24:59,280 --> 00:25:00,800 COLLABORATION AND INNOVATION AND 621 00:25:00,800 --> 00:25:02,360 TO DEVELOP AND OVERSEE A 622 00:25:02,360 --> 00:25:04,400 PUBLICLY ACCESSIBLE CENTRAL 623 00:25:04,400 --> 00:25:06,760 REPOSITORY FOR AUTOIMMUNE 624 00:25:06,760 --> 00:25:08,760 DISEASE RESEARCH AS WELL AS TO 625 00:25:08,760 --> 00:25:13,360 REPORT BACK TO THE COMMITTEES 626 00:25:13,360 --> 00:25:15,120 WITHIN 150 DAYS OF THE 627 00:25:15,120 --> 00:25:17,040 CONSOLIDATED APPROPRIATIONS ACT 628 00:25:17,040 --> 00:25:18,840 ON EFFORTS THAT NIH HAS TAKEN TO 629 00:25:18,840 --> 00:25:23,560 STAND UP OADR AND THE STATUS OF 630 00:25:23,560 --> 00:25:23,960 THESE DIRECTIVES. 631 00:25:23,960 --> 00:25:26,160 I'M GRATEFUL FOR THE FOCUS 632 00:25:26,160 --> 00:25:27,280 ATTENTION AUTOIMMUNE DISEASES 633 00:25:27,280 --> 00:25:29,280 AND THE OPPORTUNITIES TO ADVANCE 634 00:25:29,280 --> 00:25:31,920 AN IMPORTANT RESEARCH FOR WOMEN 635 00:25:31,920 --> 00:25:33,280 THAT TOUCHES ALMOST EVERY ORGAN 636 00:25:33,280 --> 00:25:37,400 IN THE BODY ACROSS THE LIFESPAN, 637 00:25:37,400 --> 00:25:39,880 AUTOIMMUNE DISEASES HAVE BEEN ON 638 00:25:39,880 --> 00:25:41,320 ORWH'S RADAR GIVEN THE HIGH 639 00:25:41,320 --> 00:25:43,560 RATES OF DISEASE AND FEMALE 640 00:25:43,560 --> 00:25:45,360 HIGHER RATES OF DISEASE IN WOMEN 641 00:25:45,360 --> 00:25:48,520 FOR MOST AUTO AWSO PESHDARY. 642 00:25:48,520 --> 00:25:59,000 THE CHARGE IS CROSS CUTTING. 643 00:26:00,080 --> 00:26:01,760 WE WILL HELP LEAD THIS NEXT 644 00:26:01,760 --> 00:26:04,280 CHAPTER OF AUTOIMMUNE DISEASE 645 00:26:04,280 --> 00:26:06,680 RESEARCH AT NIH LEVERAGING OUR 646 00:26:06,680 --> 00:26:08,360 ORWH TO COMPLIMENT, SIN I 647 00:26:08,360 --> 00:26:16,360 REMEMBERSYNERGIESTHROUGH RESEARO 648 00:26:16,360 --> 00:26:17,400 ACCELERATE PROGRESS. 649 00:26:17,400 --> 00:26:22,160 THIS GRAPHIC DEPICTS INFORMATION 650 00:26:22,160 --> 00:26:24,040 RELATED TO NIH INVESTMENTS AND 651 00:26:24,040 --> 00:26:25,840 AUTOIMMUNE DISEASE RESEARCH AND 652 00:26:25,840 --> 00:26:28,320 OVER THE PAST FIVE YEARS, THOSE 653 00:26:28,320 --> 00:26:30,240 INVESTMENTS HAVE INCREASED AND 654 00:26:30,240 --> 00:26:34,920 IN FY21 WE'RE A BILLION DOLLARS 655 00:26:34,920 --> 00:26:38,400 AT $946 MILLION AND FY21 AND 22 656 00:26:38,400 --> 00:26:41,720 OVER NEW RESEARCH AND STRAT TIVE 657 00:26:41,720 --> 00:26:42,640 SUPPLEMENT GRANTS WERE LISTED IN 658 00:26:42,640 --> 00:26:45,840 THE CATEGORY AS A SPENDING 659 00:26:45,840 --> 00:26:48,240 CATEGORY IN R CDC FOR EXAMPLE. 660 00:26:48,240 --> 00:26:55,120 THE GRAPHIC ON THE LEFT 661 00:26:55,120 --> 00:26:57,560 HIGHLIGHTS LIST THE AREAS WHERE 662 00:26:57,560 --> 00:26:58,400 THEY OVERLAP. 663 00:26:58,400 --> 00:26:59,920 JUST AS THERE ARE CROSS CUTTING 664 00:26:59,920 --> 00:27:04,080 ISSUES ACROSS ALL THE OWE 'EM AS 665 00:27:04,080 --> 00:27:07,640 SEE, THEY CAN BE CATEGORIZED 666 00:27:07,640 --> 00:27:09,640 UNDER VARIOUS MULTIPLE SPENDING 667 00:27:09,640 --> 00:27:12,920 CATEGORIES DEPICTED IN THE 668 00:27:12,920 --> 00:27:16,960 GRAPHIC HERE AND FY21 AND 22 THE 669 00:27:16,960 --> 00:27:18,600 NUMBER OF NEW INVESTMENTS AND 670 00:27:18,600 --> 00:27:20,160 THIS FIGURE SHOWS THE OTHER 671 00:27:20,160 --> 00:27:21,960 SPENDING CATEGORIES THAT WERE 672 00:27:21,960 --> 00:27:24,360 LISTED, ALONG WITH AUTOIMMUNE 673 00:27:24,360 --> 00:27:25,800 DISEASE, AND THEY DEMONSTRATE 674 00:27:25,800 --> 00:27:27,600 THE COMMON INTERSECTION OF THOSE 675 00:27:27,600 --> 00:27:29,360 INVESTMENTS AND AUTOIMMUNE 676 00:27:29,360 --> 00:27:30,760 DISEASES RESEARCH WITH OTHER 677 00:27:30,760 --> 00:27:33,600 TOPICS LIKE WOMEN'S HEALTH, LIKE 678 00:27:33,600 --> 00:27:36,200 TRANSLATIONAL RESEARCH, AND LIKE 679 00:27:36,200 --> 00:27:37,120 MINORITY HEALTH. 680 00:27:37,120 --> 00:27:40,080 SO AT NIH, DISEASE FOCUSED 681 00:27:40,080 --> 00:27:41,040 RESEARCH OFTEN ALIGNS WITH 682 00:27:41,040 --> 00:27:44,800 MULTIPLE INSTITUTES AND CENTER 683 00:27:44,800 --> 00:27:46,480 MISSIONS AND WE CHAMPION A WHOLE 684 00:27:46,480 --> 00:27:47,840 PERSON PERSPECTIVE RECOGNIZING 685 00:27:47,840 --> 00:27:50,080 THE DISEASES DO NOT HAPPEN IN A 686 00:27:50,080 --> 00:27:51,880 VACUUM AND WE LOOK FORWARD TO 687 00:27:51,880 --> 00:27:53,760 PROVIDING PATHWAYS AND 688 00:27:53,760 --> 00:27:55,760 OPPORTUNITIES FOR INTER 689 00:27:55,760 --> 00:27:56,680 DISCIPLINARY COLLABORATION 690 00:27:56,680 --> 00:27:59,200 ACROSS THE DIFFERENT ICOs AND 691 00:27:59,200 --> 00:28:01,320 CREATIVE WAYS TO INCORPORATE A 692 00:28:01,320 --> 00:28:03,360 LIFE COURSE PERSPECTIVE WITH AN 693 00:28:03,360 --> 00:28:05,720 INTEGRATED APPROACH TO HEALTH IN 694 00:28:05,720 --> 00:28:16,200 AUTOIMMUNE DISEASE RESEARCH. 695 00:28:17,080 --> 00:28:18,600 WE HAVE CURRENT AND FUTURE 696 00:28:18,600 --> 00:28:20,280 ACTIVITIES AND I'M DIVIDING THEM 697 00:28:20,280 --> 00:28:22,120 INTO INFRASTRUCTURE, SCIENTIFIC 698 00:28:22,120 --> 00:28:27,000 DIRECTION, PUBLIC ENGAGEMENT AND 699 00:28:27,000 --> 00:28:27,560 FUNDING OPPORTUNITIES. 700 00:28:27,560 --> 00:28:31,160 WITH RESPECT TO INFRASTRUCTURE 701 00:28:31,160 --> 00:28:32,560 WE HAVE A ORWH CORE WHO FOCUS IS 702 00:28:32,560 --> 00:28:41,720 TO STAND UP THE OFFICE AND WE 703 00:28:41,720 --> 00:28:43,960 HAVE EXISTING SCIENTIFIC STAFF 704 00:28:43,960 --> 00:28:45,720 WHO HAVE AGREED TO TAKE TIME 705 00:28:45,720 --> 00:28:47,680 BEYOND THEIR PRIMARY 706 00:28:47,680 --> 00:28:49,400 RESPONSIBILITIES AND SELECT AID 707 00:28:49,400 --> 00:28:50,480 SCIENTIFIC COORDINATOR TO SET UP 708 00:28:50,480 --> 00:28:52,480 THE STEPS TO LAUNCH AND WE'RE 709 00:28:52,480 --> 00:28:54,360 ABLE TO SECURE TWO FULL TIME 710 00:28:54,360 --> 00:28:56,760 STAFF POSITIONS DEDICATED TO 711 00:28:56,760 --> 00:28:58,160 OADR AND ONE OF THESE WILL BE 712 00:28:58,160 --> 00:29:00,560 THE OADR DIRECTOR AND GOING 713 00:29:00,560 --> 00:29:02,920 FORWARD TO SUSTAIN AND GROW THE 714 00:29:02,920 --> 00:29:06,000 OFFICE, WE LOOK FORWARD TO 715 00:29:06,000 --> 00:29:07,800 ASSESSING NEEDS FOR FURTHER 716 00:29:07,800 --> 00:29:11,400 RESOURCES AND EFFORTS. 717 00:29:11,400 --> 00:29:13,280 WE'RE TAPPING INTO NIH PLATFORM 718 00:29:13,280 --> 00:29:15,560 SUCH AS THE OFFICE OF INTRAMURAL 719 00:29:15,560 --> 00:29:18,720 TRAINING AND EDUCATION AND 720 00:29:18,720 --> 00:29:19,440 ACCELERATING MEDICINE 721 00:29:19,440 --> 00:29:21,520 PARTNERSHIPS FOR AUTOIMMUNE AND 722 00:29:21,520 --> 00:29:27,800 IMMUNE DISEASES OR AMP AIM AND 723 00:29:27,800 --> 00:29:30,160 WE PLAN ON IDENTIFYING EXISTING 724 00:29:30,160 --> 00:29:34,320 DATASDATASETS TO DETERMINE HOW O 725 00:29:34,320 --> 00:29:37,120 BUILD UPON THEM. 726 00:29:37,120 --> 00:29:38,320 WE CERTAINLY COORDINATE WITH NIH 727 00:29:38,320 --> 00:29:41,800 TO AND OTHER COMPONENTS TO 728 00:29:41,800 --> 00:29:43,360 DEVELOP A CORSET OF AUTOIMMUNE 729 00:29:43,360 --> 00:29:46,680 DISEASE RESEARCH COMMON DATA 730 00:29:46,680 --> 00:29:47,880 ELEMENTS THAT WILL BE RECOGNIZED 731 00:29:47,880 --> 00:29:49,280 BROADLY AND HELPED TO IDENTIFY 732 00:29:49,280 --> 00:29:51,280 AND TRACK RESEARCH EFFORTS AND 733 00:29:51,280 --> 00:29:52,480 INVESTMENTS AND COMMUNICATIONS 734 00:29:52,480 --> 00:29:54,680 AND SEE THAT AS A CRUCIAL 735 00:29:54,680 --> 00:29:56,000 BUILDING BLOCK OF THE NIH 736 00:29:56,000 --> 00:29:57,400 LANGUAGE TO EXPAND THE 737 00:29:57,400 --> 00:30:01,120 RECOGNITION OF AUTOIMMUNE 738 00:30:01,120 --> 00:30:09,040 DISEASES. 739 00:30:09,040 --> 00:30:10,920 PREVIOUSLY MENTIONED WHICH 740 00:30:10,920 --> 00:30:13,400 CLEARLY IDENTIFIED AREAS FOR 741 00:30:13,400 --> 00:30:15,560 IMPROVEMENT AND TO TO HAVE OUR 742 00:30:15,560 --> 00:30:19,400 STEPS MOVING FORWARD AND WE HAVE 743 00:30:19,400 --> 00:30:21,400 A COMMITTEE FOR AUTO I AM SEWN 744 00:30:21,400 --> 00:30:22,880 DISEASE RESEARCH PROVIDING A 745 00:30:22,880 --> 00:30:24,440 STRUCTURE FORUM TO LEVERAGE THE 746 00:30:24,440 --> 00:30:26,240 AUTOIMMUNE DISEASE RESEARCH 747 00:30:26,240 --> 00:30:27,760 EXPERTISE, ACROSS THE VARIOUS 748 00:30:27,760 --> 00:30:29,760 INSTITUTES CENTERS AND OFFICES 749 00:30:29,760 --> 00:30:32,040 AT NIH AND OFFER STREAMLINE 750 00:30:32,040 --> 00:30:34,320 PROCESSES FOR EXPANDING 751 00:30:34,320 --> 00:30:35,960 COLLABORATIONS ACROSS NIH AND 752 00:30:35,960 --> 00:30:37,640 ALL NIH INSTITUTES AND CENTERS 753 00:30:37,640 --> 00:30:38,600 DIRECTORS HAVE RECEIVE 754 00:30:38,600 --> 00:30:40,760 COMMUNICATION ANNOUNCING NEW 755 00:30:40,760 --> 00:30:42,400 CCADR AND RESPONDED TO ITS 756 00:30:42,400 --> 00:30:44,080 REQUEST TO IDENTIFY THE 757 00:30:44,080 --> 00:30:45,280 APPROPRIATE SCIENTIFIC EXPERTS 758 00:30:45,280 --> 00:30:48,680 TO SERVE AS THEIR IC 759 00:30:48,680 --> 00:30:51,440 REPRESENTATIVES AND ADDITIONALLY 760 00:30:51,440 --> 00:30:52,880 OEDR EFFORTS WE HAVE EXPLORED 761 00:30:52,880 --> 00:30:54,960 SEVERAL METHODS TO PARTNER WITH 762 00:30:54,960 --> 00:30:56,040 INSTITUTES CENTERS AND OFFICE 763 00:30:56,040 --> 00:30:58,360 THAT'S HAVE EXISTING ROBUST 764 00:30:58,360 --> 00:31:00,040 AUTOIMMUNE DIS SEE RESEARCH 765 00:31:00,040 --> 00:31:04,360 PORTFOLIOS AS WELL AS TO EXPAND 766 00:31:04,360 --> 00:31:05,520 UPON EXISTING OPPORTUNITIES AND 767 00:31:05,520 --> 00:31:06,640 MAP TO PERFORM PORTFOLIO 768 00:31:06,640 --> 00:31:08,280 ANALYSIS AS PART OF THAT HAVE 769 00:31:08,280 --> 00:31:14,760 SCIENTIFIC SETTING AND AND 770 00:31:14,760 --> 00:31:17,600 REDEVELOPING A STRATEGIC PLAN. 771 00:31:17,600 --> 00:31:20,080 WITH REGARDING TO PUBLIC 772 00:31:20,080 --> 00:31:21,720 ENGAGEMENT, WE RECENTLY MET WITH 773 00:31:21,720 --> 00:31:24,080 SEVERAL PATIENT ADVOCACY GROUPS 774 00:31:24,080 --> 00:31:25,640 AT THEIR REQUEST AND SHARED OUR 775 00:31:25,640 --> 00:31:27,720 EFFORTS TO STAND UP OADR AND 776 00:31:27,720 --> 00:31:30,440 HEARD THEIR PERSPECTIVES AND 777 00:31:30,440 --> 00:31:31,040 RECEIVED QUESTIONS. 778 00:31:31,040 --> 00:31:33,640 WE EXPECT TO HAVE ON GOING 779 00:31:33,640 --> 00:31:36,320 CONVERSATIONS WITH PATIENT 780 00:31:36,320 --> 00:31:37,760 ADVOCACY GROUPS AND PROFESSIONAL 781 00:31:37,760 --> 00:31:38,920 ASSOCIATIONS IN SOCIETY AND WE 782 00:31:38,920 --> 00:31:43,480 WILL SOLICIT I AM INPUT FOR ANF 783 00:31:43,480 --> 00:31:45,440 SAY ON PATIENT CENTRIC 784 00:31:45,440 --> 00:31:47,920 PERSPECTIVES AS WE GO FORWARD 785 00:31:47,920 --> 00:31:49,760 AND PROCESS OF MESSAGING 786 00:31:49,760 --> 00:31:51,080 COMMUNICATIONS AND PLANS AND 787 00:31:51,080 --> 00:32:01,640 STAKEHOLDER ENGAGEMENT EFFORTS. 788 00:32:05,800 --> 00:32:08,080 AND OFFICES OF SUPPORTING 789 00:32:08,080 --> 00:32:09,840 AUTOIMMUNE DISEASE RESEARCH AND 790 00:32:09,840 --> 00:32:12,120 INTEND TO SUPPORT HIGHLY 791 00:32:12,120 --> 00:32:13,480 MERITORIOUS APPLICATIONS. 792 00:32:13,480 --> 00:32:15,240 WE HAVE IDENTIFIED SEVERAL 793 00:32:15,240 --> 00:32:18,240 PATHWAYS FOR FY23 FOR FUNDING IN 794 00:32:18,240 --> 00:32:19,760 EXTRAMURAL AND INTRAMURAL 795 00:32:19,760 --> 00:32:21,560 PROJECTS AND WE'RE TAKING A 796 00:32:21,560 --> 00:32:24,200 PROACTIVE APPROACH FOR FY24 AND 797 00:32:24,200 --> 00:32:26,920 WE'LL PLAN TO SHARE MORE 798 00:32:26,920 --> 00:32:28,920 INFORMATION ABOUT THOSE EFFORTS 799 00:32:28,920 --> 00:32:31,320 SOON AS NEW OADR PROGRAMS ARE 800 00:32:31,320 --> 00:32:33,920 STOOD UP AND DEVELOPED. 801 00:32:33,920 --> 00:32:35,280 I MENTIONED A FEW MINUTES AGO 802 00:32:35,280 --> 00:32:38,880 THE WOMWOMEN'S HEALTH CONFERENCD 803 00:32:38,880 --> 00:32:40,880 THE FOCUSED EFFORT ON CHRONIC 804 00:32:40,880 --> 00:32:42,360 DISEASES TA CAME OUT OF THAT 805 00:32:42,360 --> 00:32:44,800 CONFERENCE AS WELL AS THIS 806 00:32:44,800 --> 00:32:45,280 FUNDING OPPORTUNITY. 807 00:32:45,280 --> 00:32:47,760 I WANT TO HIGHLIGHT THESE 808 00:32:47,760 --> 00:32:49,400 NOFOs ARE NOTICES OF FUNDING 809 00:32:49,400 --> 00:32:50,320 AT THE PRESENT TIME TO SUPPORT 810 00:32:50,320 --> 00:32:51,760 CHRONIC DISEASES THAT EFFECT 811 00:32:51,760 --> 00:32:53,440 WOMEN AND INDIVIDUALS A SIGNED 812 00:32:53,440 --> 00:32:55,560 FEMALE AT BIRTH TA ARE UNDER 813 00:32:55,560 --> 00:32:56,880 STUDIED AND BUILT ON THOSE 814 00:32:56,880 --> 00:32:58,040 OPPORTUNITIES IN THE WOMEN'S 815 00:32:58,040 --> 00:33:01,400 HEALTH REPORT AND THEY HIGHLIGHT 816 00:33:01,400 --> 00:33:02,600 SPECIFICALLY AUTOIMMUNE DISEASE. 817 00:33:02,600 --> 00:33:04,760 AS WELL AS DISEASES THAT ARE 818 00:33:04,760 --> 00:33:07,200 RELATE TO DIFFERENT CHRONIC 819 00:33:07,200 --> 00:33:08,480 CONDITIONS, MULTI MORBIDITY AND 820 00:33:08,480 --> 00:33:11,080 A LIFE COURSE PERSPECTIVE. 821 00:33:11,080 --> 00:33:13,480 SO THIS EXCITING -- TWO FUNDING 822 00:33:13,480 --> 00:33:15,480 OPPORTUNITIES ARE AVAILABLE NOW 823 00:33:15,480 --> 00:33:19,720 WITH A FIRST RECEIPT DATE OF MAY 824 00:33:19,720 --> 00:33:22,000 19th OF THIS YEAR TO HELP US 825 00:33:22,000 --> 00:33:23,680 GET THE WORD OUT TO ADVANCE 826 00:33:23,680 --> 00:33:26,680 RESEARCH IN THESE IMPORTANT 827 00:33:26,680 --> 00:33:27,040 AREAS. 828 00:33:27,040 --> 00:33:28,960 NEXT I'M GOING TO MOVE ON TO 829 00:33:28,960 --> 00:33:35,520 POLICY AND SCIENTIFIC UPDATES. 830 00:33:35,520 --> 00:33:37,200 NIH INCLUSION POLICIES HAVE 831 00:33:37,200 --> 00:33:38,520 EVOLVED OVER TIME. 832 00:33:38,520 --> 00:33:39,920 IT WAS MY PLEASURE TO SHARE 833 00:33:39,920 --> 00:33:41,000 INFORMATION ABOUT INCLUSION 834 00:33:41,000 --> 00:33:43,880 POLICIES ALONG WITH Dr. MONICA 835 00:33:43,880 --> 00:33:44,800 WEB HOOPER FROM THE NATIONAL 836 00:33:44,800 --> 00:33:46,320 INSTITUTE FOR MINORITY HEALTH 837 00:33:46,320 --> 00:33:48,240 AND HEALTH DISPARITIES WITH WHOM 838 00:33:48,240 --> 00:33:50,480 I CO-CHAIR THE NIH INCLUSION 839 00:33:50,480 --> 00:33:52,200 GOVERNANCE COMMITTEE RECENTLY AT 840 00:33:52,200 --> 00:33:54,360 A WORKSHOP ON I AM CONCLUSIVE 841 00:33:54,360 --> 00:33:55,920 PARTICIPATION AND CLINICAL 842 00:33:55,920 --> 00:33:57,280 RESEARCH AND LED BIT NATIONAL 843 00:33:57,280 --> 00:34:00,920 INSTITUTE OF MINORITY HEALTH. 844 00:34:00,920 --> 00:34:04,000 SOMEONE NEEDS TO MUTE. 845 00:34:04,000 --> 00:34:04,480 THANK YOU. 846 00:34:04,480 --> 00:34:06,960 YOU WILL HEAR A FULL INCLUSION 847 00:34:06,960 --> 00:34:14,440 UPDATE LATER THIS MORNING FROM 848 00:34:14,440 --> 00:34:14,760 DAWN CORBETT. 849 00:34:14,760 --> 00:34:17,720 I WANT TO HIGHLIGHT FOR YOU SOME 850 00:34:17,720 --> 00:34:19,280 INFORMATION THAT IS PARTICULARLY 851 00:34:19,280 --> 00:34:21,080 IMPORTANT TO HELP GET OUT AS 852 00:34:21,080 --> 00:34:28,360 BROADLY AS POSSIBLE. 853 00:34:28,360 --> 00:34:30,280 AS YOU KNOW, NIH HAS 854 00:34:30,280 --> 00:34:34,600 REQUIREMENTS RELATED TO NIH 855 00:34:34,600 --> 00:34:37,080 BASED CLINICAL TRIALS THAT MUST 856 00:34:37,080 --> 00:34:39,440 BE DESIGNED SUCH THAT THE VALID 857 00:34:39,440 --> 00:34:42,160 ANALYSIS FOR OUTCOMES BY SEX OR 858 00:34:42,160 --> 00:34:43,800 GENDER, RACE AND ETHNICITY CAN 859 00:34:43,800 --> 00:34:45,560 BE PERFORMED AND THOSE CLINICAL 860 00:34:45,560 --> 00:34:47,680 TRIALS MUST BE REGISTERED IN A 861 00:34:47,680 --> 00:34:50,680 CLINICAL TRIALS.GOV. 862 00:34:50,680 --> 00:34:52,680 THE REPORTS FROM THAT VALID 863 00:34:52,680 --> 00:34:55,440 ANALYSIS MUST NOW BE REPORTED IN 864 00:34:55,440 --> 00:34:57,480 CLINICAL TRIALS.GOV AS A RESULT 865 00:34:57,480 --> 00:35:01,200 OF THE 21st CENTURY CURES ACT. 866 00:35:01,200 --> 00:35:03,520 I WANT TO REMIND YOU THAT VALID 867 00:35:03,520 --> 00:35:05,560 ANALYSIS IS DIFFERENT FROM A 868 00:35:05,560 --> 00:35:07,760 STATISTICAL ANALYSIS AND THE 869 00:35:07,760 --> 00:35:08,520 PRINCIPLE REQUIREMENTS FOR 870 00:35:08,520 --> 00:35:10,560 INSURING A VALID ANALYSIS OF THE 871 00:35:10,560 --> 00:35:11,840 REQUEST OF INTEREST OR 872 00:35:11,840 --> 00:35:13,760 ALLOCATION OF STUDY PARTICIPANTS 873 00:35:13,760 --> 00:35:16,400 FROM DIFFERENT GROUPS AND AN 874 00:35:16,400 --> 00:35:18,040 UNBIASED PROCESS SUCH AS 875 00:35:18,040 --> 00:35:19,400 RANDOMIZATION AND BIASED 876 00:35:19,400 --> 00:35:20,520 EVALUATION OF THE OUT COMES OF 877 00:35:20,520 --> 00:35:21,560 THE STUDY PARTICIPANTS, FOR 878 00:35:21,560 --> 00:35:23,880 EXAMPLE, BY SEX OR GENDER AND 879 00:35:23,880 --> 00:35:26,280 USE OF UNBIASED STATISTICAL 880 00:35:26,280 --> 00:35:28,120 ANALYSIS AND PROPER METHODS OF 881 00:35:28,120 --> 00:35:29,080 INFERENCE TO ESTIMATE ASK 882 00:35:29,080 --> 00:35:33,880 COMPARE THE INTERCEPTIONS INTERX 883 00:35:33,880 --> 00:35:35,400 RACE OR ETHNICITY. 884 00:35:35,400 --> 00:35:38,000 I ALSO WANT TO HIGHLIGHT FOR YOU 885 00:35:38,000 --> 00:35:41,680 THAT NIH RECENTLY UPDATED OUR 886 00:35:41,680 --> 00:35:43,120 INSTRUCTIONS FOR RESEARCH 887 00:35:43,120 --> 00:35:44,680 PERFORMANCE AND PROGRESS REPORTS 888 00:35:44,680 --> 00:35:46,800 AND DRAW YOUR ATTENTION TO THE 889 00:35:46,800 --> 00:35:50,880 SECTION ON NIH DEFINED PHASE 3 890 00:35:50,880 --> 00:35:52,800 CL3CLINICAL TRIALS. 891 00:35:52,800 --> 00:35:54,560 THEY SHOULD HAVE A STATEMENT 892 00:35:54,560 --> 00:35:56,080 INDICATING THE STATUS OF 893 00:35:56,080 --> 00:35:57,280 ANALYSIS OF THE PRIMARY OUTCOME 894 00:35:57,280 --> 00:36:00,480 BY SEX OR GENDER, RACE AND 895 00:36:00,480 --> 00:36:00,840 ETHNICITY. 896 00:36:00,840 --> 00:36:02,960 IN ADDITION THE RESULTS OF THESE 897 00:36:02,960 --> 00:36:04,880 ANALYSIS SHOULD BE INCLUDED IN 898 00:36:04,880 --> 00:36:06,040 THE PROJECT OUTCOMES SECTION OF 899 00:36:06,040 --> 00:36:07,680 THE RPPR. 900 00:36:07,680 --> 00:36:12,800 IF APPROXIMATIF YOU NEED MORE I, 901 00:36:12,800 --> 00:36:15,160 HERE IS THE WEBSITE UNDER GRANTS 902 00:36:15,160 --> 00:36:15,480 AND FUNDING. 903 00:36:15,480 --> 00:36:16,960 I ALSO WANT TO GIVE YOU AN 904 00:36:16,960 --> 00:36:19,080 UPDATE ON SEVERAL OTHER POLICIES 905 00:36:19,080 --> 00:36:22,040 AND EFFORTS THAT ARE NIH WIDE IN 906 00:36:22,040 --> 00:36:24,000 PARTICULAR NIH UNITE. 907 00:36:24,000 --> 00:36:27,640 AND NIH UNITE LED BY NIH 908 00:36:27,640 --> 00:36:29,080 LEADERSHIP AND THE CHIEF OFFICER 909 00:36:29,080 --> 00:36:30,640 FOR SCIENTIFIC WORKFORCE 910 00:36:30,640 --> 00:36:32,680 DIVERSITY Dr. MARIE BERNARD 911 00:36:32,680 --> 00:36:34,280 PUBLISHED A PROGRESS REPORT AND 912 00:36:34,280 --> 00:36:35,760 HERE ARE SOME OF THE EFFORTS 913 00:36:35,760 --> 00:36:38,720 THAT THEY HIGHLIGHTED. 914 00:36:38,720 --> 00:36:42,400 IN THAT PROGRESS REPORT, THE RFA 915 00:36:42,400 --> 00:36:44,320 LED BY NATIONAL INSTITUTE OF 916 00:36:44,320 --> 00:36:45,480 MINORITY HEALTH AND HEALTH 917 00:36:45,480 --> 00:36:46,440 DISPARITIES ON UNDERSTANDING AND 918 00:36:46,440 --> 00:36:48,000 ADDRESSING THE IMPACT OF 919 00:36:48,000 --> 00:36:49,960 STRUCTURAL RACISM AND 920 00:36:49,960 --> 00:36:51,360 DISCRIMINATION ON MINORITY 921 00:36:51,360 --> 00:36:52,640 HEALTH AND HEALTH DISPARITIES 922 00:36:52,640 --> 00:36:55,800 WAS HIGHLIGHTED AND THE PLAN FOR 923 00:36:55,800 --> 00:36:57,840 ANYTHING DIVERSE PERSPECTIVES OR 924 00:36:57,840 --> 00:37:00,440 PDEP PILOT THAT NINDS IS LEADING 925 00:37:00,440 --> 00:37:03,360 IN THE BRAIN INITIATIVE WAS 926 00:37:03,360 --> 00:37:04,200 MENTION OF THE. 927 00:37:04,200 --> 00:37:06,360 TWO COMMON FUND PROGRAMS, THE 928 00:37:06,360 --> 00:37:07,480 TRANSFORMATIVE RESEARCH TO 929 00:37:07,480 --> 00:37:11,320 ADDRESS HEALTH DISPARITIES AND 930 00:37:11,320 --> 00:37:12,120 ADVANCE HEALTH ECONOMIC 931 00:37:12,120 --> 00:37:13,360 INITIATIVE AND ADVANCE SCIENCE 932 00:37:13,360 --> 00:37:14,720 FOR SOCIETY OR COMPASS EFFORTS 933 00:37:14,720 --> 00:37:17,360 WERE HIGHLIGHTED AS WELL AND I 934 00:37:17,360 --> 00:37:18,760 CONTINUE TO BE HOP RESIDENT TO 935 00:37:18,760 --> 00:37:22,560 CO-CHAIR THE WORKING GROUP FOR 936 00:37:22,560 --> 00:37:23,160 COMPASS. 937 00:37:23,160 --> 00:37:24,760 A VARIETY OF OTHER EFFORTS 938 00:37:24,760 --> 00:37:27,040 INCLUDING MORE TRANSPARENT DATA 939 00:37:27,040 --> 00:37:28,400 REPORTING AND THE DATA 940 00:37:28,400 --> 00:37:30,720 DASHBOARD, THE POWER OF AN 941 00:37:30,720 --> 00:37:32,280 INCLUSIVE WORK SPACE RECOGNITION 942 00:37:32,280 --> 00:37:35,080 PROJECTS AND OPPORTUNITIES FOR 943 00:37:35,080 --> 00:37:37,000 GRANTEES TO NOTIFY NIH ABOUT A 944 00:37:37,000 --> 00:37:39,960 CONCERN RELATED TO HARASSMENT, 945 00:37:39,960 --> 00:37:41,640 DISCRIMINATION OR OTHER 946 00:37:41,640 --> 00:37:42,600 INAPPROPRIATE CONDUCT INCLUDED 947 00:37:42,600 --> 00:37:45,520 BUT NOT LIMITED TO SEXUAL 948 00:37:45,520 --> 00:37:46,600 HARASSMENT, RACIAL 949 00:37:46,600 --> 00:37:48,040 DISCRIMINATION AND FULLYING AND 950 00:37:48,040 --> 00:37:51,360 WHAT CONTRIBUTING TO AN UNSAFE 951 00:37:51,360 --> 00:37:51,960 OR HOSTILE WORK ENVIRONMENT 952 00:37:51,960 --> 00:37:53,520 EFFECTING AN NIH FUNDED PROJECT 953 00:37:53,520 --> 00:37:55,640 AND A RECIPIENT INSTITUTION AND 954 00:37:55,640 --> 00:37:58,400 THERE'S A FORM AVAILABLE ON ERA 955 00:37:58,400 --> 00:38:01,480 COMMONS TO REPORT SUCH CONCERNS. 956 00:38:01,480 --> 00:38:04,360 AND I WANT TO THANK THE OFFICE 957 00:38:04,360 --> 00:38:07,040 OF SCIENTIFIC WORKFORCE 958 00:38:07,040 --> 00:38:08,400 DIVERSITY FOR LEADING THE 959 00:38:08,400 --> 00:38:09,920 PREPARATION OF THE UNITE 960 00:38:09,920 --> 00:38:11,480 PROGRESS REPORT. 961 00:38:11,480 --> 00:38:12,360 OTHER UPDATES. 962 00:38:12,360 --> 00:38:16,720 WE'RE EXCITED O SHAR EXCITE TO A 963 00:38:16,720 --> 00:38:18,800 POLICYERS AND WERE HIGHLIGHTED 964 00:38:18,800 --> 00:38:21,040 IN THE NIH IMPACT PAGES UNDER 965 00:38:21,040 --> 00:38:23,800 THE REVOLUTIONIZING SCIENCE 966 00:38:23,800 --> 00:38:24,280 SECTION. 967 00:38:24,280 --> 00:38:27,480 THE IMPACT PAGES DEMONSTRATE THE 968 00:38:27,480 --> 00:38:30,360 WAYS THAT NIH RESEARCH HAS HAD 969 00:38:30,360 --> 00:38:32,200 IN INFLUENCE AND IMPACT ON THE 970 00:38:32,200 --> 00:38:34,240 WORLD AROUND US. 971 00:38:34,240 --> 00:38:36,400 SO TAKE A LOOK AT THE IMPACT 972 00:38:36,400 --> 00:38:38,320 PAGES AND YOU CAN LEARN MORE 973 00:38:38,320 --> 00:38:42,480 ABOUT THE SABB IMPACT PAGE. 974 00:38:42,480 --> 00:38:44,240 ORWH UPDATED AND EXPANDED OUR 975 00:38:44,240 --> 00:38:47,840 SEX AND GENDER WEB PAGE ON OUR 976 00:38:47,840 --> 00:38:49,960 ORWH WEBSITE OUTLINING SEX AS A 977 00:38:49,960 --> 00:38:51,080 BIOLOGICAL VARIABLE AND GENDER 978 00:38:51,080 --> 00:38:52,800 AS A SOCIAL AND CULTURAL 979 00:38:52,800 --> 00:38:55,200 VARIABLE AND PROVIDED AN UPDATE 980 00:38:55,200 --> 00:38:57,120 TO OUR SEX AND GENDER INFORM 981 00:38:57,120 --> 00:38:59,000 GRAPHIC OUTLINE ARE VARIOUS WAYS 982 00:38:59,000 --> 00:39:01,040 THAT SEX AND GENDER CAN EFFECT 983 00:39:01,040 --> 00:39:05,000 HEALTH AND DISEASE HERE I'M JUST 984 00:39:05,000 --> 00:39:06,400 HIGHLIGHTING WITHIN OF THE MANY 985 00:39:06,400 --> 00:39:06,800 ON MENTAL HEALTH. 986 00:39:06,800 --> 00:39:08,560 TAKE A LOOK AT OUR WEBSITE AND 987 00:39:08,560 --> 00:39:11,360 YOU CAN ALSO PULL OR SEX AND 988 00:39:11,360 --> 00:39:12,840 GENDER AND HEALTH AND DISEASE 989 00:39:12,840 --> 00:39:13,880 FACT SHARE TO SHARE MORE 990 00:39:13,880 --> 00:39:17,880 INFORMATION AND I WANT TO 991 00:39:17,880 --> 00:39:22,280 ACKNOWLEDGE OUR ORWH TEAM FOR 992 00:39:22,280 --> 00:39:22,920 LEADING THOSE EFFORTS. 993 00:39:22,920 --> 00:39:25,400 I'M GOING TO MOVE INTO THIS 994 00:39:25,400 --> 00:39:27,800 SECTION ON ICO COLLABORATION AND 995 00:39:27,800 --> 00:39:31,120 I'M GOING TO SHARE A NEW 996 00:39:31,120 --> 00:39:31,960 COLLABORATION THAT ORWH HAS 997 00:39:31,960 --> 00:39:33,240 EMBARKED UPON WITH THE NIH 998 00:39:33,240 --> 00:39:36,040 OFFICE OF AIDS RESEARCH. 999 00:39:36,040 --> 00:39:37,880 DESPITE IMMENSE SCIENTIFIC 1000 00:39:37,880 --> 00:39:39,680 ADVANCES, WOMEN AND GIRLS 1001 00:39:39,680 --> 00:39:42,560 INCLUDING TRANSGENDER AND GENDER 1002 00:39:42,560 --> 00:39:44,120 CONNECTICUT FIRMING PEOPLE ARE 1003 00:39:44,120 --> 00:39:44,960 AFFECTED BY HIV. 1004 00:39:44,960 --> 00:39:47,920 HALF OF ALL NEW INFECTIONS 1005 00:39:47,920 --> 00:39:49,440 WORLDWIDE ARE AMONG WOMEN AND 1006 00:39:49,440 --> 00:39:51,960 THIS IS HEAVILY WEIGHTED AMONG 1007 00:39:51,960 --> 00:39:53,400 ADOLESCENT GIRLS AND YOUNG WOMEN 1008 00:39:53,400 --> 00:39:57,560 IN EAST AND SOUTHERN AFRICA. 1009 00:39:57,560 --> 00:40:01,520 IN 2021, 20 MILLION AND GIRLS 1010 00:40:01,520 --> 00:40:04,000 WERE LIVING WELL HIV. 1011 00:40:04,000 --> 00:40:14,480 54% OF ALL PEOPLE. 1012 00:40:14,480 --> 00:40:16,600 AND THE PREVALENCE AMONG 1013 00:40:16,600 --> 00:40:18,880 TRANSGENDER WOMEN IS HIGH 1014 00:40:18,880 --> 00:40:23,080 ESTIMATED AT 20% AND THEY 1015 00:40:23,080 --> 00:40:24,160 EXPERIENCE 14-FOLD GREATER RISK 1016 00:40:24,160 --> 00:40:28,680 OF ACQUIRING LIVED THAN ADULT 1017 00:40:28,680 --> 00:40:30,480 CISGENDER WOMEN. 1018 00:40:30,480 --> 00:40:33,720 IN 2022, THE WOMEN'S HIV 1019 00:40:33,720 --> 00:40:35,000 RESEARCH FUNDING AT NIH WAS 1020 00:40:35,000 --> 00:40:37,480 ESTIMATED AT JUST UNDER 1021 00:40:37,480 --> 00:40:38,920 $500 MILLION DELINEATED HERE ON 1022 00:40:38,920 --> 00:40:40,680 THE SLIDE ON THE LEFT. 1023 00:40:40,680 --> 00:40:43,240 ALL WOMEN'S HEALTH PROJECTS HERE 1024 00:40:43,240 --> 00:40:46,360 AND THEN ALL HIV PROJECTS HERE. 1025 00:40:46,360 --> 00:40:49,960 TOPICS FUNDED INCLUDE ALL THE 1026 00:40:49,960 --> 00:40:51,520 NIH HIV RESEARCH PRIORITIES WITH 1027 00:40:51,520 --> 00:40:52,600 INVESTMENTS IN CROSS CUTTING 1028 00:40:52,600 --> 00:40:54,400 RESEARCH AND IMPROVING THERAPIES 1029 00:40:54,400 --> 00:40:56,520 FOR HIV ASSOCIATED CO-MORBIDITY 1030 00:40:56,520 --> 00:40:59,200 AND CO INFECTIONS AND DESPITE 1031 00:40:59,200 --> 00:41:01,880 THIS INVESTMENT RESEARCH ON 1032 00:41:01,880 --> 00:41:03,360 WOMEN AND HIV UNDER REPRESENTED 1033 00:41:03,360 --> 00:41:05,280 WITHIN THE HIV PORTFOLIO AND 1034 00:41:05,280 --> 00:41:08,440 RESEARCH TO IMPROVE WOMEN'S 1035 00:41:08,440 --> 00:41:10,720 HEALTH WE KNOWS REQUIRES A 1036 00:41:10,720 --> 00:41:11,960 MULTI-DISCIPLINARY APPROACH TO 1037 00:41:11,960 --> 00:41:13,840 ENSURE COMPREHENSIVE 1038 00:41:13,840 --> 00:41:15,320 CONSIDERATION OF MANY INTERNAL 1039 00:41:15,320 --> 00:41:18,840 AND EXTERNAL FACTORS ACROSS THE 1040 00:41:18,840 --> 00:41:19,360 LIFE COURSE. 1041 00:41:19,360 --> 00:41:22,560 THIS IS REFLECTED IN THE NIH-HIV 1042 00:41:22,560 --> 00:41:25,040 RESEARCH PORTFOLIO WITH 19 OF 1043 00:41:25,040 --> 00:41:26,240 THE 27 INSTITUTES AND CENTERS 1044 00:41:26,240 --> 00:41:27,920 SHOWN HERE INVESTING IN A WIDE 1045 00:41:27,920 --> 00:41:33,240 RANGE OF RESEARCH TOPICS ON HIV 1046 00:41:33,240 --> 00:41:35,800 AND WOMEN. 1047 00:41:35,800 --> 00:41:36,720 I LOOK FORWARD CONTINUING TO 1048 00:41:36,720 --> 00:41:39,120 WORK WITH OAR ON THIS NEW 1049 00:41:39,120 --> 00:41:39,840 COLLABORATION. 1050 00:41:39,840 --> 00:41:44,280 THE OBJE OBJECT OBJECTIVES OF TS 1051 00:41:44,280 --> 00:41:45,360 ORWH SIGNATURE PROGRAM ON HIV 1052 00:41:45,360 --> 00:41:46,640 AND WOMEN IN PARTNERSHIP WITH 1053 00:41:46,640 --> 00:41:48,280 ORWH ARE TO PRE MET HEALTH FOR 1054 00:41:48,280 --> 00:41:49,920 ALL WOMEN LIVING WITH OUR AT 1055 00:41:49,920 --> 00:41:51,840 RISK WITH HIV AND SUPPORT CAREER 1056 00:41:51,840 --> 00:41:56,040 DEVELOPMENT FOR WOMEN IN HIV 1057 00:41:56,040 --> 00:41:57,920 RESEARCH. 1058 00:41:57,920 --> 00:41:58,840 THE PROGRAM WILL SUPPORT 1059 00:41:58,840 --> 00:41:59,640 EFFORTS. 1060 00:41:59,640 --> 00:42:00,840 ONE OF THE STRATEGIES THAT WE'VE 1061 00:42:00,840 --> 00:42:02,560 EMPLOYED FIRST WAS TO FORM A 1062 00:42:02,560 --> 00:42:04,680 WORKING GROUP ON HIV IN WOMEN 1063 00:42:04,680 --> 00:42:08,080 AND THAT IS LINKING THE NATIONAL 1064 00:42:08,080 --> 00:42:09,520 ADVISE AIDS ADVISORY COMMITTEE 1065 00:42:09,520 --> 00:42:13,080 AS WELL AS THE CCRWH OUR NIH 1066 00:42:13,080 --> 00:42:14,240 COORDINATING COMMITTEE FOR 1067 00:42:14,240 --> 00:42:15,920 RESEARCH ON WOMEN'S HEALTH. 1068 00:42:15,920 --> 00:42:17,760 WE HAD A JOINT SYMPOSIUM AT THE 1069 00:42:17,760 --> 00:42:19,280 13th INTERNATIONAL WORKSHOP ON 1070 00:42:19,280 --> 00:42:21,400 WOMEN AND HIV CALLED 1071 00:42:21,400 --> 00:42:23,160 CONSIDERATIONS FROM ACROSS THE 1072 00:42:23,160 --> 00:42:23,600 LIFESPAN. 1073 00:42:23,600 --> 00:42:25,920 THAT SYMPOSIUM FOCUSED ON 1074 00:42:25,920 --> 00:42:26,960 ADOLESCENT GIRLS AND YOUNG 1075 00:42:26,960 --> 00:42:27,560 WOMEN. 1076 00:42:27,560 --> 00:42:30,600 MULTI MORBIDITY AND AGING AND 1077 00:42:30,600 --> 00:42:31,680 SOCIAL AND STRUCTURAL 1078 00:42:31,680 --> 00:42:32,840 CONSIDERATIONS IN HIV RESEARCH. 1079 00:42:32,840 --> 00:42:35,280 YOU CAN LEARN MORE ABOUT THIS 1080 00:42:35,280 --> 00:42:36,920 SYMPOSIUM AND THE NEW SIGNATURE 1081 00:42:36,920 --> 00:42:39,000 PROGRAM AT OUR WEBSITE AS WELL 1082 00:42:39,000 --> 00:42:41,360 AS OAR'S WEBSITE AND I WAS 1083 00:42:41,360 --> 00:42:44,320 PLEASED TO JOIN Dr. MARINE 1084 00:42:44,320 --> 00:42:46,080 GOODNOW WITH A JOINT BLOG ABOUT 1085 00:42:46,080 --> 00:42:47,560 THESE EFFORTS AND I WANT TO 1086 00:42:47,560 --> 00:42:49,480 THANK HER FOR HER COLLABORATION 1087 00:42:49,480 --> 00:42:53,360 AND SCIENTIFIC LEADERSHIP IN 1088 00:42:53,360 --> 00:42:56,960 THIS SPACE. 1089 00:42:56,960 --> 00:42:58,840 ANOTHER CRITICAL AREA FOR 1090 00:42:58,840 --> 00:43:01,400 WOMEN'S HEALTH IS THE RATES OF 1091 00:43:01,400 --> 00:43:02,240 MATERNAL MORTALITY. 1092 00:43:02,240 --> 00:43:03,800 I SHOWED YOU WORLDWIDE RATES AT 1093 00:43:03,800 --> 00:43:05,000 THE BEGINNING OF THIS 1094 00:43:05,000 --> 00:43:06,880 PRESENTATION AND NOW I WANT TO 1095 00:43:06,880 --> 00:43:08,320 SHARE WITH YOU RECENT DATA FROM 1096 00:43:08,320 --> 00:43:10,720 THE NATIONAL CENTER FOR HEALTH 1097 00:43:10,720 --> 00:43:15,240 STATISTICS ON U.S. RATES OF 2018 1098 00:43:15,240 --> 00:43:15,680 TO 2021. 1099 00:43:15,680 --> 00:43:17,120 TOTAL, YOU CAN SEE HERE WAS 1100 00:43:17,120 --> 00:43:18,920 SIGNIFICANT INCREASES IN THE 1101 00:43:18,920 --> 00:43:21,800 LAST THREE YEARS INDICATED BY 1102 00:43:21,800 --> 00:43:27,360 THE RED ASTERISKS THE RATES HERE 1103 00:43:27,360 --> 00:43:28,560 ARE WITH SIGNIFICANT INCREASES 1104 00:43:28,560 --> 00:43:31,600 AND THE LAST TWO YEARS AND THE 1105 00:43:31,600 --> 00:43:35,200 YEAR OVER YEAR INCREASES FOR 1106 00:43:35,200 --> 00:43:36,400 NON-HISPANIC WHITE. 1107 00:43:36,400 --> 00:43:38,160 YOU CAN SEE INCREASES FOR 1108 00:43:38,160 --> 00:43:40,000 PREGNANT WOMEN AS WELL AS FOR 1109 00:43:40,000 --> 00:43:42,040 NEW TRENDS IN INCREASES IN 1110 00:43:42,040 --> 00:43:45,280 HISPANIC MATERNAL MORTALITY 1111 00:43:45,280 --> 00:43:46,480 RATES THAT ARE OF SIGNIFICANT 1112 00:43:46,480 --> 00:43:48,080 CONCERN TO US ALL. 1113 00:43:48,080 --> 00:43:50,320 WHEN YOU BREAK THIS DOWN BY AGE, 1114 00:43:50,320 --> 00:43:52,920 YOU CAN SEE INCREASES ACROSS THE 1115 00:43:52,920 --> 00:43:58,280 BOARD, EVEN IN UNDER 25 AND 25 1116 00:43:58,280 --> 00:43:59,960 TO 39 AGE GROUPS AND OF COURSE 1117 00:43:59,960 --> 00:44:01,480 OLDER AGE GROUPS OVER 40 HAVE 1118 00:44:01,480 --> 00:44:03,640 HIGHER RATES OF MATERNAL 1119 00:44:03,640 --> 00:44:05,520 MORTALITY AND WE SEE THAT 1120 00:44:05,520 --> 00:44:09,880 INCREASING EVEN FURTHERMORE FURE 1121 00:44:09,880 --> 00:44:10,920 RECENTLY. 1122 00:44:10,920 --> 00:44:12,720 IN TERMS OF PREGNANCY MORTALITY 1123 00:44:12,720 --> 00:44:16,920 RATIOS THEY'VE INCREASED, MORE 1124 00:44:16,920 --> 00:44:19,760 IN 2021 NAN 2020. 1125 00:44:19,760 --> 00:44:21,400 THIS DATA DA LYNN IT'S A THE 1126 00:44:21,400 --> 00:44:24,480 PREGNANCY RELATED WITHOUT A 1127 00:44:24,480 --> 00:44:27,640 COVID-19 CODE IN TERMS OF 1128 00:44:27,640 --> 00:44:34,360 IDENTIFYING THIS DARKER BLUE 1129 00:44:34,360 --> 00:44:44,560 AREA AND A 1130 00:44:45,320 --> 00:44:46,560 CONCERNING MATERNITY MORTALITY 1131 00:44:46,560 --> 00:44:47,960 RATE IN THIS COUNTRY. 1132 00:44:47,960 --> 00:44:51,280 AND IF YOU LOOK AT RURAL OR 1133 00:44:51,280 --> 00:44:53,120 URBAN RESIDENTS IN A SIMILAR 1134 00:44:53,120 --> 00:44:55,680 TIME PERIOD, YOU CAN SEE LARGE 1135 00:44:55,680 --> 00:44:56,880 METROPOLITAN AREAS HAVE ALSO 1136 00:44:56,880 --> 00:44:59,920 SHOWN AN INCREASE, MEDIUM AND 1137 00:44:59,920 --> 00:45:01,560 SMALL METROPOLITAN AREAS WITH 1138 00:45:01,560 --> 00:45:03,640 RURAL AND URBAN RESIDENTS 1139 00:45:03,640 --> 00:45:06,360 CATEGORIES AND JUST RURAL AREAS 1140 00:45:06,360 --> 00:45:07,960 AS WELL OVER LYING THIS 1141 00:45:07,960 --> 00:45:14,720 COMPLICATED PICTURE IS THE 1142 00:45:14,720 --> 00:45:22,640 INCREASE WHERE THEY HAVE CARE 1143 00:45:22,640 --> 00:45:23,720 FOR WOMEN TO DELIVER. 1144 00:45:23,720 --> 00:45:26,800 IN TERMS IT OF THE COVID-19 1145 00:45:26,800 --> 00:45:28,680 ISSUES, I WANT TO HIGHLIGHT THAT 1146 00:45:28,680 --> 00:45:30,080 SOME NEW RESOURCE HAVE BECOME 1147 00:45:30,080 --> 00:45:34,000 AVAILABLE AND THERE ARE SOME NEW 1148 00:45:34,000 --> 00:45:36,000 PUBLICATIONS, SCIENCE RECENTLY 1149 00:45:36,000 --> 00:45:37,480 HIGHLIGHT THERE'S A HIGHLIGHT 1150 00:45:37,480 --> 00:45:39,760 OPT NIH LED RESEARCH RESPONSE TO 1151 00:45:39,760 --> 00:45:42,480 COVID-19 AND THAT IS A EXCELLENT 1152 00:45:42,480 --> 00:45:47,200 SUMMARY OF OVER ALL EFFORTS. 1153 00:45:47,200 --> 00:45:49,400 YOU'VE HEARD HERE BEFORE WILL 1154 00:45:49,400 --> 00:45:52,640 RECOVERY SEARCH AND DROVE 1155 00:45:52,640 --> 00:45:54,120 ENHANCE RECOVER ARE IN THE LEAD 1156 00:45:54,120 --> 00:45:56,400 FOR THESE EFFORTS ON NIH 1157 00:45:56,400 --> 00:46:00,960 RESEARCH ON COVID AND INCLUDING 1158 00:46:00,960 --> 00:46:03,000 LONG COVID AND BOTH PREGNANT AND 1159 00:46:03,000 --> 00:46:05,240 LACTATING PEOPLE ARE INCLUDED IN 1160 00:46:05,240 --> 00:46:06,560 THOSE RESEARCH EFFORTS AND THE 1161 00:46:06,560 --> 00:46:09,320 NIH COMMUNITY ENGAGEMENT 1162 00:46:09,320 --> 00:46:12,560 ALLIANCE OR SEAL HAS LONG COVID 1163 00:46:12,560 --> 00:46:15,880 RESOURCES I'M HIGHLIGHTING HERE 1164 00:46:15,880 --> 00:46:17,400 AS WELL AS A VARIETY OF OTHERS. 1165 00:46:17,400 --> 00:46:19,200 IN THE INTEREST OF TIME I WANT 1166 00:46:19,200 --> 00:46:21,120 TO HIGHLIGHT THESE IN SINGLE 1167 00:46:21,120 --> 00:46:23,000 SLIDE AND REFER YOU TO THOSE WEB 1168 00:46:23,000 --> 00:46:26,840 SITES FOR MORE DETAILED 1169 00:46:26,840 --> 00:46:27,160 INFORMATION. 1170 00:46:27,160 --> 00:46:28,880 I WANT TO UPDATE YOU ON THE 1171 00:46:28,880 --> 00:46:31,040 STEPS THAT NIH HAS TAKEN JOINING 1172 00:46:31,040 --> 00:46:33,880 FORCES TO TACKLE THE CRITICAL 1173 00:46:33,880 --> 00:46:35,800 PUBLIC-HEALTH CRISIS OF MATERNAL 1174 00:46:35,800 --> 00:46:36,400 MORTALITY IN THE UNITED STATES 1175 00:46:36,400 --> 00:46:39,120 THROUGH THE IMPROVE INITIATIVE. 1176 00:46:39,120 --> 00:46:40,800 IMPROVE STANDS FOR IMPLEMENTING 1177 00:46:40,800 --> 00:46:43,160 A MATERNAL HEALTH AND PREGNANCY 1178 00:46:43,160 --> 00:46:45,760 OUTCOMES VISION FOR EVERYONE AND 1179 00:46:45,760 --> 00:46:47,160 I CONTINUE TO BE PRIVILEGED TO 1180 00:46:47,160 --> 00:46:48,520 CO-CHAIR ALONG WITH THE DIRECTOR 1181 00:46:48,520 --> 00:46:51,600 OF THE EUNICE KENNEDY SHRIVER 1182 00:46:51,600 --> 00:46:53,280 NATIONAL INSTITUTE OF CHILD 1183 00:46:53,280 --> 00:46:54,600 DEVELOPMENT AND THE CO-CHAIR 1184 00:46:54,600 --> 00:47:01,440 NATIONAL INSTITUTE OF NURSING 1185 00:47:01,440 --> 00:47:06,800 RESEARCH Dr. SHANNON ZENK. 1186 00:47:06,800 --> 00:47:08,840 THE MATERNAL RESEARCH CENTERS 1187 00:47:08,840 --> 00:47:10,120 HEALTH OF EXCELLENCE AND OTHER 1188 00:47:10,120 --> 00:47:14,720 EFFORTS THAT SURROUND THAT 1189 00:47:14,720 --> 00:47:15,440 CENTER PIECE. 1190 00:47:15,440 --> 00:47:18,400 IT WAS LAUNCHED IN FY20 AND IN 1191 00:47:18,400 --> 00:47:20,880 21 AND 22 AND NIH WORKED ACROSS 1192 00:47:20,880 --> 00:47:22,400 THE INSTITUTES AND CENTERS TO 1193 00:47:22,400 --> 00:47:26,040 FUND THESE EFFORTS ON THE 1194 00:47:26,040 --> 00:47:27,280 PERIPHERY AND WE ARE LOOKING 1195 00:47:27,280 --> 00:47:29,320 FORWARD TO FUNDING THE MATERNAL 1196 00:47:29,320 --> 00:47:30,600 HEALTH RESEARCH CENTERS OF EX 1197 00:47:30,600 --> 00:47:34,440 TENSE AND FY23 FOLLOWING A 1198 00:47:34,440 --> 00:47:36,880 CONGRESSIONAL APPROPRIATION IN 1199 00:47:36,880 --> 00:47:38,280 FY22 AND FORWARD FOR $30 MILLION 1200 00:47:38,280 --> 00:47:41,840 TO THE IMPROVE INITIATIVE. 1201 00:47:41,840 --> 00:47:45,360 WE RECENTLY HOSTED AN AWARDEE 1202 00:47:45,360 --> 00:47:46,800 WORKSHOP WHERE GRANTEES 1203 00:47:46,800 --> 00:47:48,240 HIGHLIGHTED LESSONS LEARNED FROM 1204 00:47:48,240 --> 00:47:50,160 IMPROVED PROJECTS IDENTIFIED 1205 00:47:50,160 --> 00:47:51,360 COMMON THEMES AND SHARED 1206 00:47:51,360 --> 00:47:52,560 RESEARCH GAPS AND OPPORTUNITIES 1207 00:47:52,560 --> 00:47:54,120 FOR ON GOING COLLABORATION AND 1208 00:47:54,120 --> 00:47:56,280 FURTHER DEFINED THE NEEDS OF 1209 00:47:56,280 --> 00:47:58,960 PREGNANT AND POSTPARTUM 1210 00:47:58,960 --> 00:48:02,080 INDIVIDUALS TO REDUCE 1211 00:48:02,080 --> 00:48:04,920 PREVENTABLE DEATHS. 1212 00:48:04,920 --> 00:48:06,400 IMPROVE LEADERSHIP -- DELIVERED 1213 00:48:06,400 --> 00:48:07,840 A CONGRESSIONAL BRIEFING AND 1214 00:48:07,840 --> 00:48:09,040 UPDATED NIH LEADERSHIP ON THESE 1215 00:48:09,040 --> 00:48:10,600 ACTIVITIES AND I WOULD LIKE FOR 1216 00:48:10,600 --> 00:48:12,960 YOU TO PUT ON YOUR CALENDARS AN 1217 00:48:12,960 --> 00:48:15,200 UPCOMING HYBRID WORKSHOP ON 1218 00:48:15,200 --> 00:48:16,280 INNOVATIVE APPROACHES TO 1219 00:48:16,280 --> 00:48:17,440 IMPROVED MATERNAL HEALTH THAT 1220 00:48:17,440 --> 00:48:22,160 WE'LL HOLD ON MAY EIGHTH AND 1221 00:48:22,160 --> 00:48:24,320 NINTH. 1222 00:48:24,320 --> 00:48:25,880 I'M EXCITE TODAY SHARE THE 1223 00:48:25,880 --> 00:48:28,960 DIAGNOSTIC CHALLENGE. 1224 00:48:28,960 --> 00:48:34,800 FIRST PLACE WENT TO Dr. 1225 00:48:34,800 --> 00:48:36,800 BETHANY FOR HER HOME BASED 1226 00:48:36,800 --> 00:48:38,360 DIAGNOSIS OF SURGICAL SITE 1227 00:48:38,360 --> 00:48:42,000 INFECTION AND ANEMIA AND SECOND 1228 00:48:42,000 --> 00:48:44,480 PLACE WENT TO THE UNIVERSITY OF 1229 00:48:44,480 --> 00:48:46,360 CALIFORNIA IRVINE FOR THEIR 1230 00:48:46,360 --> 00:48:48,920 MATERNAL OBSTETRICAL MONITORING 1231 00:48:48,920 --> 00:48:49,840 SOCKS. 1232 00:48:49,840 --> 00:48:52,640 THESE ARE POINT OF CARE SOCKS 1233 00:48:52,640 --> 00:48:53,320 THAT TRACK BLOOD PRESSURE AND 1234 00:48:53,320 --> 00:48:57,520 HEART RATE AND MONITOR BLOOD 1235 00:48:57,520 --> 00:48:59,640 FLOW AND CAN BE USED DURING AND 1236 00:48:59,640 --> 00:49:01,560 AFTER DELIVERY IN LOW RESOURCE 1237 00:49:01,560 --> 00:49:02,400 SETTINGS. 1238 00:49:02,400 --> 00:49:06,600 THE FIRST WAS A TIE AND IT WENT 1239 00:49:06,600 --> 00:49:10,680 TO RADIANT OX SYMMETRY FOR A 1240 00:49:10,680 --> 00:49:15,160 VARIETY OF WEARABLE DEVICES ONE 1241 00:49:15,160 --> 00:49:18,880 RELATED TO ULTRASOUND AND 1242 00:49:18,880 --> 00:49:22,960 ELECTRIC CHEMICAL CENTER AND ONE 1243 00:49:22,960 --> 00:49:24,480 MONITORS HEMORRHAGE AND FETAL 1244 00:49:24,480 --> 00:49:25,000 DISTRESS. 1245 00:49:25,000 --> 00:49:26,920 SO I WANT TO CONGRATULATE ALL 1246 00:49:26,920 --> 00:49:28,520 THE WINNERS OF THE MATERNAL 1247 00:49:28,520 --> 00:49:30,440 HEALTH DIAGNOSTIC CHALLENGE AND 1248 00:49:30,440 --> 00:49:32,080 HIGHLIGHT THAT THIS IS ONE 1249 00:49:32,080 --> 00:49:34,440 IMPORTANT MECHANISM THAT WE CAN 1250 00:49:34,440 --> 00:49:38,240 SPUR INNOVATION IN THIS 1251 00:49:38,240 --> 00:49:43,000 CRITICALLY IMPORTANT AREA. 1252 00:49:43,000 --> 00:49:44,640 YOU'VE HEARD BEFORE ABOUT ORWH 1253 00:49:44,640 --> 00:49:49,360 AND NLHBI AND NI HMD AND OTHERS 1254 00:49:49,360 --> 00:49:51,760 AT NIH AND THE OFFICE OF DISEASE 1255 00:49:51,760 --> 00:49:53,760 PREVENTION LED PATHWAYS TO 1256 00:49:53,760 --> 00:49:58,080 PREVENTION PROGRAMS OR P2P. 1257 00:49:58,080 --> 00:50:00,040 WE'VE BEEN UNDERWAY WITH THE 1258 00:50:00,040 --> 00:50:01,320 PORTFOLIO ANALYSIS AND THE 1259 00:50:01,320 --> 00:50:03,000 EVIDENCE REPORT VARIOUS 1260 00:50:03,000 --> 00:50:05,240 PRESENTATIONS AND AUDIENCE 1261 00:50:05,240 --> 00:50:06,680 PARTICIPATION AND WORKSHOPS 1262 00:50:06,680 --> 00:50:09,000 BEING CONDUCTED AND I'M EXCITED 1263 00:50:09,000 --> 00:50:10,920 TO SHARE WITH YOU THAT THE 1264 00:50:10,920 --> 00:50:12,960 RECENT WORKSHOP SOME OF THE 1265 00:50:12,960 --> 00:50:14,720 TAKEAWAYS WERE THAT THE STRESS 1266 00:50:14,720 --> 00:50:17,600 TEST OF PREGNANCY CONTINUES 1267 00:50:17,600 --> 00:50:19,520 POSTPARTUM AND WE NEED TO BRIDGE 1268 00:50:19,520 --> 00:50:20,760 BETWEEN CARE OF THE PREGNANT 1269 00:50:20,760 --> 00:50:22,080 INDIVIDUAL AND THE POSTPARTUM 1270 00:50:22,080 --> 00:50:24,640 PERSON AND TAKE A LIVE COURSE 1271 00:50:24,640 --> 00:50:25,680 PERSPECTIVE ON WOMEN'S HEALTH 1272 00:50:25,680 --> 00:50:28,240 AND LISTEN TO THE PATIENT AND 1273 00:50:28,240 --> 00:50:29,960 THEIR FAMILIES AND THE PANEL 1274 00:50:29,960 --> 00:50:31,680 REPORT FROM THE RESENT WORKSHOP 1275 00:50:31,680 --> 00:50:33,840 IS NOW AVAILABLE FOR PUBLIC 1276 00:50:33,840 --> 00:50:35,000 COMMENT AND SO PLEASE TAKE A 1277 00:50:35,000 --> 00:50:36,840 LOOK AT THIS WEBSITE AND PROVIDE 1278 00:50:36,840 --> 00:50:40,040 YOUR THOUGHTS AND PERSPECTIVES. 1279 00:50:40,040 --> 00:50:43,800 AS WE MOVE FORWARD THROUGH THE 1280 00:50:43,800 --> 00:50:45,760 PATHWAYS TO PREVENTION PROJECTS. 1281 00:50:45,760 --> 00:50:47,760 IF YOU MISSED THE WORKSHOP, IT'S 1282 00:50:47,760 --> 00:50:49,760 AVAILABLE ON THE OFFICE OF 1283 00:50:49,760 --> 00:50:51,080 DISEASE PREVENTION WEBSITE. 1284 00:50:51,080 --> 00:50:53,680 THERE WERE TWO AMAZING DYNAMIC 1285 00:50:53,680 --> 00:50:55,000 KEYNOTE SPEAKERS AMONG MANY 1286 00:50:55,000 --> 00:50:58,120 OTHER PRESENTATIONS AND CARE 1287 00:50:58,120 --> 00:51:00,080 BRIDGES AND ALAN TIDA PRESENTED 1288 00:51:00,080 --> 00:51:01,480 ON MATERNAL HEALTH AND THE 1289 00:51:01,480 --> 00:51:03,280 NATION'S FAILURE TO COMMIT 1290 00:51:03,280 --> 00:51:05,280 ITSELF TO REPRODUCTIVE JUSTICE 1291 00:51:05,280 --> 00:51:08,840 FORMALLY AND ALAN TIDA ON 1292 00:51:08,840 --> 00:51:09,680 POSTPARTUM HEALTH AND EQUITY. 1293 00:51:09,680 --> 00:51:12,040 I WANT TO HIGHLIGHT JUST ONE OF 1294 00:51:12,040 --> 00:51:14,320 THE MULTIPLE SKETCHES THAT WERE 1295 00:51:14,320 --> 00:51:16,720 CREATED DURING THE WORKSHOP AND 1296 00:51:16,720 --> 00:51:18,760 THIS ONE IS THE ROUNDTABLE ON 1297 00:51:18,760 --> 00:51:20,160 ELEVATING PATIENT CENTERS 1298 00:51:20,160 --> 00:51:22,280 STRATEGIES AND CARE AND 1299 00:51:22,280 --> 00:51:23,800 IDENTIFYING RISKS AND 1300 00:51:23,800 --> 00:51:26,080 INTERVENTION TO OPTIMIZE 1301 00:51:26,080 --> 00:51:26,800 POSTPARTUM HEALTH WAS THE TITLE 1302 00:51:26,800 --> 00:51:29,200 OF THAT WORKSHOP AND YOU CAN SEE 1303 00:51:29,200 --> 00:51:30,720 THAT IT DELINEATES THE 1304 00:51:30,720 --> 00:51:34,080 IMPORTANCE OF A VARIETY OF 1305 00:51:34,080 --> 00:51:35,480 EFFORTS AND ELEVATING, SHARING 1306 00:51:35,480 --> 00:51:37,080 THE VOICE OF THE PATIENT, FOR 1307 00:51:37,080 --> 00:51:41,040 EXAMPLE AND SUPPORTING AND 1308 00:51:41,040 --> 00:51:41,960 EDUCATING THE INDIVIDUAL 1309 00:51:41,960 --> 00:51:44,680 MATERNAL MORBIDITY AND IN 1310 00:51:44,680 --> 00:51:46,600 INDIGENOUS POPULATIONS AND THE 1311 00:51:46,600 --> 00:51:48,360 PATIENT PERSPECTIVE. 1312 00:51:48,360 --> 00:51:53,720 THERE ARE SO MANY RICH CONCEPTS 1313 00:51:53,720 --> 00:51:55,640 DISCUSSED THERE, EQUITABLE BIRTH 1314 00:51:55,640 --> 00:51:58,560 CARE AND I HIGHLIGHT THE SKETCH 1315 00:51:58,560 --> 00:52:00,400 EFFECT HERE THAT YOU CAN REVIEW 1316 00:52:00,400 --> 00:52:04,480 WE HAVE SKETCHES FROM EACH OF 1317 00:52:04,480 --> 00:52:10,080 THE SECTIONS VEIL ONLY ON THE 1318 00:52:10,080 --> 00:52:12,400 WORKSHOP. 1319 00:52:12,400 --> 00:52:21,240 ANOTHER IMPORTANT AREA IS 1320 00:52:21,240 --> 00:52:24,560 INTIMATE PARTNER VIOLENCE. 1321 00:52:24,560 --> 00:52:26,680 AND FIRST MENTAL HEALTH OUTCOMES 1322 00:52:26,680 --> 00:52:28,600 AMONG WOMEN AND DURING THE 1323 00:52:28,600 --> 00:52:30,160 PANDEMIC, THIS PAPER LOOKED AT 1324 00:52:30,160 --> 00:52:32,240 THREE PERSPECTIVE POPULATION 1325 00:52:32,240 --> 00:52:35,240 BASED LONGITUDINAL U.S. COHORT 1326 00:52:35,240 --> 00:52:36,640 STUDIES WELL-KNOWN TO YOU AND 1327 00:52:36,640 --> 00:52:39,400 INCLUDING THE NURSES HEALTH 1328 00:52:39,400 --> 00:52:40,560 STUDY AND EXAMINED INTIMATE 1329 00:52:40,560 --> 00:52:41,840 PARTNER VIOLENCE AND EXPERIENCES 1330 00:52:41,840 --> 00:52:43,840 AT THE START OF THE PANDEMIC AND 1331 00:52:43,840 --> 00:52:45,520 THEY WERE ASSOCIATED WITH HIGHER 1332 00:52:45,520 --> 00:52:47,480 REPORTS OF DEPRESSION AND 1333 00:52:47,480 --> 00:52:52,040 ANXIETY AND POST TRAUMATIC 1334 00:52:52,040 --> 00:52:53,920 STRESS SYMPTOMS AS WELL AS POOR 1335 00:52:53,920 --> 00:52:55,560 SLEEP QUALITY, SHORT SLEEP 1336 00:52:55,560 --> 00:52:56,760 DURATION AND INCREASE USE OF 1337 00:52:56,760 --> 00:52:59,200 ALCOHOL AND OTHER SUBSTANCES TO 1338 00:52:59,200 --> 00:53:04,920 COPE WITH STRESS. 1339 00:53:04,920 --> 00:53:08,320 WITH PARTNERS WITH THE NATIONAL 1340 00:53:08,320 --> 00:53:09,840 INSTITUTE OF NURSING AND OFFICE 1341 00:53:09,840 --> 00:53:13,400 OF BEHAVIORAL AND ODP ON A 1342 00:53:13,400 --> 00:53:15,120 RECENT REQUEST FOR INFORMATION 1343 00:53:15,120 --> 00:53:16,680 ON FUTURE DIRECTIONS OF VIOLENCE 1344 00:53:16,680 --> 00:53:19,200 AGAINST WOMEN RESEARCH AND WE 1345 00:53:19,200 --> 00:53:21,520 ARE IN THE PROCESS OF ANALYZING 1346 00:53:21,520 --> 00:53:24,360 THE DATA IN COLLABORATION WITH 1347 00:53:24,360 --> 00:53:26,000 NINR AND PARTNERS SO STAY TUNED 1348 00:53:26,000 --> 00:53:28,400 FOR MORE THERE. 1349 00:53:28,400 --> 00:53:30,160 AS I MOVE INTO THIS LAST SECTION 1350 00:53:30,160 --> 00:53:33,800 OF THE PRESENTATION ON CAREERS, 1351 00:53:33,800 --> 00:53:34,360 CRITICALLY IMPORTANT AREA. 1352 00:53:34,360 --> 00:53:36,200 I WANT TO HIGHLIGHT A NEW REPORT 1353 00:53:36,200 --> 00:53:37,600 FROM THE NATIONAL ACADEMIES OF 1354 00:53:37,600 --> 00:53:42,440 SCIENCE ENGINEERING AND 1355 00:53:42,440 --> 00:53:43,800 MEDICINE. 1356 00:53:43,800 --> 00:53:45,600 THERE WERE EIGHT RECOMMENDATION 1357 00:53:45,600 --> 00:53:47,120 AND I'M HIGHLIGHTING THREE AREAS 1358 00:53:47,120 --> 00:53:50,320 AND IMPORTANCE OF DEVELOPING AND 1359 00:53:50,320 --> 00:53:51,920 PLANS TO PROMOTE AN ACCESSIBLE 1360 00:53:51,920 --> 00:53:54,920 CULTURE AND ADDRESS BIAS. 1361 00:53:54,920 --> 00:54:01,040 COLLECTING DATA ON DEMOGRAPHICS 1362 00:54:01,040 --> 00:54:03,440 AND AND REDRESSING BIAS AND 1363 00:54:03,440 --> 00:54:05,200 DISCRIMINATION IN ORGANIZATIONAL 1364 00:54:05,200 --> 00:54:05,560 PROCESSES. 1365 00:54:05,560 --> 00:54:07,520 THAT REPORT IS ENTITLED 1366 00:54:07,520 --> 00:54:09,280 ADVANCING ANTI RACISM DIVERSITY, 1367 00:54:09,280 --> 00:54:12,320 EQUITY AND INCLUSION AND STEM 1368 00:54:12,320 --> 00:54:16,200 ORGANIZATIONS BEYOND BROADENING 1369 00:54:16,200 --> 00:54:20,280 PARTICIPATION, I CON SEN ANXIOUY 1370 00:54:20,280 --> 00:54:20,720 REPORT. 1371 00:54:20,720 --> 00:54:22,880 I REFER YOU TO THEIR WEBSITE FOR 1372 00:54:22,880 --> 00:54:23,480 MORE INFORMATION. 1373 00:54:23,480 --> 00:54:25,040 THROUGH THE NIH ADVISORY 1374 00:54:25,040 --> 00:54:28,120 COMMITTEE TO THE DIRECTOR HAS 1375 00:54:28,120 --> 00:54:29,800 EMBARKED ON A WORKING GROUP TO 1376 00:54:29,800 --> 00:54:31,960 ADDRESS REIN-VISIONING U.S. 1377 00:54:31,960 --> 00:54:34,040 POSTDOCTORAL RESEARCH EXPERIENCE 1378 00:54:34,040 --> 00:54:35,120 AND CAREER PROGRESSION WITHIN 1379 00:54:35,120 --> 00:54:36,960 THE BIOMEDICAL RESEARCH ENDER 1380 00:54:36,960 --> 00:54:39,440 PRICE AND THAT ACD WORKING GROUP 1381 00:54:39,440 --> 00:54:42,160 HAS FACILITATED FOUR LISTENING 1382 00:54:42,160 --> 00:54:45,440 SESSION THIS IS MARCH AND THEY 1383 00:54:45,440 --> 00:54:48,400 WERE INTERNATIONAL TRAINING 1384 00:54:48,400 --> 00:54:50,120 CONCERNS AND THE STRUCTURE AND 1385 00:54:50,120 --> 00:54:52,280 VALUE CONNECTS ON UNDER 1386 00:54:52,280 --> 00:54:53,360 REPRESENTED POPULATIONS AND 1387 00:54:53,360 --> 00:54:54,760 COMPENSATION AND BENEFITS TO 1388 00:54:54,760 --> 00:54:57,600 POSTDOCS INCLUDING CHILDCARE AND 1389 00:54:57,600 --> 00:55:01,360 DEPEDEPENDENT CARE, JOB SECURITD 1390 00:55:01,360 --> 00:55:02,800 CAREER PROSPECTS AND QUALITY OF 1391 00:55:02,800 --> 00:55:03,360 LIFE. 1392 00:55:03,360 --> 00:55:08,680 AN RFI IS AVAILABLE ON THIS 1393 00:55:08,680 --> 00:55:09,160 TOPIC. 1394 00:55:09,160 --> 00:55:13,600 WITH LOWER TIME YO MORE TIME YOL 1395 00:55:13,600 --> 00:55:14,480 RESPOND. 1396 00:55:14,480 --> 00:55:16,320 WE'RE INTERESTED IN ANYONE'S 1397 00:55:16,320 --> 00:55:17,520 CONCERNS AND ANYONE EFFECTED BY 1398 00:55:17,520 --> 00:55:21,720 THIS CHALLENGES IN THIS SPACE TO 1399 00:55:21,720 --> 00:55:23,360 ADDRESS THE FUNDAMENTAL 1400 00:55:23,360 --> 00:55:25,760 OBSTACLES FACED BY THE POSTDOC 1401 00:55:25,760 --> 00:55:27,440 TRAINEE EXPERIENCE SO PLEASE DO 1402 00:55:27,440 --> 00:55:29,560 RESPOND TO IT THIS RFI REQUEST 1403 00:55:29,560 --> 00:55:32,600 FOR INFORMATION WITH YOUR 1404 00:55:32,600 --> 00:55:33,080 THOUGHTS. 1405 00:55:33,080 --> 00:55:34,560 I'M EXCITED TO ALSO SHARE WITH 1406 00:55:34,560 --> 00:55:38,080 YOU THE PROGRESS ON OUR GENDER 1407 00:55:38,080 --> 00:55:41,440 R25 AND FIRST EVER R21 CALLED 1408 00:55:41,440 --> 00:55:42,160 GALVANIZING HEALTH EQUITY 1409 00:55:42,160 --> 00:55:44,040 THROUGH NOVEL AND DIVERSE 1410 00:55:44,040 --> 00:55:48,240 EDUCATIONAL RESOURCES OR GENDER 1411 00:55:48,240 --> 00:55:50,040 AND WE HAD OUR FIRST RECEIPT 1412 00:55:50,040 --> 00:55:51,600 DATE TO MEET THE NEED FOR GENDER 1413 00:55:51,600 --> 00:55:53,040 SPECIFIC TRAINING AND SCIENCE 1414 00:55:53,040 --> 00:55:54,560 MEDICINE AND ALLIED HEALTH 1415 00:55:54,560 --> 00:55:55,640 PROFESSIONALS AND TO SUPPORT THE 1416 00:55:55,640 --> 00:55:57,760 DEVELOPMENT OF GENDER FOCUSED 1417 00:55:57,760 --> 00:55:59,880 COURSES FOR METHODS FOR THE 1418 00:55:59,880 --> 00:56:00,840 EXTRA COMMUNITY AND PARTNERSHIP 1419 00:56:00,840 --> 00:56:04,080 WITH OUR ICOs AND ESPECIALLY I 1420 00:56:04,080 --> 00:56:06,320 WANT TO GIVE A SHOUT OUT TO THE 1421 00:56:06,320 --> 00:56:07,640 NATIONAL LIBRARY OF MEDICINE FOR 1422 00:56:07,640 --> 00:56:09,240 TAKE THE LEAD ON ADMINISTERED 1423 00:56:09,240 --> 00:56:11,760 THIS PROGRAM WITH ORWH. 1424 00:56:11,760 --> 00:56:15,640 THE NEXT APPLICATION DATE IS 1425 00:56:15,640 --> 00:56:16,840 JUNE 27th. 1426 00:56:16,840 --> 00:56:20,200 YOU HEARD LAST YEAR AT THE 1427 00:56:20,200 --> 00:56:23,400 VIVIAN PIN SYMPOSIUM ORWH 1428 00:56:23,400 --> 00:56:30,440 INTEREST IN CHAR IT TERRIZING 1429 00:56:30,440 --> 00:56:34,160 CONSISTENT WITH LATCH LER ETAL. 1430 00:56:34,160 --> 00:56:39,160 PEOPLE TAKE MANY PATHS THROUGH 1431 00:56:39,160 --> 00:56:40,240 CAREERS WHETHER IT'S TAKING CARE 1432 00:56:40,240 --> 00:56:42,120 OF THEIR FAMILIES OR LEAVING FOR 1433 00:56:42,120 --> 00:56:45,200 MILITARY SERVICE OR REENGAGING 1434 00:56:45,200 --> 00:56:49,800 IN FORMAL EDUCATION. 1435 00:56:49,800 --> 00:56:53,400 THESE PATHS ARE ALL PART OF THE 1436 00:56:53,400 --> 00:56:55,480 BRAIDED RIVER THAT REPRESENTS A 1437 00:56:55,480 --> 00:56:57,120 MORE CONTEMPORARY META FOR FOR 1438 00:56:57,120 --> 00:56:59,760 CAREER PATHS AND THESE 1439 00:56:59,760 --> 00:57:00,760 EXPERIENCES OF INDIVIDUALS WHEN 1440 00:57:00,760 --> 00:57:03,480 WE HAVE AN I AM CONCLUSIVE STEM 1441 00:57:03,480 --> 00:57:05,480 WORKFORCE UNDERPINNING THIS AND 1442 00:57:05,480 --> 00:57:07,720 MENTORSHIP AND HOLISTIC SUPPORT 1443 00:57:07,720 --> 00:57:08,920 ACROSS THE BOARD PROVIDE NEW 1444 00:57:08,920 --> 00:57:11,160 IDEAS THAT ARE MORE CREATIVE AND 1445 00:57:11,160 --> 00:57:13,760 PRACTICAL TO OFFER INTERNET 1446 00:57:13,760 --> 00:57:14,840 DISCIPLINARY SOLUTIONS TO 1447 00:57:14,840 --> 00:57:16,280 SCIENCE. 1448 00:57:16,280 --> 00:57:17,840 ALONG THOSE LINES, AT THE LAST 1449 00:57:17,840 --> 00:57:19,240 MEETING HERE, IT WAS MY 1450 00:57:19,240 --> 00:57:20,600 PRIVILEGE, ALONG WITH THE 1451 00:57:20,600 --> 00:57:22,240 DIRECTOR OF NATIONAL INSTITUTE 1452 00:57:22,240 --> 00:57:27,680 AND SKIN DISEASES HIGHLIGHT A 1453 00:57:27,680 --> 00:57:28,840 NEW PROGRAM IN WOMEN'S HEALTH 1454 00:57:28,840 --> 00:57:30,880 AUTO MANY UNION AND IMMUNE 1455 00:57:30,880 --> 00:57:32,800 MEDIATED DISEASES A PILOT 1456 00:57:32,800 --> 00:57:34,320 PROGRAM TO SUPPORT AND TRAIN 1457 00:57:34,320 --> 00:57:35,840 WOMEN'S HEALTH SCHOLARS HELPING 1458 00:57:35,840 --> 00:57:38,240 THEM TO ACQUIRE IN HOME SKILLS 1459 00:57:38,240 --> 00:57:40,080 FOR COMPLEX TEAM SCIENCE 1460 00:57:40,080 --> 00:57:42,600 LEADERSHIP AND INCLUDING ACROSS 1461 00:57:42,600 --> 00:57:45,000 TOPICS LIKE DATA SCIENCE AND 1462 00:57:45,000 --> 00:57:48,600 OTHERS THAT INVOLVE LARGE MULTI 1463 00:57:48,600 --> 00:57:49,880 COMPONENT EFFORTS. 1464 00:57:49,880 --> 00:57:52,240 THIS IMMERSIVE COST SECTOR 1465 00:57:52,240 --> 00:57:53,400 COLLABORATIVE EXPERIENCE IN THE 1466 00:57:53,400 --> 00:57:55,560 LEADERSHIP SCHOLARS PROGRAM WILL 1467 00:57:55,560 --> 00:57:57,640 ENABLE THESE INDIVIDUALS TO BE 1468 00:57:57,640 --> 00:58:00,160 WELL PREPARED TO BE LARGE 1469 00:58:00,160 --> 00:58:01,800 CONSORTIUM TEAM LEADERS. 1470 00:58:01,800 --> 00:58:04,680 AND IS BEING CONDUCTED THROUGH H 1471 00:58:04,680 --> 00:58:07,440 THE ACCELERATING ON AUTOIMMUNE 1472 00:58:07,440 --> 00:58:10,920 AND AMP AIM A PUBLIC-PRIVATE 1473 00:58:10,920 --> 00:58:11,720 PARTNERSHIP AT NIH. 1474 00:58:11,720 --> 00:58:13,200 I LOOK FORWARD TO PROVIDE YOU 1475 00:58:13,200 --> 00:58:16,760 WITH UPDATES ON THIS PROGRAM. 1476 00:58:16,760 --> 00:58:19,000 MORE UPDATES GOING FORWARD. 1477 00:58:19,000 --> 00:58:22,960 I ALSO WANT TO HIGHLIGHT FOR YOU 1478 00:58:22,960 --> 00:58:24,760 AN OPPORTUNITY ON O ADVANCING 1479 00:58:24,760 --> 00:58:26,240 GENDER INCLUSIVE EXCELLENCE THAT 1480 00:58:26,240 --> 00:58:27,160 GREW OUT OF THE NIH WORKING 1481 00:58:27,160 --> 00:58:29,400 GROUP ON WOMEN AND BIOMEDICAL 1482 00:58:29,400 --> 00:58:30,800 CAREERS THAT I CO-CHAIR WITH THE 1483 00:58:30,800 --> 00:58:35,600 NIH DIRECTOR. 1484 00:58:35,600 --> 00:58:38,160 THEY HAVE PARTNERED WITH KIDNEY 1485 00:58:38,160 --> 00:58:40,240 DISEASE AND I WANT TO HIGHLIGHT 1486 00:58:40,240 --> 00:58:44,440 THEIR LIP I LEADERSHIP IN THIS 1487 00:58:44,440 --> 00:58:44,640 SPACE. 1488 00:58:44,640 --> 00:58:46,960 THERE IS A U24 COORDINATING 1489 00:58:46,960 --> 00:58:47,280 CENTER. 1490 00:58:47,280 --> 00:58:48,960 THE PURPOSE TO PROVIDE THE 1491 00:58:48,960 --> 00:58:50,560 ORGANIZATIONAL FRAMEWORK FOR THE 1492 00:58:50,560 --> 00:58:52,120 MANAGEMENT DIRECTION AND OVER 1493 00:58:52,120 --> 00:58:54,880 ALL COORDINATING ACTIVITIES 1494 00:58:54,880 --> 00:58:56,000 AIMED AT INVESTIGATING 1495 00:58:56,000 --> 00:58:57,920 STRATEGIES, APPROACHES AND 1496 00:58:57,920 --> 00:59:01,160 INTERVENTIONS TO PROMOTE GENDER 1497 00:59:01,160 --> 00:59:04,320 EQUITY AND ADDRESS BARRIERS FOR 1498 00:59:04,320 --> 00:59:06,400 WOMEN AT FACULTY AND LEADERSHIP 1499 00:59:06,400 --> 00:59:07,880 LEVELS IN MANY AREAS OF SCIENCE 1500 00:59:07,880 --> 00:59:09,400 AND TECHNOLOGY AND ENGINEERING 1501 00:59:09,400 --> 00:59:10,400 AND MEDICINE. 1502 00:59:10,400 --> 00:59:12,600 THE NEXT RECEIPT DATE IS MAY 1503 00:59:12,600 --> 00:59:13,080 FIRST. 1504 00:59:13,080 --> 00:59:13,920 IF YOU ARE INTERESTED IN 1505 00:59:13,920 --> 00:59:15,440 APPLYING FOR THIS COORDINATING 1506 00:59:15,440 --> 00:59:18,680 CENTER, THIS AMAZING 1507 00:59:18,680 --> 00:59:19,720 OPPORTUNITY, PLEASE DO TAKE A 1508 00:59:19,720 --> 00:59:28,160 LOOK AT WEBSITE HERE. 1509 00:59:28,160 --> 00:59:29,640 LAST YEAR AT THE NIH WORKING 1510 00:59:29,640 --> 00:59:31,720 GROUP IN WOMEN AND BIOMEDICAL 1511 00:59:31,720 --> 00:59:32,800 CAREERS WE TALKED ABOUT 1512 00:59:32,800 --> 00:59:34,520 REIMAGINING WOMEN IN THE BIO 1513 00:59:34,520 --> 00:59:36,280 ENGINEERING TECHNOLOGY AND DATA 1514 00:59:36,280 --> 00:59:37,400 SCIENCE ECOSYSTEM. 1515 00:59:37,400 --> 00:59:38,800 THE SUMMARY FROM THAT REPORT IS 1516 00:59:38,800 --> 00:59:40,800 NOW AVAILABLE ON OUR WEBSITE AND 1517 00:59:40,800 --> 00:59:43,840 I'M JUST HIGHLIGHTING ONE OF THE 1518 00:59:43,840 --> 00:59:45,160 SKETCHES FROM THAT MEETING. 1519 00:59:45,160 --> 00:59:46,320 WOMEN AND THEN IMPORTANCE OF 1520 00:59:46,320 --> 00:59:48,440 WOMEN AS INNOVATORS AND 1521 00:59:48,440 --> 00:59:50,000 INVENTORS AND ENTREPRENEUR. 1522 00:59:50,000 --> 00:59:53,400 THE GOOD NEWS THAT WOMEN ARE 1523 00:59:53,400 --> 00:59:59,320 CERTAINLY OUTPERFORMING IN 1524 00:59:59,320 --> 01:00:03,840 VARIOUS WAYS, 40% WERE 1525 01:00:03,840 --> 01:00:05,760 ENTREPRENEURS IN 2020. 1526 01:00:05,760 --> 01:00:07,720 THERE ARE FUNDING GAPS IN THIS 1527 01:00:07,720 --> 01:00:09,840 SPACE AND WE NEED TO ADDRESS THE 1528 01:00:09,840 --> 01:00:11,240 STICKY FLOOR ISSUES AND AS WELL 1529 01:00:11,240 --> 01:00:14,200 AS HEALTH EQUITY AND SOCIAL 1530 01:00:14,200 --> 01:00:18,440 IDENTITY AND THIS M-SHAPED 1531 01:00:18,440 --> 01:00:20,320 CAREER PATH AND THE NEED FOR 1532 01:00:20,320 --> 01:00:21,760 CULTURE CHANGE WHERE THE THEMES 1533 01:00:21,760 --> 01:00:22,840 HIGHLIGHTED IN THE PARTNERSHIP 1534 01:00:22,840 --> 01:00:26,000 SUMMIT AND I WAS EXCITED WHEN 1535 01:00:26,000 --> 01:00:28,360 Dr. SUZANNE GREGRICK FOR DATA 1536 01:00:28,360 --> 01:00:29,680 SCIENCE AND THE DIRECTOR OF 1537 01:00:29,680 --> 01:00:31,880 OFFICE OF DATA SCIENCE STRATEGY 1538 01:00:31,880 --> 01:00:34,360 ODSS HERE AT NIH HIGHLIGHTED 1539 01:00:34,360 --> 01:00:37,720 WOMEN AND DATA SCIENCE AND HER 1540 01:00:37,720 --> 01:00:38,960 WOMEN'S HISTORY BLOG AND IT WAS 1541 01:00:38,960 --> 01:00:43,840 MY PLEASURE TO BE INCLUDED IN 1542 01:00:43,840 --> 01:00:44,920 THAT BLOG POST TALKING ABOUT 1543 01:00:44,920 --> 01:00:47,480 WOMEN IN DATA SCIENCE. 1544 01:00:47,480 --> 01:00:49,040 I'M VERY CONCERNED WE SEE DATA 1545 01:00:49,040 --> 01:00:50,840 GOING IN THE WRONG DIRECTION 1546 01:00:50,840 --> 01:00:52,400 WITH A REDUCTION OF WOMEN 1547 01:00:52,400 --> 01:00:55,040 RECEIVING COMPUTER SCIENCE 1548 01:00:55,040 --> 01:00:56,720 DEGREES AT THE UNDER GRADUATE 1549 01:00:56,720 --> 01:00:58,640 LEVEL WHEN DATA SCIENCE JUST 1550 01:00:58,640 --> 01:01:01,360 TAKING OFF CLEARLY AS CRITICALLY 1551 01:01:01,360 --> 01:01:03,600 IMPORTANT ESPECIALLY IN 1552 01:01:03,600 --> 01:01:05,360 BIOMEDICAL AND BEHAVIORAL 1553 01:01:05,360 --> 01:01:08,480 RESEARCH IN THE ECHO SYSTEM SO 1554 01:01:08,480 --> 01:01:10,320 TAKE A LOOK AT THE BLOG FOR 1555 01:01:10,320 --> 01:01:12,200 INFORMATION ON AMAZING WOMEN AND 1556 01:01:12,200 --> 01:01:14,560 NIH AND DATA SCIENCE INCLUDING 1557 01:01:14,560 --> 01:01:15,680 Dr. GREGRICK AND OTHERS. 1558 01:01:15,680 --> 01:01:17,920 I WANT TO HIGHLIGHT AGAIN, AS I 1559 01:01:17,920 --> 01:01:23,880 ROUND UP HERE, THE FEW EVENTS. 1560 01:01:23,880 --> 01:01:26,600 NIDCR IS COMING ON THEIR 75t 1561 01:01:26,600 --> 01:01:27,640 75th ANNIVERSARY AND THEY'RE 1562 01:01:27,640 --> 01:01:28,960 LAUNCHING THE EFFORTS AND I WANT 1563 01:01:28,960 --> 01:01:30,240 TO CONGRATULATE THEM FOR 75 1564 01:01:30,240 --> 01:01:33,600 YEARS OF RESEARCH ON DENTAL AND 1565 01:01:33,600 --> 01:01:34,680 CRANIAL FACIAL DISEASES. 1566 01:01:34,680 --> 01:01:36,200 IT WAS OUR PRIVILEGE TO 1567 01:01:36,200 --> 01:01:37,400 COLLABORATE WITH THEM DURING 1568 01:01:37,400 --> 01:01:39,920 BLACK HISTORY MONTH TO HOST A 1569 01:01:39,920 --> 01:01:42,160 FIRESIDE CHAT WITH ALLEGE, Dr. 1570 01:01:42,160 --> 01:01:46,640 JEAN SINKFORD WHO WAS A FORMER 1571 01:01:46,640 --> 01:01:48,160 MEMBER AND LEDGE END AT THE FOR 1572 01:01:48,160 --> 01:01:50,480 FRONT OF EQUITY AND ORAL HEALTH 1573 01:01:50,480 --> 01:01:52,440 AND HUMAN CAREER DEVELOPMENT AND 1574 01:01:52,440 --> 01:01:54,400 IN MANY OTHER SPACES AND SHE 1575 01:01:54,400 --> 01:01:56,200 TELLS HER STORY AND THIS BOOK ON 1576 01:01:56,200 --> 01:01:57,800 DOTTED TRAILBLAZERS MINORITY 1577 01:01:57,800 --> 01:02:00,240 WOMEN LEADERS IN ORAL HEALTH. 1578 01:02:00,240 --> 01:02:03,280 AND WE CHOSE TO FEATURE WOMEN'S 1579 01:02:03,280 --> 01:02:05,280 ORAL HEALTH AS A THEME IN A 1580 01:02:05,280 --> 01:02:06,840 RESENT ISSUE WOMEN'S HEALTH IN 1581 01:02:06,840 --> 01:02:08,800 FOCUS ON A QUARTERLY BASIS WE 1582 01:02:08,800 --> 01:02:10,240 WOULD SELECT A THEME AND 1583 01:02:10,240 --> 01:02:11,520 HIGHLIGHT NIH WIDE EFFORTS IN 1584 01:02:11,520 --> 01:02:11,880 THIS SPACE. 1585 01:02:11,880 --> 01:02:13,920 IF IF YOU MISSED THAT, TAKE A 1586 01:02:13,920 --> 01:02:16,320 LOOK AT IT AND YOU CAN SEE ON 1587 01:02:16,320 --> 01:02:17,400 OUR WEBSITE THIS YEAR FORT 1588 01:02:17,400 --> 01:02:21,880 SEVENTH ANNUAL VIVIAN W. PIN 1589 01:02:21,880 --> 01:02:22,400 SYMPOSIUM OUR EVENT TOLL 1590 01:02:22,400 --> 01:02:23,680 RECOGNIZE NATIONAL WOMEN'S 1591 01:02:23,680 --> 01:02:27,960 HEALTH WEEK WE ARE FOCUSING ON 1592 01:02:27,960 --> 01:02:29,480 MENOPAUSE AND OPTIMIZING MID 1593 01:02:29,480 --> 01:02:31,440 LIFE HEALTH OF WOMEN HELD ON MAY 1594 01:02:31,440 --> 01:02:32,000 16th. 1595 01:02:32,000 --> 01:02:33,880 OUR INFORMATION IS AVAILABLE ON 1596 01:02:33,880 --> 01:02:35,040 OUR WEBSITE. 1597 01:02:35,040 --> 01:02:36,440 THE KEYNOTE WILL BE DELIVERED BY 1598 01:02:36,440 --> 01:02:38,640 Dr. JOANNE MANSON PROFESSOR OF 1599 01:02:38,640 --> 01:02:39,880 MEDICINE AT HARVARD MEDICAL 1600 01:02:39,880 --> 01:02:41,080 SCHOOL AND THE CHIEF OF THE 1601 01:02:41,080 --> 01:02:42,400 DIVISION OF PREVENTATIVE 1602 01:02:42,400 --> 01:02:48,000 MEDICINE AT THE DEPARTMENT OF 1603 01:02:48,000 --> 01:02:55,600 MEDICINE THE TITLE IS PEN A MENL 1604 01:02:55,600 --> 01:02:56,320 THERAPY. 1605 01:02:56,320 --> 01:02:58,080 JOIN US ON MAY 16th, WE HAVE 1606 01:02:58,080 --> 01:03:00,200 AN AMAZING LINEUP OF INCREDIBLE 1607 01:03:00,200 --> 01:03:01,400 PRESENTATIONS ON A VERY 1608 01:03:01,400 --> 01:03:05,640 IMPORTANT TOPIC. 1609 01:03:05,640 --> 01:03:07,640 AND OUR ORWH LECTURE SERIES 1610 01:03:07,640 --> 01:03:09,800 CALLED DIVERSE VOICES I'M JUST 1611 01:03:09,800 --> 01:03:12,040 HIGHLIGHTING OUR RECENT 1612 01:03:12,040 --> 01:03:14,280 PRESENTATIONS AND TALKS ON 1613 01:03:14,280 --> 01:03:16,440 CANCER DISPARITIES, METHODS AND 1614 01:03:16,440 --> 01:03:18,080 MEASURE ON INTERSECTIONAL STIGMA 1615 01:03:18,080 --> 01:03:19,160 AND MENTAL HEALTH AND UPCOMING 1616 01:03:19,160 --> 01:03:20,560 IN JULY AND SEPTEMBER ON 1617 01:03:20,560 --> 01:03:23,440 INTERSECTIONAL APPROACHES TO 1618 01:03:23,440 --> 01:03:24,880 SUBSTANCE USE AND MISUSE AND 1619 01:03:24,880 --> 01:03:27,600 SOCIAL DETERMINANTS AND UP TAKES 1620 01:03:27,600 --> 01:03:30,080 OF INFECTIOUS DIS SEES CONTROL 1621 01:03:30,080 --> 01:03:32,000 MEASURES SO YOU OF CAN GET 1622 01:03:32,000 --> 01:03:33,080 INFORMATION ABOUT THOSE BY 1623 01:03:33,080 --> 01:03:34,480 SIGNING UP FOR OUR EVENTS. 1624 01:03:34,480 --> 01:03:36,800 YOU CAN GET OUR MONTHLY E-MAILS, 1625 01:03:36,800 --> 01:03:39,760 THE PULSE, AND OUR QUARTERLY 1626 01:03:39,760 --> 01:03:41,640 PUBLICATIONS AND LEARN MORE 1627 01:03:41,640 --> 01:03:43,560 ABOUT OUR E-LEARNING FORCES AT 1628 01:03:43,560 --> 01:03:45,200 OUR WEBSITE WITH THAT, I AM 1629 01:03:45,200 --> 01:03:47,760 GOING TO STOP SHARING. 1630 01:03:47,760 --> 01:03:53,120 AND TURN THE PODIUM BACK OVER TO 1631 01:03:53,120 --> 01:03:54,200 Dr. NOURSI. 1632 01:03:54,200 --> 01:03:55,800 I KNOW WE'RE THREE MINUTES OVER. 1633 01:03:55,800 --> 01:03:56,440 >>Samia Noursi: YOU ARE GREAT 1634 01:03:56,440 --> 01:03:56,840 ON TIME. 1635 01:03:56,840 --> 01:03:58,120 YOU ARE ONLY FOUR MINUTES. 1636 01:03:58,120 --> 01:04:00,120 CAN YOU HEAR ME? 1637 01:04:00,120 --> 01:04:04,880 >>I WOULD JUST LIKE TO WELCOME 1638 01:04:04,880 --> 01:04:06,800 DR. PHIL IS SHARPS WHO JOINED US 1639 01:04:06,800 --> 01:04:09,200 SINCE IN THE LAST HOUR AND Dr. 1640 01:04:09,200 --> 01:04:15,000 AMANDA BREGAL. 1641 01:04:15,000 --> 01:04:17,240 Dr. JUTTER IS WITH US SO YOU 1642 01:04:17,240 --> 01:04:18,640 WANT TO TAKE QUESTIONS NOW OR DO 1643 01:04:18,640 --> 01:04:20,480 YOU WANT TO DO IT LATER FOR THE 1644 01:04:20,480 --> 01:04:21,800 DISCUSSION SO WE STAY ON TIME? 1645 01:04:21,800 --> 01:04:23,440 >>YES, LET'S GO AHEAD. 1646 01:04:23,440 --> 01:04:24,280 IF YOU HAVE QUESTIONS OR 1647 01:04:24,280 --> 01:04:25,680 THOUGHTS FROM MY PRESENTATION, 1648 01:04:25,680 --> 01:04:27,120 JUST DROP THEM DOWN OR YOU CAN 1649 01:04:27,120 --> 01:04:28,400 PUT THEM IN THE CHAT SO WE CAN 1650 01:04:28,400 --> 01:04:30,160 TEE THEM UP FOR OUR DISCUSSION 1651 01:04:30,160 --> 01:04:31,080 TIME LATER. 1652 01:04:31,080 --> 01:04:33,960 I DO WANT TO GO A HAPPENED AND 1653 01:04:33,960 --> 01:04:41,000 IGO AHEAD AND INTRODUCEJOANNIE M 1654 01:04:41,000 --> 01:04:43,800 ADVANCING TRANSLATIONAL SCIENCES 1655 01:04:43,800 --> 01:04:46,160 AND FONDLY KNOWN AS N CATS AND 1656 01:04:46,160 --> 01:04:50,480 SHE'S PLANNING OF THE COMPLEX 1657 01:04:50,480 --> 01:04:52,400 AND MULTIFACETED CLINICAL 1658 01:04:52,400 --> 01:04:53,360 RESEARCH PROGRAMS AND OF COURSE 1659 01:04:53,360 --> 01:04:55,480 THE PRIMARY OBJECTIVE THERE SHE 1660 01:04:55,480 --> 01:04:58,880 HAS IS DIRECTOR IS TO USE 1661 01:04:58,880 --> 01:04:59,920 TRANSLATIONAL SCIENCE AS A MEANS 1662 01:04:59,920 --> 01:05:02,560 TO PROVIDE ALL PEOPLE WITH MORE 1663 01:05:02,560 --> 01:05:05,320 TREATMENTS, MORE QUICKLY AND 1664 01:05:05,320 --> 01:05:06,040 EFFICIENT LEASE AND AS I 1665 01:05:06,040 --> 01:05:08,160 MENTIONED BEFORE, JOANNIE, 1666 01:05:08,160 --> 01:05:09,680 BEFORE SHE JOINED NCATS SHE WAS 1667 01:05:09,680 --> 01:05:11,080 THE DIRECTOR OF SCIENTIFIC 1668 01:05:11,080 --> 01:05:13,240 PROGRESS WITH ALL OF US PROGRAM 1669 01:05:13,240 --> 01:05:15,400 AND AT THE PRECISION MEDICINE 1670 01:05:15,400 --> 01:05:16,400 INITIATIVE AND BEFORE THAT AS 1671 01:05:16,400 --> 01:05:18,000 DIRECTOR OF DIVISION OF 1672 01:05:18,000 --> 01:05:20,240 NEUROSCIENCE AND BEHAVIOR AT 1673 01:05:20,240 --> 01:05:21,880 NATIONAL INSTITUTE OF DRUG ABUSE 1674 01:05:21,880 --> 01:05:24,440 SO IT'S MY OF PLEASURE TO DO 1675 01:05:24,440 --> 01:05:34,920 WELCOME Dr. JOANNIE RUTTER. 1676 01:05:35,920 --> 01:05:38,400 >>THANK YOU SO MUCH. 1677 01:05:38,400 --> 01:05:41,160 TO TALK A LITTLE BIT MORE TO THE 1678 01:05:41,160 --> 01:05:41,480 COUNCIL. 1679 01:05:41,480 --> 01:05:42,720 IT'S A PLEASURE TO BE HERE AND 1680 01:05:42,720 --> 01:05:48,960 YOU ARE GOING TO SEE MY DOG'S 1681 01:05:48,960 --> 01:05:50,000 TAIL WAGGING IN THE BACKGROUND 1682 01:05:50,000 --> 01:05:51,400 BECAUSE SHE'S EXCITED TOO. 1683 01:05:51,400 --> 01:05:52,920 I'M GOING TO TALK ABOUT 1684 01:05:52,920 --> 01:05:53,720 TRANSLATIONAL SCIENCE AND 1685 01:05:53,720 --> 01:05:54,920 WOMEN'S HEALTH BUT BEFORE I GET 1686 01:05:54,920 --> 01:05:56,840 INTO SOME OF THOSE ASPECTS, I 1687 01:05:56,840 --> 01:05:58,360 WANT TO START OFF WITH A LITTLE 1688 01:05:58,360 --> 01:06:00,400 BIT MORE BACKGROUND OF NCATS. 1689 01:06:00,400 --> 01:06:03,240 SO YOU CAN GO TO THE NEXT SLIDE. 1690 01:06:03,240 --> 01:06:04,280 N CATS. 1691 01:06:04,280 --> 01:06:05,480 THE NATIONAL CENTER FOR 1692 01:06:05,480 --> 01:06:08,040 ADVANCING TRANSLATIONAL SCIENCES 1693 01:06:08,040 --> 01:06:18,200 OR NCATS,. 1694 01:06:27,640 --> 01:06:29,000 >>IT'S FULLY IN THE 1695 01:06:29,000 --> 01:06:30,600 TRANSLATIONAL RESEARCH AND 1696 01:06:30,600 --> 01:06:33,840 SIDISTUDYING THE SCIENCE OF 1697 01:06:33,840 --> 01:06:34,680 TRANSLATIONAL RESEARCH SO WE CAN 1698 01:06:34,680 --> 01:06:36,800 BE EFFECT IT TIVE AND EFFICIENT 1699 01:06:36,800 --> 01:06:38,600 IN GOING FROM BENCH TO BEDSIDE. 1700 01:06:38,600 --> 01:06:40,520 WITH THAT WE DON'T HAVE A 1701 01:06:40,520 --> 01:06:42,400 SPECIFIC DISEASE OR ORGAN THAT 1702 01:06:42,400 --> 01:06:43,280 WE FOCUS ON. 1703 01:06:43,280 --> 01:06:47,160 WE FOCUS ON ALL OF THEM. 1704 01:06:47,160 --> 01:06:48,960 SO I'LL TELL YOU HOW WE FOCUS ON 1705 01:06:48,960 --> 01:06:50,840 ALL OF THEM A LITTLE BIT MORE 1706 01:06:50,840 --> 01:06:51,760 APPROXIMATE WHAT WE DO. 1707 01:06:51,760 --> 01:06:53,120 I'LL START OFF BY SETTING THE 1708 01:06:53,120 --> 01:06:56,480 STAGE. 1709 01:06:56,480 --> 01:06:58,040 THERE ARE THOUSANDS OF DISEASES, 1710 01:06:58,040 --> 01:07:00,280 WE THINK THERE ARE OVER 10,000 1711 01:07:00,280 --> 01:07:02,200 DISEASES AND ACTUALLY WE KNOW 1712 01:07:02,200 --> 01:07:04,000 THAT THERE ARE 10,000 RARE 1713 01:07:04,000 --> 01:07:04,920 DISEASES ALONE. 1714 01:07:04,920 --> 01:07:06,600 THERE ARE THOUSANDS OF DISEASES. 1715 01:07:06,600 --> 01:07:07,680 WHEN YOU LOOK A LOT THE BURDEN 1716 01:07:07,680 --> 01:07:09,960 OF DISEASES AND HERE IN THIS 1717 01:07:09,960 --> 01:07:11,280 PARTICULAR IMAGE FROM OUR WORLD 1718 01:07:11,280 --> 01:07:13,440 AND DATA, THE BURDEN IS MEASURED 1719 01:07:13,440 --> 01:07:15,680 BY THE DISABILITY ADJUSTED LIFE 1720 01:07:15,680 --> 01:07:18,520 YEARS ALSO KNOWN AS DALLY AND 1721 01:07:18,520 --> 01:07:19,960 THIS IS BASICALLY MEASURING THE 1722 01:07:19,960 --> 01:07:21,880 TOTAL BURDEN OF DISEASE BOTH 1723 01:07:21,880 --> 01:07:25,280 FROM YEARS OF LIFE LOST DUE TO 1724 01:07:25,280 --> 01:07:26,160 PREMATURE DEATH, AS WELL AS 1725 01:07:26,160 --> 01:07:27,720 YEARS OF LIFE LIVED WITH THE DIS 1726 01:07:27,720 --> 01:07:30,200 A LOT. 1727 01:07:30,200 --> 01:07:31,000 SO ONE DALLY EQUALS ONE LOST 1728 01:07:31,000 --> 01:07:32,520 YEAR OF HEALTHY LIFE. 1729 01:07:32,520 --> 01:07:36,440 AND SO IN THIS GRAPHIC THIS WAS 1730 01:07:36,440 --> 01:07:38,680 DONE IN 1990 AND YOU CAN SEE THE 1731 01:07:38,680 --> 01:07:41,560 DIFFERENT DISEASES THAT HAVE 1732 01:07:41,560 --> 01:07:43,480 BEEN THE PERSISTENT DISEASES AT 1733 01:07:43,480 --> 01:07:45,120 THE TOP HERE AND I WANT YOU TO 1734 01:07:45,120 --> 01:07:47,000 JUST PAY ATTENTION TO THE 1735 01:07:47,000 --> 01:07:48,040 RIGHT-HAND SIDE NUMBERS AND THE 1736 01:07:48,040 --> 01:07:50,040 RED LINE IN THE MIDDLE. 1737 01:07:50,040 --> 01:07:51,680 BECAUSE I WANT TO KNOW WHAT YOU 1738 01:07:51,680 --> 01:07:54,480 EXPECT TO SEE AS YOU GO FORWARD 1739 01:07:54,480 --> 01:08:02,480 TO 2017 ON THE RIGHT-HAND SIDE. 1740 01:08:02,480 --> 01:08:05,640 IF YOU CLICK THAT DOT RIGHT 1741 01:08:05,640 --> 01:08:08,160 THERE, CAN YOU GO BACK ONE? 1742 01:08:08,160 --> 01:08:11,840 SEE IF YOU CAN HIT THAT PLAY 1743 01:08:11,840 --> 01:08:14,120 BUTTON. 1744 01:08:14,120 --> 01:08:15,480 SO, NOW YOU ALREADY JUMPED TO 1745 01:08:15,480 --> 01:08:18,080 THE END BUT YOU CAN SEE HOW THIS 1746 01:08:18,080 --> 01:08:20,560 HAS CHANGED OVER THE YEARS SO IF 1747 01:08:20,560 --> 01:08:22,520 YOU GO TO THE NEXT SLIDE, WE'RE 1748 01:08:22,520 --> 01:08:23,880 MOVING IN THE WRONG DIRECTION. 1749 01:08:23,880 --> 01:08:25,840 DESPITE THE FACT THAT WE HAVE 1750 01:08:25,840 --> 01:08:27,880 MORE TOOLS AND TECHNOLOGIES TO 1751 01:08:27,880 --> 01:08:30,600 BE ABLE TO EYE FIVE AND MITIGATE 1752 01:08:30,600 --> 01:08:33,560 THESE DISEASES SO WHY IS THAT? 1753 01:08:33,560 --> 01:08:35,400 HOW CAN WE START TO TRY TO TURN 1754 01:08:35,400 --> 01:08:36,480 THE CURVE IN THE OTHER WAYS SO 1755 01:08:36,480 --> 01:08:37,800 IF APPROXIMATE YOU GO TO THE 1756 01:08:37,800 --> 01:08:39,440 NEXT SLIDE, THE PUBLIC-HEALTH 1757 01:08:39,440 --> 01:08:41,720 CHALLENGE FOR US AT NCATS IS 1758 01:08:41,720 --> 01:08:43,280 THINKING ABOUT ALL OF THESE 1759 01:08:43,280 --> 01:08:44,960 DISEASES, THE OVER 10,000 1760 01:08:44,960 --> 01:08:45,440 DISEASES. 1761 01:08:45,440 --> 01:08:46,920 WHEN WE THINK ABOUT THAT, WHERE 1762 01:08:46,920 --> 01:08:52,640 IS A PLACE TO START IN WELL, 1763 01:08:52,640 --> 01:08:54,520 ONLY 5% HAS A TREATMENT FOR A 1764 01:08:54,520 --> 01:08:54,720 CURE. 1765 01:08:54,720 --> 01:08:57,720 NOT ONLY THAT, AS SORT OF A 1766 01:08:57,720 --> 01:08:59,320 BLEAK NUMBER, THE TIME FROM 1767 01:08:59,320 --> 01:09:08,120 DEVELOPING A PARTICULAR THEY ARE 1768 01:09:08,120 --> 01:09:12,400 DEVELOP PARTICULAR THERAPEUTIC, 1769 01:09:12,400 --> 01:09:14,200 NINE OUT OF 10 FAIL AT THAT 1770 01:09:14,200 --> 01:09:15,960 PHASE 1 AND PHASE 2 CLINICAL 1771 01:09:15,960 --> 01:09:17,880 TRIAL PHASE, IT'S 80% THAT FAILS 1772 01:09:17,880 --> 01:09:19,520 AT THAT PHASE AND THE REST THAT 1773 01:09:19,520 --> 01:09:22,280 HAVE IS BUSINESS DECISIONS ARE 1774 01:09:22,280 --> 01:09:23,080 OTHERWISE HOW THEY FAIL. 1775 01:09:23,080 --> 01:09:24,760 BUT MOST OF THESE ARE FAILING IN 1776 01:09:24,760 --> 01:09:29,600 THE SAFETY AND EFFICACY OF THESE 1777 01:09:29,600 --> 01:09:31,840 MEDICATIONS. 1778 01:09:31,840 --> 01:09:32,920 HIGHLIGHTING THIS A LITTLE BIT 1779 01:09:32,920 --> 01:09:34,600 MORE, THIS IS WHERE WE'RE 1780 01:09:34,600 --> 01:09:36,440 REFERENCING THESE NUMBERS, 55 1781 01:09:36,440 --> 01:09:38,600 FAILED DUE TO EFFICACY AND 28 1782 01:09:38,600 --> 01:09:49,120 FAILED IN TOXIC EFFECTS AND S 1783 01:09:49,400 --> 01:09:51,720 SO -- IT TAKES $2.6 BILLION TO 1784 01:09:51,720 --> 01:09:52,400 DO THIS. 1785 01:09:52,400 --> 01:09:53,720 WHAT CAN WE DO DIFFERENTLY? 1786 01:09:53,720 --> 01:09:55,160 RIGHT NOW THE CURRENT TOOLS WE 1787 01:09:55,160 --> 01:09:56,840 USE FOR THE DEVELOPMENT INVOLVE 1788 01:09:56,840 --> 01:09:59,640 TWO DIMENSIONAL CELLS THAT WE 1789 01:09:59,640 --> 01:10:02,120 PUT ON A PETRI DISH TO ANALYZE 1790 01:10:02,120 --> 01:10:04,040 SAFETY AND EFFICACY. 1791 01:10:04,040 --> 01:10:06,320 WE USE ANIMAL MODELS TO ANALYZE 1792 01:10:06,320 --> 01:10:10,440 SAFETY AND EFFICACY SO THESE ARE 1793 01:10:10,440 --> 01:10:12,480 AREAS THAT I THINK THAT WE HAVE 1794 01:10:12,480 --> 01:10:14,480 A OF CHANCE AND ACTUALLY 1795 01:10:14,480 --> 01:10:17,600 STARTING TO EFFECT OTHERWISE AND 1796 01:10:17,600 --> 01:10:19,680 SO RATHER THAN USING A 1797 01:10:19,680 --> 01:10:20,520 ONE-SIZE-FITS-ALL APPROACH HOW 1798 01:10:20,520 --> 01:10:22,080 DO WE TACKLE THIS IN OTHER WAYS 1799 01:10:22,080 --> 01:10:23,760 SO I'LL TALK ABOUT HOW WE'RE 1800 01:10:23,760 --> 01:10:24,440 ADDRESSING THAT. 1801 01:10:24,440 --> 01:10:26,680 NOT JUST ACROSS NCATS AS A WHOLE 1802 01:10:26,680 --> 01:10:28,440 BUT ALSO SPECIFICALLY IN WOMEN'S 1803 01:10:28,440 --> 01:10:29,880 HEALTH AND AS YOU ALL KNOW, 1804 01:10:29,880 --> 01:10:31,400 THERE'S A REASON WHY IT'S 1805 01:10:31,400 --> 01:10:33,160 IMPORTANT TO SPECIFICALLY FOCUS 1806 01:10:33,160 --> 01:10:34,520 ON WOMEN'S HEALTH. 1807 01:10:34,520 --> 01:10:41,400 SO GOING TO THE NEXT SLIDE AND 1808 01:10:41,400 --> 01:10:42,720 ESSENTIALLY, OUR MISSION AT 1809 01:10:42,720 --> 01:10:43,800 NCATS IS TURN RESEARCH INTO 1810 01:10:43,800 --> 01:10:46,000 HEALTH SOLUTIONS AND DOING THIS 1811 01:10:46,000 --> 01:10:46,960 THROUGH TRANSLATIONAL SCIENCE SO 1812 01:10:46,960 --> 01:10:50,200 IF YOU GO TO THE NEXT SLIDE, THE 1813 01:10:50,200 --> 01:10:53,880 TRANSLATIONAL SCIENCE PIPELINE 1814 01:10:53,880 --> 01:10:56,240 IS DEPICTED HERE AND FOR ANY 1815 01:10:56,240 --> 01:10:58,560 TRANSLATIONAL PROJECT WHEN YOU 1816 01:10:58,560 --> 01:11:00,480 FIND PERHAPS A DRUG TARGET AND 1817 01:11:00,480 --> 01:11:04,160 YOU NEED TO MAKE A THEY ARE 1818 01:11:04,160 --> 01:11:04,800 YOU'D THAT I CAN WOULD HIT THAT 1819 01:11:04,800 --> 01:11:05,880 DRUG TARGET AND IT'S EARLY IN 1820 01:11:05,880 --> 01:11:07,920 THE PRECLINICAL PHASE AND YOU GO 1821 01:11:07,920 --> 01:11:10,280 STEP WISE THROUGH THE 1822 01:11:10,280 --> 01:11:10,880 TRANSLATIONAL SCIENCE PIPELINE 1823 01:11:10,880 --> 01:11:13,720 TO MOVE IT TO CLINICAL USE OR 1824 01:11:13,720 --> 01:11:17,320 CLINICAL TESTING AND CLINICAL 1825 01:11:17,320 --> 01:11:17,760 APPLICABILITY. 1826 01:11:17,760 --> 01:11:18,800 SO NCATS IS REALLY HERE TO BE 1827 01:11:18,800 --> 01:11:20,760 THINKING ABOUT HOW WE CAN 1828 01:11:20,760 --> 01:11:23,960 ADDRESS THESE SORT OF 1829 01:11:23,960 --> 01:11:27,080 LONGSTANDING BOTTLENECKS IN THIS 1830 01:11:27,080 --> 01:11:29,640 PIPELINE SO WE CAN USE THE 1831 01:11:29,640 --> 01:11:31,240 PROCESS TO TRAVERSE THE PIPELINE 1832 01:11:31,240 --> 01:11:32,560 MUCH MORE EFFECTIVE AND MUCH 1833 01:11:32,560 --> 01:11:33,680 MORE EFFICIENTLY. 1834 01:11:33,680 --> 01:11:35,080 AND THAT IS THE WAY WE'RE GOING 1835 01:11:35,080 --> 01:11:36,680 TO GET MORE TREATMENTS TO PEOPLE 1836 01:11:36,680 --> 01:11:37,200 FASTER. 1837 01:11:37,200 --> 01:11:38,360 SO THIS IS SORT OF THE IDEA. 1838 01:11:38,360 --> 01:11:40,240 IF YOU GO TO THE NEXT SLIDE, I 1839 01:11:40,240 --> 01:11:43,160 HAVE A VARIETY OF WAYS THAT I 1840 01:11:43,160 --> 01:11:47,280 SHOW YOU WHERE THESE PURPLE 1841 01:11:47,280 --> 01:11:50,480 BOTTOM REPRESENT THE BOTTLENECK. 1842 01:11:50,480 --> 01:11:52,200 THEY CAN BE OPERATIONAL, 1843 01:11:52,200 --> 01:11:53,200 ADMINISTRATIVE, WORKFORCE 1844 01:11:53,200 --> 01:11:55,680 DEVELOPMENT, OR SCIENTIFIC 1845 01:11:55,680 --> 01:11:56,160 BOTTLENECKS. 1846 01:11:56,160 --> 01:11:57,800 SOMETIMES THE SCIENTIFIC 1847 01:11:57,800 --> 01:11:59,000 BOTTLENECKS ARE MORE TRACTABLE 1848 01:11:59,000 --> 01:12:00,520 THAN SOME OF THE OTHER ONCE SO 1849 01:12:00,520 --> 01:12:02,440 THEY'RE A RA VI TEE OF ASPECTS 1850 01:12:02,440 --> 01:12:03,960 THAT WE'RE TRYING TO EVALUATE 1851 01:12:03,960 --> 01:12:05,120 HERE BUT TRANSLATIONAL SCIENCE 1852 01:12:05,120 --> 01:12:08,600 IS LOOKING AT THE HOLISTIC 1853 01:12:08,600 --> 01:12:11,360 PROBLEM TO HELP BREAKDOWN THOSE 1854 01:12:11,360 --> 01:12:12,200 BOTTLENECKS SO WE CAN MOVE 1855 01:12:12,200 --> 01:12:13,280 THROUGH THAT PIPE LYNN BETTER 1856 01:12:13,280 --> 01:12:14,720 AND FASTER AND MORE EFFECTIVE 1857 01:12:14,720 --> 01:12:16,720 AND MORE EFFICIENTLY. 1858 01:12:16,720 --> 01:12:19,320 SO, I'LL SHOW YOU SOME OF THE 1859 01:12:19,320 --> 01:12:20,480 IDEAS HERE. 1860 01:12:20,480 --> 01:12:22,280 THE FIRST ONE THAT I UNDERLINE 1861 01:12:22,280 --> 01:12:24,080 ON THE RIGHT-HAND SIDE IS THAT 1862 01:12:24,080 --> 01:12:25,160 ONE OF THE THINGS WE'RE TRYING 1863 01:12:25,160 --> 01:12:28,160 TO DO IS DEVELOP PLATFORM BASED 1864 01:12:28,160 --> 01:12:29,800 APPROACHES FOR DEVELOPING TISSUE 1865 01:12:29,800 --> 01:12:33,440 AND ORGANS ON A CHIP EX DOING 3D 1866 01:12:33,440 --> 01:12:34,800 BIO FABRICATION TO UNDERSTAND A 1867 01:12:34,800 --> 01:12:36,320 DISEASE PROCESS BETTER AND WHAT 1868 01:12:36,320 --> 01:12:38,240 MIGHT BE MORE SPECIFIC IN 1869 01:12:38,240 --> 01:12:41,320 EFFECTING THE PREDICTABILITY OF 1870 01:12:41,320 --> 01:12:42,280 UNDERSTANDING MORE OF THE SAFETY 1871 01:12:42,280 --> 01:12:46,920 AND EFFICACY OF COMPOUNDS THAT 1872 01:12:46,920 --> 01:12:48,480 MIGHT BE GOING INTO PHASE 1 AND 1873 01:12:48,480 --> 01:12:49,760 PHASE 2 CLINICAL TRIALS. 1874 01:12:49,760 --> 01:12:52,960 IF IF WE USE MODEL SYSTEMS THAT 1875 01:12:52,960 --> 01:12:55,480 MIGHT BE A LOT BETTER THAN USING 1876 01:12:55,480 --> 01:12:58,760 ANIMAL MODELS OR 2D CELL CULTURE 1877 01:12:58,760 --> 01:12:59,280 MODELS. 1878 01:12:59,280 --> 01:13:00,760 I'LL TALK ABOUT THAT IN A 1879 01:13:00,760 --> 01:13:01,000 MOMENT. 1880 01:13:01,000 --> 01:13:02,520 THIS IS TO SAY IF IF YOU GO TO 1881 01:13:02,520 --> 01:13:08,080 THE NEXT SLIDE, WE HAVE THREE 1882 01:13:08,080 --> 01:13:10,440 AMBITIOUS GOALS HERE AND Dr. 1883 01:13:10,440 --> 01:13:12,320 CLAYTON HIGHLIGHTED THOSE. 1884 01:13:12,320 --> 01:13:15,560 TO BRING MORE TREATMENTS FOR ALL 1885 01:13:15,560 --> 01:13:17,640 PEOPLE MORE QUICKLY. 1886 01:13:17,640 --> 01:13:19,520 WE WANT TO METRO SIZE THIS IN A 1887 01:13:19,520 --> 01:13:19,680 WAY. 1888 01:13:19,680 --> 01:13:21,760 WE HAVE 5% OF THE TREATMENTS FOR 1889 01:13:21,760 --> 01:13:22,960 THE NORTHBOUND OF DISEASES NOW 1890 01:13:22,960 --> 01:13:24,800 THAT HAVE TREATMENT AND WE WANT 1891 01:13:24,800 --> 01:13:26,880 TO CHANGE THAT NUMBER FROM 5% TO 1892 01:13:26,880 --> 01:13:27,360 25%. 1893 01:13:27,360 --> 01:13:29,160 SO IT'S A BIG JUMP BECAUSE IT'S 1894 01:13:29,160 --> 01:13:33,080 BEEN AT 45% F 5% FOR A LONG TIM. 1895 01:13:33,080 --> 01:13:35,800 WE THINK WITH THE TOOLS THAT WE 1896 01:13:35,800 --> 01:13:38,600 HAVE CURRENTLY WITH THE 1897 01:13:38,600 --> 01:13:40,280 OPPORTUNITIES AROUND THERAPY AND 1898 01:13:40,280 --> 01:13:41,480 EDITING WE HAVE A BIG 1899 01:13:41,480 --> 01:13:43,040 OPPORTUNITY TO MAKE A DENT HERE 1900 01:13:43,040 --> 01:13:44,840 OVER THE NEXT 10 YEARS. 1901 01:13:44,840 --> 01:13:47,240 EVEN IF WE FAIL WITH 25%, I 1902 01:13:47,240 --> 01:13:49,640 WOULD RATHER FAIL AT 25% THAN 1903 01:13:49,640 --> 01:13:53,520 MEET THE GOAL OF GOING FROM 5% 1904 01:13:53,520 --> 01:13:55,920 TO 6% SO THAT'S THE 1905 01:13:55,920 --> 01:13:56,880 AUDACIOUSNESS BEHIND THAT GOAL. 1906 01:13:56,880 --> 01:13:59,720 FOR ALL PEOPLE, THIS IS REALLY 1907 01:13:59,720 --> 01:14:00,920 EXACTLY WHAT IT NEEDS. 1908 01:14:00,920 --> 01:14:02,960 IT'S INCREASING INCLUSIVITY 1909 01:14:02,960 --> 01:14:04,960 ACROSS EVERY AREA WE SUPPORT. 1910 01:14:04,960 --> 01:14:06,160 WHETHER IT'S WORKFORCE 1911 01:14:06,160 --> 01:14:09,520 DEVELOPMENT, WHETHER IT'S CAREER 1912 01:14:09,520 --> 01:14:10,600 TRAINING, WHETHER THAT'S MAKING 1913 01:14:10,600 --> 01:14:13,360 SURE THAT WE HAVE THE PIPELINE 1914 01:14:13,360 --> 01:14:16,360 IN PLACE FOR UNDER REPRESENTED 1915 01:14:16,360 --> 01:14:17,760 INDIVIDUALS IN SCIENCE AND IN 1916 01:14:17,760 --> 01:14:19,200 CLINICAL TRIALS AND IN CLINICAL 1917 01:14:19,200 --> 01:14:20,880 RESEARCH AND ALL OF THOSE AREAS 1918 01:14:20,880 --> 01:14:22,160 IS SOMETHING THAT WE WANTED TO 1919 01:14:22,160 --> 01:14:24,680 BE FOCUSED ON. 1920 01:14:24,680 --> 01:14:26,480 AND THIRDLY, MORE QUICKLY. 1921 01:14:26,480 --> 01:14:28,520 WE WANT TONE ABLE DIAGNOSTICS 1922 01:14:28,520 --> 01:14:30,280 AND THERAPEUTICS TO REACH PEOPLE 1923 01:14:30,280 --> 01:14:31,640 TWICE AS FAST. 1924 01:14:31,640 --> 01:14:33,240 I MENTION THAT 10 TO 15 YEAR 1925 01:14:33,240 --> 01:14:34,960 PIPELINE AND IT'S ON THE 1926 01:14:34,960 --> 01:14:36,600 DEVELOPMENT SIDE AND SO WHEN WE 1927 01:14:36,600 --> 01:14:38,360 INCLUDE THE BENCH TO BEDSIDE 1928 01:14:38,360 --> 01:14:40,520 MODEL AS A WHOLE, IT CAN BE EVEN 1929 01:14:40,520 --> 01:14:41,000 LONGER. 1930 01:14:41,000 --> 01:14:43,360 AND SO HOW CAN WE START TO 1931 01:14:43,360 --> 01:14:45,600 REALLY CUT THAT TIME IN HALF? 1932 01:14:45,600 --> 01:14:47,080 AND THAT GOES SOME OF THE KEY 1933 01:14:47,080 --> 01:14:48,400 GOALS THAT WE HAVE AND I HOPE 1934 01:14:48,400 --> 01:14:52,640 THAT WITH SOME OF THE VEN YETS I 1935 01:14:52,640 --> 01:14:53,840 TELL YOU ABOUT TODAY YOU WILL 1936 01:14:53,840 --> 01:14:55,280 SEE THE POSSIBILITIES TO MEET 1937 01:14:55,280 --> 01:14:56,000 THESE GOALS. 1938 01:14:56,000 --> 01:14:57,800 SO THE NEXT SLIDE IS JUST REALLY 1939 01:14:57,800 --> 01:15:01,760 TALKING ABOUT HOW NCATS APPLIES 1940 01:15:01,760 --> 01:15:03,120 THESE KEY APPROACH AND OUR 1941 01:15:03,120 --> 01:15:04,480 EFFORTS TO BRING MORE TREATMENTS 1942 01:15:04,480 --> 01:15:06,040 FOR PEOPLE MORE QUICKLY AND 1943 01:15:06,040 --> 01:15:07,760 ESSENTIALLY WHAT WE DO IS 1944 01:15:07,760 --> 01:15:10,560 BECAUSE WE CAN STUDY OVER 10,000 1945 01:15:10,560 --> 01:15:12,320 DISEASES, THAT MEANS THAT WE 1946 01:15:12,320 --> 01:15:14,640 HAVE TO UNDERSTAND WHAT SIMILAR 1947 01:15:14,640 --> 01:15:16,520 ACROSS DISEASES TO SPUR THOSE 1948 01:15:16,520 --> 01:15:18,080 MULTIPLE TREATMENTS AT A TIME. 1949 01:15:18,080 --> 01:15:20,840 AND SO IF WE CAN FIND PARTICULAR 1950 01:15:20,840 --> 01:15:22,040 PATHWAYS OR AREAS THAT ARE 1951 01:15:22,040 --> 01:15:24,040 COMMON ACROSS DISEASES, HOW CAN 1952 01:15:24,040 --> 01:15:26,520 WE LEVERAGE THAT TO HELP BRING 1953 01:15:26,520 --> 01:15:27,840 TREATMENTS TO THOSE DISEASES 1954 01:15:27,840 --> 01:15:28,680 MORE QUICKLY. 1955 01:15:28,680 --> 01:15:30,880 WE WANT MODELS THAT BETTER 1956 01:15:30,880 --> 01:15:32,320 PREDICT A PERSON'S REACTION TO 1957 01:15:32,320 --> 01:15:32,800 TREATMENT. 1958 01:15:32,800 --> 01:15:34,320 THAT'S THE PREDICTIVE MODEL 1959 01:15:34,320 --> 01:15:35,760 APPROACH I'LL TALK ABOUT LATER 1960 01:15:35,760 --> 01:15:37,640 TODAY TOO AND THEN ENHANCING 1961 01:15:37,640 --> 01:15:39,160 CLINICAL TRIALS SO THAT THE 1962 01:15:39,160 --> 01:15:41,200 RESULTS MORE ACCURATELY REFLECT 1963 01:15:41,200 --> 01:15:42,760 PATIENT POPULATION. 1964 01:15:42,760 --> 01:15:46,120 AND WE'RE DOING SO MUCH BETTER 1965 01:15:46,120 --> 01:15:47,600 IN BRINGING AND MAKING SURE WE 1966 01:15:47,600 --> 01:15:50,000 HAVE INCLUSIVITY FOR WOMEN IN 1967 01:15:50,000 --> 01:15:51,600 CLINICAL TRIALS AND THAT'S A 1968 01:15:51,600 --> 01:15:52,240 GOOD THING. 1969 01:15:52,240 --> 01:15:54,280 IT'S A NECESSARY THING BUT IT'S 1970 01:15:54,280 --> 01:15:55,680 NOT SUFFICIENT AND I'LL TALK 1971 01:15:55,680 --> 01:15:57,120 ABOUT THAT TOO. 1972 01:15:57,120 --> 01:15:59,120 AND FINALLY, HOW CAN WE MAKE 1973 01:15:59,120 --> 01:16:01,520 SURE WE'RE LEVERAGING ALL OF THE 1974 01:16:01,520 --> 01:16:03,360 REAL WORLD DATA AND DATA SCIENCE 1975 01:16:03,360 --> 01:16:04,320 APPROACHES TO ADDRESS 1976 01:16:04,320 --> 01:16:06,400 PUBLIC-HEALTH NEEDS AND I'M SO 1977 01:16:06,400 --> 01:16:08,200 GLAD Dr. CLAYTON MENTIONED THE 1978 01:16:08,200 --> 01:16:10,680 IDEA OF SUSAN AND HER WORK HERE 1979 01:16:10,680 --> 01:16:13,360 AT THE NIH AT THE OFFICE THE 1980 01:16:13,360 --> 01:16:14,960 DATA STRATEGY AND SCIENCE TO 1981 01:16:14,960 --> 01:16:16,480 REALLY MAKE SURE THAT WE'RE 1982 01:16:16,480 --> 01:16:20,800 DOING THIS IN A STRONG AND 1983 01:16:20,800 --> 01:16:26,520 ROBUST BAY. 1984 01:16:26,520 --> 01:16:29,960 THE NEXT SLIDE IS REALLY JUST 1985 01:16:29,960 --> 01:16:32,280 KIND OF ROUNDING OUT THESE WHOLE 1986 01:16:32,280 --> 01:16:33,520 IDEA OF TRANSLATIONAL SCIENCE 1987 01:16:33,520 --> 01:16:36,280 AND AGAIN IT'S THE FIELD THAT IS 1988 01:16:36,280 --> 01:16:38,280 MEANT TO ADDRESS THE SCIENTIFIC 1989 01:16:38,280 --> 01:16:40,320 AND THE OPERATIONAL INNOVATIONS 1990 01:16:40,320 --> 01:16:42,280 TO OVERCOME THE LONGSTANDING 1991 01:16:42,280 --> 01:16:44,400 BARRIERS ALONG THE TRANSLATIONAL 1992 01:16:44,400 --> 01:16:47,560 RESEARCH PIPELINE AND WE DO THIS 1993 01:16:47,560 --> 01:16:49,800 BASICALLY BY IDENTIFYING 1994 01:16:49,800 --> 01:16:52,040 ESSENTIALLY EIGHT KEY PRINCIPLES 1995 01:16:52,040 --> 01:16:54,400 THAT FOCUS ON WHAT MAKES AN 1996 01:16:54,400 --> 01:16:57,840 EFFECTIVE TRANSLATIONAL SCIENCE 1997 01:16:57,840 --> 01:16:59,400 PROGRAM GO VERY WELL AND MUCH OF 1998 01:16:59,400 --> 01:17:00,960 IT IS REALLY ABOUT THAT 1999 01:17:00,960 --> 01:17:03,480 UNDERSTANDING OF COM ON 2000 01:17:03,480 --> 01:17:04,840 CHALLENGES AND ROADBLOCKS TO 2001 01:17:04,840 --> 01:17:06,160 TRANSLATION AND DETERMINING THE 2002 01:17:06,160 --> 01:17:07,240 SCIENTIFIC AND OPERATIONAL 2003 01:17:07,240 --> 01:17:08,480 PRINCIPLES THAT CAN BE SORT OF 2004 01:17:08,480 --> 01:17:11,560 BUILT OR UTILIZED TO REMOVE 2005 01:17:11,560 --> 01:17:13,000 THOSE ROADBLOCKS AND DEVELOPING 2006 01:17:13,000 --> 01:17:14,440 THOSE SOLUTION THAT'S CAN EMPLOY 2007 01:17:14,440 --> 01:17:16,840 THESE PRINCIPLES THAT CAN BE 2008 01:17:16,840 --> 01:17:18,520 APPLICABLE TO A VARIETY OF 2009 01:17:18,520 --> 01:17:20,200 DIFFERENT DISEASES AND 2010 01:17:20,200 --> 01:17:23,000 CONDITIONS SO BY USING THESE 2011 01:17:23,000 --> 01:17:24,040 DIFFERENT PRINCIPLES WHEN 2012 01:17:24,040 --> 01:17:28,080 THEY'RE NEEDED AND WE TALKED 2013 01:17:28,080 --> 01:17:29,280 ABOUT THE IMPORTANCE OF TEAM 2014 01:17:29,280 --> 01:17:31,800 SCIENCE AND IT'S A KEY PRINCIPLE 2015 01:17:31,800 --> 01:17:32,840 HIGHLIGHTED HERE IN THE MIDDLE 2016 01:17:32,840 --> 01:17:35,680 IN THE TEAM SCIENCE BADGE. 2017 01:17:35,680 --> 01:17:37,280 SO THESE ARE IMPORTANT 2018 01:17:37,280 --> 01:17:38,120 CHARACTERISTICS FOR PEOPLE 2019 01:17:38,120 --> 01:17:39,920 WORKING IN THIS SPACE SO THAT WE 2020 01:17:39,920 --> 01:17:40,800 CAN REALLY BRING EVERYBODY THAT 2021 01:17:40,800 --> 01:17:43,040 WE HAVE TO THE TABLE TO ADDRESS 2022 01:17:43,040 --> 01:17:45,400 THOSE BOTTLENECKS IN THE 2023 01:17:45,400 --> 01:17:46,560 TRANSLATION SCIENCE PIPELINE. 2024 01:17:46,560 --> 01:17:48,240 AND THE NEXT SLIDE I JUST WANTED 2025 01:17:48,240 --> 01:17:50,440 TO GIVE YOU A SENSE OF THE 2026 01:17:50,440 --> 01:17:53,400 NCATS' BUDGET AND ESSENTIALLY WE 2027 01:17:53,400 --> 01:17:56,560 SPEND MOST OF OUR BUDGET ON THE 2028 01:17:56,560 --> 01:17:58,240 CLINICAL SIDE OF THE 2029 01:17:58,240 --> 01:17:59,080 TRANSLATIONAL SCIENCE PIPELINE 2030 01:17:59,080 --> 01:18:01,760 THROUGH THE CLINICAL AND 2031 01:18:01,760 --> 01:18:05,760 TRANSLATIONAL SCIENCE AWARD THAT 2032 01:18:05,760 --> 01:18:08,000 MAKES UP 70% OF OUR BUDGET AND 2033 01:18:08,000 --> 01:18:10,440 IT'S A LINE ITEM IS SO THAT GOES 2034 01:18:10,440 --> 01:18:13,040 TO THE CTSA PROGRAM AND THE 30% 2035 01:18:13,040 --> 01:18:19,280 THAT REMAINS IS REALLY WHAT THE 2036 01:18:19,280 --> 01:18:21,440 NCATS PROGRAMS DO ACROSS THE 2037 01:18:21,440 --> 01:18:22,320 TRANSLATIONAL SCIENCE PIPELINE 2038 01:18:22,320 --> 01:18:24,480 AND THAT WORK IS IN THE 2039 01:18:24,480 --> 01:18:25,560 PRECLINICAL SPACE AND RARE 2040 01:18:25,560 --> 01:18:28,240 DISEASES AS WELL. 2041 01:18:28,240 --> 01:18:29,760 SO NEXT SLIDE, I'M GOING TO 2042 01:18:29,760 --> 01:18:31,520 START TO TRANSITION INTO SOME OF 2043 01:18:31,520 --> 01:18:34,280 THE KEY AREAS THAT WE'RE WORKING 2044 01:18:34,280 --> 01:18:36,400 IN FOR HIGHLIGHTING THESE 2045 01:18:36,400 --> 01:18:37,240 TRANSLATIONAL SCIENCE PRINCIPLES 2046 01:18:37,240 --> 01:18:38,920 FOR ADDRESSING WOMEN'S HEALTH 2047 01:18:38,920 --> 01:18:42,560 AND I WANTED TO JUST START OFF 2048 01:18:42,560 --> 01:18:44,880 WITH THIS PAPER HERE, DRUGS AND 2049 01:18:44,880 --> 01:18:46,880 MEDICAL DEVICES AND IMPACT ON 2050 01:18:46,880 --> 01:18:48,000 WOMEN'S HEALTH AND I ABOUT THE 2051 01:18:48,000 --> 01:18:50,840 WAY I TYPICALLY USE QR CODES SO 2052 01:18:50,840 --> 01:18:52,960 YOU CAN JUST TAKE A POINT YOUR 2053 01:18:52,960 --> 01:18:55,000 CAMERA AT THE QR CODE AND IT 2054 01:18:55,000 --> 01:18:58,120 WILL TAKE YOU TO THE REFERENCE. 2055 01:18:58,120 --> 01:19:00,360 BUT THIS PARTICULAR PAPER TALKS 2056 01:19:00,360 --> 01:19:05,560 A LITTLE BIT ABOUT DATA FROM THE 2057 01:19:05,560 --> 01:19:06,640 FDA'S OFFICE OF WOMEN'S HEALTH 2058 01:19:06,640 --> 01:19:08,840 AND TALKS ABOUT THE IDEA THAT 2059 01:19:08,840 --> 01:19:11,960 FEMALES HAVE DOUBLE THE RISK OF 2060 01:19:11,960 --> 01:19:13,560 DEVELOPING DRUG ADVERSE 2061 01:19:13,560 --> 01:19:14,280 ACCORDING TO MEN. 2062 01:19:14,280 --> 01:19:16,640 I WANT TO SORT OF HIGHLIGHT THAT 2063 01:19:16,640 --> 01:19:18,360 AS SORT OF A KEY FEATURE HOW 2064 01:19:18,360 --> 01:19:20,440 WE'RE ABLE TO ATTACK THAT 2065 01:19:20,440 --> 01:19:21,040 PARTICULAR NUMBER. 2066 01:19:21,040 --> 01:19:22,800 I WILL SPEND TIME TALKING ABOUT 2067 01:19:22,800 --> 01:19:24,800 THE PRECLINICAL SPACE THAT WE 2068 01:19:24,800 --> 01:19:26,240 WORK IN AS WELL AS THE CLINICAL 2069 01:19:26,240 --> 01:19:28,720 SPACE THAT WE WORK IN. 2070 01:19:28,720 --> 01:19:32,720 WHEN WE CONSIDER SEX AS A 2071 01:19:32,720 --> 01:19:33,760 BIOLOGICAL VARIABLE, WOMEN 2072 01:19:33,760 --> 01:19:34,920 COMPROMISE HALF OF PARTICIPANTS 2073 01:19:34,920 --> 01:19:36,760 IN NIH FUNDED CLINICAL TRIALS. 2074 01:19:36,760 --> 01:19:38,360 LARGELY BECAUSE OF THE EFFORTS 2075 01:19:38,360 --> 01:19:41,640 OF Dr. CLAYTON AND HER TEAM 2076 01:19:41,640 --> 01:19:43,600 AND THE SAME NOT NECESSARILY 2077 01:19:43,600 --> 01:19:45,200 TRUE FOR THE PRECLINICAL SPACE 2078 01:19:45,200 --> 01:19:46,720 AND PRECLINICAL RESEARCH AND 2079 01:19:46,720 --> 01:19:50,400 MORE MUCH THAN NOT, PRECLINICAL 2080 01:19:50,400 --> 01:19:53,040 RESEARCH IS CONDUCTED IN MOSTLY 2081 01:19:53,040 --> 01:19:55,080 MALE DERIVED CELLS IN MALE 2082 01:19:55,080 --> 01:19:59,360 ANIMALS AND THESE PRACTICES HAVE 2083 01:19:59,360 --> 01:20:01,000 RESULTED IN A LACK OF 2084 01:20:01,000 --> 01:20:01,840 INFORMATION IN WOMEN'S HEALTH 2085 01:20:01,840 --> 01:20:03,920 AND THERE'S NO DOUBT IT'S 2086 01:20:03,920 --> 01:20:05,280 CONTRIBUTING TO THE HIGHER RISK 2087 01:20:05,280 --> 01:20:07,040 IN THE ADVERSE DRUG REACTION 2088 01:20:07,040 --> 01:20:08,160 STATISTICS THAT I JUST TALKED 2089 01:20:08,160 --> 01:20:09,880 ABOUT IN THIS REPORT. 2090 01:20:09,880 --> 01:20:12,560 AND IN ADDITION OF COURSE, AND 2091 01:20:12,560 --> 01:20:13,960 LARGELY FOR ETHICAL REASONS, BUT 2092 01:20:13,960 --> 01:20:16,120 AS YOU KNOW, PREGNANT WOMEN ARE 2093 01:20:16,120 --> 01:20:17,640 NOT ALLOWED TO PARTICIPATE IN 2094 01:20:17,640 --> 01:20:21,440 STUDIES OF NEW DRUGS AND IN 2095 01:20:21,440 --> 01:20:23,120 ADDITION TO THAT THERE ARE MANY 2096 01:20:23,120 --> 01:20:25,040 YEARS WHEN ALL WOMEN WHO HAD THE 2097 01:20:25,040 --> 01:20:26,680 POTENTIAL TO GET PREGNANT WERE 2098 01:20:26,680 --> 01:20:28,480 EXCLUDED FROM NUMEROUS RESEARCH 2099 01:20:28,480 --> 01:20:29,960 STUDIES SO WE'RE MAKING HEAD WAY 2100 01:20:29,960 --> 01:20:31,280 THERE BUT THESE APPROACHES 2101 01:20:31,280 --> 01:20:34,000 CREATED A LACK OF INFORMATION 2102 01:20:34,000 --> 01:20:36,040 ABOUT WOMEN'S HEALTH AND FEMALE 2103 01:20:36,040 --> 01:20:37,400 PHYSIOLOGY AND WE STILL HAVE A 2104 01:20:37,400 --> 01:20:39,600 LOT TO LEARN IN THIS SPACE AND I 2105 01:20:39,600 --> 01:20:42,560 WANT TO TALK ABOUT THOSE 2106 01:20:42,560 --> 01:20:43,120 OPPORTUNITIES WHERE NCATS IS 2107 01:20:43,120 --> 01:20:44,240 TRYING TO CHANGE THAT NARRATIVE 2108 01:20:44,240 --> 01:20:46,000 IF YOU WILL AND HE'LL TALK AGAIN 2109 01:20:46,000 --> 01:20:48,320 ABOUT THE PRECLINICAL AND THE 2110 01:20:48,320 --> 01:20:49,000 CLINICAL SIDE. 2111 01:20:49,000 --> 01:20:50,480 I'LL START HERE ON THE CLINICAL 2112 01:20:50,480 --> 01:20:50,800 SIDE. 2113 01:20:50,800 --> 01:20:52,960 SO YOU CAN GO TO THE NEXT SLIDE. 2114 01:20:52,960 --> 01:20:55,480 IT SHOULDN'T BE THE CLINICAL AND 2115 01:20:55,480 --> 01:20:57,360 TRANSLATIONAL SCIENCE AWARD 2116 01:20:57,360 --> 01:21:00,480 PROGRAM ALSO KNOWN AS THE CTSA 2117 01:21:00,480 --> 01:21:05,400 PROGRAM AND THIS IS A 2118 01:21:05,400 --> 01:21:07,920 INTERNATIONAL NETWORK THAT IS 2119 01:21:07,920 --> 01:21:09,560 THE LARGEST PROGRAM WITHIN THE 2120 01:21:09,560 --> 01:21:13,280 NIH TO SUPPORT CLINICAL 2121 01:21:13,280 --> 01:21:13,560 RESEARCH. 2122 01:21:13,560 --> 01:21:15,040 WE HAVE -- IT WAS FIRST 2123 01:21:15,040 --> 01:21:16,840 ESTABLISHED IN 2006 AND WE HAVE 2124 01:21:16,840 --> 01:21:19,480 NOW OVER 60 AWARDEE INSTITUTIONS 2125 01:21:19,480 --> 01:21:21,760 WITHIN A RUBRIC OF THE CTSA 2126 01:21:21,760 --> 01:21:24,200 PROGRAM AND THERE ARE GOALS TO 2127 01:21:24,200 --> 01:21:26,200 DEVELOP, DEMONSTRATE AND DES SEM 2128 01:21:26,200 --> 01:21:27,840 NATURE THESE INNOVATIONS THAT 2129 01:21:27,840 --> 01:21:29,400 SCIENCE HELPS FASTER AND THEY 2130 01:21:29,400 --> 01:21:31,640 PROMOTE IMPACTFUL PARTNERSHIPS 2131 01:21:31,640 --> 01:21:33,520 AND CONDUCT A LOT OF TEAM 2132 01:21:33,520 --> 01:21:35,120 SCIENCE AND TRAIN THEIR TRAINEES 2133 01:21:35,120 --> 01:21:35,920 IN TEAM SCIENCE. 2134 01:21:35,920 --> 01:21:37,680 THEY WORK IN ADDRESSING HEALTH 2135 01:21:37,680 --> 01:21:39,800 DISPARITIES DOING INNOVATING AND 2136 01:21:39,800 --> 01:21:40,920 COMMUNITY ENGAGEMENT AND 2137 01:21:40,920 --> 01:21:41,960 PRACTICES AND THOSE SORTS OF 2138 01:21:41,960 --> 01:21:46,240 THINGS AND THEY PROCEED PROVIDE 2139 01:21:46,240 --> 01:21:47,680 URGENT HEALTH NEEDS AND THEY 2140 01:21:47,680 --> 01:21:50,040 CREATE A ROLE DURING THE 2141 01:21:50,040 --> 01:21:51,480 PANDEMIC FOR PROVIDING WAYS IN 2142 01:21:51,480 --> 01:21:53,040 WHICH WE CAN CONDUCT CLINICAL 2143 01:21:53,040 --> 01:21:54,360 TRIALS FOR ALL THE DIFFERENT 2144 01:21:54,360 --> 01:21:56,240 STUDIES THAT NEEDED TO BE DONE 2145 01:21:56,240 --> 01:21:57,800 DURING THE PANDEMIC. 2146 01:21:57,800 --> 01:22:00,200 THEY PROMOTE TRAINING AND CAREER 2147 01:22:00,200 --> 01:22:01,600 SUPPORT AND ESSENTIALLY REALLY 2148 01:22:01,600 --> 01:22:04,640 HELP US PRACTICE THE FIELD OF 2149 01:22:04,640 --> 01:22:05,240 TRANSLATIONAL SCIENCE AND THEY 2150 01:22:05,240 --> 01:22:07,400 HAVE REALLY BEEN INSTRUMENTAL IN 2151 01:22:07,400 --> 01:22:09,040 HIGHLIGHTING AND GENERATING 2152 01:22:09,040 --> 01:22:10,360 THOSE EIGHT TRANSLATIONAL 2153 01:22:10,360 --> 01:22:11,520 SCIENCE PRINCIPLES THAT I 2154 01:22:11,520 --> 01:22:13,800 MENTIONED BEFORE SO THIS IS NO 2155 01:22:13,800 --> 01:22:16,240 DOUBT UP WITH OF THE BIGGEST AND 2156 01:22:16,240 --> 01:22:18,440 I THINK MOST BENEFICIAL PROGRAMS 2157 01:22:18,440 --> 01:22:19,920 THAT WE'VE HAD AT THE NIH AND IF 2158 01:22:19,920 --> 01:22:21,600 YOU GO TO THE NEXT SLIDE AND 2159 01:22:21,600 --> 01:22:25,960 I'LL ASK YOU TO GO AHEAD AND 2160 01:22:25,960 --> 01:22:27,280 CLICK TWICE. 2161 01:22:27,280 --> 01:22:28,560 ESSENTIALLY EACH PARTICULAR 2162 01:22:28,560 --> 01:22:30,120 INSTITUTION WITHIN THE CTSA 2163 01:22:30,120 --> 01:22:32,160 PROGRAM HAS THEIR OWN LOCAL 2164 01:22:32,160 --> 01:22:33,440 STRENGTHS BUT TOGETHER, THEY CAN 2165 01:22:33,440 --> 01:22:35,840 REALLY ENABLE A RAPID AND ROBUST 2166 01:22:35,840 --> 01:22:37,640 PUBLIC RESPONSE TO A VARIETY OF 2167 01:22:37,640 --> 01:22:38,720 ACTIVITIES AND THEY'VE BEEN 2168 01:22:38,720 --> 01:22:40,880 INVOLVED IN THE HEAL PROGRAM, 2169 01:22:40,880 --> 01:22:43,040 THE HELPING END ADDICTION 2170 01:22:43,040 --> 01:22:45,680 LONG-TERM PROGRAM AND THE ACTIVE 2171 01:22:45,680 --> 01:22:47,120 PROGRAM FOR THE CLINICAL TRAILS 2172 01:22:47,120 --> 01:22:49,280 FOR THE PANDEMIC AND DOING A LOT 2173 01:22:49,280 --> 01:22:50,280 OF THE COMMUNITY ENGAGEMENT 2174 01:22:50,280 --> 01:22:53,080 EFFORTS THAT NEEDED TO BE 2175 01:22:53,080 --> 01:22:54,280 CONDUCTED, DECENTRALIZED 2176 01:22:54,280 --> 01:22:55,960 CLINICAL TRIALS, MOBILE APP 2177 01:22:55,960 --> 01:22:56,960 DEVELOPMENT THAT HAS BEEN ON 2178 01:22:56,960 --> 01:22:59,040 GOING EVEN BEFORE THE PANDEMIC 2179 01:22:59,040 --> 01:23:01,560 AND SO THERE HAS BEEN A VARIETY 2180 01:23:01,560 --> 01:23:04,000 OF ACTIVITIES THEY HAVE 2181 01:23:04,000 --> 01:23:04,760 SUPPORTED THAT WE HAVE OF A KEY 2182 01:23:04,760 --> 01:23:06,680 COMPONENT FOR TELEHEALTH AND 2183 01:23:06,680 --> 01:23:07,440 TELEMEDICINE AND WE HAVE A LOT 2184 01:23:07,440 --> 01:23:10,640 OF ACTIVITIES AND RARE DISEASES 2185 01:23:10,640 --> 01:23:12,160 AND EVEN I GUESS ONE OF THE 2186 01:23:12,160 --> 01:23:14,080 THINGS THAT I WOULD LIKE TO 2187 01:23:14,080 --> 01:23:15,480 HIGHLIGHT HERE IS IT'S NOT JUST 2188 01:23:15,480 --> 01:23:16,760 THE SCIENTIFIC SIDE BUT THE 2189 01:23:16,760 --> 01:23:18,560 OPERATIONAL SIDE AND THE CTSA 2190 01:23:18,560 --> 01:23:20,240 PROGRAM HAS BEEN INSTRUMENTAL IN 2191 01:23:20,240 --> 01:23:23,040 DEVELOPING SOMETHING CALLED THE 2192 01:23:23,040 --> 01:23:24,320 SMART IRB AND THIS IS BEEN 2193 01:23:24,320 --> 01:23:33,640 ESSENTIALLY A WAY IN WHICH WITH 2194 01:23:33,640 --> 01:23:35,080 THAT WE CAN SPEED UP THE TIME IT 2195 01:23:35,080 --> 01:23:38,040 TAKES FOR IRB APPROVALS TO 2196 01:23:38,040 --> 01:23:39,440 HAPPEN TO STUDIES CAN BE 2197 01:23:39,440 --> 01:23:40,440 INITIATED MORE QUICKLY. 2198 01:23:40,440 --> 01:23:42,080 WE HAVE REDUCED THAT TIME IN 2199 01:23:42,080 --> 01:23:42,480 HALF. 2200 01:23:42,480 --> 01:23:50,080 THIS IS ONE ASPECT WHERE WE'RE 2201 01:23:50,080 --> 01:23:52,480 ABLE TO SPEED THINGS UP AND WE 2202 01:23:52,480 --> 01:23:54,120 HAVE A LONG WAY TO GO IN OTHER 2203 01:23:54,120 --> 01:23:54,360 SPACES. 2204 01:23:54,360 --> 01:23:56,080 THE NEXT SLIDE IS A FEW NIP ET 2205 01:23:56,080 --> 01:23:57,560 CETERA OF SOME OF THE ACTIVITIES 2206 01:23:57,560 --> 01:24:00,160 FROM THE CTSA PROGRAM AND THEIR 2207 01:24:00,160 --> 01:24:02,760 INVOLVEMENT IN WOMEN'S HEALTH 2208 01:24:02,760 --> 01:24:06,960 AND THIS EXAMPLE HERE IS JUST 2209 01:24:06,960 --> 01:24:09,640 SHOWING THAT WE HAVE A PILOT 2210 01:24:09,640 --> 01:24:11,880 AWARD PROGRAM IN THE CTSA 2211 01:24:11,880 --> 01:24:13,920 PROGRAM AND THE PILOT AWARD 2212 01:24:13,920 --> 01:24:17,080 PROGRAM PROVIDES SEED MONEY FOR 2213 01:24:17,080 --> 01:24:18,560 A LITTLE BIT OF SUPPORT FOR NEW 2214 01:24:18,560 --> 01:24:20,720 OR INNOVATIVE IDEAS OR 2215 01:24:20,720 --> 01:24:22,000 APPROACHES AND THEN THAT SEED 2216 01:24:22,000 --> 01:24:23,560 MONEY CAN REALLY HELP PROVIDE 2217 01:24:23,560 --> 01:24:27,640 THE VALUABLE PRELIMINARY DATA 2218 01:24:27,640 --> 01:24:29,040 FOR YOUNG INVESTIGATORS THAT 2219 01:24:29,040 --> 01:24:32,480 DEVELOP A RATIONAL FOR DOING A 2220 01:24:32,480 --> 01:24:33,920 R01 BASED PROJECTOR SOME OTHER 2221 01:24:33,920 --> 01:24:36,440 TYPE OF NIH AWARD PROJECT. 2222 01:24:36,440 --> 01:24:38,960 AND CURRENTLY WE HAVE ABOUT 15% 2223 01:24:38,960 --> 01:24:42,040 OF THE PILOT AWARDS ARE IN THE 2224 01:24:42,040 --> 01:24:44,640 AREA OF EMPHASIZING ASPECTS OF 2225 01:24:44,640 --> 01:24:46,600 WOMEN'S HEALTH AND MOST OF THOSE 2226 01:24:46,600 --> 01:24:48,040 ARE SPECIFICALLY FOCUSED ON 2227 01:24:48,040 --> 01:24:49,840 WOMEN'S HEALTH AND SOME OF THEM 2228 01:24:49,840 --> 01:24:55,440 ARE SPATIA PARTIALLY FOCUSED ONS 2229 01:24:55,440 --> 01:24:55,880 HEALTH. 2230 01:24:55,880 --> 01:24:57,640 UNDERSTANDING AND EVALUATING 2231 01:24:57,640 --> 01:25:00,120 SERVICES FOR IN CARS RATED AND 2232 01:25:00,120 --> 01:25:03,560 PREGNANT IN POSTPARTUM WOMEN, 2233 01:25:03,560 --> 01:25:06,040 IMPROVING CARDIOVASCULAR RISK IN 2234 01:25:06,040 --> 01:25:07,720 WOMEN AND ALSO TRYING TO THINK 2235 01:25:07,720 --> 01:25:11,600 ABOUT WAYS OF INTEGRATING 2236 01:25:11,600 --> 01:25:12,760 SMOKING SECESSION INTO 2237 01:25:12,760 --> 01:25:13,280 BREASTFEEDING PROGRAMS 2238 01:25:13,280 --> 01:25:15,760 SPECIFICALLY TO REDUCE CANCER 2239 01:25:15,760 --> 01:25:17,000 DISPARITIES BUT IT WILL HAVE 2240 01:25:17,000 --> 01:25:18,400 LONGER TERMS EFFECTS THAN JUST 2241 01:25:18,400 --> 01:25:23,440 IN CANCER SO THIS IS THAT MANY 2242 01:25:23,440 --> 01:25:30,640 DISEASES AT A TIME PREVENTION 2243 01:25:30,640 --> 01:25:31,680 STUDY THAT IS DONE IN THE 2244 01:25:31,680 --> 01:25:32,160 PROGRAM TOO. 2245 01:25:32,160 --> 01:25:33,720 THIS IS ANOTHER AREA I WANTED TO 2246 01:25:33,720 --> 01:25:34,320 MENTION. 2247 01:25:34,320 --> 01:25:35,880 THERE'S A PROGRAM CALLED THE 2248 01:25:35,880 --> 01:25:37,920 TRIAL INNOVATION NETWORK AND 2249 01:25:37,920 --> 01:25:39,800 THIS IS AN INITIATIVE THAT IS 2250 01:25:39,800 --> 01:25:43,720 BEING USED WITH ITS CTSA PROGRAM 2251 01:25:43,720 --> 01:25:46,440 AND IT'S BEING USED SPECIFICALLY 2252 01:25:46,440 --> 01:25:48,480 WITHIN THE HELPING ENDS 2253 01:25:48,480 --> 01:25:49,800 ADDICTION LONG-TERM OR THE HEAL 2254 01:25:49,800 --> 01:25:53,520 PROGRAM TO LOOK AT PAIN AND 2255 01:25:53,520 --> 01:25:55,200 OPIOID MANAGEMENT SPECIFICALLY 2256 01:25:55,200 --> 01:25:57,640 SO THIS IS MEANT TO REALLY 2257 01:25:57,640 --> 01:25:59,640 COMPARE THE EFFECTIVENESS OF 2258 01:25:59,640 --> 01:26:02,880 EXISTING NON ADDICTIVE PAIN 2259 01:26:02,880 --> 01:26:04,760 THERAPEUTICS AS WELL AS EXISTING 2260 01:26:04,760 --> 01:26:06,880 NOVEL APPROACHES FOR PAIN 2261 01:26:06,880 --> 01:26:08,120 PREVENTION AND MANAGEMENT SO WE 2262 01:26:08,120 --> 01:26:10,240 WANT TO MAKE NEW APPROACHES FOR 2263 01:26:10,240 --> 01:26:13,480 PAIN THERAPIES THAT ARE NON 2264 01:26:13,480 --> 01:26:14,640 ADDICTIVE AND THAT'S THE KEY 2265 01:26:14,640 --> 01:26:14,960 THING. 2266 01:26:14,960 --> 01:26:16,440 WE'RE COMPARING THE 2267 01:26:16,440 --> 01:26:18,440 EFFECTIVENESS OF SOME OF THESE 2268 01:26:18,440 --> 01:26:19,920 PARTICULAR THERAPEUTICS THAT ARE 2269 01:26:19,920 --> 01:26:20,920 EXAMINING DOWN THE PIPELINE FOR 2270 01:26:20,920 --> 01:26:22,600 THOSE IDEAS. 2271 01:26:22,600 --> 01:26:24,520 AND SO THERE'S A LARGER EFFORT 2272 01:26:24,520 --> 01:26:26,520 WITHIN THE CTSA PROGRAM TO 2273 01:26:26,520 --> 01:26:28,080 REALLY NOT A PART OF THIS 2274 01:26:28,080 --> 01:26:38,520 PARTICULAR ACTIVITIES AND 2275 01:26:45,360 --> 01:26:46,920 ANOTHER AREA FOR PREVENTION OF 2276 01:26:46,920 --> 01:26:48,640 THE POSTMA SEC TOMMY PAIN DIN 2277 01:26:48,640 --> 01:26:50,360 TROM AND HOW THAT CAN BE USED IN 2278 01:26:50,360 --> 01:27:00,800 A NON WAY AND IF WAYS THAT 2279 01:27:08,160 --> 01:27:09,280 THEY'RE CONDUCTED ARE VERY 2280 01:27:09,280 --> 01:27:10,560 IMPORTANT. 2281 01:27:10,560 --> 01:27:12,800 NEXT SLIDE IS JUST 2282 01:27:12,800 --> 01:27:13,520 HIGHLIGHTING -- DURING THE 2283 01:27:13,520 --> 01:27:16,240 PANDEMIC THERE WAS ONE KEY AREA 2284 01:27:16,240 --> 01:27:17,080 I THINK THAT NCATS HAS BEEN 2285 01:27:17,080 --> 01:27:19,080 REALLY ABLE TO CONTRIBUTE AND 2286 01:27:19,080 --> 01:27:20,960 IT'S IN THE AREA OF DATA SCIENCE 2287 01:27:20,960 --> 01:27:22,600 AND WE'VE BEEN, SINCE THE 2288 01:27:22,600 --> 01:27:27,800 PANDEMIC HIT, WITH THE CTSA 2289 01:27:27,800 --> 01:27:29,000 PROGRAM, THERE ARE AN 2290 01:27:29,000 --> 01:27:31,440 OPPORTUNITY FOR US TO UNDERSTAND 2291 01:27:31,440 --> 01:27:34,040 HOW WE CAN IDENTIFY OF AND 2292 01:27:34,040 --> 01:27:35,600 COLLECT THE ELECTRONIC HEALTH 2293 01:27:35,600 --> 01:27:38,960 RECORDS TO STUDY POTENTIAL 2294 01:27:38,960 --> 01:27:40,160 OUTCOMES FOR INDIVIDUALS WHO ARE 2295 01:27:40,160 --> 01:27:42,520 DEALING WITH THE PANDEMIC. 2296 01:27:42,520 --> 01:27:44,320 AND INSPECTED WITH SARS-CoV-2 2297 01:27:44,320 --> 01:27:45,880 AND WE'RE COMPARING THEM TO 2298 01:27:45,880 --> 01:27:48,200 PEOPLE WHO AREN'T INFECTED SO WE 2299 01:27:48,200 --> 01:27:50,360 RECEIVED THE ELECTRONIC HEALTH 2300 01:27:50,360 --> 01:27:53,680 RECORDS IN A WAY THAT WE CAN 2301 01:27:53,680 --> 01:27:57,400 COMPARE THEM APPLE TO APPLES 2302 01:27:57,400 --> 01:27:57,680 WAY. 2303 01:27:57,680 --> 01:28:01,920 IF YOU GO TO ONE INSTITUTION FOR 2304 01:28:01,920 --> 01:28:05,560 A CLINICAL VISIT AND THAT MIGHT 2305 01:28:05,560 --> 01:28:07,560 BE INFECTIOUS DISEASE AND YOU GO 2306 01:28:07,560 --> 01:28:11,840 TO ANOTHER HOSPITAL FOR CLINICAL 2307 01:28:11,840 --> 01:28:14,240 VISIT FOR GETTING SOME SORT OF 2308 01:28:14,240 --> 01:28:16,720 ASSESSMENT ON YOUR ANKLE THAT'S 2309 01:28:16,720 --> 01:28:18,240 VERY SORE, THESE ARE TWO VERY 2310 01:28:18,240 --> 01:28:19,880 DIFFERENT HOSPITALS OR UNITS. 2311 01:28:19,880 --> 01:28:22,360 THEY MIGHT BE ACROSS THE STREET 2312 01:28:22,360 --> 01:28:23,440 BUT THEY ARE DIFFERENT HEALTH 2313 01:28:23,440 --> 01:28:25,240 RECORDS WHICH IS FUNNY. 2314 01:28:25,240 --> 01:28:27,720 NOT IN A GOOD WAY. 2315 01:28:27,720 --> 01:28:30,400 SO, THIS A BIG DATA SCIENCE 2316 01:28:30,400 --> 01:28:32,800 PROBLEM AND WHAT THE NATIONAL 2317 01:28:32,800 --> 01:28:35,920 COVID COHORT COLLABORATIVE HAS 2318 01:28:35,920 --> 01:28:37,600 DONE IS WE'VE TAKEN IT OFF THE 2319 01:28:37,600 --> 01:28:39,840 TABLE FOR ELECTRONIC HEALTH 2320 01:28:39,840 --> 01:28:42,200 RECORD RESEARCH ANALYSIS AND NOW 2321 01:28:42,200 --> 01:28:44,200 WE'RE ABLE TO COMPARE, NO MATTER 2322 01:28:44,200 --> 01:28:46,640 WHERE THOSE ELECTRONIC HEALTH 2323 01:28:46,640 --> 01:28:47,920 RECORDS ARE FROM THEY COMPARE 2324 01:28:47,920 --> 01:28:50,040 THEM APPLES TO AMS O RIGHT NOW 2325 01:28:50,040 --> 01:28:52,960 WE HAVE 77 DIFFERENT SITES 2326 01:28:52,960 --> 01:28:55,720 CONTRIBUTING THESE RECORDS TO A 2327 01:28:55,720 --> 01:28:56,120 SECURE ENCLAVE. 2328 01:28:56,120 --> 01:29:00,000 WE HAVE OVER 17 MILLION PEOPLE 2329 01:29:00,000 --> 01:29:01,560 WITHIN THE ENCLAVE AND OVER 2330 01:29:01,560 --> 01:29:03,480 7 MILLION OF THOSE HAVE BEEN 2331 01:29:03,480 --> 01:29:04,920 COVID POSITIVE OVER THE LAST 2332 01:29:04,920 --> 01:29:08,080 COUPLE OF YEARS AND THIS 2333 01:29:08,080 --> 01:29:10,520 TRANSLATES TO 22.1 BILLION ROWS 2334 01:29:10,520 --> 01:29:11,120 OF DATA. 2335 01:29:11,120 --> 01:29:12,800 IF YOU PUT THAT IN A SPREAD 2336 01:29:12,800 --> 01:29:14,480 SHEET IN ONE LINE, IT WOULD 2337 01:29:14,480 --> 01:29:15,880 WOULD WRAP AROUND THE EARTH 2338 01:29:15,880 --> 01:29:16,280 THREE-TIME. 2339 01:29:16,280 --> 01:29:17,840 IT'S A LOT OF DATA AND WE DON'T 2340 01:29:17,840 --> 01:29:19,400 HAVE TO USE SPREAD SHEETS TO DO 2341 01:29:19,400 --> 01:29:20,120 THIS. 2342 01:29:20,120 --> 01:29:23,080 IT'S A VERY SOPHISTICATED WAY OF 2343 01:29:23,080 --> 01:29:24,760 EVALUATING THE DATA AND IT TAKES 2344 01:29:24,760 --> 01:29:26,160 A TEAM SCIENCE APPROACH TO DO 2345 01:29:26,160 --> 01:29:27,720 THAT BUT WE'VE BEEN ABLE TO 2346 01:29:27,720 --> 01:29:30,080 INFORM ON AREAS OF PUBLIC-HEALTH 2347 01:29:30,080 --> 01:29:31,920 QUESTIONS LIKE HOW IT'S IMPACTED 2348 01:29:31,920 --> 01:29:34,560 LONG COVID RISK AND THE USE OF 2349 01:29:34,560 --> 01:29:36,240 ANTIBODY EFFECTIVENESS ACROSS 2350 01:29:36,240 --> 01:29:38,160 DIFFERENT VARIANTS OF THE 2351 01:29:38,160 --> 01:29:40,600 PANDEMIC, AS WELL AS 2352 01:29:40,600 --> 01:29:41,360 UNDERSTANDING THE PAXLOVID USE 2353 01:29:41,360 --> 01:29:43,000 CHARACTER AND I CAN TALK ABOUT 2354 01:29:43,000 --> 01:29:43,760 THESE IF YOU ARE INTERESTED. 2355 01:29:43,760 --> 01:29:45,600 I WANTED TO GIVE YOU A SENSE OF 2356 01:29:45,600 --> 01:29:47,800 THE DASHBOARD AND THE QR CODE 2357 01:29:47,800 --> 01:29:48,760 SHOWN ON THE RIGHT. 2358 01:29:48,760 --> 01:29:50,160 YOU CAN LOOK AT SOME OF THE DATA 2359 01:29:50,160 --> 01:29:51,200 THAT ARE THERE NOW. 2360 01:29:51,200 --> 01:29:53,280 WITHIN THESE ELECTRONIC HEALTH 2361 01:29:53,280 --> 01:29:55,080 RECORDS IT'S A REAL WORLD DATA 2362 01:29:55,080 --> 01:29:57,040 ENTERPRISE WHERE WE HAVE CMS 2363 01:29:57,040 --> 01:30:00,200 DATA, MEDICARE, MEDICAID, 2364 01:30:00,200 --> 01:30:01,760 VACCINE, AND THIS UPDATED EVERY 2365 01:30:01,760 --> 01:30:03,800 TWO WEEKS SO WE CAN REALLY 2366 01:30:03,800 --> 01:30:05,920 MONITOR THE WE'LL SPAN OF THE 2367 01:30:05,920 --> 01:30:06,680 PANDEMIC. 2368 01:30:06,680 --> 01:30:11,400 THIS A TIME TO LIMITED RESEARCH 2369 01:30:11,400 --> 01:30:15,800 AND SO, WE WERE GOING THROUGH 2370 01:30:15,800 --> 01:30:17,800 FY24 AND SEE WHAT WE NEED TO DO 2371 01:30:17,800 --> 01:30:19,200 BUT WE'RE HOPING THAT THE 2372 01:30:19,200 --> 01:30:21,240 PANDEMIC WOULD BE ENDING BY THEN 2373 01:30:21,240 --> 01:30:23,400 AND THAT REMAINS TO BE SEEN 2374 01:30:23,400 --> 01:30:24,280 ESPECIALLY THE LONGER TERM 2375 01:30:24,280 --> 01:30:26,240 EFFECTS OF SOME OF THAT SO HOW 2376 01:30:26,240 --> 01:30:28,120 ARE WE MOVING FORWARD WE'RE 2377 01:30:28,120 --> 01:30:29,200 STILL EVALUATING THAT. 2378 01:30:29,200 --> 01:30:30,320 THIS IS BEEN AN IMPORTANT 2379 01:30:30,320 --> 01:30:30,680 PROGRAM. 2380 01:30:30,680 --> 01:30:32,320 I WANTED TO TELL YOU THE 2381 01:30:32,320 --> 01:30:33,360 BACKGROUND OF THIS BECAUSE SOME 2382 01:30:33,360 --> 01:30:36,880 OF THE WORK THAT'S BEEN 2383 01:30:36,880 --> 01:30:47,400 CONDUCTED WITHIN OF SARS-CoV-2 2384 01:30:48,800 --> 01:30:52,440 INFECTION SO, AN QUANTIFY BY 2385 01:30:52,440 --> 01:30:59,600 THIS GROUP BY VIEW IT ALL AND 2386 01:30:59,600 --> 01:31:01,040 THE EVENTS DETECTOR FOR 2387 01:31:01,040 --> 01:31:04,320 PREGNANCY HERE FOR 10PM IS THE 2388 01:31:04,320 --> 01:31:05,720 ALGORITHM IDENTIFIED AND THE 2389 01:31:05,720 --> 01:31:07,920 FIRST FOR THE EXACT GESTATIONAL 2390 01:31:07,920 --> 01:31:09,400 LINK WITH EVERY CLINICAL EVENT 2391 01:31:09,400 --> 01:31:11,120 FROM AN ELECTRONIC HEALTH RECORD 2392 01:31:11,120 --> 01:31:13,800 AND THE TIMING OF SARS-CoV-2 2393 01:31:13,800 --> 01:31:15,160 INFECTION IN PREGNANT WOMEN SO 2394 01:31:15,160 --> 01:31:19,600 THIS CAN BE USED IN IMPORTANT 2395 01:31:19,600 --> 01:31:22,800 WAYS TO HOPEFULLY FOLLOW THOSE 2396 01:31:22,800 --> 01:31:23,720 MOVING FORWARD. 2397 01:31:23,720 --> 01:31:26,640 WE SEE WAS TO EXAMINE CAN COHORT 2398 01:31:26,640 --> 01:31:30,080 BIOMARKERS IMPACTED COVID-19 2399 01:31:30,080 --> 01:31:32,080 DIFFERENTLY AND THEN IN MEN AND 2400 01:31:32,080 --> 01:31:34,680 WOMEN IN THIS WAY WE LOOKED AT 2401 01:31:34,680 --> 01:31:36,280 570,000 ADULT PATIENTS WHO WERE 2402 01:31:36,280 --> 01:31:38,680 ADMITTED FOR COVID-19 AND 2403 01:31:38,680 --> 01:31:43,960 BETWEEN 2020 AND 2021 AND THE 2404 01:31:43,960 --> 01:31:46,200 TOP FOUR FAILED CO MORBID TEASE 2405 01:31:46,200 --> 01:31:49,520 IN BOTH SEXES WERE RENAL 2406 01:31:49,520 --> 01:31:50,920 DISEASE, LIVER DISEASE, CANCER 2407 01:31:50,920 --> 01:31:57,880 AND HEART DISEASE AND WOMEN HAD 2408 01:31:57,880 --> 01:31:59,800 A HIGHER RISK. 2409 01:31:59,800 --> 01:32:01,400 IMPORTANT TO UNDERSTAND THAT 2410 01:32:01,400 --> 01:32:04,480 THOSE CHARACTERISTICS AND HOW 2411 01:32:04,480 --> 01:32:09,960 SARS-CoV-2 MIGHT HAVE SORT OF 2412 01:32:09,960 --> 01:32:11,560 WORSEN THE THE CHARACTERISTICS 2413 01:32:11,560 --> 01:32:13,040 AND WHY IS THAT AND THOSE ARE 2414 01:32:13,040 --> 01:32:14,240 QUESTIONS WE HAVE. 2415 01:32:14,240 --> 01:32:15,680 WE HAVE HINTS BECAUSE WHAT THEY 2416 01:32:15,680 --> 01:32:17,080 FOUND THERE WERE LEVELS OF 2417 01:32:17,080 --> 01:32:19,520 SEVERAL PROTEINS AND THEY WERE 2418 01:32:19,520 --> 01:32:26,280 ABLE TO IDENTIFY MY VALUES AND 2419 01:32:26,280 --> 01:32:27,840 THESE WERE STRONGER IN WOMEN, 2420 01:32:27,840 --> 01:32:36,960 THEN IN MEN SO SO THE NEXT SLIDE 2421 01:32:36,960 --> 01:32:40,680 I WANT TO GET INTO SOME 2422 01:32:40,680 --> 01:32:41,240 PRECLINICAL CAN BE I DIDN'T 2423 01:32:41,240 --> 01:32:43,160 MENTION TOO I GUESS HERE. 2424 01:32:43,160 --> 01:32:45,880 I AM FROM A RULE COMMUNITY IN 2425 01:32:45,880 --> 01:32:50,120 KANSAS AND SO I ALSO HAVE THE 2426 01:32:50,120 --> 01:32:51,680 RURAL POPULATION IF LINE AND 2427 01:32:51,680 --> 01:32:55,400 THIS IS JUST A STUDY THAT CAME 2428 01:32:55,400 --> 01:32:58,360 OUT AND IT WAS THE PAPER OF 2429 01:32:58,360 --> 01:33:00,440 Dr. LEAD AUTHOR THAT HIRED 2430 01:33:00,440 --> 01:33:03,000 HOSPITALIZATIONS AND MORTALITY 2431 01:33:03,000 --> 01:33:04,600 RATES OF SARS-CoV-2 INFECTED 2432 01:33:04,600 --> 01:33:07,880 PEOPLE IN RURAL AMERICA AND WERE 2433 01:33:07,880 --> 01:33:09,440 HIGHER THAN NOT ROLE AND 2434 01:33:09,440 --> 01:33:11,800 PATIENTS AND SO THERE WAS A SORT 2435 01:33:11,800 --> 01:33:13,600 OF RURAL THAT WAS ESTABLISHED IN 2436 01:33:13,600 --> 01:33:15,280 THIS PUBLICATION AND SO IT'S 2437 01:33:15,280 --> 01:33:17,880 REALLY IMPORTANT NOT JUST TO 2438 01:33:17,880 --> 01:33:21,520 STUDY SOME SORT OF THE EFFECTS 2439 01:33:21,520 --> 01:33:23,640 OF MEN AND WOMEN BUT THE EFFECTS 2440 01:33:23,640 --> 01:33:25,320 OF MEN AND WOMEN IN DIFFERENT 2441 01:33:25,320 --> 01:33:26,720 ENVIRONMENT INCLUDING THE RURAL 2442 01:33:26,720 --> 01:33:28,360 ENVIRONMENT SO I THINK THIS IS 2443 01:33:28,360 --> 01:33:30,400 ONE IMPORTANT PIECES OF 2444 01:33:30,400 --> 01:33:32,280 INFORMATION THAT WE'VE SEEN AND 2445 01:33:32,280 --> 01:33:34,360 SO GO TO THE NEXT SLIDE, PLEASE. 2446 01:33:34,360 --> 01:33:36,600 I WANT TO MOVE INTO SOME OF THE 2447 01:33:36,600 --> 01:33:38,840 PRECLINICAL ELEMENTS TOO BECAUSE 2448 01:33:38,840 --> 01:33:44,840 AS WE THINK ABOUT THE PREDICTED 2449 01:33:44,840 --> 01:33:46,560 NATURE IN THE HIGH FAILURE RATE 2450 01:33:46,560 --> 01:33:48,040 THIS IS AN AREA OF OPPORTUNITY 2451 01:33:48,040 --> 01:33:50,640 WHERE WE SHOULD SEE BIGGER 2452 01:33:50,640 --> 01:33:54,160 CHANGE IF WE TAKE A DIFFERENT 2453 01:33:54,160 --> 01:33:55,720 APPROACH AND SO WE ROUTINELY 2454 01:33:55,720 --> 01:33:58,080 HAVE BEEN USING 2D CELL LINES OR 2455 01:33:58,080 --> 01:34:02,360 MOUSE MODEL TO REFLECT WHAT IT 2456 01:34:02,360 --> 01:34:06,640 MEANS TO BE HUMAN AND I NEED A 2457 01:34:06,640 --> 01:34:10,240 FEMALE VERSION OF THE FIGURE 2458 01:34:10,240 --> 01:34:13,200 HERE TOO O THIS ISN'T ENOUGH. 2459 01:34:13,200 --> 01:34:15,440 WE NEED NEW TECHNOLOGY AND TOOLS 2460 01:34:15,440 --> 01:34:17,080 As COULD THE LANCETATIONAL 2461 01:34:17,080 --> 01:34:19,120 PIPELINE TO DO THIS BETTER SO WE 2462 01:34:19,120 --> 01:34:20,880 ABOUT TO THE NEXT SLIDE AND WE 2463 01:34:20,880 --> 01:34:22,080 STOP WITH THE CELL LINES AND 2464 01:34:22,080 --> 01:34:24,080 MOUSE MODEL AND THINK HOW CAN WE 2465 01:34:24,080 --> 01:34:25,880 REFLECT IT BETTER AND A LOT OF 2466 01:34:25,880 --> 01:34:29,720 THAT IS TO IMPROVE SOME OF THIS 2467 01:34:29,720 --> 01:34:33,000 3D CELL PHONE APPROACH AND AS WE 2468 01:34:33,000 --> 01:34:35,360 DO THAT YOU TEND TO LOSE THE 2469 01:34:35,360 --> 01:34:39,840 SORT OF ABILITY TO SCREEN 2470 01:34:39,840 --> 01:34:40,480 HIGH-THROUGHPUT WAY BECAUSE 2471 01:34:40,480 --> 01:34:43,480 THESE ARE COMPLEX AND WE CAN'T 2472 01:34:43,480 --> 01:34:47,000 SCREEN THEM IN THESE HIGH PLACE 2473 01:34:47,000 --> 01:34:50,280 AND SO THAT THE SCREENING IS 2474 01:34:50,280 --> 01:34:52,600 DIFFICULT BUT THE PHYSIOLOGICAL 2475 01:34:52,600 --> 01:34:55,720 COMPLEXITY AS WE START TO 2476 01:34:55,720 --> 01:34:58,040 EVALUATE TISSUE OR TISSUES ON A 2477 01:34:58,040 --> 01:35:00,840 CHIP IT'S MUCH MORE VALUABLE AND 2478 01:35:00,840 --> 01:35:03,480 SO THAT TRADE OFF IS REALLY 2479 01:35:03,480 --> 01:35:04,920 WORTH THE DIFFERENCE OF AT LEAST 2480 01:35:04,920 --> 01:35:06,600 THAT'S WHAT WE'RE PETTING ON AND 2481 01:35:06,600 --> 01:35:08,280 I THINK THAT AZTEC KNOWLEDGE 2482 01:35:08,280 --> 01:35:10,360 INVOLVES WE'LL START TO GO BACK 2483 01:35:10,360 --> 01:35:11,400 AND ADDRESS THE NATURE OF THAT 2484 01:35:11,400 --> 01:35:16,560 IS NEEDED SO THAT WE CAN DO THIS 2485 01:35:16,560 --> 01:35:17,200 AT SCALE. 2486 01:35:17,200 --> 01:35:18,720 THIS IS AN EXAMPLE OF WHAT THIS 2487 01:35:18,720 --> 01:35:20,200 MEANS AND WE HAVE THE ABILITY TO 2488 01:35:20,200 --> 01:35:22,640 TAKE BLOOD FROM ANY INDIVIDUAL 2489 01:35:22,640 --> 01:35:25,240 AND TAKE THE PATIENT CELLS OR 2490 01:35:25,240 --> 01:35:28,840 THE PARTICIPANTS CELLS AND 2491 01:35:28,840 --> 01:35:30,000 RESOURCE THEM INTO STEM CELLS 2492 01:35:30,000 --> 01:35:33,320 AND FROM THAT WE CAN 2493 01:35:33,320 --> 01:35:33,960 REDIFFERENTIATE NEEM VIRTUALLY 2494 01:35:33,960 --> 01:35:37,480 ANY CELL TYPE SO WE'RE ABLE TO 2495 01:35:37,480 --> 01:35:39,840 USE THE TECHNOLOGY TO MAKE CELLS 2496 01:35:39,840 --> 01:35:41,640 THAT REPRESENT LEADERS THAT MAKE 2497 01:35:41,640 --> 01:35:44,240 UP OUR ORGANS SO WE CAN CREATE 2498 01:35:44,240 --> 01:35:48,200 SKIN TISSUE AND WE CAN PUT THESE 2499 01:35:48,200 --> 01:35:51,920 CELLS ON AND THIS IS DEPICTION 2500 01:35:51,920 --> 01:35:53,840 SHOWN HERE BECAUSE IT'S 2501 01:35:53,840 --> 01:35:55,200 IMPORTANT TO HAVE VACUUM SECTION 2502 01:35:55,200 --> 01:35:57,400 THERE SO YOU CAN EXPAND AND 2503 01:35:57,400 --> 01:35:59,600 CONTRACT THE ABILITY OF THOSE 2504 01:35:59,600 --> 01:36:01,680 CELLS TO MIMIC MORE BLOOD CELLS 2505 01:36:01,680 --> 01:36:03,120 AS YOU BREATH IN AND BREATH OUT 2506 01:36:03,120 --> 01:36:05,120 SO IT'S AN IMPORTANT WAY OF 2507 01:36:05,120 --> 01:36:14,920 DEVELOPING THESE MODEL IN SORT 2508 01:36:14,920 --> 01:36:16,920 OF PARALLEL AND YOU CAN IMAGINE 2509 01:36:16,920 --> 01:36:19,480 NOW THAT THE NEXT STEPS AND 2510 01:36:19,480 --> 01:36:23,120 CREATE YOU ON A CHIP AND THIS IS 2511 01:36:23,120 --> 01:36:25,400 A AND THAT BEV AND TO PER STEP 2512 01:36:25,400 --> 01:36:27,080 FORWARD AND I'LL GET BACK TO 2513 01:36:27,080 --> 01:36:27,720 THIS IN A MOMENT. 2514 01:36:27,720 --> 01:36:29,840 IF YOU ARE THE NEXT SLIDE, I 2515 01:36:29,840 --> 01:36:31,160 WANT TO TALK SPECIFICALLY ABOUT 2516 01:36:31,160 --> 01:36:33,200 HOW WE'RE DOING THIS IN THE 2517 01:36:33,200 --> 01:36:36,040 FEMALE SYSTEM AND SO THIS IS 2518 01:36:36,040 --> 01:36:42,360 WORK DONE BY THERESA WOODRUFF 2519 01:36:42,360 --> 01:36:43,720 AND JOY AS WELL AS MANY OTHERS 2520 01:36:43,720 --> 01:36:45,120 BUT THEY WERE WORKING ON THESE 2521 01:36:45,120 --> 01:36:47,880 SORTS OF APPROACHES FOR VARIOUS 2522 01:36:47,880 --> 01:36:49,160 ASPECTS OF THE FEMALE 2523 01:36:49,160 --> 01:36:51,280 REPRODUCTIVE SYSTEM AND LET'S 2524 01:36:51,280 --> 01:36:53,360 GET TOGETHER AND BUILD SOMETHING 2525 01:36:53,360 --> 01:36:59,800 TOGETHER THAT CAN BE EVEN BETTER 2526 01:36:59,800 --> 01:37:08,840 AND -- AND ORGANOID MODEL SO WE 2527 01:37:08,840 --> 01:37:09,680 CAN TEST DIFFERENT THERAPIES 2528 01:37:09,680 --> 01:37:12,800 THAT MIGHT BE HELPFUL FOR THOSE. 2529 01:37:12,800 --> 01:37:16,560 THESE HAVE ALSO BEEN USED TO 2530 01:37:16,560 --> 01:37:19,680 THINK ABOUT OVARY DISEASE AS 2531 01:37:19,680 --> 01:37:20,960 WELL SO THEY HAVE BEEN VALUABLE 2532 01:37:20,960 --> 01:37:22,080 IN HELPING THE RESEARCH AND 2533 01:37:22,080 --> 01:37:23,160 APPROXIMATE PUSHING THE RESEARCH 2534 01:37:23,160 --> 01:37:24,560 FORWARD AND THIS IS THE SAME 2535 01:37:24,560 --> 01:37:26,360 TEAM AS I SHOWED YOU BEFORE AND 2536 01:37:26,360 --> 01:37:28,360 IF YOU GO TO THE NEXT SLIDE 2537 01:37:28,360 --> 01:37:29,440 THEY'VE GOT THEIR DEVELOPMENT 2538 01:37:29,440 --> 01:37:31,800 WHAT THEY CALL AN EVEN TON WHICH 2539 01:37:31,800 --> 01:37:34,200 I LOVE THAT NAME AND IT'S NOT 2540 01:37:34,200 --> 01:37:39,040 "AVATAR" BUT IT'S AN EVATAR. 2541 01:37:39,040 --> 01:37:42,000 THIS IS THE FEMALE REPRODUCTION 2542 01:37:42,000 --> 01:37:47,640 SYSTEM ON A CHIP AND ESSENTIALLY 2543 01:37:47,640 --> 01:37:51,800 WE HAVE PRODUCTS THE 2544 01:37:51,800 --> 01:37:53,120 REPRODUCTIVE SYSTEM ON A CHIP 2545 01:37:53,120 --> 01:37:55,160 AND HOW THEY TRAVEL FROM ONE 2546 01:37:55,160 --> 01:37:57,360 COMPARTMENT TO THE NEXT WHAT 2547 01:37:57,360 --> 01:37:58,800 HAPPENS DOWNSTREAM WHEN THOSE 2548 01:37:58,800 --> 01:38:01,400 CHANGES HAPPEN SO IT'S A WAY TO 2549 01:38:01,400 --> 01:38:04,080 REALLY I'LL EIGHT THE ISSUES AND 2550 01:38:04,080 --> 01:38:05,440 WE HAVE BEEN ABLE TO DO THIS 2551 01:38:05,440 --> 01:38:07,000 THREE MONTHS AND THE CELLS TEND 2552 01:38:07,000 --> 01:38:11,920 TO FAIL SO THEN OUR GOAL IN THE 2553 01:38:11,920 --> 01:38:14,720 FUTURE ARE TO HAVE THEM GO 2554 01:38:14,720 --> 01:38:17,040 LONGER AND IF WE ANOTHER LIP IT 2555 01:38:17,040 --> 01:38:18,520 SHOULD START TO PLAY THIS IS 2556 01:38:18,520 --> 01:38:20,800 ESSENTIALLY YOU CAN SEE THE 2557 01:38:20,800 --> 01:38:25,920 LITTLE SILLIA IN WHERE THE WHERE 2558 01:38:25,920 --> 01:38:30,160 IT TAKES THE EGG AND THROUGH THE 2559 01:38:30,160 --> 01:38:32,080 MOVEMENT THROUGH THE SILLIA SO 2560 01:38:32,080 --> 01:38:38,720 THIS IS HOW THE THEY SHOULD WORK 2561 01:38:38,720 --> 01:38:42,040 AND NEXT SLIDE HERE SHOWS YOU 2562 01:38:42,040 --> 01:38:43,720 WHERE WE'VE BEEN CONDUCTING IN 2563 01:38:43,720 --> 01:38:45,440 COP ABERRATION WITH THE AND I 2564 01:38:45,440 --> 01:38:48,040 WANT TODAY THANK Dr. LAYTON 2565 01:38:48,040 --> 01:38:52,160 FOR HER HERE AND THIS IS 2566 01:38:52,160 --> 01:38:54,280 REMARKABLE WORK AND IT CAN HELP 2567 01:38:54,280 --> 01:38:55,240 US FOR INDIVIDUAL TREATMENTS TO 2568 01:38:55,240 --> 01:38:57,960 LEARN MORE HOW FEMALES MAY 2569 01:38:57,960 --> 01:39:00,520 METABOLIZE DRUGS DIFFERENTLY 2570 01:39:00,520 --> 01:39:02,360 FROM MALES THERE ARE A COUPLE OF 2571 01:39:02,360 --> 01:39:05,120 EXAMPLES HERE AND ACTUALLY, THIS 2572 01:39:05,120 --> 01:39:06,800 IS A STUDY THAT WAS JUST 2573 01:39:06,800 --> 01:39:11,040 PUBLISHED AND SO, IF YOU GO TO 2574 01:39:11,040 --> 01:39:13,920 THE NEXT SLIDE AND YEAH, THIS 2575 01:39:13,920 --> 01:39:16,240 ESSENTIALLY G. TO THE NEXT 2576 01:39:16,240 --> 01:39:17,000 SLIDE. 2577 01:39:17,000 --> 01:39:22,360 THIS IS ESSENTIALLY A INTERFACE 2578 01:39:22,360 --> 01:39:25,800 AND SO THAT BOTTOM DEPICTION 2579 01:39:25,800 --> 01:39:27,080 THOSE THE DIFFERENT LAYERS OF 2580 01:39:27,080 --> 01:39:28,880 THE MATERNAL SIDE ON THE TOP 2581 01:39:28,880 --> 01:39:30,560 THAT IS IN THE TOP IN THAT THE 2582 01:39:30,560 --> 01:39:31,520 GREEN SECTION I DON'T KNOW IF IF 2583 01:39:31,520 --> 01:39:34,800 I CAN SHOW MY POINTER HERE BUT 2584 01:39:34,800 --> 01:39:38,320 IT'S THE GREEN SECTION ON THE 2585 01:39:38,320 --> 01:39:39,840 TOP IF THAT FIGURE SO THAT IS 2586 01:39:39,840 --> 01:39:41,880 THE MATERNAL SIDE AND THERE ARE 2587 01:39:41,880 --> 01:39:43,040 LAYER UNDER THAT START TO GET 2588 01:39:43,040 --> 01:39:45,680 INTO THE FETAL SIDE AND SO WE'RE 2589 01:39:45,680 --> 01:39:48,720 ABLE TO BE ABLE TO CAPTURE THAT 2590 01:39:48,720 --> 01:39:53,240 INTERFACE OF IN TERNAL AND FETAL 2591 01:39:53,240 --> 01:39:54,640 CELLS TO UNDERSTAND HOW THE 2592 01:39:54,640 --> 01:39:56,880 STRUCTURE AND FUNCTION AND 2593 01:39:56,880 --> 01:39:58,280 RESPONSES FOR DIFFERENT 2594 01:39:58,280 --> 01:40:00,880 EXPOSURES OR INFLAMMATION FOR 2595 01:40:00,880 --> 01:40:04,640 EXAMPLE HIGH THE HAVE THAT 2596 01:40:04,640 --> 01:40:06,720 EFFECT SO THIS IS REALLY GREAT 2597 01:40:06,720 --> 01:40:09,440 WORK FROM THE UNIVERSITY OF 2598 01:40:09,440 --> 01:40:12,040 TEXASAL GALVESTON AND THIS IS 2599 01:40:12,040 --> 01:40:14,040 EXCITING AND BUT THAT PAPER ON 2600 01:40:14,040 --> 01:40:18,280 THE PREVIOUS SLIDE IT'S FOR THE 2601 01:40:18,280 --> 01:40:21,320 REPORTER STUDY THAT IS PUBLICLY 2602 01:40:21,320 --> 01:40:22,880 AVAILABLE SO WE'LL GO TO THE 2603 01:40:22,880 --> 01:40:23,240 NEXT SLIDE. 2604 01:40:23,240 --> 01:40:25,720 I WANTED TO SORT OF ALSO TALK 2605 01:40:25,720 --> 01:40:26,680 ABOUT SOME OF THE OPPORTUNITIES 2606 01:40:26,680 --> 01:40:28,480 THAT YOU THINK ARE KIND OF 2607 01:40:28,480 --> 01:40:38,960 EXCITE NORTH THIS SPACE AND WE 2608 01:40:55,440 --> 01:40:56,840 LEARNED THAT OVER TIME, PEOPLE 2609 01:40:56,840 --> 01:41:07,400 HAVE GONE INTO SPACE OVER WE'VE 2610 01:41:15,440 --> 01:41:17,960 SEEN THIS WITH RENAL PROBLEMS 2611 01:41:17,960 --> 01:41:19,280 AND IMMUNITY PROBLEMS, ET 2612 01:41:19,280 --> 01:41:20,080 CETERA. 2613 01:41:20,080 --> 01:41:26,480 SO, WE KNEW THAT THESE THINGS 2614 01:41:26,480 --> 01:41:28,720 POSSESS AND WE WANT CELLS IN THE 2615 01:41:28,720 --> 01:41:29,800 MICROENVIRONMENT WHERE THEY 2616 01:41:29,800 --> 01:41:31,240 ACTUALLY AGE FASTER SO WE CAN 2617 01:41:31,240 --> 01:41:34,680 STUDY THOSE EFFECTS OF AGING AND 2618 01:41:34,680 --> 01:41:37,400 SO A GOAL OF OURS OUR TISSUE 2619 01:41:37,400 --> 01:41:39,800 SPACE PROGRAM JUST ENDED LAST 2620 01:41:39,800 --> 01:41:41,680 MONTH AND I WANT TO SHOW YOU AND 2621 01:41:41,680 --> 01:41:44,840 YOU CAN CLICK ON THE NEXT SLIDE 2622 01:41:44,840 --> 01:41:50,160 HERE AND YOU CAN REALLY HEAR THE 2623 01:41:50,160 --> 01:41:54,480 ROCKET BLASTING OFF AND HERE WE 2624 01:41:54,480 --> 01:41:56,600 HAVE TWO TISSUE PROGRAMS GOING 2625 01:41:56,600 --> 01:41:58,240 UP INTO SPACE AND THEY'RE BEING 2626 01:41:58,240 --> 01:42:02,080 EVALUATED ON THE SPACE STATION 2627 01:42:02,080 --> 01:42:08,080 AND SO AND I HOPE WE CAN DO IT 2628 01:42:08,080 --> 01:42:10,080 IN THE FUTURE, SO THIS IS ONE 2629 01:42:10,080 --> 01:42:11,280 AREA WHERE I'D LIKE TO SEE US 2630 01:42:11,280 --> 01:42:15,200 CONTINUE TO WORK IN THIS SPACE. 2631 01:42:15,200 --> 01:42:17,840 IF YOU GO TO THE NEXT SLIDE, I 2632 01:42:17,840 --> 01:42:20,040 MENTION THIS IDEA OF YOU WANT TO 2633 01:42:20,040 --> 01:42:22,240 CHIP AND CREATING ESSENTIALLY 2634 01:42:22,240 --> 01:42:26,560 DIGITAL PLANS YOU CAN IMAGINE 2635 01:42:26,560 --> 01:42:28,200 THAT YOU HAVE A CHIP AND THERE 2636 01:42:28,200 --> 01:42:32,280 WAS AN ARTICLE RECENTLY TALKING 2637 01:42:32,280 --> 01:42:35,040 ABOUT THE FUTURE OF CLINICAL 2638 01:42:35,040 --> 01:42:39,640 TRIALS FOR PROGNOSTIC DIGITAL 2639 01:42:39,640 --> 01:42:41,080 TWINS THAT HAVE EXTERNAL CONTROL 2640 01:42:41,080 --> 01:42:42,520 AND IF IF YOU ARE YOUR OWN 2641 01:42:42,520 --> 01:42:45,320 CONTROL, AND YOU CAN TEST 2642 01:42:45,320 --> 01:42:45,920 DIFFERENT APPROACHES, BECAUSE 2643 01:42:45,920 --> 01:42:47,360 YOU HAVE A DIGITAL TWIN, THAT 2644 01:42:47,360 --> 01:42:52,400 MIGHT BE REALLY VALUABLE AND I 2645 01:42:52,400 --> 01:42:53,560 THINK IT'S SOMETHING THAT WE'RE 2646 01:42:53,560 --> 01:43:03,480 TRYING TO WORK TOWARDS. 2647 01:43:03,480 --> 01:43:05,240 IN 2025 WE'RE GOING TO THE MOON. 2648 01:43:05,240 --> 01:43:08,120 THAT'S WHAT ARTEMIS III IS ALL 2649 01:43:08,120 --> 01:43:10,160 ABOUT AND WE CAN FIGURE HOUT TO 2650 01:43:10,160 --> 01:43:11,920 GET A DIGITAL TWIN OF ONE OF THE 2651 01:43:11,920 --> 01:43:16,320 FEMALE ASTRONAUTS. 2652 01:43:16,320 --> 01:43:21,040 IT'S TO SHOW YOU THERE MIGHT BE 2653 01:43:21,040 --> 01:43:24,280 OTHER OPPORTUNITIES FOR THAT 2654 01:43:24,280 --> 01:43:27,720 SPACE EXPLORATION AND WOVE IDEAS 2655 01:43:27,720 --> 01:43:29,760 OF HOW WE CAN EXPAND THE LODGE 2656 01:43:29,760 --> 01:43:30,920 GEOFF TEE OF THE CELLS TO STUDY 2657 01:43:30,920 --> 01:43:36,520 THEM LONGER AND ALSO REPRESENT 2658 01:43:36,520 --> 01:43:39,280 MORE TYPES OF ORGANS AND SPACE. 2659 01:43:39,280 --> 01:43:44,240 SO THE IDEA HYPED THIS TOO IS 2660 01:43:44,240 --> 01:43:49,280 THERE IS A LIMITED AND THEY HELP 2661 01:43:49,280 --> 01:43:51,560 US FOR EXAMPLE THE FEMALE 2662 01:43:51,560 --> 01:43:53,680 REPRODUCTIVE TRACK THIS IS A 2663 01:43:53,680 --> 01:43:57,400 PHYSIOLOGICAL SYSTEM AND WE CAN 2664 01:43:57,400 --> 01:43:58,120 UNDERSTAND MORE FOR DIFFERENT 2665 01:43:58,120 --> 01:44:02,880 CELL TYPES AND EXPOSURE TO ORAL 2666 01:44:02,880 --> 01:44:05,840 TREATMENT OR WELCOME STUDY 2667 01:44:05,840 --> 01:44:08,920 DISEASE AND OUR CAUSES AND WE 2668 01:44:08,920 --> 01:44:10,720 CAN ALSO FIGURE OUT HOW TO 2669 01:44:10,720 --> 01:44:13,120 COMBINE THAT WITH OTHER ORGANS 2670 01:44:13,120 --> 01:44:16,200 AS WELL OF THAT TOO AND ALSO 2671 01:44:16,200 --> 01:44:16,840 UNDERSTAND PERHAPS CONCEPTION 2672 01:44:16,840 --> 01:44:18,800 AND PREGNANCY AT SOME POINT IN 2673 01:44:18,800 --> 01:44:20,760 TIME SO THESE ARE IDEAS THAT 2674 01:44:20,760 --> 01:44:25,520 WE'RE TRYING TO BUILD TO WORK. 2675 01:44:25,520 --> 01:44:27,200 I'M GOING TO END ON A FEW MORE 2676 01:44:27,200 --> 01:44:27,680 THINGS. 2677 01:44:27,680 --> 01:44:30,160 ONE IS WE'RE ALSO WORKING IN A 2678 01:44:30,160 --> 01:44:31,680 SMALL MOLECULE SPACE AND THAT IS 2679 01:44:31,680 --> 01:44:33,720 A LOT OF THE WORK WE DO AND I'M 2680 01:44:33,720 --> 01:44:35,760 JUST WANT TO GO HIGHLIGHT THE 2681 01:44:35,760 --> 01:44:37,240 MORE PREDICTIVE BASED APPROACHES 2682 01:44:37,240 --> 01:44:38,480 FOR THIS PARTICULAR AUDIENCE BUT 2683 01:44:38,480 --> 01:44:40,400 I DIDN'T WANT TO HIGHLIGHT THAT 2684 01:44:40,400 --> 01:44:41,600 WE'RE WORKING ON SMALL MOLECULE 2685 01:44:41,600 --> 01:44:43,120 SPACE FOR WOMEN'S HEALTH AND 2686 01:44:43,120 --> 01:44:46,280 SPECIFICALLY HERE UNDERSTANDING 2687 01:44:46,280 --> 01:44:50,640 BRAIN MATAS SIS FOR BRAIN CANCER 2688 01:44:50,640 --> 01:44:53,040 AND WE'RE GOING TO MAKE SURE AND 2689 01:44:53,040 --> 01:44:54,880 WE'RE GOING TO FIGURE OUT 2690 01:44:54,880 --> 01:45:05,280 DRAWINGMINIMIZINGTHE RISK OF A . 2691 01:45:05,280 --> 01:45:06,440 ANOTHER AREA THAT WE TEND TO 2692 01:45:06,440 --> 01:45:08,560 WORK ON QUITE A BIT IS ON RARE 2693 01:45:08,560 --> 01:45:11,240 DISEASES AND WE DO KNOW THAT 2694 01:45:11,240 --> 01:45:13,760 THERE ARE A VARIETY OF RARE 2695 01:45:13,760 --> 01:45:14,600 DISEASES THAT EFFECT FEMALES 2696 01:45:14,600 --> 01:45:15,200 SPECIFICALLY. 2697 01:45:15,200 --> 01:45:17,360 TURNER SYNDROME AND TRIPLE X 2698 01:45:17,360 --> 01:45:19,360 SYNDROME AND ET CETERA AND SO 2699 01:45:19,360 --> 01:45:21,840 IT'S VERY IMPORTANT THAT WE 2700 01:45:21,840 --> 01:45:23,840 THINK ABOUT WAYS AND 2701 01:45:23,840 --> 01:45:25,800 UNDERSTANDING SORT OF THAT WORK 2702 01:45:25,800 --> 01:45:28,880 AND ONE DISEASE AT A TIME 2703 01:45:28,880 --> 01:45:31,720 APPROACH BUT ALSO NEW 2704 01:45:31,720 --> 01:45:33,280 THERAPEUTIC MODALITY AND THAT'S 2705 01:45:33,280 --> 01:45:34,680 WHAT I'LL FOCUS ON HERE AND IF 2706 01:45:34,680 --> 01:45:36,840 YOU GO TO THE NEXT SLIDE, IT'S 2707 01:45:36,840 --> 01:45:38,320 REALLY IMPORTANT BECAUSE RARE 2708 01:45:38,320 --> 01:45:39,560 DISEASES ARE QUITE A 2709 01:45:39,560 --> 01:45:44,400 PUBLIC-HEALTH CHALLENGE AND WE 2710 01:45:44,400 --> 01:45:45,360 KNOW WE DID NCATS THAT PEOPLE 2711 01:45:45,360 --> 01:45:48,160 WITH RARE DISEASES PAY THREE TO 2712 01:45:48,160 --> 01:45:49,600 FIVE TIMES MORE IN DIRECT 2713 01:45:49,600 --> 01:45:51,920 MEDICAL COSTS THAN PEOPLE 2714 01:45:51,920 --> 01:45:56,480 WITHOUT RARE DISEASES AND THAT 2715 01:45:56,480 --> 01:45:58,040 TRANSLATES, GIVEN THE FACT THERE 2716 01:45:58,040 --> 01:45:59,440 ARE 35 OR 40 MILLION PEOPLE WITH 2717 01:45:59,440 --> 01:46:01,880 A RARE DISEASE IT TRANSLATES TO 2718 01:46:01,880 --> 01:46:03,080 $400 BILLION A YEAR FOR DIRECT 2719 01:46:03,080 --> 01:46:05,680 MEDICAL COSTS FROM PEOPLE WHO 2720 01:46:05,680 --> 01:46:06,760 ARE DISEASES. 2721 01:46:06,760 --> 01:46:09,120 THAT'S A BIG PUBLIC ECONOMIC 2722 01:46:09,120 --> 01:46:11,520 BURDEN IN THIS SPACE SO THIS IS 2723 01:46:11,520 --> 01:46:13,160 AN AREA THAT IS SOMETHING WE'RE 2724 01:46:13,160 --> 01:46:15,960 INTERESTED IN IN PURSUING 2725 01:46:15,960 --> 01:46:16,320 PRIVATE MORE. 2726 01:46:16,320 --> 01:46:17,760 IF YOU GO TO THE NEXT SLIDE. 2727 01:46:17,760 --> 01:46:18,720 SOME OF THE WAYS WE'RE DOING 2728 01:46:18,720 --> 01:46:20,240 THIS ARE REALLY IN THE AREAS OF 2729 01:46:20,240 --> 01:46:23,800 GENE THERAPY AND GENE EDITING 2730 01:46:23,800 --> 01:46:25,200 AND WE HAVE OUR VARIETY OF 2731 01:46:25,200 --> 01:46:28,480 PROGRAMS IF THE SPACE THAT ARE 2732 01:46:28,480 --> 01:46:29,480 IN 30 STAGES OF DEVELOPMENT SOME 2733 01:46:29,480 --> 01:46:32,080 ARE EARLIER IN DEVELOPMENT AND 2734 01:46:32,080 --> 01:46:35,160 IN CLINICAL TRIAL PHASE BUT MORE 2735 01:46:35,160 --> 01:46:37,480 IN IND ENABLING PHASES AND SOME 2736 01:46:37,480 --> 01:46:40,320 ARE IN THE CLINICAL TRIAL SPACES 2737 01:46:40,320 --> 01:46:41,880 SO WE HAVE A PROGRAM AND EDITING 2738 01:46:41,880 --> 01:46:46,240 THAT ON BEHALF OF THE COMMON 2739 01:46:46,240 --> 01:46:52,640 FUND PROGRAM AND PROVIDING 2740 01:46:52,640 --> 01:46:58,160 TOOLKIT TOOLKITS AND MAKING DELT 2741 01:46:58,160 --> 01:47:07,680 CAN ARE EFFECTIVE OR AND THE 2742 01:47:07,680 --> 01:47:10,440 GENE THERAPY CONSORTIUM SO 2743 01:47:10,440 --> 01:47:13,720 THERE'S ONE THAT Dr. CLAYTON 2744 01:47:13,720 --> 01:47:14,920 TALKED ABOUT ON THE IMMUNE 2745 01:47:14,920 --> 01:47:16,560 SYSTEM OR IMMUNITY AND THIS IS 2746 01:47:16,560 --> 01:47:18,200 ON GENE THERAPY AND WHAT WE'RE 2747 01:47:18,200 --> 01:47:20,840 DOING HERE IS WE'RE ENHANCING 2748 01:47:20,840 --> 01:47:23,160 MANUFACTURING AND TRYING TO MAKE 2749 01:47:23,160 --> 01:47:24,360 SURE THAT WE CAN GET THE RIGHT 2750 01:47:24,360 --> 01:47:27,680 DELIVERY TO THE RIGHT CELLS AND 2751 01:47:27,680 --> 01:47:32,600 AT DEVICES ARE AS FULLY LOADED 2752 01:47:32,600 --> 01:47:34,920 AS POSSIBLE WITH THE THERAPEUTIC 2753 01:47:34,920 --> 01:47:36,480 GENE SO HOW DO WE ENHANCE THAT 2754 01:47:36,480 --> 01:47:37,640 GREEN EXPRESSION WITHIN THE 2755 01:47:37,640 --> 01:47:39,520 DELIVERY DEVICE AND THESE ARE 2756 01:47:39,520 --> 01:47:41,680 LARGELY ASSOCIATED VIRUS THAT'S 2757 01:47:41,680 --> 01:47:43,240 WE'RE LOOKING INTO FOR DELIVERY 2758 01:47:43,240 --> 01:47:44,680 BUT ULTIMATE LEASE THERE WILL BE 2759 01:47:44,680 --> 01:47:46,080 OTHER APPROACHES AS WELL. 2760 01:47:46,080 --> 01:47:47,480 AND THEN WE HAVE OUR FINAL 2761 01:47:47,480 --> 01:47:49,160 PROGRAM THAT I'LL TALK ABOUT IS 2762 01:47:49,160 --> 01:47:50,640 THE PLATFORM GENE THERAPY 2763 01:47:50,640 --> 01:47:54,320 PROGRAM AND THIS IS A SINGLE 2764 01:47:54,320 --> 01:47:56,320 ASSOCIATED VIRAL VECTOR AS A 2765 01:47:56,320 --> 01:47:58,960 PLATFORM FOR MULTIPLE 2766 01:47:58,960 --> 01:48:00,720 THERAPEUTIC GENES SO MULTIPLE 2767 01:48:00,720 --> 01:48:02,120 DISEASES, MULTIPLE THERAPEUTIC 2768 01:48:02,120 --> 01:48:04,120 GENES COULD BE USED IN ONE 2769 01:48:04,120 --> 01:48:06,040 SINGLE AAB VECTOR AND THIS IS 2770 01:48:06,040 --> 01:48:10,400 THE PROCESS THAT WE'RE TESTING 2771 01:48:10,400 --> 01:48:12,160 AND TRYING TO FIND WHAT IS 2772 01:48:12,160 --> 01:48:13,720 COMMON IN TERMS AND WE WANT TO 2773 01:48:13,720 --> 01:48:15,720 BE ABLE TO TEST THE ABILITY TO 2774 01:48:15,720 --> 01:48:19,200 USE THESE IN A WAY TO MAKE THE 2775 01:48:19,200 --> 01:48:20,840 DATA THAT WE FIND PUBLIC AND WE 2776 01:48:20,840 --> 01:48:22,520 HOPE THAT ULTIMATELY THIS WILL 2777 01:48:22,520 --> 01:48:24,040 INCREASE EFFICIENCY TO CLINICAL 2778 01:48:24,040 --> 01:48:25,400 TRIALS START UP AS WELL FOR 2779 01:48:25,400 --> 01:48:28,360 OTHER THERAPIES THAT I CAN SEE 2780 01:48:28,360 --> 01:48:29,440 DOWN THE PIKE BEING ON THIS 2781 01:48:29,440 --> 01:48:29,720 PROGRAM. 2782 01:48:29,720 --> 01:48:31,240 SO THOSE ARE SOME OF THE KEY 2783 01:48:31,240 --> 01:48:33,000 AREAS WE'RE WORKING ON IN TERMS 2784 01:48:33,000 --> 01:48:36,520 OF GENE EDITING AND GENE 2785 01:48:36,520 --> 01:48:37,120 THERAPY. 2786 01:48:37,120 --> 01:48:39,320 IF YOU GO TO THE NEXT SLIDE, 2787 01:48:39,320 --> 01:48:41,400 THIS IS TWO MORE SLIDES HERE AND 2788 01:48:41,400 --> 01:48:42,760 ONE IS HOW WE'RE THINKING ABOUT 2789 01:48:42,760 --> 01:48:44,320 ADVANCEMENT OF WOMEN AND 2790 01:48:44,320 --> 01:48:45,640 BIOMEDICAL CAREERS AND I 2791 01:48:45,640 --> 01:48:46,920 MENTIONED THAT THE WORKFORCE 2792 01:48:46,920 --> 01:48:48,320 DEVELOPMENT IS A KEY AS POTH OF 2793 01:48:48,320 --> 01:48:49,880 WHAT WE DO AND SO WE HAVE 2794 01:48:49,880 --> 01:48:53,080 SOMETHING CALLED THE WOMEN'S 2795 01:48:53,080 --> 01:48:55,000 SCIENTIST ADVISER GROUP WITH THE 2796 01:48:55,000 --> 01:48:59,000 INTRAMURAL PROGRAM AND WE ENGAGE 2797 01:48:59,000 --> 01:49:01,360 LOCAL COMMUNITIES PARTICULARLY 2798 01:49:01,360 --> 01:49:05,400 STUDENTS IN GRADES K-12 AND WE 2799 01:49:05,400 --> 01:49:06,920 HAVE THEM DO TOURS AND SEE WHAT 2800 01:49:06,920 --> 01:49:08,360 WE DO AND WE DO THIS IN 2801 01:49:08,360 --> 01:49:09,600 DIFFERENT WAYS DEPENDING ON 2802 01:49:09,600 --> 01:49:12,520 WHERE THEY ARE IN THEIR 2803 01:49:12,520 --> 01:49:12,960 PROGRAMS. 2804 01:49:12,960 --> 01:49:15,640 AND SO THIS IS AN ISSUE THAT 2805 01:49:15,640 --> 01:49:18,200 INCREASES THE VISIBILITY OF OUR 2806 01:49:18,200 --> 01:49:20,440 SCIENTIST AND ENCOURAGING THEM 2807 01:49:20,440 --> 01:49:22,280 AND THEN THE NEXT SLIDE IS JUST 2808 01:49:22,280 --> 01:49:23,440 THE LAST SLIDE WHERE WE'RE 2809 01:49:23,440 --> 01:49:25,120 UNDERGOING A STRATEGIC PLAN 2810 01:49:25,120 --> 01:49:26,440 PROCESS AND YOU CAN CLICK FROM 2811 01:49:26,440 --> 01:49:31,240 HERE AND I HOPE THAT THIS 2812 01:49:31,240 --> 01:49:32,520 COMMUNITY STAYS TO AND WE'LL 2813 01:49:32,520 --> 01:49:34,080 REACH OUT FOR REQUEST FOR 2814 01:49:34,080 --> 01:49:36,920 INFORMATION FAIRLY SOON AND I 2815 01:49:36,920 --> 01:49:38,360 WANTED TO MAKE SURE YOU WERE 2816 01:49:38,360 --> 01:49:40,120 AWARE OF THAT SO THAT WHEN IT IT 2817 01:49:40,120 --> 01:49:41,760 COMES OUT IT WILL BE READY TO GO 2818 01:49:41,760 --> 01:49:43,160 AND HELP US HIGHLIGHT AND MANY 2819 01:49:43,160 --> 01:49:45,800 YOU WOULD LIKE TO SEE US MAKE 2820 01:49:45,800 --> 01:49:47,680 SURE THAT OUR STRATEGIC PLAN. 2821 01:49:47,680 --> 01:49:50,360 AND WITH THAT, I WILL STOP THERE 2822 01:49:50,360 --> 01:49:53,280 AND SEE IF THERE ARE ANY 2823 01:49:53,280 --> 01:49:53,560 QUESTIONS. 2824 01:49:53,560 --> 01:49:57,920 >>THANK YOU SO MUCH, JONI FOR 2825 01:49:57,920 --> 01:49:58,320 THAT WHIRLWIND. 2826 01:49:58,320 --> 01:49:59,480 THAT WAS A WHIRLWIND. 2827 01:49:59,480 --> 01:50:03,160 I REALLY APPRECIATE YOUR 2828 01:50:03,160 --> 01:50:04,680 HIGHLIGHTING EVATA. 2829 01:50:04,680 --> 01:50:05,400 >>Debra: BECAUSE IT WAS 2830 01:50:05,400 --> 01:50:07,160 EXCITING AND I REMEMBER WHEN WE 2831 01:50:07,160 --> 01:50:08,240 FIRST TALKED THE FOLKS ABOUT 2832 01:50:08,240 --> 01:50:09,360 THIS EFFORT AND WE WERE THRILLED 2833 01:50:09,360 --> 01:50:10,920 TO BE ABLE TO SUPPORT THAT A LOT 2834 01:50:10,920 --> 01:50:15,960 THE BEGINNING AND TERESE AND 2835 01:50:15,960 --> 01:50:18,640 OTHERS HAVE DONE AN INCREDIBLE 2836 01:50:18,640 --> 01:50:20,680 JOB MOVING THINGS FORWARD AND 2837 01:50:20,680 --> 01:50:22,200 HELPING US SEE THE APPLICATIONS 2838 01:50:22,200 --> 01:50:23,840 OF THOSE POTENTIAL APPROACHES 2839 01:50:23,840 --> 01:50:27,840 WHERE I LIMITLESS AT THIS POINT. 2840 01:50:27,840 --> 01:50:28,920 >>THANK YOU SO MUCH FOR THAT. 2841 01:50:28,920 --> 01:50:36,520 I WANT TO SEE IF COUNCIL MEMBERS 2842 01:50:36,520 --> 01:50:41,400 HAVE QUESTIONS. 2843 01:50:41,400 --> 01:50:43,640 I'M NOT SEEING ANY. 2844 01:50:43,640 --> 01:50:45,800 WHILE YOU ARE THINKING OF YOUR 2845 01:50:45,800 --> 01:50:47,360 QUESTIONS, I ALSO REALLY WANT TO 2846 01:50:47,360 --> 01:50:49,400 GIVE YOU AN INCREDIBLE SHOUT OUT 2847 01:50:49,400 --> 01:50:50,800 FOR THE SEX DIFFERENCES 2848 01:50:50,800 --> 01:50:53,640 PUBLICATION THAT CAME FROM N3C. 2849 01:50:53,640 --> 01:50:55,320 WE TALKED ABOUT THAT AND YOU AND 2850 01:50:55,320 --> 01:50:57,000 I TALKED ABOUT IT AND WHY THINK 2851 01:50:57,000 --> 01:50:58,440 THAT PAPER WAS OUT WHEN WE 2852 01:50:58,440 --> 01:50:58,680 TALKED. 2853 01:50:58,680 --> 01:51:01,400 >>IT WASN'T. 2854 01:51:01,400 --> 01:51:02,080 >>Janine A. Clayton: YOU WOULD 2855 01:51:02,080 --> 01:51:03,120 HAVE TOLD ME. 2856 01:51:03,120 --> 01:51:05,760 JONI WHERE ARE THE SEX -- 2857 01:51:05,760 --> 01:51:08,520 >>THE RURAL HEALTH PAPER TOOK A 2858 01:51:08,520 --> 01:51:10,280 YEAR TO GET PUBLISHED AND FOR 2859 01:51:10,280 --> 01:51:12,520 SOME REASON IT WAS THE PAPER OF 2860 01:51:12,520 --> 01:51:13,200 THE YEAR. 2861 01:51:13,200 --> 01:51:14,360 WE'VE SEEN THERE'S BEEN DELAYS 2862 01:51:14,360 --> 01:51:15,760 OF PUBLISHING JUST BECAUSE OF 2863 01:51:15,760 --> 01:51:17,360 THE REVIEW TIMES, ET CETERA. 2864 01:51:17,360 --> 01:51:19,240 SO IT'S BEEN A WHILE. 2865 01:51:19,240 --> 01:51:19,960 >>Janine A. Clayton: RIGHT. 2866 01:51:19,960 --> 01:51:21,400 SO THANK YOU FOR HIGHLIGHTING 2867 01:51:21,400 --> 01:51:23,600 THAT AND THERE'S A LOT OF 2868 01:51:23,600 --> 01:51:28,120 POTENTIAL TO BUILD ON NC3 FOR 2869 01:51:28,120 --> 01:51:29,000 APPLICATIONS AND WE'VE DISCUSSED 2870 01:51:29,000 --> 01:51:36,840 THAT BUT I SEE THAT MY COLLEAGUS 2871 01:51:36,840 --> 01:51:37,280 HER HAND UP. 2872 01:51:37,280 --> 01:51:39,720 >>THANK YOU VERY MUCH. 2873 01:51:39,720 --> 01:51:42,920 IT WAS VERY EXCITING AND SO 2874 01:51:42,920 --> 01:51:46,280 PLEASED TO BE INTRODUCED TO THE 2875 01:51:46,280 --> 01:51:47,040 NCATS IS DOING. 2876 01:51:47,040 --> 01:51:49,160 IT BRINGS ME BACK TO MY EARLIER 2877 01:51:49,160 --> 01:51:52,280 DAYS AS A PHYSICALLOLOGIST. 2878 01:51:52,280 --> 01:52:02,840 O MY QUESTIONS ARE I USED TO DO 2879 01:52:03,160 --> 01:52:10,840 A LOT OF IN VIVO HIGH HOW DO YOU 2880 01:52:10,840 --> 01:52:12,480 MIMIC THE POSITIVE AND NEGATIVE 2881 01:52:12,480 --> 01:52:14,360 FEEDBACK SYSTEM WHICH ARE 2882 01:52:14,360 --> 01:52:17,200 OPERATIVE IN AN ENTIRE ORGANISM 2883 01:52:17,200 --> 01:52:19,520 AND VERSUS THE LIMITED 2884 01:52:19,520 --> 01:52:22,360 ENVIRONMENT THAT YOU HAVE IN A 2885 01:52:22,360 --> 01:52:22,560 CHIP. 2886 01:52:22,560 --> 01:52:23,760 >>THAT'S A GREAT QUESTION. 2887 01:52:23,760 --> 01:52:27,160 WE HAVEN'T SOLVED IT YET. 2888 01:52:27,160 --> 01:52:29,080 FOR EXAMPLE, WE WOULD REALLY 2889 01:52:29,080 --> 01:52:29,920 LIKE TO SOLVE IT. 2890 01:52:29,920 --> 01:52:32,640 IF WE CAN, WE CAN GET TO THE 2891 01:52:32,640 --> 01:52:35,160 LONGER ANALYSIS OF THESE KINDS 2892 01:52:35,160 --> 01:52:36,240 OF TISSUES NOT CHIPS FOR 2893 01:52:36,240 --> 01:52:37,800 EXAMPLE, IN THE SPACE WE SEND 2894 01:52:37,800 --> 01:52:39,640 THOSE CHIPS UP INTO SPACE, 2895 01:52:39,640 --> 01:52:41,520 THEY'RE GOOD ABOUT THREE TO FOUR 2896 01:52:41,520 --> 01:52:43,440 WEEKS BUT THEN THEY DIE OFF SO 2897 01:52:43,440 --> 01:52:45,160 WE HAVE TO BRING THEM DOWN AND 2898 01:52:45,160 --> 01:52:47,480 WE MEASURE THEM AND THAT IS 2899 01:52:47,480 --> 01:52:51,280 BECAUSE WE DON'T HAVE A ABILITY 2900 01:52:51,280 --> 01:52:52,560 TO GET RID OF THE TOXICITIES 2901 01:52:52,560 --> 01:52:53,640 THAT ARE BUILDING UP IN THE 2902 01:52:53,640 --> 01:52:55,320 CELLS AND THE WAYS THEY BUILDUP. 2903 01:52:55,320 --> 01:52:56,600 WE DON'T HAVE THAT COMPLETE SORT 2904 01:52:56,600 --> 01:52:57,800 OF SYSTEM. 2905 01:52:57,800 --> 01:53:00,320 AND SO THOSE ARE THE INNOVATION 2906 01:53:00,320 --> 01:53:02,240 THAT'S WE'RE STILL NEEDING TO 2907 01:53:02,240 --> 01:53:06,440 FIGURE OUT AND CREATE AND IT 2908 01:53:06,440 --> 01:53:07,520 WILL NEVER BE PERFECT BUT THESE 2909 01:53:07,520 --> 01:53:09,160 ARE SOME OF THE AREAS THAT I 2910 01:53:09,160 --> 01:53:11,080 THINK WE'RE WORKING ON NOW. 2911 01:53:11,080 --> 01:53:12,160 SO IT'S A GREAT QUESTION. 2912 01:53:12,160 --> 01:53:15,240 AND IF APPROXIMATE YOU HAVE 2913 01:53:15,240 --> 01:53:16,320 IDEAS, LET US KNOW. 2914 01:53:16,320 --> 01:53:18,680 ALSO THE BIOLOGICAL RHYTHMS THAT 2915 01:53:18,680 --> 01:53:19,280 ARE INHERENT. 2916 01:53:19,280 --> 01:53:20,800 >>THAT'S RIGHT. 2917 01:53:20,800 --> 01:53:23,400 THAT'S RIGHT. 2918 01:53:23,400 --> 01:53:24,800 CIRCADIAN RHYTHMS ARE IMPORTANT. 2919 01:53:24,800 --> 01:53:25,720 >>ABSOLUTELY. 2920 01:53:25,720 --> 01:53:29,000 >>THE OTHER THING THAT I WAS 2921 01:53:29,000 --> 01:53:30,480 INTERESTED IN YOUR OBSERVATION 2922 01:53:30,480 --> 01:53:32,680 IN SPACE PEOPLE AGE FASTER WHICH 2923 01:53:32,680 --> 01:53:36,760 IS LIKE A CONTRADICTION TO 2924 01:53:36,760 --> 01:53:37,200 EINSTEIN THEORY. 2925 01:53:37,200 --> 01:53:40,920 PEOPLE TRAVEL IN SPACE WHEN 2926 01:53:40,920 --> 01:53:43,440 PARADOX THAT THE TWIN IN SPACE. 2927 01:53:43,440 --> 01:53:44,640 >>THAT'S RIGHT, YEAH. 2928 01:53:44,640 --> 01:53:49,880 SO IT'S THE -- FOR IT'S THEORY 2929 01:53:49,880 --> 01:53:52,240 OF RELATIVELY TO RELATES TO THE 2930 01:53:52,240 --> 01:53:52,800 SPEED OF LIGHT. 2931 01:53:52,800 --> 01:53:56,320 IF YOU GO INTO HYPER DRIVE, IT 2932 01:53:56,320 --> 01:53:59,520 WOULD BE YOU WOULD GET YOUNGER. 2933 01:53:59,520 --> 01:54:00,280 >>YEAH. 2934 01:54:00,280 --> 01:54:02,840 >>BUT IN MICRO GRAVITY, IT'S 2935 01:54:02,840 --> 01:54:06,280 THAN LACK OF THE GRAVITATIONAL 2936 01:54:06,280 --> 01:54:06,960 COUND RECOGNIZE ARE POLE THAT 2937 01:54:06,960 --> 01:54:09,200 SEEMS TO HAVE THIS SORT OF 2938 01:54:09,200 --> 01:54:12,480 EFFECT, WE DON'T KNOW WHY, YET 2939 01:54:12,480 --> 01:54:16,520 BUT THE GRAVITY IS DOES SERVE AS 2940 01:54:16,520 --> 01:54:19,160 SORT OF THIS LIKE QUANTUM 2941 01:54:19,160 --> 01:54:22,320 ACTIVITIES IF OUR CELLS AND SO 2942 01:54:22,320 --> 01:54:24,880 IT'S AN IMPORTANT ENVIRONMENT 2943 01:54:24,880 --> 01:54:26,800 THAT TO BE INCLUSIVE WHEN WE 2944 01:54:26,800 --> 01:54:28,240 WANT TO THINK ABOUT THAT PROCESS 2945 01:54:28,240 --> 01:54:36,240 AND AGING. 2946 01:54:36,240 --> 01:54:37,240 >>THANK YOU VERY MUCH. 2947 01:54:37,240 --> 01:54:40,280 >>THESE DIFFERENCES ARE ALL 2948 01:54:40,280 --> 01:54:42,000 PUBLICATIONS IN THAT SPACE AND 2949 01:54:42,000 --> 01:54:44,480 ESPECIALLY AROUND SOME OF THE 2950 01:54:44,480 --> 01:54:46,400 BONE CONSEQUENCES SO WE ALREADY 2951 01:54:46,400 --> 01:54:49,440 KNOW THEIR SEX DIFFERENCES IN 2952 01:54:49,440 --> 01:54:52,280 BONE LOSS AND JUST IN 2953 01:54:52,280 --> 01:54:53,240 OSTEOPOROSIS FOR EXAMPLE SO IT'S 2954 01:54:53,240 --> 01:54:56,720 GREAT TO BE ABLE TO -- I WOULD 2955 01:54:56,720 --> 01:54:58,280 NOT HAVE THOUGHT Dr. RUTTER 2956 01:54:58,280 --> 01:55:00,520 THAT SPACE EXPLORATION WOULD BE 2957 01:55:00,520 --> 01:55:01,880 APPROPRIATED TO THE NCATS AND 2958 01:55:01,880 --> 01:55:02,800 WOMEN'S HEALTH PRESENTATIONS SO 2959 01:55:02,800 --> 01:55:06,840 WE ARE REAL HE'S EXCITED TO HEAR 2960 01:55:06,840 --> 01:55:08,680 JUST OF YOUR VISION AND YOUR 2961 01:55:08,680 --> 01:55:10,680 PERSPECTIVE THAT YOU ARE 2962 01:55:10,680 --> 01:55:11,280 BRINGING TO NCATS. 2963 01:55:11,280 --> 01:55:13,600 THERE IS A QUESTION IN THE CHAT 2964 01:55:13,600 --> 01:55:16,480 OF Dr. TEMPLETON. 2965 01:55:16,480 --> 01:55:20,000 SHE'S ASKING A QUESTION. 2966 01:55:20,000 --> 01:55:22,040 DO YOU WANT TO ANSWER HER 2967 01:55:22,040 --> 01:55:23,720 QUESTION ABOUT THE PARTICULAR. 2968 01:55:23,720 --> 01:55:24,680 >>YEAH, YEAH. 2969 01:55:24,680 --> 01:55:26,120 THAT WAS AN AWESOME 2970 01:55:26,120 --> 01:55:27,240 PRESENTATION. 2971 01:55:27,240 --> 01:55:30,720 THIS IS HAVE NARRO NAR THEIR OWY 2972 01:55:30,720 --> 01:55:33,080 FOCUSED AND WE IT'S CARTILAGE IN 2973 01:55:33,080 --> 01:55:34,160 PATIENTS WITH WEIGHT BEARING AND 2974 01:55:34,160 --> 01:55:36,160 YOU CAN SEE DIFFERENCES ON MRI 2975 01:55:36,160 --> 01:55:40,960 WHICH MAY OR MAY NOT WAGE MORE 2976 01:55:40,960 --> 01:55:41,600 PROGRESSIVE OSTEOARTHRITIS, HAVE 2977 01:55:41,600 --> 01:55:42,960 YOU THOUGHT OF LOOKING THAT IN 2978 01:55:42,960 --> 01:55:44,760 IN SPACE AND LOOKING AT CHANGES 2979 01:55:44,760 --> 01:55:46,560 IN BONE AND LOOKING AT CHANGES 2980 01:55:46,560 --> 01:55:47,880 IN THES CARTILAGE? 2981 01:55:47,880 --> 01:55:50,680 >>YES IN DEED. 2982 01:55:50,680 --> 01:55:54,120 IN FACT WE HAVE TISSUE CHIP THAT 2983 01:55:54,120 --> 01:55:57,880 MIMICS THAT JOINT, THE 2984 01:55:57,880 --> 01:55:58,440 CARTILAGE. 2985 01:55:58,440 --> 01:56:00,840 IT'S A KNEE JOINT THAT WE HAVE 2986 01:56:00,840 --> 01:56:01,360 IN SPACE. 2987 01:56:01,360 --> 01:56:04,280 WE ARE STUDYING THAT FOR THAT 2988 01:56:04,280 --> 01:56:04,760 VERY REASON. 2989 01:56:04,760 --> 01:56:05,400 YEAH. 2990 01:56:05,400 --> 01:56:07,480 I DON'T HAVE SPECIFIC FINDINGS 2991 01:56:07,480 --> 01:56:09,480 AT THIS POINT BUT IT'S SOMETHING 2992 01:56:09,480 --> 01:56:11,120 THAT IS OF INTERESTING AND VERY 2993 01:56:11,120 --> 01:56:12,680 IMPORTANT TO STUDY AND I HOPE 2994 01:56:12,680 --> 01:56:14,920 THEY HURRY BECAUSE, MY RIGHT 2995 01:56:14,920 --> 01:56:16,360 KNEE IS AWFUL. 2996 01:56:16,360 --> 01:56:18,720 >>AND I APPRECIATE THAT. 2997 01:56:18,720 --> 01:56:20,000 I APPRECIATE YOU LOOK AT 2998 01:56:20,000 --> 01:56:25,960 CARTILAGE BECAUSE IT GETS LOST. 2999 01:56:25,960 --> 01:56:27,440 I'M ORTHOPEDIC SURGERY WHEN WE 3000 01:56:27,440 --> 01:56:28,920 HAVE PEOPLE THAT HAVE BEEN 3001 01:56:28,920 --> 01:56:30,280 PROLONGED CANNOT WAIT BECAUSE OF 3002 01:56:30,280 --> 01:56:31,640 A JURY IT'S ALWAYS THE QUESTION. 3003 01:56:31,640 --> 01:56:34,040 HOW SOON DO YOU LET THEM PUT 3004 01:56:34,040 --> 01:56:35,480 WEIGHT ON THAT CARTILAGE BECAUSE 3005 01:56:35,480 --> 01:56:38,640 WE DON'T KNOW WHAT CHANGES THE 3006 01:56:38,640 --> 01:56:40,440 CARTILAGE IS UNDERGONE AND IF 3007 01:56:40,440 --> 01:56:44,040 TOUCHDIF ITHAS UNDER GONE CHANGE 3008 01:56:44,040 --> 01:56:49,600 YOU NEED TO CHANGE PROTO. 3009 01:56:49,600 --> 01:56:53,880 >>IN A WAY, BIOLOGY IS SUPER 3010 01:56:53,880 --> 01:56:54,160 ORGANIZED. 3011 01:56:54,160 --> 01:56:56,240 I MEAN, THE WAY THAT WE DEVELOP 3012 01:56:56,240 --> 01:56:58,040 THESE CHIPS AND ORGANOIDS IS 3013 01:56:58,040 --> 01:57:01,320 THERE A LAYER. 3014 01:57:01,320 --> 01:57:06,480 YOU HAVE THE CARTILAGE AND BONE 3015 01:57:06,480 --> 01:57:08,880 LAYER AND THEY ARE ALL LAYERS SO 3016 01:57:08,880 --> 01:57:11,360 IT IT'S ORGANIZED TO BE ABLE TO 3017 01:57:11,360 --> 01:57:14,000 DEVELOP THESE TISSUES ON A CHIP 3018 01:57:14,000 --> 01:57:15,920 AS WELL AND THEN YOU KNOW, 3019 01:57:15,920 --> 01:57:17,120 LOOKING AT THAT EPIDEMIOLOGY 3020 01:57:17,120 --> 01:57:19,320 FURTHER, HOW DO YOU CREATE THAT 3021 01:57:19,320 --> 01:57:21,840 STRESS AND THAT FORCE FOR WHEN 3022 01:57:21,840 --> 01:57:22,720 THOSE JOINTS ARE ACTUALLY 3023 01:57:22,720 --> 01:57:23,920 PRESSING ON ONE ANOTHER AND 3024 01:57:23,920 --> 01:57:24,920 UNDERSTANDING WHAT IT MEANS. 3025 01:57:24,920 --> 01:57:26,400 SO THESE ARE THE KINDS OF 3026 01:57:26,400 --> 01:57:27,480 QUESTIONS THAT WE'RE INTERESTED 3027 01:57:27,480 --> 01:57:30,520 IN ASKING AND I HOPE THAT WE CAN 3028 01:57:30,520 --> 01:57:38,520 FIND SOME GOOD PATHS FORWARD AN- 3029 01:57:38,520 --> 01:57:40,440 >>WE HAVE TWO KANSAS ON HERE. 3030 01:57:40,440 --> 01:57:43,800 >>I CAN'T EITHER. 3031 01:57:43,800 --> 01:57:44,200 [LAUGHTER] 3032 01:57:44,200 --> 01:57:45,600 >>Janine A. Clayton: CONTINUING 3033 01:57:45,600 --> 01:57:47,040 ON THE CHIP THING, I KNOW WE'RE 3034 01:57:47,040 --> 01:57:48,680 AT 11:37 SO WE HAVE THREE 3035 01:57:48,680 --> 01:57:52,920 MINUTES FOR THIS REST OF THIS 3036 01:57:52,920 --> 01:57:53,680 Q&A. 3037 01:57:53,680 --> 01:57:56,880 JONI, I LOVE THE FEMALE 3038 01:57:56,880 --> 01:57:59,920 REPRODUCTIVE CHIP ISSUES AND YOU 3039 01:57:59,920 --> 01:58:00,880 HIGHLIGHTED IN YOUR GOING INTO 3040 01:58:00,880 --> 01:58:04,960 THE WOMEN'S HEALTH SECTION OF 3041 01:58:04,960 --> 01:58:06,160 THE PRESENTATION, THE SEVERE 3042 01:58:06,160 --> 01:58:08,840 AEs THAT WE SEE IN WOMEN 3043 01:58:08,840 --> 01:58:10,800 COMPARED TO MEN IN THE FDA 3044 01:58:10,800 --> 01:58:11,000 PAPER. 3045 01:58:11,000 --> 01:58:14,760 I WANT TO ASK YOU FOR EXAMPLE, 3046 01:58:14,760 --> 01:58:16,160 DELIVER ON A CHIP PROJECT 3047 01:58:16,160 --> 01:58:18,080 BECAUSE SO MANY DRUGS PASS 3048 01:58:18,080 --> 01:58:20,720 THROUGH THE LIVER. 3049 01:58:20,720 --> 01:58:22,360 ARE YOU TRYING TO INCORPORATE 3050 01:58:22,360 --> 01:58:25,200 DIFFERENCES IN THE ORGANS ON A 3051 01:58:25,200 --> 01:58:26,920 CHIP THAT REPEAT REPRODUCTIVE 3052 01:58:26,920 --> 01:58:27,720 RELATED? 3053 01:58:27,720 --> 01:58:29,000 >>YES, EXACTLY. 3054 01:58:29,000 --> 01:58:34,320 SO THAT IS PRECISELY THE IDEA 3055 01:58:34,320 --> 01:58:36,480 AND DOING THAT BECAUSE WE CAN 3056 01:58:36,480 --> 01:58:39,000 TAKE PRIMARY CELLS AND WE CAN 3057 01:58:39,000 --> 01:58:40,440 CREATE THOSE STEM CELLS SO IF WE 3058 01:58:40,440 --> 01:58:42,240 HAVE APP OPPORTUNITY NOT JUST 3059 01:58:42,240 --> 01:58:44,360 MEN AND WOMEN BUT ALSO DIVERSE 3060 01:58:44,360 --> 01:58:44,840 POPULATIONS. 3061 01:58:44,840 --> 01:58:47,360 AND SO THAT IS DEFINITELY A 3062 01:58:47,360 --> 01:58:49,080 FEATURE THAT WE WANT TO 3063 01:58:49,080 --> 01:58:50,080 INCORPORATE A LOT MORE. 3064 01:58:50,080 --> 01:58:54,680 AS WE GET INTO MORE OF THE 3065 01:58:54,680 --> 01:58:55,960 DEVELOPMENT MODE NOW WE'RE INTO 3066 01:58:55,960 --> 01:59:00,480 SORT OF A FIGURING OUT HOW TO 3067 01:59:00,480 --> 01:59:01,120 TEST THEM MODES AND SO THAT 3068 01:59:01,120 --> 01:59:02,480 MEANS WE'RE GOING TO BE ABLE TO 3069 01:59:02,480 --> 01:59:03,760 SCALE THOSE UP. 3070 01:59:03,760 --> 01:59:05,200 AS WE START TO SCALE UP, WE'LL 3071 01:59:05,200 --> 01:59:06,960 SEE A LOT MORE OF THAT DIVERSE 3072 01:59:06,960 --> 01:59:09,400 TEASE IN THE TEXAS STUDIES. 3073 01:59:09,400 --> 01:59:10,760 IT'S A VERY IMPORTANT POINT. 3074 01:59:10,760 --> 01:59:12,480 I'M GLAD YOU ASKED IT. 3075 01:59:12,480 --> 01:59:17,040 IT'S CRITICAL TO HAVE THE SYSTEM 3076 01:59:17,040 --> 01:59:20,440 COMPONENTS ON THERE AND 3077 01:59:20,440 --> 01:59:22,840 UNDERSTANDINGINGS IF THERE'S A 3078 01:59:22,840 --> 01:59:23,880 METABOLIC FROM THE THERAPEUTIC 3079 01:59:23,880 --> 01:59:25,160 IN THE LIVER THAT MIGHT EFFECT 3080 01:59:25,160 --> 01:59:27,760 THE DOWNSTREAM EFFECTS OF IT 3081 01:59:27,760 --> 01:59:29,960 THAT WE'LL LEARN THAT BETTER 3082 01:59:29,960 --> 01:59:32,240 ESPECIALLY SUPPOSE IT'S 3083 01:59:32,240 --> 01:59:33,520 IMPORTANT TO KNOW. 3084 01:59:33,520 --> 01:59:34,200 >>Janine A. Clayton: ABSOLUTELY 3085 01:59:34,200 --> 01:59:35,320 AND IT CAN GENERATE MORE 3086 01:59:35,320 --> 01:59:36,840 RESEARCH QUESTIONS TO EXPLORE 3087 01:59:36,840 --> 01:59:41,080 THE SEX DIFFERENCES SO THAT CAN 3088 01:59:41,080 --> 01:59:42,800 ACTUALLY BE DATA USED TO WRITE 3089 01:59:42,800 --> 01:59:44,800 INVESTIGATOR INITIATED 3090 01:59:44,800 --> 01:59:47,040 APPLICATIONS SO YOUR GENERATING 3091 01:59:47,040 --> 01:59:49,640 NEW KNOWLEDGE THAT IS POPULATING 3092 01:59:49,640 --> 01:59:51,080 OUR ECOSYSTEM AND YOU 3093 01:59:51,080 --> 01:59:52,640 HIGHLIGHTED AT THE BEGINNING HOW 3094 01:59:52,640 --> 01:59:54,440 IMPORTANT IT IS, THE FACT THAT 3095 01:59:54,440 --> 01:59:58,440 THIS OVER RELIANCE ON MALE 3096 01:59:58,440 --> 01:59:59,720 APPROXIMATE HAVE RESULT INSIDE 3097 01:59:59,720 --> 02:00:01,040 OUR GAPS ABOUT FEMALE BIOLOGY 3098 02:00:01,040 --> 02:00:02,720 AND WOMEN'S HEALTH IN GENERAL SO 3099 02:00:02,720 --> 02:00:03,920 THESE ARE SOME OF THE WAYS YOU 3100 02:00:03,920 --> 02:00:05,920 MAY NOT THINK OF TRANSLATIONAL 3101 02:00:05,920 --> 02:00:07,120 RESEARCH AS WOMEN'S HEALTH 3102 02:00:07,120 --> 02:00:10,120 RESEARCH BUT THESE ARE VERY 3103 02:00:10,120 --> 02:00:11,160 FOUNDATIONAL EFFORTS SO I DO 3104 02:00:11,160 --> 02:00:13,480 WANT TO HIGHLIGHT AND JUST 3105 02:00:13,480 --> 02:00:15,720 APPLAUD NCATS FOR IN CORPORATING 3106 02:00:15,720 --> 02:00:18,680 IT INTO YOUR WORK. 3107 02:00:18,680 --> 02:00:21,640 >>I WAS GOING TO SAY THANK YOU 3108 02:00:21,640 --> 02:00:25,920 BACK BECAUSE WITHOUT YOU, Dr. 3109 02:00:25,920 --> 02:00:29,160 CLAYTON AND ORWH WE WOULD BE 3110 02:00:29,160 --> 02:00:30,120 STRUGGLING O WE ABSOLUTELY 3111 02:00:30,120 --> 02:00:35,920 CHERISH THE RELATIONSHIP THAT WE 3112 02:00:35,920 --> 02:00:37,520 HAVE WITH YOU AND YOUR TEAM AND 3113 02:00:37,520 --> 02:00:38,600 THE SCIENTIFIC COMMUNITY. 3114 02:00:38,600 --> 02:00:39,200 IT'S TEAM SCIENCE. 3115 02:00:39,200 --> 02:00:40,840 WE NEED ALL OF US AT THE TABLE 3116 02:00:40,840 --> 02:00:42,960 SO THAT'S IMPORTANT. 3117 02:00:42,960 --> 02:00:44,480 THANK YOU FOR THEIR HELP AND 3118 02:00:44,480 --> 02:00:45,320 LEADERSHIP IN GUIDING THIS. 3119 02:00:45,320 --> 02:00:48,000 >>THANK YOU SO MUCH FOR THAT 3120 02:00:48,000 --> 02:00:48,360 JONI. 3121 02:00:48,360 --> 02:00:50,640 YOU ARE RIGHT, SCIENCE IS A TEAM 3122 02:00:50,640 --> 02:00:53,200 SPORT FOR SURE. 3123 02:00:53,200 --> 02:00:54,040 EVEN THOUGH THE SPORT THAT I 3124 02:00:54,040 --> 02:00:58,440 PLAY IS AN INDIVIDUAL SPORT, 3125 02:00:58,440 --> 02:01:01,640 SCIENCE A TEAM SPORT AND WE'RE 3126 02:01:01,640 --> 02:01:03,280 JUST EXPANDING THE TEAM AND 3127 02:01:03,280 --> 02:01:05,480 GETTING MORE PLAYERS ON THE 3128 02:01:05,480 --> 02:01:06,080 TEAM. 3129 02:01:06,080 --> 02:01:06,360 EXACTLY. 3130 02:01:06,360 --> 02:01:08,600 >>BEFORE WE GO, YOU WANT TO 3131 02:01:08,600 --> 02:01:10,120 GIVE MEMBERS ONE MORE SECOND A 3132 02:01:10,120 --> 02:01:12,120 CHANCE TO MAKE ANY COMMENTS OR 3133 02:01:12,120 --> 02:01:12,680 QUESTIONS. 3134 02:01:12,680 --> 02:01:14,520 YOU ALSO ARE IN THE CHAT JONI 3135 02:01:14,520 --> 02:01:16,080 THERE WAS POSITIVE FEEDBACK ON 3136 02:01:16,080 --> 02:01:18,720 YOUR K-4 PROGRAM AND YOUR WSAs 3137 02:01:18,720 --> 02:01:19,960 AND THAT'S GREAT AND THAT'S 3138 02:01:19,960 --> 02:01:21,680 FANTASTIC TO SEE IT AS WELL AND 3139 02:01:21,680 --> 02:01:25,800 GREAT TO SEE YOUR INTRAMURAL 3140 02:01:25,800 --> 02:01:27,200 SCIENTISTS GETTING VISIBILITY IN 3141 02:01:27,200 --> 02:01:31,280 THAT PROGRAM SO CONGRATULATIONS 3142 02:01:31,280 --> 02:01:34,120 ON THAT. 3143 02:01:34,120 --> 02:01:35,280 >>Samia Noursi: THANK YOU, 3144 02:01:35,280 --> 02:01:36,000 Dr. RUTTER. 3145 02:01:36,000 --> 02:01:37,400 I APPRECIATE YOU JOINING US. 3146 02:01:37,400 --> 02:01:41,400 I'D LIKE TO MAKE SURE WE WELCOME 3147 02:01:41,400 --> 02:01:44,360 Dr. SIMON WHO JOINED US A LOT 3148 02:01:44,360 --> 02:01:45,520 WAY FROM GREECE. 3149 02:01:45,520 --> 02:01:47,240 I CAN'T BELIEVE WITH YOU ARE US 3150 02:01:47,240 --> 02:01:49,960 AND NOT ENJOYING THE BEACHES 3151 02:01:49,960 --> 02:01:50,160 THERE. 3152 02:01:50,160 --> 02:01:51,680 THANK YOU FOR JOINING US WE 3153 02:01:51,680 --> 02:01:53,720 APPRECIATE YOU BEING ABLE TO DO 3154 02:01:53,720 --> 02:01:56,120 SO AND Dr. CLAYTON WE CAN MOVE 3155 02:01:56,120 --> 02:01:58,480 TO THE NEXT SEGMENT. 3156 02:01:58,480 --> 02:01:59,080 >>Janine A. Clayton: YES, I 3157 02:01:59,080 --> 02:02:02,640 WILL TURN THE VIRTUAL MICROPHONE 3158 02:02:02,640 --> 02:02:09,160 TO Dr. JULIE AN. 3159 02:02:09,160 --> 02:02:10,640 >>THANK YOU Dr. CLAYTON. 3160 02:02:10,640 --> 02:02:14,640 CAN YOU HEAR ME OKAY? 3161 02:02:14,640 --> 02:02:16,520 >>WE CAN HEAR YOU GREAT. 3162 02:02:16,520 --> 02:02:17,920 I WOULD NOW LIKE TO INTRODUCE 3163 02:02:17,920 --> 02:02:20,360 OUR FINAL SPEAKER OF THE MORNING 3164 02:02:20,360 --> 02:02:23,120 MY COLLEAGUE DAWN CORBETT SHE'S 3165 02:02:23,120 --> 02:02:24,400 THE NIH INCLUSION POLICY OFFICER 3166 02:02:24,400 --> 02:02:28,480 AND THE OFFICE OF EXTRAMURAL 3167 02:02:28,480 --> 02:02:31,600 RESEARCH OER WHERE SHE PROVIDES 3168 02:02:31,600 --> 02:02:34,280 OVERSIGHT OF NIH WIDE EFFORTS TO 3169 02:02:34,280 --> 02:02:35,720 ENSURE I AM CONCLUSION OF WOMEN, 3170 02:02:35,720 --> 02:02:37,240 MINOR TEASE AND INDIVIDUALS As 3171 02:02:37,240 --> 02:02:39,440 COULD THE LIVES SPAN IN NIH 3172 02:02:39,440 --> 02:02:41,160 DEFINED CLINICAL RESEARCH AND 3173 02:02:41,160 --> 02:02:43,080 PRIOR TO JOINING OER SHE LED 3174 02:02:43,080 --> 02:02:45,320 EFFORTS TO INCREASE EFFICIENT' 3175 02:02:45,320 --> 02:02:46,520 AND TRANSPARENCY OF CLINICAL 3176 02:02:46,520 --> 02:02:48,160 RESEARCH THROUGH ENHANCE 3177 02:02:48,160 --> 02:02:49,480 RECRUITMENT MONITORING AND 3178 02:02:49,480 --> 02:02:50,920 INCREASE COMPLIANCE EFFORTS AS A 3179 02:02:50,920 --> 02:02:52,200 HEALTH SCIENCE POLICY ANNALIST 3180 02:02:52,200 --> 02:02:54,800 IF APPROXIMATE THE NATIONAL 3181 02:02:54,800 --> 02:02:55,440 INSTITUTE OF MENTAL HEALTH AND 3182 02:02:55,440 --> 02:02:58,120 AND OFFICE OF CLINICAL RESEARCH, 3183 02:02:58,120 --> 02:03:00,120 CLINICAL TRIAL OPERATIONS AND 3184 02:03:00,120 --> 02:03:03,480 STATISTICS BRANCH THERE AND SHE 3185 02:03:03,480 --> 02:03:05,440 BEGAN HER FEDERAL CAREER AT NIH 3186 02:03:05,440 --> 02:03:09,080 IN THE NI IN PH OFFICE FOR 3187 02:03:09,080 --> 02:03:14,280 RESEARCH IN DISPARITIES IN 3188 02:03:14,280 --> 02:03:24,680 GLOBAL MENTAL HEALTH. 3189 02:03:25,520 --> 02:03:26,400 Ms. CORBETT HAS A MASTER 3190 02:03:26,400 --> 02:03:28,320 DEGREE IN PUBLIC-HEALTH FROM 3191 02:03:28,320 --> 02:03:29,360 JOHNS HOPKINS SCHOOL FOR 3192 02:03:29,360 --> 02:03:30,640 PUBLIC-HEALTH AND A BACHELOR'S 3193 02:03:30,640 --> 02:03:32,120 DEGREE IN POLITICAL SCIENCE FROM 3194 02:03:32,120 --> 02:03:35,120 THE UNIVERSITY OF ILLINOIS. 3195 02:03:35,120 --> 02:03:39,480 WELCOME Ms. CORBETT. 3196 02:03:39,480 --> 02:03:42,600 >>BEFORE I START MY 3197 02:03:42,600 --> 02:03:45,440 PRESENTATION I WANT TODAY IF I 3198 02:03:45,440 --> 02:03:47,640 ARE MINOR SURGEON MY FACE 3199 02:03:47,640 --> 02:03:49,080 YESTERDAY SO I'M WEARING A MASK 3200 02:03:49,080 --> 02:03:50,640 SO I'M GOING OFF CAMERA DURING 3201 02:03:50,640 --> 02:03:51,880 THE PRESENTATION BUT I'LL COME 3202 02:03:51,880 --> 02:03:53,680 BACK FROM THE Q&A TO MAKE SURE 3203 02:03:53,680 --> 02:03:55,280 YOU CAN CLEARLY HEAR ME. 3204 02:03:55,280 --> 02:03:57,680 BUT I'M GOING TO GO AHEAD AND 3205 02:03:57,680 --> 02:04:02,800 GET STARTED NOW. 3206 02:04:02,800 --> 02:04:04,480 AND SO TODAY I WANTED TO GIVE 3207 02:04:04,480 --> 02:04:10,000 YOU AN UPDATE ON NIH INCLUSION 3208 02:04:10,000 --> 02:04:10,720 EFFORTS. 3209 02:04:10,720 --> 02:04:12,120 WE TOUCHED BASE LAST YEAR TO 3210 02:04:12,120 --> 02:04:14,600 TALK ABOUT WHERE WE WERE WITH 3211 02:04:14,600 --> 02:04:16,920 INCLUSION OF WOMEN AND AND 3212 02:04:16,920 --> 02:04:18,600 MEMBERS OF RACIAL AND ETHNIC 3213 02:04:18,600 --> 02:04:19,800 MINORITY GROUPS AND INDIVIDUALS 3214 02:04:19,800 --> 02:04:21,320 ACROSS THE LIFESPAN AND I WANT 3215 02:04:21,320 --> 02:04:23,200 TODAY GIVE YOU AN UPDATE OF 3216 02:04:23,200 --> 02:04:24,640 WHERE WE ARE CURRENTLY. 3217 02:04:24,640 --> 02:04:26,480 JUST TO ORIENT YOU AND GIVE YOU 3218 02:04:26,480 --> 02:04:29,520 A TIMELINE OF NIH INCLUSION 3219 02:04:29,520 --> 02:04:30,480 POLICIES, THERE WAS INCLUSION 3220 02:04:30,480 --> 02:04:33,520 POLICY ON THE BOOKS SINCE 1986 3221 02:04:33,520 --> 02:04:37,720 WHEN NIH BEGAN INCLUSION OF 3222 02:04:37,720 --> 02:04:39,800 WOMEN IN NIH CLINICAL RESEARCH 3223 02:04:39,800 --> 02:04:44,320 STUDIES IN 1994, IT WAS NAH 3224 02:04:44,320 --> 02:04:47,600 POLICY IN RESPONSE TO THE 1993 3225 02:04:47,600 --> 02:04:49,760 REVITALIZATION ACT THAT MANDATED 3226 02:04:49,760 --> 02:04:50,760 THE CONCLUSION OF WOMEN AND 3227 02:04:50,760 --> 02:04:52,880 RACIAL AND ETHNIC GROUPS AND 3228 02:04:52,880 --> 02:04:54,480 CLINICAL RESEARCH STUDIES SO IT 3229 02:04:54,480 --> 02:04:59,880 WAS REQUIRED IN 1994 AND THEN IN 3230 02:04:59,880 --> 02:05:01,440 1998, AT THAT TIME, WE REALIZE 3231 02:05:01,440 --> 02:05:03,560 THAT A NUMBER OF CONCERNS ABOUT 3232 02:05:03,560 --> 02:05:04,520 INCLUSION OF WOMEN AND MEMBERS 3233 02:05:04,520 --> 02:05:06,400 OF RACIAL AND ETHNIC MINORITY 3234 02:05:06,400 --> 02:05:08,440 GROUPS ALSO APPLIED TO INCLUSION 3235 02:05:08,440 --> 02:05:11,040 OF CHILDREN ALSO REPRESENTING -- 3236 02:05:11,040 --> 02:05:13,240 UNDER REPRESENTED IN NIH FUNDED 3237 02:05:13,240 --> 02:05:15,720 CLINICAL RESEARCH SO IN THE 3238 02:05:15,720 --> 02:05:17,000 1998, WE BEGAN REQUIRING 3239 02:05:17,000 --> 02:05:21,000 INCLUSION OF CHILDREN AND NIH 3240 02:05:21,000 --> 02:05:25,640 RESEARCH AND IT WAS PRETTY MUCH 3241 02:05:25,640 --> 02:05:28,440 THE SAME AND IN 208. 3242 02:05:28,440 --> 02:05:31,360 WE BEGAN IMPLEMENTING SOME 3243 02:05:31,360 --> 02:05:33,200 ADDITIONAL REQUIREMENT AND THE 3244 02:05:33,200 --> 02:05:34,480 21st SEPTEMBER RECURES ACT 3245 02:05:34,480 --> 02:05:36,920 WHICH WAS PASSED IN DECEMBER OF 3246 02:05:36,920 --> 02:05:38,720 2016 AND INCLUDED A NUMBER OF 3247 02:05:38,720 --> 02:05:43,360 NEW REQUIREMENTS FOR NIH AND 3248 02:05:43,360 --> 02:05:44,040 CLINICIAN. 3249 02:05:44,040 --> 02:05:46,320 SOME OF THIS REQUIREMENTS 3250 02:05:46,320 --> 02:05:50,760 INCLUDED NEW REQUIREMENTS FOR 3251 02:05:50,760 --> 02:05:52,840 RECORDING VALID FOR SEX, GENDER 3252 02:05:52,840 --> 02:05:57,000 RACE AND CLINICAL TRIALS.GOV AND 3253 02:05:57,000 --> 02:05:58,640 PHASE 3 CLINICAL TRIALS SO THAT 3254 02:05:58,640 --> 02:06:02,680 THIS IMPLEMENTED ON THE 2017 AND 3255 02:06:02,680 --> 02:06:06,800 IN 2019, THE NIH INCLUSION 3256 02:06:06,800 --> 02:06:10,240 ACROSS THE POLICY WAS INCLUSION 3257 02:06:10,240 --> 02:06:13,640 OF CHILDREN POLICY NOW INCLUDING 3258 02:06:13,640 --> 02:06:14,920 THE INDIVIDUAL ALL AGES AND NIH 3259 02:06:14,920 --> 02:06:16,840 FUNDED CLINICAL RESEARCH STUDIES 3260 02:06:16,840 --> 02:06:21,240 INCLUDING HEALTH AND OLDER 3261 02:06:21,240 --> 02:06:23,520 ADULTS AND THERE'S A SCIENTIFIC 3262 02:06:23,520 --> 02:06:24,960 OR ETHICAL REASON FOR THEIR 3263 02:06:24,960 --> 02:06:27,120 INCLUSION AND MOST RECENTLY IN 3264 02:06:27,120 --> 02:06:28,760 2022 WE CLARIFIED OUR 3265 02:06:28,760 --> 02:06:30,760 INSTRUCTIONS FOR PROGRESS 3266 02:06:30,760 --> 02:06:35,440 REPORTS AND ON INDICATING THAT 3267 02:06:35,440 --> 02:06:44,360 NIH DEFINED WHICH IS PUBLICLY 3268 02:06:44,360 --> 02:06:50,960 AVAILABLE ON THE NIH REPORT SITE 3269 02:06:50,960 --> 02:06:53,560 AND SO WE'LL GO OVER THESE IN A 3270 02:06:53,560 --> 02:06:55,440 BIT MORE DETAIL BUT I WANT TO 3271 02:06:55,440 --> 02:06:57,000 ACKNOWLEDGE DESPITE THE NUMBER 3272 02:06:57,000 --> 02:06:59,760 MANY DECADES OF EFFORTS, WE 3273 02:06:59,760 --> 02:07:00,800 ACKNOWLEDGE THERE IS STILL MORE 3274 02:07:00,800 --> 02:07:01,560 TO BE DONE. 3275 02:07:01,560 --> 02:07:04,840 WE STILL HAVE NOT REACHED THE 3276 02:07:04,840 --> 02:07:06,960 LEVEL OF CLINICAL RESEARCH 3277 02:07:06,960 --> 02:07:09,280 STUDIES AND TO THE EXTENT WE SEE 3278 02:07:09,280 --> 02:07:14,080 WOULD LIKE AND NIH COMMISSION A 3279 02:07:14,080 --> 02:07:15,880 REPORT OF THE NATIONAL ADD 3280 02:07:15,880 --> 02:07:19,800 ACADEMY OF MEDICINE THAT REPORT 3281 02:07:19,800 --> 02:07:23,440 CAME OUT LAST YEAR. 3282 02:07:23,440 --> 02:07:25,200 ABOUT A PARADIGM SHIFT THAT 3283 02:07:25,200 --> 02:07:26,400 LOOKS ON TACTICS AND PROCESS 3284 02:07:26,400 --> 02:07:29,360 CHANGES AND DISPARITIES AND 3285 02:07:29,360 --> 02:07:31,960 RESEARCH ACCESS WILL INSIST AT 3286 02:07:31,960 --> 02:07:42,480 POPULATION SUBGROUPS AND -- AND 3287 02:09:15,800 --> 02:09:18,480 THEN KINDLY IF IT'S SPOKEN 3288 02:09:18,480 --> 02:09:20,560 CLINICAL TRIAL AND IT'S 3289 02:09:20,560 --> 02:09:23,960 APPLICABLE CLINICAL TRIAL, WHICH 3290 02:09:23,960 --> 02:09:26,840 IS REFERRED TO OUR FDA REGULATED 3291 02:09:26,840 --> 02:09:28,680 DRUG DEVICE STUDY THOSE STUDIES 3292 02:09:28,680 --> 02:09:30,400 MUST ALSO REPORT THE RECORDS OF 3293 02:09:30,400 --> 02:09:34,080 THIS ANALYSIS IN CLINICAL TRIALS 3294 02:09:34,080 --> 02:09:35,720 IN ADDITION TO REQUIREMENT THAT 3295 02:09:35,720 --> 02:09:39,560 INFORMATION IN THE PROJECT 3296 02:09:39,560 --> 02:09:40,560 OUTCOME SECTION. 3297 02:09:40,560 --> 02:09:42,720 AND I MENTIONED WE EXPANDED OUR 3298 02:09:42,720 --> 02:09:49,200 INCLUSION OF CHILDREN POLICY IN 3299 02:09:49,200 --> 02:09:51,440 2019 T.S.X. EFFECTIVE THEN AND 3300 02:09:51,440 --> 02:09:53,040 WHICH REQUIRES THAT INDIVIDUALS 3301 02:09:53,040 --> 02:09:55,840 OF ALL AGES INCLUDED AND NIH 3302 02:09:55,840 --> 02:09:58,280 HUMAN SUBJECTS RESEARCH UNLESS 3303 02:09:58,280 --> 02:09:59,280 THERE'S SCIENTIFIC REASONS NOT 3304 02:09:59,280 --> 02:10:09,280 TO DO SO. 3305 02:10:09,280 --> 02:10:11,560 IF YOU HAVE A NIH GRANT YOU MAY 3306 02:10:11,560 --> 02:10:13,400 BE FAMILIAR WITH THE TABLES WE 3307 02:10:13,400 --> 02:10:14,640 REQUIRE BY SEX OR GENDER AND 3308 02:10:14,640 --> 02:10:18,320 RACE AND ETHNICITY AND WE KNOW 3309 02:10:18,320 --> 02:10:21,000 PRIORITY WITH INDIVIDUAL LEVEL 3310 02:10:21,000 --> 02:10:22,280 DATA WHICH SHOWS THE SEX OR 3311 02:10:22,280 --> 02:10:24,440 GENDER, RACE, ETHNICITY AND THE 3312 02:10:24,440 --> 02:10:26,960 AGE OF ENROLLMENT OF EACH 3313 02:10:26,960 --> 02:10:28,480 PARTICIPANT IN NIH FUNDED 3314 02:10:28,480 --> 02:10:33,880 CLINICAL RESEARCH STUDIES. 3315 02:10:33,880 --> 02:10:35,880 SO, I BRIEFLY SUMMARIZED OUR 3316 02:10:35,880 --> 02:10:37,120 REQUIREMENTS AND I KNOW WHEN WE 3317 02:10:37,120 --> 02:10:38,520 TALK ABOUT THE STATUS OF WHERE 3318 02:10:38,520 --> 02:10:42,560 WE ARE IN IMPLEMENTATION OF OUR 3319 02:10:42,560 --> 02:10:43,560 POLICIES. 3320 02:10:43,560 --> 02:10:47,200 I'VE TALKED PREVIOUSLY ABOUT THE 3321 02:10:47,200 --> 02:10:49,200 JAR REPORT TA CAME OUT IN 2015 3322 02:10:49,200 --> 02:10:51,760 WHICH INDICATED THAT BETTER 3323 02:10:51,760 --> 02:10:53,800 OVERSIGHT WAS NEEDED TO HELP 3324 02:10:53,800 --> 02:10:55,200 ENSURE CONTINUED PROGRESS 3325 02:10:55,200 --> 02:10:56,520 INCLUDING LIMITED HEALTH 3326 02:10:56,520 --> 02:10:57,000 RESEARCH. 3327 02:10:57,000 --> 02:10:58,640 THIS REPORT INCLUDED FIVE 3328 02:10:58,640 --> 02:11:00,000 RECOMMENDATIONS INCLUDING 3329 02:11:00,000 --> 02:11:03,440 IMPROVEMENTS TO REPORTING, ALSO 3330 02:11:03,440 --> 02:11:04,240 IMPROVEMENT TO TRANSPARENCY OF 3331 02:11:04,240 --> 02:11:08,240 DATA BY MAKING IC LEVEL REPORTS 3332 02:11:08,240 --> 02:11:10,040 AVAILABLE AND BY TRACKING THE 3333 02:11:10,040 --> 02:11:12,520 NUMBER OF STUDIES THAT REQUIRE 3334 02:11:12,520 --> 02:11:13,760 ANALYSIS BY SEX OR GENDER RACE 3335 02:11:13,760 --> 02:11:16,120 AND ETHNICITY AND MAKING THAT 3336 02:11:16,120 --> 02:11:19,120 INFORMATION PUBLICLY AVAILABLE. 3337 02:11:19,120 --> 02:11:21,200 SO, WE ARE REPORTING ALL OF THE 3338 02:11:21,200 --> 02:11:22,520 RECOMMENDATIONS FROM THE GAO 3339 02:11:22,520 --> 02:11:25,880 REPORT ARE CLOSED AND WE HAVE 3340 02:11:25,880 --> 02:11:26,600 IMPLEMENTED THE IMPROVEMENT 3341 02:11:26,600 --> 02:11:29,440 THAT'S GAO REQUESTED AND WE 3342 02:11:29,440 --> 02:11:39,880 CLOSED THAT OUT LAST YEAR. 3343 02:11:41,240 --> 02:11:42,800 THIS REPORT WAS PUBLISHED IN 3344 02:11:42,800 --> 02:11:45,120 DECEMBER OF 2022 AND NCI WAS 3345 02:11:45,120 --> 02:11:49,320 INVOLVED IN THIS AUDIT AS WELL 3346 02:11:49,320 --> 02:11:50,600 AS MY OFFICE. 3347 02:11:50,600 --> 02:11:54,600 THIS AUDIT FOUND THAT FEDERAL 3348 02:11:54,600 --> 02:11:56,880 AGENCIES HAD TAKEN AGENCY TO 3349 02:11:56,880 --> 02:11:59,080 FACILITATE DIVERSITY OF PATIENTS 3350 02:11:59,080 --> 02:12:03,480 AND NIH FUNDED CANCER CLINICAL 3351 02:12:03,480 --> 02:12:05,120 TRIALS. 3352 02:12:05,120 --> 02:12:06,520 THE REPORT MENTIONED ACTIONS 3353 02:12:06,520 --> 02:12:08,640 FEDERAL AGENCIES HAD TAKEN WITH 3354 02:12:08,640 --> 02:12:11,440 RESPECT TO ELIGIBILITY CRITERIA 3355 02:12:11,440 --> 02:12:13,680 AND OTHER PRACTICES AND SO THERE 3356 02:12:13,680 --> 02:12:17,680 WERE NO RECOMMENDATIONS FROM 3357 02:12:17,680 --> 02:12:21,800 THAT REPORT FOR NIH TO 3358 02:12:21,800 --> 02:12:22,320 IMPLEMENT. 3359 02:12:22,320 --> 02:12:23,360 WE'LL TALK A LITTLE BIT MORE 3360 02:12:23,360 --> 02:12:24,560 ABOUT THINGS THAT WE'VE BEEN 3361 02:12:24,560 --> 02:12:27,200 DOING IN RECENT YEARS TO IMPROVE 3362 02:12:27,200 --> 02:12:29,360 OUR MONITORING AND ENFORCEMENT 3363 02:12:29,360 --> 02:12:32,200 OF NIH INCLUSION POLICIES. 3364 02:12:32,200 --> 02:12:35,200 AMONG THOSE EFFORTS INCLUDE THE 3365 02:12:35,200 --> 02:12:37,680 DEVELOPMENT OF A HUMAN SUBJECT 3366 02:12:37,680 --> 02:12:40,280 SYSTEMSIS. 3367 02:12:40,280 --> 02:12:42,840 THIS IS A ERA MODULE THAT WORKS 3368 02:12:42,840 --> 02:12:44,880 WITH PROGRAM MODULES AND ALSO 3369 02:12:44,880 --> 02:12:47,040 ASSIST FOR THOSE OF YOU WHO USE 3370 02:12:47,040 --> 02:12:49,520 THAT TO SUBMIT NIH GRANTS. 3371 02:12:49,520 --> 02:12:51,080 AND ANY IDEA OF THE HUMAN 3372 02:12:51,080 --> 02:12:52,720 SUBJECT SYSTEM AND THAT IT 3373 02:12:52,720 --> 02:12:54,720 INCLUDES ALL HUMAN SUBJECTS AND 3374 02:12:54,720 --> 02:12:55,720 CLINICAL TRIAL INFORMATION ALL 3375 02:12:55,720 --> 02:12:57,920 IN ONE PLACE SO OUR APPLICANTS 3376 02:12:57,920 --> 02:13:00,320 AND RECIPIENTS AND OUR STAFF CAN 3377 02:13:00,320 --> 02:13:01,760 SEE ALL OF THE INFORMATION IN 3378 02:13:01,760 --> 02:13:02,560 ONE PLACE. 3379 02:13:02,560 --> 02:13:06,840 WE ALSO HAVE SYNCHRONIZED SYSTEM 3380 02:13:06,840 --> 02:13:08,520 CLINICAL TRIALS AND WE CAN 3381 02:13:08,520 --> 02:13:09,600 VALIDATE THE INFORMATION IS 3382 02:13:09,600 --> 02:13:13,680 CONSISTENT AND APPROPRIATE 3383 02:13:13,680 --> 02:13:16,240 ACROSS SYSTEMS THEY CAPTURE THE 3384 02:13:16,240 --> 02:13:18,080 INDIVIDUAL LEVEL DATA WHICH I'VE 3385 02:13:18,080 --> 02:13:18,800 MENTIONED. 3386 02:13:18,800 --> 02:13:22,200 WE ARE ALSO USING THIS SYSTEM TO 3387 02:13:22,200 --> 02:13:23,720 MONITOR THE NUMBER OF STUDIES TA 3388 02:13:23,720 --> 02:13:25,400 REQUIRE ANALYSIS BY SEX OR 3389 02:13:25,400 --> 02:13:27,520 GENDER, RACE AND ETHNICITY SO IT 3390 02:13:27,520 --> 02:13:28,920 ALLOWS OUR PROGRAM OFFICERS TO 3391 02:13:28,920 --> 02:13:31,080 SEE AT A GLANCE, THE REQUIREMENT 3392 02:13:31,080 --> 02:13:32,960 FOR EACH STUDIES AND THEIR 3393 02:13:32,960 --> 02:13:40,240 ENROLLMENT GOALS AND PROGRESS. 3394 02:13:40,240 --> 02:13:41,200 IN ADDITION. 3395 02:13:41,200 --> 02:13:42,960 NIH HAS CONTINUED TO ENHANCE ITS 3396 02:13:42,960 --> 02:13:45,320 REPORTING OF INCLUSION OF 3397 02:13:45,320 --> 02:13:47,600 INDIVIDUALS AND NIH RESEARCH. 3398 02:13:47,600 --> 02:13:53,880 MOST RECENTLY, LAST YEAR IN 2022 3399 02:13:53,880 --> 02:13:58,240 WE DEPLOYED A NEW REPORT, WHICH 3400 02:13:58,240 --> 02:14:00,040 SHOWS NIH INCLUSION DATA BY 3401 02:14:00,040 --> 02:14:02,400 RESEARCH CONDITION OR DISEASE 3402 02:14:02,400 --> 02:14:06,960 CATEGORY AND INCLUDES AGE FOR 3403 02:14:06,960 --> 02:14:14,920 THE FIRST TIME. 3404 02:14:14,920 --> 02:14:17,480 A FEW YEARS IT DEPLOYED DATA AND 3405 02:14:17,480 --> 02:14:20,640 WE CAN THAT INITIALLY FOR SEX OR 3406 02:14:20,640 --> 02:14:23,320 GENDER RACE AND ETHNICITY 3407 02:14:23,320 --> 02:14:24,320 BECAUSE WE HAD BEEN COLLECTING 3408 02:14:24,320 --> 02:14:30,840 THIS DATA FOR SOME TIME SO IT'S 3409 02:14:30,840 --> 02:14:32,120 AVAILABLE BY AGE AND IT'S 3410 02:14:32,120 --> 02:14:33,480 AVAILABLE ON OUR WEBSITE AND YOU 3411 02:14:33,480 --> 02:14:35,560 CAN GO TO THE WEBSITE AND CLICK 3412 02:14:35,560 --> 02:14:39,680 ON ANY RESEARCH DISEASE OR 3413 02:14:39,680 --> 02:14:45,800 CONDITION AND MEDIUM PREPORTION 3414 02:14:45,800 --> 02:14:47,360 AND THE PEOPLE AND WE CAN ALSO 3415 02:14:47,360 --> 02:14:50,840 LOOK BY IC FOR THOSE DATA SO 3416 02:14:50,840 --> 02:14:52,760 THERE'S A WEATHER OF INFORMATION 3417 02:14:52,760 --> 02:14:54,240 ABOUT PARTICIPATION AND OUR 3418 02:14:54,240 --> 02:14:55,400 RESEARCH AVAILABLE. 3419 02:14:55,400 --> 02:14:56,840 ONE NOTE ABOUT THE AGE DATA 3420 02:14:56,840 --> 02:14:58,480 THAT'S AVAILABLE, WE ONLY HAVE 3421 02:14:58,480 --> 02:14:59,800 AGE DATA FOR THOSE THAT FOLLOW 3422 02:14:59,800 --> 02:15:01,960 UNDER THE INCLUSION OF LIFESPAN 3423 02:15:01,960 --> 02:15:04,120 AND INCLUDING APPLICATIONS 3424 02:15:04,120 --> 02:15:06,920 SUBMITTED JANUARY 25th, 2019 3425 02:15:06,920 --> 02:15:07,440 OR LATER. 3426 02:15:07,440 --> 02:15:08,920 THIS IS A SNAPSHOT OF THE DATA 3427 02:15:08,920 --> 02:15:12,160 AND WE DON'T HAVE ALL OF OUR 3428 02:15:12,160 --> 02:15:13,320 GRANTS AND CONTRACTS THAT 3429 02:15:13,320 --> 02:15:15,200 CURRENTLY FULL UNDER THIS 3430 02:15:15,200 --> 02:15:22,960 POLICY. 3431 02:15:22,960 --> 02:15:24,720 FINALLY, WE CONTINUE TO WORK ON 3432 02:15:24,720 --> 02:15:26,160 COLLABORATION BUT WITH OUR 3433 02:15:26,160 --> 02:15:30,520 FEDERAL PARTNERS ALSO PUBLIC AND 3434 02:15:30,520 --> 02:15:32,720 PRIVATE PARTNERS NEXT SUN AND IN 3435 02:15:32,720 --> 02:15:43,280 WORKING TO IMPROVE INCLUSION AND 3436 02:15:45,560 --> 02:15:48,600 WORKING IN CLINICAL TRIALS AND 3437 02:15:48,600 --> 02:15:49,800 AND ORGANIZATIONAL LEVEL 3438 02:15:49,800 --> 02:15:54,600 STRATEGIES TO INCLUDE THAT 3439 02:15:54,600 --> 02:15:55,960 INCLUSION. 3440 02:15:55,960 --> 02:15:57,320 THIS IS FROM OUR RECENT PAPER 3441 02:15:57,320 --> 02:15:59,440 THAT CAME OUT WHICH I WAS A 3442 02:15:59,440 --> 02:16:00,800 CO-AUTHOR OF THIS PAPER ALONG 3443 02:16:00,800 --> 02:16:02,880 WITH MY COLLEAGUES ON THE OTHER 3444 02:16:02,880 --> 02:16:06,000 TEAM LEADS ON THE DIVERSITY 3445 02:16:06,000 --> 02:16:06,760 PROJECT. 3446 02:16:06,760 --> 02:16:07,680 ONE OF THE QUOTES YOU CAN SEE 3447 02:16:07,680 --> 02:16:09,680 HERE IS ALL THEY MUCH WORK HAS 3448 02:16:09,680 --> 02:16:11,240 FOCUSED ON STUDY LEVEL 3449 02:16:11,240 --> 02:16:12,440 STRATEGIES, RESEARCH 3450 02:16:12,440 --> 02:16:14,120 ORGANIZATIONS MUST MAKE SYSTEMIC 3451 02:16:14,120 --> 02:16:15,200 CHANGES TO HOW CLINICAL TRIALS 3452 02:16:15,200 --> 02:16:18,560 ARE ENVISIONED IN IMPLEMENTED 3453 02:16:18,560 --> 02:16:19,640 AND CHIEF SUN TAPE ABLE SUPPORT 3454 02:16:19,640 --> 02:16:22,320 FOR DIVERSITY AND INCLUSION 3455 02:16:22,320 --> 02:16:22,520 TIMES. 3456 02:16:22,520 --> 02:16:23,240 THIS IS SOMETHING WE'VE BEEN 3457 02:16:23,240 --> 02:16:24,280 THINKING ABOUT A LOT AND OUR 3458 02:16:24,280 --> 02:16:25,960 OFFICE IS HOW CAN ORGANIZATIONS 3459 02:16:25,960 --> 02:16:27,720 CREATE A SUSTAINABILITY 3460 02:16:27,720 --> 02:16:28,760 INFRASTRUCTURE TO SUPPORT 3461 02:16:28,760 --> 02:16:33,320 INCLUSION OVER THE LONG-TERM 3462 02:16:33,320 --> 02:16:37,680 RATHER THAN LACTAID LOOKING STUY 3463 02:16:37,680 --> 02:16:39,560 SIDE AND THIS REQUIRES EFFORTS 3464 02:16:39,560 --> 02:16:40,800 FROM EFFORTS TO CREATE SOMETHING 3465 02:16:40,800 --> 02:16:42,680 THAT IS ALREADY BEEN CREATED AND 3466 02:16:42,680 --> 02:16:44,360 IT'S DIFFICULT TO SUSTAIN 3467 02:16:44,360 --> 02:16:54,760 RELATIONSHIPS OVER TIME. 3468 02:16:58,200 --> 02:16:59,800 AND ADDRESS ISSUES GOING 3469 02:16:59,800 --> 02:17:00,400 FORWARD. 3470 02:17:00,400 --> 02:17:02,320 AS I ACKNOWLEDGED AT BEGINNING, 3471 02:17:02,320 --> 02:17:04,360 WE KNOW WE STILL HAVE MORE TO DO 3472 02:17:04,360 --> 02:17:06,240 SO MOST RECENTLY ON MARCH 30th 3473 02:17:06,240 --> 02:17:08,760 AND THE 31st, THE NATIONAL 3474 02:17:08,760 --> 02:17:10,440 INSTITUTE OF HEALTH AND HEALTH 3475 02:17:10,440 --> 02:17:12,160 DISPARITIES HELD A WORKSHOP ON I 3476 02:17:12,160 --> 02:17:13,120 AM CONCLUSIVE PARTICIPATION AND 3477 02:17:13,120 --> 02:17:15,720 RESEARCH AND THIS WAS A VERY 3478 02:17:15,720 --> 02:17:16,920 INTERESTING MEETING AND WE 3479 02:17:16,920 --> 02:17:20,360 TOUCHED ON A LOT OF IMPORTANT 3480 02:17:20,360 --> 02:17:20,920 TOPICS. 3481 02:17:20,920 --> 02:17:22,040 FOR BEFORE AND DURING AND AFTER 3482 02:17:22,040 --> 02:17:25,760 THE STUDY MANY OF WE TALKED 3483 02:17:25,760 --> 02:17:27,360 ABOUT ISSUES SUCH AS 3484 02:17:27,360 --> 02:17:28,360 PARTICIPANTS COP PENNIZATION AND 3485 02:17:28,360 --> 02:17:30,280 HOW WE THINK OF THIS IN TERMS OF 3486 02:17:30,280 --> 02:17:31,920 INCLUSION IN CLINICAL RESEARCH 3487 02:17:31,920 --> 02:17:33,480 AND THE NUMBER OF POPULATIONS 3488 02:17:33,480 --> 02:17:35,840 THAT NEED TO BE CONSIDERED TO 3489 02:17:35,840 --> 02:17:39,520 HAVE TRULY DIVERSE AND INCLUSIVE 3490 02:17:39,520 --> 02:17:41,560 CLINICAL RESEARCH STUDIES THAT 3491 02:17:41,560 --> 02:17:43,200 ARE GENERALIZABLE UP TO THOSE 3492 02:17:43,200 --> 02:17:44,520 WHO CAN BENEFIT FROM THE 3493 02:17:44,520 --> 02:17:46,200 RESEARCH IF YOU DIDN'T HAVE A 3494 02:17:46,200 --> 02:17:47,640 CHANCE TO CATCH THIS MEETING 3495 02:17:47,640 --> 02:17:49,360 IT'S AVAILABLE. 3496 02:17:49,360 --> 02:17:50,920 WE LOOK FORWARD TO THE REPORT 3497 02:17:50,920 --> 02:17:59,280 COMING OUT OF THIS MEETING. 3498 02:17:59,280 --> 02:18:01,280 I WOULD LIKE TO TALK ABOUT OUR 3499 02:18:01,280 --> 02:18:01,560 DATA. 3500 02:18:01,560 --> 02:18:04,880 I HAVE TWO YEARS PRESENTED HERE. 3501 02:18:04,880 --> 02:18:07,440 WE HAVE DATA FROM FISCAL YEAR 3502 02:18:07,440 --> 02:18:09,160 2021 AND 2022. 3503 02:18:09,160 --> 02:18:12,760 I'VE ALSO INCLUDED A JUSTED DATA 3504 02:18:12,760 --> 02:18:15,440 FOR 2022 ON WHICH I'LL. 3505 02:18:15,440 --> 02:18:19,120 IF YOU LOOK AT OUR OVER ALL 3506 02:18:19,120 --> 02:18:20,840 PORTFOLIO, 2021 WE HAD ABOUT 3507 02:18:20,840 --> 02:18:21,520 13 MILLION PARTICIPANTS IN 3508 02:18:21,520 --> 02:18:23,080 CLINICAL RESEARCH AND THE VAST 3509 02:18:23,080 --> 02:18:26,800 MAJORITY IS 77% WERE U.S. 3510 02:18:26,800 --> 02:18:29,520 RESEARCH AND 23% OF RESEARCH 3511 02:18:29,520 --> 02:18:31,680 CONDUCTED OUTSIDE THE U.S. 3512 02:18:31,680 --> 02:18:33,120 WE SEE THIS BIG JUMP WHEN YOU 3513 02:18:33,120 --> 02:18:37,920 LOOK AT 2022 FROM 13 MILLION TO 3514 02:18:37,920 --> 02:18:38,240 97 MILLION. 3515 02:18:38,240 --> 02:18:40,000 THIS IS LARGE SOCIAL MEDIA STUDY 3516 02:18:40,000 --> 02:18:44,760 THAT WE HAD FOCUSED ON COVID-19 3517 02:18:44,760 --> 02:18:53,080 CATEGORIES. 3518 02:18:53,080 --> 02:18:57,560 I'M GOING TO FOCUS ON THE 2022 3519 02:18:57,560 --> 02:18:58,400 ADJUSTED DATA WHICH EXPLAINED 3520 02:18:58,400 --> 02:19:00,800 THAT STUDY ON THE 86 MILLION 3521 02:19:00,800 --> 02:19:01,880 PARTICIPANTS SO WE CAN GET A 3522 02:19:01,880 --> 02:19:06,720 BETTER SENSE OF WHAT THE I AM 3523 02:19:06,720 --> 02:19:08,080 CONCLUSION LOOKS LIKE ACROSS THE 3524 02:19:08,080 --> 02:19:09,560 PORTFOLIO. 3525 02:19:09,560 --> 02:19:11,520 SO WE HAD ABOUT 11 MILLION 3526 02:19:11,520 --> 02:19:13,640 PARTICIPANTS AND 81% OF THOSE 3527 02:19:13,640 --> 02:19:17,400 FROM U.S. STUDIES AND ABOUT 19% 3528 02:19:17,400 --> 02:19:18,840 STUDIES OUTSIDE THE U.S. 3529 02:19:18,840 --> 02:19:24,040 WHEN WE LOOK AT NIH DEFINED 3530 02:19:24,040 --> 02:19:25,360 PHASE 3 CLINICAL TRIALS MUCH 3531 02:19:25,360 --> 02:19:26,680 SMALLER NUMBER OF PAR ANTS. 3532 02:19:26,680 --> 02:19:31,840 WE HAVE IN 2021 AND IT JUMPED UP 3533 02:19:31,840 --> 02:19:36,720 WHEN WE LOOKED AT AT JUSTED DATA 3534 02:19:36,720 --> 02:19:37,960 FROM 2022. 3535 02:19:37,960 --> 02:19:40,320 AGAIN, MOST PARTICIPANTS WE SAW 3536 02:19:40,320 --> 02:19:43,040 AN INCREASE IN U.S. PARTICIPANTS 3537 02:19:43,040 --> 02:19:47,520 FROM 2021 TO 2022 FROM 66% TO 3538 02:19:47,520 --> 02:19:51,280 ABOUT 82% IN 2022 AND WHEN WE 3539 02:19:51,280 --> 02:19:53,640 LOOK AT FOREIGN STUDIES AGAIN WE 3540 02:19:53,640 --> 02:19:56,880 SAW IT WAS A DECREASE FROM ABOUT 3541 02:19:56,880 --> 02:20:00,160 34% OF STUDIES OUTSIDE THE U.S. 3542 02:20:00,160 --> 02:20:05,600 IN 2021 UP TO 19% IN 2022. 3543 02:20:05,600 --> 02:20:12,120 I'D LIKE IT O TO SHOW GENDER AG 3544 02:20:12,120 --> 02:20:13,600 CLINICAL TRIALS AND NON TRIALS. 3545 02:20:13,600 --> 02:20:16,600 WE LOOK AT FISCAL YEAR '21 WE 3546 02:20:16,600 --> 02:20:19,360 CAN SEE ABOUT 39% OF OUR 3547 02:20:19,360 --> 02:20:21,000 PARTICIPANTS ARE MALE AND ABOUT 3548 02:20:21,000 --> 02:20:23,040 59% OF OUR PARTICIPANTS WERE 3549 02:20:23,040 --> 02:20:24,160 FEMALE AND THIS IS BEEN A TREND 3550 02:20:24,160 --> 02:20:26,880 OVER TIME AND WE'VE INTEND TODAY 3551 02:20:26,880 --> 02:20:28,080 SEE FEMALE PARTICIPANTS AND THE 3552 02:20:28,080 --> 02:20:30,480 MALE PARTICIPANTS AND FAIRLY 3553 02:20:30,480 --> 02:20:35,040 ABOUT TWO AND A HALF PERCENT 3554 02:20:35,040 --> 02:20:37,040 IDENTIFIED AS EITHER CATEGORY OR 3555 02:20:37,040 --> 02:20:38,840 UNKNOWN OR NOT RECORDED. 3556 02:20:38,840 --> 02:20:41,560 I'M GOING TO SKIP THE 2022 AND 3557 02:20:41,560 --> 02:20:45,120 DISCUSS TO THE 2022 ADJUSTED AND 3558 02:20:45,120 --> 02:20:46,120 THE TRENDS ARE SIMILAR WHERE 3559 02:20:46,120 --> 02:20:51,320 WHAT IS ADJUSTED ON ABOUT 56% 3560 02:20:51,320 --> 02:20:54,200 ABOUT 45% MALE AND 2.8% UNKNOWN 3561 02:20:54,200 --> 02:20:55,640 ARE NOT RECORDED. 3562 02:20:55,640 --> 02:20:57,520 SO WHEN YOU LOOK AT THESE FREE 3563 02:20:57,520 --> 02:21:00,040 CLINICAL TRIALS WE SEE MORE 3564 02:21:00,040 --> 02:21:01,840 FEMALES IN THE NIH TIME PHRASE 3565 02:21:01,840 --> 02:21:03,200 CLINICAL TRIALS THAN THE NIH 3566 02:21:03,200 --> 02:21:05,200 CLINICAL RESEARCH PORTFOLIO AS A 3567 02:21:05,200 --> 02:21:07,920 WHOLE AND THIS IS A TREND AGAIN 3568 02:21:07,920 --> 02:21:09,000 WHERE WE'VE TENDED TO SEE OVER 3569 02:21:09,000 --> 02:21:09,280 TIME. 3570 02:21:09,280 --> 02:21:11,040 WE HAVE FEMALE ONLY STUDIES AND 3571 02:21:11,040 --> 02:21:13,160 MALE ONLY STUDIES AND IT'S ONE 3572 02:21:13,160 --> 02:21:14,960 REASON WHY WE TENDS TO SEIZE 3573 02:21:14,960 --> 02:21:18,400 THIS SO IT CAN BOTH 2021 AND IN 3574 02:21:18,400 --> 02:21:23,240 2022 A JUSTED UP 61% FEMALES AND 3575 02:21:23,240 --> 02:21:25,400 THEN WE SAW JUST A BIT OF AN 3576 02:21:25,400 --> 02:21:27,400 INCREASE IN THE UNKNOWN THAT ARE 3577 02:21:27,400 --> 02:21:31,040 NOT RECORDED FROM ABOUT 1% IN 3578 02:21:31,040 --> 02:21:37,600 THE NEAR 2021 TO 2004 IN 2022. 3579 02:21:37,600 --> 02:21:39,760 LOOKING AT RACE, AGAIN, I'LL 3580 02:21:39,760 --> 02:21:44,400 FOCUS ON THE 2021 AND THE 2022 3581 02:21:44,400 --> 02:21:45,280 ADJUSTED. 3582 02:21:45,280 --> 02:21:48,160 NO MAJOR JUMPS IN AMERICAN 3583 02:21:48,160 --> 02:21:51,320 INDIAN OR ALASKA NATIVE ADJUSTED 3584 02:21:51,320 --> 02:21:55,440 A BIT TO 1%. 3585 02:21:55,440 --> 02:21:56,880 DECREASE IN EACH PARTICIPANTS 3586 02:21:56,880 --> 02:22:00,200 FROM 5% IN 2021 TO 3.4% SO THIS 3587 02:22:00,200 --> 02:22:03,760 IS AN AREA WE'VE BEEN FOCUSED ON 3588 02:22:03,760 --> 02:22:07,120 LOOKING AT WHY ARE WE SEEING A 3589 02:22:07,120 --> 02:22:08,520 DECREASE IN PARTICIPANTS. 3590 02:22:08,520 --> 02:22:10,640 WE ALSO SEE WHEN WE LOOK AT 3591 02:22:10,640 --> 02:22:12,280 BLACK OR AFRICAN AMERICAN 3592 02:22:12,280 --> 02:22:14,920 PARTICIPATION THAT STUDY AT 3593 02:22:14,920 --> 02:22:16,800 ABOUT 13% AND NATIVE HAWAIIAN OR 3594 02:22:16,800 --> 02:22:19,880 OTHER PACIFIC ISLANDER DECREASED 3595 02:22:19,880 --> 02:22:24,520 .8% IN 2021 TO 3% IN 2033 AND 3596 02:22:24,520 --> 02:22:26,400 WHITE PARTICIPATION INCREASED A 3597 02:22:26,400 --> 02:22:33,800 BIT FROM 64% TO 68%. 3598 02:22:33,800 --> 02:22:36,880 WE HAD ABOUT 2% IN 2021 AND THAT 3599 02:22:36,880 --> 02:22:37,720 INCREASED TO TWO AND A HALF 3600 02:22:37,720 --> 02:22:40,080 PERCENT IN 2022 AND WE DID SEE A 3601 02:22:40,080 --> 02:22:42,880 BIT OF A DECREASE AND UNKNOWN OR 3602 02:22:42,880 --> 02:22:46,600 NOT RECORDED FROM 14% TO 12.2% 3603 02:22:46,600 --> 02:22:51,160 SO IT'S HIGH BUT WE'RE SEEING A 3604 02:22:51,160 --> 02:22:51,720 DECREASE. 3605 02:22:51,720 --> 02:22:54,440 WHEN WE LOOK AT NIH DEFINED 3606 02:22:54,440 --> 02:22:56,920 PHASE 3 CLINICAL TRIAL 3607 02:22:56,920 --> 02:22:58,560 ENROLLMENT, THEY'VE BEEN FAIRLY 3608 02:22:58,560 --> 02:23:00,080 STUDIES AND WE TEND TO SEE MORE 3609 02:23:00,080 --> 02:23:01,560 JOBS BECAUSE THERE ARE FEWER 3610 02:23:01,560 --> 02:23:02,880 STUDIES AND THEY'RE QUITE LARGE 3611 02:23:02,880 --> 02:23:05,120 BUT WE DIDN'T SEE A LOT OF JUMPS 3612 02:23:05,120 --> 02:23:07,960 WHEN WE ADJUSTED IN 2022 DATA 3613 02:23:07,960 --> 02:23:09,600 AND SO I'LL DECREASE AND 3614 02:23:09,600 --> 02:23:14,640 AMERICAN INDIAN OR ALAS ALASKA E 3615 02:23:14,640 --> 02:23:17,400 AND ASIAN PARTICIPANTS SO IT'S 3616 02:23:17,400 --> 02:23:20,920 2.1% IN 2022. 3617 02:23:20,920 --> 02:23:31,400 AND WE ALSO WITH WE LOOK AT 3618 02:23:45,240 --> 02:23:48,440 WHITE IT'S 75% TO 76% IN 2022 3619 02:23:48,440 --> 02:23:50,640 AND A DECREASE IN IDENTIFIED AS 3620 02:23:50,640 --> 02:23:55,080 MORE THAN ONE RACE AND IT'S 4% 3621 02:23:55,080 --> 02:23:57,600 IN 2021 TO 1% IF 2022 AND WE SAW 3622 02:23:57,600 --> 02:24:00,680 AN INCREASE OF UNKNOWN OR NOT 3623 02:24:00,680 --> 02:24:02,320 RECORDED IN THE CLINICAL TRIALS 3624 02:24:02,320 --> 02:24:10,600 WHICH IS NOW ABOVE 8.6% IN 2022. 3625 02:24:10,600 --> 02:24:12,520 MOVING OR NOT TO ETHNICITY WHEN 3626 02:24:12,520 --> 02:24:14,280 WE LOOK AT ENROLLMENT OF 3627 02:24:14,280 --> 02:24:16,080 HISPANIC OR LATINO WE SAW AN 3628 02:24:16,080 --> 02:24:19,200 INCREASE FROM 10.5% TO 2021 TO 3629 02:24:19,200 --> 02:24:22,120 12% IN 2022. 3630 02:24:22,120 --> 02:24:24,400 WE LOOK AT PHASE 3 CLINICAL 3631 02:24:24,400 --> 02:24:25,760 TRIALS THEY JUMPED AROUND QUITE 3632 02:24:25,760 --> 02:24:29,160 A BIT DUE TO ONE LARGE STUDY 3633 02:24:29,160 --> 02:24:31,160 WITH HISPANIC OR LATINO 3634 02:24:31,160 --> 02:24:32,160 PARTICIPANTS THAT ENDED SO WE 3635 02:24:32,160 --> 02:24:35,800 HAD LARGE NUMBER OF HISPANIC 3636 02:24:35,800 --> 02:24:38,480 LATINO PARTICIPANTS ALMOST 40% 3637 02:24:38,480 --> 02:24:40,560 OF 2021 THAT IS A DECREASE TO 3638 02:24:40,560 --> 02:24:42,080 ABOUT 12% WHICH IS MORE TYPICAL 3639 02:24:42,080 --> 02:24:43,600 OF WHAT WE'VE SEEN IN TERMS OF 3640 02:24:43,600 --> 02:24:47,400 ENROLLMENT OF HISPANIC OR 3641 02:24:47,400 --> 02:24:47,920 ENROLLMENT PARTICIPANTS. 3642 02:24:47,920 --> 02:24:49,320 WE HAVE SOME DATA ON AGE FOR 3643 02:24:49,320 --> 02:24:50,640 THOSE STUDIES THAT FALL UNDER 3644 02:24:50,640 --> 02:24:52,200 THE INCLUSION ACROSS THE 3645 02:24:52,200 --> 02:24:54,960 LIFESPAN POLICY AND FOR THE 3646 02:24:54,960 --> 02:24:58,000 FIRST TIME WE GET A SENSE OF 3647 02:24:58,000 --> 02:24:59,760 WHAT OUR PORTFOLIO LOOKS LIKE IN 3648 02:24:59,760 --> 02:25:00,600 TIMS OF AGE. 3649 02:25:00,600 --> 02:25:05,240 WE CAN SEE WE SAW A DECREASE ON 3650 02:25:05,240 --> 02:25:07,520 CHILDREN UNDER THE AGE OF 18 3651 02:25:07,520 --> 02:25:11,720 FROM 20% IN 2021 TO 14% IN 2022. 3652 02:25:11,720 --> 02:25:13,720 THESE ARE STILL EARLY AND IT'S 3653 02:25:13,720 --> 02:25:15,800 ONLY A SNAPSHOT OF DATA SO WE'LL 3654 02:25:15,800 --> 02:25:18,520 SEE THESE TRENDS OVER TIME. 3655 02:25:18,520 --> 02:25:21,480 WE SAW AN INCREASE IN ADULTS 3656 02:25:21,480 --> 02:25:23,400 18-64 AND WE SAW AN INCREASE IN 3657 02:25:23,400 --> 02:25:28,000 OLDER ADULT 0 ABOUT 19% TO 21% 3658 02:25:28,000 --> 02:25:33,520 IN THIS 2022 AND MUCH IT'S LOW 3659 02:25:33,520 --> 02:25:36,160 ABOUT 3% IN 2021 AND TO JUST 3660 02:25:36,160 --> 02:25:40,960 UNDER 5% IN 2022. 3661 02:25:40,960 --> 02:25:42,520 I WOULD LIKE TO MENTION WE HAVE 3662 02:25:42,520 --> 02:25:44,280 A NUMBER OF TRAINING AND 3663 02:25:44,280 --> 02:25:45,720 RESOURCES AVAILABLE ON OUR 3664 02:25:45,720 --> 02:25:48,360 WEBSITE WHICH I LINKED TO HERE. 3665 02:25:48,360 --> 02:25:50,240 WE HAVE PODCASTS ON HOW TO 3666 02:25:50,240 --> 02:25:52,040 DEVELOP INCLUSION PLANS WHICH WE 3667 02:25:52,040 --> 02:25:53,760 PRODUCED AND WE HAVE OTHER 3668 02:25:53,760 --> 02:25:56,920 PODCASTS ABOUT NIH DEFINED 3669 02:25:56,920 --> 02:25:58,000 CLINICAL TRIALS AND I HAVE 3670 02:25:58,000 --> 02:25:59,280 INVESTIGATOR TRAINING WHICH I DO 3671 02:25:59,280 --> 02:26:02,480 EVERY YEAR THAT WE UPDATE FROM 3672 02:26:02,480 --> 02:26:03,960 OUR NIH GRANTS WHICH WE MAKE 3673 02:26:03,960 --> 02:26:05,480 AVAILABLE ON OUR WEBSITE WHICH 3674 02:26:05,480 --> 02:26:08,520 COVERS THESE TOPICS IN MORE 3675 02:26:08,520 --> 02:26:10,320 DEPTH AND WE HAVE INVESTIGATORS 3676 02:26:10,320 --> 02:26:14,560 CAN USE WHICH INCLUDES RESOURCES 3677 02:26:14,560 --> 02:26:16,560 AND TOOLS THAT FOLKS CAN USE AS 3678 02:26:16,560 --> 02:26:21,400 WE THINK ABOUT INCLUSION OF 3679 02:26:21,400 --> 02:26:22,800 VARIOUS GROUPS AND INCLUDE 3680 02:26:22,800 --> 02:26:25,080 INDIVIDUALS IN THE STUDIES. 3681 02:26:25,080 --> 02:26:27,320 SO WITH THAT, WE HAVE TIME, I'M 3682 02:26:27,320 --> 02:26:32,440 HAPPY TO TURN IT OVER TO ANY 3683 02:26:32,440 --> 02:26:37,560 QUESTIONS. 3684 02:26:37,560 --> 02:26:39,920 >>THANK YOU, DAWN. 3685 02:26:39,920 --> 02:26:43,200 THANK YOU Dr. CORBETT. 3686 02:26:43,200 --> 02:26:45,880 I'LL TURN IT TO Dr. CLAYTON TO 3687 02:26:45,880 --> 02:26:47,720 MODERATE A Q&A SESSION IF YOU 3688 02:26:47,720 --> 02:26:52,160 HAVE ANY QUESTIONS FOR Ms. 3689 02:26:52,160 --> 02:26:54,080 CORBETT, OUT ARE CAN UTILIZE THE 3690 02:26:54,080 --> 02:26:54,800 CHAT. 3691 02:26:54,800 --> 02:26:58,400 FEEL FREE TO COME BACK ON 3692 02:26:58,400 --> 02:27:00,000 CAMERA. 3693 02:27:00,000 --> 02:27:01,960 THANK YOU. 3694 02:27:01,960 --> 02:27:03,360 Dr. SIDEMAN. 3695 02:27:03,360 --> 02:27:05,760 >>HI, THIS IS GREAT. 3696 02:27:05,760 --> 02:27:08,240 FIRST, I ASKED IF WE CAN PLEASE 3697 02:27:08,240 --> 02:27:11,440 HAVE A COPY OR SOMEHOW THE 3698 02:27:11,440 --> 02:27:13,240 SLIDES IT WOULD BE VERY HELPFUL 3699 02:27:13,240 --> 02:27:14,880 AND I ALWAYS HAVE A QUESTION 3700 02:27:14,880 --> 02:27:16,960 THAT I'M SORRY IF YOU OF MAY 3701 02:27:16,960 --> 02:27:19,720 HAVE ANSWERED IT OR IT'S BEEN 3702 02:27:19,720 --> 02:27:22,840 DISCUSSED BEFORE BUT WHEN WE 3703 02:27:22,840 --> 02:27:26,000 TALK ABOUT INCLUSION IN FOR 3704 02:27:26,000 --> 02:27:27,920 SECTIONS OF BIOLOGICAL VARIABLE 3705 02:27:27,920 --> 02:27:29,560 OR WOMEN AND WE'RE TALKING ABOUT 3706 02:27:29,560 --> 02:27:35,400 GENERALLERGENDER AND SEX ARE WEG 3707 02:27:35,400 --> 02:27:38,760 ALL-INCLUSIVE? 3708 02:27:38,760 --> 02:27:40,560 IS THAT CLEAR IN HOW WE'RE 3709 02:27:40,560 --> 02:27:42,240 COUNTING AND INCLUDING WITH 3710 02:27:42,240 --> 02:27:45,840 RESPECT TO NIH RESEARCH WHEN 3711 02:27:45,840 --> 02:27:47,760 WE'RE TALKING ABOUT SEX AND THEN 3712 02:27:47,760 --> 02:27:48,280 GENDER? 3713 02:27:48,280 --> 02:27:51,760 HOW ARE WE REALLY 3714 02:27:51,760 --> 02:27:52,520 OPERATIONALIZING THAT CAN 3715 02:27:52,520 --> 02:27:53,800 COUNTING THAT? 3716 02:27:53,800 --> 02:27:56,520 >>I CAN TALK ABOUT THIS FROM 3717 02:27:56,520 --> 02:27:58,040 PERSPECTIVE OF INCLUSION POLICY 3718 02:27:58,040 --> 02:28:00,800 AND I WELCOME MY COLLEAGUES IN 3719 02:28:00,800 --> 02:28:01,320 ORWH. 3720 02:28:01,320 --> 02:28:03,080 IN TERMS OF THE INCLUSION POLICY 3721 02:28:03,080 --> 02:28:05,680 THE MANDATE THAT WE HAVE BY-LAW 3722 02:28:05,680 --> 02:28:08,280 IS THAT WOMEN (INAUDIBLE) AND 3723 02:28:08,280 --> 02:28:10,960 NIH FUNDED FROM THE RESEARCH AND 3724 02:28:10,960 --> 02:28:14,720 THIS WAS CAME OUT OF CONCERNS 3725 02:28:14,720 --> 02:28:15,840 THAT INDIVIDUALS TOUT THEIR 3726 02:28:15,840 --> 02:28:19,000 POTENTIAL WERE BEING 3727 02:28:19,000 --> 02:28:20,680 SYSTEMATICALLY EXCLUDED FROM 3728 02:28:20,680 --> 02:28:22,480 RESEARCH STUDIES, NIH HAVE TAKEN 3729 02:28:22,480 --> 02:28:23,920 A FLEXIBLE POSITION THAT EITHER 3730 02:28:23,920 --> 02:28:25,800 SEX OR GENDER MAY BE CONSIDERED 3731 02:28:25,800 --> 02:28:28,040 FOR THE PURPOSES OF INCLUSION 3732 02:28:28,040 --> 02:28:30,400 INCLUDING WOMEN, DEPENDING ON A 3733 02:28:30,400 --> 02:28:31,280 SCIENTIFIC QUESTION BEING ASKED 3734 02:28:31,280 --> 02:28:37,840 AND WHAT IS MISSED IMPORTANT AND 3735 02:28:37,840 --> 02:28:41,640 FOR THAT QUESTION IF YOU REPORT 3736 02:28:41,640 --> 02:28:45,280 IT SO IT WAS EITHER SEX OR 3737 02:28:45,280 --> 02:28:48,760 GENDER WE ENCOURAGE THEM TO, FOR 3738 02:28:48,760 --> 02:28:52,760 EXAMPLE, PROVIDE A POINT IN TIME 3739 02:28:52,760 --> 02:28:56,920 OVER TIME BUT WE PROVIDE A GREAT 3740 02:28:56,920 --> 02:28:58,320 DEAL OF FLEXIBILITY HOW IT'S 3741 02:28:58,320 --> 02:28:59,160 REPORTED AND WE HAVE CONCERNS 3742 02:28:59,160 --> 02:29:01,440 FROM THE EXTERNAL COMMUNITY AND 3743 02:29:01,440 --> 02:29:03,920 IN TERMS OF IF APPROXIMATE IT'S 3744 02:29:03,920 --> 02:29:05,120 CLEAR INDIVIDUALS WHO ARE 3745 02:29:05,120 --> 02:29:10,200 TRANSGENDER OR NON BINARY 3746 02:29:10,200 --> 02:29:11,480 UNDERSTAND OR ARE INCLUDED IN 3747 02:29:11,480 --> 02:29:12,920 THESE NUMBERS AND IT'S SOMETHING 3748 02:29:12,920 --> 02:29:14,120 THAT WE'RE UNDER DISCUSSION. 3749 02:29:14,120 --> 02:29:16,800 WE WANT TO MAKE SURE THAT PEOPLE 3750 02:29:16,800 --> 02:29:19,800 SEE THEMSELVES IN OUR DATA AND 3751 02:29:19,800 --> 02:29:21,400 THAT WE INCLUDE ALL THE 3752 02:29:21,400 --> 02:29:23,040 INDIVIDUALS THAT NEED TO BE 3753 02:29:23,040 --> 02:29:24,760 INCLUDED BUT THE WAY WE 3754 02:29:24,760 --> 02:29:26,560 CURRENTLY COLLECT THE DATA IS 3755 02:29:26,560 --> 02:29:30,000 REALLY FLEXIBILITY. 3756 02:29:30,000 --> 02:29:32,320 >>SO WHEN WE'RE TALKING ABOUT 3757 02:29:32,320 --> 02:29:34,960 WOMEN, ANYONE WHO HAD 3758 02:29:34,960 --> 02:29:37,920 REPRODUCTIVE CAPACITY OR WILL 3759 02:29:37,920 --> 02:29:38,640 HAVE REPRODUCTIVE CAPACITY AT 3760 02:29:38,640 --> 02:29:40,880 ANY POINT IN THEIR LIFETIME? 3761 02:29:40,880 --> 02:29:51,320 IS THAT KIND OF -- FEMALE 3762 02:29:53,160 --> 02:29:53,600 SEXUALITY BIRTH? 3763 02:29:53,600 --> 02:29:56,560 >>WE DO NOT HAVE THAT FOR THE 3764 02:29:56,560 --> 02:29:57,160 RESEARCH COMMUNITY. 3765 02:29:57,160 --> 02:30:00,160 WE ALLOW INVESTIGATORS TO USE 3766 02:30:00,160 --> 02:30:02,920 SEX OR GENDER AND ORWH HAS 3767 02:30:02,920 --> 02:30:04,320 DEFINITIONS WHICH THEY HAVE ON 3768 02:30:04,320 --> 02:30:06,920 THEIR WEBSITE OF THOSE CONTEXT. 3769 02:30:06,920 --> 02:30:08,080 WE DO RECOGNIZE THERE ARE 3770 02:30:08,080 --> 02:30:09,920 SEVERAL CONTEXT AND WE DON'T 3771 02:30:09,920 --> 02:30:11,560 LIMIT THE INCLUSION OF WOMEN 3772 02:30:11,560 --> 02:30:12,760 CURRENTLY TO SEX FOR THE 3773 02:30:12,760 --> 02:30:15,560 PURPOSES OF I AM CONCLUSION 3774 02:30:15,560 --> 02:30:15,760 POLICY. 3775 02:30:15,760 --> 02:30:24,440 >>THANK YOU. 3776 02:30:24,440 --> 02:30:25,400 >>Janine A. Clayton: SALON 3777 02:30:25,400 --> 02:30:25,640 McGREGOR. 3778 02:30:25,640 --> 02:30:27,040 >>THANK YOU. 3779 02:30:27,040 --> 02:30:30,560 AND IT'S AN EXTENSION OF Dr. 3780 02:30:30,560 --> 02:30:31,280 SIMON'S QUESTION. 3781 02:30:31,280 --> 02:30:33,480 I WAS LOOKING A LOT THE FIGURES 3782 02:30:33,480 --> 02:30:35,520 OF CLINICAL TRIAL ENROLLMENTS 3783 02:30:35,520 --> 02:30:39,920 AND YOU USE THE TERMINOLOGY 3784 02:30:39,920 --> 02:30:42,520 MALES AND FEMALES. 3785 02:30:42,520 --> 02:30:46,600 SO IS THAT AN ASSUMPTION THAT IS 3786 02:30:46,600 --> 02:30:49,000 BEING MADE ON NIH'S PART JUST 3787 02:30:49,000 --> 02:30:51,640 FOR SIMPLICITY? 3788 02:30:51,640 --> 02:30:52,880 AND THEN LIKE WHAT APPROXIMATE 3789 02:30:52,880 --> 02:30:54,440 THE NOT REPORTED? 3790 02:30:54,440 --> 02:30:58,680 HOW DOES THAT GET THROUGH THE 3791 02:30:58,680 --> 02:30:59,040 PROCESS? 3792 02:30:59,040 --> 02:31:01,440 >>SO, WHAT WE KEEP IN MIND IS 3793 02:31:01,440 --> 02:31:04,120 ALL THE DATA WE COLLECT ARE 3794 02:31:04,120 --> 02:31:04,920 (INAUDIBLE). 3795 02:31:04,920 --> 02:31:05,680 INVESTIGATORS CAN USE 3796 02:31:05,680 --> 02:31:07,040 TERMINOLOGY THAT IS APPROPRIATE 3797 02:31:07,040 --> 02:31:08,760 TO THEIR STUDY IN TERMS OF THE 3798 02:31:08,760 --> 02:31:11,040 DATA THAT THEY COLLECT. 3799 02:31:11,040 --> 02:31:14,920 WE DO USE FOR THE REPORTING, WE 3800 02:31:14,920 --> 02:31:16,800 ALSO DO NOT SPECIFY WHETHER THAT 3801 02:31:16,800 --> 02:31:18,360 SEX OR GENDER. 3802 02:31:18,360 --> 02:31:21,760 IT CAN BE EITHER SEX OR GENDER. 3803 02:31:21,760 --> 02:31:23,160 FOR INDIVIDUALS WHO DID NOT 3804 02:31:23,160 --> 02:31:26,360 IDENTIFY AS EITHER MALE OR 3805 02:31:26,360 --> 02:31:28,360 FEMALE, THEY WOULD BE REPORTED 3806 02:31:28,360 --> 02:31:32,920 AND UNKNOWN OR NOT REPORTED. 3807 02:31:32,920 --> 02:31:34,240 AGAIN, WE DON'T DEFINE WHAT 3808 02:31:34,240 --> 02:31:36,440 INVESTIGATORS TO USE TO COLLECT 3809 02:31:36,440 --> 02:31:38,200 DATA FROM PARTICIPANTS, WE ALLOW 3810 02:31:38,200 --> 02:31:40,080 EITHER SEX OR GENDER TO BE 3811 02:31:40,080 --> 02:31:41,640 REPORTED BUT THE TERMINOLOGY WE 3812 02:31:41,640 --> 02:31:43,640 USE DOES INCLUDE THOSE 3813 02:31:43,640 --> 02:31:45,320 CATEGORIES OF MALE, FEMALE OR 3814 02:31:45,320 --> 02:31:52,080 UNKNOWN AND NOT REPORTED. 3815 02:31:52,080 --> 02:31:53,800 >>THANK YOU. 3816 02:31:53,800 --> 02:31:54,680 SO YOU'VE HEARD YOU ARE HEARING 3817 02:31:54,680 --> 02:31:57,720 FROM AN INCLUSION POLICY 3818 02:31:57,720 --> 02:31:59,840 PERSPECTIVE, WHAT'S THE POLICY? 3819 02:31:59,840 --> 02:32:03,040 HOW THE POLICIES ORIGINATE AND 3820 02:32:03,040 --> 02:32:04,240 THEY ORIGINATED WHEN WOMEN WERE 3821 02:32:04,240 --> 02:32:06,440 BEING EXCLUDED SO THERE'S A 3822 02:32:06,440 --> 02:32:08,680 POLICY FOR IN CONCLUSION OF 3823 02:32:08,680 --> 02:32:12,320 WOMEN AND THAT RACIAL AND ETHNIC 3824 02:32:12,320 --> 02:32:14,240 PRIORITY POPULATIONS BUT WE'RE 3825 02:32:14,240 --> 02:32:16,480 ALSO NOW TALKING ABOUT EVOLVING 3826 02:32:16,480 --> 02:32:19,920 CONCEPTS OF BOTH SEX AND GENDER 3827 02:32:19,920 --> 02:32:20,840 AND HOW IMPORTANT THEY ARE 3828 02:32:20,840 --> 02:32:22,520 BECAUSE WE KNOW THAT THEY HAVE 3829 02:32:22,520 --> 02:32:24,960 AN IMPACT ON HEALTH OUTCOMES AND 3830 02:32:24,960 --> 02:32:28,080 CAN BE HIGHLY RELEVANT TO THE 3831 02:32:28,080 --> 02:32:29,040 RESEARCH QUESTIONS UNDER STUDIED 3832 02:32:29,040 --> 02:32:31,960 SO WE HAVE A POLICIES ASPECT BUT 3833 02:32:31,960 --> 02:32:36,520 WE ALSO HAVE A RESEA RESEARCH AT 3834 02:32:36,520 --> 02:32:37,680 BECAUSE WE KNOW KNOW MORE ABOUT 3835 02:32:37,680 --> 02:32:39,640 THESE CONCEPTS AND SO AS A 3836 02:32:39,640 --> 02:32:42,160 RESULT OF THAT, ONE OF THE 3837 02:32:42,160 --> 02:32:44,520 REASONS WHY WE HOSTED EARLIER 3838 02:32:44,520 --> 02:32:46,560 THIS YEAR THE GENDER AND HEALTH 3839 02:32:46,560 --> 02:32:48,480 WORKSHOPS TO START TALKING ABOUT 3840 02:32:48,480 --> 02:32:49,880 HOW THE WAYS THAT -- THE MANY 3841 02:32:49,880 --> 02:32:53,080 WAYS THAT GENDER CAN EFFECT 3842 02:32:53,080 --> 02:32:56,400 HEALTH AND HAVE ALSO EXPANDED 3843 02:32:56,400 --> 02:32:58,520 OUR WEB PAGE WITH 3844 02:32:58,520 --> 02:32:59,440 CONCEPTUALIZATIONS OF THOSE 3845 02:32:59,440 --> 02:33:01,720 CONCEPTS AND SUPPORTING RESEARCH 3846 02:33:01,720 --> 02:33:05,800 ON GENDER MEASUREMENT BECAUSE WE 3847 02:33:05,800 --> 02:33:10,040 NEED ADDITIONAL TOOLS WITH MORE 3848 02:33:10,040 --> 02:33:11,680 RIGOR AND RANGE TO ASCERTAIN 3849 02:33:11,680 --> 02:33:12,880 GENDER BECAUSE ALISON, I THINK 3850 02:33:12,880 --> 02:33:14,920 YOU ASKED EARLIER, OR I CAN'T 3851 02:33:14,920 --> 02:33:16,680 REMEMBER WHO IT WAS, I'M SORRY, 3852 02:33:16,680 --> 02:33:18,560 IF APPROXIMATE YOUR COLLECTING 3853 02:33:18,560 --> 02:33:20,000 SEX YOU IS SHOULD SAY WHAT YOU 3854 02:33:20,000 --> 02:33:21,400 ARE COLLECTING AND HOW YOU 3855 02:33:21,400 --> 02:33:21,920 COLLECT IT. 3856 02:33:21,920 --> 02:33:23,000 WHATEVER YOU ARE DOING, RIGHT. 3857 02:33:23,000 --> 02:33:27,240 THAT'S A METHOD ISSUE RIGHT AND 3858 02:33:27,240 --> 02:33:29,720 SO IT IF YOU DON'T, IT'S VERY 3859 02:33:29,720 --> 02:33:32,600 CHALLENGING TO BE ABLE TO 3860 02:33:32,600 --> 02:33:34,320 UNDERSTAND THE DATA. 3861 02:33:34,320 --> 02:33:36,480 IT LOOKS LIKE -- I'M SOON SURE 3862 02:33:36,480 --> 02:33:37,920 WHOSE HAND WAS UP NEXT. 3863 02:33:37,920 --> 02:33:42,880 WAS IT MELISSA OR JUDY? 3864 02:33:42,880 --> 02:33:46,120 >>OKAY. 3865 02:33:46,120 --> 02:33:46,720 ALL RIGHT. 3866 02:33:46,720 --> 02:33:48,040 >>QUICK COMMENT AND QUESTION 3867 02:33:48,040 --> 02:33:49,840 THAT WAS A VERY IMPORTANT 3868 02:33:49,840 --> 02:33:51,200 SESSION AND I'M ALWAYS GRATEFUL 3869 02:33:51,200 --> 02:33:55,240 TO BE PART OF THE GROUP. 3870 02:33:55,240 --> 02:33:57,040 CURRENTLY TO MY UNDERSTANDING 3871 02:33:57,040 --> 02:33:59,400 AND IT'S NOT COLLECT DATA ON 3872 02:33:59,400 --> 02:34:01,640 GENDER MINORITIES AND FOR 3873 02:34:01,640 --> 02:34:03,800 INSTANCE, WITH THE VIRTUAL 3874 02:34:03,800 --> 02:34:08,640 THERE'S TRANSGENDER AND WITHOUT 3875 02:34:08,640 --> 02:34:12,800 THE DATA THAT WE DO ON OTHER 3876 02:34:12,800 --> 02:34:17,240 MINORTIZIED POPULATIONS SUCH AS 3877 02:34:17,240 --> 02:34:18,920 BLACK, NATIVE AMERICAN, ET 3878 02:34:18,920 --> 02:34:21,240 CETERA, THEN I THINK IT HURTS US 3879 02:34:21,240 --> 02:34:23,880 IN KNOWING THE MAGNITUDE OF 3880 02:34:23,880 --> 02:34:26,280 ISSUES THAT SHOULD BE ADDRESSED 3881 02:34:26,280 --> 02:34:27,720 AND IT'S ALSO A RECOGNITION OF 3882 02:34:27,720 --> 02:34:31,760 THE IMPORTANCE OF BEING FOR 3883 02:34:31,760 --> 02:34:33,920 PEOPLE WHO ARE A GENDER MINORITY 3884 02:34:33,920 --> 02:34:35,880 IN ONE WAY OR ANOTHER. 3885 02:34:35,880 --> 02:34:39,160 IS THERE A THOUGHT TO COLLECT 3886 02:34:39,160 --> 02:34:39,480 THIS DATA? 3887 02:34:39,480 --> 02:34:41,400 >>I THINK WE CERTAINLY 3888 02:34:41,400 --> 02:34:43,160 ACKNOWLEDGE THE IMPORTANCE OF 3889 02:34:43,160 --> 02:34:45,400 COLLECTION OF DATA ON SEXUAL 3890 02:34:45,400 --> 02:34:46,880 GENDER MINORITY POPULATIONS. 3891 02:34:46,880 --> 02:34:48,920 THE QUESTIONS IS, THE METHODS 3892 02:34:48,920 --> 02:34:50,200 FOR COLLECTING AND REPORTING 3893 02:34:50,200 --> 02:34:51,760 THIS DATA AND WHAT IS MOST 3894 02:34:51,760 --> 02:34:53,680 USEFUL FOR THE SCIENTIFIC 3895 02:34:53,680 --> 02:34:55,000 COMMUNITY AND THE DATA THAT I 3896 02:34:55,000 --> 02:34:57,240 SHOWED YOU HERE ARE REALLY TO 3897 02:34:57,240 --> 02:34:58,560 DEMONSTRATE COMPLAINTS WITH OUR 3898 02:34:58,560 --> 02:35:01,080 POLICIES AND SOEL OUR POLICY ON 3899 02:35:01,080 --> 02:35:05,160 I AM CONCLUINCLUSION OF WOMEN AY 3900 02:35:05,160 --> 02:35:06,840 GROUPS ARE CURRENTLY FOUND AS A 3901 02:35:06,840 --> 02:35:08,280 POLICY ON INCLUSION OF SEXUAL 3902 02:35:08,280 --> 02:35:12,440 AND GENDER MINORITY POPULATION 3903 02:35:12,440 --> 02:35:14,400 AND SO YOU COME CLEAR IN TERMS 3904 02:35:14,400 --> 02:35:16,960 OF WHAT MIGHT BE THE BEST METHOD 3905 02:35:16,960 --> 02:35:17,760 OF REPORTING THAT. 3906 02:35:17,760 --> 02:35:20,480 I THINK WHAT WE FOUND OVER THE 3907 02:35:20,480 --> 02:35:25,040 YEARS THERE'S BEEN SOME 3908 02:35:25,040 --> 02:35:26,000 INTERESTING PAPERS AND 3909 02:35:26,000 --> 02:35:27,640 COLLECTING THE DATA AT NIH 3910 02:35:27,640 --> 02:35:28,000 LEVEL. 3911 02:35:28,000 --> 02:35:30,000 IT DOESN'T GET THE DATA INTO 3912 02:35:30,000 --> 02:35:31,880 PUBLICATION AS WE WOULD EXPECT 3913 02:35:31,880 --> 02:35:33,000 AND WHERE THEY CAN BE UNDERSTAND 3914 02:35:33,000 --> 02:35:34,920 OR THEY CAN BE USED IN THE 3915 02:35:34,920 --> 02:35:37,440 CONTEXT OF HEALTH OUTCOMES O I 3916 02:35:37,440 --> 02:35:39,200 THINK IT'S SOMETHING WE NEED TO 3917 02:35:39,200 --> 02:35:41,360 KEEP IN MIND AS WE THINK ABOUT 3918 02:35:41,360 --> 02:35:48,560 WHAT KIND OF INFORMATION IS THE 3919 02:35:48,560 --> 02:35:50,960 MOST USEFUL AND HOW CAN IT BE 3920 02:35:50,960 --> 02:35:52,320 USED IN THE SCIENTIFIC 3921 02:35:52,320 --> 02:35:52,600 COMMUNITY. 3922 02:35:52,600 --> 02:35:54,240 >>AND I THINK I CAN ALSO ADD 3923 02:35:54,240 --> 02:35:56,400 THAT JUDY, YES, WE ARE THINKING 3924 02:35:56,400 --> 02:35:58,560 ABOUT THESE ISSUES AS TO WHERE 3925 02:35:58,560 --> 02:36:00,520 WE NEED TO GO AND WE ARE 3926 02:36:00,520 --> 02:36:02,040 COLLABORATING WITH THE SEXUAL 3927 02:36:02,040 --> 02:36:03,840 GENDER MINORITY RESEARCH OFFICE 3928 02:36:03,840 --> 02:36:07,240 AND WE HAVE SUPPORTED EFFORTS 3929 02:36:07,240 --> 02:36:08,440 INCLUDING FUNDING RESEARCH 3930 02:36:08,440 --> 02:36:12,080 AROUND ASCERTAINING AND GENDER 3931 02:36:12,080 --> 02:36:13,640 IDENTITY AND OTHER MEASURES AND 3932 02:36:13,640 --> 02:36:15,120 WE ARE AWARE OF THE RESENT 3933 02:36:15,120 --> 02:36:18,080 NATIONAL ACADEMIES REPORT ON SEX 3934 02:36:18,080 --> 02:36:19,840 GENDER IDENTITY AND SEXUAL 3935 02:36:19,840 --> 02:36:21,880 ORIENTATION AND THEIR 3936 02:36:21,880 --> 02:36:23,040 RECOMMENDATIONS WHICH WE ARE 3937 02:36:23,040 --> 02:36:26,480 CONSIDERING INTERNALLY TO BEST 3938 02:36:26,480 --> 02:36:28,640 UNDERSTAND WHERE WE CAN GO IT TO 3939 02:36:28,640 --> 02:36:30,720 MOVE THIS SCIENCE FORWARD AND 3940 02:36:30,720 --> 02:36:32,440 ORWH HAS TAKEN A PROACTIVE 3941 02:36:32,440 --> 02:36:34,120 APPROACH AND WE HAVE MADE FUNDS 3942 02:36:34,120 --> 02:36:37,160 AVAILABLE TO SUPPORT RESEARCH TO 3943 02:36:37,160 --> 02:36:40,000 EXPAND THE RIGOR AND 3944 02:36:40,000 --> 02:36:42,960 AVAILABILITY OF VARIOUS TOOLS 3945 02:36:42,960 --> 02:36:44,880 AND INSTRUMENTS TO MEASURE 3946 02:36:44,880 --> 02:36:45,920 GENDER BECAUSE THERE'S NOT A 3947 02:36:45,920 --> 02:36:50,360 SINGLE TOOL THAT IS AGREED UPON 3948 02:36:50,360 --> 02:36:52,600 OR SO THAT IS AN IMPORTANT PIECE 3949 02:36:52,600 --> 02:36:53,800 OF MOVING THIS FIELD FORWARD IS 3950 02:36:53,800 --> 02:36:55,720 GETTING THE TOOLS TO MOVE THE 3951 02:36:55,720 --> 02:36:58,320 FIELD FORWARD AND THEN THERE'S 3952 02:36:58,320 --> 02:37:00,520 ALSO A DIFFERENCE BETWEEN 3953 02:37:00,520 --> 02:37:02,000 COLLECTING DATA ABOUT 3954 02:37:02,000 --> 02:37:02,720 INDIVIDUALS MORE PARTICIPATING 3955 02:37:02,720 --> 02:37:04,600 IN A RESEARCH STUDY VERSUS 3956 02:37:04,600 --> 02:37:06,840 SURVEY OR OTHER TYPES OF DATA 3957 02:37:06,840 --> 02:37:07,920 WORKFORCE RELATED DATA. 3958 02:37:07,920 --> 02:37:09,480 THESE ARE FOR DIFFERENT PURPOSES 3959 02:37:09,480 --> 02:37:11,200 SO WE ALWAYS HAVE TO KEEP IN 3960 02:37:11,200 --> 02:37:12,640 MIND WHY WE'RE COLLECTING THE 3961 02:37:12,640 --> 02:37:15,560 INFORMATION AND AS DOUG SAID, 3962 02:37:15,560 --> 02:37:21,120 IT'S SOMETIMES VERY SURPRISING 3963 02:37:21,120 --> 02:37:22,800 THAT EVEN WITH DATA COLLECTED 3964 02:37:22,800 --> 02:37:24,880 YOU ARE NOT ABLE TO SEE 3965 02:37:24,880 --> 02:37:26,160 INTERPRETATIONS FOR POPULATIONS 3966 02:37:26,160 --> 02:37:28,960 AS WOULD EXPECT AND WE'LL 3967 02:37:28,960 --> 02:37:30,480 HIGHLIGHT FOR THIS GROUP, I 3968 02:37:30,480 --> 02:37:34,400 THINK YOU KNOW THIS VERY WELL, 3969 02:37:34,400 --> 02:37:37,080 THAT FOR SEX FEWER THAN 3970 02:37:37,080 --> 02:37:39,240 ONE-THIRD OF THE PHASE 3 3971 02:37:39,240 --> 02:37:41,440 CLINICAL TRIALS THAT ARE NIH 3972 02:37:41,440 --> 02:37:44,000 DEFINED HAVE ANY SEX SPECIFIC 3973 02:37:44,000 --> 02:37:46,280 RESULTS EVER PUBLISHED IN 3974 02:37:46,280 --> 02:37:47,680 LITERATURE SO WE HAVE ALSO NEED 3975 02:37:47,680 --> 02:37:49,360 TO WORK WITH OUR JOURNAL EDITORS 3976 02:37:49,360 --> 02:37:53,680 AND PUBLISHING COLLEAGUES ABOUT 3977 02:37:53,680 --> 02:37:56,320 THEIR GUIDELINES AND THEIR 3978 02:37:56,320 --> 02:37:57,720 MANUSCRIPT GUIDELINES PROMOTING 3979 02:37:57,720 --> 02:38:00,560 SEX AND GENDER EQUITY AND 3980 02:38:00,560 --> 02:38:02,160 SIDELINES AND BECAUSE THIS IS A 3981 02:38:02,160 --> 02:38:03,560 ECOSYSTEM ISSUE NOT JUST APP NIH 3982 02:38:03,560 --> 02:38:05,480 INCLUSION POLICY ISSUE. 3983 02:38:05,480 --> 02:38:07,640 DOES THAT ANSWER YOUR QUESTION, 3984 02:38:07,640 --> 02:38:07,840 JUDY? 3985 02:38:07,840 --> 02:38:09,240 >>YEAH. 3986 02:38:09,240 --> 02:38:12,320 THANK YOU, DAWN AND JANINE. 3987 02:38:12,320 --> 02:38:13,440 Dr. SIMON. 3988 02:38:13,440 --> 02:38:16,440 >>THANK YOU. 3989 02:38:16,440 --> 02:38:19,280 SO, THE REASON WHY I KEEP ASKING 3990 02:38:19,280 --> 02:38:20,680 THIS QUESTIONS JUST TO PIGGYBACK 3991 02:38:20,680 --> 02:38:22,920 ON WHAT YOU JUST MENTIONED Dr. 3992 02:38:22,920 --> 02:38:27,520 CLAY TOMCLAYTON, I AM NEW FOR WN 3993 02:38:27,520 --> 02:38:30,720 THE DEI AND THE WOMEN'S HEALTH 3994 02:38:30,720 --> 02:38:32,160 STUFF AND THIS IS THE FOREFRONT 3995 02:38:32,160 --> 02:38:33,920 OF MY MIND BECAUSE HOW TO HELP 3996 02:38:33,920 --> 02:38:36,560 SHIFT HOW THINGS ARE REPORTED 3997 02:38:36,560 --> 02:38:38,600 AND REQUIRED FOR REPORTING AND 3998 02:38:38,600 --> 02:38:40,200 THINGS LIKE THAT AND WHAT I 3999 02:38:40,200 --> 02:38:41,680 WORRY ABOUT IS WHEN WE JUST TALK 4000 02:38:41,680 --> 02:38:43,800 ABOUT SEX AS A BIOLOGICAL 4001 02:38:43,800 --> 02:38:44,080 VARIABLE. 4002 02:38:44,080 --> 02:38:48,040 I KNOW IT'S THE TAGLINE, SABB, 4003 02:38:48,040 --> 02:38:50,040 YOU CHAMPIONED THIS AND IT'S 4004 02:38:50,040 --> 02:38:52,440 INGRAINED IN STUDY SECTION AND 4005 02:38:52,440 --> 02:38:53,080 REVIEW, ET CETERA. 4006 02:38:53,080 --> 02:38:56,680 IT'S SEX IS A BIOLOGICAL 4007 02:38:56,680 --> 02:38:58,720 VARIABLE AND GENDER IS A SOCIAL 4008 02:38:58,720 --> 02:39:00,960 CONSTRUCT OR SOCIAL CONSTRUCT 4009 02:39:00,960 --> 02:39:04,680 IMPACTS BIOLOGY AS WELL AS WE 4010 02:39:04,680 --> 02:39:05,240 KNOW. 4011 02:39:05,240 --> 02:39:09,360 SO I'M WONDERING IF THERE COULD 4012 02:39:09,360 --> 02:39:11,960 BE OPPORTUNITIES TO -- WHY WANT 4013 02:39:11,960 --> 02:39:16,240 TO THINK I'M COMMITTING HARASSY 4014 02:39:16,240 --> 02:39:20,200 BUT TO CHANGE THE TAGLINE OR 4015 02:39:20,200 --> 02:39:22,320 MODIFY THE TAGLINE OF SEX IS A 4016 02:39:22,320 --> 02:39:24,680 BIOLOGICAL VARIABLE. 4017 02:39:24,680 --> 02:39:25,640 IT'S LIKE OKAY SEX IS A 4018 02:39:25,640 --> 02:39:26,680 BIOLOGICAL VARIABLE AND WE'RE 4019 02:39:26,680 --> 02:39:28,600 NOT INCLUDING THE WORD GENDER 4020 02:39:28,600 --> 02:39:30,840 AND SOCIAL THINGS AND IDENTITY 4021 02:39:30,840 --> 02:39:35,360 IS IN GENERAL WE'RE JUST KIND OF 4022 02:39:35,360 --> 02:39:37,600 THING THAT YOU CLICK ON THE TAB 4023 02:39:37,600 --> 02:39:39,280 WHEN YOU COMPLETE IT NIH REVIEW 4024 02:39:39,280 --> 02:39:42,920 NEAR THE END ABOUT INCLUSIONS. 4025 02:39:42,920 --> 02:39:44,000 ADEQUATE, RIGHT. 4026 02:39:44,000 --> 02:39:46,600 SO THE WAY REVIEW HAPPENS STILL 4027 02:39:46,600 --> 02:39:49,440 IS NOT REALLY MINDFUL GRANT 4028 02:39:49,440 --> 02:39:51,600 REVIEW AND MANUSCRIPT REVIEW 4029 02:39:51,600 --> 02:39:56,160 IT'S NOT STILL MINDFUL OF 4030 02:39:56,160 --> 02:39:58,080 INCLUDING THINGS LIKE HOW SEX 4031 02:39:58,080 --> 02:40:00,600 AND OTHER EYE DEN FEES GENDER 4032 02:40:00,600 --> 02:40:02,680 INCLUDING RACE ETHNICITY AND 4033 02:40:02,680 --> 02:40:04,920 OTHER IDENTITIES ACTUALLY PLAY 4034 02:40:04,920 --> 02:40:07,520 INTO THE RESEARCH. 4035 02:40:07,520 --> 02:40:09,800 SO I'M WONDERING IF THERE'S AN 4036 02:40:09,800 --> 02:40:10,920 OPPORTUNITY PERHAPS IN -- JUST 4037 02:40:10,920 --> 02:40:13,240 IF YOU THINK ABOUT NIH REVIEW OF 4038 02:40:13,240 --> 02:40:14,960 THAT REVIEW FORM THAT WE ALL 4039 02:40:14,960 --> 02:40:18,440 HAVE TO FILL OUT, FOR ALMOST ALL 4040 02:40:18,440 --> 02:40:23,080 THE REVIEWS, EXCEPT FOR THE 4041 02:40:23,080 --> 02:40:24,200 RESENT COMPASS REVIEWS THERE WAS 4042 02:40:24,200 --> 02:40:25,640 NOTHING THERE FOR SEX OR GENDER 4043 02:40:25,640 --> 02:40:29,880 OR IDENTITIES IS THERE APP 4044 02:40:29,880 --> 02:40:31,680 OPPORTUNITY TO THINK THROUGH HOW 4045 02:40:31,680 --> 02:40:35,280 THAT COULD BE MODIFIED OR BETTER 4046 02:40:35,280 --> 02:40:36,800 INCOMPETENT GREATED INTO GRANT 4047 02:40:36,800 --> 02:40:37,080 REVIEW AT NIH? 4048 02:40:41,000 --> 02:40:43,360 I HOPE IT MAKES SENSE AND IT'S 4049 02:40:43,360 --> 02:40:45,040 LATER HERE AND MY BRAIN MIGHT 4050 02:40:45,040 --> 02:40:46,360 NOT BE FULL BECAUSE I'M IN 4051 02:40:46,360 --> 02:40:46,560 GRACE. 4052 02:40:46,560 --> 02:40:47,920 >>THANK YOU, Dr. SIMON. 4053 02:40:47,920 --> 02:40:51,720 DO YOU WANT TO MAKE COMMENTS 4054 02:40:51,720 --> 02:40:52,040 ABOUT THAT? 4055 02:40:52,040 --> 02:40:54,880 >>I WOULD JUST SAY THAT WE 4056 02:40:54,880 --> 02:40:55,840 APPRECIATE THE FEEDBACK AND I 4057 02:40:55,840 --> 02:40:57,160 THINK THESE ARE ALL THINGS THAT 4058 02:40:57,160 --> 02:41:01,360 NIH IS CAREFULLY CONSIDERING 4059 02:41:01,360 --> 02:41:02,720 WITH ALL OF OUR DATA COLLECTION 4060 02:41:02,720 --> 02:41:04,440 AND WE'RE WORKING ALSO WITH THE 4061 02:41:04,440 --> 02:41:06,640 DEPARTMENT AND MAKING SURE THAT 4062 02:41:06,640 --> 02:41:11,720 WE HAVE CONSISTENCY WITH FEDERAL 4063 02:41:11,720 --> 02:41:12,720 AGENCIES AS WELL. 4064 02:41:12,720 --> 02:41:16,720 >>TO ADD TO THAT, MELISSA, I 4065 02:41:16,720 --> 02:41:17,840 COMPLETELY AGREE THAT OF COURSE 4066 02:41:17,840 --> 02:41:22,000 BOTH SEX AND GENDER AFFECT 4067 02:41:22,000 --> 02:41:22,560 HEALTH. 4068 02:41:22,560 --> 02:41:30,000 THE SABB POLICY WAS SEEKING 4069 02:41:30,000 --> 02:41:32,240 PRIMARILY, BUT NOT ONLY, TO 4070 02:41:32,240 --> 02:41:34,880 ADDRESS NOT SOME OF THE GAPS AND 4071 02:41:34,880 --> 02:41:37,520 KNOWLEDGE IN THE PRECLINICAL 4072 02:41:37,520 --> 02:41:39,680 SPACE BECAUSE SEX WAS NOT BEING 4073 02:41:39,680 --> 02:41:42,080 CONSIDERED AT ALL AND THERE WAS 4074 02:41:42,080 --> 02:41:44,320 A OVER LINE ON MALE ANIMALS AND 4075 02:41:44,320 --> 02:41:45,280 MALE CELLS HOWEVER IT WAS 4076 02:41:45,280 --> 02:41:48,480 CLEARLY STATED IN THE POLICY IT 4077 02:41:48,480 --> 02:41:50,880 DOES A PLAY TO HUMAN STUDIES AND 4078 02:41:50,880 --> 02:41:53,680 THERE WAS A LINK PROVIDED IN THE 4079 02:41:53,680 --> 02:41:56,960 POLICY, THE ORIGINAL POLICY THAT 4080 02:41:56,960 --> 02:41:59,480 WEPT TO A LONGER DOCUMENT THAT 4081 02:41:59,480 --> 02:42:01,800 INCLUDED DESCRIPTION THAT GENDER 4082 02:42:01,800 --> 02:42:03,480 WAS IMPORTANT FOR HUMAN STUDIES 4083 02:42:03,480 --> 02:42:06,440 AND A LOT OF PEOPLE THAT DON'T 4084 02:42:06,440 --> 02:42:17,000 GOAT THAT SECOND DOCUMENT, BUT I 4085 02:42:17,000 --> 02:42:20,080 HEAR YOU AND WE AGREE WITH YOU. 4086 02:42:20,080 --> 02:42:21,400 AS AN APPLICANT IS MAKING THE 4087 02:42:21,400 --> 02:42:22,920 CASE FOR THEIR RESEARCH QUESTION 4088 02:42:22,920 --> 02:42:33,240 UNDER STUDY, WE ARE LOOKING AT 4089 02:42:33,240 --> 02:42:34,640 HOW THESE OTHER ASPECTS SHOULD 4090 02:42:34,640 --> 02:42:35,720 BE CONSIDERED SO WE'RE LOOKING 4091 02:42:35,720 --> 02:42:37,360 TO THE CONTEXT OF THE SCIENCE 4092 02:42:37,360 --> 02:42:39,240 UNDER STUDY BUT I HEAR YOU ABOUT 4093 02:42:39,240 --> 02:42:43,680 RAISING YOUR CONCERNS ABOUT 4094 02:42:43,680 --> 02:42:45,000 ABOUT THE PEER REVIEW PROCESS 4095 02:42:45,000 --> 02:42:46,920 AND CONCERNS ABOUT ADDRESSING 4096 02:42:46,920 --> 02:42:49,640 BOTH SEX AND GENDER. 4097 02:42:49,640 --> 02:42:50,960 >>THIS IS ONE LITTLE BIT I 4098 02:42:50,960 --> 02:42:51,680 APPRECIATE THAT. 4099 02:42:51,680 --> 02:42:54,720 THAT ONE LAST THING IS BECAUSE 4100 02:42:54,720 --> 02:42:56,120 IN STUDY SECTION AND REVIEW IT'S 4101 02:42:56,120 --> 02:43:00,480 CLEAR AMONGST REVIEWERS FOR MY 4102 02:43:00,480 --> 02:43:01,320 SCIENTIFIC EXPERIENCE IT'S MORE 4103 02:43:01,320 --> 02:43:03,680 BEING COUNTING WILL INCLUSIONS 4104 02:43:03,680 --> 02:43:05,200 THAN ABOUT INCORPORATEING AND 4105 02:43:05,200 --> 02:43:06,560 BEING THOUGHTFUL ABOUT THE 4106 02:43:06,560 --> 02:43:09,240 SCIENCE AND HOW THIS RESEARCH 4107 02:43:09,240 --> 02:43:10,440 PROJECT ACTUALLY -- HOW 4108 02:43:10,440 --> 02:43:12,920 DIFFERENT IDENTITIES PLAY OUT 4109 02:43:12,920 --> 02:43:16,000 WITH THE PHENOTYPES OF THE END 4110 02:43:16,000 --> 02:43:16,840 POINTS IN THESE PARTICULAR 4111 02:43:16,840 --> 02:43:20,400 RESEARCH STUDIES. 4112 02:43:20,400 --> 02:43:23,280 THAT'S WHAT I'M TRYING TO 4113 02:43:23,280 --> 02:43:23,640 EXPRESS. 4114 02:43:23,640 --> 02:43:24,800 MORE COUNTING THAN INTEGRATION 4115 02:43:24,800 --> 02:43:25,880 INTO THE SCIENCE AND IF THERE'S 4116 02:43:25,880 --> 02:43:28,520 A WAY TO DO THAT AT THE CSR OR 4117 02:43:28,520 --> 02:43:31,880 AT THAT LEVEL OF THE NIH REVIEW 4118 02:43:31,880 --> 02:43:33,520 FORM, OR REVIEWERS THAT WOULD BE 4119 02:43:33,520 --> 02:43:35,320 HIGHLY IMPACTFUL. 4120 02:43:35,320 --> 02:43:37,640 >>THANK YOU, Dr. SIMON. 4121 02:43:37,640 --> 02:43:39,040 ABSOLUTELY FROM MY PERSPECTIVE 4122 02:43:39,040 --> 02:43:41,560 IT'S CRITICAL TO THE SCIENCE 4123 02:43:41,560 --> 02:43:44,160 BEING CONDUCTED AND SO IT SHOULD 4124 02:43:44,160 --> 02:43:47,240 BE INCORPORATED FOR INTO THE 4125 02:43:47,240 --> 02:43:52,280 ASSESSMENT OF A RIGOR AND 4126 02:43:52,280 --> 02:43:58,760 SUITABILITY OF THE SCIENCE AND I 4127 02:43:58,760 --> 02:44:00,200 HEAR THE IMPACT AND I APPRECIATE 4128 02:44:00,200 --> 02:44:07,880 THE INPUT. 4129 02:44:12,200 --> 02:44:18,200 WE CAN ALSO DO, Dr. NOURSI 4130 02:44:18,200 --> 02:44:22,400 WILDNURSEUNTIL 12:30. 4131 02:44:22,400 --> 02:44:24,040 WE CAN GIVE YOU AN OPPORTUNITY 4132 02:44:24,040 --> 02:44:25,760 TO MAKE MY BRIEF CLOSING REMARKS 4133 02:44:25,760 --> 02:44:29,480 AND WE CAN USE THAT 15 MINUTES 4134 02:44:29,480 --> 02:44:33,600 FOR QUESTIONS FROM THE EARLIER 4135 02:44:33,600 --> 02:44:34,760 REPRESENTATIONS. 4136 02:44:34,760 --> 02:44:35,760 SO DAWN, WOULD YOU LIKE TO GO 4137 02:44:35,760 --> 02:44:37,560 AHEAD AND GIVE CLOSING REMARKS. 4138 02:44:37,560 --> 02:44:38,400 >>SURE. 4139 02:44:38,400 --> 02:44:40,160 THANK YOU. 4140 02:44:40,160 --> 02:44:42,000 SO MUCH SO I REALLY APPRECIATE 4141 02:44:42,000 --> 02:44:44,000 YOUR ATTENTION AND ALL OF THE 4142 02:44:44,000 --> 02:44:48,360 FEEDBACK THAT YOU'VE GIVEN US. 4143 02:44:48,360 --> 02:44:50,240 I WILL SAY THAT WE ARE REALLY 4144 02:44:50,240 --> 02:44:52,040 WORKING TO MAKE SURE THAT 4145 02:44:52,040 --> 02:44:55,600 INCLUSION MEANINGFULLY 4146 02:44:55,600 --> 02:44:57,160 CONSIDERED, MY OFFICE HAS BEEN 4147 02:44:57,160 --> 02:44:59,760 DOING QUITE A LOT TO TRY TO MAKE 4148 02:44:59,760 --> 02:45:02,320 SURE THAT PEOPLE KNOW HOW TO 4149 02:45:02,320 --> 02:45:03,520 DEVELOP INCLUSION PLANS. 4150 02:45:03,520 --> 02:45:05,920 WHAT NEEDS TO BE IN THIS. 4151 02:45:05,920 --> 02:45:07,320 SO THEY ARE THOUGHTFUL AND THEY 4152 02:45:07,320 --> 02:45:08,880 GO BEYOND BEING COUNTING BUT 4153 02:45:08,880 --> 02:45:10,440 THEY ADDRESS MANY OF THE ISSUES 4154 02:45:10,440 --> 02:45:12,800 THAT YOU'VE MENTIONED ON HERE 4155 02:45:12,800 --> 02:45:13,960 TODAY'S AND SO WE CONTINUE TO 4156 02:45:13,960 --> 02:45:17,160 WORK ON THIS AND I APPRECIATE 4157 02:45:17,160 --> 02:45:18,600 YOUR IDEAS THAT YOU'VE BROUGHT 4158 02:45:18,600 --> 02:45:19,640 TO US. 4159 02:45:19,640 --> 02:45:23,360 I HAVE TO MAKE THE SLIDES 4160 02:45:23,360 --> 02:45:24,800 AVAILABLE TO YOU ALL AND THANK 4161 02:45:24,800 --> 02:45:28,240 YOU SO MUCH FOR ALL OF YOUR 4162 02:45:28,240 --> 02:45:29,240 FEEDBACK. 4163 02:45:29,240 --> 02:45:29,840 >>Samia Noursi: THANK YOU SO 4164 02:45:29,840 --> 02:45:30,040 MUCH. 4165 02:45:30,040 --> 02:45:33,080 >>Janine A. Clayton: I WANT TO 4166 02:45:33,080 --> 02:45:34,480 MENTION THAT DAWN DOES AN 4167 02:45:34,480 --> 02:45:36,560 OUTSTANDING JOB AS A INCLUSION 4168 02:45:36,560 --> 02:45:39,320 OFFICER AND SUPPORTS US AT ANY 4169 02:45:39,320 --> 02:45:40,960 WAYS AT THE NIH INCLUSION 4170 02:45:40,960 --> 02:45:47,240 GOVERNANCE COMMITTEE AND Dr. 4171 02:45:47,240 --> 02:45:48,520 NOURSI IS THE SUPERVISOR AND 4172 02:45:48,520 --> 02:45:50,120 PLAYS A CRITICAL ROLE IN ALL THE 4173 02:45:50,120 --> 02:45:51,920 SCIENCE POLICY ACTIVITIES AS 4174 02:45:51,920 --> 02:45:54,360 ASSOCIATE DIRECTOR FOR SCIENCE 4175 02:45:54,360 --> 02:45:55,640 AND POLICIES AND SO I WANT TO 4176 02:45:55,640 --> 02:45:58,480 THANK THEM ALL FOR THEIR SUPPORT 4177 02:45:58,480 --> 02:45:59,680 FOR HAVING THE GREAT DATA. 4178 02:45:59,680 --> 02:46:01,960 THANK YOU, DAWN FOR AN AMAZING 4179 02:46:01,960 --> 02:46:03,040 PRESENTATION. 4180 02:46:03,040 --> 02:46:06,040 MORE DATA THAN WE'VE HAD BEFORE 4181 02:46:06,040 --> 02:46:06,720 AND WE APPRECIATE THAT. 4182 02:46:06,720 --> 02:46:08,280 WITH THAT, I THINK WE CAN TAKE A 4183 02:46:08,280 --> 02:46:12,520 LITTLE BIT OF TIME, IF THERE ARE 4184 02:46:12,520 --> 02:46:14,080 QUESTIONS OR COMMENTS OR 4185 02:46:14,080 --> 02:46:15,920 FEEDBACK WE ALWAYS LIKE TO KNOW 4186 02:46:15,920 --> 02:46:18,200 FROM OUR ADVISORY COMMITTEE 4187 02:46:18,200 --> 02:46:19,840 MEMBERS YOUR THOUGHTS AND GET 4188 02:46:19,840 --> 02:46:22,040 YOUR FEEDBACK ON ORWH EFFORTS 4189 02:46:22,040 --> 02:46:26,640 AND IDEAS AND I SAW A HAPPENED. 4190 02:46:26,640 --> 02:46:28,000 >>THANK YOU Dr. CLAY TOP. 4191 02:46:28,000 --> 02:46:34,240 CLAYTON.YOU SHOWEDS VERY EXCITIA 4192 02:46:34,240 --> 02:46:36,520 REALLY HAPPY TO SEE ALL OF THAT. 4193 02:46:36,520 --> 02:46:38,480 THE DATA ON THE MORTALITY IN THE 4194 02:46:38,480 --> 02:46:40,880 RISE THAT YOU SHOWED IN THE 4195 02:46:40,880 --> 02:46:42,280 BEGINNING OF YOUR TALK ARE 4196 02:46:42,280 --> 02:46:43,040 REALLY CONCERNING. 4197 02:46:43,040 --> 02:46:45,400 WHAT I WANT TODAY ASK YOU, I 4198 02:46:45,400 --> 02:46:46,720 THINK A LOT OF THE RECENT 4199 02:46:46,720 --> 02:46:49,200 INCREASE WE SAW IS ATTRIBUTE 4200 02:46:49,200 --> 02:46:51,000 TODAY COVID-19. 4201 02:46:51,000 --> 02:46:53,000 HAVE YOU SEEN ANY RELIABLE DATA 4202 02:46:53,000 --> 02:46:54,320 FROM OTHER COUNTRY TO SEE WHAT 4203 02:46:54,320 --> 02:46:57,040 THE EVENT OF COVID-19 ON O 4204 02:46:57,040 --> 02:46:59,040 VARIOUS INCIDENTS OF MATERNAL 4205 02:46:59,040 --> 02:47:03,440 MORTALITY MIGHT HAVE BEEN LOWER 4206 02:47:03,440 --> 02:47:06,120 THAN OURS BUT WAS THERE A 30 TO 4207 02:47:06,120 --> 02:47:08,600 35% INCREASE IN WHAT WE SAW 4208 02:47:08,600 --> 02:47:09,160 HERE? 4209 02:47:09,160 --> 02:47:12,280 >>Janine A. Clayton: IT'S A 4210 02:47:12,280 --> 02:47:16,240 GREAT QUESTION. 4211 02:47:16,240 --> 02:47:18,000 >>I WOULD HAVE TO PULL THAT TO 4212 02:47:18,000 --> 02:47:24,200 TAKE A LOOK AT IT ONE OF THE 4213 02:47:24,200 --> 02:47:34,760 THINGS AND IN PARTICULAR, AS YOU 4214 02:47:37,600 --> 02:47:38,400 ARE AWARE. 4215 02:47:38,400 --> 02:47:40,000 RATES OF COVID-19 WERE 4216 02:47:40,000 --> 02:47:41,560 PARTICULARLY HIGH IN SOME 4217 02:47:41,560 --> 02:47:43,760 HISPANIC POPULATIONS AND IN 4218 02:47:43,760 --> 02:47:45,240 INDIVIDUALS IN WOMEN IN 4219 02:47:45,240 --> 02:47:46,080 PARTICULAR. 4220 02:47:46,080 --> 02:47:47,720 AND SO, I'M WONDERING WHETHER 4221 02:47:47,720 --> 02:47:50,600 IT'S A PIECE OF THAT HISPANIC 4222 02:47:50,600 --> 02:47:52,520 INCREASE THOSE NUMBERS OR IS 4223 02:47:52,520 --> 02:48:03,040 THIS JUST EXACERBATING PREGNANCY 4224 02:48:06,960 --> 02:48:08,200 ASSOCIATED COSTS LIKE SUICIDE 4225 02:48:08,200 --> 02:48:09,000 AND HOMICIDE. 4226 02:48:09,000 --> 02:48:11,760 I THINK WE NEED -- IT TELLS ME 4227 02:48:11,760 --> 02:48:13,640 WE NEED TO LOOK AT THIS IN A 4228 02:48:13,640 --> 02:48:16,040 HOLISTIC WAY AND ACCOUNT FOR 4229 02:48:16,040 --> 02:48:17,920 MORE EVERYTHING THAT A PERSON IS 4230 02:48:17,920 --> 02:48:19,440 EXPERIENCING DURING A PREGNANCY 4231 02:48:19,440 --> 02:48:21,360 AND AFTER AND BEFORE THE 4232 02:48:21,360 --> 02:48:23,040 PREGNANCY FOR THAT MATTER. 4233 02:48:23,040 --> 02:48:25,520 BUT I DON'T HAVE A DATA POINT TO 4234 02:48:25,520 --> 02:48:28,200 GIVE YOU ON THAT. 4235 02:48:28,200 --> 02:48:30,320 I APPRECIATE YOUR INSIGHTS THAT 4236 02:48:30,320 --> 02:48:33,680 LOOKING AT THAT MIGHT GIVE US 4237 02:48:33,680 --> 02:48:35,080 SOME MORE CLOSE WHERE WE FOCUS 4238 02:48:35,080 --> 02:48:37,120 ON IN THE UNITED STATES AND WHAT 4239 02:48:37,120 --> 02:48:41,840 WAS NOTABLE HOWEVER, WAS THE 4240 02:48:41,840 --> 02:48:43,520 REDUCTION IN THE MATERNAL 4241 02:48:43,520 --> 02:48:45,840 MORTALITY SEEN IN EASTERN YOU'RE 4242 02:48:45,840 --> 02:48:47,320 NOT. 4243 02:48:47,320 --> 02:48:49,080 AT FIRST PART ON THE LEFT, I HAD 4244 02:48:49,080 --> 02:48:50,760 TO ABOUT BACK TO THE DATA AND 4245 02:48:50,760 --> 02:48:51,680 SAY IS THIS CORRECT. 4246 02:48:51,680 --> 02:48:52,360 WAIT. 4247 02:48:52,360 --> 02:48:54,280 AND I WENT BACK TO THE DATA AND 4248 02:48:54,280 --> 02:49:04,840 IT'S ABSOLUTELY CORRECT BECAUSE 4249 02:49:06,840 --> 02:49:09,320 THIS IS AN AREA THAT'S BEEN 4250 02:49:09,320 --> 02:49:15,800 RECOGNIZED BY THE ADMINISTRATION 4251 02:49:15,800 --> 02:49:25,880 ASS. 4252 02:49:30,200 --> 02:49:32,560 >>THANK YOU, AGAIN. 4253 02:49:32,560 --> 02:49:37,080 I FEEL SO FORTUNATE TO BE PART 4254 02:49:37,080 --> 02:49:38,760 OF THIS GROUP AND PROVIDE INPUT 4255 02:49:38,760 --> 02:49:40,080 AND THIS DOES TALK ABOUT 4256 02:49:40,080 --> 02:49:41,400 SOMETHING THAT YOU SPOKE OF 4257 02:49:41,400 --> 02:49:43,880 Dr. CLAYTON WAS THE NEW OFFICE 4258 02:49:43,880 --> 02:49:46,160 FOR AUTOIMMUNE DISEASE RESEARCH 4259 02:49:46,160 --> 02:49:48,040 AND AS YOU WERE DESCRIBING THAT 4260 02:49:48,040 --> 02:49:49,720 I THOUGHT, THAT IS INCREDIBLE 4261 02:49:49,720 --> 02:49:51,760 BECAUSE THAT'S A HUGE AREA THAT 4262 02:49:51,760 --> 02:49:54,840 WE KNOW VERY LITTLE ABOUT. 4263 02:49:54,840 --> 02:49:56,720 IT AFFECTS WOMEN IN PARTICULAR. 4264 02:49:56,720 --> 02:50:06,520 IT STARTED MAKING ME THINK ABO 4265 02:50:06,520 --> 02:50:07,760 ABOUT, WE SILO A LOT OF THESE 4266 02:50:07,760 --> 02:50:10,760 CONDITIONS THAT IMPACT WOMEN AND 4267 02:50:10,760 --> 02:50:13,520 MORE SO THAN MEN AND WITHOUT 4268 02:50:13,520 --> 02:50:14,720 HAVING SORT OF THE COLLECTIONS 4269 02:50:14,720 --> 02:50:21,200 THAT THE INTEGRATION COMES. 4270 02:50:21,200 --> 02:50:22,760 MORE WOMEN UTILIZE THE EMERGENCY 4271 02:50:22,760 --> 02:50:23,680 DEPARTMENT AND IT WAS JUST PART 4272 02:50:23,680 --> 02:50:26,280 OF A STUDY WE PUBLISHED WHEN WE 4273 02:50:26,280 --> 02:50:28,800 LOOKED AT THE TIMING THAT A 4274 02:50:28,800 --> 02:50:29,840 PATIENT GOES THROUGH FROM START 4275 02:50:29,840 --> 02:50:34,000 TO FINISH AND WOMEN WAIT LONGER 4276 02:50:34,000 --> 02:50:36,120 AND IT'S LONGER TO BE DIAGNOSED 4277 02:50:36,120 --> 02:50:39,200 AND TO HAVE THE TEST ORDERS AND 4278 02:50:39,200 --> 02:50:41,320 THROUGHOUT THE WHOLE PROCESS AND 4279 02:50:41,320 --> 02:50:44,640 SO, I'M WONDERING IF IF THE 4280 02:50:44,640 --> 02:50:50,000 OFFICE COULD LOOK AT ACUTE CARE 4281 02:50:50,000 --> 02:50:51,560 PRESENTATIONS OR AN INCOMPETENT 4282 02:50:51,560 --> 02:50:53,280 GREATED PROCESS WHERE WE CAN 4283 02:50:53,280 --> 02:50:55,760 IDENTIFY THESE CONDITIONS FOR 4284 02:50:55,760 --> 02:50:58,360 WOMEN AND AT THE BREAK OF WHEN 4285 02:50:58,360 --> 02:51:05,800 THEY ARE MOST VULNERABLE MANY 4286 02:51:05,800 --> 02:51:05,960 OF. 4287 02:51:05,960 --> 02:51:08,280 >>YOU ARE ABSOLUTELY RIGHT THE 4288 02:51:08,280 --> 02:51:15,080 FRAGMENTATION OF CARE IS 4289 02:51:15,080 --> 02:51:16,120 IMPORTANT FOR WOMEN'S HEALTH AND 4290 02:51:16,120 --> 02:51:18,320 IT'S CLEAR ABOUT THE DELAY OF 4291 02:51:18,320 --> 02:51:22,520 DIAGNOSIS AND TYPE OF TREATMENT 4292 02:51:22,520 --> 02:51:24,160 AND THIS WELL DOCUMENTED THAT 4293 02:51:24,160 --> 02:51:26,240 THERE ARE DIFFERENCES AND 4294 02:51:26,240 --> 02:51:27,800 HEALTHCARE DELIVERY. 4295 02:51:27,800 --> 02:51:29,080 SO, THOSE ARE KINDS OF STUDIES 4296 02:51:29,080 --> 02:51:30,480 THAT ARE ALSO IMPORTANT FOR US 4297 02:51:30,480 --> 02:51:35,440 TO BE ABLE TO SUPPORT AUTOIMMUNE 4298 02:51:35,440 --> 02:51:36,000 DISEASES. 4299 02:51:36,000 --> 02:51:37,640 THEY'RE A SET OF DISEASES THAT 4300 02:51:37,640 --> 02:51:39,200 ARE VERY IMPORTANT FOR WOMEN'S 4301 02:51:39,200 --> 02:51:40,960 HEALTH AND THERE ARE OTHER 4302 02:51:40,960 --> 02:51:42,640 DISEASES THAT ARE ALSO IMPORTANT 4303 02:51:42,640 --> 02:51:46,200 FOR WOMEN'S HEALTH AND WE TAKE A 4304 02:51:46,200 --> 02:51:46,680 HEAD-TO-TOE APPROACH. 4305 02:51:46,680 --> 02:51:48,320 EVERYTHING THAT AFFECTS A WOMAN 4306 02:51:48,320 --> 02:51:49,720 HEAD-TO-TOE SO WE NEED TO WORK 4307 02:51:49,720 --> 02:51:51,520 MORE CLOSELY WITH THE INSTITUTES 4308 02:51:51,520 --> 02:51:53,880 AND CENTERS TO BE ABLE TO BRING 4309 02:51:53,880 --> 02:51:55,760 THEIR RESOURCES TO BEAR ON THESE 4310 02:51:55,760 --> 02:52:00,600 PROBLEMS BUT FOR ACUTE CARE AND 4311 02:52:00,600 --> 02:52:02,120 EMERGENCY MEDICINE, I'M TRYING 4312 02:52:02,120 --> 02:52:03,600 TO THINK OF WHICH INSTITUTES IT 4313 02:52:03,600 --> 02:52:04,920 FALLS UNDER AND ALISON I'M 4314 02:52:04,920 --> 02:52:05,840 HAVING TROUBLE BECAUSE THERE'S 4315 02:52:05,840 --> 02:52:14,120 AN OFFICE OF EMERGE EMERGENCY -A 4316 02:52:14,120 --> 02:52:15,560 AND EMERGENCY WHICH I THOUGHT 4317 02:52:15,560 --> 02:52:17,800 WAS IN THE NIGMS AND YOU KNOWING 4318 02:52:17,800 --> 02:52:20,320 I'M NOT SURE WHERE THAT IS AND 4319 02:52:20,320 --> 02:52:22,240 SO THAT MEANS YOU HAVE GIVEN ME 4320 02:52:22,240 --> 02:52:24,480 SOMETHING TO TAKE BACK TO MY 4321 02:52:24,480 --> 02:52:26,160 COLLEAGUES HERE TO FIND WHO 4322 02:52:26,160 --> 02:52:27,960 WOULD BE THE FOLKS THAT WE 4323 02:52:27,960 --> 02:52:30,080 SHOULD TALK TO ABOUT BRINGING A 4324 02:52:30,080 --> 02:52:32,320 SEX AND GENDER PERSPECTIVE AND A 4325 02:52:32,320 --> 02:52:34,080 WOMEN'S HEALTH PERSPECTIVE TO 4326 02:52:34,080 --> 02:52:36,960 THAT WORK, DID I INTERPRET THAT 4327 02:52:36,960 --> 02:52:37,200 CORRECTLY? 4328 02:52:37,200 --> 02:52:38,320 BRINGING THAT PERSPECTIVE TO THE 4329 02:52:38,320 --> 02:52:39,560 WORK IS THERE AN OPPORTUNITY TO 4330 02:52:39,560 --> 02:52:41,000 BRING THAT PERSPECTIVE TO THAT 4331 02:52:41,000 --> 02:52:45,760 WORK FROM A RESEARCH VANTAGE 4332 02:52:45,760 --> 02:52:45,960 POINT. 4333 02:52:45,960 --> 02:52:48,320 >>EXACTLY. 4334 02:52:48,320 --> 02:52:50,320 >>I WILL WORK ON THAT. 4335 02:52:50,320 --> 02:52:51,600 I DON'T HAVE AN ANSWER FOR YOU 4336 02:52:51,600 --> 02:52:54,120 RIGHT NOW AND WE WILL GET BACK 4337 02:52:54,120 --> 02:52:54,880 TO YOU. 4338 02:52:54,880 --> 02:52:57,720 Dr. JONES. 4339 02:52:57,720 --> 02:52:59,720 >>THANK YOU FOR A REALLY 4340 02:52:59,720 --> 02:53:02,200 EXCITING PRESENTATION THIS 4341 02:53:02,200 --> 02:53:03,760 MORNING AND IT'S ALWAYS PACKED 4342 02:53:03,760 --> 02:53:05,120 WITH SO MUCH INFORMATION AND I 4343 02:53:05,120 --> 02:53:08,760 WANT TO GO BACK TO THE MATERNAL 4344 02:53:08,760 --> 02:53:10,280 MORTALITY DATA AT THE END AND 4345 02:53:10,280 --> 02:53:11,880 LOOKING AT THE COVID-19 PANDEMIC 4346 02:53:11,880 --> 02:53:14,400 AND WONDERING HOW MUCH OF THAT 4347 02:53:14,400 --> 02:53:19,080 DATA IS SORT OF MOVED ALSO IS 4348 02:53:19,080 --> 02:53:22,160 RELATED TO OPIOID OR OTHER DRUG 4349 02:53:22,160 --> 02:53:24,880 OVERDOSE AS WELL AS SUICIDES AND 4350 02:53:24,880 --> 02:53:26,720 ALSO LOOKED AT ITEL THROUGH A 4351 02:53:26,720 --> 02:53:29,840 LENS OF GENDER AND ETHNICITY. 4352 02:53:29,840 --> 02:53:35,360 -- RACE AND ETHNICITY. 4353 02:53:35,360 --> 02:53:41,920 >>Janine A. Clayton: THAT IS 4354 02:53:41,920 --> 02:53:43,960 CDC DATA AND IT'S TOM A AND 4355 02:53:43,960 --> 02:53:45,880 CLERK AND I HAVE NOT EXAMINED 4356 02:53:45,880 --> 02:53:47,440 THAT DATA IN THAT WAY. 4357 02:53:47,440 --> 02:53:50,080 I WILL PUT THE LINK IN THE CHAT 4358 02:53:50,080 --> 02:53:53,840 IN A FEW MINUTES O TH SO THAT YN 4359 02:53:53,840 --> 02:53:54,560 LOOK AT THAT DATA. 4360 02:53:54,560 --> 02:53:57,040 YOUR POINT ABOUT SUBSTANCE USE 4361 02:53:57,040 --> 02:54:00,680 AND OVERDOSE REALLY VERY WELL 4362 02:54:00,680 --> 02:54:02,440 TAKEN AND WE ARE KEENLY AWARE OF 4363 02:54:02,440 --> 02:54:06,480 THE VERY DISTURBING RATES FOR 4364 02:54:06,480 --> 02:54:08,080 PREGNANT AND POSTPARTUM PEOPLE 4365 02:54:08,080 --> 02:54:12,520 AND IT'S A CRITICAL ASPECT OF 4366 02:54:12,520 --> 02:54:13,720 MATERNAL HEALTH AND WE NEED TO 4367 02:54:13,720 --> 02:54:17,720 MAKE SURE WE INCORPORATE IN FACT 4368 02:54:17,720 --> 02:54:20,480 THOSE ISSUES WERE PART MENTAL 4369 02:54:20,480 --> 02:54:21,240 HEALTH IN HEALTH WAS PRIORITIZED 4370 02:54:21,240 --> 02:54:25,800 IN THE SECOND YEAR OF 4371 02:54:25,800 --> 02:54:28,560 IMPROVEMENT INITIATIVE AND MOST 4372 02:54:28,560 --> 02:54:31,000 SALIENT GOING FORWARD AS 4373 02:54:31,000 --> 02:54:32,760 COVID-19 AND THE CONSEQUENCES, 4374 02:54:32,760 --> 02:54:38,640 HEALTH CONSEQUENCES OF RACIAL 4375 02:54:38,640 --> 02:54:47,000 DISCRIMINATION. 4376 02:54:47,000 --> 02:54:50,280 I DON'T HAVE THAT DATA TOP OF 4377 02:54:50,280 --> 02:54:51,360 MIND BUT I'M GOING TO SHARE THE 4378 02:54:51,360 --> 02:54:53,160 LINK TO THE CDC DATA AND THE 4379 02:54:53,160 --> 02:54:55,480 PAPER IN THE CHAT FOR THE GROUP. 4380 02:54:55,480 --> 02:54:56,880 >>THANK YOU. 4381 02:54:56,880 --> 02:55:00,680 >>THANK YOU FOR THOSE 4382 02:55:00,680 --> 02:55:01,280 QUESTIONS. 4383 02:55:01,280 --> 02:55:04,200 Dr. TEMPLETON. 4384 02:55:04,200 --> 02:55:05,920 >>GREAT WORK AND AMAZING 4385 02:55:05,920 --> 02:55:07,000 PRESENTATIONS TODAY. 4386 02:55:07,000 --> 02:55:08,320 THE QUESTION I HAD WAS EARLIER 4387 02:55:08,320 --> 02:55:11,040 TALKING ABOUT THE VIOLENCE 4388 02:55:11,040 --> 02:55:13,960 AGAINST WOMEN RESEARCH. 4389 02:55:13,960 --> 02:55:16,280 IS THERE GOING TO BE EMPHASIS OR 4390 02:55:16,280 --> 02:55:17,760 CARVE OUT REGARDING VIOLENCE 4391 02:55:17,760 --> 02:55:19,200 AGAINST WOMEN IN STEM? 4392 02:55:19,200 --> 02:55:21,360 BECAUSE AS WE KNOW I THINK ONE 4393 02:55:21,360 --> 02:55:22,640 IT'S AN ISSUE THAT KEEPS WOMEN 4394 02:55:22,640 --> 02:55:25,000 OUT OF STEM BECAUSE IT IMPACTS 4395 02:55:25,000 --> 02:55:26,960 THE CULTURE THAT WOMEN DON'T 4396 02:55:26,960 --> 02:55:28,480 WANT TO ENTER. 4397 02:55:28,480 --> 02:55:29,800 WOMEN PHYSICIANS IN PARTICULAR I 4398 02:55:29,800 --> 02:55:32,760 THINK IT'S SOMETHING THAT ISN'T 4399 02:55:32,760 --> 02:55:34,160 RECORDED BECAUSE WE'RE 4400 02:55:34,160 --> 02:55:35,680 EMBARRASSED WHILE SERVICE IS 4401 02:55:35,680 --> 02:55:37,840 SUPPORT FOR WOMEN IN STEM IN 4402 02:55:37,840 --> 02:55:38,760 GENERAL AND NEGATIVE CAREER 4403 02:55:38,760 --> 02:55:41,040 AGENTS IF YOU DO REPORT IT BUT 4404 02:55:41,040 --> 02:55:42,920 MAYBE IF THERE'S FOCUSED OR 4405 02:55:42,920 --> 02:55:44,520 TARGETED RESEARCH ON THAT THAT 4406 02:55:44,520 --> 02:55:46,560 MIGHT HELP REDUCE SOME OF THE 4407 02:55:46,560 --> 02:55:47,960 STIGMA THAT MAY BE GET PEOPLE 4408 02:55:47,960 --> 02:55:50,240 TALKING ABOUT THIS AND FIGURING 4409 02:55:50,240 --> 02:55:52,000 OUT HOW WE ADDRESS VIOLENCE 4410 02:55:52,000 --> 02:55:54,400 AGAIN WOMEN AND ALL AREAS OF 4411 02:55:54,400 --> 02:55:54,600 STEM. 4412 02:55:54,600 --> 02:55:58,440 >>THANK YOU FOR THAT COMMENT. 4413 02:55:58,440 --> 02:56:01,040 THE DATA ON HARASSMENT AND 4414 02:56:01,040 --> 02:56:02,720 SEXUAL HARASSMENT OF WOMEN AND 4415 02:56:02,720 --> 02:56:05,680 STEM IS VERY DISTURBING AND IT 4416 02:56:05,680 --> 02:56:06,960 IT DIDN'T SHOW THE DATA TODAY 4417 02:56:06,960 --> 02:56:09,280 AND I'VE SHOWN IT BEFORE THAT WE 4418 02:56:09,280 --> 02:56:13,160 SEE VERY HIGH RATES AND LIFE 4419 02:56:13,160 --> 02:56:16,000 SCIENCES DEGREE GRANTING 4420 02:56:16,000 --> 02:56:17,160 ORGANIZATIONS AND IN STEM IN 4421 02:56:17,160 --> 02:56:19,080 GENERAL MEDICAL STUDENTS HAVE A 4422 02:56:19,080 --> 02:56:20,920 MUCH HIGHER RATE THAN IN OTHER 4423 02:56:20,920 --> 02:56:23,480 GRADUATE PROGRAMS AND THAT ARE 4424 02:56:23,480 --> 02:56:26,360 ARE NOT STEM CREE LATED SO IT IT 4425 02:56:26,360 --> 02:56:27,040 IS AN AREA OF SIGNIFICANT 4426 02:56:27,040 --> 02:56:27,560 CONCERNS. 4427 02:56:27,560 --> 02:56:30,040 YOU MAY RECALL THE NIH DIRECTOR 4428 02:56:30,040 --> 02:56:32,040 HAD AN ADVISORY COMMITTEE TO THE 4429 02:56:32,040 --> 02:56:33,160 DIRECTOR WORKING GROUP FOCUSED 4430 02:56:33,160 --> 02:56:37,440 ON ADDRESSING THE CU CULTURE TOD 4431 02:56:37,440 --> 02:56:38,440 SEXUAL HARASSMENT AND I WAS PART 4432 02:56:38,440 --> 02:56:39,960 OF THE WORKING GROUP AND ONE OF 4433 02:56:39,960 --> 02:56:41,280 THE RECOMMENDATION 0 THAT 4434 02:56:41,280 --> 02:56:42,640 WORKING GROUP, ALL OF WHICH WERE 4435 02:56:42,640 --> 02:56:44,160 ACCEPTED BY THE NIH DIRECTOR 4436 02:56:44,160 --> 02:56:46,320 FRANCIS COLLINS AND HAVE BEEN 4437 02:56:46,320 --> 02:56:47,960 PUT INTO PRACTICE SOME OF WHICH 4438 02:56:47,960 --> 02:56:49,280 HAVE BEEN PUT INTO PRACTICE 4439 02:56:49,280 --> 02:56:51,040 GOING FORWARD ONE OF THEM LOST 4440 02:56:51,040 --> 02:56:53,320 FUND RESEARCH ON INTERVENTIONS 4441 02:56:53,320 --> 02:56:57,760 AND RELATED TO SEXUAL HARASSMENT 4442 02:56:57,760 --> 02:56:59,440 INCORPORATING GENDER HARASSMENT 4443 02:56:59,440 --> 02:57:02,760 AND SO SEXUAL APPROPRIATE GENDER 4444 02:57:02,760 --> 02:57:06,520 HARASSMENT IN STEM AND NIGMS HAS 4445 02:57:06,520 --> 02:57:08,920 A FUNDING OPPORTUNITY 4446 02:57:08,920 --> 02:57:11,040 ANNOUNCEMENT ON INTERVENTION TO 4447 02:57:11,040 --> 02:57:13,280 ADDRESS SCIENTIFIC WORKFORCE 4448 02:57:13,280 --> 02:57:14,880 ISSUES AND THEY ISSUED A NOTICE 4449 02:57:14,880 --> 02:57:17,800 OF SPECIAL INTEREST TO THAT 4450 02:57:17,800 --> 02:57:19,440 FUNDING OPPORTUNITY SPECIFICALLY 4451 02:57:19,440 --> 02:57:20,840 FOCUSED ON RESEARCH TO ADDRESS 4452 02:57:20,840 --> 02:57:23,000 SEXUAL HARASSMENT AND I AM 4453 02:57:23,000 --> 02:57:25,040 PLEASED TO SHARE WITH YOU THAT 4454 02:57:25,040 --> 02:57:28,240 THERE WERE TWO APPLICATIONS THAT 4455 02:57:28,240 --> 02:57:31,760 WERE FUNDED LAST YEAR ON FOR 4456 02:57:31,760 --> 02:57:33,640 THAT PURPOSE AND WE WILL ALSO 4457 02:57:33,640 --> 02:57:35,640 PROVIDE THE LINK TO THAT FUNDING 4458 02:57:35,640 --> 02:57:40,520 OPPORTUNITY IN THE CHATEAU THATU 4459 02:57:40,520 --> 02:57:42,080 CAN GET THE WORD OUT IN THE 4460 02:57:42,080 --> 02:57:45,160 OPPORTUNITIES AND IN THE FOCUS 4461 02:57:45,160 --> 02:57:47,280 QUARTERLY WE FEATURE THESE TWO 4462 02:57:47,280 --> 02:57:51,600 INVESTIGATORS WHO RECEIVED THOSE 4463 02:57:51,600 --> 02:57:52,000 GRANTS. 4464 02:57:52,000 --> 02:57:54,280 Dr. STOCKDALE AND SALAS SO YOU 4465 02:57:54,280 --> 02:57:56,040 CAN LEARN ABOUT THEM AND THEIR 4466 02:57:56,040 --> 02:57:57,720 RESEARCH IN OUR IN FOCUS BECAUSE 4467 02:57:57,720 --> 02:57:59,000 WE SPOT HEIGHTED THEM TO TELL 4468 02:57:59,000 --> 02:58:00,840 MORE ABOUT THE RESEARCH THAT 4469 02:58:00,840 --> 02:58:02,360 THEY'RE DOING TO TEST 4470 02:58:02,360 --> 02:58:04,320 INTERVENTION THAT'S COULD BE 4471 02:58:04,320 --> 02:58:05,440 DEPLOYED ELSEWHERE SO THAT WE 4472 02:58:05,440 --> 02:58:08,120 CAN RAMP THEM UP. 4473 02:58:08,120 --> 02:58:12,720 AND SO, Dr. TEMPLETON WHAT IS 4474 02:58:12,720 --> 02:58:15,000 HELPFUL TO GET THE WORT OUT 4475 02:58:15,000 --> 02:58:17,400 ABOUT THE RESEARCH BECAUSE IF IT 4476 02:58:17,400 --> 02:58:18,520 WAS KNOWN THERE WAS RESEARCH ON 4477 02:58:18,520 --> 02:58:21,080 GOING OR INTERVENTION THAT'S 4478 02:58:21,080 --> 02:58:22,720 HAVE BEEN SHOWN TO BE EFFECTIVE 4479 02:58:22,720 --> 02:58:24,040 IN THIS REGARD IT COULD EFFECT 4480 02:58:24,040 --> 02:58:27,280 THE CULTURE TO SUPPORT PROGRESS. 4481 02:58:27,280 --> 02:58:31,160 WE WILL PROVIDE THAT INFORMATION 4482 02:58:31,160 --> 02:58:32,360 TO YOU ALSO. 4483 02:58:32,360 --> 02:58:40,520 >>THA THANK YOU SO MUCH. 4484 02:58:40,520 --> 02:58:44,360 > WE'LL TAKE 4485 02:58:44,360 --> 02:58:47,640 THE LAST QUESTION BEFORE THE 4486 02:58:47,640 --> 02:58:48,040 BREAK. 4487 02:58:48,040 --> 02:58:50,040 >>THANK YOU THIS IS A QUICK 4488 02:58:50,040 --> 02:58:52,360 QUESTION COMMENT AND IT WAS 4489 02:58:52,360 --> 02:58:54,840 ABOUT THE AUTOIMMUNE DISEASE 4490 02:58:54,840 --> 02:58:56,560 RESEARCH WHICH IS VERY EXCITING 4491 02:58:56,560 --> 02:58:58,960 AND I'M A DENTIST AND MANY TIMES 4492 02:58:58,960 --> 02:59:00,280 PEOPLE DON'T THINK ABOUT THE 4493 02:59:00,280 --> 02:59:02,160 IMPACT ON ORAL HEALTHCARE AND I 4494 02:59:02,160 --> 02:59:06,080 WAS REALLY GLAD TO SEE THAT 4495 02:59:06,080 --> 02:59:08,280 NIAMS HAS SHA ROGEN CLINICAL 4496 02:59:08,280 --> 02:59:09,720 TRIAL GOING ON RIGHT NOW AND 4497 02:59:09,720 --> 02:59:10,640 REALLY LARGE TRIAL SO THAT'S 4498 02:59:10,640 --> 02:59:12,320 GOING TO BE FOCUSING ON DRY 4499 02:59:12,320 --> 02:59:19,560 MOUTH FOR DEPARTME DEPARTMENT DD 4500 02:59:19,560 --> 02:59:21,640 THE IMPACT ON THE ORAL CAVITY 4501 02:59:21,640 --> 02:59:23,200 NOT JUST OF THE DISEASE ITSELF 4502 02:59:23,200 --> 02:59:25,240 BUT THE THERAPEUTICS OF THE 4503 02:59:25,240 --> 02:59:27,800 DISEASE BECAUSE SOMETIMES THEY 4504 02:59:27,800 --> 02:59:28,200 FORGET ABOUT THAT. 4505 02:59:28,200 --> 02:59:30,680 >>THANK YOU, VERY MUCH. 4506 02:59:30,680 --> 02:59:34,880 YOU KNOW, NIAMS AND NICDS ALSO 4507 02:59:34,880 --> 02:59:39,640 HAS A ROBUST PORTFOLIO AND 4508 02:59:39,640 --> 02:59:41,360 SHOWGRIN SYNDROME AND WE'VE 4509 02:59:41,360 --> 02:59:43,000 FUNDED THAT RESEARCH AND 4510 02:59:43,000 --> 02:59:44,040 SUPPORTED THAT. 4511 02:59:44,040 --> 02:59:44,560 THANK YOU VERY MUCH. 4512 02:59:44,560 --> 02:59:46,440 ORAL HEALTH IS VERY MUCH A PIECE 4513 02:59:46,440 --> 02:59:49,320 OF OVER ALL HEALTH JUST LIKE 4514 02:59:49,320 --> 02:59:49,960 MENTAL HEALTH AND I THOUGHT YOU 4515 02:59:49,960 --> 02:59:51,640 WOULD BE EXCITE TODAY SEE THAT 4516 02:59:51,640 --> 02:59:57,440 WE DEDICATED A THEMED ISSUE TO 4517 02:59:57,440 --> 02:59:58,640 WOMEN'S HORAL HEALTH AND FOR OUR 4518 02:59:58,640 --> 03:00:01,400 IN FOCUS SQUARELY QUARTERLY SO 4519 03:00:01,400 --> 03:00:03,840 THANK YOU FOR RAISING THAT ISSUE 4520 03:00:03,840 --> 03:00:06,200 THAT IT'S NOT JUST ABOUT DISEASE 4521 03:00:06,200 --> 03:00:08,000 MANIFESTATION BUT ALSO 4522 03:00:08,000 --> 03:00:09,760 COMPLICATION AND ADVERSE 4523 03:00:09,760 --> 03:00:13,160 EFFECTED TREATMENT CAN HAVE 4524 03:00:13,160 --> 03:00:14,840 ORGAN SPECIFIC IMPACTS THAT WE 4525 03:00:14,840 --> 03:00:19,640 SHOULD CONSIDER AS WELL. 4526 03:00:19,640 --> 03:00:22,680 Dr. NOURSI OVER TO YOU. 4527 03:00:22,680 --> 03:00:25,400 >>THANK YOU Dr. CLAYTON. 4528 03:00:25,400 --> 03:00:26,720 WE WILL BREAK IN A FEW MINUTES 4529 03:00:26,720 --> 03:00:28,960 BEFORE WE BREAK, I'D LIKE TO ASK 4530 03:00:28,960 --> 03:00:30,760 THE MEMBERS OF THE COMMITTEE TO 4531 03:00:30,760 --> 03:01:33,240 TURN ON THEIR CAMERAS. 4532 03:01:33,240 --> 03:01:34,080 WELCOME BACK. 4533 03:01:34,080 --> 03:01:37,520 I HOPE YOU ALL ENJOYED YOUR 4534 03:01:37,520 --> 03:01:39,560 QUICK BREAK AND THE SLIDE SHOW. 4535 03:01:39,560 --> 03:01:41,920 I'D LIKE TO CALL THE MEETING TO 4536 03:01:41,920 --> 03:01:43,760 ORDER AND HAND IT OFF TO Dr. 4537 03:01:43,760 --> 03:01:48,000 LISA BEGG A SENIOR RESEARCH 4538 03:01:48,000 --> 03:01:48,960 PROGRAM OFFICER AT ORWH WHO WILL 4539 03:01:48,960 --> 03:01:52,160 BE MODERATING OUR AUTOIMMUNE 4540 03:01:52,160 --> 03:01:53,760 RESEARCH SPOTLIGHT IN THE NEXT 4541 03:01:53,760 --> 03:01:55,160 HOUR. 4542 03:01:55,160 --> 03:01:55,400 LISA -- 4543 03:01:55,400 --> 03:01:57,520 >>THANK YOU Dr. NOURSI AND 4544 03:01:57,520 --> 03:01:58,480 GOOD AFTERNOON TO EVERYONE. 4545 03:01:58,480 --> 03:02:00,280 I'M HAPPY TO MODERATE THIS 4546 03:02:00,280 --> 03:02:03,680 SESSION AND PLEASED TO INTRODUCE 4547 03:02:03,680 --> 03:02:08,080 Dr. KAPLAN AND ANDREW MAMME IN 4548 03:02:08,080 --> 03:02:09,600 FROM THE NATIONAL ARTHRITIS AND 4549 03:02:09,600 --> 03:02:11,120 SKIN DISORDERS AND BETTER NOPE 4550 03:02:11,120 --> 03:02:13,480 AS NIAMS. 4551 03:02:13,480 --> 03:02:15,920 I WILL INTRODUCE BOTH SPEAKERS 4552 03:02:15,920 --> 03:02:17,040 AT THE SAME TIME AND Dr. CAP 4553 03:02:17,040 --> 03:02:21,480 KAPLAN WILL LEAD OFF. 4554 03:02:21,480 --> 03:02:23,640 Dr. KAPLAN IS THE CHIEFEST 4555 03:02:23,640 --> 03:02:26,000 BRANCH AND DEPUTY SCIENTIFIC 4556 03:02:26,000 --> 03:02:30,800 DIRECTOR FOR THE INTRAMURAL 4557 03:02:30,800 --> 03:02:31,200 PROGRAM AT NIMES. 4558 03:02:31,200 --> 03:02:33,360 HER RESEARCH IS IDENTIFYING 4559 03:02:33,360 --> 03:02:35,600 MECHANISMS OF THE IMMUNE 4560 03:02:35,600 --> 03:02:40,880 DISREGULATION, ORGAN DAMAGE, AND 4561 03:02:40,880 --> 03:02:46,080 PREMATURE VASCULAR DISEASE, MORE 4562 03:02:46,080 --> 03:02:46,720 SPECIFICALLY, SHE INVESTIGATES 4563 03:02:46,720 --> 03:02:50,160 HOW INNATE IMMUNITY AND INTRA 4564 03:02:50,160 --> 03:02:53,320 FUR OWNS IN THE CELLS PROMOTE 4565 03:02:53,320 --> 03:02:54,840 AUTOIMMUNE RESPONSES AND ORGAN 4566 03:02:54,840 --> 03:02:59,320 DAMAGE AND SYSTEMIC LUPUS AND 4567 03:02:59,320 --> 03:03:02,080 ARTHRITIS AND OTHER SYSTEMIC 4568 03:03:02,080 --> 03:03:03,400 OUGHTN'T IMMUNE DISEASE AND IN 4569 03:03:03,400 --> 03:03:05,040 ADDITION TO HER RESEARCH 4570 03:03:05,040 --> 03:03:07,920 INTEREST, SHE'S ALSO AN ACTIVE 4571 03:03:07,920 --> 03:03:09,240 CLINICIAN AND TEACHER. 4572 03:03:09,240 --> 03:03:11,000 SHE SEES PATIENTS AT THE NIH 4573 03:03:11,000 --> 03:03:12,680 CLINICAL RESEARCH CENTER AND IS 4574 03:03:12,680 --> 03:03:15,280 INVOLVED IN THE DEVELOPMENT OF 4575 03:03:15,280 --> 03:03:16,160 VARIOUS CLINICAL TIMES FOR 4576 03:03:16,160 --> 03:03:18,000 PATIENTS WITH AUTO 'EM UNION 4577 03:03:18,000 --> 03:03:19,320 DISEASES ACROSS THE NIH. 4578 03:03:19,320 --> 03:03:22,560 OUR SECOND SPEAKER Dr. ANDREW 4579 03:03:22,560 --> 03:03:23,960 MAMMEN A SENIOR INVESTIGATOR AND 4580 03:03:23,960 --> 03:03:27,840 LEADS THE MUSCLE DISEASE UNIT AT 4581 03:03:27,840 --> 03:03:31,960 NIAMS AND HAD A DEGREE IN PH.D 4582 03:03:31,960 --> 03:03:34,960 WHERE HE COMPLETED HIS MEDICAL 4583 03:03:34,960 --> 03:03:37,240 INTERNSHIP AND NEUROLOGY 4584 03:03:37,240 --> 03:03:42,840 RESIDENCY AND NEURO MUSCULAR. 4585 03:03:42,840 --> 03:03:45,680 HE CO FOUNDED THE JOHNS HOPKINS 4586 03:03:45,680 --> 03:03:47,720 CENTER WHERE HE AND HIS 4587 03:03:47,720 --> 03:03:48,640 COLLEAGUES HAVE DISCOVERED A 4588 03:03:48,640 --> 03:03:58,640 FORM OF THE AUTOIMMUNE MY ON A 4589 03:03:58,640 --> 03:04:01,800 THEE AND THE CO A REDUCT THE 4590 03:04:01,800 --> 03:04:03,400 PHARMACOLOGICAL TARGET OF 4591 03:04:03,400 --> 03:04:03,880 STATUS. 4592 03:04:03,880 --> 03:04:08,040 Dr. MAMMEN MOVED TO NIH IN 4593 03:04:08,040 --> 03:04:10,240 2014 WHERE HE 1 HIS HIGH SCHOOL 4594 03:04:10,240 --> 03:04:12,360 ARE FOCUSED ON DEFINING 4595 03:04:12,360 --> 03:04:13,840 PATHOLOGICAL MECHANISM AND 4596 03:04:13,840 --> 03:04:16,600 THERAPEUTIC TARGETS AND VARIOUS 4597 03:04:16,600 --> 03:04:27,320 FORMS OF AUTOIMMUNE MIAWPUKEK. 4598 03:04:27,320 --> 03:04:30,960 WE'LL BEGIN THE FIRST 4599 03:04:30,960 --> 03:04:39,120 REPRESENTATION. 4600 03:04:39,120 --> 03:04:43,720 I'M A RHUMATOLOGIST SO I STUDY 4601 03:04:43,720 --> 03:04:49,480 AND TREAT ARE PR PREVALENT IN 4602 03:04:49,480 --> 03:04:49,760 WOMEN. 4603 03:04:49,760 --> 03:04:52,120 I WOULD LIKE TO TELL YOU HOW SEX 4604 03:04:52,120 --> 03:04:57,080 DIFFERENCES MAY IMPACT THE ORGAM 4605 03:04:57,080 --> 03:05:00,000 EIGHT IMMUNE SYSTEM AND HOW WE 4606 03:05:00,000 --> 03:05:01,200 THINK THIS COULD HAVE A ROLE IN 4607 03:05:01,200 --> 03:05:07,800 THE DEVELOPMENT AND OF CERTAIN 4608 03:05:07,800 --> 03:05:09,560 AUTO 'EM UNION DISEASES. 4609 03:05:09,560 --> 03:05:10,920 I DON'T THINK I HAVE CONTROL 4610 03:05:10,920 --> 03:05:15,160 OVER THE SLIDES. 4611 03:05:15,160 --> 03:05:18,200 SO THIS IS JUST A LIST OF SOME 4612 03:05:18,200 --> 03:05:21,480 OF THE SYSTEMIC AUTOIMMUNE 4613 03:05:21,480 --> 03:05:23,600 DISEASES THAT WE DIAGNOSE AND 4614 03:05:23,600 --> 03:05:28,600 TREAT AS RUMTOLOGISTS THATTER 4615 03:05:28,600 --> 03:05:30,360 HERRER OWE GENEROUS AND HARD TO 4616 03:05:30,360 --> 03:05:32,040 DIAGNOSE AND TREAT HOWEVER, 4617 03:05:32,040 --> 03:05:34,280 WHILE COMPLEX AND OUTAOUAIS 4618 03:05:34,280 --> 03:05:44,680 THERE ARE COMMONALITIES. 4619 03:05:56,400 --> 03:05:58,280 AND THIS CAN BE SEEN EARLY ON IN 4620 03:05:58,280 --> 03:05:59,680 THEIR LIFE PERHAPS FROM THE 4621 03:05:59,680 --> 03:06:02,760 MOMENT OF BIRTH AND THROUGH A 4622 03:06:02,760 --> 03:06:04,320 VARIETY OF POORLY UNDERSTOOD 4623 03:06:04,320 --> 03:06:09,200 ENVIRONMENTAL FACTORS AND SOONAL 4624 03:06:09,200 --> 03:06:10,760 EVENTS AND INDIVIDUAL TRANSITION 4625 03:06:10,760 --> 03:06:13,960 FROM A PHASE TO A PHASE OF SUB 4626 03:06:13,960 --> 03:06:15,480 CLINICAL ABNORMALITIES IN THE 4627 03:06:15,480 --> 03:06:17,040 IMMUNE SYSTEM AND AT SOME POINT 4628 03:06:17,040 --> 03:06:20,560 THERE'S A BREAKING TOLERANCE 4629 03:06:20,560 --> 03:06:22,040 WHERE VICTIMS WITH POSITION TO 4630 03:06:22,040 --> 03:06:24,560 REDEVELOP THE SYSTEMIC OR IMMUNE 4631 03:06:24,560 --> 03:06:26,240 DISEASES WILL HAVE INTENTION OF 4632 03:06:26,240 --> 03:06:28,080 OR ALAN TEE BODIES IN THEIR 4633 03:06:28,080 --> 03:06:32,000 BLOOD THAT TARGET ANTIGENS AND 4634 03:06:32,000 --> 03:06:36,080 THESE CAN HAPPEN MANY YEARS 4635 03:06:36,080 --> 03:06:41,960 BEFORE THE DISEASE DEVELOPED BUT 4636 03:06:41,960 --> 03:06:44,760 WE'LL HAVE A SIGNIFICANT HAVE 4637 03:06:44,760 --> 03:06:53,560 THA INDIVIDUAL FROMEMISS 4638 03:06:53,560 --> 03:06:55,840 REMISSION BECAUSE OF THE ENGLISH 4639 03:06:55,840 --> 03:06:56,880 POSE POSE YOU'RE OF STRESS AND 4640 03:06:56,880 --> 03:06:58,720 NOW THESE PATIENTS SLEEP LONGER 4641 03:06:58,720 --> 03:07:00,240 BECAUSE WE GOT BETTER TREATMENTS 4642 03:07:00,240 --> 03:07:02,720 WE'RE SEEING MORE AND MORE THE 4643 03:07:02,720 --> 03:07:08,600 CHRONIC COMPLICATIONS THAT MAKE 4644 03:07:08,600 --> 03:07:10,280 MORTALITY CARDIOVASCULAR DISEASE 4645 03:07:10,280 --> 03:07:14,400 AND FIBRO SIS AND CANCER, ET 4646 03:07:14,400 --> 03:07:15,040 CETERA. 4647 03:07:15,040 --> 03:07:17,880 SOMETHING THAT IS DRAMATIC IS 4648 03:07:17,880 --> 03:07:19,920 THE PREVALENCE OF SYSTEM I CAN 4649 03:07:19,920 --> 03:07:21,480 IMMUNITY IS HIGHER IN WOMEN THAN 4650 03:07:21,480 --> 03:07:24,600 MEN AND THIS IS MORE STRIKING 4651 03:07:24,600 --> 03:07:25,520 FOR CERTAIN AUTOIMMUNITY 4652 03:07:25,520 --> 03:07:27,600 THINKING APPROXIMATE THE 4653 03:07:27,600 --> 03:07:33,960 SYSTEMIC IS LUPUS IS A RACIAL 4654 03:07:33,960 --> 03:07:37,880 FOR EVERY MAN WITH LUPUS ARE 10 4655 03:07:37,880 --> 03:07:39,560 WOMEN WITH LUPUS BUT YOU CAN SEE 4656 03:07:39,560 --> 03:07:42,640 FROM THIS SLIDE A NUMBER OF 4657 03:07:42,640 --> 03:07:44,040 AUTOIMMUNE BOTH ORGAN SYSTEM I 4658 03:07:44,040 --> 03:07:52,960 CAN AND SYSTEMIC ARE MORE PR 4659 03:07:52,960 --> 03:07:53,760 PREVALENT IN WOMEN. 4660 03:07:53,760 --> 03:07:55,360 THERE'S A KNOWN FACTOR. 4661 03:07:55,360 --> 03:07:57,040 THERE'S BEEN A LOT OF RESEARCH 4662 03:07:57,040 --> 03:07:58,600 ON THE REASONS FOR THESE WHICH 4663 03:07:58,600 --> 03:08:03,200 ARE COMPLEX AND IT'S BETWEEN 4664 03:08:03,200 --> 03:08:06,720 GENETIC FACTORS AND PRESENCE TO 4665 03:08:06,720 --> 03:08:10,800 X CHROMOSOMES AND HORMONAL 4666 03:08:10,800 --> 03:08:12,560 FACTORS THAT HAVE BEEN CITED FOR 4667 03:08:12,560 --> 03:08:16,560 MANY YEARS THAT ARE UNCLEAR AND 4668 03:08:16,560 --> 03:08:18,000 THEN WHAT MAY HAPPEN DURING 4669 03:08:18,000 --> 03:08:21,640 PREGNANCY A FACTOR SUCH AS 4670 03:08:21,640 --> 03:08:25,840 ANTIGENS, AND ET CETERA. 4671 03:08:25,840 --> 03:08:29,680 NEXT SLIDE. 4672 03:08:29,680 --> 03:08:31,800 THEY ARE DESCRIBING WHERE ONE 4673 03:08:31,800 --> 03:08:33,600 HAPPENED WOMEN ARE BETTER AT 4674 03:08:33,600 --> 03:08:35,160 FIGHTING INFECTIONS BUT MORE 4675 03:08:35,160 --> 03:08:37,280 PRONE TO DEVELOP AUTOIMMUNITY 4676 03:08:37,280 --> 03:08:42,000 AND THE OPPOSITE IS SEEN IN MEN 4677 03:08:42,000 --> 03:08:45,200 AND BOTH INNATE AND ADAPTIVE 4678 03:08:45,200 --> 03:08:47,320 HAVE BEEN FOUND TO BE DIFFERENT 4679 03:08:47,320 --> 03:08:52,120 IN WOMEN VERSUS MEN AND SO 4680 03:08:52,120 --> 03:08:53,320 BETTER THAN OTHERS AND BETTER 4681 03:08:53,320 --> 03:08:54,960 UNDERSTOOD THAN OTHERS BUT THE 4682 03:08:54,960 --> 03:08:56,760 SPOKE ROLE THAT IS DIFFERENT 4683 03:08:56,760 --> 03:08:59,160 THAT THE DIFFERENCE IS PLAYED IN 4684 03:08:59,160 --> 03:09:01,680 THE POSITION TO INFECTIONS AND 4685 03:09:01,680 --> 03:09:05,560 AUTOIMMUNE IS ALSO NOT 4686 03:09:05,560 --> 03:09:08,880 COMPLETELY CLEAR. 4687 03:09:08,880 --> 03:09:10,000 SO, THE AUTOIMMUNE DISEASE AND 4688 03:09:10,000 --> 03:09:11,880 THE ONE MY LAB HAS BEEN 4689 03:09:11,880 --> 03:09:13,320 INTERESTING IN STUDYING FOR A 4690 03:09:13,320 --> 03:09:18,080 NUMBER OF DECADES IS SLE. 4691 03:09:18,080 --> 03:09:20,680 THIS IS AS I MENTIONED AFFECTS 4692 03:09:20,680 --> 03:09:21,960 WOMEN OF CHILD BEARING AGE OR 4693 03:09:21,960 --> 03:09:24,640 ANY AGE GROUPS IN MEN AND WOMEN 4694 03:09:24,640 --> 03:09:27,840 AND IT'S I A CLINICAL COMPANY WE 4695 03:09:27,840 --> 03:09:37,600 THINK IS A SYNDROME RATHER THAN 4696 03:09:37,600 --> 03:09:38,520 DISEASE. 4697 03:09:38,520 --> 03:09:39,800 THERE ARE IN FACT FORCE SEEN IN 4698 03:09:39,800 --> 03:09:41,400 THIS DISEASE BECAUSE IT WILL 4699 03:09:41,400 --> 03:09:42,280 HELP BETTER UNDERSTAND THE REST 4700 03:09:42,280 --> 03:09:43,400 OF MY TALK. 4701 03:09:43,400 --> 03:09:50,360 ONE IS THAT THE PRESENCE OF ORAL 4702 03:09:50,360 --> 03:09:52,400 AUTOIMMUNE THAT FOCUS DNA AND 4703 03:09:52,400 --> 03:09:54,560 RNA AND PROTEINS THAT LOOK LIKE 4704 03:09:54,560 --> 03:09:56,520 SUCH SYSTEMS AND IF WE DON'T SEE 4705 03:09:56,520 --> 03:09:58,760 THESE AUTO ANTIBODIES WE REALLY 4706 03:09:58,760 --> 03:10:00,600 DOUBT THAT THE DISEASE IS 4707 03:10:00,600 --> 03:10:02,760 PRESENT AND THE OTHER IS THAT 4708 03:10:02,760 --> 03:10:08,960 THIS REVELATION IN THE PATHWAY, 4709 03:10:08,960 --> 03:10:11,560 THE FORMATION OF THIS 4710 03:10:11,560 --> 03:10:12,400 INCOMPETENT TRA NEURONS FIGHT 4711 03:10:12,400 --> 03:10:13,120 ININFECTIONS AND PLAYING ROLES 4712 03:10:13,120 --> 03:10:15,560 IN OUR IMMUNITY IT'S A SURE 4713 03:10:15,560 --> 03:10:17,080 FEATURE IN MANY PATIENTS WITH 4714 03:10:17,080 --> 03:10:19,160 LUPUS AND THEY MAKE MORE 4715 03:10:19,160 --> 03:10:23,320 INTERFERENCE AND THEY MAKE MORE 4716 03:10:23,320 --> 03:10:23,920 INTRA NEURONS OR THEY RESPOND 4717 03:10:23,920 --> 03:10:26,880 MORE AND THE LASTLY, IS THAT 4718 03:10:26,880 --> 03:10:27,960 PREMATURE CARDIOVASCULAR DISEASE 4719 03:10:27,960 --> 03:10:30,320 IS A VERY IMPORTANT CAUSE OF 4720 03:10:30,320 --> 03:10:37,920 MORBIDITY AND MORTALITY IN LUPUS 4721 03:10:37,920 --> 03:10:42,960 AND WE THINK THIS IS I VERY 4722 03:10:42,960 --> 03:10:44,840 IMPORTANT IN MORALITY AND IT'S 4723 03:10:44,840 --> 03:10:47,440 PROVEN BY THE IMMUNE 4724 03:10:47,440 --> 03:10:49,000 DISREGULATION OF LUPUS MORE THAN 4725 03:10:49,000 --> 03:10:51,040 BY WHAT WE TYPICALLY THINK WHEN 4726 03:10:51,040 --> 03:10:53,040 WE THINK ABOUT HAVING RISK 4727 03:10:53,040 --> 03:10:57,120 FACTORS FOR HEART ATTACK SUCH AS 4728 03:10:57,120 --> 03:11:02,320 SMOKING, DIABETES, ET CETERA. 4729 03:11:02,320 --> 03:11:04,720 SIMILAR TO AUTOIMMUNE DISEASE IN 4730 03:11:04,720 --> 03:11:07,120 GENERAL THERE'S BEEN A LOT OF 4731 03:11:07,120 --> 03:11:09,560 SPECULATION WHY MORE WOMEN GET 4732 03:11:09,560 --> 03:11:11,360 MORE LUPUS THAN MEN AND AGAIN 4733 03:11:11,360 --> 03:11:16,040 THIS IS COMPLEX AND OUR GENETIC 4734 03:11:16,040 --> 03:11:18,440 MECHANISMS HAVE BEEN PROPOSED IN 4735 03:11:18,440 --> 03:11:23,280 ADDITION HORMONAL EXPOSURE AND 4736 03:11:23,280 --> 03:11:24,640 THE ROLE OF OTHER FACTORS SUCH 4737 03:11:24,640 --> 03:11:27,240 AS DIFFERENCES IN MICROBIOME 4738 03:11:27,240 --> 03:11:29,040 BETWEEN WOMEN AND MEN THAT COULD 4739 03:11:29,040 --> 03:11:33,840 BE PLAYING A ROLE IN THE 4740 03:11:33,840 --> 03:11:36,920 PREDISPOSITION TO LUPUS. 4741 03:11:36,920 --> 03:11:39,480 A KEY QUESTION FOR AUTOIMMUNE IS 4742 03:11:39,480 --> 03:11:44,560 HOW COME THESE PATIENTS MAKE 4743 03:11:44,560 --> 03:11:46,680 ANTIBODIES AGAINST SUCH EXPRESS 4744 03:11:46,680 --> 03:11:51,960 MOLECULES SUCH AS THEIR OWN DNA 4745 03:11:51,960 --> 03:11:55,960 AND RNA AND WHAT HAPPENS AND HOW 4746 03:11:55,960 --> 03:11:58,040 DO DO THESE EXPRESS ANTIGENS 4747 03:11:58,040 --> 03:12:00,040 BECOME IMMUNOGENS THAT CAN 4748 03:12:00,040 --> 03:12:02,240 TRIGGER AND MAINTAIN STRONG 4749 03:12:02,240 --> 03:12:04,320 AUTOIMMUNE RESPONSES AND SO FOR 4750 03:12:04,320 --> 03:12:06,320 MANY YEARS, THE THOUGHT WAS THAT 4751 03:12:06,320 --> 03:12:09,920 THERE WERE A NORMALITIES IN THE 4752 03:12:09,920 --> 03:12:12,520 WAY CELLS DIE AND MAYBE DRIVING 4753 03:12:12,520 --> 03:12:15,840 THE AGAIN RACE OF MODIFY ORAL 4754 03:12:15,840 --> 03:12:20,000 AUTO AGAIN AND THEY EXPEL THESE 4755 03:12:20,000 --> 03:12:23,000 AUTO ANTIGEN AND THEY THINK IT 4756 03:12:23,000 --> 03:12:25,640 WAS CALLED A POP TOY SIS AND 4757 03:12:25,640 --> 03:12:27,640 THERE ARE MANY WAYS WHICH CELLS 4758 03:12:27,640 --> 03:12:38,200 DIE AND THESE MAY BE IMPORTANTS 4759 03:12:46,480 --> 03:12:48,320 WE'VE BEEN INTERESTING IN 4760 03:12:48,320 --> 03:12:50,200 UNDERSTANDING HOW KNEW TREE FILL 4761 03:12:50,200 --> 03:12:53,320 LIVE AND DIE BECAUSE NEUTROPHILS 4762 03:12:53,320 --> 03:12:55,840 MAY BE RELEVANT BECAUSE THE THE 4763 03:12:55,840 --> 03:13:01,560 MOST AB A BUNT ANT WHITE CELLS. 4764 03:13:01,560 --> 03:13:05,360 SO THE NORMALITY IN THE 4765 03:13:05,360 --> 03:13:06,240 MECHANISMS OF NEWT ROW FILLS IT 4766 03:13:06,240 --> 03:13:08,400 COULD HAVE IMPORTANT 4767 03:13:08,400 --> 03:13:09,760 IMPLICATIONS IN HOW THEY AGAIN 4768 03:13:09,760 --> 03:13:12,400 RATE AND THE OR ALAN TEE BODIES 4769 03:13:12,400 --> 03:13:15,360 GET FORMED AND WAYS WHICH CELLS 4770 03:13:15,360 --> 03:13:16,920 CAUSE TISSUE DAMAGE AND I JUST 4771 03:13:16,920 --> 03:13:19,920 WANT TO EMPHASIZE THE STUDY OF 4772 03:13:19,920 --> 03:13:21,240 NEUTROPHILS HAS LEFT HYPED 4773 03:13:21,240 --> 03:13:23,960 COMPARE TO WHAT WE KNOW ABOUT 4774 03:13:23,960 --> 03:13:27,200 OTHER IMMUNO CELL TYPES BECAUSE 4775 03:13:27,200 --> 03:13:28,280 THEY'RE DIFFICULT TO STUDY. 4776 03:13:28,280 --> 03:13:29,960 THEY TIE OFTEN AND THEY'RE 4777 03:13:29,960 --> 03:13:31,800 SENSITIVE TO MANIPULATIONS BUT 4778 03:13:31,800 --> 03:13:33,600 THROUGH TECHNOLOGICAL ADVANCES 4779 03:13:33,600 --> 03:13:37,200 WE KNOW THAT NEUTROPHILS ARE NOT 4780 03:13:37,200 --> 03:13:39,680 JUST CELLS THEY GO TO THE 4781 03:13:39,680 --> 03:13:41,600 INFECTION AND KILL MICROBES AND 4782 03:13:41,600 --> 03:13:44,280 DIE AND THEY PLAY A CENTRAL ROLE 4783 03:13:44,280 --> 03:13:46,000 IN SHAPING THE LANDSCAPE IN 4784 03:13:46,000 --> 03:13:48,440 HEALTH AND DISEASE AND IN THAT 4785 03:13:48,440 --> 03:13:50,600 CONTEXT, MY LAB HAS A 4786 03:13:50,600 --> 03:13:53,880 PARTICULARLY INTERESTING 4787 03:13:53,880 --> 03:14:01,000 UNDERSTANDING HOW MECHANISMS 4788 03:14:01,000 --> 03:14:03,400 NEUTROPHILS MAY BE PLAYING IN A 4789 03:14:03,400 --> 03:14:05,800 ROLE IN OUR AUTISM UNITY. 4790 03:14:05,800 --> 03:14:12,200 WE KNOW THE FUNCTI FUNCTIONS MAE 4791 03:14:12,200 --> 03:14:15,360 HAVING THE KNEW TREE FILL IN THE 4792 03:14:15,360 --> 03:14:18,600 MORNING WILL BE DIFFERENT THAN 4793 03:14:18,600 --> 03:14:29,160 AT NIGHT AND HOW THEY BEHAVE AND 4794 03:14:33,000 --> 03:14:36,000 THE LIFE CYCLE OF HOW IT CHANGES 4795 03:14:36,000 --> 03:14:37,800 OVER THE LIFE CYCLE OF BEING A 4796 03:14:37,800 --> 03:14:38,760 MAN OR WOMEN. 4797 03:14:38,760 --> 03:14:40,880 IT'S BEEN UNDERSTANDING A 4798 03:14:40,880 --> 03:14:42,840 CERTAIN TYPE OF NEUTROPHIL 4799 03:14:42,840 --> 03:14:45,760 CALLED THE FORMATION OF 4800 03:14:45,760 --> 03:14:47,000 NEUTROPHIL NETS OR TRAPS. 4801 03:14:47,000 --> 03:14:51,000 IT'S A DRAMATIC PROCESS WHERE IT 4802 03:14:51,000 --> 03:14:52,080 EX USED ITS NUCLEAR MATERIAL 4803 03:14:52,080 --> 03:14:53,680 BOUND TO A PROTEINS PRESENT 4804 03:14:53,680 --> 03:14:56,120 INSIDE THE NEUTROPHIL IN THIS 4805 03:14:56,120 --> 03:15:02,440 MESH YOU SEE HERE, THAT CALLED 4806 03:15:02,440 --> 03:15:02,960 TERMED TRAPS OR NETS. 4807 03:15:02,960 --> 03:15:05,240 WHAT IS IMPORTANT WHEN THESE 4808 03:15:05,240 --> 03:15:10,760 NETS FORM, NOT ONLY DO 24th DO O 4809 03:15:10,760 --> 03:15:13,120 THE MICROBES BUT THEY EXPOS A 4810 03:15:13,120 --> 03:15:15,560 VARIETY OF PHOTO ANTIGENS THAT 4811 03:15:15,560 --> 03:15:19,600 ARE NOT TARGETS OF THE SYSTEM 4812 03:15:19,600 --> 03:15:23,440 AND ESSENTIALS. 4813 03:15:23,440 --> 03:15:28,000 SO THIS TRIGGER THE FORMATION 4814 03:15:28,000 --> 03:15:35,480 THESE NETS AND IT'S HAVING THE 4815 03:15:35,480 --> 03:15:36,640 ABILITY TO INDUCE NETS AND WE 4816 03:15:36,640 --> 03:15:39,840 KNOW THAT THIS PROCESS BECOMES 4817 03:15:39,840 --> 03:15:41,520 DIS-REGULATED IN AUTO MANY UNITY 4818 03:15:41,520 --> 03:15:46,440 SO PATIENTS WHERE IMMUNE 4819 03:15:46,440 --> 03:15:50,560 DISEASES MAKE MORE NETS EVEN IN 4820 03:15:50,560 --> 03:15:54,640 THE ABSENCE OF AN INFECTION AND 4821 03:15:54,640 --> 03:15:56,760 THEY'RE GETTING RID OF THESE 4822 03:15:56,760 --> 03:15:58,200 NETS IN MANY PATIENTS WITH 4823 03:15:58,200 --> 03:15:59,480 AUTOIMMUNE DISEASES SO AT ENDS 4824 03:15:59,480 --> 03:16:00,240 OF THE DAY. 4825 03:16:00,240 --> 03:16:02,640 YOU HAVE THESE NETS NOT 4826 03:16:02,640 --> 03:16:03,840 CIRCULATING OR BEING DEPOSITED 4827 03:16:03,840 --> 03:16:07,440 IN TISSUE EXPOSING ALL OF THESE 4828 03:16:07,440 --> 03:16:10,400 AUTOANTIGEN THAT MAY EXPOS THE 4829 03:16:10,400 --> 03:16:13,200 IMMUNE SYSTEM THAT HAS PRONE TO 4830 03:16:13,200 --> 03:16:16,080 REACT TO THESE IN THE SHAPE AND 4831 03:16:16,080 --> 03:16:19,200 PERPETUATE OUR IMMUNITY. 4832 03:16:19,200 --> 03:16:19,920 NEXT SLIDE. 4833 03:16:19,920 --> 03:16:21,080 WE'RE NOT GOING TO SPEND MUCH 4834 03:16:21,080 --> 03:16:22,840 TIME ON THIS BUT WE KNOW THAT 4835 03:16:22,840 --> 03:16:24,360 MAKING NETS IN AN UNCONTROLLED 4836 03:16:24,360 --> 03:16:26,720 MATTER IS BAD FOR YOU AND THESE 4837 03:16:26,720 --> 03:16:29,240 NETS HAVE THE ABILITY TO 4838 03:16:29,240 --> 03:16:33,000 STIMULATE MANY IMMUNE CELLS AND 4839 03:16:33,000 --> 03:16:35,160 STIMULATE CLOTS AND DAMAGE BLOOD 4840 03:16:35,160 --> 03:16:36,600 VESSELS THE FIELD HAS EXPLODED 4841 03:16:36,600 --> 03:16:38,240 AND HERE ON THE LEFT I MENTIONED 4842 03:16:38,240 --> 03:16:42,800 A LIST OF DISEASES BOTH SYSTEMIC 4843 03:16:42,800 --> 03:16:46,360 AUTOIMMUNE AND FLAMMATORY WHERE 4844 03:16:46,360 --> 03:16:48,240 NETS HAVE AN IMPORTANT 4845 03:16:48,240 --> 03:16:49,600 PATHOGENIC ROLE AND WE KNOW FOR 4846 03:16:49,600 --> 03:16:52,880 EXAMPLE THAT IN COVID-19, 4847 03:16:52,880 --> 03:16:54,480 DISREGULATION IS IMPORTANT IN 4848 03:16:54,480 --> 03:16:57,720 THOM BOW SIS BUT THERE'S BASED 4849 03:16:57,720 --> 03:16:58,880 NOT AUTOIMMUNE AND I AM FLAM 4850 03:16:58,880 --> 03:17:01,240 TORI CONDITIONS WHERE ABNORMAL 4851 03:17:01,240 --> 03:17:05,480 MALL FORMATION HAS BEEN 4852 03:17:05,480 --> 03:17:15,680 IMPLICATED. 4853 03:17:37,480 --> 03:17:40,640 IT THIS WAS ALL GENES RELATED TO 4854 03:17:40,640 --> 03:17:42,920 NEUTROPHIL BIOLOGY SO THERE WERE 4855 03:17:42,920 --> 03:17:46,240 GENES THAT NEUTROPHIL THAT 4856 03:17:46,240 --> 03:17:47,760 EXPRESS WE KNOW WOMEN AND MEN 4857 03:17:47,760 --> 03:17:50,720 AND WHAT WE FOUND IS THAT THE 4858 03:17:50,720 --> 03:17:53,200 NEUTROPHILS IN HEALTHY MEN ARE 4859 03:17:53,200 --> 03:17:56,320 MORE IMMATURE THAN NO IN HEALTHY 4860 03:17:56,320 --> 03:17:57,000 WOMEN. 4861 03:17:57,000 --> 03:18:00,480 THIS WAS THAT VERY PICTURE WE 4862 03:18:00,480 --> 03:18:02,360 HAVE OBSERVED IN MULTIPLE 4863 03:18:02,360 --> 03:18:07,040 COHORTS THAT WE'VE STUDIED. 4864 03:18:07,040 --> 03:18:11,240 THIS MA IMMATURITY IN MALES 4865 03:18:11,240 --> 03:18:11,880 COMPARED TO FEMALES TRANSLATED 4866 03:18:11,880 --> 03:18:13,880 INTO THE FINDINGS WHEN YOU LOOK 4867 03:18:13,880 --> 03:18:15,680 AT NITRO FILLS OF HEALTHY, YOUNG 4868 03:18:15,680 --> 03:18:18,320 ADULTS AND COMPARE FEMALES AND 4869 03:18:18,320 --> 03:18:19,840 MALES, FEMALE NEUTROPHILS ARE 4870 03:18:19,840 --> 03:18:21,640 WAY MORE ACT RATE ISED THAN MALE 4871 03:18:21,640 --> 03:18:22,240 NEUTROPHILS. 4872 03:18:22,240 --> 03:18:24,520 THEY RESPOND MORE AND THEY 4873 03:18:24,520 --> 03:18:27,280 EXPRESS MARKERS THIS THE CELL 4874 03:18:27,280 --> 03:18:29,080 SURFACE AT HIGHER LEVELS THAT 4875 03:18:29,080 --> 03:18:31,440 MAY HAVE MORE FLAM TORI FEATURES 4876 03:18:31,440 --> 03:18:34,200 AND WHAT IS STRIKING OBSERVATION 4877 03:18:34,200 --> 03:18:35,800 WAS THAT AT NORMAL CONDITIONS OR 4878 03:18:35,800 --> 03:18:39,440 WHEN EXPOSED TO BACTERIA OR 4879 03:18:39,440 --> 03:18:42,360 BACTERIA PRODUCTS OR IMMUNE 4880 03:18:42,360 --> 03:18:46,960 COMPLEX, THE FEMALE NEUTROPHIL 4881 03:18:46,960 --> 03:18:49,200 ARE MORE LIKELY TO MAKE NETS. 4882 03:18:49,200 --> 03:18:51,880 THIS IS IMPORTANT BECAUSE THE 4883 03:18:51,880 --> 03:18:53,720 MECHANISMS THAT ARE ANTIGENS SO 4884 03:18:53,720 --> 03:18:55,960 IF WOMEN ARE BETTER AT MAKING 4885 03:18:55,960 --> 03:18:59,160 NETS, THESE MAY BE A FACTOR THAT 4886 03:18:59,160 --> 03:19:03,400 INDUCES MORE ANTIGENS AND MORE 4887 03:19:03,400 --> 03:19:07,000 PREDISPOSED TO AGAIN EIGHT 4888 03:19:07,000 --> 03:19:08,440 ANTIBODIES IF THEY HAVE THE 4889 03:19:08,440 --> 03:19:09,800 RIGHT GENETIC MAKE UP. 4890 03:19:09,800 --> 03:19:14,160 THEY'RE MORE LIKELY TO MAKE 4891 03:19:14,160 --> 03:19:17,880 THESE NETS. 4892 03:19:17,880 --> 03:19:20,640 WHAT IS INTERESTING IS THAT 4893 03:19:20,640 --> 03:19:22,440 THESE CHANGES IN NEUTROPHILS 4894 03:19:22,440 --> 03:19:25,040 MATURATION AND BIOLOGY CHANGE 4895 03:19:25,040 --> 03:19:28,120 THROUGHOUT THE PREGNANCY. 4896 03:19:28,120 --> 03:19:30,160 SO WHEN WOMEN WERE PREGNANT, WE 4897 03:19:30,160 --> 03:19:33,560 FOUND IS THAT THEY ACQUIRED MORE 4898 03:19:33,560 --> 03:19:36,440 NEUTROPHIL PHENOTYPE OF MALES. 4899 03:19:36,440 --> 03:19:38,640 THEY WERE LESS MATURE AND WHEN 4900 03:19:38,640 --> 03:19:40,200 THEY DELIVERED THE BABY THEY 4901 03:19:40,200 --> 03:19:42,480 WENT BACK TO HAVE THE PHENOTYPE 4902 03:19:42,480 --> 03:19:45,680 OF THE PRE PREGNANCY FEMALES AND 4903 03:19:45,680 --> 03:19:48,520 WERE MORE MATURE THAN THE MALE 4904 03:19:48,520 --> 03:19:51,640 NEUTROPHILS SO THIS IS JUST TO 4905 03:19:51,640 --> 03:19:52,960 ADD THAT PERHAPS A HORMONAL FACT 4906 03:19:52,960 --> 03:19:55,120 OR WAS INCOMPETENT INDICATED IN 4907 03:19:55,120 --> 03:19:57,840 MATURATION OF ACTIVATION AND 4908 03:19:57,840 --> 03:20:00,200 DURING PREGNANCY THERE'S A 4909 03:20:00,200 --> 03:20:04,200 GENETIC RESPONSE THAT MAKES THE 4910 03:20:04,200 --> 03:20:08,920 FEMALE NEUTROPHIL BEHAVIOR LIKE 4911 03:20:08,920 --> 03:20:10,200 THE MALE. 4912 03:20:10,200 --> 03:20:12,800 THE METABOLISM OF A MALE AND 4913 03:20:12,800 --> 03:20:13,920 FEMALE NEUTROPHIL IS DIFFERENT 4914 03:20:13,920 --> 03:20:16,720 AND IT MAY BE TELLING US WHAT 4915 03:20:16,720 --> 03:20:20,040 THEY USE AS THEIR SOURCE OF 4916 03:20:20,040 --> 03:20:22,200 ENERGY AND HOW PRO FLAM TORI 4917 03:20:22,200 --> 03:20:23,480 THEY ARE. 4918 03:20:23,480 --> 03:20:26,600 MALE NEUTROPHILS HAVE MORE 4919 03:20:26,600 --> 03:20:28,120 MITOCHONDRIA BECAUSE THEY'RE 4920 03:20:28,120 --> 03:20:32,080 MORE IMMATURE AND THEY RELY MORE 4921 03:20:32,080 --> 03:20:33,720 ON MAESTRO CON AGREE A BY THE 4922 03:20:33,720 --> 03:20:36,120 FEMALE WAS RELY MORE ON THE USE 4923 03:20:36,120 --> 03:20:39,680 OF GLUCOSE AND GLYCOLYSIS BUT IF 4924 03:20:39,680 --> 03:20:43,200 WE ADDED IN THE I DON'T HAVE 4925 03:20:43,200 --> 03:20:52,040 ACCESS TO THE POINTER HERE. 4926 03:20:52,040 --> 03:20:56,760 IF YOU LOOK AT THE RIGHT GRAPH, 4927 03:20:56,760 --> 03:20:59,000 IF WE HAVE A FEMALE HORMONE TO 4928 03:20:59,000 --> 03:21:03,280 THE MALE NEUTROPHIL THEY HAVE 4929 03:21:03,280 --> 03:21:04,960 THE FEMALE NEUTROPHIL SUGGESTING 4930 03:21:04,960 --> 03:21:07,880 THAT SOME OF THE DIFFERENCES AT 4931 03:21:07,880 --> 03:21:09,640 LEAST IN THE FEMALES AND MALES 4932 03:21:09,640 --> 03:21:15,160 MAY BE RELATED TO SEX HORMONES. 4933 03:21:15,160 --> 03:21:17,160 SO WE WENT AHEAD AND WANTED TO 4934 03:21:17,160 --> 03:21:20,600 BE MORE SPECIFIC AT WHETHER THE 4935 03:21:20,600 --> 03:21:22,440 FIRST DAY THAT SHOW YOU WAS IN 4936 03:21:22,440 --> 03:21:26,760 THOSE CELLS BUT WE STARTED TO 4937 03:21:26,760 --> 03:21:28,480 PURIFY NEUTROPHILS AND THE GENE 4938 03:21:28,480 --> 03:21:30,480 EXPRESSION BETWEEN FEMALE AND 4939 03:21:30,480 --> 03:21:32,160 MALE NEUTROPHILS AND WHAT WE SAW 4940 03:21:32,160 --> 03:21:34,880 AS YOU CAN SEE ON THE GRAPH ON 4941 03:21:34,880 --> 03:21:36,760 THE LEFT, IS THAT THE MAIN GENES 4942 03:21:36,760 --> 03:21:39,760 THAT INTEREST DIFFERENTIALLY 4943 03:21:39,760 --> 03:21:40,600 REGULATED INTO FEMALES AND MALES 4944 03:21:40,600 --> 03:21:42,880 ARE TYPE ONE INTRA FEWER ON 4945 03:21:42,880 --> 03:21:45,280 REGULATED GENES THAT ARE 4946 03:21:45,280 --> 03:21:49,720 RESPONDING TO CYTOKINES IN 4947 03:21:49,720 --> 03:21:53,840 INFECTIONS AND AUTOIMMUNITY AND 4948 03:21:53,840 --> 03:21:55,840 COP CONSISTENTLY ALWAYS REGULATE 4949 03:21:55,840 --> 03:22:00,280 THE GENES SO JUST IN THEIR HYPER 4950 03:22:00,280 --> 03:22:02,880 RESPONDING, TO TYPE ONE 4951 03:22:02,880 --> 03:22:04,800 INTERFERENCE AND ON THE RIGHT 4952 03:22:04,800 --> 03:22:10,840 GRAPH IT CAN GENERATE A 4953 03:22:10,840 --> 03:22:11,920 INTERFERENCE CORE AND IT'S 4954 03:22:11,920 --> 03:22:13,320 INTERESTING AND THIS IS THE 4955 03:22:13,320 --> 03:22:15,360 RIGHT LOWER GRAPH IS THAT WHEN 4956 03:22:15,360 --> 03:22:20,240 WE HAVE DID NOT SINGLE CELL RNA 4957 03:22:20,240 --> 03:22:22,120 SEQUENCING IT'S IN NEUTROPHILS 4958 03:22:22,120 --> 03:22:24,040 ALL THE OTHER CELL PATH WHEN WE 4959 03:22:24,040 --> 03:22:25,120 COMPARE MALE AND FEMALE THEY 4960 03:22:25,120 --> 03:22:27,000 DON'T HAVE DIFFERENCES IN THE 4961 03:22:27,000 --> 03:22:30,320 GENES BUT THE FEMALE AND MALE 4962 03:22:30,320 --> 03:22:31,280 NEWT TREE FILLS ARE SHOWING 4963 03:22:31,280 --> 03:22:32,840 DIFFERENCES WITH THE FEMALE 4964 03:22:32,840 --> 03:22:37,400 MOWING MORE HYPER RESPONSIVE SO, 4965 03:22:37,400 --> 03:22:39,560 JUST TO SUMMARIZE, THESE MAY 4966 03:22:39,560 --> 03:22:41,480 HAVE IMPORTANT IMPLICATIONS 4967 03:22:41,480 --> 03:22:43,960 BECAUSE IF THE FEMALE RESPONDS 4968 03:22:43,960 --> 03:22:45,960 BETTER TO TYPE ONE INTRA NEURONS 4969 03:22:45,960 --> 03:22:47,560 THEY ARE MORE LIKELY TO BE 4970 03:22:47,560 --> 03:22:48,720 DIS-REGULATED IN THE CONTEXT OF 4971 03:22:48,720 --> 03:22:52,200 OUR IMMUNITY AND THEY BE 4972 03:22:52,200 --> 03:22:56,120 FIGHTING CERTAIN INFECTIONS 4973 03:22:56,120 --> 03:23:02,840 BECAUSE THEY SUCH ADDS THE CASEF 4974 03:23:02,840 --> 03:23:03,800 COVID-19 WHERE FEMALES HAVE A 4975 03:23:03,800 --> 03:23:05,080 BETTER RESPONSE THAN MEN. 4976 03:23:05,080 --> 03:23:06,280 HOW EXACTLY IS THIS HAPPENING 4977 03:23:06,280 --> 03:23:07,720 AND THE HINGE FROM THE PREGNANCY 4978 03:23:07,720 --> 03:23:11,640 TOLD US, WELL, PERHAPS THIS IS 4979 03:23:11,640 --> 03:23:16,200 DIFFERENT IN SEX HOR MONTHS BUT 4980 03:23:16,200 --> 03:23:18,640 NOT X CHROMOSOMES AND THERE'S 4981 03:23:18,640 --> 03:23:20,120 SUGGESTING THAT THEY CAN 4982 03:23:20,120 --> 03:23:21,760 REGULATE NEUTROPHIL FUNCTIONS 4983 03:23:21,760 --> 03:23:24,960 AND THEY CAN CHANGE THEIR 4984 03:23:24,960 --> 03:23:34,120 NUMBERS AND LINK TO ALL AB 4985 03:23:34,120 --> 03:23:35,320 ABNORMALITY WE KNEW LITTLE 4986 03:23:35,320 --> 03:23:37,640 DIFFERENCES BETWEEN SEX AND 4987 03:23:37,640 --> 03:23:39,600 NEUTROPHIL FUNCTION. 4988 03:23:39,600 --> 03:23:43,000 SO, TO TRY TO OF WHETHER THIS IS 4989 03:23:43,000 --> 03:23:47,280 SEX HORMONE REGULATED OR X CREM 4990 03:23:47,280 --> 03:23:54,520 SO MANXCHROMOSOMES AND WHAT WE F 4991 03:23:54,520 --> 03:23:57,520 WE TOOK MALE, YOUNG ADULT MALES 4992 03:23:57,520 --> 03:24:00,240 AND YOUNG ADULT FEMALES AND 4993 03:24:00,240 --> 03:24:05,840 COMPARED THEIR TYPE OF INTRA 4994 03:24:05,840 --> 03:24:09,600 FEWER ON RESPONSE TO MALES WITHK 4995 03:24:09,600 --> 03:24:11,400 LIKE MALES BUT THEY HAVE A XXY. 4996 03:24:11,400 --> 03:24:14,040 THEY HAVE AN EXTRA X CHROMOSOME 4997 03:24:14,040 --> 03:24:15,640 LIKE WOMEN AND WE WILL HAVE 4998 03:24:15,640 --> 03:24:17,280 EXPECTED THAT THIS WAS AN EFFECT 4999 03:24:17,280 --> 03:24:20,640 OF HAVING TWO X CHROMOSOMES AND 5000 03:24:20,640 --> 03:24:23,120 MAY NEUTROPHILS WOULD MORE LOOK 5001 03:24:23,120 --> 03:24:24,760 LIKE THE FEMALE INTRO FILL BUT 5002 03:24:24,760 --> 03:24:27,160 THEY LOOK SIMILAR TO THE MALE SO 5003 03:24:27,160 --> 03:24:31,680 JUST HAVING AN EXTRA X 5004 03:24:31,680 --> 03:24:32,480 CHROMOSOME IS NOT DRIVING THE 5005 03:24:32,480 --> 03:24:34,240 DIFFERENCE AND SIMILARLY WHEN WE 5006 03:24:34,240 --> 03:24:39,600 LOOK AT CHILDREN WHERE THE SEX 5007 03:24:39,600 --> 03:24:40,040 HORMONE SHOULD BE MORE 5008 03:24:40,040 --> 03:24:46,320 BANKRUPTBLUNTED WEDON'T SEE A DS 5009 03:24:46,320 --> 03:24:46,840 AND GIRLS. 5010 03:24:46,840 --> 03:24:49,280 THIS IS ON GOING WORK THAT 5011 03:24:49,280 --> 03:24:57,080 SECTION HOR MONTHS ARE HORMONESR 5012 03:24:57,080 --> 03:24:57,920 TO CERTAIN HOR MONDAYAL 5013 03:24:57,920 --> 03:25:00,320 STRATEGIES THAT MAY ALLOW US TO 5014 03:25:00,320 --> 03:25:02,880 REGULATE NEUTROPHIL FUNCTIONS IN 5015 03:25:02,880 --> 03:25:07,560 CERTAIN EXISTENCE AS A MECHANISM 5016 03:25:07,560 --> 03:25:10,200 TO INDUCE AUTOIMMUNITY ET CETERA 5017 03:25:10,200 --> 03:25:13,960 AND THIS IS ON GOING WORK THAT 5018 03:25:13,960 --> 03:25:18,160 MY LAB IS PERFORMING. 5019 03:25:18,160 --> 03:25:22,360 I WANT TO TOUCH UPON BRIEFLY IS 5020 03:25:22,360 --> 03:25:25,200 THE EFFECT OF LUPUS ON 5021 03:25:25,200 --> 03:25:26,760 CARDIOVASCULAR DISEASE AND WHAT 5022 03:25:26,760 --> 03:25:28,880 TYPICAL THING OF CARDIOVASCULAR 5023 03:25:28,880 --> 03:25:30,520 DISEASE IS MIDDLE AGE MEN WE 5024 03:25:30,520 --> 03:25:32,280 KNOW THAT WOMEN WITH LUPUS HAVE 5025 03:25:32,280 --> 03:25:36,360 A SIGNIFICANT INCREASE IN 5026 03:25:36,360 --> 03:25:36,800 CARDIOVASCULAR RATES. 5027 03:25:36,800 --> 03:25:38,120 THEY HAVE A LOT OF INFLAMMATION 5028 03:25:38,120 --> 03:25:42,400 WE CAN ASSIST AND THEY HAVE CORP 5029 03:25:42,400 --> 03:25:44,160 ARY FORMATION AND THIS HAPPENS 5030 03:25:44,160 --> 03:25:54,640 AS MUCH ACCELERATED BASIS. 5031 03:25:54,640 --> 03:26:00,280 WE HAVE FOUND THE SAME AND HAVE 5032 03:26:00,280 --> 03:26:02,040 INFLAMMATORY ROLES ARE PLAYING A 5033 03:26:02,040 --> 03:26:05,000 ROLE IN DRIVING THESE 5034 03:26:05,000 --> 03:26:05,640 CARDIOVASCULAR DISEASE AND WE'VE 5035 03:26:05,640 --> 03:26:07,840 FOUND HAVING THESE KNOW TREE 5036 03:26:07,840 --> 03:26:10,760 FILL SUBSET MAKE MORE NETS 5037 03:26:10,760 --> 03:26:14,240 ASSOCIATED WITH HAVING MORE 5038 03:26:14,240 --> 03:26:14,880 VASCULAR INFLAMMATION SO THIS 5039 03:26:14,880 --> 03:26:21,080 HAS IMPLICATION FORCE 5040 03:26:21,080 --> 03:26:21,800 COMPLICATIONS IN AUTOIMMUNE 5041 03:26:21,800 --> 03:26:23,960 DISEASES AND WE'RE UNDERSTANDING 5042 03:26:23,960 --> 03:26:25,120 HOW THESE SEX DIFFERENCES 5043 03:26:25,120 --> 03:26:26,280 BETWEEN MALES AND FEELS THAT WE 5044 03:26:26,280 --> 03:26:31,440 HAVE OBSERVED IN HEALTHY PEOPLE 5045 03:26:31,440 --> 03:26:33,160 AND WHEN WE COMPARE MALES AND 5046 03:26:33,160 --> 03:26:35,360 FEELS WITH AUTOIMMUNE DES CEASES 5047 03:26:35,360 --> 03:26:36,960 AND WHETHER THEY EXPLAIN SOME OF 5048 03:26:36,960 --> 03:26:41,120 THE DIFFERENCES IN 5049 03:26:41,120 --> 03:26:42,760 CARDIOVASCULAR RISK. 5050 03:26:42,760 --> 03:26:45,320 SO IN SUMMARY, I WOULD LIKE TO 5051 03:26:45,320 --> 03:26:46,720 EMPHASIZE THAT SEX DIFFERENCES 5052 03:26:46,720 --> 03:26:49,280 IN NEUTROPHIL BIOLOGY PLAYS A 5053 03:26:49,280 --> 03:26:52,720 ROLE IN THE IMMUNITY AND BETTER 5054 03:26:52,720 --> 03:26:56,240 UNDERSTANDING THEM AND HOW TO 5055 03:26:56,240 --> 03:26:57,640 HAVE THE ROLE THEY PLAY IN 5056 03:26:57,640 --> 03:26:59,560 DRIVING THIS REGULATED IMMUNITY 5057 03:26:59,560 --> 03:27:04,280 MAY BE KEY IN FINDING BETTER 5058 03:27:04,280 --> 03:27:04,760 THERAPY FOR AUTOIMMUNE 5059 03:27:04,760 --> 03:27:07,640 SUPPRESSIVE AND WE THINK THIS 5060 03:27:07,640 --> 03:27:08,280 NET DIFFER ESSENTIALLY MADE 5061 03:27:08,280 --> 03:27:11,000 BETWEEN MEN AND WOMEN ARE A 5062 03:27:11,000 --> 03:27:12,400 SOURCE OF AUTOIMMUNE THAT 5063 03:27:12,400 --> 03:27:15,920 PROMOTE OF FOR DISPOSED PEOPLE 5064 03:27:15,920 --> 03:27:17,960 AND THAT THESE SUBSTANCES MAKING 5065 03:27:17,960 --> 03:27:21,720 MORE NETS AND THE DIFFERENCES 5066 03:27:21,720 --> 03:27:22,680 BETWEEN MALES AND FEMALES MAY 5067 03:27:22,680 --> 03:27:25,640 HELP US FIND BETTER STRATEGIES 5068 03:27:25,640 --> 03:27:27,360 TO MITIGATE PREMATURE AND ALL 5069 03:27:27,360 --> 03:27:30,080 THE END ORGAN DAMAGE THAN OCCURS 5070 03:27:30,080 --> 03:27:32,360 IN LUPUS IN A VARIETY FOR 5071 03:27:32,360 --> 03:27:34,640 IMMUNITY AND EXPANDING IT TO 5072 03:27:34,640 --> 03:27:36,400 BETTER UNDERSTANDING FOR EXAMPLE 5073 03:27:36,400 --> 03:27:38,760 OF DEVELOPMENT OF CARDIOVASCULAR 5074 03:27:38,760 --> 03:27:43,200 DISEASE IN WOMEN THAT DON'T HAVE 5075 03:27:43,200 --> 03:27:53,440 AUTOIMMUNITY. 5076 03:28:03,080 --> 03:28:10,280 TO MITIGATE PREMATURE AND AL 5077 03:28:10,280 --> 03:28:12,440 >>WE'LL ASK EVERYONE TO TOLD 5078 03:28:12,440 --> 03:28:13,360 THEIR QUESTIONS UNTIL BOTH 5079 03:28:13,360 --> 03:28:16,880 SPEAKER PRESENT AND WE'LL HAVE A 5080 03:28:16,880 --> 03:28:17,920 MODERATED JOINT SESSION. 5081 03:28:17,920 --> 03:28:19,120 FOR THOSE WHO HAVE QUESTIONS, 5082 03:28:19,120 --> 03:28:23,560 PUT THEM IN THE CHAT OR RAISE 5083 03:28:23,560 --> 03:28:25,600 YOUR HAPPENED AS WE GET TO THE 5084 03:28:25,600 --> 03:28:31,760 END OF Dr. MAMMEN'S TALK. 5085 03:28:31,760 --> 03:28:33,120 >>GREAT. 5086 03:28:33,120 --> 03:28:35,040 IT LOOKS LIKE YOU GUYS HAVE MY 5087 03:28:35,040 --> 03:28:35,640 TALK UP THERE. 5088 03:28:35,640 --> 03:28:36,440 THANK YOU VERY MUCH. 5089 03:28:36,440 --> 03:28:38,480 CAN YOU SEE MY POINTER. 5090 03:28:38,480 --> 03:28:46,000 LET ME SEE IF I CAN GENERATE A 5091 03:28:46,000 --> 03:28:47,800 POINTER DO YOU SEE IT NOW? 5092 03:28:47,800 --> 03:28:51,000 >>NOPE. 5093 03:28:51,000 --> 03:29:00,520 >>OKAY. 5094 03:29:00,520 --> 03:29:04,640 SO I HAVE A PATENT FOR THIS 5095 03:29:04,640 --> 03:29:05,720 ANTI-AGING ANTIBODY TEST BUT I 5096 03:29:05,720 --> 03:29:07,000 DON'T RECEIVE COMPENSATION FOR 5097 03:29:07,000 --> 03:29:09,720 THAT AND SOMETIMES I DISCUSS OFF 5098 03:29:09,720 --> 03:29:12,240 TABLE TREATMENTS FOR AUTOIMMUNE 5099 03:29:12,240 --> 03:29:13,640 MUSCLE DISEASES BUT I WOULDN'T 5100 03:29:13,640 --> 03:29:17,960 DO THAT TODAY. 5101 03:29:17,960 --> 03:29:20,560 SO, IN TERMS OF OVER VIEW, I 5102 03:29:20,560 --> 03:29:21,800 WANTED TO TALK ABOUT FIRST I 5103 03:29:21,800 --> 03:29:24,880 WOULD LIKE TO THANK Dr. KAPLAN 5104 03:29:24,880 --> 03:29:28,680 FOR FIRE FIGH GIVING A GREAT OVF 5105 03:29:28,680 --> 03:29:29,160 SYSTEMIC AUTOIMMUNE. 5106 03:29:29,160 --> 03:29:31,880 EVERYTHING SHE SAID HOW THESE 5107 03:29:31,880 --> 03:29:33,560 DISEASES OVER TIME AND BREAKING 5108 03:29:33,560 --> 03:29:35,760 TOLERANCE AND SUCH IS RELEVANT 5109 03:29:35,760 --> 03:29:37,000 TO THE AUTOIMMUNE MUSCLE 5110 03:29:37,000 --> 03:29:38,200 DISEASES THAT I'M GOING TO TALK 5111 03:29:38,200 --> 03:29:41,200 ABOUT TODAY SO I WON'T REPEAT 5112 03:29:41,200 --> 03:29:41,800 THAT SAME STUFF. 5113 03:29:41,800 --> 03:29:44,880 I WILL TELL YOU ABOUT THE FOUR 5114 03:29:44,880 --> 03:29:46,960 MAJOR TYPES OF AUTOIMMUNE MUSCLE 5115 03:29:46,960 --> 03:29:48,160 DISEASE OUR GROUP STUDIES AND 5116 03:29:48,160 --> 03:29:50,880 TELL YOU ABOUT THE SEX 5117 03:29:50,880 --> 03:29:51,400 DIFFERENCES AMONG THOSE 5118 03:29:51,400 --> 03:29:54,000 DIFFERENT TYPES OF AUTOIMMUNE 5119 03:29:54,000 --> 03:29:55,920 MUSCLE DISEASES AND I'M GOING TO 5120 03:29:55,920 --> 03:29:59,120 DO A DEEPER DIVE INTO A STUDY 5121 03:29:59,120 --> 03:30:02,080 THAT WE DID IN ONE OF THOSE 5122 03:30:02,080 --> 03:30:05,880 TYPES WHERE WE CAN LOOKING AT 5123 03:30:05,880 --> 03:30:06,520 CLINICAL DIFFERENCES BETWEEN 5124 03:30:06,520 --> 03:30:09,600 MALES AND FEMALES WITH THE SAME 5125 03:30:09,600 --> 03:30:14,520 DISEASE SO NEXT SLIDE. 5126 03:30:14,520 --> 03:30:15,920 THIS ARE FOUR TYPES THAT WE 5127 03:30:15,920 --> 03:30:16,320 STUDIED. 5128 03:30:16,320 --> 03:30:20,440 I WOULD SAY, THIS IS REALLY A 5129 03:30:20,440 --> 03:30:22,240 HETERO GENIOUS FAMILY OF MUSCLE 5130 03:30:22,240 --> 03:30:25,240 DISEASES AND EACH ONE IS REALLY 5131 03:30:25,240 --> 03:30:29,080 DISTINCT SO BEFORE OUR THE NAME 5132 03:30:29,080 --> 03:30:30,160 I AM FLIES HAS BOTH SKIN AND 5133 03:30:30,160 --> 03:30:31,720 MUSCLE INVOLVEMENT, THERE'S 5134 03:30:31,720 --> 03:30:37,320 ANOTHER DISEASE CALLED THE ANTI 5135 03:30:37,320 --> 03:30:41,520 OFSYNTHETASE SYNDROME AND THE 5136 03:30:41,520 --> 03:30:42,720 AND I'LL TELL YOU A LITTLE BIT 5137 03:30:42,720 --> 03:30:43,560 ABOUT THOSE. 5138 03:30:43,560 --> 03:30:45,440 THERE ARE PATIENTS WHO HAVE 5139 03:30:45,440 --> 03:30:54,560 IMMUNE MEDIATED NEP ROW TIEING 5140 03:30:54,560 --> 03:30:56,360 MYOPATHY AND I'LL TALK ABOUT 5141 03:30:56,360 --> 03:30:58,920 INCLUSION BODY MYOSITIS WHERE WE 5142 03:30:58,920 --> 03:31:03,680 HAVE A DETAILED LOOK AT SEX 5143 03:31:03,680 --> 03:31:03,960 DIFFERENCES. 5144 03:31:03,960 --> 03:31:05,520 I SHOULD MENTION THESE ARE 5145 03:31:05,520 --> 03:31:07,400 REALLY PRETTY RARE DISEASES AND 5146 03:31:07,400 --> 03:31:09,080 WE THINK THAT OVER ALL 5147 03:31:09,080 --> 03:31:13,520 PREVALENCE OF THESE DISEASES IS 5148 03:31:13,520 --> 03:31:15,680 SOMEWHERE BETWEEN THROW AND 40 5149 03:31:15,680 --> 03:31:16,680 PER 100,000 IN THE POPULATION 5150 03:31:16,680 --> 03:31:17,800 AND REPHRASING I MENTIONED HERE 5151 03:31:17,800 --> 03:31:27,360 IS IN GENERAL, THEY WE CAN WOMEN 5152 03:31:27,360 --> 03:31:28,920 MORE THAN MEN AND WE'LL TALK 5153 03:31:28,920 --> 03:31:32,520 ABOUT THAT IN SOME DETAIL. 5154 03:31:32,520 --> 03:31:38,480 IS DERMATOMYOSITIS IS THE MOST 5155 03:31:38,480 --> 03:31:39,720 COMMON FORM OF AUTOIMMUNE MUSCLE 5156 03:31:39,720 --> 03:31:41,120 DISEASE IN THE PATIENT 5157 03:31:41,120 --> 03:31:43,280 POPULATION SO THOSE UNDER 50. 5158 03:31:43,280 --> 03:31:45,840 AND THESE PATIENTS WILL PRESENT 5159 03:31:45,840 --> 03:31:50,560 WITH EITHER MUSCLE WEAKNESS AOR 5160 03:31:50,560 --> 03:31:51,040 A RASH FIRST. 5161 03:31:51,040 --> 03:31:53,560 WHEN THEY PRESENT WITH MUSCLE 5162 03:31:53,560 --> 03:31:57,480 WEAKNESS, THE KIND OF WEAKNESS 5163 03:31:57,480 --> 03:31:58,200 IS THEY WILL COMPLAIN FIRST OF 5164 03:31:58,200 --> 03:32:00,080 THINGS LIKE DIFFICULTY GOING 5165 03:32:00,080 --> 03:32:03,240 UPSTAIRS AND THEN AS THE DISEASE 5166 03:32:03,240 --> 03:32:04,880 PROGRESSES, THEY MAY HAVE CULT 5167 03:32:04,880 --> 03:32:06,400 GETTING OUT A CHAIR WITHOUT 5168 03:32:06,400 --> 03:32:08,280 USING THEIR ARMS TO PUSH OFF AND 5169 03:32:08,280 --> 03:32:10,560 IF THEY GET REALLY WEAK THEY 5170 03:32:10,560 --> 03:32:12,920 MIGHT REQUIRE A WHEELCHAIR. 5171 03:32:12,920 --> 03:32:16,520 THERE ARE LEFT WITH THE RAISING 5172 03:32:16,520 --> 03:32:17,960 THINGS ABOVE THEIR HEAD. 5173 03:32:17,960 --> 03:32:19,760 THEY MAY DEVELOP DOING THINGS 5174 03:32:19,760 --> 03:32:22,080 LIKE SHAVING OR WASHING THEIR 5175 03:32:22,080 --> 03:32:23,520 HAIR BECAUSE OF MUSCLE. 5176 03:32:23,520 --> 03:32:25,200 WHAT THEY DON'T HAVE IS WEAKNESS 5177 03:32:25,200 --> 03:32:27,800 OF THE DISTAL MUSCLES LIKE THE 5178 03:32:27,800 --> 03:32:32,280 HANDS AND FEET. 5179 03:32:32,280 --> 03:32:39,280 SA SKIN RASHPROGRESSES QUICKLY R 5180 03:32:39,280 --> 03:32:41,080 MONTHS SO THEY MIGHT BE FINE IN 5181 03:32:41,080 --> 03:32:42,880 DECEMBER AND NOTICE A RASH IN 5182 03:32:42,880 --> 03:32:46,040 JANUARY AND BY MARCH THEY HAVE 5183 03:32:46,040 --> 03:32:47,240 RASH AND WEAKNESS. 5184 03:32:47,240 --> 03:32:49,360 I'LL SHOW YOU THE RASHES THESE 5185 03:32:49,360 --> 03:32:50,920 PATIENTS GET. 5186 03:32:50,920 --> 03:32:52,480 BECAUSE OF THE MUSCLE BREAKDOWN 5187 03:32:52,480 --> 03:32:54,120 OCCURS THE LEVEL OF MUSCLE 5188 03:32:54,120 --> 03:32:56,960 ENZYME LIKE CK LEVELS AND THEIR 5189 03:32:56,960 --> 03:32:59,200 SERUM IS USUALLY ELEVATED AND 5190 03:32:59,200 --> 03:33:01,200 JUST LIKE Dr. KAPLAN MENTIONED 5191 03:33:01,200 --> 03:33:04,760 FOR LUPUS AND OTHER TYPES OF 5192 03:33:04,760 --> 03:33:06,040 SYSTEMIC AUTOIMMUNE PATIENTS 5193 03:33:06,040 --> 03:33:11,120 PATIENTS GENERALLY DEVELOP AUTO 5194 03:33:11,120 --> 03:33:13,640 ANTIBODIES AND THEY CAN DEFINE 5195 03:33:13,640 --> 03:33:15,160 DIFFERENT TYPES AND I WON'T GET 5196 03:33:15,160 --> 03:33:17,600 TOO MUCH INTO THAT TODAY AND WE 5197 03:33:17,600 --> 03:33:22,640 DID ELECTRIC PHYSICAL STUDIES 5198 03:33:22,640 --> 03:33:24,280 THEY HAVE MIO PACT I CAN 5199 03:33:24,280 --> 03:33:26,080 FEATURES AS OPPOSED IT NEURO 5200 03:33:26,080 --> 03:33:28,760 AGAIN I CAN FEATURES AND WHEN WE 5201 03:33:28,760 --> 03:33:39,400 DO MUSCLE BUY ON SEES -- AND A H 5202 03:33:51,000 --> 03:33:53,320 OVER THE UPPER EYELIDS. 5203 03:33:53,320 --> 03:33:58,520 IT'S A PURPLE RASH. 5204 03:33:58,520 --> 03:34:07,000 IT'S JUST DIAGNOSED FOR 5205 03:34:07,000 --> 03:34:11,440 DERMATOMYOSITI IS S AND THESE 5206 03:34:11,440 --> 03:34:14,760 LESION ON THE EX TENSER SURFACE 5207 03:34:14,760 --> 03:34:17,480 OF THE HANDS AND AGAIN, THIS IS 5208 03:34:17,480 --> 03:34:20,760 A KIND OF RASH THAT WE ONLY SEE 5209 03:34:20,760 --> 03:34:26,600 IN DERMATOMYOSITIS PATIENTS. 5210 03:34:26,600 --> 03:34:30,560 WE HAVE LESIONS THAT CAN OCCUR. 5211 03:34:30,560 --> 03:34:32,600 YOU HAVE AN ULCER EIGHTING 5212 03:34:32,600 --> 03:34:34,760 LESION ON THE FINGER TIP AND ON 5213 03:34:34,760 --> 03:34:40,200 THE RIGHT, YOU SEE THAT ARE 5214 03:34:40,200 --> 03:34:43,600 ULCER EIGHTING AND SELLING ASK 5215 03:34:43,600 --> 03:34:54,120 CAUSE DOUBLE FOR TOUR PATIENTS. 5216 03:34:56,280 --> 03:34:58,520 AND IF YOU LOOK AT THE NAIL BED 5217 03:34:58,520 --> 03:35:02,840 OF THE MIDDLE FINGER YOU SEE 5218 03:35:02,840 --> 03:35:06,120 DILATED CAPILLARY. 5219 03:35:06,120 --> 03:35:08,240 SO THEY HAVE EFFECT CAPILLARY 5220 03:35:08,240 --> 03:35:10,440 AND YOU CAN SEE IT IN THE NAIL 5221 03:35:10,440 --> 03:35:12,360 BEDS AND ALSO CAPILLARY DROP 5222 03:35:12,360 --> 03:35:14,480 OUT. 5223 03:35:14,480 --> 03:35:19,200 THESE ARE TYPICAL FEATURES. 5224 03:35:19,200 --> 03:35:20,760 I'M GOING TO SHOW YOU IN THE 5225 03:35:20,760 --> 03:35:23,280 NEXT SLIDE SOME ABNORMAL MUSCLE 5226 03:35:23,280 --> 03:35:27,200 BIOPSY FROM PATIENTS. 5227 03:35:27,200 --> 03:35:29,120 WHAT I HAVE HERE IS A NORMAL 5228 03:35:29,120 --> 03:35:31,720 MUSCLE BIOPSY ON THE LEFT AND 5229 03:35:31,720 --> 03:35:32,560 THE RIGHT. 5230 03:35:32,560 --> 03:35:33,880 THE LEFT A LOW POWER. 5231 03:35:33,880 --> 03:35:36,800 ABOUT WHAT YOU CAN SEE THERE, 5232 03:35:36,800 --> 03:35:39,080 THIS IS A CROSS SECTION THROUGH 5233 03:35:39,080 --> 03:35:40,640 MUSCLE VIBERS AND EACH OF THOSE 5234 03:35:40,640 --> 03:35:42,440 RED CIRCLES IS AN INDIVIDUAL 5235 03:35:42,440 --> 03:35:43,400 MUSCLE FIBER. 5236 03:35:43,400 --> 03:35:50,200 YOU CAN SEE THEY'RE ORGANIZED IN 5237 03:35:50,200 --> 03:35:52,440 VLASICAL SO HAS ONE IN THE 5238 03:35:52,440 --> 03:35:55,680 CENTER WHERE YOU SEE A FULL MIO 5239 03:35:55,680 --> 03:35:59,800 FIBER AND YOU SEE THOSE WITH 5240 03:35:59,800 --> 03:36:02,480 THEIR DARK PURPLE NUKELY EYE 5241 03:36:02,480 --> 03:36:03,720 AROUND THE EDGES. 5242 03:36:03,720 --> 03:36:08,440 AND YOU DID SEE ARE DAMAGED MIO 5243 03:36:08,440 --> 03:36:10,160 FIBERS. 5244 03:36:10,160 --> 03:36:12,400 ON THE NEXT SLIDE, ARE EXAMPLES 5245 03:36:12,400 --> 03:36:16,280 OF MUSCLE BIOPSY WITH A PATIENT 5246 03:36:16,280 --> 03:36:18,000 WITH DERMATO. 5247 03:36:18,000 --> 03:36:19,440 THIS IS A CROSS THE SECTION AND 5248 03:36:19,440 --> 03:36:25,920 YOU CAN STILL SEE THE 5249 03:36:25,920 --> 03:36:26,720 ARCHITECTURE AROUND THE EDGES. 5250 03:36:26,720 --> 03:36:28,880 YOU SEE THE INDIVIDUAL MUSCLE 5251 03:36:28,880 --> 03:36:31,640 FIBERS ARE SMALL AND A TROPHIC 5252 03:36:31,640 --> 03:36:34,280 AND ATROPHY, ONE OF THE HALLMARK 5253 03:36:34,280 --> 03:36:34,880 FEATURES. 5254 03:36:34,880 --> 03:36:37,120 IN CONTRAST THE MIO FIBERS IN 5255 03:36:37,120 --> 03:36:39,200 THE CENTER ARE RELATIVELY NORMAL 5256 03:36:39,200 --> 03:36:41,560 AND OTHER THE RIGHT, YOU WITH 5257 03:36:41,560 --> 03:36:46,160 SEE IS EVIDENCE OF PERRY 5258 03:36:46,160 --> 03:36:46,760 VASCULAR INFLAMMATION. 5259 03:36:46,760 --> 03:36:57,280 SO THOSE DARK PURPLE DOTS ARE 5260 03:37:00,840 --> 03:37:02,600 WHERE IT'S A VERY HIGH LEVELS OF 5261 03:37:02,600 --> 03:37:07,760 TYPE ONE INTRA FUR OPPOSITE ANDY 5262 03:37:07,760 --> 03:37:10,360 CELLS WOULD BE PLASMA SIGH TIED 5263 03:37:10,360 --> 03:37:11,560 THAT ARE POTENCY COTTAGE 5264 03:37:11,560 --> 03:37:22,760 COUNTRIERS OF TYPE ONE PO -- THS 5265 03:37:22,760 --> 03:37:24,800 THE SECOND MAJOR TYPE OF 5266 03:37:24,800 --> 03:37:26,440 AUTOIMMUNE MUSCLE DISEASE WE SEE 5267 03:37:26,440 --> 03:37:31,400 AND IT IS DEFINED PARTNERSHIP BE 5268 03:37:31,400 --> 03:37:32,760 AUTOIMMUNE THAT RECOGNIZE ONE OF 5269 03:37:32,760 --> 03:37:35,600 THE TNRA SO THESE ARE THEN TIMES 5270 03:37:35,600 --> 03:37:39,240 THAT ATTACH THE APPROPRIATE 5271 03:37:39,240 --> 03:37:41,120 AMINO ACID SO THEY'RE IMPORTANT 5272 03:37:41,120 --> 03:37:44,720 FOR PROTEIN PRODUCTION AND FOR 5273 03:37:44,720 --> 03:37:45,960 REASONS WE DON'T UNDERSTAND, 5274 03:37:45,960 --> 03:37:48,000 THESE ENZYMES ARE TARGETS OF THE 5275 03:37:48,000 --> 03:37:50,560 IMMUNE RESPONSE AND SOME OF OUR 5276 03:37:50,560 --> 03:37:51,480 PATIENTS WITH AUTOIMMUNE MUSCLE 5277 03:37:51,480 --> 03:37:55,560 DISEASE AND THE MOST COMMON AUTO 5278 03:37:55,560 --> 03:37:58,120 ANTIBODY AND REALLY ONE OF THE 5279 03:37:58,120 --> 03:38:01,640 MOST AUTO ANTIBODIES IN PATIENTS 5280 03:38:01,640 --> 03:38:06,240 WITH MYOSITIS AND IT'S OTHERWISE 5281 03:38:06,240 --> 03:38:11,360 KNOWN AS JO1. 5282 03:38:11,360 --> 03:38:13,880 SEVERAL OF THE OTHER TRNA ARE 5283 03:38:13,880 --> 03:38:17,080 RECOGNIZED LESS COMMONLY THAN HI 5284 03:38:17,080 --> 03:38:22,760 IS STIDYL-TRNA. 5285 03:38:22,760 --> 03:38:26,080 THESE PATIENTS DON'T JUST HAVE 5286 03:38:26,080 --> 03:38:27,800 MYOSITIS. 5287 03:38:27,800 --> 03:38:32,640 THEY ALSO HAVE A SYNDROME THAT 5288 03:38:32,640 --> 03:38:33,360 CONCLUDES ARTHRITIS AND UP THERE 5289 03:38:33,360 --> 03:38:38,480 IN THE LEFT CORNER, YOU SEE A 5290 03:38:38,480 --> 03:38:41,240 PATIENT WHOSE HANDS IS SWOLLEN 5291 03:38:41,240 --> 03:38:41,640 WITH ARTHRITIS. 5292 03:38:41,640 --> 03:38:43,840 THEY GET FEATURES OTHER THAN THE 5293 03:38:43,840 --> 03:38:45,480 RASHES AND ONE OF THOSE 5294 03:38:45,480 --> 03:38:46,200 MECHANICS HANDS THERE'S A 5295 03:38:46,200 --> 03:38:47,680 PICTURE OF THAT IN THE UPPER 5296 03:38:47,680 --> 03:38:51,880 RIGHT CORNER IS THESE ARE TYPIER 5297 03:38:51,880 --> 03:38:53,320 LESIONS THAT OCCUR ON THE RAID 5298 03:38:53,320 --> 03:39:04,760 Y'ALL SURFARAID Y'ALLAND YOU SEG 5299 03:39:10,000 --> 03:39:14,320 WOMAN WITH THE SYNDROME AND 5300 03:39:14,320 --> 03:39:15,920 BOTTOM LOWER LEFT THERE, THAT IS 5301 03:39:15,920 --> 03:39:19,600 AN X-RAY OF A PATIENT WITH LUNG 5302 03:39:19,600 --> 03:39:21,480 DISEASE AND IT'S QUITE COMMON 5303 03:39:21,480 --> 03:39:23,400 AND PATIENTS WITH THE SYNDROME 5304 03:39:23,400 --> 03:39:25,200 AND EVEN MORE THAN THE RASH OR 5305 03:39:25,200 --> 03:39:28,960 THE MUSCLE INVOLVEMENT AND CAN 5306 03:39:28,960 --> 03:39:33,160 REALLY CAUSE LIFE-THREATENING 5307 03:39:33,160 --> 03:39:43,640 COMPLICATIONS FOR PATIENTS. 5308 03:39:44,480 --> 03:39:47,480 >>THE REASON IT'S CALLED NEP 5309 03:39:47,480 --> 03:39:48,240 ROW TIDES ASKING IN THE RIGHT 5310 03:39:48,240 --> 03:39:51,160 AND IT SHOWS A MUSCLE FROM 5311 03:39:51,160 --> 03:39:55,440 PATIENT WITH IMMUNE MEDIATED 5312 03:39:55,440 --> 03:39:58,640 NECROTIZING AND YOU SEE AGAIN 5313 03:39:58,640 --> 03:40:00,400 GENERATING MIO FIBERS AND 5314 03:40:00,400 --> 03:40:02,720 REGENERATING MYOFIBERS BUT YOU 5315 03:40:02,720 --> 03:40:05,760 DID SEE THIS ASTRO FEE OR 5316 03:40:05,760 --> 03:40:07,160 PERIVASCULAR INFORMATION AND YOU 5317 03:40:07,160 --> 03:40:08,640 DON'T SEE MUCH INFLAMMATION AT 5318 03:40:08,640 --> 03:40:13,600 ALL SO THIS IS A NECROTIZING 5319 03:40:13,600 --> 03:40:13,840 PROCESS. 5320 03:40:13,840 --> 03:40:16,720 THEY HAVE AN AUTO ANTIBODIES 5321 03:40:16,720 --> 03:40:17,880 THAT RECOGNIZES A SINGLE 5322 03:40:17,880 --> 03:40:20,640 RECOGNITION PARTICLE AND IT'S A 5323 03:40:20,640 --> 03:40:22,200 PROTEIN IMPORTANT FOR MOVING 5324 03:40:22,200 --> 03:40:30,600 NEWLY TRAPS KNEW TRANSLATED PROM 5325 03:40:30,600 --> 03:40:33,360 THEY HAVE ANTIBODIES THAT TARGET 5326 03:40:33,360 --> 03:40:39,040 AN ENZYME CALLED HMG-COA REDUCT 5327 03:40:39,040 --> 03:40:42,480 ACE AND IT'S THE BIO SYNTHETIC 5328 03:40:42,480 --> 03:40:45,000 PATHWAY AND STAFF MEDICATIONS 5329 03:40:45,000 --> 03:40:46,800 WHICH ARE PRESCRIBED IN THE 5330 03:40:46,800 --> 03:40:51,360 WORLD I BELIEVE, THEY LOWER 5331 03:40:51,360 --> 03:40:55,440 CHOLESTEROL LEVELS BY INHIBITING 5332 03:40:55,440 --> 03:40:57,680 HMG-COA AND LIMITING CHOLESTEROL 5333 03:40:57,680 --> 03:40:59,040 PRODUCTION AND ONE OF THE MAJOR 5334 03:40:59,040 --> 03:41:01,480 RISK FACTORS FOR DEVELOPING AN 5335 03:41:01,480 --> 03:41:07,120 ANTI HMG-CR IS EXPOSURE TO STAT. 5336 03:41:07,120 --> 03:41:09,480 IT PRE DISPOSES PATIENTS TO 5337 03:41:09,480 --> 03:41:10,920 DEVELOPING THAT DISEASE. 5338 03:41:10,920 --> 03:41:14,320 PATIENTS WITH THIS TYPE OF 5339 03:41:14,320 --> 03:41:16,440 MYOSTATI IS S HAS MUSCLE 5340 03:41:16,440 --> 03:41:18,120 WEAKNESS THAT TAKES THEM FROM 5341 03:41:18,120 --> 03:41:21,520 WALKING NORMALLY TO BEING IN A 5342 03:41:21,520 --> 03:41:24,240 WHEELCHAIR WITHIN A FEW SHORT 5343 03:41:24,240 --> 03:41:24,720 MONTHS. 5344 03:41:24,720 --> 03:41:26,160 THE WEAKNESS IS SEVERE. 5345 03:41:26,160 --> 03:41:31,160 UNLIKE PATIENTS WITH MYOSITIS 5346 03:41:31,160 --> 03:41:34,120 AND WHO HAVE EXTRA MUSCULAR 5347 03:41:34,120 --> 03:41:36,600 INVOLVEMENT LIKE SKIN, LUNG AND 5348 03:41:36,600 --> 03:41:40,960 JOINT, THE LAB IS A REALLY SEEMS 5349 03:41:40,960 --> 03:41:42,720 TO BE RESTRICTED TO DAMAGING 5350 03:41:42,720 --> 03:41:44,760 MUSCLE CELLS IN MOST PATIENCE 5351 03:41:44,760 --> 03:41:47,160 AND THIS IS ONE OF THE MORE 5352 03:41:47,160 --> 03:41:48,440 DIFFICULT TO TREAT TYPES OF MIO 5353 03:41:48,440 --> 03:41:59,000 SIGHT IS AND IN OUR YOUNG WOMEN. 5354 03:42:04,320 --> 03:42:07,080 THIS IS THE FOURTH TYPE OF 5355 03:42:07,080 --> 03:42:08,120 MYOSITIS, THE FOURTH OF FOUR 5356 03:42:08,120 --> 03:42:09,080 THAT I WILL TELL YOU ABOUT 5357 03:42:09,080 --> 03:42:09,480 TODAY. 5358 03:42:09,480 --> 03:42:13,360 I'LL TELL YOU MORE ABOUT THIS IN 5359 03:42:13,360 --> 03:42:16,560 DETAIL BUT INCLUSION BESIDE' 5360 03:42:16,560 --> 03:42:18,360 MYOSITIS IS THE MOST COMMON 5361 03:42:18,360 --> 03:42:21,880 ACQUIRED MUSCLE DISEASE THATS 5362 03:42:21,880 --> 03:42:23,440 PATIENTS OVER 50-YEARS-OLD. 5363 03:42:23,440 --> 03:42:25,120 THE IT'S THE MOST COMMON MUSCLE 5364 03:42:25,120 --> 03:42:26,840 DISEASE IN THAT PATIENT 5365 03:42:26,840 --> 03:42:27,800 POPULATION. 5366 03:42:27,800 --> 03:42:28,760 PATIENTS WHO DEVELOPED THE OTHER 5367 03:42:28,760 --> 03:42:30,640 TYPES OF MIO SIGHT US QUICKLY 5368 03:42:30,640 --> 03:42:33,240 OVER WEEKS OR MONTHS, INCLUSION 5369 03:42:33,240 --> 03:42:37,080 BY MYOSITIS HAS AN INSIDIOUS 5370 03:42:37,080 --> 03:42:39,680 ONSET TO PATIENTS MIGHT NOT EVEN 5371 03:42:39,680 --> 03:42:41,600 REALLY RECOGNIZE HOW WEAK THEY 5372 03:42:41,600 --> 03:42:43,120 ARE UNTIL THEY START FALLING AND 5373 03:42:43,120 --> 03:42:45,320 THAT IS OFTEN THE COMMON REASON 5374 03:42:45,320 --> 03:42:49,160 WHY THESE PATIENTS WILL SEE A 5375 03:42:49,160 --> 03:42:50,160 NEUROLOGIST BECAUSE THEY STARTED 5376 03:42:50,160 --> 03:42:51,360 FALLING. 5377 03:42:51,360 --> 03:42:55,360 IF YOU ASK THEM, THEY'LL REALIZE 5378 03:42:55,360 --> 03:42:56,680 YEARS AGO THEY DEVELOPEDEL 5379 03:42:56,680 --> 03:42:57,880 DIFFICULTY GOING UPSTAIRS OR 5380 03:42:57,880 --> 03:42:59,560 SOMETHING LIKE THAT SO WE THINK 5381 03:42:59,560 --> 03:43:04,720 THAT WITH THE DISEASE STARTS AND 5382 03:43:04,720 --> 03:43:05,960 TAKES YEAR BEFORE THE PATIENTS 5383 03:43:05,960 --> 03:43:07,000 ARE AWARE. 5384 03:43:07,000 --> 03:43:10,320 THEY HAVE A YOU NEXT PATTERN OF 5385 03:43:10,320 --> 03:43:10,840 WEAKNESS. 5386 03:43:10,840 --> 03:43:13,600 ALL THE TOO TYPES HAVE MUSCLE 5387 03:43:13,600 --> 03:43:14,200 WEAKNESS THAT WILL I DETAILED 5388 03:43:14,200 --> 03:43:15,880 FOR YOU WHEN I DESCRIBED IT IN 5389 03:43:15,880 --> 03:43:16,440 PATIENTS. 5390 03:43:16,440 --> 03:43:21,200 THESE PATIENTS IF CONTRAST, HAVE 5391 03:43:21,200 --> 03:43:22,040 SIGNIFICANT DISTAL WEAKNESS SO 5392 03:43:22,040 --> 03:43:24,160 ON THE TOP PICTURE THERE ON THE 5393 03:43:24,160 --> 03:43:27,360 RIGHT, YOU SEE A PATIENT WHO IS 5394 03:43:27,360 --> 03:43:29,360 TRYING TO FORM A STRONG GRIP 5395 03:43:29,360 --> 03:43:31,480 WITH THEIR HANDS. 5396 03:43:31,480 --> 03:43:32,920 TRYING TO BURY THE FINGERS BUT 5397 03:43:32,920 --> 03:43:35,520 ON THE LEFT THE PATIENT IS 5398 03:43:35,520 --> 03:43:36,200 UNABLE TO FLEX THE THINGERS 5399 03:43:36,200 --> 03:43:37,760 THERE AND THAT IS THE CLASSIC 5400 03:43:37,760 --> 03:43:46,680 PATTERN OF WEAKNESS. 5401 03:43:46,680 --> 03:43:49,360 THEIR HANDS MIGHT NOT WAKE AND 5402 03:43:49,360 --> 03:43:59,920 SIMILARLY IN THE LEGS, THEIR HIP 5403 03:44:00,360 --> 03:44:04,480 AND THE RIGHT AND THE LEFT OF 5404 03:44:04,480 --> 03:44:06,920 THE QUADRA. 5405 03:44:06,920 --> 03:44:11,200 WHEN YOUR KNEE STARTS BENDING 5406 03:44:11,200 --> 03:44:16,840 AND YOU CAN'T EXTEND IT YOU WILL 5407 03:44:16,840 --> 03:44:24,520 GO DOWN. 5408 03:44:24,520 --> 03:44:25,960 INSTEAD OF HAVING WEAKNESS ON 5409 03:44:25,960 --> 03:44:27,040 BOTH SIDES THERE'S AS I 5410 03:44:27,040 --> 03:44:27,320 SYMMETRY. 5411 03:44:27,320 --> 03:44:30,800 A THIRD OF THEE PATIENTS DEVELOP 5412 03:44:30,800 --> 03:44:31,640 SWALLOWING DIFFICULTIES AND SOME 5413 03:44:31,640 --> 03:44:34,600 OF THEM AS THE DISEASE 5414 03:44:34,600 --> 03:44:37,600 PROGRESSES, CAN REQUIRE FEEDING 5415 03:44:37,600 --> 03:44:38,200 TUBES. 5416 03:44:38,200 --> 03:44:46,000 I HAVEN TALKED A LOT ABOUT TREAT 5417 03:44:46,000 --> 03:44:47,560 BUT WE HAVE PRETTY GOOD 5418 03:44:47,560 --> 03:44:50,680 TREATMENTS FOR WITH TYPICAL 5419 03:44:50,680 --> 03:44:51,880 IMMUNOSUPPRESS LENT MEDICATIONS 5420 03:44:51,880 --> 03:45:00,160 IN CONTRAST, INCLUSION BODY 5421 03:45:00,160 --> 03:45:01,520 MYOSITIS BUT THERE ARE 5422 03:45:01,520 --> 03:45:04,120 TREATMENTS COMING ON-LINE THAT 5423 03:45:04,120 --> 03:45:07,560 ARE SPECIFICALLY TARGETED FOR IN 5424 03:45:07,560 --> 03:45:09,920 CONCLUSION BODY MYOSITIS SO 5425 03:45:09,920 --> 03:45:10,520 UNDERSTANDING THE NATURAL 5426 03:45:10,520 --> 03:45:12,400 HISTORY OF THE DISEASE IS 5427 03:45:12,400 --> 03:45:13,120 PARTICULARLY IMPORTANT. 5428 03:45:13,120 --> 03:45:18,480 AND THE NEXT SLIDE, WILL SHOW 5429 03:45:18,480 --> 03:45:21,120 YOU PATIENT WITH I AM CONCLUSION 5430 03:45:21,120 --> 03:45:22,640 BODY MYOSITIS AND THE POWER VIEW 5431 03:45:22,640 --> 03:45:27,560 OF A SINGLE MIO FIBER AND IT HAS 5432 03:45:27,560 --> 03:45:29,480 STRUCTURES THAT WE CALL RIMMED 5433 03:45:29,480 --> 03:45:32,880 VACUUMS AND THOSE ARE ABNORMAL 5434 03:45:32,880 --> 03:45:37,560 STRUCTURES WE ON THE SEE 5435 03:45:37,560 --> 03:45:48,000 INCLUSION PAYS SHE WAS AND 5436 03:45:58,440 --> 03:46:01,320 IT'S A TIME OF AGGRESSIVE CYTO 5437 03:46:01,320 --> 03:46:07,960 TOXIC T-CELL THAT IS RESI RESIS. 5438 03:46:07,960 --> 03:46:11,600 THAT'S ONE REASON WHY WE DON'T 5439 03:46:11,600 --> 03:46:13,160 HAVE BRAIN LUCK TREATING THESE 5440 03:46:13,160 --> 03:46:14,520 PATIENTS BUT ONE OF THE CRIMINAL 5441 03:46:14,520 --> 03:46:17,080 TRIALS GOING ON IS A ANTIBODY 5442 03:46:17,080 --> 03:46:19,600 TARGETING JUST EXACTLY THOSE CDA 5443 03:46:19,600 --> 03:46:25,160 POSITIVE AND CD57 POSITIVE T 5444 03:46:25,160 --> 03:46:31,640 CELLS. 5445 03:46:31,640 --> 03:46:33,680 ALL OF THE FIRST THREE ARE MORE 5446 03:46:33,680 --> 03:46:35,440 COMMON THAN MEN. 5447 03:46:35,440 --> 03:46:42,200 RAGING FROM 61% TO 70% IN IN 5448 03:46:42,200 --> 03:46:48,400 CONTRAST INCLUSION BODY IBM IS 5449 03:46:48,400 --> 03:46:52,240 MALE DOMIN APART DOMINANT AND TA 5450 03:46:52,240 --> 03:46:57,920 DISEASE THAT AFFECTS OLDER MEN 5451 03:46:57,920 --> 03:46:59,040 AND SO SOMETIMES WE THINK THAT 5452 03:46:59,040 --> 03:47:01,360 THE DIAGNOSIS MAY BE MISSED IN 5453 03:47:01,360 --> 03:47:02,640 WOMEN AND THE STUDY THAT I'M 5454 03:47:02,640 --> 03:47:07,240 GOING TO TELL YOU ABOUT ON THE 5455 03:47:07,240 --> 03:47:12,320 NEXT SLIDE, IS GOING TO HELP 5456 03:47:12,320 --> 03:47:14,120 ADDRESS THE SEX DIFFERENCES SO 5457 03:47:14,120 --> 03:47:16,760 AGAIN, I TOLD YOU MOST OF THESE 5458 03:47:16,760 --> 03:47:18,280 THINGS AND IT'S SLOWLY 5459 03:47:18,280 --> 03:47:18,840 PROGRESSIVE. 5460 03:47:18,840 --> 03:47:20,760 POOR RESPONSE TO 5461 03:47:20,760 --> 03:47:21,560 IMMUNOSUPPRESSIVE THERAPY 5462 03:47:21,560 --> 03:47:23,040 ALTHOUGH WE HOPED FOR SOME OF 5463 03:47:23,040 --> 03:47:28,040 THESE NEW TREATMENTS AND ONE 5464 03:47:28,040 --> 03:47:29,920 THING THAT IS IMPORTANT IS TO 5465 03:47:29,920 --> 03:47:31,840 RECOGNIZE THERE'S CLINICAL 5466 03:47:31,840 --> 03:47:32,840 HETEROGENEITY THAT INFLUENCES 5467 03:47:32,840 --> 03:47:34,440 TREATMENT RESPONSE IN THIS SO IF 5468 03:47:34,440 --> 03:47:35,520 MEN, FOR EXAMPLE, HAVE A 5469 03:47:35,520 --> 03:47:37,240 DIFFERENT COURSE OF PRE GRES 5470 03:47:37,240 --> 03:47:41,640 THAN WOMEN IT WILL BE REALLY 5471 03:47:41,640 --> 03:47:45,160 IMPORTANT TO UNDERSTAND FOR 5472 03:47:45,160 --> 03:47:45,560 CLINICAL TRIALS. 5473 03:47:45,560 --> 03:47:48,320 WE HAD VERY LIMITED DATA 5474 03:47:48,320 --> 03:47:50,760 REGARDING THE HETERO BEGIN A TEE 5475 03:47:50,760 --> 03:47:53,240 OF DISEASE AND MOST PATIENTS OF 5476 03:47:53,240 --> 03:47:57,240 INCLUSION, BODY MYOSITIS 5477 03:47:57,240 --> 03:47:59,640 INCLUDED 100 OR LESS PATIENTS EX 5478 03:47:59,640 --> 03:48:03,800 THAT MEANT THERE WERE FEW WOMEN 5479 03:48:03,800 --> 03:48:07,120 AND OTHER MINORITY POPULATIONS, 5480 03:48:07,120 --> 03:48:09,160 WOMEN AROUND MINORITY 5481 03:48:09,160 --> 03:48:09,880 POPULATIONS BUT THEY HAVE LARGE 5482 03:48:09,880 --> 03:48:11,400 NUMBERS OF MINORITY POPULATIONS 5483 03:48:11,400 --> 03:48:15,720 SO WE DID A BIGGER STUDY, NEXT 5484 03:48:15,720 --> 03:48:20,800 SLIDE, WHERE WE TOOK ALL OF THE 5485 03:48:20,800 --> 03:48:26,920 PATIENTS THAT WERE EVALUATED 5486 03:48:26,920 --> 03:48:29,280 BETWEEN 2003 AND 2018 AND I 5487 03:48:29,280 --> 03:48:30,800 MENTIONED THAT AT THE NIH NOW 5488 03:48:30,800 --> 03:48:33,040 BUT I STILL HAVE A STRONG 5489 03:48:33,040 --> 03:48:34,040 COLLABORATION AND I'M STILL PART 5490 03:48:34,040 --> 03:48:37,480 OF THAT MYOSITIS CENTER AT 5491 03:48:37,480 --> 03:48:38,800 HOPKINS AND THAT'S WHERE IT WAS 5492 03:48:38,800 --> 03:48:43,360 THE POPULATION THAT WE UTILIZED 5493 03:48:43,360 --> 03:48:47,080 FOR THIS AND WE IDENTIFIED 5494 03:48:47,080 --> 03:48:48,480 PROGNOSTIC FACTORS AND INTO 5495 03:48:48,480 --> 03:48:50,720 STUDY THE DISEASE OVER TIME SO 5496 03:48:50,720 --> 03:48:54,600 WE LOOKED AT THE EVOLUTION OF 5497 03:48:54,600 --> 03:48:55,960 MUSCLE ENZYME CLAIMS AND 5498 03:48:55,960 --> 03:48:58,960 STRENGTH USING LINEAR REGRESSION 5499 03:48:58,960 --> 03:49:00,160 MODELS AND WE ADJUSTED FOR 5500 03:49:00,160 --> 03:49:02,760 THINGS LIKE SEX, RACE, DISEASE 5501 03:49:02,760 --> 03:49:12,120 AND AGE ON ON IS S-SET. 5502 03:49:12,120 --> 03:49:19,840 SO WE WERE ABLE TO COLLECT 335 5503 03:49:19,840 --> 03:49:21,600 WITH THE NEXT BIGGEST STUDY AND 5504 03:49:21,600 --> 03:49:22,880 TWO-THIRDS OF THE PATIENTS WERE 5505 03:49:22,880 --> 03:49:27,560 MALE AND THE AVERAGE AGE OF 5506 03:49:27,560 --> 03:49:32,000 DISEASE WAS 60-YEARS-OLD AND YOU 5507 03:49:32,000 --> 03:49:34,600 KNOW I WOULD HIGHLIGHT THE 5508 03:49:34,600 --> 03:49:36,320 AVERAGE DIAGNOSIS WAS FIVE 5509 03:49:36,320 --> 03:49:36,840 YEARS. 5510 03:49:36,840 --> 03:49:38,600 IT TOOK FIVE YEARS OF THESE 5511 03:49:38,600 --> 03:49:40,200 PATIENTS SEEING DOCTORS WITH A 5512 03:49:40,200 --> 03:49:41,400 COMPLAINT OF WEAKNESS BEFORE 5513 03:49:41,400 --> 03:49:42,680 THEY WERE ABLE DIAGNOSED WITH 5514 03:49:42,680 --> 03:49:47,720 THE CORRECT DISEASE AND 50% 5515 03:49:47,720 --> 03:49:54,160 RECEIVED THE WRONG DYING K DIAGS 5516 03:49:54,160 --> 03:49:55,520 MANY PEOPLE HAVE THE WRONG 5517 03:49:55,520 --> 03:49:56,840 DIAGNOSIS FOR YEARS AND ONE 5518 03:49:56,840 --> 03:49:58,720 THING WE FOUND LOOKING AT THE 5519 03:49:58,720 --> 03:50:02,320 PATIENTS CLOSELY IS BLACK 5520 03:50:02,320 --> 03:50:03,880 PATIENT WERE SIGNIFICANTLY 5521 03:50:03,880 --> 03:50:08,560 WEAKER IN ARM ABDUCTORS AND HIP 5522 03:50:08,560 --> 03:50:11,440 FLEXORS AND KNEE EXTENDERS THAN 5523 03:50:11,440 --> 03:50:12,200 OUR NON BLACK NATION. 5524 03:50:12,200 --> 03:50:15,400 THAT WAS IMPORTANT THAT WE 5525 03:50:15,400 --> 03:50:17,240 LEARNED WHICH IS THE DISEASE IS 5526 03:50:17,240 --> 03:50:18,360 MORE SEVERE IN THE BLACK 5527 03:50:18,360 --> 03:50:18,960 POPULATION. 5528 03:50:18,960 --> 03:50:24,280 NEXT SLIDE, PLEASE. 5529 03:50:24,280 --> 03:50:27,040 WE LOOKED AT DIFFERENCES BETWEEN 5530 03:50:27,040 --> 03:50:29,240 MEN AND WOMEN SO WE WERE ABLE TO 5531 03:50:29,240 --> 03:50:31,120 DO THIS BECAUSE WE HAD OVER 100 5532 03:50:31,120 --> 03:50:36,240 WOMEN AND 200 MEN AND WE FOUND 5533 03:50:36,240 --> 03:50:46,560 THAT WOMEN HAD STRONGER QUADRA 5534 03:50:46,560 --> 03:50:50,360 AND THEY JUST IN STRONGER. 5535 03:50:50,360 --> 03:50:52,520 ON THE OTHER HAND, THEY WERE 5536 03:50:52,520 --> 03:50:54,480 MANY SIGNIFICANTLY MORE AT RISK 5537 03:50:54,480 --> 03:50:56,040 FOR DEVELOPING SWALLOWING 5538 03:50:56,040 --> 03:50:56,720 DIFFICULTIES. 5539 03:50:56,720 --> 03:51:07,000 TWICE AS LIKELY. 5540 03:51:12,200 --> 03:51:13,480 THE SLOPE WAS NOT AS STEEP IN 5541 03:51:13,480 --> 03:51:13,960 WOMEN. 5542 03:51:13,960 --> 03:51:15,560 WHEN WE LOOKED AT THESE 5543 03:51:15,560 --> 03:51:16,720 PATIENTS, WE FOUND THAT THE 5544 03:51:16,720 --> 03:51:20,000 WOMAN WERE MUCH MORE LIKELY TO 5545 03:51:20,000 --> 03:51:21,680 RECEIVE A WRONG DIAGNOSIS AND TO 5546 03:51:21,680 --> 03:51:26,040 BE MISTREATED OR MESS MANAGED 5547 03:51:26,040 --> 03:51:29,080 FOR YEARS AND WE THINK THAT IT 5548 03:51:29,080 --> 03:51:31,080 CAN BE BECAUSE THEY JUST 5549 03:51:31,080 --> 03:51:33,960 PRESENTED THE STRONGER AND THEY 5550 03:51:33,960 --> 03:51:36,680 HAVE MORE SWELLING AND ET CETED 5551 03:51:36,680 --> 03:51:42,720 IT TOOK LOOPER LONGER SO ON AVET 5552 03:51:42,720 --> 03:51:44,560 TOOK SIX YEARS FOR WOMEN TO 5553 03:51:44,560 --> 03:51:46,040 RECEIVE THE CORRECT DIAGNOSIS 5554 03:51:46,040 --> 03:51:48,920 AND COMPARED TO 4.7 YEARS FOR 5555 03:51:48,920 --> 03:51:52,920 MEN TO RECEIVE THE CORRECT 5556 03:51:52,920 --> 03:51:56,400 DIAGNOSIS. 5557 03:51:56,400 --> 03:51:58,520 ONE OF THE IMPLICATIONS OF THIS 5558 03:51:58,520 --> 03:51:59,000 STUDY. 5559 03:51:59,000 --> 03:52:00,280 THE FEMALE PATIENTS WITH 5560 03:52:00,280 --> 03:52:03,840 INCLUSION BODY MYOSITIS HAVE A 5561 03:52:03,840 --> 03:52:05,560 DISTINCT CLINICAL PHENOTYPE AND 5562 03:52:05,560 --> 03:52:07,600 A DIFFERENT DISEASE TRAJECTORY 5563 03:52:07,600 --> 03:52:09,080 AND THIS IS REALLY IMPORTANT TO 5564 03:52:09,080 --> 03:52:12,800 DEEP IN MIND FOR CLINICAL TRIALS 5565 03:52:12,800 --> 03:52:14,720 WHICH INCLUDE WOMEN AND MEN 5566 03:52:14,720 --> 03:52:19,480 BECAUSE OF THE WOMENNER GOING 5567 03:52:19,480 --> 03:52:20,680 TO, EVEN IN THE ABSENCE OF 5568 03:52:20,680 --> 03:52:21,760 TREATMENT, HAVE A SLOWER 5569 03:52:21,760 --> 03:52:22,560 PROGRESSION. 5570 03:52:22,560 --> 03:52:26,520 IT MAY MEAN THAT THE PATH OF 5571 03:52:26,520 --> 03:52:29,440 PHYSIOLOGY IS DIFFERENT AND 5572 03:52:29,440 --> 03:52:31,360 WE'RE INTERESTED IF STUDYING 5573 03:52:31,360 --> 03:52:35,840 THAT AND WHY DO WOMEN DO BETTER 5574 03:52:35,840 --> 03:52:36,880 THAN MEN. 5575 03:52:36,880 --> 03:52:37,880 THESE UNRECOGNIZED DIFFERENCES 5576 03:52:37,880 --> 03:52:40,280 MAY HAVE CONTRIBUTED TO THE 5577 03:52:40,280 --> 03:52:41,480 DELAY OF THE CORRECT DIAGNOSIS 5578 03:52:41,480 --> 03:52:42,920 IN WOMEN AND WE'RE TRYING TO GET 5579 03:52:42,920 --> 03:52:53,400 THE WORD OUT THERE THEY HAD NOT 5580 03:52:53,400 --> 03:52:55,560 LOOK OUT FOR WOMEN COMPARED TO 5581 03:52:55,560 --> 03:52:58,920 MEN AND WE THINK AT GOING TO 5582 03:52:58,920 --> 03:53:00,440 IMPLEMENT THE DESIGN OF FUTURE 5583 03:53:00,440 --> 03:53:01,400 CLINICAL TRIALS AND IT'S NOW 5584 03:53:01,400 --> 03:53:03,640 CAUSING US TO GO BACK AND LOOK 5585 03:53:03,640 --> 03:53:07,280 AT MUSCLE TISSUE TO SEE IF WE 5586 03:53:07,280 --> 03:53:10,480 CAN TROY TO BETTER UNDERSTAND 5587 03:53:10,480 --> 03:53:17,800 THE PHYSIOLOGY NOT BETWEEN MEN D 5588 03:53:17,800 --> 03:53:19,040 WOMEN IN THIS DISEASE. 5589 03:53:19,040 --> 03:53:20,440 THIS IS MY LAST SLIDE. 5590 03:53:20,440 --> 03:53:23,840 WE HAVE TO THINK ALONG WITH MARY 5591 03:53:23,840 --> 03:53:26,040 KAPLAN TO TAKE ANY QUESTIONS. 5592 03:53:26,040 --> 03:53:29,080 >>THANK YOU BOTH. 5593 03:53:29,080 --> 03:53:31,200 AT THIS TIME, WE WELCOME 5594 03:53:31,200 --> 03:53:32,520 QUESTIONS. 5595 03:53:32,520 --> 03:53:35,400 YOU CAN EITH EITHER RAISE YOUR 5596 03:53:35,400 --> 03:53:36,360 HAPPENED OR IF THERE'S 5597 03:53:36,360 --> 03:53:38,160 SOMETHING, I DON'T SEE ANYTHING 5598 03:53:38,160 --> 03:53:40,240 IN THE CHATBOX. 5599 03:53:40,240 --> 03:53:42,840 ARE THERE ANY INITIAL QUESTIONS 5600 03:53:42,840 --> 03:53:52,080 FOR OUR PRESENTERS? 5601 03:53:52,080 --> 03:53:56,200 FIRST QUESTION TO Dr. KAPLAN. 5602 03:53:56,200 --> 03:53:57,960 YOU COVERED LUPUS WHICH IS OF 5603 03:53:57,960 --> 03:53:59,560 COURSE A HUGE CONCERN BECAUSE OF 5604 03:53:59,560 --> 03:54:03,200 HEALTH DISPARITIES. 5605 03:54:03,200 --> 03:54:06,280 IS THERE INTERSECTIONALITY 5606 03:54:06,280 --> 03:54:09,960 BETWEEN FEMALE SEX AND MINORITY 5607 03:54:09,960 --> 03:54:10,320 WOMEN? 5608 03:54:10,320 --> 03:54:15,440 DO YOU CARE TO COMMENT, PLEASE? 5609 03:54:15,440 --> 03:54:16,480 >>WHETHER SOME OF THE 5610 03:54:16,480 --> 03:54:18,400 DIFFERENCES WE'VE SEEN MAY BE 5611 03:54:18,400 --> 03:54:21,360 OBSERVED WHEN YOU COMPARE 5612 03:54:21,360 --> 03:54:22,560 DIFFERENT ETHNIC GROUPS? 5613 03:54:22,560 --> 03:54:23,640 IS THAT YOUR QUESTION. 5614 03:54:23,640 --> 03:54:32,320 THAT'S A GREAT QUESTION. 5615 03:54:32,320 --> 03:54:34,200 THIS IS AN ONGOING STUDY AND 5616 03:54:34,200 --> 03:54:36,000 WE'RE LOOKING ACROSS THE AGE SO 5617 03:54:36,000 --> 03:54:37,160 WE HOPE TO HAVE MORE INFORMATION 5618 03:54:37,160 --> 03:54:37,600 ABOUT THAT. 5619 03:54:37,600 --> 03:54:39,960 I MEAN, THERE ARE SOME 5620 03:54:39,960 --> 03:54:43,640 INTERESTING OBSERVATIONS ABOUT 5621 03:54:43,640 --> 03:54:44,840 NEUTROPHIL NUMBERS THAT PEOPLE 5622 03:54:44,840 --> 03:54:46,600 OF AFRICAN DIS SEPTEMBER HAVE 5623 03:54:46,600 --> 03:54:50,040 LOWER NEUTROPHIL NUMBERS. 5624 03:54:50,040 --> 03:54:52,160 HOW THAT RELATES TO THE 5625 03:54:52,160 --> 03:54:56,880 OBSERVATIONS AND IT'S STILL 5626 03:54:56,880 --> 03:55:05,960 UNCLEAR. 5627 03:55:05,960 --> 03:55:07,880 IT MAY BE DIFFERENCES IN 5628 03:55:07,880 --> 03:55:09,160 NEUTROPHIL BIOLOGY THAT'S A 5629 03:55:09,160 --> 03:55:09,640 GREAT QUESTION. 5630 03:55:09,640 --> 03:55:10,000 THANK YOU. 5631 03:55:10,000 --> 03:55:13,200 >>I HAVE A QUESTION FOR Dr. 5632 03:55:13,200 --> 03:55:15,680 MAMMEN IN TERMS OF THE IBM IN 5633 03:55:15,680 --> 03:55:18,440 WOMEN, EVEN THOUGH THEY'RE A 5634 03:55:18,440 --> 03:55:23,320 LOWER PERCENTAGE, B WOULD WOULDE 5635 03:55:23,320 --> 03:55:26,280 MORE LIKELY TO PICK THIS UP IN 5636 03:55:26,280 --> 03:55:26,800 WOMEN? 5637 03:55:26,800 --> 03:55:27,960 YOU MENTIONED YOU ARE TRYING TO 5638 03:55:27,960 --> 03:55:28,920 GET THE WORD OUT? 5639 03:55:28,920 --> 03:55:34,320 >>YES, SO, USUALLY THEY WIND UP 5640 03:55:34,320 --> 03:55:38,880 IN THE OFFICE A NEUROLOGIST 5641 03:55:38,880 --> 03:55:40,800 WHERE IT'S MADE. 5642 03:55:40,800 --> 03:55:45,120 ONE OF THE THINGS THAT MAKES IT 5643 03:55:45,120 --> 03:55:48,960 DIFFICULT IS THIS MISS 5644 03:55:48,960 --> 03:55:50,400 UNDERSTANDING THAT IT'S NORMAL 5645 03:55:50,400 --> 03:55:57,040 FOR AN OLDER PERSON AND TO JUST 5646 03:55:57,040 --> 03:55:58,680 WRITE IT OFF WE MEET MORE 5647 03:55:58,680 --> 03:56:00,920 EXERCISE WHEN PATIENTS ARE 5648 03:56:00,920 --> 03:56:05,000 DEVELOPING YOU KNOW, A NEURO 5649 03:56:05,000 --> 03:56:07,160 MUSCULAR PROBLEM. 5650 03:56:07,160 --> 03:56:09,240 IT OFTEN TAKES PATIENTS STARTING 5651 03:56:09,240 --> 03:56:13,000 TO DO SOMETHING LIKE FALL OR 5652 03:56:13,000 --> 03:56:15,360 REALLY HAVE PROBLEMS WHERE THEIR 5653 03:56:15,360 --> 03:56:17,800 DOCTORS WILL REFER THEM TO SEE A 5654 03:56:17,800 --> 03:56:18,960 SPECIALIST WHO WILL BE BETTER 5655 03:56:18,960 --> 03:56:20,680 EQUIPPED TO MAKE THE DIAGNOSIS. 5656 03:56:20,680 --> 03:56:26,320 I THINK IT'S ASKING A LOT OF 5657 03:56:26,320 --> 03:56:29,480 INTERNISTS TOSH ABLE TO MAKE THE 5658 03:56:29,480 --> 03:56:31,880 DIAGNOSIS OF IBM EVEN IN 5659 03:56:31,880 --> 03:56:34,840 SPECIALIST EARLY ON IT CAN BE 5660 03:56:34,840 --> 03:56:36,600 DIFFICULT TO MAKE THE CORRECT 5661 03:56:36,600 --> 03:56:37,640 DIAGNOSIS. 5662 03:56:37,640 --> 03:56:40,280 SO, MOSTLY WE'RE TRYING TO 5663 03:56:40,280 --> 03:56:42,600 TARGET RHUMATOLOGIST AND 5664 03:56:42,600 --> 03:56:45,160 NEUROLOGISTS AND REALLY EXPLAIN 5665 03:56:45,160 --> 03:56:47,280 TO THEM YOU MAY NOT SEE THE SAME 5666 03:56:47,280 --> 03:56:49,800 TYPICAL PATTERN OF WEAKNESS 5667 03:56:49,800 --> 03:56:52,400 EARLY ON IN FEMALE PATIENTS WITH 5668 03:56:52,400 --> 03:56:54,800 INCLUSION BODY MYOSITIS SO IT 5669 03:56:54,800 --> 03:56:56,480 NEEDS TO BETTER CHANCE FOR 5670 03:56:56,480 --> 03:56:58,040 MAKING AN EASTERLY YEAR 5671 03:56:58,040 --> 03:56:59,840 INCORRECT DIAGNOSIS. 5672 03:56:59,840 --> 03:57:01,240 THANK YOU. 5673 03:57:01,240 --> 03:57:03,080 I SEE Dr. McGREGOR HAS HER 5674 03:57:03,080 --> 03:57:13,360 HAND UP, PLEASE. 5675 03:57:14,640 --> 03:57:15,560 JUST LAST COMMENT ADDRESSED WHAT 5676 03:57:15,560 --> 03:57:18,160 I WAS GOING TO SAY. 5677 03:57:18,160 --> 03:57:19,560 THIS REQUIRED A REFERRAL TO A 5678 03:57:19,560 --> 03:57:27,800 SPECIALIST SO TO ME IT'S REALLY 5679 03:57:27,800 --> 03:57:30,480 INTERESTING AND IT'S BACK TO MY 5680 03:57:30,480 --> 03:57:33,480 PRODUCTION AND WHICH IS IT'S 5681 03:57:33,480 --> 03:57:36,080 REALLY THAT MOMENT OF 5682 03:57:36,080 --> 03:57:37,880 INTERACTION WITH THE HEALTHCARE 5683 03:57:37,880 --> 03:57:39,480 PROVIDERS AND IT'S CRITICAL AND 5684 03:57:39,480 --> 03:57:48,960 SO I THINK THAT REALLY JUST AND 5685 03:57:48,960 --> 03:57:51,680 MAKING SURE THAT AWARE OF THESE 5686 03:57:51,680 --> 03:57:53,560 THINGS TO THEY KNOW WHEN THEY 5687 03:57:53,560 --> 03:57:59,800 FEE FER AND THEM THE OTHER POINT 5688 03:57:59,800 --> 03:58:02,160 IS WE GENDER DISEASE AND IT'S 5689 03:58:02,160 --> 03:58:03,920 MORE MALE AND IT'S LESS LIKELY 5690 03:58:03,920 --> 03:58:07,560 TO BE DIAGNOSED WITH WOMEN AND 5691 03:58:07,560 --> 03:58:10,440 WE CAN SEE IT WITH OSTEOPOROSIS 5692 03:58:10,440 --> 03:58:14,480 DYING KNOWED IN MEN KEEPING 5693 03:58:14,480 --> 03:58:16,320 THESE THINGS IN MINDS ARE 5694 03:58:16,320 --> 03:58:20,680 CRITICAL FOR BOTH MEN AND WOMEN 5695 03:58:20,680 --> 03:58:21,960 BASICALLY. 5696 03:58:21,960 --> 03:58:24,440 >>I HAVE A QUICK QUESTION. 5697 03:58:24,440 --> 03:58:27,480 >>CORRECT ME IF I'M WRONG, I'M 5698 03:58:27,480 --> 03:58:29,680 A NEUROLOGIST TO I'M IGNORANT 5699 03:58:29,680 --> 03:58:33,160 ABOUT MOST OTHER AUTOIMMUNE 5700 03:58:33,160 --> 03:58:34,600 DISEASES, ALTHOUGH LUPUS IS MUCH 5701 03:58:34,600 --> 03:58:37,320 LESS COMMON IN MEN, WHEN MEN GET 5702 03:58:37,320 --> 03:58:38,880 LUPUS IT'S MUCH MORE SEVERE AND 5703 03:58:38,880 --> 03:58:42,920 I WONDER WHAT YOUR THOUGHTS ARE. 5704 03:58:42,920 --> 03:58:44,240 DO YOU THINK IT'S THE SAME 5705 03:58:44,240 --> 03:58:44,840 DISEASE EVEN? 5706 03:58:44,840 --> 03:58:46,080 A DIFFERENT DISEASE? 5707 03:58:46,080 --> 03:58:47,160 WHAT ARE YOUR THOUGHTS ABOUT 5708 03:58:47,160 --> 03:58:47,400 THAT? 5709 03:58:47,400 --> 03:58:49,480 >>YEAH, THAT'S A REAL FIFTH 5710 03:58:49,480 --> 03:58:50,360 GREAT QUESTION AND I ALMOST 5711 03:58:50,360 --> 03:58:52,160 MENTIONED IT DURING THE TALK BUT 5712 03:58:52,160 --> 03:58:54,520 IT'S TRUE TYPICALLY WHEN WE SEE 5713 03:58:54,520 --> 03:59:03,200 LUPUS IN MEN IT'S VERY SEVERE 5714 03:59:03,200 --> 03:59:04,360 ORGAN DAMAGE. 5715 03:59:04,360 --> 03:59:07,480 MORE STUDIES ARE TOGETHER SO WE 5716 03:59:07,480 --> 03:59:09,280 DON'T HAVE A FULL EXPLANATION. 5717 03:59:09,280 --> 03:59:10,840 MANY GROUPS ARE DOING RESEARCH 5718 03:59:10,840 --> 03:59:12,440 IN MALE LUPUS AND WE'RE STARTING 5719 03:59:12,440 --> 03:59:13,720 BECAUSE WE'RE TRYING TO LOOK AT 5720 03:59:13,720 --> 03:59:20,080 THIS DIFFERENCES AND IF THERE 5721 03:59:20,080 --> 03:59:22,640 ARE DIFFERENT GENETICS THAT ARE 5722 03:59:22,640 --> 03:59:26,840 COMPACOMPARED TO RISK FOR DISEAD 5723 03:59:26,840 --> 03:59:29,040 THE PATHWAY IN THIS MALE LUPUS 5724 03:59:29,040 --> 03:59:32,840 IS CONTRARY TO WHAT WE SEE MALES 5725 03:59:32,840 --> 03:59:36,720 DIFFERENT, RIGHT AND THEY 5726 03:59:36,720 --> 03:59:40,800 RESPOND WHERE WHICH DON'T SEE IT 5727 03:59:40,800 --> 03:59:51,000 IN MALES. 5728 03:59:51,840 --> 03:59:55,200 >>I WILL HAND IT BACK TO Dr. 5729 03:59:55,200 --> 03:59:57,120 NOURSI TO CONTINUE WITH THE 5730 03:59:57,120 --> 03:59:58,640 AFTERNOON'S PROGRAM. 5731 03:59:58,640 --> 04:00:00,440 >>Samia Noursi: THANK YOU Dr. 5732 04:00:00,440 --> 04:00:07,360 BEGG AND Dr. KAPLAN AND Dr. 5733 04:00:07,360 --> 04:00:08,560 MAMME INTO JOIN US. 5734 04:00:08,560 --> 04:00:09,760 NOW WE'LL TURN TO A DIFFERENT 5735 04:00:09,760 --> 04:00:12,520 PART OF OUR MEETING AND PROVIDE 5736 04:00:12,520 --> 04:00:14,320 YOU WITH UPDATES ON THE PROCESS 5737 04:00:14,320 --> 04:00:18,240 OR THE DEVELOPMENT OF THE 5738 04:00:18,240 --> 04:00:20,240 2024-2028 NIH WIDE STRATEGIC 5739 04:00:20,240 --> 04:00:27,520 PLAN ON RESEARCH. 5740 04:00:27,520 --> 04:00:31,480 THIS IS JOINT PRESENTATION. 5741 04:00:31,480 --> 04:00:33,520 THE OTHER OVERARCHING STRATEGIC 5742 04:00:33,520 --> 04:00:35,520 PLAN TO PROVIDE A ROADMAP TO 5743 04:00:35,520 --> 04:00:36,920 GUIDE NIH WIDE RESEARCH ON THE 5744 04:00:36,920 --> 04:00:40,360 HEALTH OF WOMEN FOR THE NEXT 5745 04:00:40,360 --> 04:00:42,640 FIVE YEARS. 5746 04:00:42,640 --> 04:00:44,800 WE HAVE ENGAGE MULTIPLE PARTNERS 5747 04:00:44,800 --> 04:00:46,840 INCLUDING THE NIH INSTITUTE AND 5748 04:00:46,840 --> 04:00:52,120 CENTERS, AND OFFICES. 5749 04:00:52,120 --> 04:01:01,880 REPEATS WE CALWE CALLTHEM ICOs. 5750 04:01:01,880 --> 04:01:03,040 THEY DEVELOPED A PROCESS MODEL 5751 04:01:03,040 --> 04:01:05,160 THAT OUTLINES THE KEY STEPS FOR 5752 04:01:05,160 --> 04:01:08,080 THE DEVELOPMENT OF THE PLAN. 5753 04:01:08,080 --> 04:01:11,400 THE PROCESS BEGAN WITH ALL ORWH 5754 04:01:11,400 --> 04:01:14,800 COLLECTING AND ANALYZING DATA 5755 04:01:14,800 --> 04:01:16,360 FROM ACTIVITIES ALONGSIDE THIS 5756 04:01:16,360 --> 04:01:18,160 COMMITTEE, THIS ADVISORY 5757 04:01:18,160 --> 04:01:22,640 COMMITTEE AND THESE ACTIVITIES 5758 04:01:22,640 --> 04:01:26,720 INCLUDED RFI, BY ANNUAL REPORT 5759 04:01:26,720 --> 04:01:30,160 AND THE CONGRESSIONALLY MAP 5760 04:01:30,160 --> 04:01:32,880 DATED ORWH IC DIRECTOR'S 5761 04:01:32,880 --> 04:01:36,440 MEETINGS WHICH HAPPEN EVERY 5762 04:01:36,440 --> 04:01:39,600 YEAR. 5763 04:01:39,600 --> 04:01:41,040 THEY HAVE FIFTH PLAN WORKING 5764 04:01:41,040 --> 04:01:44,440 GROUP COMPRISED OF MEMBERS AND 5765 04:01:44,440 --> 04:01:45,960 REPRESENTATIVES FROM THE ICOs 5766 04:01:45,960 --> 04:01:55,400 AND FEDERAL PARTNERS. 5767 04:01:55,400 --> 04:01:57,640 WE HAVE INITIAL FINDINGS TO THE 5768 04:01:57,640 --> 04:01:58,960 STRATEGIC PLAN WORKING GROUP IN 5769 04:01:58,960 --> 04:02:00,520 A KICKOFF MEETING WE HELD IN 5770 04:02:00,520 --> 04:02:02,640 JUNE OF 2022. 5771 04:02:02,640 --> 04:02:04,480 FEEDBACK WAS OBTAINED FROM THE 5772 04:02:04,480 --> 04:02:09,880 EXTRA TOMMY I CASTRATEGIC GROUPE 5773 04:02:09,880 --> 04:02:11,080 MEETING AND FOLLOWING THE 5774 04:02:11,080 --> 04:02:11,560 MEETING. 5775 04:02:11,560 --> 04:02:14,520 THE STRATEGIC PLAN AREAS WITH 5776 04:02:14,520 --> 04:02:17,240 DEVELOPED USING INPUTS FROM THE 5777 04:02:17,240 --> 04:02:19,360 STRATEGIC PLAN WORKING GROUP, 5778 04:02:19,360 --> 04:02:21,280 THE RFI I MENTIONED THAT THE 5779 04:02:21,280 --> 04:02:24,880 DIRECTOR'S MEETINGS AND OR THE 5780 04:02:24,880 --> 04:02:25,160 ORWH. 5781 04:02:25,160 --> 04:02:27,000 THESE AREAS WERE APPROVED BY THE 5782 04:02:27,000 --> 04:02:30,200 WORKING GROUP AS WELL AS ACRWH 5783 04:02:30,200 --> 04:02:36,920 AT THAT OCTOBER 2020. 5784 04:02:36,920 --> 04:02:38,720 ORWH RECRUITED PARTICIPANTS FOR 5785 04:02:38,720 --> 04:02:39,880 FIVE THINK-TANK GROUPS, ONE FOR 5786 04:02:39,880 --> 04:02:41,000 EACH CONTENT AREA. 5787 04:02:41,000 --> 04:02:43,120 THE FIVE OF THINK TANKS WORK 5788 04:02:43,120 --> 04:02:45,400 TOGETHER WITH ORWH TO DEVELOP 5789 04:02:45,400 --> 04:02:48,920 THE STRATEGIC CALLS, OBJECTIVES, 5790 04:02:48,920 --> 04:02:51,080 AND PRELIMINARY METRICS FOR THE 5791 04:02:51,080 --> 04:02:59,520 RESPECTIVE CONTENT YEARS. 5792 04:02:59,520 --> 04:03:01,080 THEY HAVE A PLAN THAT WOULD BE 5793 04:03:01,080 --> 04:03:03,440 FOLLOWED BY IMPLEMENTATION AND 5794 04:03:03,440 --> 04:03:04,720 EVALUATION GUIDES AND THIS WILL 5795 04:03:04,720 --> 04:03:08,840 BE PUBLISHED SIX MONTHS LATER. 5796 04:03:08,840 --> 04:03:09,920 TODAY WE ARE HERE IN THE 5797 04:03:09,920 --> 04:03:10,640 PROCESS. 5798 04:03:10,640 --> 04:03:13,560 DRAFTING THE STRATEGIC PLAN WITH 5799 04:03:13,560 --> 04:03:16,480 THAT I'D LIKE TO INTERPRET IT TO 5800 04:03:16,480 --> 04:03:20,200 Dr. McGREGOR FOR THE NEXT 5801 04:03:20,200 --> 04:03:22,160 PORTION OF THIS PRESENTATION. 5802 04:03:22,160 --> 04:03:24,560 >>GREAT, THANK YOU SO MUCH FOR 5803 04:03:24,560 --> 04:03:26,000 INVOLVING ME IN THIS PROCESS. 5804 04:03:26,000 --> 04:03:27,880 WE WOULD LIKE TO ACKNOWLEDGE 5805 04:03:27,880 --> 04:03:32,200 THAT ACRWH WORKING GROUP CO 5806 04:03:32,200 --> 04:03:35,000 CHAIRED BY Dr. NOURSI AND 5807 04:03:35,000 --> 04:03:36,160 MYSELF THERE WERE GROUPS FOR THE 5808 04:03:36,160 --> 04:03:37,800 NEXT STRATEGIC PLAN AND APPROVE 5809 04:03:37,800 --> 04:03:39,480 THE CONTENT YEARS WHICH SERVED 5810 04:03:39,480 --> 04:03:50,000 TO INFORM THE STRATEGIC GOALS. 5811 04:03:55,640 --> 04:04:05,600 S. 5812 04:04:13,000 --> 04:04:16,400 >>BIOMEDICAL WORKFORCE AND 5813 04:04:16,400 --> 04:04:17,120 CAREER DEVELOP. 5814 04:04:17,120 --> 04:04:19,080 , BASIC SCIENCE AND 5815 04:04:19,080 --> 04:04:19,880 TRANSLATIONAL RESEARCH AS WELL 5816 04:04:19,880 --> 04:04:25,160 AS IMPLEMENTATION SCIENCE AND 5817 04:04:25,160 --> 04:04:26,120 COMMUNITY ENGAGEMENT. 5818 04:04:26,120 --> 04:04:28,240 I'LL TURN IT OVER TO Dr. KELLY 5819 04:04:28,240 --> 04:04:29,080 CHANDLER WHO WILL TALK ABOUT 5820 04:04:29,080 --> 04:04:36,280 WHERE WE ARE IN THIS PROCESS. 5821 04:04:36,280 --> 04:04:39,640 AS YOU CAN SEE IN THE PROCESS 5822 04:04:39,640 --> 04:04:40,320 MODEL, ORWH ESTABLISHED FIVE 5823 04:04:40,320 --> 04:04:43,280 THINK-TANK GROUPS THAT WERE 5824 04:04:43,280 --> 04:04:45,320 COMPRISED OF ORWH STAFF, ICO 5825 04:04:45,320 --> 04:04:48,200 SCIENTIFIC EXPERTS, APRWH 5826 04:04:48,200 --> 04:04:50,840 MEMBERS AND FEDERAL PARTNERS TO 5827 04:04:50,840 --> 04:04:51,400 ELABORATE ON THE INDIVIDUAL 5828 04:04:51,400 --> 04:04:53,640 CONCEPT AREAS AND DEVELOP A 5829 04:04:53,640 --> 04:04:57,600 STRATEGIC GOALS AND OBJECTIVES 5830 04:04:57,600 --> 04:04:58,480 FROM WITHIN. 5831 04:04:58,480 --> 04:04:59,840 THEY GO THROUGH EACH OF THE 5832 04:04:59,840 --> 04:05:02,880 DELIVERABLES AND THE THINK TANKS 5833 04:05:02,880 --> 04:05:03,280 PRODUCE. 5834 04:05:03,280 --> 04:05:06,080 THINK-TANK DEVELOP THE STRATEGIC 5835 04:05:06,080 --> 04:05:07,120 GOAL EXAMS, RESEARCH THAT EXAMS 5836 04:05:07,120 --> 04:05:09,840 THE MULTIPLE BIOLOGICAL AND 5837 04:05:09,840 --> 04:05:11,640 BEHAVIORAL AND SOCIAL STRUCTURAL 5838 04:05:11,640 --> 04:05:13,320 AND ENVIRONMENTAL FACTORS THAT 5839 04:05:13,320 --> 04:05:15,120 INFLUENCE THE HEALTH OF WOMEN 5840 04:05:15,120 --> 04:05:19,560 AND THE INTERSECTIONS OF THESE 5841 04:05:19,560 --> 04:05:20,080 FACTORS. 5842 04:05:20,080 --> 04:05:24,240 THEY HAD SIX OBJECTIVES TO SUB 5843 04:05:24,240 --> 04:05:25,720 STAN THEE EIGHT THESE GOALS AND 5844 04:05:25,720 --> 04:05:26,880 WE'LL TOUCH UPON THE HIGHLIGHTS 5845 04:05:26,880 --> 04:05:28,000 OF THESE OBJECTIVES. 5846 04:05:28,000 --> 04:05:29,080 ON DIFFERENCE ONE AND TWO AND 5847 04:05:29,080 --> 04:05:31,320 THE INTERSECTIONALITY OF SOCIAL 5848 04:05:31,320 --> 04:05:33,240 CULTURAL BEHAVIORAL AND 5849 04:05:33,240 --> 04:05:34,960 BIOLOGICAL FACTORS CONSIDERING 5850 04:05:34,960 --> 04:05:38,080 THE HISTORICAL CONTEXT HEALTH 5851 04:05:38,080 --> 04:05:38,760 DISPARITIES AND EQUITY AND 5852 04:05:38,760 --> 04:05:40,720 PAYING ATTENTION TO THE DIVERSE 5853 04:05:40,720 --> 04:05:44,360 AND MARGINALIZED POPULATION. 5854 04:05:44,360 --> 04:05:46,240 OBJECTIVE THREE ENCOURAGED 5855 04:05:46,240 --> 04:05:47,600 EXAMINING UP TREATMENT CAUSES OF 5856 04:05:47,600 --> 04:05:53,920 HEALTH DISPARITIES AND RACE AND 5857 04:05:53,920 --> 04:05:58,640 I WILL DETERMINANTS OF HEALTH 5858 04:05:58,640 --> 04:06:01,280 AND AND FOUR THROUGH SIX JUSTIFY 5859 04:06:01,280 --> 04:06:02,680 THE IMPORTANCE MULTI DIMENSIONAL 5860 04:06:02,680 --> 04:06:04,920 APPROACH AND IN ADDITION TO 5861 04:06:04,920 --> 04:06:06,120 INTERSECTIONALITY, WE ALSO NEED 5862 04:06:06,120 --> 04:06:08,040 TO INVESTIGATE A VARIOUS DOMAINS 5863 04:06:08,040 --> 04:06:13,640 OF GENDER AND FINALLY BECAUSE 5864 04:06:13,640 --> 04:06:15,040 AEROMEXICO AGE HEALTH CONDITIONS 5865 04:06:15,040 --> 04:06:18,280 AND AND WE SHOULD APPRAISE THE 5866 04:06:18,280 --> 04:06:22,800 WOMEN AND SHOULD BE WITHOUT THE 5867 04:06:22,800 --> 04:06:24,040 LIFE COURSE. 5868 04:06:24,040 --> 04:06:25,640 IT IMPROVES THE GOAL AND DATA 5869 04:06:25,640 --> 04:06:27,320 SCIENCE AND DATA MANAGEMENT 5870 04:06:27,320 --> 04:06:28,840 PROCESSES WITH INNOVATIVE 5871 04:06:28,840 --> 04:06:30,400 RESEARCH METHODS AND 5872 04:06:30,400 --> 04:06:31,840 MEASUREMENTS AND CUTTING EDGE 5873 04:06:31,840 --> 04:06:33,720 TECHNOLOGIES TO PREVENT AND 5874 04:06:33,720 --> 04:06:38,120 TREAT CONTINUES EFFECTING WOMEN. 5875 04:06:38,120 --> 04:06:38,680 ACCORDINGLY, THINK-TANK TWO 5876 04:06:38,680 --> 04:06:39,960 DEVELOPED FOUR OBJECTIVES. 5877 04:06:39,960 --> 04:06:41,400 THE FIRST FOCUSES ON DATA 5878 04:06:41,400 --> 04:06:41,720 SHARING. 5879 04:06:41,720 --> 04:06:43,880 WHICH WILL ENCOURAGE MORE 5880 04:06:43,880 --> 04:06:45,800 SCIENTIFIC INVESTIGATIONS AND 5881 04:06:45,800 --> 04:06:47,240 ENHANCE ANALYTICAL 5882 04:06:47,240 --> 04:06:49,520 REPRODUCIBILITY AND TRANSPARENCY 5883 04:06:49,520 --> 04:06:50,880 AND PROVIDE AN EVIDENCE-BASED TO 5884 04:06:50,880 --> 04:06:54,000 HELP US UNDERSTAND THE HEALTH OF 5885 04:06:54,000 --> 04:06:55,560 WOMEN. 5886 04:06:55,560 --> 04:06:56,840 OBJECTIVE TWO UNDERSCORES HOW 5887 04:06:56,840 --> 04:06:58,880 INNOVATIVE ANALYTICAL METHODS 5888 04:06:58,880 --> 04:07:00,440 SUCH AS DATA VISUALIZATION AND 5889 04:07:00,440 --> 04:07:03,160 A.I. AND ML AND SOPHISTICATED IS 5890 04:07:03,160 --> 04:07:06,040 SPECIFIC MODELING TECHS 5891 04:07:06,040 --> 04:07:07,680 TECHNIQUES ENABLE FOR COMPLEX 5892 04:07:07,680 --> 04:07:11,320 DATA STRUCTURES, EXAM NON LINEAR 5893 04:07:11,320 --> 04:07:12,800 TIME VARYING RELATIONSHIPS AND 5894 04:07:12,800 --> 04:07:13,880 HELP US GAIN FURTHER INSIGHTS 5895 04:07:13,880 --> 04:07:23,360 INTO THE HEALTH OF WOMEN. 5896 04:07:23,360 --> 04:07:26,240 AND TO EXAM AND PROGRESSION AND 5897 04:07:26,240 --> 04:07:28,520 THROUGH DIAGNOSIS AND 5898 04:07:28,520 --> 04:07:30,200 INTERVENTIONS AND INVESTIGATE 5899 04:07:30,200 --> 04:07:33,760 THE EFFECT OF LIFE TRANSITIONS 5900 04:07:33,760 --> 04:07:36,120 HERE AND FINALLY AND SUPPORT THE 5901 04:07:36,120 --> 04:07:41,400 DEVELOPMENT AND CUTTING EDGE 5902 04:07:41,400 --> 04:07:43,920 COMPUTATIONAL AND FACILITATE 5903 04:07:43,920 --> 04:07:48,440 SCREEN ASKING DIAGNOSIS AND 5904 04:07:48,440 --> 04:07:51,480 TREATMENT AND THE STRATEGIC GOAL 5905 04:07:51,480 --> 04:07:54,440 IS TO PROMOTE FOR NOT TRAINING 5906 04:07:54,440 --> 04:07:55,960 AND EDUCATION THAT ADVANCES FOR 5907 04:07:55,960 --> 04:07:57,400 HEALTH IN WOMEN AND THE SCIENCE 5908 04:07:57,400 --> 04:07:59,440 OF SEX AND GENDER INFLUENCES AND 5909 04:07:59,440 --> 04:08:01,080 TO FOSTER WOMEN'S SCIENCES 5910 04:08:01,080 --> 04:08:02,600 CAREER DEVELOPMENT. 5911 04:08:02,600 --> 04:08:04,720 THERE ARE FIVE OBJECTIVES TO 5912 04:08:04,720 --> 04:08:05,520 THIS. 5913 04:08:05,520 --> 04:08:07,600 OBJECTIVE ONE AND TWO ADDRESS 5914 04:08:07,600 --> 04:08:09,840 HOW TO TRAIN OR SCIENTIFIC 5915 04:08:09,840 --> 04:08:11,040 WORKFORCE AND IN PARTICULAR 5916 04:08:11,040 --> 04:08:12,680 OBJECTIVE ONE EMPHASIZES 5917 04:08:12,680 --> 04:08:14,000 INTEGRATING KNOWLEDGE OF SEX AND 5918 04:08:14,000 --> 04:08:16,120 GENDER INFLUENCES AT ALL LEVELS 5919 04:08:16,120 --> 04:08:17,800 AND TO ACCELERATE THE 5920 04:08:17,800 --> 04:08:19,720 TRANSLATION OF KNOWLEDGE AND 5921 04:08:19,720 --> 04:08:20,440 PRACTICE. 5922 04:08:20,440 --> 04:08:25,560 OBJECTIVE TWO ENCOURAGES THE 5923 04:08:25,560 --> 04:08:27,080 METHODS WITH NEXT GENERATION 5924 04:08:27,080 --> 04:08:29,560 RESEARCH AND THE NEXT OBJECTIVE, 5925 04:08:29,560 --> 04:08:31,760 ENCOURAGES IC OLYMPICS TO PART 5926 04:08:31,760 --> 04:08:33,640 PROGRAMS TO RECRUIT AND RETAIN 5927 04:08:33,640 --> 04:08:35,560 AND FACILITATE REENTRY AND 5928 04:08:35,560 --> 04:08:39,600 ADVANCEMENT OF ALL STAGES OF 5929 04:08:39,600 --> 04:08:42,840 THIS CAREER. 5930 04:08:42,840 --> 04:08:45,200 AND POLICIES AND MEASURING AND 5931 04:08:45,200 --> 04:08:46,480 COLLABORATIVE NETWORKS AND 5932 04:08:46,480 --> 04:08:48,120 ADVANCE WOMEN SCIENCES CAREERS 5933 04:08:48,120 --> 04:08:49,560 AND SPECIAL ATTENTION TO UNDER 5934 04:08:49,560 --> 04:08:56,120 REPRESENTED POPULATIONS AND 5935 04:08:56,120 --> 04:08:58,120 DISABILITY AND AIMS TO TACKLE A 5936 04:08:58,120 --> 04:08:59,400 BARRIER THAT HINDER WOMEN 5937 04:08:59,400 --> 04:09:01,240 SCIENCES CAREER DEVELOPMENT AND 5938 04:09:01,240 --> 04:09:02,880 THROUGH PROPER INNER VISIONS WE 5939 04:09:02,880 --> 04:09:04,800 HOPE TO INCREASE WOMEN'S 5940 04:09:04,800 --> 04:09:12,600 RECRUITMENT, RETENTION AND 5941 04:09:12,600 --> 04:09:15,840 REENTRY THINK THINK FOUR 5942 04:09:15,840 --> 04:09:17,560 DEVELOPED THE GOALS AND BASIC 5943 04:09:17,560 --> 04:09:19,800 AND TRANSLATIONAL STUDY UNDER 5944 04:09:19,800 --> 04:09:22,480 THE BIOLOGY AND INFLUENCEs AND 5945 04:09:22,480 --> 04:09:25,160 INTERSECTION IS A DID I SEES AND 5946 04:09:25,160 --> 04:09:26,320 HEALTH PRESSURE OVATION ACROSS 5947 04:09:26,320 --> 04:09:29,040 THE LIFE COURSE AND THE GROUP 5948 04:09:29,040 --> 04:09:31,520 PROPOSED FOUR DIVORCE PONDING 5949 04:09:31,520 --> 04:09:33,960 AND THE FIRST RESEARCHES TO 5950 04:09:33,960 --> 04:09:35,960 ADVANCE MECHANISTIC BASIC AND 5951 04:09:35,960 --> 04:09:37,360 TRANSLATIONAL RESEARCH INTO THE 5952 04:09:37,360 --> 04:09:39,600 EFFECT OF SEX AND GENDER OF 5953 04:09:39,600 --> 04:09:41,480 BIOLOGY DISEASES AND HEALTH 5954 04:09:41,480 --> 04:09:44,440 OUTCOMES ASSESSMENTS. 5955 04:09:44,440 --> 04:09:47,040 OBJECTIVES TO IS ENHANCING THE 5956 04:09:47,040 --> 04:09:48,920 YEARS OF INVETO IN VIVO AND EX 5957 04:09:48,920 --> 04:09:53,760 IN VIVO AND BIO MEDICINE. 5958 04:09:53,760 --> 04:09:55,160 OBJECTIVES THREE SUGGESTS THE 5959 04:09:55,160 --> 04:09:56,480 RESEARCH ON THE ROLE OF SEX AND 5960 04:09:56,480 --> 04:09:59,080 GENDER ON THE INTRINSIC 5961 04:09:59,080 --> 04:10:00,240 PROCESSES FOR EXAMPLE SLEEP AND 5962 04:10:00,240 --> 04:10:02,600 PAIN AND IN RESPONSE TO STRESS 5963 04:10:02,600 --> 04:10:04,880 FACTORS SUCH AS MICROBIOME, 5964 04:10:04,880 --> 04:10:06,040 NUTRITION AND TOX OWNS ACROSS 5965 04:10:06,040 --> 04:10:11,480 THE LIFE COURS COURSE. 5966 04:10:11,480 --> 04:10:13,160 STIMULATE INTRA DISCIPLINARY 5967 04:10:13,160 --> 04:10:14,800 SYSTEM APPROACHES WITH 5968 04:10:14,800 --> 04:10:16,520 BIOMEDICAL DEMAND SUCH AS 5969 04:10:16,520 --> 04:10:18,280 MOLECULAR AND CELLULAR BIOLOGY 5970 04:10:18,280 --> 04:10:23,320 TO IMMUNOLOGY. 5971 04:10:23,320 --> 04:10:25,360 OUR LAST GROUP THINK-TANK FIVE 5972 04:10:25,360 --> 04:10:27,120 PROPOSED THE GOAL ADVANCED 5973 04:10:27,120 --> 04:10:29,120 COMMUNITY ENGAGE SCIENCE ACROSS 5974 04:10:29,120 --> 04:10:32,960 THE RESEARCH PRACTICE CONTINUUM 5975 04:10:32,960 --> 04:10:34,200 AND IMPLEMENTATION OF EVIDENCE 5976 04:10:34,200 --> 04:10:36,760 BASED SOLUTIONS O IMPROVE THE 5977 04:10:36,760 --> 04:10:37,240 HEALTH. 5978 04:10:37,240 --> 04:10:42,120 THERE ARE FIVE OBJECTIVES WITH 5979 04:10:42,120 --> 04:10:43,840 THIS GOAL. 5980 04:10:43,840 --> 04:10:48,520 ONE AND TWO FOR COMMUNITY 5981 04:10:48,520 --> 04:10:50,960 ENGAGEMENT AND TRAINING AND 5982 04:10:50,960 --> 04:10:52,360 RESEARCHERS AND PUBLIC-HEALTH 5983 04:10:52,360 --> 04:10:54,000 PRACTITIONERS ON IMPLEMENTATIONS 5984 04:10:54,000 --> 04:11:00,680 SCIENCE AND METHODS AND 5985 04:11:00,680 --> 04:11:02,680 BIDIRECTIONAL LISTENING AND 5986 04:11:02,680 --> 04:11:07,120 CULTURALLY AND COMMUNICATIONS 5987 04:11:07,120 --> 04:11:10,160 AND AND ENGAGEMENT AND RELATED 5988 04:11:10,160 --> 04:11:11,160 TO IMPLEMENTATIONS, BEHAVIORS 5989 04:11:11,160 --> 04:11:13,280 AND HEALTH OUTCOMES RELEVANT TO 5990 04:11:13,280 --> 04:11:16,120 IMPROVING THE HEALTH OF WOMEN. 5991 04:11:16,120 --> 04:11:18,600 AND OBJECTIVES FOUR AND FIVE 5992 04:11:18,600 --> 04:11:20,720 SUPPORT EXPANDING 5993 04:11:20,720 --> 04:11:21,680 IMPLEMENTATIONS SCIENCE, 5994 04:11:21,680 --> 04:11:22,760 TAILORING DELIVERING TO THE 5995 04:11:22,760 --> 04:11:25,320 NEEDS OF WOMEN AND INVESTIGATING 5996 04:11:25,320 --> 04:11:26,760 AND INTERVENING ON THE MULTI 5997 04:11:26,760 --> 04:11:28,400 DIMENSIONAL FACTORS THAT 5998 04:11:28,400 --> 04:11:29,640 INFLUENCE SEX AND GENDER 5999 04:11:29,640 --> 04:11:33,480 DISPARITIES AND THE HEALTH OF 6000 04:11:33,480 --> 04:11:43,400 WOMEN. 6001 04:11:43,400 --> 04:11:45,400 WE REALLY APPRECIATE YOUR 6002 04:11:45,400 --> 04:11:47,160 ENGAGEMENT AND WOULD NOT BE HERE 6003 04:11:47,160 --> 04:11:50,000 WITHOUT YOU HAVING THE DIVERSE 6004 04:11:50,000 --> 04:11:51,440 PERSPECTIVE AND CRITICAL SUCCESS 6005 04:11:51,440 --> 04:12:01,240 OF THIS AND PORTION PLAN AND EYE 6006 04:12:01,240 --> 04:12:04,440 TAL SIZED THE THE TOP OF EACH 6007 04:12:04,440 --> 04:12:06,240 LIST FOR EACH THINK-TANK AND WE 6008 04:12:06,240 --> 04:12:07,280 HAVE WONDERFUL BROAD 6009 04:12:07,280 --> 04:12:12,440 REPRESENTATION ACROSS THE NIH 6010 04:12:12,440 --> 04:12:14,240 AND FROM OUR ADVISORY COMMITTEES 6011 04:12:14,240 --> 04:12:20,120 AND OTHER FEDERAL PARTNERS. 6012 04:12:20,120 --> 04:12:24,880 SO AS WE LOOK AHEAD TO THE 2024, 6013 04:12:24,880 --> 04:12:26,520 2028-INCH WIDE STRATEGIC PLAN ON 6014 04:12:26,520 --> 04:12:27,960 RESEARCH ON THE HEALTH OF WOMEN 6015 04:12:27,960 --> 04:12:31,080 WE'RE INFORMED BY THE CURRENT 6016 04:12:31,080 --> 04:12:32,000 STRATEGIC PLAN AND FRAMEWORK 6017 04:12:32,000 --> 04:12:35,360 THAT WAS DEVELOPED BY DOCTORS 6018 04:12:35,360 --> 04:12:37,840 SHEA AND WE WOULD LIKE TO SHARE 6019 04:12:37,840 --> 04:12:40,440 WITH YOU AND MODEL STRATEGIC 6020 04:12:40,440 --> 04:12:42,200 PLAN AND IN RESPONSE TOP SHIFTS 6021 04:12:42,200 --> 04:12:44,080 IN THE SCIENTIFIC LANDSCAPE AND 6022 04:12:44,080 --> 04:12:46,440 UPDATE THE MULTI DIMENSIONAL 6023 04:12:46,440 --> 04:12:48,120 FRAMEWORK TO ADDRESS SOCIAL 6024 04:12:48,120 --> 04:12:49,160 DETERMINANTS OF HEALTH AND IN 6025 04:12:49,160 --> 04:12:50,880 SOCIAL SERIES OF HEALTH AND 6026 04:12:50,880 --> 04:12:52,560 HEALTH DISPARITIES AND 6027 04:12:52,560 --> 04:12:53,160 BEHAVIORAL AND ENVIRONMENTAL 6028 04:12:53,160 --> 04:12:57,640 DRIVERS OF HEALTH. 6029 04:12:57,640 --> 04:12:59,760 WE WE WITH LIKE YOUR INPUT AS WE 6030 04:12:59,760 --> 04:13:02,440 MAKE ADJUSTMENTS TO THIS MODEL. 6031 04:13:02,440 --> 04:13:04,120 TO MAINTAIN A LIFE COURSE 6032 04:13:04,120 --> 04:13:04,720 PERSPECTIVE CONSIDERING THE 6033 04:13:04,720 --> 04:13:06,280 HEALTH OF WOMEN FROM 6034 04:13:06,280 --> 04:13:07,440 PRECONCEPTION TO CAPTURE 6035 04:13:07,440 --> 04:13:09,640 GENERATIONAL TRANSMISSION AND 6036 04:13:09,640 --> 04:13:10,320 CONTRIBUTIONS, ALL THE WAY 6037 04:13:10,320 --> 04:13:13,720 THROUGH AGING. 6038 04:13:13,720 --> 04:13:15,880 EXAMPLES OF THE BIOLOGICAL 6039 04:13:15,880 --> 04:13:17,280 FACTORS AND SOCIAL AND 6040 04:13:17,280 --> 04:13:18,960 ENVIRONMENTAL EXPOSURES ARE 6041 04:13:18,960 --> 04:13:20,720 SHOWN HERE. 6042 04:13:20,720 --> 04:13:22,880 THESE INCLUDE HEALTHCARE ACCESS 6043 04:13:22,880 --> 04:13:25,000 AND EQUALITY, DIFFICULT EXPOSURE 6044 04:13:25,000 --> 04:13:26,280 SUCHS RISING TEMPERATURES DUE TO 6045 04:13:26,280 --> 04:13:27,400 CLIMATE CHANGE OR CHEMICALS 6046 04:13:27,400 --> 04:13:29,320 FOUND IN DRINKING WATER WHERE 6047 04:13:29,320 --> 04:13:29,760 YOU LIVE. 6048 04:13:29,760 --> 04:13:32,160 MENTAL HEALTH OR THE INTERNAL 6049 04:13:32,160 --> 04:13:33,200 DIALOGUE THAT EXPERIENCES HOW WE 6050 04:13:33,200 --> 04:13:34,840 GO THROUGH THE WORLD. 6051 04:13:34,840 --> 04:13:37,480 LIFE CONTEXT INCLUDING BEHAVIOR 6052 04:13:37,480 --> 04:13:38,880 SUCH AS EXERCISE AND NUTRITION 6053 04:13:38,880 --> 04:13:41,840 OR NIGHT SHIFT WORK. 6054 04:13:41,840 --> 04:13:43,640 SOCIAL AND COMMUNITY CONTEXT AS 6055 04:13:43,640 --> 04:13:46,680 WELL AS EDUCATION ACCESS AND 6056 04:13:46,680 --> 04:13:47,640 INEQUALITY. 6057 04:13:47,640 --> 04:13:52,120 BIOLOGICAL FACTORS SUCH AS A MAA 6058 04:13:52,120 --> 04:13:54,320 NATALIE AND PHYSIOLOGY AND 6059 04:13:54,320 --> 04:13:57,640 HORMONES AND GENOMIC SOCIAL AND 6060 04:13:57,640 --> 04:13:59,120 ENVIRONMENTAL EXPOSURE TO SHAPE 6061 04:13:59,120 --> 04:14:00,080 HEALTH As COULD THE LIFE 6062 04:14:00,080 --> 04:14:01,120 COURSE OF A WOMAN. 6063 04:14:01,120 --> 04:14:02,560 A COMPLEX INTERSECTION OF 6064 04:14:02,560 --> 04:14:05,000 MULTIPLE FACTORS AND EXPOSURES 6065 04:14:05,000 --> 04:14:07,600 EFFECT THE HEALTH STATUS, 6066 04:14:07,600 --> 04:14:08,480 DISEASE PRESENTATIONS, TREATMENT 6067 04:14:08,480 --> 04:14:10,800 RESPONSE, AND QUALITIES OF LIFE 6068 04:14:10,800 --> 04:14:11,520 FOR WOMEN. 6069 04:14:11,520 --> 04:14:12,920 THESE LIFE COURSE INTERACTIONS 6070 04:14:12,920 --> 04:14:15,520 OCCUR UNDER THE INFLUENCE OF 6071 04:14:15,520 --> 04:14:17,280 INTER GENERATIONAL FACTORS SUCH 6072 04:14:17,280 --> 04:14:20,080 AS EXPOSURE TO VIOLENCE, WEALTH 6073 04:14:20,080 --> 04:14:22,160 OR ENDOCRINE EXPOSURE CHEMICALS 6074 04:14:22,160 --> 04:14:24,480 EX CONSIDERATIONS OF A 6075 04:14:24,480 --> 04:14:25,920 THEORETICAL MODEL WILL IMPROVE 6076 04:14:25,920 --> 04:14:27,560 THE QUALITY OF WOMEN'S LIVES, 6077 04:14:27,560 --> 04:14:29,680 REDUCE THEIR DISEASES BURDEN 6078 04:14:29,680 --> 04:14:31,120 ACROSS THE LIFE COURSE AND 6079 04:14:31,120 --> 04:14:32,560 ADDRESS HEALTH DISPARITY FROM 6080 04:14:32,560 --> 04:14:34,200 POPULATIONS OF WOMEN AT GREATEST 6081 04:14:34,200 --> 04:14:35,920 RISKS FOR DISEASE. 6082 04:14:35,920 --> 04:14:38,120 I'LL TURN IT OVER TO Dr. 6083 04:14:38,120 --> 04:14:42,160 NOURSI TO FINISH US OUT. 6084 04:14:42,160 --> 04:14:43,880 >> 6085 04:14:43,880 --> 04:14:44,840 >>Samia Noursi: THANK YOU Dr. 6086 04:14:44,840 --> 04:14:48,320 CHANDLER AND Dr. McGREGOR. 6087 04:14:48,320 --> 04:14:49,840 IN THE NEXT STEPS OF DEVELOPMENT 6088 04:14:49,840 --> 04:14:55,880 OF STRATEGIC PLAN WE WILL 6089 04:14:55,880 --> 04:14:57,080 EVALUATE THE STRATEGIC PLAN AND 6090 04:14:57,080 --> 04:14:59,760 WE WILL DO THAT IN COLLABORATION 6091 04:14:59,760 --> 04:15:02,400 WITH VARIOUS ICOs AT NIH AND 6092 04:15:02,400 --> 04:15:04,840 WE EXPECT TO RELEASE STRATEGIC 6093 04:15:04,840 --> 04:15:07,520 PLAN IN JANUARY OF 2024 AND THE 6094 04:15:07,520 --> 04:15:09,880 GUIDE AS I MENTIONED EARLIER, 6095 04:15:09,880 --> 04:15:13,160 ABOUT SIX MONTHS LATER. 6096 04:15:13,160 --> 04:15:14,800 I'D LIKE TO THANK ALL OF THE 6097 04:15:14,800 --> 04:15:16,600 MEMBERS OF OUR ADVISORY 6098 04:15:16,600 --> 04:15:19,360 COMMITTEE AND EVERYONE WHO 6099 04:15:19,360 --> 04:15:20,200 PARTICIPATED IN THIS PROCESS 6100 04:15:20,200 --> 04:15:22,600 FROM NIH AND THE FEDERAL 6101 04:15:22,600 --> 04:15:24,240 GOVERNMENT AND WE WILL OPEN THE 6102 04:15:24,240 --> 04:15:28,960 FLOOR RIGHT NOW FOR QUESTIONS OR 6103 04:15:28,960 --> 04:15:32,880 COMMENTS. 6104 04:15:32,880 --> 04:15:34,320 FELL FREE TO USE THE CHAT AND 6105 04:15:34,320 --> 04:15:35,680 CAN YOU BRING EVERYONE HOME, 6106 04:15:35,680 --> 04:15:45,160 THANK YOU. 6107 04:15:45,160 --> 04:15:46,600 WE'D LIKE TO HEAR YOUR COMMENTS 6108 04:15:46,600 --> 04:15:55,280 AND YOUR SUGGESTION TO THE 6109 04:15:55,280 --> 04:15:56,000 THEORETICAL COMMENTS. 6110 04:15:56,000 --> 04:15:58,960 Dr. SIMON WE'LL START WITH 6111 04:15:58,960 --> 04:15:59,120 YOU. 6112 04:15:59,120 --> 04:16:02,480 >>HI, EVERYONE, THIS IS REALLY 6113 04:16:02,480 --> 04:16:05,560 GREAT AND AGAIN, I WANT TO BRING 6114 04:16:05,560 --> 04:16:07,880 UP SEX IS A BIOLOGICAL VARIABLE 6115 04:16:07,880 --> 04:16:09,360 BECAUSE I REALLY THINK THIS IS 6116 04:16:09,360 --> 04:16:13,720 AN IMPORTANT SHOE AND THE TIME 6117 04:16:13,720 --> 04:16:16,360 IS RIGHT AND WOMEN'S HEALTH ARE 6118 04:16:16,360 --> 04:16:20,600 BEAK A TAGGED WITH AN FDA 6119 04:16:20,600 --> 04:16:21,800 UNPRECEDENTED RULING FROM A 6120 04:16:21,800 --> 04:16:25,240 JUDGE AND SO I THINK RIGHT NOW 6121 04:16:25,240 --> 04:16:26,760 WE HAVE TO PUSH WITH HOW YOU 6122 04:16:26,760 --> 04:16:27,840 ADVANCE THE SCIENCE THAT MEANS 6123 04:16:27,840 --> 04:16:29,480 THAT CLINICAL HEALTHCARE NEEDS 6124 04:16:29,480 --> 04:16:32,160 OF WOMEN IN THIS COUNTRY AND SO, 6125 04:16:32,160 --> 04:16:35,560 I WOULD REALLY LIKE, I THINK, 6126 04:16:35,560 --> 04:16:39,880 THE STRATEGIC PLAN, THIS IDEA OF 6127 04:16:39,880 --> 04:16:42,240 REVISITING THE SABB POLICY FOR 6128 04:16:42,240 --> 04:16:44,120 CLINICAL RESEARCH AND BE A PART 6129 04:16:44,120 --> 04:16:46,400 OF THE STRATEGIC PLAN AND REALLY 6130 04:16:46,400 --> 04:16:47,840 CONSIDERING WHAT I TALKED ABOUT 6131 04:16:47,840 --> 04:16:50,720 EARLIER, IN TERMS OF INTER 6132 04:16:50,720 --> 04:16:53,400 SEXUALITIES INCLUDING GENDER, 6133 04:16:53,400 --> 04:16:55,080 AND SEX AND PERHAPS OTHER 6134 04:16:55,080 --> 04:16:56,880 IDENTITIES BECAUSE WE ALL KNOW 6135 04:16:56,880 --> 04:16:59,920 THAT RACIAL ETHNIC MINORTIZIED 6136 04:16:59,920 --> 04:17:01,600 PERSONS, WOMEN VERSUS MEN, GET 6137 04:17:01,600 --> 04:17:03,600 TREATED DIFFERENTLY AND THEY GET 6138 04:17:03,600 --> 04:17:04,320 TREATED DIFFERENTLY THAN WHITE 6139 04:17:04,320 --> 04:17:06,240 WOMEN VERSUS MEN AND AGAIN 6140 04:17:06,240 --> 04:17:10,280 ACROSS THE LIFESPAN, ADOLESCENCE 6141 04:17:10,280 --> 04:17:11,440 GET TREATED DIFFERENTLY THAN 6142 04:17:11,440 --> 04:17:13,680 PEOPLE IN MIDDLE AGE AND TREAT 6143 04:17:13,680 --> 04:17:20,400 VOWED DIFFETREATEDDIFFERENTLY TR 6144 04:17:20,400 --> 04:17:20,960 AGE. 6145 04:17:20,960 --> 04:17:21,840 THERE'S SEX ADDRESSING, I DON'T 6146 04:17:21,840 --> 04:17:25,600 KNOW HOW TO WORD IT WELL AND I'M 6147 04:17:25,600 --> 04:17:27,880 HOPING MEMBERS OF THE COMMITTEE 6148 04:17:27,880 --> 04:17:28,840 CAN HELP ME TWEAK IT. 6149 04:17:28,840 --> 04:17:31,400 IN HIGHWAY BRINGING UP TO THE 6150 04:17:31,400 --> 04:17:32,760 STRATEGIC PLAN ADDRESSING SEX IS 6151 04:17:32,760 --> 04:17:37,640 A BIOLOGICAL VARIABLE. 6152 04:17:37,640 --> 04:17:38,440 >>Samia Noursi: THANK YOU SO 6153 04:17:38,440 --> 04:17:41,280 MUCH FOR THAT COMMENT AND 6154 04:17:41,280 --> 04:17:43,040 SUGGESTION Dr. SIMON. 6155 04:17:43,040 --> 04:17:46,920 WE REALLY VALUE THAT AND AS WE 6156 04:17:46,920 --> 04:17:49,120 MOVE FORWARD FROM THE STRATEGIC 6157 04:17:49,120 --> 04:17:50,920 PLAN WE'LL BE INCORPORATING 6158 04:17:50,920 --> 04:17:51,880 THOSE TYPES OF EFFECT. 6159 04:17:51,880 --> 04:17:53,800 ONE THING I WANTED TO POINT OUT 6160 04:17:53,800 --> 04:17:56,080 IS THAT WE DIDN'T MENTION IN THE 6161 04:17:56,080 --> 04:17:57,760 PRESENTATION IS THAT PART OF THE 6162 04:17:57,760 --> 04:18:00,560 STRATEGIC PLAN WILL HAVE MORE OF 6163 04:18:00,560 --> 04:18:03,200 A DESCRIPTION OF SOME OF THESE 6164 04:18:03,200 --> 04:18:06,800 CROSS-CUTTING AND OVERARCHING 6165 04:18:06,800 --> 04:18:10,480 THEMES THAT WE ACCEPTED AS PART 6166 04:18:10,480 --> 04:18:12,160 OF RESEARCH ON THE HEALTH OF 6167 04:18:12,160 --> 04:18:14,720 WOMEN AND THERE WILL BE A 6168 04:18:14,720 --> 04:18:18,400 SECTION ON SEX AND GENDER, 6169 04:18:18,400 --> 04:18:20,200 REPRODUCIBILITY AND THINGS LIKE 6170 04:18:20,200 --> 04:18:21,720 THAT SO PERHAPS WE'LL BE ABLE TO 6171 04:18:21,720 --> 04:18:25,440 ADDRESS YOUR FEEDBACK IN THAT 6172 04:18:25,440 --> 04:18:27,800 WAY. 6173 04:18:27,800 --> 04:18:28,960 >>Samia Noursi: THANK YOU, 6174 04:18:28,960 --> 04:18:29,440 Dr. SIMON. 6175 04:18:29,440 --> 04:18:32,400 Dr. ROBINSON. 6176 04:18:32,400 --> 04:18:38,240 >>MY QUESTION IS ABOUT THE 6177 04:18:38,240 --> 04:18:39,600 CONVERGENCE BETWEEN THINK-TANK 2 6178 04:18:39,600 --> 04:18:40,680 AND THINK-TANK 3. 6179 04:18:40,680 --> 04:18:44,120 2 WAS REIS SEARCH REGARDING DATA 6180 04:18:44,120 --> 04:18:47,040 SCIENCE AND DATA MANAGEMENT AND 6181 04:18:47,040 --> 04:18:49,080 THEN THINK-TANK 3 WAS THE 6182 04:18:49,080 --> 04:18:50,880 WORKFORCE TRAINING AND EDUCATION 6183 04:18:50,880 --> 04:18:53,840 SO I WAS WONDERING IF THERE ARE 6184 04:18:53,840 --> 04:18:57,040 SPECIFIC TARGETED EFFORTS TO 6185 04:18:57,040 --> 04:19:00,000 MAKE SURE THAT WOMEN ARE 6186 04:19:00,000 --> 04:19:01,760 DIRECTED TOWARDS RESEARCH 6187 04:19:01,760 --> 04:19:04,600 INVOLVING DATA SCIENCE AND DATA 6188 04:19:04,600 --> 04:19:05,280 MODELING, A.I., AND THAT'S NOT 6189 04:19:05,280 --> 04:19:08,440 AN AREA WHERE WE ACTUALLY SEE A 6190 04:19:08,440 --> 04:19:09,280 LOT OF WOMEN. 6191 04:19:09,280 --> 04:19:11,280 IN ADDITION TO MAKING SURE THAT 6192 04:19:11,280 --> 04:19:14,080 WOMEN ARE INCLUDED IN THE 6193 04:19:14,080 --> 04:19:16,680 RESEARCH, AS SUBJECTS, MAKING 6194 04:19:16,680 --> 04:19:18,320 SURE THAT WOMEN ARE ALSO PART OF 6195 04:19:18,320 --> 04:19:20,160 THE TRAINING AND THAT THERE'S 6196 04:19:20,160 --> 04:19:21,960 SPECIFIC EFFORTS TO PUSH WOMEN 6197 04:19:21,960 --> 04:19:25,040 IN THAT DIRECTION. 6198 04:19:25,040 --> 04:19:25,640 >>Samia Noursi: YES, YES. 6199 04:19:25,640 --> 04:19:27,960 THE ANSWER IS YES. 6200 04:19:27,960 --> 04:19:28,280 DEFINITELY. 6201 04:19:28,280 --> 04:19:30,640 THIS IS PART OF THE DISCUSSION 6202 04:19:30,640 --> 04:19:31,880 THAT PARTICULARLY THE GROUP THAT 6203 04:19:31,880 --> 04:19:34,760 WAS FOCUSING ON CARRIER BROUGHT 6204 04:19:34,760 --> 04:19:37,640 UP SO THERE WILL BE MORE 6205 04:19:37,640 --> 04:19:39,400 DETAILED OF INVOLVED IN THAT THE 6206 04:19:39,400 --> 04:19:40,600 DESCRIPTION OF ABOUT WHAT THE 6207 04:19:40,600 --> 04:19:41,920 GOAL OR THE OBJECT OF THE THIS 6208 04:19:41,920 --> 04:19:42,400 GROUP ARE. 6209 04:19:42,400 --> 04:19:46,680 THANK YOU FOR POINTING THAT OUT. 6210 04:19:46,680 --> 04:19:56,920 >>THANK YOU. 6211 04:20:09,600 --> 04:20:12,000 >>WHAT IS THE STRATEGY FOR 6212 04:20:12,000 --> 04:20:13,720 REDUNDANCY OR OVERLAP BETWEEN 6213 04:20:13,720 --> 04:20:14,400 THE AREAS BECAUSE I KNOW A LOT 6214 04:20:14,400 --> 04:20:15,720 OF REPORTING FOR EXAMPLE WE HAD 6215 04:20:15,720 --> 04:20:19,600 SOME CHALLENGES WITH MAKING SURE 6216 04:20:19,600 --> 04:20:30,080 THAT THE OBJECTIVES IT'S NOT 6217 04:20:41,320 --> 04:20:41,560 REITERATING. 6218 04:20:41,560 --> 04:20:43,520 >>SO THAT WAS ONE OF THE TOPICS 6219 04:20:43,520 --> 04:20:47,400 WE DISCUSSED WHEN WE MET AS 6220 04:20:47,400 --> 04:20:48,000 CHAIRS AND THE CO-CHAIRS MET 6221 04:20:48,000 --> 04:20:49,200 TOGETHER IN THE MEETING IF 6222 04:20:49,200 --> 04:20:51,120 FEBRUARY AND WE DISCUSSED THAT 6223 04:20:51,120 --> 04:20:58,240 BUT WE'LL DEFINITELY AND AS WE 6224 04:20:58,240 --> 04:20:59,520 REFINE THE REPORT WE'LL DISCUSS 6225 04:20:59,520 --> 04:21:04,240 IT AND MAKE SURE THERE ARE NO 6226 04:21:04,240 --> 04:21:06,720 REDUNDANCY ACROSS THE OBJECTIVES 6227 04:21:06,720 --> 04:21:08,360 ASSOCIATED WITH EACH ONE OF THE 6228 04:21:08,360 --> 04:21:10,720 GOALS AND WE'RE ALSO THE NEXT 6229 04:21:10,720 --> 04:21:12,360 STEP WE'RE DOING IS THE PLAN IS 6230 04:21:12,360 --> 04:21:17,360 TO ALLOW THE CO-CHAIR TO TO 6231 04:21:17,360 --> 04:21:20,600 REVIEW THE SECTION THAT ARE 6232 04:21:20,600 --> 04:21:21,920 COMING THAT THE GOALS AND 6233 04:21:21,920 --> 04:21:23,080 OBJECTIVE OF EACH GROUP SO THEY 6234 04:21:23,080 --> 04:21:26,640 CAN HAVE ANOTHER REVIEW OF THE 6235 04:21:26,640 --> 04:21:35,480 REPORT BEFORE IT'S FINALIZED. 6236 04:21:35,480 --> 04:21:36,280 >>YES. 6237 04:21:36,280 --> 04:21:37,880 >>YOUR WELCOME. 6238 04:21:37,880 --> 04:21:42,920 >>Dr. SIMON IS THIS PLEASE. 6239 04:21:42,920 --> 04:21:45,040 >>A QUICK ONE. 6240 04:21:45,040 --> 04:21:47,440 WHY IS FETUS. 6241 04:21:47,440 --> 04:21:49,640 I UNDERSTAND IN THE SENSE OF 6242 04:21:49,640 --> 04:21:59,360 IMPACT PREGNANCY AND WHAT FETAL 6243 04:21:59,360 --> 04:22:01,600 PROGRAM AND I'M NOT SURE THE O 6244 04:22:01,600 --> 04:22:02,760 STRATEGIC PLAN BECAUSE I'M 6245 04:22:02,760 --> 04:22:05,640 WORRIED IN SOME SENSE FETUS IS 6246 04:22:05,640 --> 04:22:11,560 TAKEN OUT OF CONTEXT FOR THE 6247 04:22:11,560 --> 04:22:12,640 POLITICIZATION OF WOMEN'S HEALTH 6248 04:22:12,640 --> 04:22:20,000 AND SO I WORRY ABOUT FETUS. 6249 04:22:20,000 --> 04:22:21,560 I'M FAMILY PLANNING TRAIN. 6250 04:22:21,560 --> 04:22:22,720 >>Samia Noursi: I KNEW THIS 6251 04:22:22,720 --> 04:22:24,520 WOULD COME Dr. SIMON SO GOING 6252 04:22:24,520 --> 04:22:26,880 TO HAND YOU TO Dr. CLAYTON AND 6253 04:22:26,880 --> 04:22:28,640 I THINK WE'LL DISCUSS IT IN THE 6254 04:22:28,640 --> 04:22:29,520 PAST. 6255 04:22:29,520 --> 04:22:30,400 Dr. CLAYTON WOULD YOU LIKE TO 6256 04:22:30,400 --> 04:22:32,240 RESPONDED TO THAT? 6257 04:22:32,240 --> 04:22:34,200 >>YOU ARE TALKING ABOUT THE 6258 04:22:34,200 --> 04:22:35,400 MULTI DIMENSIONAL FRAMEWORK 6259 04:22:35,400 --> 04:22:39,280 UPDATE, IS THAT WHAT YOU ARE 6260 04:22:39,280 --> 04:22:49,520 TALKING ABOUT. 6261 04:22:51,120 --> 04:22:57,120 >>BECAUSE THE WORK AND IN UTE 6262 04:22:57,120 --> 04:22:57,320 UTERO. 6263 04:22:57,320 --> 04:22:59,160 >>O, THAT'S WHAT I WORRY ABOUT. 6264 04:22:59,160 --> 04:23:01,600 I JUST WORRY ABOUT WHEN WE USE 6265 04:23:01,600 --> 04:23:03,840 THE WORD FETUS -- I'M NOT SURE 6266 04:23:03,840 --> 04:23:10,840 IF IT'S GOING TOKING WRITTEN 6267 04:23:10,840 --> 04:23:12,760 DOWN BUT I WORRY ABOUT POLITICS 6268 04:23:12,760 --> 04:23:17,760 ENTERING THE RA EVE THE ARENA. 6269 04:23:17,760 --> 04:23:19,920 >>THE MULTI DIMENSIONAL 6270 04:23:19,920 --> 04:23:24,760 FRAMEWORK THE ACTUAL LIFE COURSE 6271 04:23:24,760 --> 04:23:25,920 LABELS HERE ARE SIMILAR TO THE 6272 04:23:25,920 --> 04:23:33,200 PREVIOUS VERSION IF I'M NOT 6273 04:23:33,200 --> 04:23:38,240 MISTAKEN SO THE THINKING THERE 6274 04:23:38,240 --> 04:23:39,560 IS IT'S IMPORTANT WHEN YOU THINK 6275 04:23:39,560 --> 04:23:40,720 ABOUT THE HEALTH OF WOMEN YOU 6276 04:23:40,720 --> 04:23:42,720 NEED TO THINK ABOUT EACH OF 6277 04:23:42,720 --> 04:23:44,240 THESE STAGES OF THE LIFE COURSE 6278 04:23:44,240 --> 04:23:52,480 AS CONTRIBUTING AND AS IT US AND 6279 04:23:52,480 --> 04:23:57,960 CONNECTED TO DO YOU HAVE 6280 04:23:57,960 --> 04:24:00,440 CONCERNS ABOUT THE FRAMEWORK OR 6281 04:24:00,440 --> 04:24:02,560 ARE YOU ENCOURAGING US TO LOOK 6282 04:24:02,560 --> 04:24:05,080 AT DOCUMENT THAT THE OBJECTIVES 6283 04:24:05,080 --> 04:24:06,640 OR ANOTHER PIECE OF THE 6284 04:24:06,640 --> 04:24:07,200 DOCUMENT, MELISSA. 6285 04:24:07,200 --> 04:24:09,000 >>I JUST WANT TO MAKE SURE THAT 6286 04:24:09,000 --> 04:24:13,520 WHEN WE TALK ABOUT LIFE COURSE 6287 04:24:13,520 --> 04:24:16,840 AND IN UTERO AND THING LIKE THAT 6288 04:24:16,840 --> 04:24:24,760 THAT WE JUST ARE MINDFUL WE ARE 6289 04:24:24,760 --> 04:24:26,800 ABOUT FETUS AND WE NEED TO BE 6290 04:24:26,800 --> 04:24:28,200 MIND MANY OF ABOUT HOW WE PUT 6291 04:24:28,200 --> 04:24:30,320 OURSELVES IN A POSITION OF 6292 04:24:30,320 --> 04:24:35,480 VULNERABILITY WHEN IT COMES 6293 04:24:35,480 --> 04:24:37,760 TO -- I WANT FEEDBACK AND I WANT 6294 04:24:37,760 --> 04:24:38,720 TO BUCKLE IT UP. 6295 04:24:38,720 --> 04:24:39,320 >>Samia Noursi: I WANT TO 6296 04:24:39,320 --> 04:24:40,840 RESPOND TO THAT AND MAYBE SOME 6297 04:24:40,840 --> 04:24:43,600 KIND OF COLLEAGUES HERE ON THAT 6298 04:24:43,600 --> 04:24:45,600 ADVISORY COMMITTEE. 6299 04:24:45,600 --> 04:24:47,000 WE STRUGGLED WITH THIS. 6300 04:24:47,000 --> 04:24:50,240 WE STRUGGLED OF HOW TO DEPICT, 6301 04:24:50,240 --> 04:24:52,200 YOU KNOW, WE CAN'T START AT 6302 04:24:52,200 --> 04:24:53,480 BIRTH, RIGHT. 6303 04:24:53,480 --> 04:24:58,280 WE CAN'T START AND AT BIRTH. 6304 04:24:58,280 --> 04:25:03,800 WE BRING WITH US MANY OF THE 6305 04:25:03,800 --> 04:25:06,000 FACTORS THAT HELP TO WHO WE ARE. 6306 04:25:06,000 --> 04:25:09,280 IF OUR MOTHER WAS DRINKING, IF 6307 04:25:09,280 --> 04:25:11,960 OUR MOTHER WAS USING ANYTHING, 6308 04:25:11,960 --> 04:25:13,960 WE BRING OUR GENETICS WITH US SO 6309 04:25:13,960 --> 04:25:16,040 WE STRUGGLE WITH HOW DO WE START 6310 04:25:16,040 --> 04:25:19,120 AND WE CAN'T START IT AT BIRTH. 6311 04:25:19,120 --> 04:25:22,840 SO, WE'RE HAPPY TO HAVE ANY 6312 04:25:22,840 --> 04:25:24,160 SUGGESTION THAT YOU MAY TO 6313 04:25:24,160 --> 04:25:30,080 ENSURE THAT WE ARE PRESENTING 6314 04:25:30,080 --> 04:25:31,240 THE HISTORY OF (INAUDIBLE) US. 6315 04:25:31,240 --> 04:25:34,960 >>THIS IS EXACTLY WHY SEX IS A 6316 04:25:34,960 --> 04:25:37,080 BIOLOGICAL VARIABLE POLICY NEEDS 6317 04:25:37,080 --> 04:25:39,000 TO BE ADDRESSED IN TERMS OF HOW 6318 04:25:39,000 --> 04:25:40,200 GENDER, HOW YOU SHOW UP IN THE 6319 04:25:40,200 --> 04:25:40,800 WORLD. 6320 04:25:40,800 --> 04:25:42,560 AT BIRTH, WHEN YOU ARE 6321 04:25:42,560 --> 04:25:44,840 IDENTIFIED OF OR ASSIGNED FEMALE 6322 04:25:44,840 --> 04:25:47,640 AT BIRTH YOU ARE -- THAT'S WHEN 6323 04:25:47,640 --> 04:25:55,640 YOU START YOUR WOMANHOOD SO TO 6324 04:25:55,640 --> 04:26:00,880 SPEAK YOU TEEN TYPICALLY SHOW UP 6325 04:26:00,880 --> 04:26:02,320 AT A WOMAN IN THE WORLD AND 6326 04:26:02,320 --> 04:26:04,600 THAT'S WHEN THE DISCRIMINATION 6327 04:26:04,600 --> 04:26:06,840 AND THE DIFFERENCES I WOULD 6328 04:26:06,840 --> 04:26:07,800 ARGUE START. 6329 04:26:07,800 --> 04:26:10,680 NOW, NOT THE BIOLOGICAL ALTHOUGH 6330 04:26:10,680 --> 04:26:13,520 I WOULD SAY THAT SOME SOCIAL, 6331 04:26:13,520 --> 04:26:15,760 THE WAY I SHOW UP SOCIALLY AND 6332 04:26:15,760 --> 04:26:17,080 THAT EXPERIENCE OF 6333 04:26:17,080 --> 04:26:18,240 DISCRIMINATION OVER TIME WHETHER 6334 04:26:18,240 --> 04:26:29,240 IT'S MASSAGE MASS -- THIS IS TD 6335 04:26:34,840 --> 04:26:35,040 STUFF. 6336 04:26:35,040 --> 04:26:36,800 THIS IS WHAT THIS COMMITTEE AND 6337 04:26:36,800 --> 04:26:39,080 THIS OFFICE IS MEANT TO DO TO 6338 04:26:39,080 --> 04:26:40,600 ADVANCE THE SCIENCE. 6339 04:26:40,600 --> 04:26:42,720 SO THE MINUTE, AT BIRTH, IS WHEN 6340 04:26:42,720 --> 04:26:45,960 YOU ARE A WATCH INSIDE THE 6341 04:26:45,960 --> 04:26:49,240 UTERUS, YOU ARE A FETUS, YOU ARE 6342 04:26:49,240 --> 04:26:50,520 NOT GENDERED. 6343 04:26:50,520 --> 04:26:53,400 YOU HAVE OF A SEX, YES, I AGREE 6344 04:26:53,400 --> 04:26:55,160 BIOLOGICALLY, BUT WHEN YOU COME 6345 04:26:55,160 --> 04:26:57,040 OUT, INTO THE WORLD, AND THEY 6346 04:26:57,040 --> 04:26:59,080 SEE YOUR PARTS, YOU ALREADY PUT 6347 04:26:59,080 --> 04:27:00,720 A PINK HAT ON. 6348 04:27:00,720 --> 04:27:03,640 ON OUR LABOR FLOOR YOU ARE STILL 6349 04:27:03,640 --> 04:27:04,640 GIVEN PINK OR BLUE. 6350 04:27:04,640 --> 04:27:07,160 YOU ARE ALREADY THEN WITHIN THAT 6351 04:27:07,160 --> 04:27:12,440 FIRST MINUTE OF LIFE, YOU GET A 6352 04:27:12,440 --> 04:27:16,960 HAT AND YOU HAVE AN IDENTITY AND 6353 04:27:16,960 --> 04:27:22,160 YOU ARE SOCIALIZED TO BE A WOMEN 6354 04:27:22,160 --> 04:27:24,280 VERSUS MALE. 6355 04:27:24,280 --> 04:27:25,120 >>THANK YOU. 6356 04:27:25,120 --> 04:27:26,400 WE HAVE FIVE MORE MINUTES AND 6357 04:27:26,400 --> 04:27:30,760 I'D LIKE TO GIVE AN OPPORTUNITY 6358 04:27:30,760 --> 04:27:31,800 TO Dr. RAG NOTSTEINER AND 6359 04:27:31,800 --> 04:27:35,880 OTHERS BUT THIS IS ALL GREAT 6360 04:27:35,880 --> 04:27:39,240 CONVERSATION AND WE'LL 6361 04:27:39,240 --> 04:27:40,520 INCORPORATE AS WE LOOK AT THIS 6362 04:27:40,520 --> 04:27:46,160 AND MAKE ADJUSTMENTS AND WE'LL 6363 04:27:46,160 --> 04:27:48,120 START WITH Dr. RAG ANSTEINER. 6364 04:27:48,120 --> 04:27:49,280 >>I DON'T KNOW WHERE THE 6365 04:27:49,280 --> 04:27:51,760 THINKING COMES IN THIS BUT THE 6366 04:27:51,760 --> 04:27:54,840 FETAL ORIGINS OF ADULT DISEASE 6367 04:27:54,840 --> 04:27:57,040 WE HAVE TO STUDY THE FEE AT 6368 04:27:57,040 --> 04:27:59,400 ORIGINS OF THE ADULT DISEASE AND 6369 04:27:59,400 --> 04:28:00,840 THAT HAS AFFECT SEX DIFFERENCES 6370 04:28:00,840 --> 04:28:04,160 MAKE A BIG DIFFERENCE IN THAT 6371 04:28:04,160 --> 04:28:04,840 ROLE. 6372 04:28:04,840 --> 04:28:06,840 I AGREE WITH THIS CHART AS 6373 04:28:06,840 --> 04:28:12,240 WRITTEN, EVEN WHEN PEOPLE ARE IN 6374 04:28:12,240 --> 04:28:12,840 UTERO. 6375 04:28:12,840 --> 04:28:17,440 I THINK THAT'S REALLY AN 6376 04:28:17,440 --> 04:28:19,760 IMPORTANT AREA OF STUDY. 6377 04:28:19,760 --> 04:28:22,920 I THINK IT'S PART OF THE 6378 04:28:22,920 --> 04:28:25,320 EXPERIENCE AND THE WHOLE AREA OF 6379 04:28:25,320 --> 04:28:28,640 EPIGENETICS SHOULD BE CONSIDERED 6380 04:28:28,640 --> 04:28:29,960 AS WELL. 6381 04:28:29,960 --> 04:28:32,880 >>THANK YOU, DOCTOR. 6382 04:28:32,880 --> 04:28:34,840 >>I'M CHANGING THE DIRECTION 6383 04:28:34,840 --> 04:28:38,360 HERE SO I DON'T KNOW IF Dr. 6384 04:28:38,360 --> 04:28:39,800 SUDOSKI WANTS TO GO BEFORE ME. 6385 04:28:39,800 --> 04:28:41,440 >>SURE. 6386 04:28:41,440 --> 04:28:43,640 >>YEAH, I'M NOT CHANGING THE 6387 04:28:43,640 --> 04:28:45,760 DIRECTION I'M STAYING ON IT IT. 6388 04:28:45,760 --> 04:28:48,400 I THINK THAT, I MEAN I 6389 04:28:48,400 --> 04:28:49,480 UNDERSTAND THE SENSITIVITIES BUT 6390 04:28:49,480 --> 04:28:54,160 I DO THINK THAT BIOLOGICAL SEX 6391 04:28:54,160 --> 04:28:56,080 IS A DETERMINANT OF GENDER AND 6392 04:28:56,080 --> 04:28:58,120 OF COURSE GENDER HAS MANY OTHER 6393 04:28:58,120 --> 04:29:01,560 COMPONENTS BUT FETAL SEX 6394 04:29:01,560 --> 04:29:03,360 BIOLOGICAL SEX INFLUENCES I ALSO 6395 04:29:03,360 --> 04:29:07,000 WANT TO SAY MANY PARTS OF THE 6396 04:29:07,000 --> 04:29:09,800 WORLD WOMEN MAY TREAT THEIR 6397 04:29:09,800 --> 04:29:11,160 PREGNANCY DIFFERENTLY IF IT'S A 6398 04:29:11,160 --> 04:29:12,800 MALE OR A FEMALE. 6399 04:29:12,800 --> 04:29:14,240 ESPECIALLY IF THEY WANTED THE 6400 04:29:14,240 --> 04:29:17,320 OPPOSITE SEX IS VERY SAD BUT 6401 04:29:17,320 --> 04:29:20,280 IT'S A REALITY SO I THINK THAT 6402 04:29:20,280 --> 04:29:22,280 MANY COMPONENTS OF FETAL SEX 6403 04:29:22,280 --> 04:29:23,480 PRIOR TO GENDER DETERMINATION 6404 04:29:23,480 --> 04:29:24,840 AND BIRTH ARE CRITICAL AND ONE 6405 04:29:24,840 --> 04:29:26,880 MORE THING IS THAT FETAL SEX 6406 04:29:26,880 --> 04:29:28,960 DOES EFFECT MATERNAL HEALTH 6407 04:29:28,960 --> 04:29:29,800 DURING PREGNANCY AND MATERNAL 6408 04:29:29,800 --> 04:29:32,960 HEALTH IS A KEY PART OF WHAT 6409 04:29:32,960 --> 04:29:36,560 WE'RE TALKING ABOUT. 6410 04:29:36,560 --> 04:29:39,160 >>Samia Noursi: THANK YOU. 6411 04:29:39,160 --> 04:29:41,880 >>I WAS HEADING TO THE OTHER 6412 04:29:41,880 --> 04:29:44,000 END OF THE SPECTRUM ON AGING AND 6413 04:29:44,000 --> 04:29:46,040 THESE STAND ORDER CATEGORIES 6414 04:29:46,040 --> 04:29:53,040 THAT YOU CHOSE HERE BUT WONDERED 6415 04:29:53,040 --> 04:29:54,080 STOOD OF ADULTHOOD AND AGING 6416 04:29:54,080 --> 04:29:57,600 COULD IT BE EARLY, MID, LATE 6417 04:29:57,600 --> 04:29:58,800 ADULTHOOD IN WOULD BE MORE A 6418 04:29:58,800 --> 04:30:00,320 CONTINUUM THAN THE WAY IT IS IF 6419 04:30:00,320 --> 04:30:03,040 IF THE WAY IT IS SET UP RIGHT 6420 04:30:03,040 --> 04:30:06,840 NOW AND THEN JUST A QUICK SIDE 6421 04:30:06,840 --> 04:30:09,280 WITH THINK-TANK FIVE, OBJECTIVE 6422 04:30:09,280 --> 04:30:11,440 TALKING ABOUT TAILORING NEEDS OF 6423 04:30:11,440 --> 04:30:15,160 WOMEN, A GROUP REALLY CAME TO 6424 04:30:15,160 --> 04:30:18,920 MIND THAT IS THE MAJORITY ARE 6425 04:30:18,920 --> 04:30:24,800 WOMEN OR INFORMAL CARE CURVES SO 6426 04:30:24,800 --> 04:30:26,640 I WANTED TO THROW THAT AS A 6427 04:30:26,640 --> 04:30:28,880 GROUP THAT HAS A LOT OF CHRONIC 6428 04:30:28,880 --> 04:30:30,680 DISEASE AND IT'S IMPORTANT GROUP 6429 04:30:30,680 --> 04:30:32,120 AS WE'RE MOVING FORWARD WITH 6430 04:30:32,120 --> 04:30:39,800 AGING AND TAKING CARE OF THOSE 6431 04:30:39,800 --> 04:30:41,120 WITH DEMENTIA. 6432 04:30:41,120 --> 04:30:45,800 SO, I'D LIKE TO THANK EVERYONE 6433 04:30:45,800 --> 04:30:47,440 AND THIS WAS GREAT. 6434 04:30:47,440 --> 04:30:48,320 IS AREA HAND STILL UP? 6435 04:30:48,320 --> 04:30:55,640 YOU ARE DONE. 6436 04:30:55,640 --> 04:30:58,840 I'D LIKE TO THANK Dr. 6437 04:30:58,840 --> 04:31:01,400 McGREGOR AND THANK Dr. 6438 04:31:01,400 --> 04:31:02,720 CHANDLER FOR THEIR EFFORTS 6439 04:31:02,720 --> 04:31:06,920 WORKING WITH ME AND LEADING THIS 6440 04:31:06,920 --> 04:31:09,560 AND THANK YOU ALL FOR YOUR 6441 04:31:09,560 --> 04:31:10,640 CONTRIBUTIONS, WE APPRECIATE ALL 6442 04:31:10,640 --> 04:31:12,280 YOUR COMMITMENT TO ENSURING THAT 6443 04:31:12,280 --> 04:31:14,040 WE ARE IN THE RIGHT DIRECTION 6444 04:31:14,040 --> 04:31:15,360 WITH REGARDS TO THE STRATEGIC 6445 04:31:15,360 --> 04:31:15,680 PLAN. 6446 04:31:15,680 --> 04:31:17,800 BUT IF YOU DO HAVE ADDITIONAL 6447 04:31:17,800 --> 04:31:19,440 COMMENTS THAT YOU DIDN'T HAVE A 6448 04:31:19,440 --> 04:31:22,600 CHANCE TO SHARE HERE, PLEASE 6449 04:31:22,600 --> 04:31:25,600 REACH OUT TO US, SARAH OR MYSELF 6450 04:31:25,600 --> 04:31:27,600 ARE ALWAYS HAPPY TO RESPOND TO 6451 04:31:27,600 --> 04:31:30,360 YOUR E-MAILS SO THANK YOU AGAIN. 6452 04:31:30,360 --> 04:31:33,240 WE'RE GOING TO MOVE TO HAVE THE 6453 04:31:33,240 --> 04:31:38,360 NEXT PART OF OUR MEETING RIGHT 6454 04:31:38,360 --> 04:31:42,520 NOW AND LET ME JUST LOOK HERE AT 6455 04:31:42,520 --> 04:31:46,160 THE NEXT PART AND THAT IS WHERE 6456 04:31:46,160 --> 04:31:52,760 I WELCOME Dr. XENIA TIGNO WHO 6457 04:31:52,760 --> 04:31:55,640 IS ASSOCIATE DIRECTOR FOR CAREER 6458 04:31:55,640 --> 04:31:59,040 AT ORWH AND SHE WILL BE OUR NEXT 6459 04:31:59,040 --> 04:32:01,040 SPEAKER. 6460 04:32:01,040 --> 04:32:04,960 PRIOR TO THIS CURRENT POSITION 6461 04:32:04,960 --> 04:32:08,080 Dr. TIGNO WAS PROGRAM AT THING 6462 04:32:08,080 --> 04:32:09,520 HEART AND LUNG BLOOD INSTITUTE 6463 04:32:09,520 --> 04:32:11,080 AND THE NATIONAL INSTITUTE FOR 6464 04:32:11,080 --> 04:32:12,360 NURSING RESEARCH AT THE NIH. 6465 04:32:12,360 --> 04:32:14,720 SHE HAS PUBLISHED IN THE YEARS 6466 04:32:14,720 --> 04:32:18,160 OF BIOPHYSICS OF THE MICRO 6467 04:32:18,160 --> 04:32:19,520 CIRCULATION, OWE BEE TEES, 6468 04:32:19,520 --> 04:32:23,960 DIABETES, AGING, COMMUNITY BASED 6469 04:32:23,960 --> 04:32:25,480 EPIDEMIOLOGY AND PURPLE MEDICINE 6470 04:32:25,480 --> 04:32:27,320 AND WOMAN'S HEALTH. 6471 04:32:27,320 --> 04:32:30,840 Dr. TIGNO'S CURRENT EFFORTS 6472 04:32:30,840 --> 04:32:33,400 ARE DIRECTED TOWARDS SUPPORTING 6473 04:32:33,400 --> 04:32:35,600 ADVANCEMENT OF WOMEN IN 6474 04:32:35,600 --> 04:32:37,400 BIOMEDICAL CAREERS AND PROMOTING 6475 04:32:37,400 --> 04:32:38,920 DIVERSITY OF INCLUSION IN 6476 04:32:38,920 --> 04:32:39,760 ACADEMIA. 6477 04:32:39,760 --> 04:32:41,680 WELCOME Dr. TIGNO. 6478 04:32:41,680 --> 04:32:44,720 >>THANK YOU VERY MUCH Dr. 6479 04:32:44,720 --> 04:32:45,320 NOURSI. 6480 04:32:45,320 --> 04:32:46,920 GOOD AFTERNOON, LADIES AND 6481 04:32:46,920 --> 04:32:47,360 GENTLEMEN. 6482 04:32:47,360 --> 04:32:52,560 IT IS MY PLEASURE TO GIVE YOU AN 6483 04:32:52,560 --> 04:32:54,520 UPDATE ON THE OLDEST FUNDING 6484 04:32:54,520 --> 04:32:55,720 OPPORTUNITY EVER ISSUED BY THE 6485 04:32:55,720 --> 04:32:58,040 OFFICE OF RESEARCH ON WOMEN'S 6486 04:32:58,040 --> 04:32:58,600 HEALTH. 6487 04:32:58,600 --> 04:33:00,280 AND AT THE SAME TIME, ALSO SEEK 6488 04:33:00,280 --> 04:33:02,440 YOUR APPROVAL FOR THE NEXT 6489 04:33:02,440 --> 04:33:08,240 REISSUANCE OF THIS FUNDING 6490 04:33:08,240 --> 04:33:18,280 MECHANISM. 6491 04:33:18,280 --> 04:33:19,720 SO THIS REFERS TO ISSUES WAY 6492 04:33:19,720 --> 04:33:20,800 BACK IN FIRST-DEGREE 92. 6493 04:33:20,800 --> 04:33:27,480 1992 TO ALLOWFULSCIENTISTS, WOMR 6494 04:33:27,480 --> 04:33:29,360 THE SCIENTIFIC WORKFORCE AFTER 6495 04:33:29,360 --> 04:33:31,560 HAVING HAD AN INTERRUPTION OF 6496 04:33:31,560 --> 04:33:35,840 THEIR CAREERS DUE TO RESPONSE 6497 04:33:35,840 --> 04:33:36,320 ABILITIES. 6498 04:33:36,320 --> 04:33:38,400 SINCE THOSE THAT DROPPED OUT OF 6499 04:33:38,400 --> 04:33:39,840 THE WORKFORCE BECAUSE OF FAMILY 6500 04:33:39,840 --> 04:33:42,800 CONCERNS, MOSTLY WOMEN, THE 6501 04:33:42,800 --> 04:33:44,840 REENTERED PROGRAM WHILE NOT 6502 04:33:44,840 --> 04:33:48,160 DISQUALIFYING MEN, WAS MORE 6503 04:33:48,160 --> 04:33:49,840 LIKELY TO BE BY WOMEN. 6504 04:33:49,840 --> 04:33:51,360 CANDIDATES WHO WISHED TO APPLY 6505 04:33:51,360 --> 04:33:53,400 FOR THESE ADMINISTRATIVE 6506 04:33:53,400 --> 04:33:54,720 SUPPLEMENTS WERE ASKED TO 6507 04:33:54,720 --> 04:33:57,320 IDENTIFY A MENTOR WITH AN NIH 6508 04:33:57,320 --> 04:33:59,320 FUNDED RESEARCH PROJECT GRANT 6509 04:33:59,320 --> 04:34:00,640 WHO WOULD BE WILLING TO 6510 04:34:00,640 --> 04:34:03,000 INTEGRATE THIS CALLER INTO THE 6511 04:34:03,000 --> 04:34:05,840 RESEARCH PROJECT AND PROVIDE 6512 04:34:05,840 --> 04:34:07,160 RESEARCH TRAINING FOR THE 6513 04:34:07,160 --> 04:34:10,200 DURATION OF THE SUPPLEMENT 6514 04:34:10,200 --> 04:34:10,720 AWARD. 6515 04:34:10,720 --> 04:34:12,600 AS CAN BE SEEN FROM THE SLIDE, 6516 04:34:12,600 --> 04:34:13,360 THIS FUNDING OPPORTUNITY HAS 6517 04:34:13,360 --> 04:34:15,360 BEEN CONTINUOUSLY REISSUED 6518 04:34:15,360 --> 04:34:16,640 THROUGHOUT THE YEARS AND THE 6519 04:34:16,640 --> 04:34:21,400 LATEST ONE BEING IN 2021 AND 6520 04:34:21,400 --> 04:34:23,040 IT'S PRIOR IN OCTOBER OF THIS 6521 04:34:23,040 --> 04:34:23,640 YEAR. 6522 04:34:23,640 --> 04:34:25,280 THE REST OF THE PRESENTATION 6523 04:34:25,280 --> 04:34:26,720 WILL TOUCH UPON THE ASSESSMENT 6524 04:34:26,720 --> 04:34:29,880 WE HAVE PERFORMED PRESENTING 6525 04:34:29,880 --> 04:34:32,360 DATA FROM PREVIOUS ISSUANCES AND 6526 04:34:32,360 --> 04:34:35,000 SUGGEST MODIFICATIONS TO MAKE 6527 04:34:35,000 --> 04:34:37,080 THIS MECHANISM MORE RESPONSE 6528 04:34:37,080 --> 04:34:39,280 ITCH AND THE CHANGING CHALLENGES 6529 04:34:39,280 --> 04:34:42,240 THAT WOMEN SCIENTISTS FACE. 6530 04:34:42,240 --> 04:34:52,560 NEXT LINE, PLEASE. 6531 04:34:54,480 --> 04:35:02,120 SO, SINCE THE DATA AND THE NIH 6532 04:35:02,120 --> 04:35:03,640 QVR DATABASE DID NOT GO BACK TO 6533 04:35:03,640 --> 04:35:10,480 THE 1990s WE MADE FROM 2012 TO 6534 04:35:10,480 --> 04:35:10,920 22021. 6535 04:35:10,920 --> 04:35:12,560 20 YEARS TO THE PENULTIMATE 6536 04:35:12,560 --> 04:35:18,120 ISSUANCE OF 2018 AS PA-18-592. 6537 04:35:18,120 --> 04:35:20,400 THE PERSON OF THE FOA IS STATED 6538 04:35:20,400 --> 04:35:21,240 HERE. 6539 04:35:21,240 --> 04:35:22,760 SOME OF THE INTERRUPTIONS THAT 6540 04:35:22,760 --> 04:35:24,160 WERE CONSIDERED AS APPROPRIATE 6541 04:35:24,160 --> 04:35:27,960 FOR THIS ADMINISTRATIVE 6542 04:35:27,960 --> 04:35:31,680 SUPPLEMENTS, WERE A COMPLETE OR 6543 04:35:31,680 --> 04:35:33,400 PARTIAL RESEARCH TECHNIQUES IT 6544 04:35:33,400 --> 04:35:36,520 TO THE CHILD BEARING AND CHILD 6545 04:35:36,520 --> 04:35:38,200 REARING AND ILLNESS OR INJURY OF 6546 04:35:38,200 --> 04:35:41,280 THE CANDIDATE, HIS OR HER 6547 04:35:41,280 --> 04:35:43,560 SPOUSE, PARTNER OR A MEMBER OF 6548 04:35:43,560 --> 04:35:45,400 THE IMMEDIATE FAMILY. 6549 04:35:45,400 --> 04:35:47,760 RELOCATION OF DOCTORAL SCIENTIST 6550 04:35:47,760 --> 04:35:50,000 TO ACCOMMODATE A SPOUSE, PARTNER 6551 04:35:50,000 --> 04:35:51,640 OR OTHER CLOSE FAMILY MEMBER. 6552 04:35:51,640 --> 04:35:54,280 JOB OFFERS THAT WERE RESCINDED 6553 04:35:54,280 --> 04:35:56,880 DUE TO NATURAL DISASTERS OR 6554 04:35:56,880 --> 04:35:58,080 PUBLIC-HEALTH EMERGENCIES SUCH 6555 04:35:58,080 --> 04:36:00,480 AS THE COVID PANDEMIC. 6556 04:36:00,480 --> 04:36:02,920 OR EVEN PURSUIT OF NON RESEARCH 6557 04:36:02,920 --> 04:36:05,080 ENDEAVORS TO PERMIT EARLIER 6558 04:36:05,080 --> 04:36:07,120 REPAYMENT OF DEBT INCURRED IN 6559 04:36:07,120 --> 04:36:10,560 OBTAINING THE DOCTORAL DEGREE. 6560 04:36:10,560 --> 04:36:11,760 A HIATUS DUE TO MILITARY SERVICE 6561 04:36:11,760 --> 04:36:14,640 IS ELIGIBLE. 6562 04:36:14,640 --> 04:36:16,160 CANDIDATES WHO ARE IN NON 6563 04:36:16,160 --> 04:36:18,440 RESEARCH CAREER AND HAVE HAD NO 6564 04:36:18,440 --> 04:36:20,440 PREVIOUS RESEARCH TRAINING ARE 6565 04:36:20,440 --> 04:36:23,080 NOT ELIGIBLE TO APPLY. 6566 04:36:23,080 --> 04:36:25,320 THESE ADMINISTRATIVE SUPPLEMENTS 6567 04:36:25,320 --> 04:36:26,640 PROVIDED PART-TIME OR FULL TIME 6568 04:36:26,640 --> 04:36:28,920 SUPPORT TO THE CANDIDATES AS HE 6569 04:36:28,920 --> 04:36:31,760 OR SHE UPDATES AND ENHANCES HER 6570 04:36:31,760 --> 04:36:33,440 RESEARCH SKILLS WITH THE 6571 04:36:33,440 --> 04:36:34,680 EXPECTATION THAT AT THE END OF 6572 04:36:34,680 --> 04:36:37,240 THE SUPPLEMENT PERIOD, HE OR SHE 6573 04:36:37,240 --> 04:36:41,120 WILL BE COMPETITIVE ENOUGH TO 6574 04:36:41,120 --> 04:36:45,880 APPLY FOR INDIVIDUAL K OR RO1 6575 04:36:45,880 --> 04:36:47,520 AWARDS. 6576 04:36:47,520 --> 04:36:51,760 SHOWN HERE IS THE USAGE OF THIS 6577 04:36:51,760 --> 04:36:53,520 SUPPLEMENT AS MENTIONED AND THE 6578 04:36:53,520 --> 04:36:55,320 RELATIVE SUCCESS RATE OF 6579 04:36:55,320 --> 04:36:56,240 OBTAINING AN AWARD. 6580 04:36:56,240 --> 04:36:58,760 THE TOTAL NUMBER OF APPLICATIONS 6581 04:36:58,760 --> 04:37:01,000 ARE SHOWN IN BLUE AND THE NUMBER 6582 04:37:01,000 --> 04:37:04,480 OF A WARPEDDED APPLICATIONS IN 6583 04:37:04,480 --> 04:37:04,920 VIOLET. 6584 04:37:04,920 --> 04:37:08,040 ALL AND ALL THERE WERE ONLY 144 6585 04:37:08,040 --> 04:37:10,200 APPLICATIONS AND 88 AWARDS FOR A 6586 04:37:10,200 --> 04:37:18,200 SUCCESS RATE OF 61%. 6587 04:37:18,200 --> 04:37:19,400 BECAUSE THERE WAS NO SEX OR 6588 04:37:19,400 --> 04:37:22,480 TENURE DATA IT COULD BE THE QVR 6589 04:37:22,480 --> 04:37:24,160 DATABASE FROM THE TRAINEES WE 6590 04:37:24,160 --> 04:37:27,520 USED THE SUPPORTING DOCUMENTS TO 6591 04:37:27,520 --> 04:37:28,200 DETERMINE THE GENDER OF THE 6592 04:37:28,200 --> 04:37:30,200 APPLICANTS AND AWARDEES AND ASK 6593 04:37:30,200 --> 04:37:35,520 AND BE SEEN THE MAJORITY THAT IS 6594 04:37:35,520 --> 04:37:37,520 80ER OF THOSE APPLIED WERE 6595 04:37:37,520 --> 04:37:38,600 IDENTIFIED AS SHEs. 6596 04:37:38,600 --> 04:37:45,480 ALSO THE MAJORITY OR 76% WHY 6597 04:37:45,480 --> 04:37:47,800 ALSO IDENTIFIED AS SHE. 6598 04:37:47,800 --> 04:37:52,840 NEXT SLIDE, PLEASE. 6599 04:37:52,840 --> 04:37:56,280 THE DATA FROM 2012 TO 2021 6600 04:37:56,280 --> 04:38:02,960 REVEALS THAT 62% OF WOMEN 6601 04:38:02,960 --> 04:38:08,400 APPLICANTS CITED CHILD BEARING 6602 04:38:08,400 --> 04:38:11,400 AND 27.6% OF CITED THE. 6603 04:38:11,400 --> 04:38:13,280 AS FOR CAREGIVING FOR FAMILY 6604 04:38:13,280 --> 04:38:16,160 MEMBERS WITH ILLNESS, THIS WAS 6605 04:38:16,160 --> 04:38:20,640 MENTIONED 51% OF THE TIME BY THE 6606 04:38:20,640 --> 04:38:23,240 HE AND 22% OF THE TIME BY THE 6607 04:38:23,240 --> 04:38:23,840 SHE. 6608 04:38:23,840 --> 04:38:26,200 PLEASE NOTE HOWEVER IN THIS 6609 04:38:26,200 --> 04:38:27,880 CATEGORIES ARE NOT MUTUALLY 6610 04:38:27,880 --> 04:38:28,480 EXCLUSIVE. 6611 04:38:28,480 --> 04:38:29,920 NEEDING TO SAY YOU CAN CHOSE 6612 04:38:29,920 --> 04:38:34,200 MORE THAN ONE AT ANY GIVEN TIME 6613 04:38:34,200 --> 04:38:39,360 DURING THE APPLICATION. 6614 04:38:39,360 --> 04:38:43,600 APART FROM THE ORWH, 23 OTHER 6615 04:38:43,600 --> 04:38:45,400 INSTITUTES CENTERS OR OFFICES 6616 04:38:45,400 --> 04:38:47,680 PARTICIPATED IN THE REENTER TREE 6617 04:38:47,680 --> 04:38:48,720 SUPPLEMENT PROGRAM AND THEY CAN 6618 04:38:48,720 --> 04:38:51,000 BE SEEN FROM THESE SLIDES. 6619 04:38:51,000 --> 04:38:55,240 SO MAJORITY OF ALL OF THE 6620 04:38:55,240 --> 04:38:56,880 ICOs, THEY HAD SUITABLE 6621 04:38:56,880 --> 04:38:58,720 PROJECTS GRANTS THAT COULD APPLY 6622 04:38:58,720 --> 04:39:04,240 FOR SUPPLEMENTS WERE INCLUDED. 6623 04:39:04,240 --> 04:39:05,760 THE NATIONAL INSTITUTE OF 6624 04:39:05,760 --> 04:39:10,200 GENERAL MEDICAL SCIENTISTS OR 6625 04:39:10,200 --> 04:39:14,160 NIGMS SHOWED IN GRAY WAS THE IC 6626 04:39:14,160 --> 04:39:15,840 WHICH HAD GIVEN THE MOST NUMBER 6627 04:39:15,840 --> 04:39:16,840 OF AWARDS. 6628 04:39:16,840 --> 04:39:18,440 THIS WAS FOLLOWED BY THE 6629 04:39:18,440 --> 04:39:20,880 NATIONAL CANCER INSTITUTE 6630 04:39:20,880 --> 04:39:25,120 DEPICTED IN BLUE. 6631 04:39:25,120 --> 04:39:27,360 AND MOST SUPPLEMENTS WERE 6632 04:39:27,360 --> 04:39:30,120 ATTACHED TO OUR O1 AWARDS SHOWN 6633 04:39:30,120 --> 04:39:34,080 IN GREEN FOLLOWED BY SPECIALIZED 6634 04:39:34,080 --> 04:39:36,760 CENTER OF GRANTS AND ALSO 6635 04:39:36,760 --> 04:39:37,120 R35s. 6636 04:39:37,120 --> 04:39:39,200 AS CAN BE SEEN, THERE ARE MANY 6637 04:39:39,200 --> 04:39:44,480 THAT ARE ELIGIBLE FOR HAVING 6638 04:39:44,480 --> 04:39:48,280 SUPPLEMENTS. 6639 04:39:48,280 --> 04:39:50,240 IN 2021, WE MADE SOME CHANGES TO 6640 04:39:50,240 --> 04:39:53,880 THE REENTRY SUPPLEMENTS TO 6641 04:39:53,880 --> 04:39:56,600 ENABLE ORWH TO ADDRESS OTHER 6642 04:39:56,600 --> 04:39:58,280 CONTEMPORARY CHALLENGES FACED BY 6643 04:39:58,280 --> 04:40:00,760 WOMEN IN STEM. 6644 04:40:00,760 --> 04:40:04,800 AND THAT NOSI WAS PROVED BY THE 6645 04:40:04,800 --> 04:40:05,640 ACRWH. 6646 04:40:05,640 --> 04:40:08,280 SO THE ISSUANCE OF THE REENTRY 6647 04:40:08,280 --> 04:40:10,200 SUPPLEMENT THIS IS 2021 ADDED A 6648 04:40:10,200 --> 04:40:12,760 NEW PROGRAM TO ADDRESS THE ISSUE 6649 04:40:12,760 --> 04:40:15,200 OF SEXUAL HARASSMENT AND ISSUE 6650 04:40:15,200 --> 04:40:18,120 THAT WOMEN SIGNED TO FACE AND 6651 04:40:18,120 --> 04:40:19,760 EXTENSIVELY DISCUSSED IN A 6652 04:40:19,760 --> 04:40:22,840 REPORT PUBLISHED IN 2020. 6653 04:40:22,840 --> 04:40:26,440 IN RESPONSE, ORWH CREATED THE 6654 04:40:26,440 --> 04:40:31,840 REINCOMPETENT INAUGURATION 6655 04:40:31,840 --> 04:40:35,560 REINTEGRATE AND CHARGE THE ISSUE 6656 04:40:35,560 --> 04:40:37,640 BROUGHT ABOUT BY THE REPORT AND 6657 04:40:37,640 --> 04:40:40,960 FULFILL THE CHARGE OF THE NIH 6658 04:40:40,960 --> 04:40:42,520 ACT WORKING GROUP TO PROMOTE A 6659 04:40:42,520 --> 04:40:47,600 SAFE AND INCLUSIVE CULTURE AND 6660 04:40:47,600 --> 04:40:50,640 INDIVIDUALS IN TRAINING WHO ARE 6661 04:40:50,640 --> 04:40:52,000 EXPERIENCING VARIOUS FORMS OF 6662 04:40:52,000 --> 04:40:53,640 DEPRESSION SUCH AS SEXUAL, 6663 04:40:53,640 --> 04:40:55,880 RACIAL, GENDER BASED, DISABILITY 6664 04:40:55,880 --> 04:40:57,680 BASED, RELIGIOUS BASED AND OTHER 6665 04:40:57,680 --> 04:41:01,080 FORMS OF HARASSMENT, WERE 6666 04:41:01,080 --> 04:41:03,000 PROVIDED AN EXIT TO RAPIDLY 6667 04:41:03,000 --> 04:41:04,080 TRANSITION FROM THEIR 6668 04:41:04,080 --> 04:41:07,000 ENVIRONMENT INTO A NEW AND SAFER 6669 04:41:07,000 --> 04:41:08,320 ONE THAT WOULD SUPPORT AND 6670 04:41:08,320 --> 04:41:10,000 ENABLE THEM TO PURSUE AND 6671 04:41:10,000 --> 04:41:11,920 CONTINUE THEIR SCIENTIFIC 6672 04:41:11,920 --> 04:41:12,360 PREMIERES. 6673 04:41:12,360 --> 04:41:14,760 AND IMPORTANTLY, IN CONTRAST TO 6674 04:41:14,760 --> 04:41:16,920 THE REENTRY SUPPLEMENTS, 6675 04:41:16,920 --> 04:41:19,080 CANDIDATES FOR THE REINTEGRATION 6676 04:41:19,080 --> 04:41:21,000 PROGRAM DID NOT NEED TO BE IN 6677 04:41:21,000 --> 04:41:24,280 THE POSTDOCTORAL STAGE. 6678 04:41:24,280 --> 04:41:31,120 THEY COULD BE GRANT STUDENTS. 6679 04:41:31,120 --> 04:41:32,840 SINCE THE NOTICE IN 2021, TWO 6680 04:41:32,840 --> 04:41:35,480 YEARS AGO, WE'VE RECEIVED 22 NEW 6681 04:41:35,480 --> 04:41:35,920 APPLICATIONS. 6682 04:41:35,920 --> 04:41:38,800 TWO OF WHICH WERE FOR THE 6683 04:41:38,800 --> 04:41:40,200 REINTEGRATIONS ON THE LIST. 6684 04:41:40,200 --> 04:41:42,320 BOTH OF THESE WERE INTEGRATION 6685 04:41:42,320 --> 04:41:44,440 SUPPLEMENT APPLICATIONS WERE 6686 04:41:44,440 --> 04:41:44,920 FUNDED. 6687 04:41:44,920 --> 04:41:46,880 WHEREAS THE FUNDING RATE FOR THE 6688 04:41:46,880 --> 04:41:52,000 PURE REENTRY WAS 13/20 OR 65%. 6689 04:41:52,000 --> 04:41:54,120 SOME OF THE REASONS GIVEN FORAY 6690 04:41:54,120 --> 04:41:58,200 FLYING FOR THE REENTRY 6691 04:41:58,200 --> 04:41:59,040 SUPPLEMENTS ARE SHOWN HERE. 6692 04:41:59,040 --> 04:42:01,560 THEY INCLUDE CHILDBIRTH, SPOUSAL 6693 04:42:01,560 --> 04:42:04,280 ACCOMMODATION, CAREGIVERS AND 6694 04:42:04,280 --> 04:42:06,280 SELF-ILLNESS. 6695 04:42:06,280 --> 04:42:08,200 OF NOTE, COVID WAS MENTIONED IN 6696 04:42:08,200 --> 04:42:13,480 FIVE OF THE REENTRY SUPPLEMENTS 6697 04:42:13,480 --> 04:42:21,000 REQUESTS. 6698 04:42:21,000 --> 04:42:23,640 WE ASKED FOR YOUR APPROVAL FOR A 6699 04:42:23,640 --> 04:42:25,760 DIDDATIONAL COM POPE ANT TO THE 6700 04:42:25,760 --> 04:42:26,720 PREVIOUS VERSION THE MAJOR 6701 04:42:26,720 --> 04:42:30,720 CHANGE WILL BE TO OFFER AN 6702 04:42:30,720 --> 04:42:35,960 OPPORTUNITY FOR INDIVIDUALS 6703 04:42:35,960 --> 04:42:36,920 POSTDOCTORAL EXPERIENCE TO 6704 04:42:36,920 --> 04:42:38,440 EXPAND THEIR SKILLS SET SO THAT 6705 04:42:38,440 --> 04:42:40,840 UNDER REPRESENTED GROUP, 6706 04:42:40,840 --> 04:42:42,960 ESPECIALLY WOMEN IN MID CAREER 6707 04:42:42,960 --> 04:42:44,880 STAGES, WILL BE ABLE TO ADVANCE 6708 04:42:44,880 --> 04:42:47,960 IN THEIR CAREERS. 6709 04:42:47,960 --> 04:42:50,880 ASK AND BE SEEN FROM THE SLIDES, 6710 04:42:50,880 --> 04:42:55,640 THE RETRAINING AND RETOOLING 6711 04:42:55,640 --> 04:42:57,640 PROGRAM PROVIDES SUPPORT FOR AN 6712 04:42:57,640 --> 04:43:00,280 INTENSIVE SUPERVISED IMMERSIVE 6713 04:43:00,280 --> 04:43:04,120 EXPERIENCE IN A LABORATORY AND 6714 04:43:04,120 --> 04:43:06,960 INSTITUTION, GOVERNMENT 6715 04:43:06,960 --> 04:43:07,800 ORGANIZATIONS, NON-PROFIT OR 6716 04:43:07,800 --> 04:43:10,080 CHARITABLE ORGANIZATIONS, AND 6717 04:43:10,080 --> 04:43:16,920 PUBLISHING HOUSING AND OTHER 6718 04:43:16,920 --> 04:43:18,920 FORMS OF SCIENCE RELATED 6719 04:43:18,920 --> 04:43:20,720 INDUSTRY AND THE INTENT OF THE 6720 04:43:20,720 --> 04:43:24,640 PROGRAM AND TO FACILITATE INTER 6721 04:43:24,640 --> 04:43:25,600 DISCIPLINARY PARTNERSHIPS AND 6722 04:43:25,600 --> 04:43:27,280 CROSS SECTOR AND COLLABORATIONS 6723 04:43:27,280 --> 04:43:30,640 THAT WOULD ENABLE THE CALLER TO 6724 04:43:30,640 --> 04:43:32,200 ACQUIRE SPECIALIZED SKILLS AND 6725 04:43:32,200 --> 04:43:36,080 NOVEL PERSPECTIVES THAT COULD 6726 04:43:36,080 --> 04:43:38,080 PROVIDE MOMENTUM TO THEIR 6727 04:43:38,080 --> 04:43:41,400 CAREERS AND NEXT SLIDE. 6728 04:43:41,400 --> 04:43:45,080 SO WHY ARE WE DOING THIS? 6729 04:43:45,080 --> 04:43:46,880 WHY IS THERE A SNEED OF THIS 6730 04:43:46,880 --> 04:43:50,240 COMPONENT AND SCIENCES IN 2020 6731 04:43:50,240 --> 04:43:51,920 IN THEIR REPORT PROMISING 6732 04:43:51,920 --> 04:43:54,120 PRACTICES FOR ADDRESSING UNDER 6733 04:43:54,120 --> 04:43:55,200 REPRESENTED VERY WOMEN AND IN 6734 04:43:55,200 --> 04:44:00,520 SCIENCE AND ENGINEERING OPENING 6735 04:44:00,520 --> 04:44:05,640 DOORS AND AND RELATIVE TO BE 6736 04:44:05,640 --> 04:44:12,000 LOWER AT HIGHER AK RAIZATION AND 6737 04:44:12,000 --> 04:44:13,480 DOCTOR BLOOD SCIENCES AND THEY 6738 04:44:13,480 --> 04:44:17,240 ARE UNDER REPRESENTED AND THE 6739 04:44:17,240 --> 04:44:22,440 ASSOCIATE RANKS BY MORE THAN 40% 6740 04:44:22,440 --> 04:44:26,680 AND TRUE AND IT'S ALSO REPORTED 6741 04:44:26,680 --> 04:44:28,720 MANY MID CAREER WOMEN TO NOT 6742 04:44:28,720 --> 04:44:32,800 ADVANCE IN THEIR CAREER OR DROP 6743 04:44:32,800 --> 04:44:35,880 OUT OF THE BIOMEDICAL RESEARCH 6744 04:44:35,880 --> 04:44:40,920 AND IN THE TECHNOLOGY AND 6745 04:44:40,920 --> 04:44:43,280 ARTICLE ESTIMATES WHILE WOMEN 6746 04:44:43,280 --> 04:44:45,320 MAKE UP 57% OF THE OVER ALL 6747 04:44:45,320 --> 04:44:47,000 WORKFORCE THEY ONLY MAKE UP 27% 6748 04:44:47,000 --> 04:44:49,880 OF THE TECHNOLOGY INDUSTRY. 6749 04:44:49,880 --> 04:44:52,160 AND THAT WOMEN REPRESENT AND 6750 04:44:52,160 --> 04:44:55,240 QUARTER OF COMPUTER WORKERS AND 6751 04:44:55,240 --> 04:44:58,400 50% OF THOSE ENGINEERING 6752 04:44:58,400 --> 04:44:59,000 OCCUPATIONS. 6753 04:44:59,000 --> 04:45:00,760 IN MORE RESEARCH REPORT ON THE 6754 04:45:00,760 --> 04:45:02,800 IMPACT OF COVID-19 AND ON THE 6755 04:45:02,800 --> 04:45:05,600 CAREER OR WOMEN AND ACADEMIC 6756 04:45:05,600 --> 04:45:09,960 SCIENCE AND ENGINEERING AND ALSO 6757 04:45:09,960 --> 04:45:11,360 ARGUED THAT THE THEY HAVE 6758 04:45:11,360 --> 04:45:16,520 REDUCED MORE GENDER IN EQUITABLE 6759 04:45:16,520 --> 04:45:19,000 AND AND LEADING TO FURTHER 6760 04:45:19,000 --> 04:45:20,800 ISOLATION THE WOMEN WITHIN THEIR 6761 04:45:20,800 --> 04:45:25,720 FIELDS NETWORKS AND COMMUNITIES 6762 04:45:25,720 --> 04:45:29,680 FURTHERMORE, THE ORWH SPONSORING 6763 04:45:29,680 --> 04:45:31,440 PARTNERSHIP SUMMIT REIMAGINING 6764 04:45:31,440 --> 04:45:33,560 WOMEN IN THE BIO ENGINEERING 6765 04:45:33,560 --> 04:45:34,880 TECHNOLOGY AND DATA SCIENCE AND 6766 04:45:34,880 --> 04:45:37,240 THE SYSTEM WHICH WAS HELD LAST 6767 04:45:37,240 --> 04:45:39,920 YEAR IN MAY AND HIGHLIGHTED THE 6768 04:45:39,920 --> 04:45:43,760 CAREER PATHS AND INSTEAD AND 6769 04:45:43,760 --> 04:45:47,840 RIVERS INSTEAD OF A STRENGTH 6770 04:45:47,840 --> 04:45:49,240 PIPELINE AND THAT CROSS SECTOR 6771 04:45:49,240 --> 04:45:51,760 CAN CREATE ECOSYSTEMS IN WHICH 6772 04:45:51,760 --> 04:45:56,680 ALL SCIENTISTS ENGINEER AND 6773 04:45:56,680 --> 04:45:58,720 INNOVATORS, PROBLEM SOLVERS AND 6774 04:45:58,720 --> 04:46:01,080 LEADERS AND THE SUMMIT IT WAS 6775 04:46:01,080 --> 04:46:03,640 NOTED AND CROSS SECTOR 6776 04:46:03,640 --> 04:46:07,600 OPPORTUNITIES I NEEDED TO FOSTER 6777 04:46:07,600 --> 04:46:10,400 DIVERSITY AND EMPLOYMENT AND 6778 04:46:10,400 --> 04:46:14,080 HELPS ROW GAIN SCIENTISTS 6779 04:46:14,080 --> 04:46:22,640 PARTICULARLY WOMEN, IN RESEARCH. 6780 04:46:22,640 --> 04:46:23,840 THE RETOOLING PROGRAM IS HELP 6781 04:46:23,840 --> 04:46:26,320 MITIGATE THE RISK OF WOMEN 6782 04:46:26,320 --> 04:46:27,880 LEAVING STEM PROVIDING A SAFE 6783 04:46:27,880 --> 04:46:32,040 AND COLLABORATIVE SPACE BY WHICH 6784 04:46:32,040 --> 04:46:33,840 TO RETAIN WITHOUT FEAR OF LOSING 6785 04:46:33,840 --> 04:46:38,720 THE SOURCE OF EMPLOYMENT IT MAY 6786 04:46:38,720 --> 04:46:41,880 BE THREE MONTHS TO A NEARBY NIH 6787 04:46:41,880 --> 04:46:42,600 WILL PROVIDE A STIPEND 6788 04:46:42,600 --> 04:46:43,880 CORRESPONDING TO THE NUMBER OF 6789 04:46:43,880 --> 04:46:46,960 MONTHS SPENT IN TRAINING THE 6790 04:46:46,960 --> 04:46:50,240 BUDGET LIMITS ARE 90,000 A YEAR 6791 04:46:50,240 --> 04:46:53,600 AND AN ADDITIONAL 50,000 PROGRAM 6792 04:46:53,600 --> 04:46:54,120 RELATED EXPENSES. 6793 04:46:54,120 --> 04:46:56,600 IN ALL CASES, THE TRAIN 6794 04:46:56,600 --> 04:46:57,800 EXPERIENCE MUST HAVE THE 6795 04:46:57,800 --> 04:46:59,320 POTENTIAL TO CONTRIBUTE 6796 04:46:59,320 --> 04:47:03,040 SIGNIFICANTLY TO THE RESEARCH 6797 04:47:03,040 --> 04:47:04,720 CAREER DEVELOPMENT OF THE 6798 04:47:04,720 --> 04:47:06,240 CANDIDATE AND EXPAND HIS OR HER 6799 04:47:06,240 --> 04:47:10,600 NETWORK AND FOSTER INNOVATIVE 6800 04:47:10,600 --> 04:47:13,520 THINKING. 6801 04:47:13,520 --> 04:47:15,160 IT'S A FULL PARTICIPANT IN THE 6802 04:47:15,160 --> 04:47:18,720 RESEARCH PROJECTS AND GIVEN AN 6803 04:47:18,720 --> 04:47:22,120 OPPORTUNITY TO UM DATE AND 6804 04:47:22,120 --> 04:47:26,840 ENHANCE AND ALLOWING THEM AND 6805 04:47:26,840 --> 04:47:30,280 RESURRECTING THE CAREER 6806 04:47:30,280 --> 04:47:33,640 PRODUCTIVE COMPETITIVE 6807 04:47:33,640 --> 04:47:35,280 INVESTIGATOR AND IT WILL HAVE A 6808 04:47:35,280 --> 04:47:37,080 CHANCE TO EXPERIENCE A VARIETY 6809 04:47:37,080 --> 04:47:42,240 OF SCIENTIFIC CAREER OPTIONS 6810 04:47:42,240 --> 04:47:44,120 INCLUDING RESEARCH, INDUSTRY, 6811 04:47:44,120 --> 04:47:47,960 SCIENCE POLICY AND 6812 04:47:47,960 --> 04:47:48,920 ENTREPRENEURSHIP, SCIENCE 6813 04:47:48,920 --> 04:47:51,160 COMMUNICATION, REGULATORY 6814 04:47:51,160 --> 04:47:54,000 AFFAIRS, CONSULTING, DRUG 6815 04:47:54,000 --> 04:47:56,160 DISCOVERY, PATTERNS, REOPEN 6816 04:47:56,160 --> 04:47:57,800 ADMINISTRATION AND GOVERNMENT AS 6817 04:47:57,800 --> 04:47:59,920 WELL AS IN OTHER FUNDING 6818 04:47:59,920 --> 04:48:02,160 AGENCIES. 6819 04:48:02,160 --> 04:48:04,280 TO ENABLE THIS FOR THIS FUNDING 6820 04:48:04,280 --> 04:48:07,080 MECHANISM HAS BEEN EXPANDED TO 6821 04:48:07,080 --> 04:48:08,720 INCLUDE THOSE WHICH SUPPORT 6822 04:48:08,720 --> 04:48:11,840 TECHNOLOGY DEVELOPMENT AND AS 6823 04:48:11,840 --> 04:48:15,880 ALWAYS, TRAINING FOR ARE 6824 04:48:15,880 --> 04:48:18,920 ENCOURAGED ARE ENCOURAGED TO 6825 04:48:18,920 --> 04:48:19,400 APPLY. 6826 04:48:19,400 --> 04:48:21,640 AND THE RETAINING AND RETOOLING 6827 04:48:21,640 --> 04:48:24,920 ARTIST AND FROM THE OTHER TO 6828 04:48:24,920 --> 04:48:26,120 COMPONENTS 69 SUPPLEMENTS IN 6829 04:48:26,120 --> 04:48:28,240 THAT THE SUPPLEMENTS CALLER WILL 6830 04:48:28,240 --> 04:48:31,200 BE ENGAGE IN THE LAB OR 6831 04:48:31,200 --> 04:48:32,360 ENVIRONMENT DISTINCT FROM THEIR 6832 04:48:32,360 --> 04:48:34,840 CURRENT PLACE OF WORK. 6833 04:48:34,840 --> 04:48:36,600 THE IDEA IS WHERE THE TRAINING 6834 04:48:36,600 --> 04:48:38,400 CAN CROSS CENTER AND RETAINING 6835 04:48:38,400 --> 04:48:41,120 THE CURRENT POSITION. 6836 04:48:41,120 --> 04:48:43,000 FOR EXAMPLE, AN ASSOCIATE 6837 04:48:43,000 --> 04:48:46,720 PROFESSOR WHO IS A NIH FUNDED 6838 04:48:46,720 --> 04:48:49,200 MAY OFF TO IMMERSE OURSELF IN A 6839 04:48:49,200 --> 04:48:52,480 DRUG COMPANY EXPERIENCE FOR 6840 04:48:52,480 --> 04:48:53,600 THREE MONTHS AND DURING WIND 6841 04:48:53,600 --> 04:48:55,120 CHILL FOR THE THREE MONTH SALARY 6842 04:48:55,120 --> 04:48:57,520 AND PLUS, PROVIDES RESEARCH 6843 04:48:57,520 --> 04:49:02,160 FUNDS OF AROUND $50,000 AND FOR 6844 04:49:02,160 --> 04:49:05,400 HER INITIAL START UP OF EYE NEW 6845 04:49:05,400 --> 04:49:05,960 PROJECT. 6846 04:49:05,960 --> 04:49:07,800 WE DECIDE TO RETURN TO HER 6847 04:49:07,800 --> 04:49:10,400 UNIVERSITY WITH ADDED SKILLS AND 6848 04:49:10,400 --> 04:49:12,120 POTENTIAL NEW PROJECT THAT WILL 6849 04:49:12,120 --> 04:49:13,960 ENABLE HER TO OBTAIN A 6850 04:49:13,960 --> 04:49:15,800 SUBSEQUENT RO1 AND BE PROMOTED 6851 04:49:15,800 --> 04:49:18,840 AT HER CURRENT UNIVERSITY. 6852 04:49:18,840 --> 04:49:21,160 SIMILAR LEANNE INDUSTRY BASED 6853 04:49:21,160 --> 04:49:23,440 SCIENTIST MAY OPT TO JOIN AN NIH 6854 04:49:23,440 --> 04:49:24,760 FUNDED INVESTIGATORS LAB FOR A 6855 04:49:24,760 --> 04:49:28,480 PERIOD OF TIME TO LEARN MU 6856 04:49:28,480 --> 04:49:29,280 TECHNIQUES WHICH COULD BRING 6857 04:49:29,280 --> 04:49:30,920 BACK HER JOB AND IMPROVE HER 6858 04:49:30,920 --> 04:49:34,160 CHANCES OF CAREER ADVANCEMENT. 6859 04:49:34,160 --> 04:49:37,520 IT WILL ALSO ASSIST AND THE 6860 04:49:37,520 --> 04:49:39,400 MENTOR TO GAIN NEW PERSPECTIVES 6861 04:49:39,400 --> 04:49:40,960 FROM INDUSTRY AND THE 6862 04:49:40,960 --> 04:49:44,760 ESTABLISHED NEW CONNECTIONS AND 6863 04:49:44,760 --> 04:49:47,160 FORGE NEW PARTNERSHIPS. 6864 04:49:47,160 --> 04:49:48,480 THIS CROSS SEC ACTUAL 6865 04:49:48,480 --> 04:49:50,840 COLLABORATION CAN HELP BRIDGE 6866 04:49:50,840 --> 04:49:53,560 SILOS, CROSS POLLENATE 6867 04:49:53,560 --> 04:49:57,760 SCIENTIFIC IDEAS, GENERATE NEW 6868 04:49:57,760 --> 04:49:59,440 ONES AS WELL AS FROM DIVERSITY 6869 04:49:59,440 --> 04:50:00,720 AND EQUITY IN THE WORKFORCE. 6870 04:50:00,720 --> 04:50:04,280 NEXT SLIDE, PLEASE. 6871 04:50:04,280 --> 04:50:05,920 THE THREE DIFFERENT SUPPLEMENT 6872 04:50:05,920 --> 04:50:09,160 ARMS HAVE ELIGIBILITY CRITERIA 6873 04:50:09,160 --> 04:50:12,240 AND THEY MENTIONED ARE PRIMARILY 6874 04:50:12,240 --> 04:50:13,760 INTENDED FOR EARLY SCIENTISTS IN 6875 04:50:13,760 --> 04:50:16,600 THE POSTDOCTORAL FACE. 6876 04:50:16,600 --> 04:50:21,960 THE REINTEGRATION SUPPLEMENTS 6877 04:50:21,960 --> 04:50:24,600 AND STUDENTS WHEREAS THE NEW 6878 04:50:24,600 --> 04:50:26,840 RETRAINING SUPPLEMENTS ARE EARLY 6879 04:50:26,840 --> 04:50:29,000 AS WELL AS MID CAREER SIGNISTS 6880 04:50:29,000 --> 04:50:31,720 ESPECIALLY THOSE WHO HAVE NEVER 6881 04:50:31,720 --> 04:50:33,680 RECEIVED OR ARE CURRENTLY NOT 6882 04:50:33,680 --> 04:50:37,440 RECEIVING ANY PROJECT WORK. 6883 04:50:37,440 --> 04:50:40,320 THEY'RE OPEN TO SCIENTISTS OR 6884 04:50:40,320 --> 04:50:43,560 NOT IN THE FIRST OF ALL THEY 6885 04:50:43,560 --> 04:50:45,840 HAVE HAD REACH SEARCH EXPERIENCE 6886 04:50:45,840 --> 04:50:47,560 WITH TWO YEARS OF THE 6887 04:50:47,560 --> 04:50:51,080 POSTDOCTORAL TRAINING. 6888 04:50:51,080 --> 04:50:53,880 WE ARE ASKING YOUR APPROVAL FOR 6889 04:50:53,880 --> 04:50:56,760 THE RENEWAL OF THE INCOMPETENT 6890 04:50:56,760 --> 04:50:57,320 INAUGURATION SYSTEM PROGRAM 6891 04:50:57,320 --> 04:51:00,000 TOGETHER WITH A NEWLY ADDED 6892 04:51:00,000 --> 04:51:01,680 RETRAINING SUPPLEMENTS PROGRAM. 6893 04:51:01,680 --> 04:51:04,680 WE ALSO ASKED YOUR HELP IN 6894 04:51:04,680 --> 04:51:05,880 ADVERTISING THE OPPORTUNITIES TO 6895 04:51:05,880 --> 04:51:10,080 YOUR NETWORK AND YOUR RESEARCH 6896 04:51:10,080 --> 04:51:10,320 COMMUNITY. 6897 04:51:10,320 --> 04:51:13,840 YOU ARE PROBABLY IN THE BEST 6898 04:51:13,840 --> 04:51:15,400 POSITION VICTIMS WHO MAY BENEFIT 6899 04:51:15,400 --> 04:51:17,560 FROM THESE PROGRAMS WHICH ARE 6900 04:51:17,560 --> 04:51:19,400 INTENDED TO FOSTER THE REENTRY 6901 04:51:19,400 --> 04:51:24,080 AND RETENTION AND AND A 6902 04:51:24,080 --> 04:51:26,360 TRANSFORMATION AND 6903 04:51:26,360 --> 04:51:28,040 INFIGURIZATION OF THEIR CAREER. 6904 04:51:28,040 --> 04:51:29,440 THANK YOU, VERY MUCH. 6905 04:51:29,440 --> 04:51:31,440 I'M HAPPY TO ANSWER THE 6906 04:51:31,440 --> 04:51:31,840 QUESTIONS. 6907 04:51:31,840 --> 04:51:34,880 >>THANK YOU DOCTOR. 6908 04:51:34,880 --> 04:51:36,160 WE HAVE TIME FOR QUESTIONS HERE 6909 04:51:36,160 --> 04:51:38,200 BEFORE WE TAKE A VOTE. 6910 04:51:38,200 --> 04:51:40,720 PLEASE UTILIZE THE CHAT IF IT'S 6911 04:51:40,720 --> 04:51:44,920 MORE COMFORTABLE AND I'M SURE 6912 04:51:44,920 --> 04:51:47,040 THE DOCTOR MAY ANSWER THE 6913 04:51:47,040 --> 04:51:53,440 QUESTIONS THAT YOU MAY HAVE. 6914 04:51:53,440 --> 04:51:55,680 Dr. ANDERSON. 6915 04:51:55,680 --> 04:51:59,480 >>YOU ARE ON MUTE, Dr. 6916 04:51:59,480 --> 04:51:59,920 HANDSER SON. 6917 04:51:59,920 --> 04:52:00,760 >>THANK YOU. 6918 04:52:00,760 --> 04:52:02,880 YOU THINK I WOULD KNOW AFTER 6919 04:52:02,880 --> 04:52:04,080 THIS MANY YEARS. 6920 04:52:04,080 --> 04:52:05,520 THIS A GREAT PROGRAM I WASN'T 6921 04:52:05,520 --> 04:52:08,800 AWARE OF IT BEFORE AND IT'S 6922 04:52:08,800 --> 04:52:10,600 FANTASTIC AND I WOULD LOVE TO 6923 04:52:10,600 --> 04:52:13,160 OFFER IT TO SOME OF OUR FACULTY 6924 04:52:13,160 --> 04:52:14,880 WHEN THEY'RE ELIGIBLE. 6925 04:52:14,880 --> 04:52:18,880 CAN YOU TELL ME A FOLLOW-UP ON 6926 04:52:18,880 --> 04:52:20,520 THE ORIGINAL RECIPIENT OF IT 6927 04:52:20,520 --> 04:52:23,960 GRANT AND HOW WELL THEY HAVE 6928 04:52:23,960 --> 04:52:25,480 REENTERED THE WORKFORCE AND 6929 04:52:25,480 --> 04:52:29,400 THEIR SUCCESS THERE. 6930 04:52:29,400 --> 04:52:30,560 >>YES, SO WE'RE IN THE PROCESS 6931 04:52:30,560 --> 04:52:33,600 OF EVALUATING, AS WE MENTIONED, 6932 04:52:33,600 --> 04:52:35,640 WE CON OBTAIN ALL OF THE DATA 6933 04:52:35,640 --> 04:52:38,000 FROM WAY BACK IN THE 1990s SO 6934 04:52:38,000 --> 04:52:43,800 WE JUST OPTED FOR THOSE 10 YEARS 6935 04:52:43,800 --> 04:52:47,560 FROM 201 TO 2018 GRANTEES WHICH 6936 04:52:47,560 --> 04:52:50,320 INCLUDED UP TO 2021 AND IT'S 6937 04:52:50,320 --> 04:52:54,920 REALLY VERY DIFFICULT TO TRACE A 6938 04:52:54,920 --> 04:52:56,560 TRAINEE BECAUSE THEY ARE NOT 6939 04:52:56,560 --> 04:53:00,360 INCLUDED IN THE QER AS 6940 04:53:00,360 --> 04:53:00,760 INDIVIDUALS. 6941 04:53:00,760 --> 04:53:02,560 THEY ARE UNDERNEATH THEIR 6942 04:53:02,560 --> 04:53:06,400 MENTORS AND SO EVEN UPON 6943 04:53:06,400 --> 04:53:09,280 REQUEST, FROM THE DATA WORKING 6944 04:53:09,280 --> 04:53:11,360 GROUP AND OER, WE GET THE DATA 6945 04:53:11,360 --> 04:53:13,520 ABOUT THE MENTOR BUT NOT THE 6946 04:53:13,520 --> 04:53:16,240 TRAINEES AND BECAUSE THE 6947 04:53:16,240 --> 04:53:18,840 TRAINEES HAVE NAMES WHICH MAY BE 6948 04:53:18,840 --> 04:53:20,360 SIMILAR, TRACING THEM IS REALLY 6949 04:53:20,360 --> 04:53:23,240 BEEN VERY DIFFICULT TASK FOR OUR 6950 04:53:23,240 --> 04:53:24,520 COLLEAGUES HERE AT THE CAREER 6951 04:53:24,520 --> 04:53:28,320 CENTER WHERE WE HAVE TO GO TO 6952 04:53:28,320 --> 04:53:30,960 GOOGLE AND LinkedIn AND SEE 6953 04:53:30,960 --> 04:53:32,960 WHERE WHEN LOOK AGAIN BUT IT'S 6954 04:53:32,960 --> 04:53:35,400 VERY DIFFICULT TO HAVE A WAY 6955 04:53:35,400 --> 04:53:36,440 ESPECIALLY IF YOU HAVE THE SAME 6956 04:53:36,440 --> 04:53:37,000 NAMES. 6957 04:53:37,000 --> 04:53:39,640 SO I THINK NIH IS TRYING ITS 6958 04:53:39,640 --> 04:53:44,240 BEST NOW TO BE ABLE TO FOLLOW 6959 04:53:44,240 --> 04:53:46,640 THEIR TRAINEES BY HAVING THEM 6960 04:53:46,640 --> 04:53:50,880 HAVE AN ORCHID OR THIS I.D. BUT 6961 04:53:50,880 --> 04:53:52,640 IT'S NEW TO THE SYSTEM SO WE 6962 04:53:52,640 --> 04:53:56,000 HAVE NOT BEEN ABLE TO AVAIL THAT 6963 04:53:56,000 --> 04:53:58,240 FOR THESE PAST TRAININGS. 6964 04:53:58,240 --> 04:54:00,880 BUT WE DID GET A GOOD LETTER 6965 04:54:00,880 --> 04:54:03,360 RECENTLY IN FACT FROM ONE OF THE 6966 04:54:03,360 --> 04:54:06,160 NIDDK AWARDING SAY HOW HAPPY SHE 6967 04:54:06,160 --> 04:54:08,000 WAS THAT SHE OBTAINED THE 6968 04:54:08,000 --> 04:54:12,800 SUPPLEMENT AND IT HAD ACTUALLY 6969 04:54:12,800 --> 04:54:14,640 REVIVED HER CAREER AND WE THOUGH 6970 04:54:14,640 --> 04:54:18,600 SHARE THAT IN THE FUTURE INFO OF 6971 04:54:18,600 --> 04:54:21,040 THIS ISSUE. 6972 04:54:21,040 --> 04:54:22,200 THANK YOU. 6973 04:54:22,200 --> 04:54:22,920 >>Samia Noursi: Dr. 6974 04:54:22,920 --> 04:54:23,600 McGREGOR AND WE HAVE ANOTHER 6975 04:54:23,600 --> 04:54:26,080 QUESTION IN THE CHAT SO WE'LL GO 6976 04:54:26,080 --> 04:54:27,720 WITH Dr. McGREGOR. 6977 04:54:27,720 --> 04:54:33,200 >>ACTUALLY TEMPLETON TYPED MY 6978 04:54:33,200 --> 04:54:34,440 EXPECT QUESTION. 6979 04:54:34,440 --> 04:54:38,160 SO SOMEONE IS AVAILABLE TO 6980 04:54:38,160 --> 04:54:39,560 QUESTION SCIENTISTS AS WELL OR 6981 04:54:39,560 --> 04:54:44,080 JUST POSTDOCS. 6982 04:54:44,080 --> 04:54:47,400 >>CLINICIAN SCIENTISTS ARE 6983 04:54:47,400 --> 04:54:50,840 POSTDOCS AND WHO SO THEY ARE 6984 04:54:50,840 --> 04:54:51,800 ELIGIBLE. 6985 04:54:51,800 --> 04:54:52,960 SPECIFICALLY FOR REENTER 6986 04:54:52,960 --> 04:54:54,680 FORECAST THEY LET THE CLINICAL 6987 04:54:54,680 --> 04:54:57,400 SPACE FOR A BED? 6988 04:54:57,400 --> 04:54:59,240 >>SURE FOR AS LONG AS THEY HAVE 6989 04:54:59,240 --> 04:55:01,160 A DOCTORAL DEGREE EX THEY'RE 6990 04:55:01,160 --> 04:55:03,760 CURRENTLY NOT EMPLOYED IN 6991 04:55:03,760 --> 04:55:05,560 RESEARCH AND THEY COULD BE 6992 04:55:05,560 --> 04:55:07,000 EMPLOYED IN SOME OTHER 6993 04:55:07,000 --> 04:55:11,200 PROFESSION IT'S NOT A RESEARCH 6994 04:55:11,200 --> 04:55:13,080 CAREER. 6995 04:55:13,080 --> 04:55:14,320 MAYBE THEY HAVE ADDITIONAL. 6996 04:55:14,320 --> 04:55:17,160 >>NO, I APPRECIATE ABOUT THAT 6997 04:55:17,160 --> 04:55:19,520 AND SO WHAT I IT HAD TYPED IN 6998 04:55:19,520 --> 04:55:21,320 THE COMMENTS IT'S CLINICIAN 6999 04:55:21,320 --> 04:55:22,720 SCIENTISTS WHICH WE KNOW ARE 7000 04:55:22,720 --> 04:55:24,080 RARE BREEDS AND WE NEED MORE OF 7001 04:55:24,080 --> 04:55:25,480 THEM IN MY PERSONAL OPINION, 7002 04:55:25,480 --> 04:55:27,720 IT'S NOT JUST FUNDING TO GET 7003 04:55:27,720 --> 04:55:29,360 THEM BACK AND GET THEM RESTARTED 7004 04:55:29,360 --> 04:55:31,720 ON THE RESEARCH ASPECT OF THEIR 7005 04:55:31,720 --> 04:55:33,480 CAREER BUT IT'S REENTRY OF THE 7006 04:55:33,480 --> 04:55:34,920 CLINICAL SIDE OF THEIR CAREER 7007 04:55:34,920 --> 04:55:36,560 AND IT IT HAS ITS OWN SET OF 7008 04:55:36,560 --> 04:55:38,840 CHALLENGE AND CAN BE INCREDIBLY 7009 04:55:38,840 --> 04:55:40,960 EXPENSIVE AND THERE ARE PROGRAMS 7010 04:55:40,960 --> 04:55:43,160 FOR PHYSICIANS WHICH ONE ABOUT 7011 04:55:43,160 --> 04:55:44,120 $20,000 IF YOU WANT IT ON 7012 04:55:44,120 --> 04:55:45,560 AVERAGE IF IF YOU WANT TO GET 7013 04:55:45,560 --> 04:55:48,080 BACK TO CLINICAL WORK SO, CAN 7014 04:55:48,080 --> 04:55:50,360 ANY OF THIS FUNDING BE USED FOR 7015 04:55:50,360 --> 04:55:52,440 THE CLINICAL SIDE OF THEIR WORK 7016 04:55:52,440 --> 04:55:54,240 AND IF NOT ARE THERE WAYS IN 7017 04:55:54,240 --> 04:55:56,600 WHICH WE CAN START LOOKING AT 7018 04:55:56,600 --> 04:55:56,960 THAT? 7019 04:55:56,960 --> 04:56:00,040 BECAUSE YES, WE NEED TO SUPPORT 7020 04:56:00,040 --> 04:56:01,840 THE RESEARCH SIDE BUT IF THE 7021 04:56:01,840 --> 04:56:03,840 CLINICAL SIDE ISN'T SUPPORTED IT 7022 04:56:03,840 --> 04:56:05,720 WILL BE HARD TO BRING BACK 7023 04:56:05,720 --> 04:56:10,200 CLINICIAN SCIENTISTS BACK IN THE 7024 04:56:10,200 --> 04:56:10,480 WORKFORCE. 7025 04:56:10,480 --> 04:56:13,120 >>THANK YOU FOR BRINGING THAT 7026 04:56:13,120 --> 04:56:13,280 UP. 7027 04:56:13,280 --> 04:56:18,000 THAT WAS NOT IN OUR RADAR SO TO 7028 04:56:18,000 --> 04:56:18,480 SPEAK. 7029 04:56:18,480 --> 04:56:28,280 IT'S WORTH THINKING ABOUT. 7030 04:56:28,280 --> 04:56:30,240 THIS IS FOR RESEARCH RATHER THAN 7031 04:56:30,240 --> 04:56:32,320 SUPPORT. 7032 04:56:32,320 --> 04:56:34,280 THERE'S ANOTHER COMMENT AND IT'S 7033 04:56:34,280 --> 04:56:35,200 CHALLENGING TO FIND INDIVIDUALS 7034 04:56:35,200 --> 04:56:38,880 WITH COMMON NAMES O SHE'S GLAD 7035 04:56:38,880 --> 04:56:41,800 THAT THE ORCHID I.D. IS MOVING 7036 04:56:41,800 --> 04:56:42,120 FORWARD. 7037 04:56:42,120 --> 04:56:42,520 >>YEAH. 7038 04:56:42,520 --> 04:56:43,160 >>THANK YOU. 7039 04:56:43,160 --> 04:56:51,080 >>DO YOU HAVE ANY QUESTIONS? 7040 04:56:51,080 --> 04:56:52,560 OKAY WITH THAT I WOULD LIKE TO 7041 04:56:52,560 --> 04:56:56,800 TAKE TIME TO VOTE TO APPROVE THE 7042 04:56:56,800 --> 04:56:59,640 REENTRY AND REINTEGRATION AND 7043 04:56:59,640 --> 04:57:02,680 RETRAINING SUPPLEMENTS CLEARANCE 7044 04:57:02,680 --> 04:57:04,120 IS THERE A MOTION ON THE TABLE 7045 04:57:04,120 --> 04:57:06,640 TO APPROVE THE REENTRY AND 7046 04:57:06,640 --> 04:57:08,880 REINTEGRATION AND RETRAINING 7047 04:57:08,880 --> 04:57:11,920 SUPPLEMENTS CONCEPT CLEARANCE? 7048 04:57:11,920 --> 04:57:14,480 >>I MAKE A MOTION. 7049 04:57:14,480 --> 04:57:18,120 >>Samia Noursi: WHO WAS THAT? 7050 04:57:18,120 --> 04:57:20,960 >>Dr. REGULARRENSTEINER. 7051 04:57:20,960 --> 04:57:21,720 >>DO I HAVE A SECOND. 7052 04:57:21,720 --> 04:57:22,840 >>I'LL SECOND. 7053 04:57:22,840 --> 04:57:26,040 >>Dr. SIMON SECONDED THE 7054 04:57:26,040 --> 04:57:26,680 MOTION. 7055 04:57:26,680 --> 04:57:27,840 THE POM IS OPEN TO RESTART IF 7056 04:57:27,840 --> 04:57:29,240 APPROXIMATE YOU ARE IN FAVOR 7057 04:57:29,240 --> 04:57:31,960 OPPOSED OR OBTAINED AND PLEASE 7058 04:57:31,960 --> 04:57:36,320 AND YOU HAVE 0 SECONDS. 7059 04:57:36,320 --> 04:57:46,520 TO RESPOND. 7060 04:57:57,720 --> 04:57:58,760 >>THANK YOU. 7061 04:57:58,760 --> 04:58:00,360 SARAH DO WE HAVE THE VOTES? 7062 04:58:00,360 --> 04:58:02,760 >>YES, WITH 14 IN FAVOR. 7063 04:58:02,760 --> 04:58:04,320 >>THANK YOU. 7064 04:58:04,320 --> 04:58:07,520 THE REENTRY REINCOMPETENT 7065 04:58:07,520 --> 04:58:08,080 INAUGURATION AND RETRAINING 7066 04:58:08,080 --> 04:58:09,520 CLEARANCE HAS BEEN ACCEPTED WITH 7067 04:58:09,520 --> 04:58:11,320 14 IN FAVOR. 7068 04:58:11,320 --> 04:58:12,840 THANK YOU EVERYONE FOR THE 7069 04:58:12,840 --> 04:58:16,280 DISCUSSION FEEDBACK AND VOTING. 7070 04:58:16,280 --> 04:58:18,640 I WOULD LIKE TO WELCOME BACK 7071 04:58:18,640 --> 04:58:20,760 LISA BEGG FOR OUR NEXT 7072 04:58:20,760 --> 04:58:21,240 PRESENTATION. 7073 04:58:21,240 --> 04:58:24,920 OVER HER CAREER, HE HAS WORKED A 7074 04:58:24,920 --> 04:58:27,160 SO I SENIOR SCIENTIST AND 7075 04:58:27,160 --> 04:58:29,680 EDUCATOR WITHIN THE FEDERAL 7076 04:58:29,680 --> 04:58:31,360 GOVERNMENT AND RESEARCH SETTINGS 7077 04:58:31,360 --> 04:58:33,320 AND SINCE JOINING THE NIH, HE 7078 04:58:33,320 --> 04:58:37,400 HAD DEVELOPED IMPLEMENTED AND 7079 04:58:37,400 --> 04:58:40,800 MANAGED SEVERAL LARGE EXTRAMURAL 7080 04:58:40,800 --> 04:58:44,080 RESEARCH AND ORWH AND Dr. BEGG 7081 04:58:44,080 --> 04:58:47,080 WORKS ACROSS ICOs TO DEVELOP 7082 04:58:47,080 --> 04:58:48,440 AND ENHANCE A VARIETY OF 7083 04:58:48,440 --> 04:58:49,960 INITIATIVES AND WOMAN'S HEALTH 7084 04:58:49,960 --> 04:58:51,280 AND SEX GENDER DIFFERENCES 7085 04:58:51,280 --> 04:58:55,160 RESEARCH AND INCLUDING FEDERAL 7086 04:58:55,160 --> 04:59:02,080 WIDE RESEARCH AND INITIATIVES 7087 04:59:02,080 --> 04:59:07,600 AND Dr. BEGG OVERSEES THE PIR 7088 04:59:07,600 --> 04:59:14,000 MUCH PROGRAM IT WAS CREATE AID 7089 04:59:14,000 --> 04:59:16,760 GRANT PROGRAM AND WELCOME LISA 7090 04:59:16,760 --> 04:59:16,960 BEGG. 7091 04:59:16,960 --> 04:59:19,040 >>THANK YOU SO MUCH AND GOOD 7092 04:59:19,040 --> 04:59:20,320 AFTERNOON TO EVERYONE AGAIN AND 7093 04:59:20,320 --> 04:59:22,040 IT'S MY PLEASURE TO COME BEFORE 7094 04:59:22,040 --> 04:59:25,880 YOU TO PRESENT A FEW SLIDES 7095 04:59:25,880 --> 04:59:27,080 APPROXIMATE TO GIVE YOU 7096 04:59:27,080 --> 04:59:28,800 BACKGROUND AND REQUEST YOUR 7097 04:59:28,800 --> 04:59:30,720 APPROVAL FOR THE CONCEPT 7098 04:59:30,720 --> 04:59:32,240 CLEARANCE FOR ITS BEING TITLED 7099 04:59:32,240 --> 04:59:34,920 THE FY21 BIRCH PROGRAM 7100 04:59:34,920 --> 04:59:35,960 ADMINISTRATIVE SUPPLEMENTS AND I 7101 04:59:35,960 --> 04:59:40,560 CAN HELP THE NEXT SLIDE, PLEASE. 7102 04:59:40,560 --> 04:59:42,680 TO GIVE FOLKS A LITTLE 7103 04:59:42,680 --> 04:59:43,400 BACKGROUND BECAUSE SOME PEOPLE 7104 04:59:43,400 --> 04:59:45,000 ARE MORE AWARE OF THE PROBLEM 7105 04:59:45,000 --> 04:59:47,760 THAN OTHERS, I INVITE YOU TO GO 7106 04:59:47,760 --> 04:59:50,960 TO OUR WEBSITE THE ORWH HOME 7107 04:59:50,960 --> 04:59:53,240 PAGE AND THIS IS SCREEN CAPTURE 7108 04:59:53,240 --> 04:59:55,520 OF IT AND YOU CAN SEE THAT 7109 04:59:55,520 --> 04:59:57,440 THERE'S A BACKGROUND AND THE 7110 04:59:57,440 --> 05:00:00,520 PROGRAM WAS CREATED BY CONGRESS 7111 05:00:00,520 --> 05:00:03,640 IN 2000 SO IT'S 23 YEARS AND 7112 05:00:03,640 --> 05:00:05,000 THRIVING SO TO SPEAK TO WE'RE 7113 05:00:05,000 --> 05:00:06,720 VERY PLEASED IT AND THERE'S A 7114 05:00:06,720 --> 05:00:09,440 LOT OF INFORMATION AND WE HAVE 7115 05:00:09,440 --> 05:00:11,560 19 ACTIVE PROGRAMS EACH OF THEM 7116 05:00:11,560 --> 05:00:14,520 HAVE THEIR OWN WEB SITES AND 7117 05:00:14,520 --> 05:00:16,920 THEY CAN GO ON THEM SPECIFICALLY 7118 05:00:16,920 --> 05:00:19,000 AND WE HAVE ARCHIVED THE VARIOUS 7119 05:00:19,000 --> 05:00:21,520 ANNUAL MEETINGS THAT ARE HELD IN 7120 05:00:21,520 --> 05:00:24,400 LATE FALL EACH YEAR AND ARE 7121 05:00:24,400 --> 05:00:27,840 INTENTED TO HELP PROMOTE 7122 05:00:27,840 --> 05:00:30,200 MENTORING AND COLLABORATION 7123 05:00:30,200 --> 05:00:32,880 ACROSS THE 19 PROGRAMS OF THE 7124 05:00:32,880 --> 05:00:34,320 PIs AS WELL AS THE SCHOLARS 7125 05:00:34,320 --> 05:00:35,720 AND NIH STAFF SO IF I COULD HAVE 7126 05:00:35,720 --> 05:00:39,000 THE NEXT SLIDE. 7127 05:00:39,000 --> 05:00:44,520 SO TO GIVE A IS SUMMARY AND THE 7128 05:00:44,520 --> 05:00:45,400 ADMINISTRATIVE SUPPLEMENT CAME 7129 05:00:45,400 --> 05:00:47,400 FROM AND ORWH IS UP TO 7130 05:00:47,400 --> 05:00:49,720 $15 MILLION A YEAR AND OUR 7131 05:00:49,720 --> 05:00:52,400 DIRECTOR Dr. CLAYTON MENTIONED 7132 05:00:52,400 --> 05:00:56,080 WE'RE GETTING IN FY22 AND FY23 7133 05:00:56,080 --> 05:00:59,400 ADDITIONAL FUNDING FOR THE BIRCH 7134 05:00:59,400 --> 05:01:00,480 PROGRAM AND IT'S BECAUSE IT'S 7135 05:01:00,480 --> 05:01:02,440 ACTUALLY BEEN HIGHLY EFFECTIVE 7136 05:01:02,440 --> 05:01:04,080 SO IT'S NOW $15 MILLION A YEAR 7137 05:01:04,080 --> 05:01:08,160 AND I LISTED THE NINENS TO USE 7138 05:01:08,160 --> 05:01:10,760 THE AND CENTERS AND THAT HAVE 7139 05:01:10,760 --> 05:01:14,280 BEEN CO PARTNERS WITH US AND THE 7140 05:01:14,280 --> 05:01:16,960 23 YEARS AND SOME CONTINUES FOR 7141 05:01:16,960 --> 05:01:19,880 ALL 23 YEARS AND OTHERS HAVE IN 7142 05:01:19,880 --> 05:01:22,240 AND OUT DEPENDING ON THEIR 7143 05:01:22,240 --> 05:01:23,800 MISSION AND OR PRIORITY SETTING 7144 05:01:23,800 --> 05:01:26,320 AND NEXT SLIDE, PLEASE. 7145 05:01:26,320 --> 05:01:28,680 HERE IS A MAP AND WE'RE QUITE 7146 05:01:28,680 --> 05:01:31,040 PLEASED WITH THIS BECAUSE IT'S 7147 05:01:31,040 --> 05:01:33,800 WELL AND DISTRIBUTED ACROSS THE 7148 05:01:33,800 --> 05:01:37,600 COUNTRY AND WE HAVE 19 ACTIVE 7149 05:01:37,600 --> 05:01:38,240 PROGRAMS IN THE DARK TOOL WOULD 7150 05:01:38,240 --> 05:01:40,880 BE DESCRIPTION OF THE COLOR AND 7151 05:01:40,880 --> 05:01:42,560 MINNESOTA HAS TWO BIRCH PROGRAMS 7152 05:01:42,560 --> 05:01:44,800 AND UNIVERSITY OF MINNESOTA AND 7153 05:01:44,800 --> 05:01:47,200 MAYO CLINIC AND CALIFORNIA HAS 7154 05:01:47,200 --> 05:01:52,240 TWO PROGRAMS AND UCSF AND UC 7155 05:01:52,240 --> 05:01:53,800 DAVIS AND THEY HAVE TWO 7156 05:01:53,800 --> 05:01:55,000 PROGRAMS, HARVARD AS WELL AS 7157 05:01:55,000 --> 05:01:57,240 TUFTS AND THEN THERE'S WITHIN 7158 05:01:57,240 --> 05:01:59,760 PROGRAM IN EACH OF THE OTHER 7159 05:01:59,760 --> 05:02:00,000 STATES. 7160 05:02:00,000 --> 05:02:03,320 THEY ARE SO VERY PLEASED WITH 7161 05:02:03,320 --> 05:02:06,280 THAT AND THE MECHANISM IS A K-12 7162 05:02:06,280 --> 05:02:10,200 SO IT'S AN INSTITUTIONAL CAREER 7163 05:02:10,200 --> 05:02:11,120 DEVELOPMENT AWARD. 7164 05:02:11,120 --> 05:02:12,920 THE PROGRAM IS A ORIGINALLY 7165 05:02:12,920 --> 05:02:15,120 FUNDED IN 2000 WITH AN RFA AND 7166 05:02:15,120 --> 05:02:18,960 THERE WAS THE SECOND RFA IN 2002 7167 05:02:18,960 --> 05:02:20,440 AND EACH FOR FIVE YEARS AND EACH 7168 05:02:20,440 --> 05:02:22,560 ONE OF THOSE RF ANTI-SEMITISM 7169 05:02:22,560 --> 05:02:24,360 HAVE BEEN REISSUED AND SO IT'S 7170 05:02:24,360 --> 05:02:27,680 BEEN CONTINUOUSLY FUNDED OVER 7171 05:02:27,680 --> 05:02:29,640 THE 23 YEARS AND 19 ACTIVE 7172 05:02:29,640 --> 05:02:30,920 AWARDS AND THERE'S BEEN ACTUALLY 7173 05:02:30,920 --> 05:02:34,480 A TOTAL OF ABOUT 42 INSTITUTIONS 7174 05:02:34,480 --> 05:02:35,400 WHO HAVE RECEIVED GRANTS OVER 7175 05:02:35,400 --> 05:02:37,880 THE YEARS AND THESE ARE HIGHLY 7176 05:02:37,880 --> 05:02:42,080 COMPETITIVE AND RENEWAL SO IT'S 7177 05:02:42,080 --> 05:02:44,080 DIFFICULT FOR PROGRAMS TO 7178 05:02:44,080 --> 05:02:45,640 MAINTAIN BUT THE CURRENT BLOCK 7179 05:02:45,640 --> 05:02:48,720 WE HAVE NOW IS HIGHLY SUCCESSFUL 7180 05:02:48,720 --> 05:02:51,040 AND FOR THE CURRENT RFAs WE 7181 05:02:51,040 --> 05:02:54,960 HAVE CO PARTNERS FROM NIAAD AND 7182 05:02:54,960 --> 05:02:59,920 NIAAA AND NICHD AND NCI AND 7183 05:02:59,920 --> 05:03:03,320 NAIDA AND WE HAVE 12 OF THE 7184 05:03:03,320 --> 05:03:05,360 MULTI PEIs WORE SEEING IT NOW 7185 05:03:05,360 --> 05:03:08,200 IN ELSE IT OF THE SCIENTIFIC 7186 05:03:08,200 --> 05:03:12,240 TEAMWORK AND 14 OF THE 19 7187 05:03:12,240 --> 05:03:13,680 PHYSICIAN-SCIENTISTS AS PIs 7188 05:03:13,680 --> 05:03:16,640 SOL OR OR WITHIN THE MULTI PI 7189 05:03:16,640 --> 05:03:19,280 AND WE HAVE LAST COUNT 750 7190 05:03:19,280 --> 05:03:22,800 SCHOLARS SINCE 2000 AND 88% HAVE 7191 05:03:22,800 --> 05:03:25,320 STAYED IN RESEARCH AND 42% ARE 7192 05:03:25,320 --> 05:03:28,080 PHYSICIANS SCIENTISTS. 7193 05:03:28,080 --> 05:03:29,520 AND 80% OF THE SCHOLARS ARE 7194 05:03:29,520 --> 05:03:31,760 WOMEN AND 20% OF MEN AND THAT 7195 05:03:31,760 --> 05:03:35,600 HAS BEEN PRETTY STABLE OVER THE 7196 05:03:35,600 --> 05:03:37,800 FULL 23 YEARS AND NEXT SLIDE, 7197 05:03:37,800 --> 05:03:38,800 PLEASE. 7198 05:03:38,800 --> 05:03:40,800 IN TERMS OF THE ACTUAL NOSI 7199 05:03:40,800 --> 05:03:42,240 WE'RE ASKING FOR APPROVAL FOR 7200 05:03:42,240 --> 05:03:43,880 THE CONCEPT CLEARANCE THIS IS 7201 05:03:43,880 --> 05:03:45,440 CONSIDERED AN ADMINISTRATIVE 7202 05:03:45,440 --> 05:03:48,680 SUPPLEMENT TO THE PARENT K-1s 7203 05:03:48,680 --> 05:03:49,280 WE DID THIS YACHT L'ISLE-VERTE 7204 05:03:49,280 --> 05:03:50,600 WITH THE CONGRESSIONAL FUNDING 7205 05:03:50,600 --> 05:03:52,800 AS WELL AND WE DIDN'T HAVE TO EX 7206 05:03:52,800 --> 05:03:54,160 TO YOU LAST YEAR BECAUSE IT WAS 7207 05:03:54,160 --> 05:03:57,520 AN RFA ROUND SO THE APPROVAL WAS 7208 05:03:57,520 --> 05:03:59,840 GRANTED AS PART OF THE RFA PLAN 7209 05:03:59,840 --> 05:04:02,080 AND APPROVAL OF THOSE 7210 05:04:02,080 --> 05:04:03,160 APPLICATIONS. 7211 05:04:03,160 --> 05:04:06,960 THE BUDGET LIP ITS THIS YEAR ARE 7212 05:04:06,960 --> 05:04:07,920 SLIGHTLY DIFFERENT THAN PREVIOUS 7213 05:04:07,920 --> 05:04:11,600 DREAD COST OF $90,000 A YEAR 7214 05:04:11,600 --> 05:04:14,560 FROM NIH FUNDS FOR EACH GRANTEE 7215 05:04:14,560 --> 05:04:17,920 AND SO WE HAVE ENOUGH SUFFICIENT 7216 05:04:17,920 --> 05:04:19,280 MONEY FOR EACH OF THE 19 7217 05:04:19,280 --> 05:04:22,280 PROGRAMS THAT HAVE ONE OF THESE 7218 05:04:22,280 --> 05:04:23,840 TRAINEE AND THAT INCLUDES A 7219 05:04:23,840 --> 05:04:27,680 MAXIMUM OF NIH FUNDS OF 65,000 7220 05:04:27,680 --> 05:04:31,520 AND CAN BE AUGMENTED BY THE 7221 05:04:31,520 --> 05:04:33,440 INSTITUTES IN CASE IT THIS WOULD 7222 05:04:33,440 --> 05:04:34,880 MAKE THEM MORE COMPETITIVE IN 7223 05:04:34,880 --> 05:04:38,040 TERMS OF RECRUITING AN 7224 05:04:38,040 --> 05:04:38,920 APPROPRIATE TRAINING AND SAME 7225 05:04:38,920 --> 05:04:41,800 WITH THE 25,000 SO WE'RE 7226 05:04:41,800 --> 05:04:44,360 ALLOWING 90,000 DIVIDED 65 AND 7227 05:04:44,360 --> 05:04:46,920 25 BUT IT CAN'T BE AUGMENTED AND 7228 05:04:46,920 --> 05:04:49,440 PER NIH POLICIES THESE ARE 8% IN 7229 05:04:49,440 --> 05:04:51,240 DIRECTION COST FOR EACH AWARDS 7230 05:04:51,240 --> 05:04:53,920 AND IT'S ONLY OPEN TO THE 19 7231 05:04:53,920 --> 05:04:56,960 ACTIVE BIRCH PROGRAMS AND AGAIN 7232 05:04:56,960 --> 05:04:59,120 BECAUSE THIS IS ADMINISTRATIVE 7233 05:04:59,120 --> 05:05:01,160 SUPPLEMENT TO THEM AND THERE'S A 7234 05:05:01,160 --> 05:05:02,600 TRAINEE ELIGIBILITY IN TERMS OF 7235 05:05:02,600 --> 05:05:05,760 BEING A U.S. CITIZEN OR A NON 7236 05:05:05,760 --> 05:05:06,720 CITIZEN NATIONAL AND IN THE 7237 05:05:06,720 --> 05:05:10,120 UNITED STATES YOU CAN SEE WE 7238 05:05:10,120 --> 05:05:11,520 ALSO REQUIRED TO ENCOURAGE AND 7239 05:05:11,520 --> 05:05:14,680 WORE PLEASED WITH THE TYPE OF 7240 05:05:14,680 --> 05:05:17,400 RECRUITMENT THAT IS HAPPENING IN 7241 05:05:17,400 --> 05:05:20,160 TERMS OF RECRUITING CANDIDATES 7242 05:05:20,160 --> 05:05:22,680 WHO ARE REPRESENTING POPULATIONS 7243 05:05:22,680 --> 05:05:25,840 AND FOR THOSE WHO MEET THE 7244 05:05:25,840 --> 05:05:28,600 DEFINITION AND DISADVANTAGED SO 7245 05:05:28,600 --> 05:05:30,720 THAT IS THERE BUT NOT A 7246 05:05:30,720 --> 05:05:31,120 REQUIREMENT. 7247 05:05:31,120 --> 05:05:34,440 NEXT SLIDE, PLEASE. 7248 05:05:34,440 --> 05:05:36,480 THE REASON WE'RE COMING TO YOU 7249 05:05:36,480 --> 05:05:39,760 NOW IS FUNDING CAME OUT OF THE 7250 05:05:39,760 --> 05:05:42,160 OMNIBUS BILL SIGNED BY PRESIDENT 7251 05:05:42,160 --> 05:05:43,920 BIDEN BEFORE CHRISTMAS AND THESE 7252 05:05:43,920 --> 05:05:46,040 FUNDS HAD TO BE COMMITTED IN 7253 05:05:46,040 --> 05:05:48,200 ORDER IN FY23 AND CAN BE DONE 7254 05:05:48,200 --> 05:05:50,280 OVER WITH YOUR APPROVAL TODAY 7255 05:05:50,280 --> 05:05:53,480 AND NUMBER OF TRAINEES AS WE 7256 05:05:53,480 --> 05:05:55,640 SAID 19 TRAININGS AND TOTAL ONE 7257 05:05:55,640 --> 05:05:58,360 PER PROGRAM IF THE REMEMBER LAGS 7258 05:05:58,360 --> 05:06:02,360 TO APPLY AND THAT'S GIVEN AND WE 7259 05:06:02,360 --> 05:06:03,200 ARE GIVEN EVERYONE THE 7260 05:06:03,200 --> 05:06:05,120 OPPORTUNITY AND LAST YEAR ALL 19 7261 05:06:05,120 --> 05:06:07,840 PROGRAMS DID ADD A NEW LAST YEAR 7262 05:06:07,840 --> 05:06:13,120 CASE OF SCHOLARS. 7263 05:06:13,120 --> 05:06:15,920 WHEN THE APPROVAL OBTAINED AND 7264 05:06:15,920 --> 05:06:18,360 PUT THE NOTICE OF SPECIAL 7265 05:06:18,360 --> 05:06:19,920 INTEREST IN THE NIH GUIDE SO 7266 05:06:19,920 --> 05:06:22,040 THAT IT WILL HOPEFULLY COME OUT 7267 05:06:22,040 --> 05:06:24,080 IN THE NEXCOM OF WEEKS AND WE'RE 7268 05:06:24,080 --> 05:06:29,200 REQUIRED TO ALLOW 30 DAYS FOR 7269 05:06:29,200 --> 05:06:30,640 APPLICATIONS TO COME IN AND 7270 05:06:30,640 --> 05:06:32,760 THESE ARE CONSIDERED NOT 7271 05:06:32,760 --> 05:06:34,800 COMPETITIVE AND ADMINISTRATIVE 7272 05:06:34,800 --> 05:06:36,880 SUPPLEMENTS AND THERE IS AN 7273 05:06:36,880 --> 05:06:39,360 INTERNAL NIH REVIEW TO WORKING 7274 05:06:39,360 --> 05:06:43,120 DILIGENCE EX MAKE EVERYTHING IS 7275 05:06:43,120 --> 05:06:53,640 IN ORDER AND FOR THE K12 AND THE 7276 05:07:03,200 --> 05:07:04,680 NEXT SLIDE IS THE CLOSING ONE. 7277 05:07:04,680 --> 05:07:06,240 I WOULD BE HAPPY TO TAKE ANY 7278 05:07:06,240 --> 05:07:08,080 QUESTIONS OR COMMENTS AND THEN 7279 05:07:08,080 --> 05:07:11,120 HOPEFULLY AT END THE GUIDANCE 7280 05:07:11,120 --> 05:07:14,240 AND SHE WILL TAKE A VOTE AND I'M 7281 05:07:14,240 --> 05:07:16,720 OPEN FOR QUESTIONS OR COMMENTS. 7282 05:07:16,720 --> 05:07:17,600 >>Samia Noursi: THERE'S A 7283 05:07:17,600 --> 05:07:19,840 COMMENT IN THE CHAT. 7284 05:07:19,840 --> 05:07:21,960 FROM Dr. SIMON. 7285 05:07:21,960 --> 05:07:22,720 >>OKAY. 7286 05:07:22,720 --> 05:07:23,400 >>Samia Noursi: WOULD YOU LIKE 7287 05:07:23,400 --> 05:07:24,360 US TO READ IT? 7288 05:07:24,360 --> 05:07:27,280 >>I'M JUST WONDERING IF ANY 7289 05:07:27,280 --> 05:07:31,200 PROGRAMS ARE HBCUs OR 7290 05:07:31,200 --> 05:07:32,640 FEDERALLY DESIGNATED MINORITY 7291 05:07:32,640 --> 05:07:33,600 SERVING INSTITUTIONS. 7292 05:07:33,600 --> 05:07:35,200 >>THANK YOU FOR THAT QUESTION. 7293 05:07:35,200 --> 05:07:39,720 OF THE 19, I BELIEVE THERE'S 7294 05:07:39,720 --> 05:07:42,280 EIGHT PROGRAMS THAT HAS 7295 05:07:42,280 --> 05:07:44,560 COLLABORATION WITH AN HBCU OR 7296 05:07:44,560 --> 05:07:47,160 MINORITY SERVING INSTITUTION OR 7297 05:07:47,160 --> 05:07:49,560 TRIBAL HEALTH SO WE HAVE OVER 7298 05:07:49,560 --> 05:07:52,240 THE YEARS REQUIRING IT AND WE 7299 05:07:52,240 --> 05:07:53,720 HAVE ENCOURAGED AND HELPED 7300 05:07:53,720 --> 05:07:55,520 FACILITATE RECRUITMENT OF 7301 05:07:55,520 --> 05:08:01,240 CANDIDATES AND SCHOLARS SO WHOA 7302 05:08:01,240 --> 05:08:03,640 THINK ANY OF THE 19 IS A PRETTY 7303 05:08:03,640 --> 05:08:04,960 DECENT AMOUNT AND I WOULD BE 7304 05:08:04,960 --> 05:08:06,640 HAPPY TO TALK WITH YOU OFF LINE 7305 05:08:06,640 --> 05:08:09,600 IF YOU HAVE ANY QUESTIONS AND WE 7306 05:08:09,600 --> 05:08:11,840 DO CONSIDER THAT VITALLY 7307 05:08:11,840 --> 05:08:14,960 IMPORTANT. 7308 05:08:14,960 --> 05:08:18,600 ABSOLUTELY. 7309 05:08:18,600 --> 05:08:20,960 >>CAN THIS BE A POSTDOC, NOT 7310 05:08:20,960 --> 05:08:21,720 ONLY FACULTY. 7311 05:08:21,720 --> 05:08:25,360 >>YES, THE WAY IT'S CLIN ON 7312 05:08:25,360 --> 05:08:27,040 YOUR POSTDOCTORAL TRAINING WE 7313 05:08:27,040 --> 05:08:29,320 TRIED TO KEEP IT SOMEWHAT 7314 05:08:29,320 --> 05:08:31,160 GENERAL BECAUSE AGAIN WE KNOW 7315 05:08:31,160 --> 05:08:33,920 THAT THIS IS SHORT TIME TO FIND 7316 05:08:33,920 --> 05:08:36,400 PEOPLE AND SO FOURTH AND SO, 7317 05:08:36,400 --> 05:08:38,680 YES, IN TERMS OF POSTDOC, WE'RE 7318 05:08:38,680 --> 05:08:40,440 HOPEFULLY AN INSTRUCTOR LEVEL 7319 05:08:40,440 --> 05:08:44,480 BUT YES, THE WAY IT'S WORDED, 7320 05:08:44,480 --> 05:08:45,640 HOPEFULLY IT WILL BE REASONABLE 7321 05:08:45,640 --> 05:08:52,720 FOR THE PIs TO WORK WITH. 7322 05:08:52,720 --> 05:08:54,240 >>ANY COMMENTS OR QUESTIONS? 7323 05:08:54,240 --> 05:08:55,640 WE HAVE TIME FOR MORE QUESTIONS 7324 05:08:55,640 --> 05:08:57,200 IF THERE ARE ANY. 7325 05:08:57,200 --> 05:08:58,720 >>I HAVE A QUESTION. 7326 05:08:58,720 --> 05:09:01,280 >>YES, PLEASE. 7327 05:09:01,280 --> 05:09:05,280 >>SO, WE WOULD LOOK, AS A BIRCH 7328 05:09:05,280 --> 05:09:07,520 PI WOULD LOOK FOR THE SECOND 7329 05:09:07,520 --> 05:09:09,600 YEAR OF THEIR POSTDOCTORAL 7330 05:09:09,600 --> 05:09:10,760 TRAINING AND WITH THAT 7331 05:09:10,760 --> 05:09:15,440 TRANSITION ONTO THE FACULTY AND 7332 05:09:15,440 --> 05:09:16,920 SO THE WAY THAT WE'RE TRYING TO 7333 05:09:16,920 --> 05:09:18,400 BE CAREFUL WITH THE WORDINGS 7334 05:09:18,400 --> 05:09:20,040 BECAUSE LAST YEAR AND IT WAS A 7335 05:09:20,040 --> 05:09:22,880 STRAIGHT FORWARD AND A FOURTH 7336 05:09:22,880 --> 05:09:25,040 SCHOLAR SO ALL THE DEFINITIONS 7337 05:09:25,040 --> 05:09:27,440 AND THE RFA AND THIS YEAR 7338 05:09:27,440 --> 05:09:29,920 BECAUSE OF A REDUCED LEVEL OF 7339 05:09:29,920 --> 05:09:32,560 FUNDING AVAILABLE AND BY THE WAY 7340 05:09:32,560 --> 05:09:35,280 THIS IS ONLY ONE YEAR AND WE'RE 7341 05:09:35,280 --> 05:09:38,560 TRYING TO BE RESPONSIVE TO THE 7342 05:09:38,560 --> 05:09:39,880 CONGRESSIONAL INTENT AND NEW 7343 05:09:39,880 --> 05:09:41,800 CANDIDATES BUT, I THINK PROBABLY 7344 05:09:41,800 --> 05:09:43,800 THE WAY TO DESCRIBE IT WOULD BE 7345 05:09:43,800 --> 05:09:45,200 SOMEONE WHO WOULD COME ON THIS 7346 05:09:45,200 --> 05:09:47,440 YEAR AND BE ELIGIBLE OR 7347 05:09:47,440 --> 05:09:48,640 COMPETITIVE FOR CONSIDERATION 7348 05:09:48,640 --> 05:09:51,320 FOR A FULL SCHOLAR IN A 7349 05:09:51,320 --> 05:09:52,600 SUBSEQUENT YEAR. 7350 05:09:52,600 --> 05:09:54,960 SO, I HOPE THAT'S HELPFUL. 7351 05:09:54,960 --> 05:09:57,680 >>IT'S EXCELLENT. 7352 05:09:57,680 --> 05:09:59,680 Dr. BEGG IT'S EXCITING THE 7353 05:09:59,680 --> 05:10:01,320 BIRCH IS GETTING SO MUCH 7354 05:10:01,320 --> 05:10:02,320 SUBPOENA OR THE AND I'M THRILLED 7355 05:10:02,320 --> 05:10:04,080 TO HEAR IT AND I'M JUST TRYING 7356 05:10:04,080 --> 05:10:06,440 TO MAKE SURE I CARRY OUT THE 7357 05:10:06,440 --> 05:10:06,760 RIGHT CONCEPT. 7358 05:10:06,760 --> 05:10:08,600 >>ONE OF THE REASONS IT'S ONLY 7359 05:10:08,600 --> 05:10:11,640 FOR ONE YEAR AND WE RECOGNIZE 7360 05:10:11,640 --> 05:10:13,680 THAT THESE PROGRAMS ARE 7361 05:10:13,680 --> 05:10:15,240 TIME-CONSUMING AND DIFFICULT AND 7362 05:10:15,240 --> 05:10:17,480 COMPLEX IMPLEMENT AND SO THE 7363 05:10:17,480 --> 05:10:19,560 ORIGINAL FUNDING AND THE 7364 05:10:19,560 --> 05:10:22,920 ORIGINAL DESIGN WAS ALWAYS FOR 7365 05:10:22,920 --> 05:10:24,840 THREE SCHOLARS AND SO THE FOURTH 7366 05:10:24,840 --> 05:10:26,480 WAS ADDED LAST YEAR AND NOW 7367 05:10:26,480 --> 05:10:29,080 WE'RE ADDING A FIFTH TRAINING AS 7368 05:10:29,080 --> 05:10:31,000 WE SUB THIS PERSON SO WE 7369 05:10:31,000 --> 05:10:32,560 RECOGNIZE IT'S INCREASED 7370 05:10:32,560 --> 05:10:33,760 ADMINISTRATIVE BURDEN AND 7371 05:10:33,760 --> 05:10:36,440 COMPLEXITY SO WE THOUGHT WE 7372 05:10:36,440 --> 05:10:38,480 WOULD MOVE THIS FORWARD AND 7373 05:10:38,480 --> 05:10:40,720 SECURE THE ADDED TRAINEES AND 7374 05:10:40,720 --> 05:10:45,040 THEN BE ABLE TO REDESIGN AND 7375 05:10:45,040 --> 05:10:46,800 TAKE INTO CONSIDERATION THE 7376 05:10:46,800 --> 05:10:49,000 EXTRA WORKLOAD AND ON THE P.I. 7377 05:10:49,000 --> 05:10:51,280 AND THE LEADERSHIP GROUP SO THIS 7378 05:10:51,280 --> 05:10:54,360 PERSON WOULD NOT BE A BIRCH 7379 05:10:54,360 --> 05:10:54,600 SCHOLAR? 7380 05:10:54,600 --> 05:10:57,760 >>WE DON'T THINK SO BECAUSE 7381 05:10:57,760 --> 05:11:00,440 IT -- NUMBER ONE THERE ISN'T 7382 05:11:00,440 --> 05:11:03,320 FUNDING FOR THAT AND ON THE 7383 05:11:03,320 --> 05:11:04,880 AVERAGE, AND THE P.I.s EX 7384 05:11:04,880 --> 05:11:06,640 THOSE ARE FAMILIAR WITH THE 7385 05:11:06,640 --> 05:11:08,400 PROGRAM AND ASSISTANT PROFESSORS 7386 05:11:08,400 --> 05:11:11,600 THESE ARE HIGHLY COMPETITIVE AND 7387 05:11:11,600 --> 05:11:15,760 THEY AVERAGE 190,000 A YEAR PER 7388 05:11:15,760 --> 05:11:17,160 SCHOLAR BECAUSE YOU NIH DOES 7389 05:11:17,160 --> 05:11:19,800 REQUIRE A MAXIMUM OF $100,000 7390 05:11:19,800 --> 05:11:21,560 FOR DIRECTION SALARY AND THAT 7391 05:11:21,560 --> 05:11:23,800 CAN BE AUGMENTED BY THE 7392 05:11:23,800 --> 05:11:27,000 INSTITUTION IN MANY TYPES IT IS 7393 05:11:27,000 --> 05:11:28,800 AND FRINGE BENEFITS AND WE 7394 05:11:28,800 --> 05:11:32,040 FIGURE THAT TO BE 33,000 AND ADD 7395 05:11:32,040 --> 05:11:34,360 50,000 FOR RESEARCH SUPPORT PER 7396 05:11:34,360 --> 05:11:38,960 YEAR AND THEN THE 8% GETS UP TO 7397 05:11:38,960 --> 05:11:42,840 190 TO 200,000 SO THESE ARE 7398 05:11:42,840 --> 05:11:45,960 VALUABLE TRAININGS BUT THEY'RE 7399 05:11:45,960 --> 05:11:48,000 EXPENSIVE, SO, OUR THOUGHT WAS 7400 05:11:48,000 --> 05:11:50,480 THAT AT LEAST GET THE PIPELINE 7401 05:11:50,480 --> 05:11:53,880 GOING HERE AND THEN BE ABLE TO 7402 05:11:53,880 --> 05:11:59,680 REGROUP IN FY24 AND BEYOND. 7403 05:11:59,680 --> 05:12:01,920 Dr. McGREGOR DO YOU WANT TO 7404 05:12:01,920 --> 05:12:06,240 ASK YOUR QUESTION. 7405 05:12:06,240 --> 05:12:07,760 FEEL FREE TO ASK YOUR QUESTION. 7406 05:12:07,760 --> 05:12:09,960 >>IT'S SPECIFIC TO THE BIRCH. 7407 05:12:09,960 --> 05:12:11,680 IS THERE SPECIFIC FUNDING TO 7408 05:12:11,680 --> 05:12:12,840 SUBPOENA OR THE ANY DELAYS DUE 7409 05:12:12,840 --> 05:12:14,840 TO THE PANDEMIC? 7410 05:12:14,840 --> 05:12:17,720 >>WELL, WHAT HAPPENED IS WE 7411 05:12:17,720 --> 05:12:20,400 WERE AND THIS WAS WHEN THE 7412 05:12:20,400 --> 05:12:22,200 PANDEMIC CAME OBVIOUSLY Dr. 7413 05:12:22,200 --> 05:12:24,720 COLLINS WAS OUR DIRECTOR AND DR. 7414 05:12:24,720 --> 05:12:27,240 TABAK HAS CONTINUED THAT 7415 05:12:27,240 --> 05:12:28,160 EVERYONE AT NIH WAS TOLD TO BE 7416 05:12:28,160 --> 05:12:31,600 AS FLEXIBLE AS YOU COULD WITH 7417 05:12:31,600 --> 05:12:33,600 THE RESTRICTIONS AND THE DELAYS 7418 05:12:33,600 --> 05:12:35,440 THAT WHY INHER ENTER BECAUSE OF 7419 05:12:35,440 --> 05:12:37,560 THE PANDEMIC AND WE DIDN'T HAVE 7420 05:12:37,560 --> 05:12:41,320 EXTRA FUNDING TO BE ABLE TO 7421 05:12:41,320 --> 05:12:43,480 PROVIDE MORE MONEY TO THE 7422 05:12:43,480 --> 05:12:45,960 PROGRAMS BUT OUR P.I.s WERE 7423 05:12:45,960 --> 05:12:47,360 REMARKABLE AND IN KEEPING 7424 05:12:47,360 --> 05:12:49,360 EVERYONE ON TARGET AND I HAVE TO 7425 05:12:49,360 --> 05:12:51,920 GET THEM A GREAT DEAL OF CREDIT 7426 05:12:51,920 --> 05:12:54,640 WE'VE HEARD COMMENTS ABOUT THE 7427 05:12:54,640 --> 05:12:57,720 IMPACT OF COVID ON WOMEN AND 7428 05:12:57,720 --> 05:12:59,840 RESEARCHERS AND SO, THE PROGRAM 7429 05:12:59,840 --> 05:13:03,400 STAYED TOGETHER AND THE RFA LAST 7430 05:13:03,400 --> 05:13:04,840 YEAR WAS HIGHLY COMPETITIVE AND 7431 05:13:04,840 --> 05:13:08,520 THE VAST MAJORITY OF THE ACTIVE 7432 05:13:08,520 --> 05:13:11,440 PROGRAMS WERE RENEWED AND SO I 7433 05:13:11,440 --> 05:13:15,760 THINK IT'S JUST A VERY STRONG 7434 05:13:15,760 --> 05:13:17,320 UNIT IN TERMS OF THE BIRCH 7435 05:13:17,320 --> 05:13:20,720 PROGRAM OVER ALL. 7436 05:13:20,720 --> 05:13:21,560 >>Samia Noursi: WE HAVE TIMES 7437 05:13:21,560 --> 05:13:22,920 FOR YOUR COMMENTS AND IF YOU 7438 05:13:22,920 --> 05:13:23,840 WANT TO SHARE ABOUT YOUR 7439 05:13:23,840 --> 05:13:24,920 EXPERIENCE AND YOU WOULD TALK 7440 05:13:24,920 --> 05:13:25,360 ABOUT IT. 7441 05:13:25,360 --> 05:13:26,720 WE HAVE TIME. 7442 05:13:26,720 --> 05:13:27,480 >>FELL FREE. 7443 05:13:27,480 --> 05:13:32,240 >>THERE WAS A LOT OF ACROSS 7444 05:13:32,240 --> 05:13:33,160 DESPERATION WITH OUR YOUNG 7445 05:13:33,160 --> 05:13:34,720 SCIENTISTS WHO WANTED TO DO 7446 05:13:34,720 --> 05:13:36,200 THEIR WORK AND COULD SUDDENLY 7447 05:13:36,200 --> 05:13:38,280 NOT DO IT IT AT ALL IN OUR 7448 05:13:38,280 --> 05:13:39,200 UNIVERSITY AND PEOPLE COULDN'T 7449 05:13:39,200 --> 05:13:41,120 DO RESEARCH FOR A PERIOD OF 7450 05:13:41,120 --> 05:13:44,720 SEVERAL MONTHS SO, NORMALLY OUR 7451 05:13:44,720 --> 05:13:46,600 SCHOLARS ARE BY AND LARGE 7452 05:13:46,600 --> 05:13:50,400 SCHOLARS FOR TWO YEARS AND OUR 7453 05:13:50,400 --> 05:13:52,240 BOARD, OUR INTERNAL ADVISORY 7454 05:13:52,240 --> 05:13:53,480 BOARD VOTED TO ALLOW A THIRD 7455 05:13:53,480 --> 05:13:55,960 YEAR ARE INFORM THE SCHOLARS 7456 05:13:55,960 --> 05:13:58,760 ACKNOWLEDGING THE PROGRESS WAS 7457 05:13:58,760 --> 05:14:02,560 SLOWED DOWN AND YOU KNOW, YOUNG 7458 05:14:02,560 --> 05:14:03,640 SCIENTISTS ARE VERY SERIOUS 7459 05:14:03,640 --> 05:14:06,440 ABOUT WANT TO GO DO THEIR WORK 7460 05:14:06,440 --> 05:14:09,400 AND BY GIVING THE THIRD YEAR NOW 7461 05:14:09,400 --> 05:14:10,840 WE'RE SEEING THEY'VE ALL STAYED 7462 05:14:10,840 --> 05:14:12,400 IN AND THEY'RE ALL DOING WELL 7463 05:14:12,400 --> 05:14:15,640 AND WE JUST HAD THE FIRST K COME 7464 05:14:15,640 --> 05:14:18,440 OUT OF THIS SCHOLAR FOR WHICH WE 7465 05:14:18,440 --> 05:14:22,440 ARE THRILLED AND THE BIRCH P.I. 7466 05:14:22,440 --> 05:14:25,480 AND SUPPORT OUR YOUNG SCHOLARS 7467 05:14:25,480 --> 05:14:27,600 AND I KNOW THAT OUR CITE IS NOT 7468 05:14:27,600 --> 05:14:29,720 THE ONLY ONE THAT FIGURED OUT A 7469 05:14:29,720 --> 05:14:33,840 WAY INCREASED FUNDING. 7470 05:14:33,840 --> 05:14:36,880 >>YES, AND YOU HAVE STRONG 7471 05:14:36,880 --> 05:14:38,400 INSTITUTIONAL SUPPORT AS WELL SO 7472 05:14:38,400 --> 05:14:39,520 I THINK THAT NODES TO BE 7473 05:14:39,520 --> 05:14:40,640 ACKNOWLEDGED THAT YOU'VE 7474 05:14:40,640 --> 05:14:42,080 NEGOTIATED QUITE WELL ON BEHALF 7475 05:14:42,080 --> 05:14:45,840 OF THE PROGRAM AND SO, WE 7476 05:14:45,840 --> 05:14:49,680 APPRECIATE THAT AND ORWH VERY 7477 05:14:49,680 --> 05:14:49,880 MUCH. 7478 05:14:49,880 --> 05:14:50,840 >>ALL RIGHT. 7479 05:14:50,840 --> 05:14:52,760 DO WE HAVE ANYMORE COMMENTS OR 7480 05:14:52,760 --> 05:14:56,480 QUESTIONS BEFORE WE MOVE ON TO 7481 05:14:56,480 --> 05:15:00,040 VOTING ON THE APPROVING THE 7482 05:15:00,040 --> 05:15:04,320 BIRCH POSTDOCTORAL CONCEPT 7483 05:15:04,320 --> 05:15:05,320 CLEARANCES? 7484 05:15:05,320 --> 05:15:14,120 I AM GOING TO MOVE ON AND ASK IF 7485 05:15:14,120 --> 05:15:16,280 ANYONE IS THERE A MOTION ON THE 7486 05:15:16,280 --> 05:15:24,160 TABLE TO APPROVE THE BIRCH? 7487 05:15:24,160 --> 05:15:24,760 POSTDOCTORAL OPPORTUNITIES COP 7488 05:15:24,760 --> 05:15:30,120 SEPTEMBER CLEARANCE. 7489 05:15:30,120 --> 05:15:31,880 IS THERE A MOTION? 7490 05:15:31,880 --> 05:15:33,080 Dr. SIMON DID YOU RAISE YOUR 7491 05:15:33,080 --> 05:15:33,480 HAND? 7492 05:15:33,480 --> 05:15:35,080 >>I MAKE A MOTION TO DO THAT. 7493 05:15:35,080 --> 05:15:37,920 >>Dr. SIMON MADE A MOTION. 7494 05:15:37,920 --> 05:15:41,440 DO I HEAR A SECOND. 7495 05:15:41,440 --> 05:15:45,320 >>IT'S A SECOND AND SECOND TIME 7496 05:15:45,320 --> 05:15:47,080 AND PAUL HAS BEEN OPEN FOR YOU 7497 05:15:47,080 --> 05:15:50,400 TO RESPOND IF YOU ARE IN FAVOR, 7498 05:15:50,400 --> 05:15:51,200 OPPOSED OR ABSTAINED PLEASANT 7499 05:15:51,200 --> 05:15:53,000 YOUR RESPONSES NOW AND YOU WILL 7500 05:15:53,000 --> 05:16:03,480 HAVE 30 SECONDS TO RESPOND. 7501 05:16:26,120 --> 05:16:27,440 >>DO WE HAVE THE VOTE. 7502 05:16:27,440 --> 05:16:28,800 >>YES, 14 IN FAVOR. 7503 05:16:28,800 --> 05:16:36,640 >>GREAT, THANK YOU EVERYONE. 7504 05:16:36,640 --> 05:16:37,880 THEY HAVE BEEN ACCEPTED WITH 14 7505 05:16:37,880 --> 05:16:38,280 IN FAVOR. 7506 05:16:38,280 --> 05:16:41,520 THANK YOU ALL FOR YOUR COMMENTS 7507 05:16:41,520 --> 05:16:43,080 WITH THAT I WOULD LIKE TO TURN 7508 05:16:43,080 --> 05:16:44,520 IT BACK TO THE CHAIR OF THIS 7509 05:16:44,520 --> 05:16:48,400 COMMITTEE Dr. CLAYTON. 7510 05:16:48,400 --> 05:16:49,080 >>Janine A. Clayton: THANK YOU 7511 05:16:49,080 --> 05:16:50,880 SO MUCH Dr. NOURSI AND THANK 7512 05:16:50,880 --> 05:16:52,680 YOU EVERYONE, SPECIAL THANKS TO 7513 05:16:52,680 --> 05:16:55,680 THE CAREER SECTION FOR TWO 7514 05:16:55,680 --> 05:16:59,080 AMAZING CONCEPT CLEARANCES AND 7515 05:16:59,080 --> 05:17:01,120 Dr. THE CAREER SECTION AND FOR 7516 05:17:01,120 --> 05:17:02,800 HELPING US GET TO THIS POINT AND 7517 05:17:02,800 --> 05:17:05,520 IT'S BEEN AN EXTREMELY BUSY YEAR 7518 05:17:05,520 --> 05:17:07,880 ACROSS THE BOARD AND THEY HAVE 7519 05:17:07,880 --> 05:17:11,240 BEEN WORKING HARD AS HAS TEAM 7520 05:17:11,240 --> 05:17:13,400 ORWH IN GENERAL SO I HOPE THAT I 7521 05:17:13,400 --> 05:17:15,560 WAS ABLE TO SHARE WITH YOU AND 7522 05:17:15,560 --> 05:17:18,680 MY PRESENTATION EARLIER A LOT OF 7523 05:17:18,680 --> 05:17:20,240 THE ACTIVITIES THAT WE HAVE 7524 05:17:20,240 --> 05:17:21,920 UNDERTAKEN WHICH HAVE CERTAINLY 7525 05:17:21,920 --> 05:17:24,760 INVOLVED THE ENTIRE STAFF OF 7526 05:17:24,760 --> 05:17:27,000 ORWH WHO I WANT TO ACKNOWLEDGE 7527 05:17:27,000 --> 05:17:29,840 NOW FOR THEIR INCREDIBLE EFFORTS 7528 05:17:29,840 --> 05:17:32,480 TO KEEP ALL OF THE MISSION AREAS 7529 05:17:32,480 --> 05:17:35,200 MOVING FORWARD WITH REALLY 7530 05:17:35,200 --> 05:17:36,840 ROBUST PROGRAMMINGEN OWE HAVE A 7531 05:17:36,840 --> 05:17:39,080 TIVE APPROACHES AND CREATIVE 7532 05:17:39,080 --> 05:17:43,280 STRATEGIES TO ADVANCE WOMEN'S 7533 05:17:43,280 --> 05:17:44,560 HEALTH AND WOMEN IN STEM. 7534 05:17:44,560 --> 05:17:50,080 WE HAVE TIME ON OUR AGENDA FOR 7535 05:17:50,080 --> 05:17:51,800 OPEN DISCUSSION AND WE'VE HAD 7536 05:17:51,800 --> 05:17:52,880 Q&A FOR SPECIFIC ISSUES DURING 7537 05:17:52,880 --> 05:17:54,520 THIS MEETING BUT I ALWAYS LIKE 7538 05:17:54,520 --> 05:17:59,640 TO MAKE SURE THAT WE HAVE A GOOD 7539 05:17:59,640 --> 05:18:03,640 SPOT ON THE AGENDA FOR MEMBERS 7540 05:18:03,640 --> 05:18:06,000 TO EXPRESSION THEIR THOUGHTS AND 7541 05:18:06,000 --> 05:18:07,200 REGARDING WOMEN'S HEALTH 7542 05:18:07,200 --> 05:18:11,640 RESEARCH HERE AT NIH AND 7543 05:18:11,640 --> 05:18:13,600 INTEGRATION ACROSS THE RESEARCH 7544 05:18:13,600 --> 05:18:18,680 CONTINUUM AND POLE SEIZE AND 7545 05:18:18,680 --> 05:18:19,680 WOMEN AND ALL OF THE AREAS 7546 05:18:19,680 --> 05:18:21,560 COVERED BY OUR MISSION SO LET ME 7547 05:18:21,560 --> 05:18:23,680 OPEN THE FLOOR FOR COMMENTS AND 7548 05:18:23,680 --> 05:18:24,960 SO THEY DON'T NEED TO BE 7549 05:18:24,960 --> 05:18:26,000 REQUESTED BUT THEY COULD BE 7550 05:18:26,000 --> 05:18:30,160 COMMENTS PERSPECTIVES AND YOUR 7551 05:18:30,160 --> 05:18:33,800 FEEDBACK ON THINGS THAT YOU 7552 05:18:33,800 --> 05:18:34,440 HEARD ABOUT THAT YOU APPRECIATE 7553 05:18:34,440 --> 05:18:36,000 THAT YOU WOULD LIKE FOR US TO 7554 05:18:36,000 --> 05:18:38,000 CONTINUE AND IT'S REALLY UP TO 7555 05:18:38,000 --> 05:18:40,160 YOU AND YOUR TIME ON THE AGENDA. 7556 05:18:40,160 --> 05:18:48,560 WITH THAT I'LL PAUSE. 7557 05:18:48,560 --> 05:18:51,560 Dr. ANDERSON. 7558 05:18:51,560 --> 05:18:53,760 YOUR LIGHT CAME ON. 7559 05:18:53,760 --> 05:18:56,240 >>O, YOU KNOW, YOUR 7560 05:18:56,240 --> 05:18:58,960 PRESENTATION MORNING ON MATERNAL 7561 05:18:58,960 --> 05:19:00,360 MORTALITY WAS COMPELLING AND 7562 05:19:00,360 --> 05:19:01,920 IT'S NOT ANY AREA AND THE THINGS 7563 05:19:01,920 --> 05:19:03,560 I WORK ON SEEM A LITTLE BIT 7564 05:19:03,560 --> 05:19:05,040 SMALL COMPARED TO THAT AND I 7565 05:19:05,040 --> 05:19:06,360 REALLY WOULD LIKE TO SEE A LOT 7566 05:19:06,360 --> 05:19:08,760 OF EMPHASIS ON ADDRESSING THAT 7567 05:19:08,760 --> 05:19:09,160 PROBLEM. 7568 05:19:09,160 --> 05:19:11,280 THERE ARE TWO OTHERS THAT I 7569 05:19:11,280 --> 05:19:14,000 WANTED TO MENTION AND THAT IS 7570 05:19:14,000 --> 05:19:16,120 ADDRESSING MENOPAUSE. 7571 05:19:16,120 --> 05:19:17,040 UNDERSTANDING BIOLOGICALLY WHAT 7572 05:19:17,040 --> 05:19:19,800 IS GOING ON AND HOW WE CAN 7573 05:19:19,800 --> 05:19:23,000 PROVIDE WOMEN AND PERRY 7574 05:19:23,000 --> 05:19:24,880 MENOPAUSE WITH REAL VERY SOLID 7575 05:19:24,880 --> 05:19:27,520 EVIDENCE BASED GUIDELINES ON HOW 7576 05:19:27,520 --> 05:19:30,920 TO AROUND THE SYMPTOMS OF 7577 05:19:30,920 --> 05:19:32,920 MENOPAUSE AND THERE'S A LOT OF 7578 05:19:32,920 --> 05:19:33,960 CONTROVERSY AND A LOT OF 7579 05:19:33,960 --> 05:19:35,720 INTEREST IN HOW WE HELP WOMEN 7580 05:19:35,720 --> 05:19:39,240 GOING TO THIS TRANSITION AND THE 7581 05:19:39,240 --> 05:19:40,720 OTHER ONE MENTIONED BEFORE AND 7582 05:19:40,720 --> 05:19:45,400 THAT IS CAREGIVING AND WOMEN 7583 05:19:45,400 --> 05:19:47,600 CERTAINLY A LOT OF THE BURDEN 7584 05:19:47,600 --> 05:19:49,800 CAREGIVING AND IT'S MID LIFE AND 7585 05:19:49,800 --> 05:19:52,360 THEN OLDER AGES TIP HE CANNILY 7586 05:19:52,360 --> 05:19:56,360 AND FOR ELDERS AND PARTNERS AND 7587 05:19:56,360 --> 05:19:59,640 THAT'S A HUGE BURDEN ON BOTH 7588 05:19:59,640 --> 05:20:00,520 MENTAL AND PHYSICAL HEALTH OF 7589 05:20:00,520 --> 05:20:02,080 WOMEN AND I THINK WE'RE NOT 7590 05:20:02,080 --> 05:20:05,080 DOING ENOUGH TO ADDRESS THAT. 7591 05:20:05,080 --> 05:20:07,400 >>THANK YOU SO MUCH FOR SHARING 7592 05:20:07,400 --> 05:20:09,080 BOTH OF THOSE SUGGESTED AREAS 7593 05:20:09,080 --> 05:20:11,320 AND THOSE ARE AREAS OF PROFOUND 7594 05:20:11,320 --> 05:20:12,840 INTEREST BUT WHAT I'M HEARING 7595 05:20:12,840 --> 05:20:16,040 FROM YOU IS ENCOURAGEMENT TO 7596 05:20:16,040 --> 05:20:19,120 ELEVATE THE ATTENTION TO 7597 05:20:19,120 --> 05:20:20,280 MENOPAUSE IN MID LIFE WOMEN AND 7598 05:20:20,280 --> 05:20:22,200 THE REMAINING RESEARCH QUESTIONS 7599 05:20:22,200 --> 05:20:25,120 OF COURSE YOU DO KNOW AND WE'LL 7600 05:20:25,120 --> 05:20:27,880 BE HOSTING THE SYMPOSIUM 7601 05:20:27,880 --> 05:20:29,680 FOCUSING ON THAT SO I HOPE YOU 7602 05:20:29,680 --> 05:20:31,600 CAN JOIN HIM THERE AND GIVE US 7603 05:20:31,600 --> 05:20:35,520 FOLLOW-UP AND FEEDBACK FROM THE 7604 05:20:35,520 --> 05:20:36,960 SYMPOSIUM AS WELL. 7605 05:20:36,960 --> 05:20:42,200 CAREGIVING AND ITS CONSEQUENCES 7606 05:20:42,200 --> 05:20:42,800 BOTH ON MOTEL PHYSICAL HEALTH 7607 05:20:42,800 --> 05:20:44,640 AND I DID MENTION THIS BUT ALSO 7608 05:20:44,640 --> 05:20:45,760 THERE ARE CAREGIVING 7609 05:20:45,760 --> 05:20:47,200 RESPONSIBILITY AND IT'S 7610 05:20:47,200 --> 05:20:48,880 INTERFACES WITH CAREER CHOICES 7611 05:20:48,880 --> 05:20:51,240 OF WOMEN AND STEM IS ALSO AN 7612 05:20:51,240 --> 05:20:52,640 IMPORTANT ISSUE AND YOU HAVE 7613 05:20:52,640 --> 05:20:56,040 HEARD A FEW THINGS ABOUT 7614 05:20:56,040 --> 05:20:57,560 STRATEGIES THAT ARE TAKEN TO TRY 7615 05:20:57,560 --> 05:21:00,480 IT TO ADDRESS THAT BUT, WITH THE 7616 05:21:00,480 --> 05:21:02,080 PANDEMIC, I THINK THIS SITUATION 7617 05:21:02,080 --> 05:21:04,680 HAS EVOLVED EVEN FURTHER AND SO 7618 05:21:04,680 --> 05:21:07,480 HOW CAN WE REMAIN CURRENT AND 7619 05:21:07,480 --> 05:21:11,600 CONTEMPORARY AND PROVIDE US MANY 7620 05:21:11,600 --> 05:21:14,800 OPTIONS FOR CAREER SIDE BUT ALSO 7621 05:21:14,800 --> 05:21:17,440 WAYS THAT WE'RE ADJUSTING AND 7622 05:21:17,440 --> 05:21:18,840 HEALTH RESEARCH PERSPECTIVES. 7623 05:21:18,840 --> 05:21:20,880 THANK YOU SO MUCH Dr. 7624 05:21:20,880 --> 05:21:21,160 ANDERSON. 7625 05:21:21,160 --> 05:21:30,240 I WILL GO WITH -- 7626 05:21:30,240 --> 05:21:32,840 >>I SUPPORT THE COMMENTS ON THE 7627 05:21:32,840 --> 05:21:35,880 MENOPAUSE AND I'M GLAD THAT THEY 7628 05:21:35,880 --> 05:21:38,600 HAVE FOCUSED ON MENOPAUSE. 7629 05:21:38,600 --> 05:21:41,280 IT STRIKES ME SINCE ONCE HEALTH 7630 05:21:41,280 --> 05:21:44,120 INITIATIVE RESEARCH HORMONE 7631 05:21:44,120 --> 05:21:49,560 REPLACEMENT WAS SHUT DOWN AND AS 7632 05:21:49,560 --> 05:21:51,120 WAS NOTED IN THE "NEW YORK 7633 05:21:51,120 --> 05:21:52,680 TIMES," IT'S AMAZING HOW MUCH 7634 05:21:52,680 --> 05:21:55,600 SUFFERING PEOPLE WILL TOLERATE 7635 05:21:55,600 --> 05:21:58,920 FOR WOMAN SO I THINK THAT IS THE 7636 05:21:58,920 --> 05:21:59,680 ISSUE OF HORMONE REPLACEMENT 7637 05:21:59,680 --> 05:22:01,400 THERAPY IS REVISITED AND THERE'S 7638 05:22:01,400 --> 05:22:03,280 A LOT OF EVIDENCE SUGGESTING 7639 05:22:03,280 --> 05:22:05,440 THAT IT WASN'T ADDRESSED AND 7640 05:22:05,440 --> 05:22:07,560 GIVEN THE TIMES HE HAZARDED AS 7641 05:22:07,560 --> 05:22:09,320 BEST IT COULD BE THEM BUT 7642 05:22:09,320 --> 05:22:10,680 NEIGHBOR NOT DA FIN TO HAVE TEE 7643 05:22:10,680 --> 05:22:12,760 AND I WANT TO THANK YOU Dr. 7644 05:22:12,760 --> 05:22:13,280 CLAYTON. 7645 05:22:13,280 --> 05:22:14,520 IT'S AMAZING WHAT YOUR OFFICE 7646 05:22:14,520 --> 05:22:16,320 DOES AND WHAT YOU'VE DONE AND AS 7647 05:22:16,320 --> 05:22:18,360 I CONTINUE TO KEEP HOPING AND 7648 05:22:18,360 --> 05:22:20,400 WORKING ON MAKING WOMEN'S HEALTH 7649 05:22:20,400 --> 05:22:21,720 AND SEX DIFFERENCES RESEARCH 7650 05:22:21,720 --> 05:22:26,080 MORE OF A PRIORITY, YOU AND YOUR 7651 05:22:26,080 --> 05:22:28,120 OFFICE HAVE BROUGHT THIS TO BEAR 7652 05:22:28,120 --> 05:22:30,200 IN AN AMAZING WAY SO I WANT TO 7653 05:22:30,200 --> 05:22:30,520 THANK YOU. 7654 05:22:30,520 --> 05:22:33,000 >>THANK YOU, JUDY FOR THAT AND 7655 05:22:33,000 --> 05:22:36,480 IT'S A TRUE TEAM EFFORT AS YOU 7656 05:22:36,480 --> 05:22:39,720 KNOW AND INCREDIBLE COMMITTED 7657 05:22:39,720 --> 05:22:43,560 DEDICATED INDIVIDUALS HERE SO 7658 05:22:43,560 --> 05:22:44,680 WE'LL DEFINITELY SHARE THE CROSS 7659 05:22:44,680 --> 05:22:45,480 THE BOARD. 7660 05:22:45,480 --> 05:22:47,880 I AGREE WITH YOU THAT MENOPAUSE 7661 05:22:47,880 --> 05:22:50,880 RESEARCH AND UNDERSTAND HE'D AND 7662 05:22:50,880 --> 05:22:53,720 IT'S APP UNDER STUDIED TOPIC AND 7663 05:22:53,720 --> 05:22:59,160 MANY QUESTIONS THAT REMAIN 7664 05:22:59,160 --> 05:23:02,000 AROUND MENOPAUSE AND THAT AS WE 7665 05:23:02,000 --> 05:23:04,080 LEARN MORE, I MEAN, WE'VE 7666 05:23:04,080 --> 05:23:06,360 LEARNED SO MUCH SINCE THE W.H.I. 7667 05:23:06,360 --> 05:23:08,520 WAS OF COURSE, A LANDMARK, 7668 05:23:08,520 --> 05:23:11,160 AMAZING INCREDIBLE FOCUSED 7669 05:23:11,160 --> 05:23:13,280 INVESTMENTS AND FIRST EVER OF 7670 05:23:13,280 --> 05:23:15,800 ITS KIND JUST ON THE HEALTH OF 7671 05:23:15,800 --> 05:23:18,560 MID LIFE AND A LITTLE BIT OLDER 7672 05:23:18,560 --> 05:23:20,480 WOMEN THE FOCUS WAS A LITTLE BIT 7673 05:23:20,480 --> 05:23:21,680 DIFFERENT AT THAT TIME. 7674 05:23:21,680 --> 05:23:24,760 THE FORMULATIONS OF FORMAL 7675 05:23:24,760 --> 05:23:25,760 AVAILABLE FOR DIFFERENT AT THE 7676 05:23:25,760 --> 05:23:28,040 TIME AND WE ACTUALLY HAVE A LOT 7677 05:23:28,040 --> 05:23:29,960 MORE INFORMATION NOW BECAUSE OF 7678 05:23:29,960 --> 05:23:32,960 W.H.I. AND BECAUSE OF RESEARCH 7679 05:23:32,960 --> 05:23:35,360 AND SO NO AS WE LEARN MORE WE 7680 05:23:35,360 --> 05:23:38,600 CAN DEVELOP MORE QUESTIONS AND 7681 05:23:38,600 --> 05:23:40,000 COMPELLING QUESTIONS AND 7682 05:23:40,000 --> 05:23:42,120 SCENARIOS FOR WHICH WE NEED 7683 05:23:42,120 --> 05:23:43,320 EVIDENCE OF CLINICIANS HAVE 7684 05:23:43,320 --> 05:23:45,440 EVIDENCE IT MAKE THEIR TREATMENT 7685 05:23:45,440 --> 05:23:46,800 DECISIONS FOR MANY DIFFERENT 7686 05:23:46,800 --> 05:23:49,640 SITUATIONS AS POSSIBLE AND WE 7687 05:23:49,640 --> 05:23:51,120 HAVE VARIOUS BACKGROUNDS SO I 7688 05:23:51,120 --> 05:23:56,280 HEAR YOU ON THAT, JUDY. 7689 05:23:56,280 --> 05:23:58,840 >>TWO QUICK COMMENTS ABOUT THE 7690 05:23:58,840 --> 05:24:00,520 LIFE COURSE SLIDE AND ONE THING 7691 05:24:00,520 --> 05:24:01,960 I'VE BEEN THINKING ABOUT IS THE 7692 05:24:01,960 --> 05:24:04,760 FACT THAT WE UTILIZE THE WORD 7693 05:24:04,760 --> 05:24:07,000 CHILDREN A LOT AND THERE'S A LOT 7694 05:24:07,000 --> 05:24:08,480 OF SEX SPECIFIC DIFFERENCES THAT 7695 05:24:08,480 --> 05:24:11,600 ARE PRESENT FROM BIRTH AND SO WE 7696 05:24:11,600 --> 05:24:13,600 DON'T REALLY DISTINGUISH GIRLS 7697 05:24:13,600 --> 05:24:15,040 AND BOYS PRIOR TO ADD LESS 7698 05:24:15,040 --> 05:24:16,840 ENTERS AND I THINK PERHAPS WE 7699 05:24:16,840 --> 05:24:18,880 SHOULD AND IT'S LUMPING THEM ALL 7700 05:24:18,880 --> 05:24:19,920 TOGETHER. 7701 05:24:19,920 --> 05:24:21,480 THE OTHER THOUGHT IS I PUT THIS 7702 05:24:21,480 --> 05:24:26,040 IN THE CHAT ABOUT THE ADULTHOOD 7703 05:24:26,040 --> 05:24:29,440 CONCEPTS AND DEFINITELY HAVING 7704 05:24:29,440 --> 05:24:31,320 PERI-PRE POST MENOPAUSE BECAUSE 7705 05:24:31,320 --> 05:24:32,920 PART OF THAT I WAS TALKING ABOUT 7706 05:24:32,920 --> 05:24:34,520 A COLLEAGUE OF MINE AND MANY 7707 05:24:34,520 --> 05:24:36,920 MIGHT KNOW HER BUT SHE MADE A 7708 05:24:36,920 --> 05:24:39,560 GREAT POINT AND THAT WHETHER OR 7709 05:24:39,560 --> 05:24:41,960 NOT YOU HAVE CHILDREN EFFECTS 7710 05:24:41,960 --> 05:24:43,280 YOUR RISK OF IT PARTICULAR 7711 05:24:43,280 --> 05:24:45,960 DISEASES SO IF YOU HAVE CHILDREN 7712 05:24:45,960 --> 05:24:48,760 AND PRE-ECLAMPSIA AND RISK FOR 7713 05:24:48,760 --> 05:24:49,960 CARDIOVASCULAR DISEASE IF YOU 7714 05:24:49,960 --> 05:24:52,040 DON'T HAVE CHILDREN AND YOUR 7715 05:24:52,040 --> 05:24:54,440 RISK OF PRE PRODUCTIVE CANCER 7716 05:24:54,440 --> 05:24:55,520 DIFFERENCE AND SO IT MIGHT NOT 7717 05:24:55,520 --> 05:24:58,600 ALWAYS LOOK AT A LINEAR PROCESS 7718 05:24:58,600 --> 05:25:02,280 BUT THANK YOU AGAIN THIS WAS AN 7719 05:25:02,280 --> 05:25:02,600 AMAZING DAY. 7720 05:25:02,600 --> 05:25:04,760 >>THANK YOU FOR ADDING THOSE 7721 05:25:04,760 --> 05:25:06,320 ADDITIONAL CONTEXT. 7722 05:25:06,320 --> 05:25:08,680 THAT MULTI DIMENSIONAL FRAMEWORK 7723 05:25:08,680 --> 05:25:10,600 HAS SO MANY POTENTIAL WAYS IT 7724 05:25:10,600 --> 05:25:15,360 CAN BE NUANCES AND SO WE'RE 7725 05:25:15,360 --> 05:25:19,600 TRYING TO MAKE SURE WE HAVE THE 7726 05:25:19,600 --> 05:25:22,880 MOST SALIENT ELEMENT THE WITHOUT 7727 05:25:22,880 --> 05:25:24,440 HANGING THINGS ON IT AND HAVING 7728 05:25:24,440 --> 05:25:26,880 IT BE THE FOUNDATION ALLOWS US 7729 05:25:26,880 --> 05:25:29,480 TO EXPLORE ALL OF THOSE ISSUES 7730 05:25:29,480 --> 05:25:31,280 LIKE YOU MIND THAT ARE ALL VERY 7731 05:25:31,280 --> 05:25:33,280 IMPORTANT SO THANK YOU FOR THAT 7732 05:25:33,280 --> 05:25:34,120 AS WELL. 7733 05:25:34,120 --> 05:25:37,280 Dr. JONES IF. 7734 05:25:37,280 --> 05:25:43,960 >>THANK YOU FOR THE OPPORTUNITY 7735 05:25:43,960 --> 05:25:45,560 TO JUST SHARE TWO THOUGHTS THAT 7736 05:25:45,560 --> 05:25:48,720 HAVE COME TO ME TODAY AND I'M 7737 05:25:48,720 --> 05:25:50,720 LOOKING AT THE DIFFERENT THINGS 7738 05:25:50,720 --> 05:25:51,600 THAT WE HAVE. 7739 05:25:51,600 --> 05:25:53,360 AND A WONDERFUL PRESENTATIONS 7740 05:25:53,360 --> 05:25:55,680 THAT WITH GIVEN SO GOING BACK TO 7741 05:25:55,680 --> 05:25:57,960 THE MATERNAL MORTALITY PIECE AND 7742 05:25:57,960 --> 05:25:59,960 THE STRIKING DATA YOU PRESENTED 7743 05:25:59,960 --> 05:26:01,640 THIS MORNING AROUND SO MANY 7744 05:26:01,640 --> 05:26:03,080 OTHER COUNTRIES AND CULTURES ARE 7745 05:26:03,080 --> 05:26:06,200 DOING A BETTER JOB WITH THE TOTE 7746 05:26:06,200 --> 05:26:07,680 MORTALITY SO ASKING MORE 7747 05:26:07,680 --> 05:26:08,640 STRUCTURAL QUESTIONS AND WHAT 7748 05:26:08,640 --> 05:26:09,920 ARE THEY DOING RIGHT NOW AND 7749 05:26:09,920 --> 05:26:13,000 WHAT ARE THEY DOING AND THINKING 7750 05:26:13,000 --> 05:26:15,040 I KNOW MATERNAL DESERTS AND THAT 7751 05:26:15,040 --> 05:26:18,680 ARE HAPPENING IN OUR COUNTRY AND 7752 05:26:18,680 --> 05:26:20,880 THERE'S I THINK WE COULD ALSO 7753 05:26:20,880 --> 05:26:22,600 ASK QUESTIONS ABOUT THINGS LIKE 7754 05:26:22,600 --> 05:26:24,520 MIDWIVES AND FOLLOW-UP VISITS 7755 05:26:24,520 --> 05:26:27,240 AND OTHER COUNTRIES TEND TO SEE 7756 05:26:27,240 --> 05:26:29,480 AND VISITING THERE'S MUCH MORE 7757 05:26:29,480 --> 05:26:33,480 INTERACTIONS AND SUPPORT OF CARE 7758 05:26:33,480 --> 05:26:35,920 GIVEN.POSTPARTUM PERIOD SO JUST 7759 05:26:35,920 --> 05:26:36,720 MAKING SEE WE'RE LOOKING AT WHAT 7760 05:26:36,720 --> 05:26:38,280 OTHER CULTURES ARE DOING WELL 7761 05:26:38,280 --> 05:26:40,680 AND WHAT LESSONS COULD BE 7762 05:26:40,680 --> 05:26:41,680 LEARNED AND FIGHT WITHIN OUR 7763 05:26:41,680 --> 05:26:44,280 CULTURAL CONTEXT AND I THINK THE 7764 05:26:44,280 --> 05:26:47,400 SECOND THING SUCH AS THROUGHOUT 7765 05:26:47,400 --> 05:26:49,360 THE PAST YEARS SO, WE'VE SEEN A 7766 05:26:49,360 --> 05:26:54,080 LOT OF CHANGING AND REPRODUCTIVE 7767 05:26:54,080 --> 05:26:56,080 RIGHTS AND ACCESS TO ABORTION 7768 05:26:56,080 --> 05:26:58,080 AND THIS IS A IMPORTANT 7769 05:26:58,080 --> 05:26:59,000 OPPORTUNITY TO ASK QUESTIONS AND 7770 05:26:59,000 --> 05:27:01,880 TO BE ABLE TO FOLLOW AND MONITOR 7771 05:27:01,880 --> 05:27:05,840 AND PROVIDE SOME DATA IN TERMS 7772 05:27:05,840 --> 05:27:06,880 OF ALL DIFFERENT STATES ARE 7773 05:27:06,880 --> 05:27:08,120 DOING DIFFERENT THINGS AND WHAT 7774 05:27:08,120 --> 05:27:15,480 CAN WE LEARN FROM THAT. 7775 05:27:15,480 --> 05:27:17,000 SO THE SECOND PART FIRST AND I 7776 05:27:17,000 --> 05:27:21,040 JUST CONTINUED TO SUPPORT 7777 05:27:21,040 --> 05:27:23,720 RESEARCH ON REPRODUCTIVE HEALTH 7778 05:27:23,720 --> 05:27:25,200 AND EFFORTS THAT WOULD ALLOW US 7779 05:27:25,200 --> 05:27:27,200 TO CHARACTERIZE THE IMPACT OF 7780 05:27:27,200 --> 05:27:29,000 POLICY CHANGES ON THE HEALTH OF 7781 05:27:29,000 --> 05:27:31,520 WOMEN AND REPRODUCTIVE HEALTH 7782 05:27:31,520 --> 05:27:33,200 OPTIONS AND SO THAT IS AVAILABLE 7783 05:27:33,200 --> 05:27:35,080 AND I EXPECT TO SEE MORE DATA 7784 05:27:35,080 --> 05:27:36,800 THERE AND DATA ARE VERY 7785 05:27:36,800 --> 05:27:40,280 IMPORTANT TO FOREIGN POLICY AND 7786 05:27:40,280 --> 05:27:42,880 I AGREE THERE BUT THE FIRST ITEM 7787 05:27:42,880 --> 05:27:44,880 WAS ABOUT WHAT WE COULD LEARN 7788 05:27:44,880 --> 05:27:46,280 FROM OUR COLLEAGUES AROUND THE 7789 05:27:46,280 --> 05:27:48,240 WORLD AND THAT IS WHAT I THOUGHT 7790 05:27:48,240 --> 05:27:50,800 WHAT I SAW THE EASTERN EUROPEAN 7791 05:27:50,800 --> 05:27:52,440 DATA AND WHAT IS THE 7792 05:27:52,440 --> 05:27:54,400 INTERSECTION HERE AND FOR THE 7793 05:27:54,400 --> 05:27:57,640 COMMODITIES FUND DATA I CAN TELL 7794 05:27:57,640 --> 05:28:00,440 YOU THE UNITED STATES IS THE 7795 05:28:00,440 --> 05:28:01,600 LOWEST HIVE EXPECTANT SEE AND 7796 05:28:01,600 --> 05:28:05,520 THE SIGHEST COST OF HEALTHCARE 7797 05:28:05,520 --> 05:28:08,920 HAD THE LOWEST NUMBER OF 7798 05:28:08,920 --> 05:28:10,440 PHYSICIAN HEALTHCARE VISITS 7799 05:28:10,440 --> 05:28:12,040 BASICALLY INTERFACING WITH THE 7800 05:28:12,040 --> 05:28:13,840 HEALTH-CARE SYSTEM AND ONE OF 7801 05:28:13,840 --> 05:28:15,160 THE BIGGEST DIFFERENCES BETWEEN 7802 05:28:15,160 --> 05:28:17,800 THE U.S. AND THE OTHER COUNTRIES 7803 05:28:17,800 --> 05:28:19,840 WAS A LACK OF UNIVERSAL 7804 05:28:19,840 --> 05:28:22,280 HEALTHCARE PROVIDED. 7805 05:28:22,280 --> 05:28:26,680 AND THE PATHWAYS TO PRE FOCUSED 7806 05:28:26,680 --> 05:28:28,560 ON POSTPARTUM HEALTH MAY ADDRESS 7807 05:28:28,560 --> 05:28:29,920 SOME OF THE THINGS THAT YOU 7808 05:28:29,920 --> 05:28:31,640 MENTIONED SO I WOULD REALLY 7809 05:28:31,640 --> 05:28:32,960 ENCOURAGE YOU STRONGLY TO TAKE A 7810 05:28:32,960 --> 05:28:36,240 LOOK AT THAT DRAFT PANEL REPORT 7811 05:28:36,240 --> 05:28:41,120 AND WEIGH IN AND IT'S THE FULL 7812 05:28:41,120 --> 05:28:45,120 YEAR AND YOU MENTIONED MIDWIVES 7813 05:28:45,120 --> 05:28:46,320 AND DOULA AND ACTIONS THERE IN 7814 05:28:46,320 --> 05:28:49,920 TERMS OF HOW WE ARE PROVIDING 7815 05:28:49,920 --> 05:28:52,480 CARE AND WEIGH IN. 7816 05:28:52,480 --> 05:28:54,320 IMPROVE IS FUNDING RESEARCH IN 7817 05:28:54,320 --> 05:28:56,720 THAT SPACE AND THE MIDWIFE SPACE 7818 05:28:56,720 --> 05:29:00,200 SO, THAT HELPS TO GENERATE 7819 05:29:00,200 --> 05:29:01,760 ADDITIONAL DATA AND IT'S 7820 05:29:01,760 --> 05:29:04,040 CHALLENGING WHEN YOU HAVE A 7821 05:29:04,040 --> 05:29:06,280 COMPLICATED NATIONAL LANDSCAPE 7822 05:29:06,280 --> 05:29:13,160 AND REGARDING DELIVERY OF DOULA 7823 05:29:13,160 --> 05:29:15,960 CARE AND IT THE MORE COMPLICATED 7824 05:29:15,960 --> 05:29:17,560 FOR PREGNANT AND POSTPARTUM 7825 05:29:17,560 --> 05:29:19,200 PEOPLE SO WE'RE KEEPING AN EYE 7826 05:29:19,200 --> 05:29:26,200 ON ALL OF THE THINGS THAT AND I 7827 05:29:26,200 --> 05:29:28,440 APPRECIATE YOUR SUGGESTIONS ON 7828 05:29:28,440 --> 05:29:29,680 MAKING SURE THAT THESE ARE STILL 7829 05:29:29,680 --> 05:29:32,720 ON OUR RADAR AND HOW WE CAN 7830 05:29:32,720 --> 05:29:35,000 INCLUDE THEM IN OUR EVENTS GOING 7831 05:29:35,000 --> 05:29:36,800 FORWARD AND HOPE TO BE ABLE TO 7832 05:29:36,800 --> 05:29:41,040 SHARE MORE IN THE FUTURE AND THE 7833 05:29:41,040 --> 05:29:42,600 DOCTOR REMIND ME THAT WE ARE 7834 05:29:42,600 --> 05:29:45,200 SUPPORTING A NATIONAL ACADEMIES 7835 05:29:45,200 --> 05:29:47,600 STUDY ON THE EFFECTS OF 7836 05:29:47,600 --> 05:29:49,480 CAREGIVING ON PARENTS AND STEM 7837 05:29:49,480 --> 05:29:53,160 AND SO THAT IS ON GOING AND THE 7838 05:29:53,160 --> 05:29:54,840 COMMITTEE HAS SPENT SEVERAL 7839 05:29:54,840 --> 05:29:56,880 TIMES AND THERE ARE AT LEAST TWO 7840 05:29:56,880 --> 05:29:58,240 SESSION THAT'S HAVE BEEN OPEN TO 7841 05:29:58,240 --> 05:30:00,480 THE PUBLIC SO WE ARE SUPPORTING 7842 05:30:00,480 --> 05:30:02,040 THAT ALONG WITH OTHERS AND SO 7843 05:30:02,040 --> 05:30:05,840 HOPE TO BE ABLE TO BRING A 7844 05:30:05,840 --> 05:30:09,480 REPORT IN THE FUTURE AND THAT 7845 05:30:09,480 --> 05:30:12,520 WILL PROVIDE LARGE EVIDENCE 7846 05:30:12,520 --> 05:30:15,120 BASED RECOMMENDATIONS FOR THE 7847 05:30:15,120 --> 05:30:17,000 ECOSYSTEM AND AROUND CAREGIVING 7848 05:30:17,000 --> 05:30:19,880 IN STEM AND IT WAS PARTICULARLY 7849 05:30:19,880 --> 05:30:21,160 CONCERNED AND SHARED WITH YOU 7850 05:30:21,160 --> 05:30:23,920 ALL THE EFFECT OF PANDEMIC AND 7851 05:30:23,920 --> 05:30:25,600 WOMEN IN STEM EX CLINICAL 7852 05:30:25,600 --> 05:30:26,880 RESEARCH AND SOME FIELDS OF 7853 05:30:26,880 --> 05:30:28,440 RESEARCH AND IT WAS EASIER TO 7854 05:30:28,440 --> 05:30:30,240 KEEP THE RESEARCH GOING AND IT 7855 05:30:30,240 --> 05:30:32,480 WASN'T EASY FOR ANYONE BUT IT 7856 05:30:32,480 --> 05:30:36,840 WAS MORE DIFFICULT FOR SOME 7857 05:30:36,840 --> 05:30:40,400 PEOPLE AND DESPITE THE REPORTS 7858 05:30:40,400 --> 05:30:42,440 THAT WE SEE IN THIS THE 7859 05:30:42,440 --> 05:30:43,880 LITERATURE ABOUT PUBLISHING 7860 05:30:43,880 --> 05:30:46,240 RATES, WOMEN BEING FEWER, FIRST 7861 05:30:46,240 --> 05:30:47,920 FEW WOMEN BEING FIRST AUTHOR AND 7862 05:30:47,920 --> 05:30:51,240 SENIOR AUTHOR WHEN WE LOOK AT 7863 05:30:51,240 --> 05:30:52,080 THE APPLICATION RATES AND 7864 05:30:52,080 --> 05:30:55,360 RECOGNIZING THAT IS A VERY 7865 05:30:55,360 --> 05:31:02,840 SPECIFIC PART OF THE ECOSYSTEM. 7866 05:31:02,840 --> 05:31:05,680 FOR APPLICATIONS PUBLISHED BY 7867 05:31:05,680 --> 05:31:09,240 MIKE AND MAUREEN ON THE OPEN MIC 7868 05:31:09,240 --> 05:31:10,440 BLOG AND SO HOWEVER THE 7869 05:31:10,440 --> 05:31:11,760 ECOSYSTEM IS CHANGING AND I 7870 05:31:11,760 --> 05:31:13,120 THINK THAT IT'S IMPORTANT FOR US 7871 05:31:13,120 --> 05:31:14,840 TO UNDERSTAND ALL OF THESE FORCE 7872 05:31:14,840 --> 05:31:18,360 AND DO OUR BEST TO HAVE SUPPORT 7873 05:31:18,360 --> 05:31:20,520 INCLUSIVE EXCELLENCE BECAUSE WE 7874 05:31:20,520 --> 05:31:22,080 KNOTS TEST BEST FOR OUR SCIENCE. 7875 05:31:22,080 --> 05:31:26,800 THANK YOU FOR THOSE COMMENTS. 7876 05:31:26,800 --> 05:31:27,400 >>Samia Noursi: Dr. HIGGINS 7877 05:31:27,400 --> 05:31:28,960 HAS A COMMENT IN THE CHAT. 7878 05:31:28,960 --> 05:31:32,640 >>YES, I JUST WANTED TO CONQUER 7879 05:31:32,640 --> 05:31:43,720 TO CONCUR,IT'S BEEN A WONDERFUL. 7880 05:31:45,400 --> 05:31:46,680 IT'S BEEN MENTIONED BUT THE 7881 05:31:46,680 --> 05:31:48,920 IMPORTANCE OF THE ADVOCACY FOR 7882 05:31:48,920 --> 05:31:51,720 IMPLEMENTATION OF EVIDENCE BASED 7883 05:31:51,720 --> 05:31:53,120 INTERVENTIONS AND I KNOW IN MY 7884 05:31:53,120 --> 05:31:58,400 OWN FIELD, IT CAN BE STAGGERING 7885 05:31:58,400 --> 05:31:59,800 HOW OFTEN COMMUNITY CLINICS ARE 7886 05:31:59,800 --> 05:32:01,720 NOT USING EVIDENCE BASED 7887 05:32:01,720 --> 05:32:03,280 TREATMENTS, I DOUBT THAT IT'S 7888 05:32:03,280 --> 05:32:04,920 SPECIFIC TO ADDICTIONS AND IT 7889 05:32:04,920 --> 05:32:12,600 MAY BE MORE COMMON BUT THE OTHER 7890 05:32:12,600 --> 05:32:14,280 THING THAT COMES TO MIND IN THIS 7891 05:32:14,280 --> 05:32:16,400 AREA IS THAT I THINK THERE'S A 7892 05:32:16,400 --> 05:32:20,760 ROLE FOR NIH TO DO MORE ADVOCACY 7893 05:32:20,760 --> 05:32:25,440 THAN PERHAPS AS COMMON AND IT 7894 05:32:25,440 --> 05:32:27,280 ESPECIALLY FOR POPULATIONS OR 7895 05:32:27,280 --> 05:32:28,960 CONDITIONS THAT ARE OVER 7896 05:32:28,960 --> 05:32:30,640 REPRESENTED AND DISADVANTAGED 7897 05:32:30,640 --> 05:32:31,840 POPULATIONS AND BECAUSE THEY 7898 05:32:31,840 --> 05:32:34,480 DON'T HAVE THE LEVEL OF ADVOCACY 7899 05:32:34,480 --> 05:32:39,600 AND THE COMMUNITY THAT AFFLUENT 7900 05:32:39,600 --> 05:32:42,360 POPULATIONS DO OR PATIENTS. 7901 05:32:42,360 --> 05:32:45,280 AND IT COULD RELATE TO A LITTLE 7902 05:32:45,280 --> 05:32:47,920 BIT AT LEAST TO THE POINT THAT 7903 05:32:47,920 --> 05:32:50,200 Dr. JONES BROUGHT UP ABOUT US 7904 05:32:50,200 --> 05:32:52,920 DOING SOME POORLY WITH MATERNAL 7905 05:32:52,920 --> 05:32:54,840 MORTALITY AND I'LL GIVE YOU ONE 7906 05:32:54,840 --> 05:32:57,720 EXAMPLE, WE'VE BEEN WORKING ON 7907 05:32:57,720 --> 05:33:00,800 SMOKING CESSATION IN PREGNANCY 7908 05:33:00,800 --> 05:33:03,680 FOR 20 YEARS AND THERE'S A 7909 05:33:03,680 --> 05:33:05,000 PARTICULAR INTERCEPTIONS THAT 7910 05:33:05,000 --> 05:33:06,560 WORKS WELL THAT INVOLVES 7911 05:33:06,560 --> 05:33:08,160 FINANCIAL INCENTIVES WHICH CAN 7912 05:33:08,160 --> 05:33:11,640 BE A LITTLE CONTROVERSIAL BUT 7913 05:33:11,640 --> 05:33:14,040 THERE'S A COLLEAGUE IN FRANCE 7914 05:33:14,040 --> 05:33:16,680 WHO GOT ON TO THIS APPROACH JUST 7915 05:33:16,680 --> 05:33:19,080 SEVERAL YEARS AGO AND DID A 7916 05:33:19,080 --> 05:33:20,680 MULTI-SITE TRIAL AND I GOT AN 7917 05:33:20,680 --> 05:33:22,160 E-MAIL FROM HIM THAT FRANCE IS 7918 05:33:22,160 --> 05:33:25,120 GOING FORWARD WITH NATIONAL 7919 05:33:25,120 --> 05:33:25,480 IMPLEMENTATION. 7920 05:33:25,480 --> 05:33:27,000 HE WAS CHECKING IN WITH ME TO 7921 05:33:27,000 --> 05:33:29,640 SEE HOW WE'RE DOING IN THE U.S. 7922 05:33:29,640 --> 05:33:31,480 AND SADLY I HAD TO SAY, THERE'S 7923 05:33:31,480 --> 05:33:35,760 NOTHING THAT I KNOW OF THAT'S 7924 05:33:35,760 --> 05:33:41,640 EVEN CLOSE TO IMPLEMENTATION 7925 05:33:41,640 --> 05:33:42,560 EVEN IN THE HOME STATE. 7926 05:33:42,560 --> 05:33:45,000 I ONLY BRING IT UP TO YOU 7927 05:33:45,000 --> 05:33:49,280 BECAUSE I THINK THAT YOUR 7928 05:33:49,280 --> 05:33:52,080 ADVOCACY COULD BE IMPACTFUL. 7929 05:33:52,080 --> 05:33:52,480 SO, YEAH. 7930 05:33:52,480 --> 05:33:54,280 >>THANK YOU FOR YOUR FEEDBACK. 7931 05:33:54,280 --> 05:33:55,720 A COUPLE THINGS, SO REGARDING 7932 05:33:55,720 --> 05:33:57,520 UNDER REPRESENTED RACIAL AND 7933 05:33:57,520 --> 05:34:08,000 ETHNIC MINORITY POPULATIONS -- 7934 05:35:33,000 --> 05:35:35,280 >>AND SO, IT IS A CONFLICT 7935 05:35:35,280 --> 05:35:40,880 ECOSYSTEM AND I APPRECIATE THE 7936 05:35:40,880 --> 05:35:42,160 ATTENTION BECAUSE THE GOAL OF 7937 05:35:42,160 --> 05:35:44,040 TRYING DISCOVERY INTO HEALTH IS 7938 05:35:44,040 --> 05:35:50,600 DEPEND AN ON THAT LAST STEP OF 7939 05:35:50,600 --> 05:35:52,600 CARE SO WE WANT TO CREATE NEW 7940 05:35:52,600 --> 05:35:53,800 KNOWLEDGE SO WE CAN BE APPLIED 7941 05:35:53,800 --> 05:35:55,600 AND WE CAN PREVENT RESULTS SO 7942 05:35:55,600 --> 05:36:05,280 THANK YOU SO MUCH FOR THAT. 7943 05:36:05,280 --> 05:36:05,960 OTHER QUESTIONS. 7944 05:36:05,960 --> 05:36:10,240 >>I JUST PUT THAT LINK TO THE 7945 05:36:10,240 --> 05:36:11,560 REPORT THAT Dr. CLAYTON 7946 05:36:11,560 --> 05:36:13,200 MENTIONED ABOUT MATERNAL 7947 05:36:13,200 --> 05:36:15,480 MORBIDITY THAT IS PART OF THE 7948 05:36:15,480 --> 05:36:18,040 WORKED ON WITH OUR OFFICE OF DIS 7949 05:36:18,040 --> 05:36:22,120 SEE PREVENTION AT THE NIH SO 7950 05:36:22,120 --> 05:36:23,280 THAT DATE FOR ACCEPTING COMMENTS 7951 05:36:23,280 --> 05:36:26,480 IS COMING UP ON APRIL 21 SO 7952 05:36:26,480 --> 05:36:28,800 FOLLOW THE LINK AND I'M SURE 7953 05:36:28,800 --> 05:36:37,160 THEY WILL BE VERY HAPPY TO I'M 7954 05:36:37,160 --> 05:36:41,400 NOT SURE IF SHE WANTS TO SAY IT 7955 05:36:41,400 --> 05:36:51,520 BUT FELL FREE TO PUT IT ON MUTE. 7956 05:36:51,520 --> 05:36:56,240 >>AND I HAVE ANY HERE AND I 7957 05:36:56,240 --> 05:36:58,480 PROMISE. 7958 05:36:58,480 --> 05:37:00,320 >>IT'S A JOKE. 7959 05:37:00,320 --> 05:37:04,840 IMPLEMENTATION SCIENCE AND YOU 7960 05:37:04,840 --> 05:37:06,440 SAID IT AND IT'S IMPORTANT WHEN 7961 05:37:06,440 --> 05:37:08,560 YOU SEE THIS AT THE U IS SPTF 7962 05:37:08,560 --> 05:37:11,120 AND NOW THE CDC COMMUNITY 7963 05:37:11,120 --> 05:37:12,560 PREVENTION SERVICES TASK FORCE, 7964 05:37:12,560 --> 05:37:16,400 AND ON THE GROUPED 7965 05:37:16,400 --> 05:37:18,880 IMPLEMENTATION LEVEL IS DUMPED 7966 05:37:18,880 --> 05:37:20,520 THAT WE DON'T KNOW HOW TO TAKE A 7967 05:37:20,520 --> 05:37:22,200 PACKAGE PROGRAM AND PUT IT IN 7968 05:37:22,200 --> 05:37:23,960 THE GROUND AND EVIDENCE BASED 7969 05:37:23,960 --> 05:37:25,520 GROUPED IS PUT IT INTO A 7970 05:37:25,520 --> 05:37:26,560 CLINICAL CARE WORKFLOW EASILY 7971 05:37:26,560 --> 05:37:28,960 AND AS MUCH AS IT SEEMS EASY TO 7972 05:37:28,960 --> 05:37:31,240 DO THAT'S WHY WE NEED TO REALLY 7973 05:37:31,240 --> 05:37:32,680 THINK ABOUT INNOVATING THE 7974 05:37:32,680 --> 05:37:34,680 SCIENCE OF IMPLEMENTATION 7975 05:37:34,680 --> 05:37:36,800 SCIENCE AND WHAT ARE DIFFERENT 7976 05:37:36,800 --> 05:37:38,040 IMPLEMENTATIONS STRATEGIES AND 7977 05:37:38,040 --> 05:37:40,040 HOW TO BEST DO THAT MAKES IT 7978 05:37:40,040 --> 05:37:42,040 WORK FOR DIFFERENT CLINICAL CARE 7979 05:37:42,040 --> 05:37:43,480 AND COMMUNITIES SETTINGS. 7980 05:37:43,480 --> 05:37:47,200 LIKE SOME OF THIS CIGARETTES 7981 05:37:47,200 --> 05:37:48,520 SMOKING CESSATION FOR PREGNANT 7982 05:37:48,520 --> 05:37:50,160 PERSONS COULD POTENTIALLY BE 7983 05:37:50,160 --> 05:37:52,800 EFFECTIVE IN THE LIBRARY SETTING 7984 05:37:52,800 --> 05:37:55,280 FOR EXAMPLE, DARE I SAY. 7985 05:37:55,280 --> 05:37:57,480 THERE ARE SO MANY OPPORTUNITIES 7986 05:37:57,480 --> 05:38:00,560 FOR PLACES AND SPACES TO ADVANCE 7987 05:38:00,560 --> 05:38:01,960 IMPLEMENTATION SCIENCE IN REALLY 7988 05:38:01,960 --> 05:38:06,600 IMPROVING HOW IMPLEMENT WORKS OF 7989 05:38:06,600 --> 05:38:09,800 IDIs THAT ARE LONG STANDING. 7990 05:38:09,800 --> 05:38:10,480 >>Samia Noursi: THAT'S ALSO I 7991 05:38:10,480 --> 05:38:13,160 WANT TO REMIND EVERYONE OF GOAL 7992 05:38:13,160 --> 05:38:14,840 FIVE OF THE NEW STRATEGIC PLAN 7993 05:38:14,840 --> 05:38:16,240 THAT FOCUSES ON. 7994 05:38:16,240 --> 05:38:20,880 SO I JUST WANT TO BRING THAT UP 7995 05:38:20,880 --> 05:38:22,800 AGAIN. 7996 05:38:22,800 --> 05:38:27,560 JONI RUTTER TALKED ABOUT SMOKING 7997 05:38:27,560 --> 05:38:30,520 CESSATION WITH A BREAST FEEDING 7998 05:38:30,520 --> 05:38:31,800 INTERCEPTIONS. 7999 05:38:31,800 --> 05:38:33,160 YOU SAW THAT Dr. HIGGINS? 8000 05:38:33,160 --> 05:38:34,320 >>YES I DID. 8001 05:38:34,320 --> 05:38:35,640 I MADE A NOTE OF THAT. 8002 05:38:35,640 --> 05:38:38,200 >>I WILL MAKE SURE WE FOLLOW-UP 8003 05:38:38,200 --> 05:38:42,400 WITH JANUA JONI ON THAT AND GIVA 8004 05:38:42,400 --> 05:38:43,160 FOLLOW-UP IN THE FUTURE. 8005 05:38:43,160 --> 05:38:46,800 I HOPE WE ALSO WOULD LOVE YOUR 8006 05:38:46,800 --> 05:38:49,000 FEEDBACK ON THE AGENDA THAT'S WE 8007 05:38:49,000 --> 05:38:50,560 CREATE FOR YOU IF THERE ARE 8008 05:38:50,560 --> 05:38:51,640 SPECIFIC TOPICS YOU WANT TO HEAR 8009 05:38:51,640 --> 05:38:52,800 MORE ABOUT OR A PARTICULAR 8010 05:38:52,800 --> 05:38:53,880 INSTITUTE DIRECTOR THAT YOU'D 8011 05:38:53,880 --> 05:38:56,480 LIKE TO HEAR FROM IN THE FUTURE 8012 05:38:56,480 --> 05:38:59,360 AND SINCE Dr. NOURSI HAS BEEN 8013 05:38:59,360 --> 05:39:01,920 EXECUTIVE SECRETARY WHICH WAS I 8014 05:39:01,920 --> 05:39:03,480 ASKED HER TO DO IT FOR A YEAR 8015 05:39:03,480 --> 05:39:07,000 AND IT'S BEEN MUCH MORE THAN A 8016 05:39:07,000 --> 05:39:11,320 YEAR, WE'VE DONE AT LEAST -- 8017 05:39:11,320 --> 05:39:14,200 >>Samia Noursi: SIX MEETINGS, I 8018 05:39:14,200 --> 05:39:14,720 COUNTED. 8019 05:39:14,720 --> 05:39:15,560 >>Janine A. Clayton: AT LEAST 8020 05:39:15,560 --> 05:39:17,600 SEVEN IC DIRECTORS AND WE MIGHT 8021 05:39:17,600 --> 05:39:19,240 NOT HAVE GOT IT ON THE FIRST ONE 8022 05:39:19,240 --> 05:39:20,160 SO WE'RE GOING THROUGH ALL THE 8023 05:39:20,160 --> 05:39:22,280 THE IC DIRECTORS BUT THERE'S 8024 05:39:22,280 --> 05:39:24,200 SOMETHING THAT YOU WANT TO HEAR 8025 05:39:24,200 --> 05:39:26,240 ABOUT AND ISSUE, PLEASE LET US 8026 05:39:26,240 --> 05:39:29,880 KNOWS AND ANYTHING COME TO MIND 8027 05:39:29,880 --> 05:39:30,720 NOW? 8028 05:39:30,720 --> 05:39:31,920 PARTICULAR TOPIC OR INSTITUTE 8029 05:39:31,920 --> 05:39:33,800 THAT YOU WANT TO HEAR ABOUT IN 8030 05:39:33,800 --> 05:39:39,760 THE FUTURE PLEASE LET US KNOW. 8031 05:39:39,760 --> 05:39:40,480 >>Samia Noursi: IF YOU WOULD 8032 05:39:40,480 --> 05:39:42,040 LIKE ANY ADDITIONAL INFORMATION 8033 05:39:42,040 --> 05:39:44,280 THAT WE SENT YOU, YOU ALL 8034 05:39:44,280 --> 05:39:46,120 RECEIVED E-MAILS FROM US ON THE 8035 05:39:46,120 --> 05:39:47,240 BEGINNING OF EVERY MONTH AND 8036 05:39:47,240 --> 05:39:49,800 SOMETIMES ON THE SECOND IF IT'S 8037 05:39:49,800 --> 05:39:51,480 ON A SUNDAY WE TRY NOT TO 8038 05:39:51,480 --> 05:40:00,320 ACCEPTED US OIR NEWS LET ARE ONA 8039 05:40:00,320 --> 05:40:00,840 SUNDAY. 8040 05:40:00,840 --> 05:40:02,600 IF YOU NEED ANYTHING, ACCEPTED 8041 05:40:02,600 --> 05:40:05,160 US AN E-MAIL AND WE'LL BE HAPPY 8042 05:40:05,160 --> 05:40:06,520 TO DISCUSS IT WITH Dr. CLAYTON 8043 05:40:06,520 --> 05:40:09,440 >>Janine A. Clayton: ABSOLUTELY 8044 05:40:09,440 --> 05:40:09,600 . 8045 05:40:09,600 --> 05:40:12,560 AND I HOPE THOSE E-MAILS THAT 8046 05:40:12,560 --> 05:40:14,360 ARE HELPFUL TO KEEP YOU 8047 05:40:14,360 --> 05:40:15,560 UP-TO-DATE ON OUR ACTIVITIES ON 8048 05:40:15,560 --> 05:40:17,800 A MONTH TO MONTH BASIS SO WHEN 8049 05:40:17,800 --> 05:40:20,240 YOU COME TO MEET WITH US TWICE A 8050 05:40:20,240 --> 05:40:21,800 YEAR, YOU KNOW, I ALWAYS HAVE 8051 05:40:21,800 --> 05:40:26,840 MORE THAN I CAN TELL YOU IN MY 8052 05:40:26,840 --> 05:40:27,880 DIRECTOR'S REPORT THAN I HAVE 8053 05:40:27,880 --> 05:40:30,040 TIME TO CONVEY AND SOMETIMES 8054 05:40:30,040 --> 05:40:31,080 IT'S DIFFICULT TO LEAVE A PIECE 8055 05:40:31,080 --> 05:40:32,880 OF THAT INFORMATION OUT BUT IF 8056 05:40:32,880 --> 05:40:33,520 APPROXIMATE THERE'S INFORMATION 8057 05:40:33,520 --> 05:40:34,880 THAT YOU WANT TO HEAR ABOUT, 8058 05:40:34,880 --> 05:40:39,920 PLEASE DO LET US KNOW. 8059 05:40:39,920 --> 05:40:41,920 >>Samia Noursi: I THINK WE ARE 8060 05:40:41,920 --> 05:40:43,200 ALREADY, YOU CAN PLAN FOR THE 8061 05:40:43,200 --> 05:40:48,640 OTH MEETING TO BE VIRTUAL AGAIN. 8062 05:40:48,640 --> 05:40:49,200 >>Janine A. Clayton: YES, 8063 05:40:49,200 --> 05:40:49,720 THAT'S OUR PLAN. 8064 05:40:49,720 --> 05:40:50,320 >>Samia Noursi: THAT'S THE 8065 05:40:50,320 --> 05:40:51,960 PLAN. 8066 05:40:51,960 --> 05:40:54,760 UNLESS WE RECEIVE OTHER 8067 05:40:54,760 --> 05:40:55,000 GUIDANCE. 8068 05:40:55,000 --> 05:40:55,600 >>Janine A. Clayton: IF YOU 8069 05:40:55,600 --> 05:40:57,040 HAVE STRONG FEELINGS ABOUT THAT 8070 05:40:57,040 --> 05:41:05,560 LET US KNOW AS WELL. 8071 05:41:05,560 --> 05:41:07,000 Dr. NOURSI THERE'S NOTHING 8072 05:41:07,000 --> 05:41:08,400 WRONG WITH ENDING EARLY AND 8073 05:41:08,400 --> 05:41:09,600 GIVING OUR COLLEAGUES THE GIFT 8074 05:41:09,600 --> 05:41:10,880 OF TIME. 8075 05:41:10,880 --> 05:41:13,440 WE ALL APPRECIATE THAT. 8076 05:41:13,440 --> 05:41:17,680 IT'S BEEN A BUSY DAY. 8077 05:41:17,680 --> 05:41:18,920 THERE'S A LOT HAPPENING TODAY 8078 05:41:18,920 --> 05:41:20,800 BESIDES WHICH WE'RE DOING WHICH 8079 05:41:20,800 --> 05:41:22,480 WE THINK VERY IMPORTANT TOO. 8080 05:41:22,480 --> 05:41:27,480 I AM NOT SEEING -- THANK YOU FOR 8081 05:41:27,480 --> 05:41:29,840 FEEDBACK AND I PUT THE LINKS TO 8082 05:41:29,840 --> 05:41:31,040 THE DATA FROM MY SLIDE AND YOU 8083 05:41:31,040 --> 05:41:32,640 ARE GOING TO GET ALL THE SLIDES 8084 05:41:32,640 --> 05:41:33,600 AVAILABLE TO YOU SO YOU WILL 8085 05:41:33,600 --> 05:41:35,640 HAVE THAT INFORMATION AND THANK 8086 05:41:35,640 --> 05:41:38,880 YOU FOR THE FEEDBACK. 8087 05:41:38,880 --> 05:41:41,480 AND WITH THAT, SARAH AND SAMIA 8088 05:41:41,480 --> 05:41:43,560 ARE THERE ANY OTHER ITEMS WE 8089 05:41:43,560 --> 05:41:46,160 NEED TO COVER BEFORE WE ADJOURN? 8090 05:41:46,160 --> 05:41:46,920 >>Samia Noursi: BUT JUST A 8091 05:41:46,920 --> 05:41:49,720 COMMENT FROM Dr. TEMPLETON 8092 05:41:49,720 --> 05:41:55,120 IT'S HEAR FROM NIADS AND I 8093 05:41:55,120 --> 05:41:56,760 THOUGHT WE HAD Dr. -- 8094 05:41:56,760 --> 05:41:57,840 >>Janine A. Clayton: WE DID, 8095 05:41:57,840 --> 05:41:58,680 YES. 8096 05:41:58,680 --> 05:42:00,320 YOU KNOW KIM YOU WERE IN THE 8097 05:42:00,320 --> 05:42:02,120 O.R. AT THE LAST MEETING AND YOU 8098 05:42:02,120 --> 05:42:05,040 COULD ONLY JOIN FOR A FEW 8099 05:42:05,040 --> 05:42:06,840 MINUTES AND Dr. CRISWELL 8100 05:42:06,840 --> 05:42:08,200 PRESENTED IF THE MORNING AND YOU 8101 05:42:08,200 --> 05:42:12,960 WERE IN THE O.R. IF I REMEMBER 8102 05:42:12,960 --> 05:42:13,280 CORRECTLY. 8103 05:42:13,280 --> 05:42:13,920 >>OKAY. 8104 05:42:13,920 --> 05:42:15,080 >>Samia Noursi: WE'LL BE HAPPY 8105 05:42:15,080 --> 05:42:17,920 TO DIRECT YOU TO THE REPORT IF 8106 05:42:17,920 --> 05:42:19,320 YOU CAN LISTEN TO OUR 8107 05:42:19,320 --> 05:42:21,280 PRESENTATION AND WE'LL BE HAPPY 8108 05:42:21,280 --> 05:42:24,600 TO FOLLOW-UP WITH YOU ON THAT. 8109 05:42:24,600 --> 05:42:25,280 >>Janine A. Clayton: ALL OF THE 8110 05:42:25,280 --> 05:42:26,480 MEETINGS ARE VIDEO CAST AND YOU 8111 05:42:26,480 --> 05:42:28,280 CAN LOOK AT THEM AND GET ACCESS 8112 05:42:28,280 --> 05:42:30,520 TO SLIDES AND CONTENT SO WE'LL 8113 05:42:30,520 --> 05:42:34,280 PROVIDE THAT FOR YOU, KIM, NO 8114 05:42:34,280 --> 05:42:34,640 PROBLEM. 8115 05:42:34,640 --> 05:42:36,880 WITH THAT I WANT TO DEFINITELY 8116 05:42:36,880 --> 05:42:42,840 ACKNOWLEDGE ALL OF THE AMAZING 8117 05:42:42,840 --> 05:42:43,600 WORK DONE THAT YOU HEARD ABOUT 8118 05:42:43,600 --> 05:42:44,080 TODAY. 8119 05:42:44,080 --> 05:42:46,280 THE COMMUNICATIONS SUPPORT, 8120 05:42:46,280 --> 05:42:47,920 LOGISTICAL SUPPORT PROJECT 8121 05:42:47,920 --> 05:42:49,600 MANAGEMENT SUPPORT, PROGRAM 8122 05:42:49,600 --> 05:42:51,880 SUPPORT, EXECUTIVE ASSISTANCE, 8123 05:42:51,880 --> 05:42:53,200 EVERYTHING, WE CAN'T DO ANYTHING 8124 05:42:53,200 --> 05:42:55,680 OF THIS WITHOUT OUR AMAZING 8125 05:42:55,680 --> 05:42:56,960 COLLEAGUES WHO HELP US DO IT AND 8126 05:42:56,960 --> 05:42:57,960 KEEP US ON TRACK. 8127 05:42:57,960 --> 05:42:59,400 THANK YOU VERY MUCH TO ALL OF 8128 05:42:59,400 --> 05:43:01,400 THEM INCLUDING OUR 8129 05:43:01,400 --> 05:43:03,480 COMMUNICATIONS SUPPORT AND OUR 8130 05:43:03,480 --> 05:43:05,040 PARTNERS ACROSS THE NIH 8131 05:43:05,040 --> 05:43:06,120 INSTITUTES AND CENTERS. 8132 05:43:06,120 --> 05:43:08,520 AS YOU VERY WELL KNOW, WOMEN'S 8133 05:43:08,520 --> 05:43:09,680 HEALTH RESEARCH IS BEING 8134 05:43:09,680 --> 05:43:11,600 CONDUCTED BY ALL OF THOSE 8135 05:43:11,600 --> 05:43:14,200 INSTITUTES AND CENTERS AND IT IS 8136 05:43:14,200 --> 05:43:15,880 IMPORTANT TO CONNECT THE DOTS 8137 05:43:15,880 --> 05:43:17,040 BETWEEN THOSE INSTITUTES AND 8138 05:43:17,040 --> 05:43:19,440 CENTERS AND THAT'S PART OF ROLE 8139 05:43:19,440 --> 05:43:21,200 THAT WE PLAY AS WELL AS 8140 05:43:21,200 --> 05:43:23,320 ELEVATING AND PRIORITIZING 8141 05:43:23,320 --> 05:43:25,320 SPECIFIC TOPICS WHICH ARE AGAIN 8142 05:43:25,320 --> 05:43:27,120 YOU PLAY A CRITICAL ROLE IN 8143 05:43:27,120 --> 05:43:28,720 HELPING UP IDENTIFY WHICH ARE 8144 05:43:28,720 --> 05:43:31,360 THOSE TOPICS WE NEED TO ELEVATE 8145 05:43:31,360 --> 05:43:32,840 AND MAKE ON THE RADAR SCREEN AND 8146 05:43:32,840 --> 05:43:35,760 I HAVE TO SAY, WE WERE VERY 8147 05:43:35,760 --> 05:43:38,240 EFFECTIVE IN GETTING ATTENTION 8148 05:43:38,240 --> 05:43:41,920 TO MORTALITY AT NIH AND A LOT 8149 05:43:41,920 --> 05:43:43,640 THAT HAVE CAME FROM INDIVIDUALS 8150 05:43:43,640 --> 05:43:46,800 ON OUR ADVISORY COMMITTEE AS 8151 05:43:46,800 --> 05:43:48,520 WELL AS IN ORWH AND NIH. 8152 05:43:48,520 --> 05:43:50,520 SO WE TRY TO WORK VERY 8153 05:43:50,520 --> 05:43:51,560 EFFECTIVELY WITH OUR INSTITUTE 8154 05:43:51,560 --> 05:43:53,640 AND CENTER PARTNERS AND I WANTED 8155 05:43:53,640 --> 05:43:55,440 TO ACKNOWLEDGE THEIR 8156 05:43:55,440 --> 05:43:57,120 CONTRIBUTION TO THE THINK TANKS 8157 05:43:57,120 --> 05:43:59,320 AS CO-CHAIRS AS PARTICIPANTS AND 8158 05:43:59,320 --> 05:44:01,920 AS THOUGHT PARTNERS AND TO OUR 8159 05:44:01,920 --> 05:44:02,840 COORDINATING COMMITTEE ON 8160 05:44:02,840 --> 05:44:04,520 RESEARCH ON WOMEN'S HEALTH WHERE 8161 05:44:04,520 --> 05:44:06,560 WE PRESENT A LOT OF IDEAS AND 8162 05:44:06,560 --> 05:44:07,760 HEAR SCIENTIFIC PRESENTATION AND 8163 05:44:07,760 --> 05:44:12,480 I WANT TO ACKNOWLEDGE OUR CWPT 8164 05:44:12,480 --> 05:44:13,400 AND WE HAVE SEVERAL WORKING 8165 05:44:13,400 --> 05:44:17,680 GROUP ON THAT BODY NOW TOO. 8166 05:44:17,680 --> 05:44:20,160 SOUND WITH THAT, I WOULD ALSO 8167 05:44:20,160 --> 05:44:22,520 THANK ALL OF THOSE WHO PRESENTED 8168 05:44:22,520 --> 05:44:23,640 TODAY. 8169 05:44:23,640 --> 05:44:24,800 FOR OUT STANDING PRESENTATIONS, 8170 05:44:24,800 --> 05:44:35,320 INTERESTING TOPICS, AND BEING 8171 05:44:41,720 --> 05:44:43,320 EXPANDED AND ENHANCES AND 8172 05:44:43,320 --> 05:44:46,680 IMPROVED HERE AT NIH AND WE HAVE 8173 05:44:46,680 --> 05:44:48,720 OF ORWH I WANT TO THANK ALL OF 8174 05:44:48,720 --> 05:44:50,200 YOU AND THANK YOU TO THOSE OF 8175 05:44:50,200 --> 05:44:51,840 YOU WHO HAVE ATTENDED VIRTUALLY 8176 05:44:51,840 --> 05:44:53,240 AND WE LOOK FORWARD TO SEEING 8177 05:44:53,240 --> 05:44:55,240 YOU AT THE 59th MEETING OF THE 8178 05:44:55,240 --> 05:44:59,160 ADVISORY COMMITTEE AND ON 8179 05:44:59,160 --> 05:45:01,760 OCTOBER 18th 2023 AND I WANT 8180 05:45:01,760 --> 05:45:04,480 TO END WITH SPECIAL THANKS TO 8181 05:45:04,480 --> 05:45:06,440 Dr. SAMMY AND Ms. SARAH HAIL 8182 05:45:06,440 --> 05:45:10,440 MAN AND Mr. ERIC BEHIND THE 8183 05:45:10,440 --> 05:45:11,560 SCENES AND EVERYONE ELSE HYPED 8184 05:45:11,560 --> 05:45:13,040 THE SCENES HELP US CREATE 8185 05:45:13,040 --> 05:45:14,800 TODAY'S MEETING FOR YOU AND STAY 8186 05:45:14,800 --> 05:45:17,080 SAFE AND HEALTHY AND TODAY'S 8187 05:45:17,080 --> 05:45:17,800 MEETING IS NOW ADJOURNED. 8188 05:45:17,800 --> 05:45:18,840 THANK YOU VERY MUCH. 8189 05:45:18,840 --> 05:45:20,400 >>Samia Noursi: BY, EVERYONE.